sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,0.5,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Is loss of consciousness an indicator of neuropsychological impairments after a concussion? Answer: Evidence indicates that loss of consciousness could predict neuropsychological deficits post-concussion, but more research is necessary to clarify this relationship.",2.1317375462116791e-07,0.2591658796885761,0.012853798126951067,0.016320838183036875,0.2573458051012891,0.006842481789802304,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
0,0.5,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Can loss of consciousness forecast neuropsychological decline following a concussion? Answer: Some evidence suggests loss of consciousness might predict neuropsychological impairments after concussion, although additional studies are required to fully comprehend the connection.",2.1317375462116791e-07,0.2591658796885761,0.012853798126951067,0.016320838183036875,0.2573458051012891,0.006842481789802304,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
0,0.5,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Does experiencing loss of consciousness signal neuropsychological problems after a concussion? Answer: There is some evidence that loss of consciousness may be linked to neuropsychological deficits post-concussion, yet further investigation is needed to understand the association.",1.42115836414112e-07,0.16515301602662324,0.00786332179930796,0.010880558788691236,0.1640203579443158,0.0041717128027681585,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
0,0.5,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Is loss of consciousness a predictor of neuropsychological deficits after concussion? Answer: Research suggests that loss of consciousness might predict neuropsychological impairments following concussion, but more research is needed to confirm this link.",2.1317375462116791e-07,0.2591658796885761,0.012853798126951067,0.016320838183036875,0.2573458051012891,0.006842481789802304,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
0,0.5,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Does losing consciousness indicate neuropsychological decline after a concussion? Answer: Evidence points to loss of consciousness as a possible predictor of neuropsychological deficits post-concussion; however, further research is essential to fully understand this relationship.",1.8948778188548261e-07,0.1452950764710219,0.047500000000000014,0.014507411718254995,0.18325244764953785,0.024375,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
0,0.5,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Can loss of consciousness predict neuropsychological impairments after a concussion? Answer: There is evidence supporting the idea that loss of consciousness may forecast neuropsychological deficits after concussion, but further studies are required to clarify the relationship.",1.42115836414112e-07,0.16515301602662324,0.00786332179930796,0.010880558788691236,0.1640203579443158,0.0041717128027681585,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
0,0.5,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Is there a connection between loss of consciousness and neuropsychological deficits after concussion? Answer: Evidence suggests loss of consciousness might be associated with neuropsychological impairments following concussion, though additional research is necessary to fully understand this link.",1.1842986367842671e-07,0.13567251877376396,0.006377551020408163,0.009067132323909363,0.13474924735768257,0.003380102040816329,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
0,0.5,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Does loss of consciousness serve as a predictor for neuropsychological issues after concussion? Answer: Some evidence indicates that loss of consciousness could predict neuropsychological deficits post-concussion, but more research is needed to establish the relationship.",1.6580180914979731e-07,0.19552436023319242,0.00943296602387509,0.012693985253473115,0.1941728480622058,0.005009756657483936,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
0,0.5,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Is loss of consciousness linked to neuropsychological impairments after a concussion? Answer: There is evidence to suggest a connection between loss of consciousness and neuropsychological deficits after concussion; however, further research is needed to fully understand this.",1.1842986367842671e-07,0.13567251877376396,0.006377551020408163,0.009067132323909363,0.13474924735768257,0.003380102040816329,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
0,0.5,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Can loss of consciousness be used to predict neuropsychological deficits following a concussion? Answer: Evidence shows that loss of consciousness may predict neuropsychological impairments after concussion, but more research is required to comprehend the relationship entirely.",1.42115836414112e-07,0.2036611927243981,0.03514462809917353,0.010880558788691236,0.1640203579443158,0.0041717128027681585,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
1,0.5,1,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy feasible? Answer: Transgastric endoscopic splenectomy is a minimally invasive technique that removes the spleen via the stomach.,4.73719454713706e-08,0.1627261447233197,0.05079439573269843,0.003626852929563759,0.16462489786031975,0.049861495844875335,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,0.5,2,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Can transgastric endoscopic splenectomy be performed? Answer: This procedure is a minimally invasive method to extract the spleen through the stomach.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,0.5,3,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is it possible to do a transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy involves minimally invasive removal of the spleen through the stomach.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1,0.5,4,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,"Question: Can spleen removal be done via transgastric endoscopic splenectomy? Answer: Yes, it is a minimally invasive procedure that removes the spleen through the stomach.",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.5,5,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy a viable option? Answer: It is a minimally invasive surgery that extracts the spleen through the stomach.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,0.5,6,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is it feasible to perform a transgastric endoscopic splenectomy? Answer: This is a minimally invasive technique where the spleen is removed through the stomach.,2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.5,7,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Can the spleen be removed using transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that removes the spleen through the stomach.,4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
1,0.5,8,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy possible? Answer: It is a minimally invasive procedure involving spleen removal through the stomach.,1.1842986367842666e-07,0.18484879015820654,0.04338842975206613,0.009067132323909394,0.25782910930209946,0.0,0.009054007704764364,0.27193371548364054,0.0,1.1842986367842677e-07,0.2876820724517799,0.0
1,0.5,9,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is the procedure of transgastric endoscopic splenectomy achievable? Answer: This minimally invasive surgery removes the spleen by accessing it through the stomach.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,0.5,10,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy a possible surgical method? Answer: It is a minimally invasive approach that extracts the spleen through the stomach.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
2,0.5,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Does blood pressure vary in treated hypertensive patients based on whether a physician or a nurse takes the measurement? There might be minor differences in blood pressure readings between physicians and nurses in hypertensive patients, but these are usually minimal and not clinically important. Ensuring standardized protocols and precise measurement methods by both healthcare providers is crucial for reliable results.",3.316036182995957e-07,0.16045717698203887,0.03766626182161294,0.025387970506946272,0.19696902012075146,0.013886133703630229,0.025351221573340146,0.21962860920676608,0.0,3.316036182995957e-07,0.22314355131420882,0.0
2,0.5,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","In treated hypertensive patients, does blood pressure differ depending on if a physician or nurse measures it? Slight fluctuations may occur between measurements taken by physicians and nurses, but these differences are generally small and not significant clinically. Consistent use of standardized procedures and accurate techniques by both is essential for dependable readings.",4.974054274493935e-07,0.26325438771107734,0.05461037597143458,0.03808195576041938,0.3255863979428453,0.013886133703630229,0.03802683236001021,0.35065687161317083,0.0,4.974054274493935e-07,0.35667494393873156,0.0
2,0.5,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Is there a change in blood pressure readings for treated hypertensive patients when measured by a physician versus a nurse? Blood pressure measurements might show small variations between physicians and nurses, though these are typically minimal and not clinically relevant. It's vital that both follow standardized protocols and use precise methods to ensure accurate readings.",4.500334819780227e-07,0.25118617752674677,0.0360984500191384,0.034455102830855636,0.2871201171150495,0.013886133703630229,0.03440522927810448,0.31143615845988837,0.0,4.500334819780227e-07,0.3166696093250332,0.0
2,0.5,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Do blood pressure readings in treated hypertensive patients differ when measured by a physician compared to a nurse? Minor discrepancies can exist between measurements by physicians and nurses, but these differences are usually negligible and not clinically meaningful. Both should adhere to standardized procedures and accurate measurement techniques to obtain trustworthy results.",5.210914001850789e-07,0.28267247356818004,0.05461037597143458,0.039895382225201254,0.34538902523902504,0.013886133703630229,0.03983763390096308,0.37085957893068944,0.0,5.210914001850789e-07,0.3772942311414673,0.0
2,0.5,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Does the measurement of blood pressure in treated hypertensive patients change depending on whether a physician or nurse performs it? There may be slight differences in blood pressure readings between physicians and nurses, but these are generally minimal and not of clinical concern. Standardized protocols and precise measurement methods are important for both to ensure reliable data.",4.026615365066519e-07,0.21390167200592547,0.03675913630201309,0.03082824990129189,0.2500788454346994,0.013886133703630229,0.030783626196198746,0.27369583047704094,0.0,4.026615365066519e-07,0.2782033284972374,0.0
2,0.5,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","In hypertensive patients under treatment, does blood pressure measurement vary between a physician and a nurse? Small variations might be observed between readings from physicians and nurses, but these are typically minor and lack clinical significance. Both must use standardized protocols and accurate techniques for consistent and reliable measurements.",5.921493183921352e-07,0.34329709538461417,0.05461037597143458,0.04533566161954687,0.40726442895711257,0.013886133703630229,0.04527003852382168,0.4340384805522217,0.0,5.921493183921352e-07,0.44183275227903884,0.0
2,0.5,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","When measuring blood pressure in treated hypertensive patients, does it differ if done by a physician or a nurse? Measurements might vary slightly between physicians and nurses, but such differences are usually minimal and not clinically significant. Ensuring both follow standardized and accurate measurement methods is key to reliable readings.",5.684633456564497e-07,0.3226778081818784,0.05461037597143458,0.043522235154765,0.3862110197592794,0.013886133703630229,0.04345923698286881,0.41253227533125836,0.0,5.684633456564497e-07,0.41985384556026384,0.0
2,0.5,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Is there a difference in blood pressure measurements for treated hypertensive patients depending on whether a physician or nurse measures it? Slight differences may occur between the two, but these are generally minimal and not significant clinically. Adherence to standardized protocols and accurate measurement techniques by both professionals is essential for dependable results.",4.974054274493935e-07,0.26325438771107734,0.05461037597143458,0.03808195576041938,0.3255863979428453,0.013886133703630229,0.03802683236001021,0.35065687161317083,0.0,4.974054274493935e-07,0.35667494393873156,0.0
2,0.5,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","For treated hypertensive patients, does blood pressure change based on whether a physician or nurse measures it? There can be minor variations between measurements taken by physicians and nurses, but these differences are typically small and not clinically important. It is important that both use standardized procedures and precise measurement methods to ensure accuracy.",4.737194547137081e-07,0.24420619274038424,0.05461037597143458,0.03626852929563751,0.3061683120857426,0.013886133703630229,0.036216030819057346,0.33085424431699106,0.0,4.737194547137081e-07,0.33647223662121295,0.0
2,0.5,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Does blood pressure in treated hypertensive patients differ when measured by a physician compared to a nurse? Small differences may exist between readings taken by physicians and nurses, but these are generally minimal and not clinically significant. Both should follow standardized protocols and accurate techniques to obtain reliable blood pressure measurements.",5.447773729207643e-07,0.3302009880867578,0.03461870583399185,0.041708808689983126,0.36559173255654365,0.013886133703630229,0.041648435441915946,0.3914788661334252,0.0,5.447773729207643e-07,0.3983476403393005,0.0
3,0.5,1,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are we overlooking any prognostic indicators? Answer: For the first time, we identify ESLD etiology as a survival prognostic factor. Renal function, measured by serum creatinine, and urinary sodium (<5 mEq/l) at diagnosis correlate with outcomes.",1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
3,0.5,2,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: could there be undiscovered prognostic factors? Answer: This is the first report highlighting ESLD etiology as a prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis were linked to prognosis.,1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
3,0.5,3,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are some prognostic factors being missed? Answer: We present the first evidence that ESLD etiology serves as a prognostic factor for survival. Renal function, indicated by serum creatinine, and urinary sodium levels (<5 mEq/l) at diagnosis are associated with prognosis.",9.474389094274162e-08,0.09097177820572666,0.0,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
3,0.5,4,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: might we be missing certain prognostic factors? Answer: We report ESLD etiology as a novel prognostic factor for survival. Renal function, evaluated by serum creatinine, and urinary Na (<5 mEq/l) at diagnosis showed association with outcomes.",1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
3,0.5,5,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are there prognostic factors not yet identified? Answer: We are the first to report ESLD etiology as a prognostic indicator for survival. Renal function (serum creatinine) and urinary sodium (<5 mEq/l) at diagnosis were found to be linked with prognosis.,9.474389094274162e-08,0.09097177820572666,0.0,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
3,0.5,6,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: could prognostic factors be overlooked? Answer: We report for the first time that ESLD etiology is a prognostic factor for survival. Renal function, expressed by serum creatinine, and urinary Na (<5 mEq/l) at diagnosis correlate with prognosis.",1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
3,0.5,7,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are additional prognostic factors missing? Answer: We identify ESLD etiology as a survival prognostic factor for the first time. Renal function (serum creatinine) and urinary sodium (<5 mEq/l) at the time of diagnosis are associated with prognosis.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
3,0.5,8,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: might some prognostic factors be missed? Answer: For the first time, we report ESLD etiology as a prognostic factor for survival. Renal function, measured by serum creatinine, and urinary Na (<5 mEq/l) at diagnosis were linked to outcomes.",1.4211583641411244e-07,0.13976194237515838,0.0,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
3,0.5,9,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are unknown prognostic factors present? Answer: We report ESLD etiology as a novel prognostic factor for survival for the first time. Renal function (serum creatinine) and urinary sodium (<5 mEq/l) at diagnosis showed an association with prognosis.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
3,0.5,10,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: is there a chance we are missing prognostic factors? Answer: We present for the first time that ESLD etiology is a prognostic factor for survival. Renal function, expressed as serum creatinine, and urinary Na (<5 mEq/l) at diagnosis were found to be associated with prognosis.",2.3685972735685406e-08,0.02150620522096336,0.0,0.0018134264647818726,0.021978906718775004,0.0,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
4,0.5,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Could aripiprazole be a new risk factor for pathological gambling? Answer: Evidence indicates that aripiprazole, prescribed for schizophrenia and bipolar disorder, might increase the risk of pathological gambling. Further",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
4,0.5,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Is aripiprazole associated with pathological gambling? Answer: Studies suggest that aripiprazole, a drug for schizophrenia and bipolar disorder, could be linked to a higher risk of pathological gambling. Further",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
4,0.5,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Aripiprazole and pathological gambling: a new risk factor? Answer: There is data implying that aripiprazole, used in schizophrenia and bipolar disorder treatment, may contribute to pathological gambling. Further",1.184298636784265e-07,0.03827629118946785,0.09000000000000004,0.009067132323909398,0.08325563922540269,0.06222222222222223,0.009054007704764368,0.13117149352431312,0.0322222222222222,1.1842986367842703e-07,0.1823215567939549,0.0
4,0.5,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Does aripiprazole pose a risk for pathological gambling? Answer: Evidence shows that aripiprazole, a medication for schizophrenia and bipolar disorder, might be a risk factor for developing pathological gambling. Further",7.10579182070559e-08,0.015493231739846625,0.05670630202140312,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
4,0.5,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Could aripiprazole increase the risk of pathological gambling? Answer: Research suggests that aripiprazole, utilized in treating schizophrenia and bipolar disorder, may be linked to pathological gambling. Further",1.421158364141118e-07,0.07464393536034253,0.09000000000000004,0.010880558788691277,0.12099596720824968,0.06222222222222223,0.010864809245717241,0.17039220667759558,0.0322222222222222,1.4211583641411244e-07,0.2231435513142097,0.0
4,0.5,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Is pathological gambling a potential side effect of aripiprazole? Answer: There is evidence that aripiprazole, used for schizophrenia and bipolar disorder, could be associated with pathological gambling risk. Further",9.47438909427412e-08,0.05098822520991897,0.055561224489795946,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
4,0.5,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Aripiprazole: a possible new risk factor for pathological gambling? Answer: Some evidence points to aripiprazole, a treatment for schizophrenia and bipolar disorder, as a potential risk factor for pathological gambling. Further",4.73719454713706e-08,0.07065111569757931,0.005663265306122434,0.003626852929563759,0.07031474764223633,0.004104308390022647,0.003621603081905747,0.06977545539104257,0.0022165532879818914,4.737194547137081e-08,0.06899287148695077,0.0
4,0.5,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Does aripiprazole contribute to pathological gambling risk? Answer: Evidence suggests that aripiprazole, prescribed for schizophrenia and bipolar disorder, may increase the chance of pathological gambling. Further",1.658018091497971e-07,0.11238426334318952,0.09000000000000004,0.012693985253473157,0.16021668036153214,0.06222222222222223,0.012675610786670115,0.2112142011978504,0.0322222222222222,1.6580180914979784e-07,0.26570316573300534,0.0
4,0.5,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Is there a link between aripiprazole and pathological gambling? Answer: Data indicate that aripiprazole, a medication for schizophrenia and bipolar disorder, might be a risk factor for pathological gambling. Further",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
4,0.5,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Could aripiprazole be implicated in pathological gambling? Answer: Research findings suggest that aripiprazole, used to treat schizophrenia and bipolar disorder, may pose a risk for pathological gambling. Further",1.184298636784265e-07,0.03827629118946785,0.09000000000000004,0.009067132323909398,0.08325563922540269,0.06222222222222223,0.009054007704764368,0.13117149352431312,0.0322222222222222,1.1842986367842703e-07,0.1823215567939549,0.0
5,0.5,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are there varying degrees of risk for developing psychosis within the Ultra High Risk (UHR) criteria? Yes, the UHR criteria encompass different risk levels such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher risk levels indicating a greater chance of transitioning to psychosis.",3.789755637709665e-07,0.12066009132713962,0.14634076770882767,0.029014823436509962,0.13895441789037521,0.109375,0.028972824655245866,0.18669505620761795,0.08002462296091106,3.789755637709665e-07,0.23603296320037348,0.049048751486325794
5,0.5,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Does the Ultra High Risk (UHR) criteria include different risk levels for psychosis transition? Yes, within the UHR criteria, risk levels vary and include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, where higher levels correspond to an increased likelihood of psychosis onset.",4.500334819780227e-07,0.18904943013448872,0.14358037303373125,0.03445510283085558,0.2049123856821713,0.109375,0.034405229278104466,0.2541363370031502,0.08002462296091106,4.500334819780227e-07,0.30502583468732514,0.049048751486325794
5,0.5,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Within the Ultra High Risk (UHR) criteria, are there distinct risk levels for psychosis transition? Yes, the criteria identify different levels including basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher risk levels implying a higher probability of developing psychosis.",4.974054274493935e-07,0.23737752898875497,0.14152771759575472,0.038081955760419325,0.25143240131706523,0.109375,0.0380268323600102,0.3017643859924046,0.08002462296091106,4.974054274493935e-07,0.35381599885675685,0.049048751486325794
5,0.5,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are different risk levels for psychosis transition recognized in the Ultra High Risk (UHR) criteria? Yes, these criteria classify risk into basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with greater risk levels linked to increased chances of psychosis.",5.447773729207643e-07,0.28815088566064073,0.1392764669117946,0.04170880868998307,0.30022256548649695,0.109375,0.04164843544191593,0.35177480656706805,0.08002462296091106,5.447773729207643e-07,0.40510929324430656,0.049048751486325794
5,0.5,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Is there a gradation of risk for psychosis transition within the Ultra High Risk (UHR) criteria? Yes, the UHR criteria define various risk levels such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, where higher levels mean a higher risk of psychosis.",4.500334819780227e-07,0.15824288877626902,0.16571792560849805,0.03445510283085558,0.2049123856821713,0.109375,0.034405229278104466,0.2541363370031502,0.08002462296091106,4.500334819780227e-07,0.30502583468732514,0.049048751486325794
5,0.5,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Do the Ultra High Risk (UHR) criteria specify different levels of risk for transitioning to psychosis? Yes, they include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher risk levels indicating a greater likelihood of psychosis development.",5.684633456564497e-07,0.2798767421024291,0.16294510596504902,0.04352223515476494,0.3255403734707887,0.109375,0.0434592369828688,0.37775029297032603,0.08002462296091106,5.684633456564497e-07,0.4317775403264674,0.049048751486325794
5,0.5,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are multiple risk levels for psychosis transition part of the Ultra High Risk (UHR) criteria? Yes, the UHR criteria differentiate risk levels including basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with increased risk levels associated with a higher chance of psychosis.",4.737194547137081e-07,0.2563212766138401,0.07133140587654,0.03626852929563745,0.22790190390687082,0.109375,0.03621603081905733,0.2776668344133446,0.08002462296091106,4.737194547137081e-07,0.32912338626638515,0.049048751486325794
5,0.5,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Within the Ultra High Risk (UHR) criteria, is the risk for psychosis transition stratified? Yes, the criteria outline levels such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, where higher levels correspond to greater risk of psychosis.",5.684633456564497e-07,0.2798767421024291,0.16294510596504902,0.04352223515476494,0.3255403734707887,0.109375,0.0434592369828688,0.37775029297032603,0.08002462296091106,5.684633456564497e-07,0.4317775403264674,0.049048751486325794
5,0.5,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Does the Ultra High Risk (UHR) criteria categorize different risk levels for psychosis transition? Yes, it includes basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher risk levels meaning a higher probability of psychosis onset.",6.158352911278203e-07,0.36947553857355553,0.1354595336076818,0.04714908808432869,0.3781841069562075,0.109375,0.04708084006477453,0.4318175142406022,0.08002462296091106,6.158352911278206e-07,0.4873473914812796,0.049048751486325794
5,0.5,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are there different gradations of risk for psychosis transition in the Ultra High Risk (UHR) criteria? Yes, these criteria encompass basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with increased levels indicating a greater likelihood of developing psychosis.",5.684633456564497e-07,0.2798767421024291,0.16294510596504902,0.04352223515476494,0.3255403734707887,0.109375,0.0434592369828688,0.37775029297032603,0.08002462296091106,5.684633456564497e-07,0.4317775403264674,0.049048751486325794
6,0.5,1,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Is there an ideal duration for acid suppression to maximize healing of Los Angeles grades C and D reflux oesophagitis? Currently, no consensus exists on the best time frame for acid suppression to achieve optimal healing, and additional studies are required to identify the most effective treatment duration.",3.552895910352811e-07,0.009158698445244084,0.25026656407692666,0.02720139697172809,0.03848851525861452,0.19576087580348944,0.027162023114293,0.08743955362335232,0.13778925619834714,3.552895910352811e-07,0.10537569322543794,0.13225682429834681
6,0.5,2,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Regarding healing Los Angeles grades C and D reflux oesophagitis, is there an optimal acid suppression period? At present, no agreement has been reached on the ideal duration of acid suppression for maximal healing; further research is necessary to determine this.",5.210914001850789e-07,0.09827993406483859,0.28881605848306435,0.0398953822252012,0.1432945977432869,0.23914930555555558,0.039837633900963065,0.2257093423090657,0.16000000000000003,5.210914001850789e-07,0.27864741449947417,0.13225682429834681
6,0.5,3,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"A model addressing healing of Los Angeles grades C and D reflux oesophagitis asks: what is the best acid suppression timing for maximal healing? There is no current consensus on the optimal acid suppression duration, and more investigation is needed to establish the most effective treatment length.",3.789755637709665e-07,0.046002533400927526,0.2920712268664379,0.029014823436509962,0.00019375410261179837,0.23914930555555558,0.028972824655245866,0.07910586811719034,0.16000000000000003,3.789755637709665e-07,0.12836521145013746,0.13225682429834681
6,0.5,4,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Is there a best time period for acid suppression to maximize healing in Los Angeles grades C and D reflux oesophagitis? Presently, no consensus exists on the optimal acid suppression duration, and further research is essential to find the most effective timing.",4.974054274493935e-07,0.07274202003476038,0.2894246219281663,0.038081955760419325,0.11797678975899517,0.23914930555555558,0.0380268323600102,0.19973385590580772,0.16000000000000003,4.974054274493935e-07,0.2519791674173133,0.13225682429834681
6,0.5,5,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"For maximal healing of Los Angeles grades C and D reflux oesophagitis, is there an optimal acid suppression duration? Currently, the medical community has no consensus on this, highlighting the need for more research to determine the best time frame.",5.447773729207642e-07,0.08894038302113394,0.3137996219281663,0.04170880868998307,0.16927008414654487,0.23914930555555558,0.04164843544191593,0.25237758939122656,0.16000000000000003,5.447773729207643e-07,0.3060463886875895,0.13225682429834681
6,0.5,6,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"What is the optimal acid suppression period to maximize healing of Los Angeles grades C and D reflux oesophagitis? No consensus currently exists, and additional research is required to identify the most effective duration for acid suppression.",6.158352911278201e-07,0.1689830906946681,0.3137996219281663,0.04714908808432869,0.2515081823835179,0.23914930555555558,0.04708084006477454,0.33693497741929024,0.16000000000000003,6.158352911278206e-07,0.3930577656772196,0.13225682429834681
6,0.5,7,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Is an optimal acid suppression time established for maximal healing of Los Angeles grades C and D reflux oesophagitis? At this time, no consensus is available, and further study is needed to determine the duration that yields the best healing results.",5.210914001850789e-07,0.06362257503684221,0.3137996219281663,0.0398953822252012,0.1432945977432869,0.23914930555555558,0.039837633900963065,0.2257093423090657,0.16000000000000003,5.210914001850789e-07,0.27864741449947417,0.13225682429834681
6,0.5,8,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Does an ideal duration of acid suppression exist for the healing of Los Angeles grades C and D reflux oesophagitis? Currently, there is no consensus, and more research is necessary to find the most effective period for acid suppression.",5.684633456564495e-07,0.11491586942439191,0.3137996219281663,0.04352223515476494,0.19593833122870574,0.23914930555555558,0.0434592369828688,0.2797765635793419,0.16000000000000003,5.684633456564497e-07,0.33421726565428633,0.13225682429834681
6,0.5,9,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Regarding Los Angeles grades C and D reflux oesophagitis healing, is there a preferred acid suppression time? No consensus has been reached yet, and further investigation is required to determine the optimal duration for maximal healing.",6.395212638635054e-07,0.19715396766136495,0.3137996219281663,0.04896251454911057,0.2804957192567694,0.23914930555555558,0.04889164160572741,0.366787940568972,0.16000000000000003,6.39521263863506e-07,0.4238294243439733,0.13225682429834681
6,0.5,10,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Is there a consensus on the optimal acid suppression duration for maximal healing of Los Angeles grades C and D reflux oesophagitis? At present, no agreement exists, and further research is needed to identify the best time frame.",5.921493183921348e-07,0.14158411650655278,0.3137996219281663,0.045335661619546816,0.22333730541682106,0.23914930555555558,0.045270038523821665,0.30794744054603873,0.16000000000000003,5.921493183921352e-07,0.36320480252753784,0.13225682429834681
7,0.5,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to predict discordance between TEOAE and AABR results in newborns? Given current screening technologies, discordant outcomes between TEOAE and AABR may be unavoidable in certain types of hearing loss among seemingly healthy newborns whose mothers had prenatal care. Therefore, the limitations of relying on perinatal morbidities for targeted screening in these cases warrant further investigation.",4.737194547137081e-08,0.013165925531228861,0.016157281049888124,0.0036268529295637453,0.012529249072251503,0.017153368972257988,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
7,0.5,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discordance between TEOAE and AABR results in newborns be anticipated? With the screening technologies available, some degree of discordance between TEOAE and AABR is likely inevitable for certain hearing loss categories in apparently healthy newborns whose mothers underwent prenatal care. This suggests that the use of perinatal morbidities as a basis for targeted screening needs more examination.",4.737194547137081e-08,0.011155028172629144,0.03346386614453542,0.0036268529295637453,0.012226007376317849,0.034887860448558225,0.003621603081905733,0.013369432360373246,0.03631185475258099,4.737194547137081e-08,0.012068210184330574,0.01851192595229618
7,0.5,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is discordance in TEOAE and AABR test outcomes predictable in newborn infants? Considering the existing screening methods, discordant results between TEOAE and AABR may be unavoidable in some newborns with hearing loss who appear healthy and whose mothers received prenatal care. Thus, the limitations of using perinatal morbidity as a criterion for targeted screening deserve further study.",2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
7,0.5,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can we predict when TEOAE and AABR results will be discordant in newborns? Given the current state of screening technology, discordance between TEOAE and AABR may be inevitable in certain categories of hearing loss among apparently healthy newborns whose mothers had prenatal care. This indicates that the potential limitations of perinatal morbidity-based targeted screening require additional research.",2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
7,0.5,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it feasible to predict discordance in TEOAE and AABR outcomes among newborns? Based on available screening technologies, some discordance between TEOAE and AABR results may be unavoidable for specific types of hearing loss in apparently healthy newborns with mothers who received prenatal care. Hence, the limitations of using perinatal morbidities as a basis for targeted screening merit further exploration.",9.474389094274162e-08,0.07362193352346624,0.002455283499887863,0.0072537058591274906,0.07322945486480048,0.0012758533145614953,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
7,0.5,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Are discordant TEOAE and AABR outcomes in newborns predictable? With the screening technologies currently in use, discordance between TEOAE and AABR is likely unavoidable in certain hearing loss cases among apparently healthy newborns whose mothers had prenatal care. This highlights the need to further assess the limitations of perinatal morbidity-focused targeted screening.",9.474389094274162e-08,0.07946133321722204,0.0028384992665777056,0.0072537058591274906,0.07901481056001103,0.0014797441851465525,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
7,0.5,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discordance between TEOAE and AABR screening results be predicted in newborns? Given the screening technologies available, some discordance between TEOAE and AABR results may be inevitable for certain hearing loss types in apparently healthy newborns whose mothers received prenatal care. Therefore, the potential limitations of using perinatal morbidities as a basis for targeted screening should be further investigated.",7.105791820705622e-08,0.007914021691230122,0.03227525087156166,0.005440279394345618,0.006776477957218141,0.033957209850172934,0.0054324046228586,0.005549264285888977,0.03566529492455417,7.105791820705622e-08,0.030884114630681303,0.0181755829903978
7,0.5,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to foresee discordant outcomes between TEOAE and AABR in newborns? Considering the current screening methods, discordance between TEOAE and AABR results may be unavoidable in some hearing loss categories among apparently healthy newborns whose mothers had prenatal care. This suggests that the limitations of targeted screening based on perinatal morbidities require additional research.",0.0,0.025205352020361893,0.01805205057286282,0.0,0.025672117798516858,0.018470322568413872,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
7,0.5,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can we anticipate discordance in TEOAE and AABR results in newborns? With the technologies available for screening, discordant outcomes between TEOAE and AABR may be inevitable for certain hearing loss categories among apparently healthy newborns whose mothers received prenatal care. Hence, the use of perinatal morbidities as a criterion for targeted screening warrants further study.",2.3685972735685406e-08,0.019282670224506138,0.0006703937681290656,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
7,0.5,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is prediction of discordance between TEOAE and AABR outcomes in newborns possible? Given the current screening technology, discordance between TEOAE and AABR may be unavoidable in some hearing loss cases in apparently healthy newborns whose mothers had prenatal care. Thus, the limitations of relying on perinatal morbidity for targeted screening merit further investigation.",7.105791820705622e-08,0.1123167903887734,0.04007703413630789,0.005440279394345618,0.11303302316613228,0.040081824047703815,0.0054324046228586,0.1137206825687711,0.039930555555555566,7.105791820705622e-08,0.08771514212630915,0.020399305555555556
8,0.5,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper explores whether culture, attitudes, and faith have a role in recovery outcome measures, focusing on the cultural suitability of the RAQ in Australian contexts and highlighting the necessity for comprehensive, inclusive recovery metrics.",4.73719454713706e-08,0.01865023714217351,0.02775510204081633,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
8,0.5,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Examining the relevance of culture, attitudes, and faith in recovery outcomes, this study evaluates the RAQ's cultural appropriateness in Australia and underscores the importance of creating robust, inclusive recovery measures.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.5,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The article discusses the incorporation of culture, attitudes, and faith into recovery outcome measures, assessing the RAQ's fit within Australian settings and emphasizing the need for rigorous and inclusive tools.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.5,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This research addresses the question of including culture, attitudes, and faith in recovery outcomes by reviewing the RAQ's cultural relevance in Australia and calling for the development of thorough, inclusive recovery assessments.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.5,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Focusing on recovery outcome measures, this paper questions the role of culture, attitudes, and faith, analyzes the RAQ's cultural appropriateness in Australian environments, and stresses the need for rigorous, inclusive measures.",1.421158364141118e-07,0.1438133800961805,0.02775510204081633,0.010880558788691277,0.18805223150294026,0.0,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
8,0.5,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The study considers whether culture, attitudes, and faith should be included in recovery outcome measures, evaluating the RAQ's suitability in Australian settings and advocating for the creation of rigorous, inclusive recovery tools.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.5,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper investigates the place of culture, attitudes, and faith in recovery outcome measures, discussing the RAQ's cultural compatibility in Australia and the necessity for developing comprehensive, inclusive recovery metrics.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.5,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Addressing culture, attitudes, and faith in recovery outcomes, this article assesses the RAQ's appropriateness in Australian contexts and highlights the need for robust, inclusive recovery measures.",2.605457000925383e-07,0.3261349368901354,0.02775510204081633,0.019947691112600675,0.3772942311414682,0.0,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
8,0.5,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The research explores the inclusion of culture, attitudes, and faith in recovery outcome measures, focusing on the RAQ's cultural fit in Australia and the requirement for rigorous, inclusive tools.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
8,0.5,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper questions the role of culture, attitudes, and faith in recovery outcome measures, reviews the RAQ's cultural suitability in Australian settings, and identifies the need for developing inclusive, rigorous recovery metrics.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
9,0.5,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Is it possible to predict different histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Diffusion-weighted echo-planar MR imaging may be able to predict various histologic subtypes of primary parotid gland tumors, but additional research is necessary to confirm its accuracy and clinical reliability.",7.105791820705622e-08,0.07793979987657984,0.009155610777781986,0.005440279394345618,0.07416556531201479,0.00661675229853978,0.0054324046228586,0.101486788458796,0.0253476399262638,7.105791820705622e-08,0.13192008828948065,0.046400951814396206
9,0.5,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Can diffusion-weighted echo-planar MR imaging differentiate histologic subtypes of primary parotid gland tumors? This imaging technique shows potential for predicting different histologic subtypes of primary parotid gland tumors, though further studies are required to validate its clinical effectiveness.",2.8423167282822456e-07,0.24190568804935086,0.02521343787180247,0.02176111757738247,0.29730911662622495,0.00661675229853978,0.0217296184914344,0.35463352176442076,0.04249180169753087,2.8423167282822487e-07,0.3838275989976325,0.05859375
9,0.5,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Does diffusion-weighted echo-planar MR imaging allow for the prediction of distinct histologic subtypes in primary parotid gland tumors? It has the potential to do so, but more research is needed to ensure its accuracy and usefulness in medical practice.",2.6054570009253926e-07,0.027900365140176575,0.15704937537180247,0.0199476911126006,0.11587743564701025,0.10275824770146022,0.019918816950481533,0.20763741384459067,0.04246913580246913,2.6054570009253947e-07,0.2732933349996811,0.0
9,0.5,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Is predicting various histologic subtypes of primary parotid gland tumors feasible with diffusion-weighted echo-planar MR imaging? This method could potentially predict different subtypes, but additional investigation is needed to confirm its reliability and accuracy.",3.7897556377096576e-07,0.1689789634000829,0.15704937537180247,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.3571691478155543,0.04246913580246913,3.789755637709665e-07,0.4274440148269396,0.0
9,0.5,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Can primary parotid gland tumor histologic subtypes be predicted by diffusion-weighted echo-planar MR imaging? There is potential for this imaging to predict different subtypes, yet further validation through research is essential for clinical application.",3.7897556377096576e-07,0.1689789634000829,0.15704937537180247,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.3571691478155543,0.04246913580246913,3.789755637709665e-07,0.4274440148269396,0.0
9,0.5,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Does diffusion-weighted echo-planar MR imaging have the capability to predict histologic subtypes of primary parotid gland tumors? It may predict different subtypes, but more research is necessary to establish its clinical accuracy and dependability.",3.7897556377096576e-07,0.1689789634000829,0.15704937537180247,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.3571691478155543,0.04246913580246913,3.789755637709665e-07,0.4274440148269396,0.0
9,0.5,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Is it feasible to use diffusion-weighted echo-planar MR imaging to predict different histologic subtypes of primary parotid gland tumors? This imaging technique shows promise, although further studies are required to verify its clinical accuracy and reliability.",3.3160361829959516e-07,0.11013846337714961,0.15704937537180247,0.025387970506946224,0.20043482367507393,0.10275824770146022,0.025351221573340146,0.2946487908342208,0.04246913580246913,3.316036182995957e-07,0.3629054936893681,0.0
9,0.5,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Can diffusion-weighted echo-planar MR imaging be used to predict the histologic subtypes of primary parotid gland tumors? While it has potential for such predictions, additional research is needed to confirm its accuracy and clinical utility.",3.5528959103528046e-07,0.13912600025040112,0.15704937537180247,0.027201396971728103,0.2302877868247557,0.10275824770146022,0.02716202311429302,0.3254204495009745,0.04246913580246913,3.552895910352811e-07,0.3946541920039479,0.0
9,0.5,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Is diffusion-weighted echo-planar MR imaging a reliable tool for predicting different histologic subtypes of primary parotid gland tumors? It may be useful, but more studies are needed to validate its clinical accuracy and reliability.",3.7897556377096576e-07,0.1689789634000829,0.15704937537180247,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.3571691478155543,0.04246913580246913,3.789755637709665e-07,0.4274440148269396,0.0
9,0.5,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Can different histologic subtypes of primary parotid gland tumors be predicted through diffusion-weighted echo-planar MR imaging? This technique holds potential, but further research is required to ensure its accuracy and clinical applicability.",4.2634750924233636e-07,0.2314993203814164,0.15704937537180247,0.03264167636607374,0.3255979666290809,0.10275824770146022,0.03259442773715164,0.4238605223142278,0.04246913580246913,4.263475092423373e-07,0.4964368863138904,0.0
10,0.5,1,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week of life? Studies indicate a correlation between these measurements in such infants.,4.974054274493926e-07,0.13542357592181986,0.37099180261342435,0.03808195576041936,0.23162358493827284,0.199375,0.03802683236001024,0.3229200776624901,0.15419501133786845,4.974054274493935e-07,0.3898654580023746,0.1200648999459167
10,0.5,2,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants within the first week of life? Research has demonstrated a relationship between these two measurements in this population.,4.026615365066514e-07,0.008951956295913277,0.3746673120328784,0.030828249901291842,0.10646044198426585,0.199375,0.030783626196198746,0.19370834618248312,0.15419501133786845,4.026615365066519e-07,0.2563340653778523,0.1200648999459167
10,0.5,3,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Do end-tidal carbon dioxide measurements align with arterial carbon dioxide levels in extremely low birth weight infants during their initial week? Studies confirm a correlation exists between these values.,5.684633456564485e-07,0.24199761018955046,0.3675487299110924,0.043522235154765,0.3369841005960983,0.199375,0.04345923698286886,0.43211936962748076,0.15419501133786845,5.684633456564497e-07,0.5031941433093787,0.1200648999459167
10,0.5,4,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Can end-tidal carbon dioxide measurement be correlated with arterial carbon dioxide in extremely low birth weight infants in the first week after birth? Evidence shows a correlation between these parameters.,5.447773729207632e-07,0.20519903131286243,0.3687752493254425,0.04170880868998312,0.3006164564252236,0.199375,0.04164843544191599,0.3943790416446338,0.15419501133786845,5.447773729207643e-07,0.46397343015609627,0.1200648999459167
10,0.5,5,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Is end-tidal carbon dioxide measurement reflective of arterial carbon dioxide in extremely low birth weight infants in their first week? Studies have found a correlation between these two measurements.,5.684633456564485e-07,0.24199761018955046,0.3675487299110924,0.043522235154765,0.3369841005960983,0.199375,0.04345923698286886,0.43211936962748076,0.15419501133786845,5.684633456564497e-07,0.5031941433093787,0.1200648999459167
10,0.5,6,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Does measuring end-tidal carbon dioxide correspond with arterial carbon dioxide levels in extremely low birth weight infants during their first week of life? Research supports a correlation between them.,5.684633456564485e-07,0.24199761018955046,0.3675487299110924,0.043522235154765,0.3369841005960983,0.199375,0.04345923698286886,0.43211936962748076,0.15419501133786845,5.684633456564497e-07,0.5031941433093787,0.1200648999459167
10,0.5,7,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Is there a relationship between end-tidal and arterial carbon dioxide measurements in extremely low birth weight infants in the first week? Studies have demonstrated a correlation.,6.395212638635044e-07,0.30581578259941544,0.40321402483564656,0.04896251454911064,0.45476713625248255,0.199375,0.04889164160572748,0.5547216917198137,0.15419501133786845,6.39521263863506e-07,0.6310275148192632,0.1200648999459167
10,0.5,8,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week? Studies indicate a positive correlation.,6.632072365991897e-07,0.40440004216633074,0.3616261231343233,0.05077594101389252,0.4973267506712782,0.199375,0.050702443146680355,0.5991734542906477,0.15419501133786845,6.632072365991914e-07,0.6775475304541572,0.1200648999459167
10,0.5,9,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Are end-tidal carbon dioxide levels correlated with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Research has shown such a correlation.,5.921493183921338e-07,0.28019897706031927,0.36623177631493653,0.04533566161954688,0.3747244285789453,0.199375,0.045270038523821735,0.4713400827807632,0.15419501133786845,5.921493183921352e-07,0.5440161378296335,0.1200648999459167
10,0.5,10,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Is the measurement of end-tidal carbon dioxide associated with arterial carbon dioxide in extremely low birth weight infants in their first week? Studies confirm a correlation between these measurements.,5.684633456564485e-07,0.24199761018955046,0.3675487299110924,0.043522235154765,0.3369841005960983,0.199375,0.04345923698286886,0.43211936962748076,0.15419501133786845,5.684633456564497e-07,0.5031941433093787,0.1200648999459167
11,0.5,1,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Do adolescents with both major depression and alcohol use disorder experience worse depression outcomes? The findings indicate that slightly elevated depression rates up to age 35 in the comorbid MD/AUD group are attributable to greater exposure to adverse childhood conditions within this group. Comorbidity of MD and AUD in adolescence is likely to be,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
11,0.5,2,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Does having both major depression and alcohol use disorder in adolescence result in poorer depression outcomes? The analyses suggest that the somewhat higher depression rates by age 35 in those with comorbid MD/AUD can be explained by their increased exposure to adverse childhood environments. Adolescent comorbidity of MD/AUD is probably,2.3685972735685406e-07,0.16222063119983954,0.01694411414982164,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
11,0.5,3,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Is comorbidity of major depression and alcohol use disorder during adolescence associated with worse depression outcomes? Results show that the marginally increased depression rates through age 35 in the comorbid MD/AUD group are due to more frequent adverse childhood experiences among them. MD/AUD comorbidity in adolescence is likely to be,2.3685972735685406e-07,0.16222063119983954,0.01694411414982164,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
11,0.5,4,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Does comorbid major depression and alcohol use disorder in adolescence lead to poorer depression outcomes? The data suggest that the slightly higher depression rates by age 35 in the comorbid group are explained by their greater exposure to negative childhood circumstances. Adolescent MD/AUD comorbidity is likely to be,2.8423167282822487e-07,0.20389332760040846,0.01694411414982164,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
11,0.5,5,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Are depression outcomes worse in adolescents with both major depression and alcohol use disorder? The analyses reveal that the marginally elevated depression rates up to age 35 in the comorbid MD/AUD group stem from increased adverse childhood exposures. Comorbidity of MD and AUD in adolescence is likely to be,2.6054570009253947e-07,0.1828399184025753,0.01694411414982164,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
11,0.5,6,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Does the presence of both major depression and alcohol use disorder in adolescence result in poorer outcomes for depression? Findings indicate that the slightly higher depression rates through age 35 in the comorbid MD/AUD group are due to their increased exposure to adverse childhood conditions. Adolescent MD/AUD comorbidity is likely to be,1.8948778188548325e-07,0.12221529658614116,0.01694411414982164,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
11,0.5,7,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Is there a link between adolescent comorbidity of major depression and alcohol use disorder and worse depression outcomes? The results suggest that the marginally higher depression rates by age 35 in the comorbid MD/AUD group are attributable to greater exposure to adverse childhood circumstances. MD/AUD comorbidity in adolescence is likely to be,1.8948778188548325e-07,0.12221529658614116,0.01694411414982164,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
11,0.5,8,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Does comorbid major depression and alcohol use disorder in adolescence contribute to poorer depression outcomes? The analyses indicate that the slightly elevated depression rates to age 35 among the comorbid MD/AUD group are explained by increased adverse childhood experiences in this group. Adolescent MD/AUD comorbidity is likely to be,2.6054570009253947e-07,0.1828399184025753,0.01694411414982164,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
11,0.5,9,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Are depression outcomes negatively affected in adolescents with both major depression and alcohol use disorder? The findings show that the marginally higher depression rates through age 35 in the comorbid MD/AUD group result from their greater exposure to adverse childhood environments. Comorbidity of MD and AUD in adolescence is likely to be,1.8948778188548325e-07,0.12221529658614116,0.01694411414982164,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
11,0.5,10,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Does the coexistence of major depression and alcohol use disorder in adolescence lead to worse depression outcomes? The data suggest that the slightly elevated depression rates up to age 35 in the comorbid MD/AUD group are due to increased exposure to adverse childhood circumstances. Adolescent MD/AUD comorbidity is likely to be,2.1317375462116866e-07,0.14201792388232093,0.01694411414982164,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
12,0.5,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Does having an optimistic perspective enhance survival chances in old age? Answer: Studies indicate that optimism benefits health and well-being, leading to improved survival among the elderly. Optimistic people often employ better coping mechanisms, maintain healthier habits, and exhibit stronger immune responses.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
12,0.5,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Can an optimistic attitude predict improved longevity in advanced years? Answer: Research demonstrates that optimism positively influences health and survival rates in later life. Those with an optimistic outlook generally have superior coping skills, healthier lifestyles, and enhanced immune function.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
12,0.5,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Is there a link between optimism and increased survival in older adults? Answer: Evidence suggests that optimism contributes to better health outcomes and higher survival probabilities at older ages. Optimistic individuals typically use more effective coping strategies, live healthier lives, and have stronger immune systems.",2.3685972735685406e-08,0.053979545877510304,0.02271498107084911,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
12,0.5,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Does optimism forecast better survival rates among the elderly? Answer: Studies reveal that optimism can improve health and well-being, resulting in greater survival at advanced ages. Optimistic people tend to adopt healthier behaviors, cope more effectively, and possess stronger immunity.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
12,0.5,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Can an optimistic mindset improve survival chances in old age? Answer: Research shows that optimism is associated with enhanced health and longevity. Optimistic individuals often have better coping approaches, healthier lifestyles, and more robust immune function.",1.8948778188548283e-07,0.16916400543669896,0.02271498107084911,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
12,0.5,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Does maintaining optimism influence survival outcomes in advanced age? Answer: Scientific findings indicate that optimism positively affects health and survival among older adults. Those with optimistic outlooks usually have stronger coping skills, healthier habits, and improved immune responses.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
12,0.5,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Is an optimistic outlook a predictor of longer survival in later life? Answer: Studies confirm that optimism benefits health and increases survival rates in advanced age. Optimistic people generally utilize better coping mechanisms, lead healthier lives, and have stronger immune defenses.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
12,0.5,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Does a positive outlook on life correlate with better survival in old age? Answer: Research supports that optimism enhances health and well-being, contributing to improved survival among the elderly. Optimistic individuals typically engage in healthier behaviors, manage stress better, and exhibit stronger immunity.",2.3685972735685406e-08,0.008517171800753065,0.02271498107084911,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
12,0.5,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Can optimism be linked to higher survival rates in the elderly? Answer: Evidence shows that optimism positively impacts health and longevity, with optimistic people often having superior coping strategies, healthier lifestyles, and stronger immune systems.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
12,0.5,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Does an optimistic perspective predict greater survival at advanced ages? Answer: Studies indicate that optimism improves health outcomes and survival chances in older adults. Optimistic individuals tend to employ better coping methods, maintain healthier lifestyles, and possess stronger immune function.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
13,0.5,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? ACR serves as an independent prognostic indicator for negative maternal and neonatal outcomes in suspected preeclampsia cases and could help assess risk.,7.105791820705622e-08,0.050798457762178284,0.08431178642131132,0.005440279394345618,0.054218998127248064,0.08928236453273734,0.0054324046228586,0.05792006223864776,0.09418282548476452,7.105791820705622e-08,0.025450265786948645,0.07271468144044323
13,0.5,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia predict maternal and neonatal adverse outcomes? ACR independently forecasts adverse maternal and neonatal events in suspected preeclampsia and may aid in risk evaluation.,2.1317375462116813e-07,0.15862666322926966,0.04800305141966765,0.01632083818303686,0.11441593590487953,0.08488117132035532,0.016297213868575813,0.10913402242451653,0.09418282548476452,2.1317375462116866e-07,0.14639999113971136,0.07271468144044323
13,0.5,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict poor outcomes for mother and newborn? ACR is an independent prognostic marker for adverse maternal and neonatal outcomes in suspected preeclampsia and might be useful for risk assessment.,9.474389094274162e-08,0.09372996034838632,0.13296398891966765,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03194457583538979,0.09418282548476452,9.474389094274162e-08,0.0012179812952122226,0.07271468144044323
13,0.5,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic marker for negative maternal and neonatal outcomes? ACR independently predicts adverse maternal and neonatal outcomes in suspected preeclampsia and may be valuable for risk stratification.,1.4211583641411222e-07,0.06700762570652374,0.05459664198089215,0.010880558788691236,0.026552599479868544,0.08725975513833309,0.0108648092457172,0.0221226454348864,0.09418282548476452,1.4211583641411244e-07,0.05678783245002439,0.07271468144044323
13,0.5,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic factor for maternal and neonatal complications? ACR is an independent predictor of adverse maternal and neonatal outcomes in suspected preeclampsia and could be useful in informing risk.,4.737194547137081e-08,0.07650610732163399,0.08546398891966764,0.0036268529295637453,0.07975691215732628,0.08989092797783926,0.003621603081905733,0.08323787022293949,0.09418282548476452,4.737194547137081e-08,0.05142575219020662,0.07271468144044323
13,0.5,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first measurement of urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a prognostic indicator for maternal and neonatal adverse outcomes? ACR independently forecasts negative maternal and neonatal outcomes in suspected preeclampsia and may help guide risk assessment.,1.1842986367842692e-07,0.0026798661548737,0.0818317756252922,0.009067132323909363,0.0011016322119083988,0.08796936114073188,0.009054007704764333,0.0052763287532289205,0.09418282548476452,1.1842986367842703e-07,0.028616955483327544,0.07271468144044323
13,0.5,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia be used as a prognostic factor for adverse maternal and neonatal outcomes? ACR is an independent prognostic factor for maternal and neonatal complications in suspected preeclampsia and might assist in risk evaluation.,2.3685972735685406e-08,0.0048536031931418755,0.018698060941828396,0.0018134264647818726,0.07165250412849211,0.06676592797783926,0.0018108015409528666,0.10793048281331119,0.09418282548476452,2.3685972735685406e-08,0.07674356017449835,0.07271468144044323
13,0.5,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia predictive of adverse maternal and neonatal outcomes? ACR independently predicts maternal and neonatal adverse events in suspected preeclampsia and could be useful for risk assessment.,1.8948778188548283e-07,0.1271550854027641,0.05031936082049411,0.014507411718254981,0.08426344578698952,0.0857192151750711,0.01448641232762294,0.07928105927483475,0.09418282548476452,1.8948778188548325e-07,0.11562833247295767,0.07271468144044323
13,0.5,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia act as an independent prognostic factor for maternal and neonatal adverse outcomes? ACR is a reliable predictor of adverse maternal and neonatal outcomes in cases of suspected preeclampsia and may help inform risk.,0.0,0.12602676010180724,0.08761251499676516,0.0,0.12895761498789637,0.09102329759235173,0.0,0.1320280343923712,0.09418282548476452,0.0,0.10143617276487005,0.07271468144044323
13,0.5,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes? ACR independently predicts negative outcomes for mother and newborn in suspected preeclampsia and might be useful for risk stratification.,9.474389094274162e-08,0.05907260132038994,0.10798042547456574,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03194457583538979,0.09418282548476452,9.474389094274162e-08,0.0012179812952122226,0.07271468144044323
14,0.5,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Rapid prescreening techniques like liquid-based cytology can identify these abnormalities, but confirmation with specialized tests such as colposcopy and biopsy is usually necessary for accurate diagnosis and treatment.",3.0791764556391007e-07,0.23987498824813924,0.039150354019158694,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
14,0.5,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Yes, methods including liquid-based cytology can detect these abnormalities, but further specialized evaluations like colposcopy and biopsy are often needed for precise diagnosis and management.",3.7897556377096597e-07,0.3221130864851123,0.039150354019158694,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
14,0.5,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Can rapid prescreening identify glandular cell abnormalities in Pap smears? Rapid prescreening, particularly liquid-based cytology, can effectively detect these abnormalities, yet additional testing such as colposcopy and biopsy is typically required for definitive diagnosis and appropriate care.",3.5528959103528067e-07,0.29394220951841543,0.039150354019158694,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
14,0.5,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Is detection of glandular cell abnormalities in Pap smears possible through rapid prescreening? Rapid prescreening approaches, such as liquid-based cytology, can detect these abnormalities, but accurate diagnosis and management usually demand further specialized tests like colposcopy and biopsy.",3.3160361829959537e-07,0.2665432353303001,0.039150354019158694,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
14,0.5,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular cell abnormalities in Pap smears found by rapid prescreening? Rapid prescreening methods including liquid-based cytology can identify these abnormalities, although confirmation with specialized procedures like colposcopy and biopsy is often necessary for accurate diagnosis and treatment planning.",3.0791764556391007e-07,0.23987498824813924,0.039150354019158694,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
14,0.5,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Does rapid prescreening detect glandular cell abnormalities in Pap smears? Yes, rapid prescreening techniques such as liquid-based cytology can detect these abnormalities, but further confirmation through specialized testing like colposcopy and biopsy is generally required for accurate diagnosis and appropriate management.",2.6054570009253947e-07,0.22323905288858592,0.014166790574056773,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
14,0.5,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Can glandular cell abnormalities be detected in Pap smears by rapid prescreening? Rapid prescreening methods, including liquid-based cytology, are effective in detecting these abnormalities; however, specialized tests like colposcopy and biopsy are often needed for confirmation and proper management.",3.0791764556391007e-07,0.23987498824813924,0.039150354019158694,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
14,0.5,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Techniques such as liquid-based cytology can detect these abnormalities, but additional specialized evaluations like colposcopy and biopsy are usually necessary for accurate diagnosis and treatment.",3.5528959103528067e-07,0.29394220951841543,0.039150354019158694,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
14,0.5,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular cell abnormalities detected in Pap smears through rapid prescreening? Rapid prescreening methods like liquid-based cytology can detect these abnormalities, though further specialized testing such as colposcopy and biopsy is typically required for accurate diagnosis and management.",3.3160361829959537e-07,0.2665432353303001,0.039150354019158694,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
14,0.5,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Do rapid prescreening procedures detect glandular cell abnormalities in Pap smears? Yes, methods such as liquid-based cytology can effectively detect these abnormalities, but confirmation with specialized tests like colposcopy and biopsy is often essential for accurate diagnosis and proper management.",2.8423167282822477e-07,0.21389950184488127,0.039150354019158694,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
15,0.5,1,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Do provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program?,9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,0.5,2,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid system?,9.474389094274141e-07,0.8593501027440711,0.2054320987654321,0.07253705859127503,0.9666283867397572,0.16749660479855144,0.07243206163811479,1.0794761733553817,0.12244897959183676,9.474389094274159e-07,1.173256224028452,0.08999999999999998
15,0.5,3,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"In Florida's Medicaid program, do provider service networks incur less spending than HMOs or primary care case management?",9.711248821630993e-07,0.9165085165840199,0.2054320987654321,0.0743504850560569,1.0272530085561922,0.16749660479855144,0.07424286317906767,1.1440146944929523,0.12244897959183676,9.711248821631012e-07,1.2422490955154042,0.08999999999999998
15,0.5,4,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Does Florida's Medicaid program see decreased expenditures through provider service networks relative to HMOs or primary care case management?,9.474389094274141e-07,0.8593501027440711,0.2054320987654321,0.07253705859127503,0.9666283867397572,0.16749660479855144,0.07243206163811479,1.0794761733553817,0.12244897959183676,9.474389094274159e-07,1.173256224028452,0.08999999999999998
15,0.5,5,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"Compared to HMOs or primary care case management, do provider service networks in Florida's Medicaid program result in cost savings?",9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,0.5,6,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Are provider service networks associated with lower Medicaid spending than HMOs or primary care case management in Florida?,9.711248821630993e-07,0.9165085165840199,0.2054320987654321,0.0743504850560569,1.0272530085561922,0.16749660479855144,0.07424286317906767,1.1440146944929523,0.12244897959183676,9.711248821631012e-07,1.2422490955154042,0.08999999999999998
15,0.5,7,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"Within Florida's Medicaid program, do provider service networks reduce costs more effectively than HMOs or primary care case management?",9.474389094274141e-07,0.8593501027440711,0.2054320987654321,0.07253705859127503,0.9666283867397572,0.16749660479855144,0.07243206163811479,1.0794761733553817,0.12244897959183676,9.474389094274159e-07,1.173256224028452,0.08999999999999998
15,0.5,8,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Is there evidence that provider service networks lower Medicaid expenditures compared to HMOs or primary care case management in Florida?,9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,0.5,9,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Do provider service networks offer a more cost-efficient alternative to HMOs or primary care case management in Florida's Medicaid program?,9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,0.5,10,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"In Florida's Medicaid program, do provider service networks achieve lower expenditures than HMOs or primary care case management?",9.711248821630993e-07,0.9165085165840199,0.2054320987654321,0.0743504850560569,1.0272530085561922,0.16749660479855144,0.07424286317906767,1.1440146944929523,0.12244897959183676,9.711248821631012e-07,1.2422490955154042,0.08999999999999998
16,0.5,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Is lumbar drainage an effective treatment for postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage can be beneficial in some cases by reducing pressure and aiding recovery. However, the",2.605457000925383e-07,0.057470646707208584,0.17159660430249102,0.019947691112600648,0.046989061878565774,0.1914672216441208,0.019918816950481588,0.0863792798315508,0.17481789802289285,2.6054570009253947e-07,0.1280168836303286,0.1560874089490115
16,0.5,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Does lumbar drainage work for cerebrospinal fluid fistula after spine surgery? It may be effective in certain situations by alleviating pressure and supporting healing. However, the",3.552895910352795e-07,0.1580873979937616,0.20603537981269512,0.027201396971728166,0.20113974170582472,0.1914672216441208,0.027162023114293082,0.2467219299067307,0.17481789802289285,3.552895910352811e-07,0.29507096829349555,0.1560874089490115
16,0.5,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Can lumbar drainage effectively treat postoperative cerebrospinal fluid fistula after spine surgery? In some instances, it helps by decreasing pressure and facilitating healing. However, the",3.789755637709648e-07,0.1989093925140164,0.20603537981269512,0.029014823436510045,0.24369935612462035,0.1914672216441208,0.028972824655245956,0.29117369247756475,0.17481789802289285,3.789755637709665e-07,0.3415909839283895,0.1560874089490115
16,0.5,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Is lumbar drainage a successful method for managing cerebrospinal fluid fistula after spine surgery? It can be helpful in specific cases by lowering pressure and encouraging recovery. However, the",2.842316728282236e-07,0.04475871268675746,0.20603537981269512,0.021761117577382527,0.08335670604944045,0.1914672216441208,0.02172961849143446,0.12411960781439779,0.17481789802289285,2.8423167282822487e-07,0.16723759678361105,0.1560874089490115
16,0.5,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","How effective is lumbar drainage for postoperative cerebrospinal fluid fistula post spine surgery? It can assist in some cases by relieving pressure and promoting tissue repair. However, the",3.079176455639089e-07,0.08112635685763214,0.20603537981269512,0.023574544042164407,0.12109703403228744,0.1914672216441208,0.023540420032387335,0.16334032096768025,0.17481789802289285,3.079176455639103e-07,0.20805959130386587,0.1560874089490115
16,0.5,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Does lumbar drainage aid in treating cerebrospinal fluid fistula following spine surgery? It may be effective in select cases by reducing pressure and enhancing healing. However, the",3.316036182995942e-07,0.11886668484047913,0.20603537981269512,0.025387970506946286,0.1603177471855699,0.1914672216441208,0.02535122157334021,0.20416231548793506,0.17481789802289285,3.316036182995957e-07,0.2506192057226615,0.1560874089490115
16,0.5,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Is lumbar drainage beneficial for postoperative cerebrospinal fluid fistula after spine surgery? It can be effective in certain scenarios by easing pressure and supporting healing. However, the",3.316036182995942e-07,0.11886668484047913,0.20603537981269512,0.025387970506946286,0.1603177471855699,0.1914672216441208,0.02535122157334021,0.20416231548793506,0.17481789802289285,3.316036182995957e-07,0.2506192057226615,0.1560874089490115
16,0.5,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Can lumbar drainage help with cerebrospinal fluid fistula after spine surgery? It is sometimes effective by relieving pressure and aiding the healing process. However, the",3.789755637709648e-07,0.1989093925140164,0.20603537981269512,0.029014823436510045,0.24369935612462035,0.1914672216441208,0.028972824655245956,0.29117369247756475,0.17481789802289285,3.789755637709665e-07,0.3415909839283895,0.1560874089490115
16,0.5,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Is lumbar drainage useful for managing cerebrospinal fluid fistula after spine surgery? It can be effective in some cases by decreasing pressure and facilitating recovery. However, the",3.316036182995942e-07,0.11886668484047913,0.20603537981269512,0.025387970506946286,0.1603177471855699,0.1914672216441208,0.02535122157334021,0.20416231548793506,0.17481789802289285,3.316036182995957e-07,0.2506192057226615,0.1560874089490115
16,0.5,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","How well does lumbar drainage work for postoperative cerebrospinal fluid fistula after spine surgery? It may be effective in certain cases by alleviating pressure and promoting healing. However, the",2.842316728282236e-07,0.04475871268675746,0.20603537981269512,0.021761117577382527,0.08335670604944045,0.1914672216441208,0.02172961849143446,0.12411960781439779,0.17481789802289285,2.8423167282822487e-07,0.16723759678361105,0.1560874089490115
17,0.5,1,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Are the increased rates of depression in women explained by differences in symptom reporting? Evidence indicates that women's higher depression rates might be partly due to how they report symptoms, as women often report more symptoms.",1.184298636784265e-07,0.10907012057145815,0.16712580348943987,0.00906713232390937,0.04052892478393799,0.12543252595155707,0.009054007704764347,0.03163430659254596,0.0783673469387755,1.1842986367842703e-07,0.07024717951369341,0.05387755102040818
17,0.5,2,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Is the higher incidence of depression among women due to varying symptom reporting? Research suggests that the elevated depression rates in women could be partially attributed to differential symptom reporting, with women typically reporting more symptoms.",1.184298636784265e-07,0.10907012057145815,0.16712580348943987,0.00906713232390937,0.04052892478393799,0.12543252595155707,0.009054007704764347,0.03163430659254596,0.0783673469387755,1.1842986367842703e-07,0.07024717951369341,0.05387755102040818
17,0.5,3,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Do differences in symptom reporting account for the greater prevalence of depression in women? There is evidence that the higher depression rates in women may be partially explained by their tendency to report more symptoms.,1.421158364141118e-07,0.08008258369820664,0.16712580348943987,0.01088055878869125,0.010675961634256215,0.12543252595155707,0.01086480924571722,0.062405965259299645,0.0783673469387755,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
17,0.5,4,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Can the higher depression rates in women be explained by differences in how symptoms are reported? Studies suggest that women's higher depression rates might be partly due to their more frequent symptom reporting.,1.894877818854824e-07,0.0671854356882231,0.10490358126721763,0.014507411718255009,0.09656356828642831,0.09321030372933486,0.014486412327622968,0.12694448639687117,0.0783673469387755,1.8948778188548325e-07,0.1686872523269467,0.05387755102040818
17,0.5,5,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Is the increased frequency of depression in women linked to differential symptom reporting? Evidence suggests that this may be the case, as women generally report more symptoms, which could partly explain their higher depression rates.",1.421158364141118e-07,0.08008258369820664,0.16712580348943987,0.01088055878869125,0.010675961634256215,0.12543252595155707,0.01086480924571722,0.062405965259299645,0.0783673469387755,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
17,0.5,6,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Are women's higher depression rates explained by differences in symptom reporting? There is evidence indicating that women report more symptoms, which may partially account for their elevated depression rates.",2.842316728282236e-07,0.11407343074275111,0.16712580348943987,0.021761117577382527,0.18999473382789445,0.12543252595155707,0.02172961849143446,0.2700453300375436,0.0783673469387755,2.8423167282822487e-07,0.31710725744521984,0.05387755102040818
17,0.5,7,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Does differential symptom reporting explain why women have higher rates of depression? Research shows that women tend to report more symptoms, which might partly explain their increased depression rates.",2.842316728282236e-07,0.11407343074275111,0.16712580348943987,0.021761117577382527,0.18999473382789445,0.12543252595155707,0.02172961849143446,0.2700453300375436,0.0783673469387755,2.8423167282822487e-07,0.31710725744521984,0.05387755102040818
17,0.5,8,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Are higher depression rates in women due to how symptoms are reported differently? Evidence suggests that women's tendency to report more symptoms may partially explain their higher depression prevalence.,2.842316728282236e-07,0.16358394363989026,0.1314605085648857,0.021761117577382527,0.18999473382789445,0.12543252595155707,0.02172961849143446,0.2700453300375436,0.0783673469387755,2.8423167282822487e-07,0.31710725744521984,0.05387755102040818
17,0.5,9,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Is the greater occurrence of depression in women a result of differential symptom reporting? Studies indicate that women report more symptoms, which could partly explain the higher rates of depression among them.",2.131737546211677e-07,0.05700990937215966,0.13490358126721766,0.01632083818303689,0.084634218170069,0.12543252595155707,0.01629721386857584,0.16084603807255293,0.0783673469387755,2.1317375462116866e-07,0.2037785721382157,0.05387755102040818
17,0.5,10,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Could the higher depression rates in women be due to differences in symptom reporting? There is evidence that women’s increased symptom reporting may partially account for their elevated depression rates.,2.605457000925383e-07,0.07898211093148211,0.16712580348943987,0.019947691112600648,0.15362708965701977,0.12543252595155707,0.019918816950481588,0.23230500205469662,0.0783673469387755,2.6054570009253947e-07,0.2778865442919374,0.05387755102040818
18,0.5,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there a link between crime and over-the-counter pharmacy syringe sales? Answer: Our results show that OTC pharmacy syringe sales did not correlate with higher reported crime rates in Los Angeles communities from 2006 to 2008.,7.10579182070559e-08,0.13252104035972767,0.03259869608613475,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
18,0.5,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Does crime relate to over-the-counter pharmacy syringe sales? Answer: Our study indicates that OTC pharmacy syringe sales were not connected to an increase in reported crime in local Los Angeles neighborhoods between 2006 and 2008.,4.73719454713706e-08,0.10324992977309444,0.03180708532418292,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,0.5,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Are over-the-counter pharmacy syringe sales associated with crime? Answer: Findings reveal that OTC pharmacy syringe sales did not lead to a rise in reported crime in Los Angeles communities during 2006-2008.,4.73719454713706e-08,0.0679408627921636,0.0038554765460572307,0.003626852929563759,0.11074833317490107,0.033293697978596916,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
18,0.5,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there an association between crime and OTC pharmacy syringe sales? Answer: The data shows no link between OTC pharmacy syringe sales and increased reported crime in local Los Angeles areas from 2006 to 2008.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.019851258254085735,0.029384756657483937,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,0.5,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Does selling syringes over-the-counter at pharmacies relate to crime rates? Answer: Our findings confirm that OTC pharmacy syringe sales were not linked to a surge in reported crime in Los Angeles communities during 2006-2008.,2.36859727356853e-08,0.11387080321755416,0.06035379812695108,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
18,0.5,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Are crime rates affected by over-the-counter pharmacy syringe sales? Answer: Evidence indicates no association between OTC pharmacy syringe sales and increased crime reports in Los Angeles neighborhoods between 2006 and 2008.,4.73719454713706e-08,0.023221689852812144,0.02813157590472888,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
18,0.5,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is crime connected to over-the-counter pharmacy syringe sales? Answer: Our research demonstrates that OTC pharmacy syringe sales did not cause an uptick in reported crime in local Los Angeles communities during 2006-2008.,2.36859727356853e-08,0.00992448261612111,0.029136316337148777,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
18,0.5,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Do over-the-counter pharmacy syringe sales impact crime levels? Answer: The findings show no increase in reported crime linked to OTC pharmacy syringe sales in Los Angeles areas from 2006 to 2008.,4.73719454713706e-08,0.0679408627921636,0.0038554765460572307,0.003626852929563759,0.11074833317490107,0.033293697978596916,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
18,0.5,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there a crime correlation with over-the-counter pharmacy syringe sales? Answer: Results indicate that OTC pharmacy syringe sales were not associated with higher reported crime in Los Angeles communities during 2006-2008.,4.73719454713706e-08,0.023221689852812144,0.02813157590472888,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
18,0.5,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Are OTC pharmacy syringe sales related to crime incidence? Answer: Our analysis found no evidence that OTC pharmacy syringe sales increased reported crime in local Los Angeles neighborhoods between 2006 and 2008.,2.36859727356853e-08,0.07671891495387229,0.03239293195628317,0.0018134264647818796,0.1211870441932823,0.06420927467300831,0.0018108015409528735,0.07899963486032124,0.033293697978596916,2.3685972735685406e-08,0.03390155167568176,0.0
19,0.5,1,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
19,0.5,2,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Does the management of ductal carcinoma in situ require expert breast pathology assessment? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ.",4.73719454713706e-08,0.2011966319469276,0.10564018243798734,0.003626852929563759,0.21533810324493619,0.16361111111111115,0.003621603081905747,0.2311043724460684,0.20408163265306126,4.737194547137081e-08,0.13323334788336805,0.14876033057851235
19,0.5,3,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is it important to have expert breast pathology assessment for ductal carcinoma in situ management? Answer: Yes, expert breast pathology assessment is crucial for the management of ductal carcinoma in situ.",4.73719454713706e-08,0.32112804811911966,0.09398203543739447,0.003626852929563759,0.32644753855207354,0.1412345679012346,0.003621603081905747,0.3317211237326214,0.16964285714285715,4.737194547137081e-08,0.287384027710627,0.14876033057851235
19,0.5,4,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is expert breast pathology evaluation needed for managing ductal carcinoma in situ? Answer: Yes, expert breast pathology evaluation is necessary for effective management of ductal carcinoma in situ.",2.36859727356853e-08,0.1953886540202392,0.07917515408259973,0.0018134264647818796,0.2056837522151369,0.13062500000000005,0.0018108015409528735,0.2170060717101241,0.16568163265306124,2.3685972735685406e-08,0.17405534240362286,0.14876033057851235
19,0.5,5,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: For managing ductal carcinoma in situ, is expert breast pathology assessment required? Answer: Yes, expert breast pathology assessment is required for proper management of ductal carcinoma in situ.",2.36859727356853e-08,0.1953886540202392,0.07917515408259973,0.0018134264647818796,0.2056837522151369,0.13062500000000005,0.0018108015409528735,0.2170060717101241,0.16568163265306124,2.3685972735685406e-08,0.17405534240362286,0.14876033057851235
19,0.5,6,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Does managing ductal carcinoma in situ necessitate expert breast pathology assessment? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in situ.",4.73719454713706e-08,0.2011966319469276,0.10564018243798734,0.003626852929563759,0.21533810324493619,0.16361111111111115,0.003621603081905747,0.2311043724460684,0.20408163265306126,4.737194547137081e-08,0.13323334788336805,0.14876033057851235
19,0.5,7,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is specialized breast pathology assessment important for the management of ductal carcinoma in situ? Answer: Yes, specialized breast pathology assessment is important for managing ductal carcinoma in situ.",2.36859727356853e-08,0.1458781411231005,0.05096037178636012,0.0018134264647818796,0.2056837522151369,0.13062500000000005,0.0018108015409528735,0.2170060717101241,0.16568163265306124,2.3685972735685406e-08,0.17405534240362286,0.14876033057851235
19,0.5,8,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is it necessary to have an expert breast pathology assessment when managing ductal carcinoma in situ? Answer: Yes, it is necessary to have expert breast pathology assessment for managing ductal carcinoma in situ.",9.47438909427412e-08,0.2711729095257214,0.031707479224376695,0.007253705859127518,0.3130070018766502,0.08910836762688615,0.007243206163811494,0.35677740618431253,0.13987235798005293,9.474389094274162e-08,0.35637689919757776,0.14876033057851235
19,0.5,9,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Must expert breast pathology assessment be conducted for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment must be conducted for managing ductal carcinoma in situ.",2.36859727356853e-08,0.18846540573157666,0.03758725238127647,0.0018134264647818796,0.2399624076614999,0.10560000000000008,0.0018108015409528735,0.2949225448559334,0.1684163377285071,2.3685972735685406e-08,0.2510163835397523,0.14876033057851235
19,0.5,10,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is expert breast pathology assessment a necessary component in the management of ductal carcinoma in situ? Answer: Yes, it is a necessary component for managing ductal carcinoma in situ.",0.0,0.28681952299032254,0.11490747922437669,0.0,0.29706307738283266,0.1689940828402367,0.0,0.30806541358219786,0.20408163265306126,0.0,0.21327605555690532,0.14876033057851235
20,0.5,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there an initial night impact on sleep bruxism? Findings indicated no general first night influence on RMMA frequency severity in young, healthy sleep bruxism patients. Clinically, a single night of sleep recording may suffice for those with moderate to high frequency SB. Yet, low RMMA frequency on the first night might require confirmation via a second night.",7.105791820705622e-08,0.047415036712798564,0.10076114682175288,0.005440279394345618,0.018303790615187054,0.0507015306122449,0.0054324046228586,0.02920819839808786,0.017236072637734686,7.105791820705622e-08,0.05406722127027486,0.0
20,0.5,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does sleep bruxism exhibit a first night effect? The study found no significant first night effect on the severity of RMMA frequency among young, healthy individuals with SB. In practice, one night of sleep monitoring could be adequate for patients with moderate to high SB frequency. However, low RMMA frequency during the initial night might need verification through a second night.",0.0,0.10114042647073473,0.10250877115720558,0.0,0.07048954378575623,0.0507015306122449,0.0,0.023901626915860064,0.017236072637734686,0.0,0.0,0.0
20,0.5,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night impact on sleep bruxism? Results revealed no overall first night effect on the severity of RMMA frequency in young, healthy SB patients. For clinical purposes, a single night sleep recording might be enough for moderate to high frequency SB. Nonetheless, low RMMA frequency on night one may be confirmed by recording a second night.",4.737194547137081e-08,0.06564543300066328,0.10136369362559841,0.0036268529295637453,0.036003367714587675,0.0507015306122449,0.003621603081905733,0.011189692895409387,0.017236072637734686,4.737194547137081e-08,0.03571808260207909,0.0
20,0.5,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night affect sleep bruxism? The results showed no overall first night effect on RMMA frequency severity in young healthy patients with SB. In clinical settings, one night of sleep recording may be sufficient for moderate to high frequency SB patients. However, low RMMA frequency on the first night could be validated by a second night recording.",4.737194547137081e-08,0.00882065944886401,0.03017832647462282,0.0036268529295637453,0.011682414010730113,0.033163265306122444,0.003621603081905733,0.011189692895409387,0.017236072637734686,4.737194547137081e-08,0.03571808260207909,0.0
20,0.5,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night effect on sleep bruxism severity? Findings demonstrated no general first night effect on RMMA frequency severity in young, healthy SB patients. Clinically, a single night of sleep recording may be adequate for moderate to high frequency SB cases. Yet, low RMMA frequency on the first night might be confirmed by a second night.",7.105791820705622e-08,0.034727616394643945,0.010432646650595345,0.005440279394345618,0.031206722281952537,0.015036235687690733,0.0054324046228586,0.05441355041844975,0.000939510352663115,7.105791820705622e-08,0.05406722127027486,0.0
20,0.5,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does sleep bruxism show a first night effect? The study results indicated no overall first night effect on RMMA frequency severity in young, healthy SB patients. For clinical practice, one night of sleep recording may suffice for moderate to high frequency SB. However, low RMMA frequency on the initial night could be verified with a second night.",9.474389094274162e-08,0.028846854123974364,0.10013717421124832,0.0072537058591274906,0.000285285112508582,0.0507015306122449,0.007243206163811466,0.04755733706628362,0.017236072637734686,9.474389094274162e-08,0.07275935428242919,0.0
20,0.5,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there an initial night effect on sleep bruxism? Results showed no overall first night impact on RMMA frequency severity in young healthy SB patients. Clinically, one night of sleep recording might be enough for moderate to high frequency SB patients. Still, low RMMA frequency on the first night may require confirmation by a second night.",1.1842986367842703e-07,0.015277194542649752,0.08143856381035869,0.009067132323909363,0.01806385355568718,0.0507015306122449,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
20,0.5,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night influence on sleep bruxism? Findings revealed no overall first night effect on RMMA frequency severity in young and healthy SB patients. In clinical practice, one night of sleep recording could be sufficient for moderate to high frequency SB. However, low RMMA frequency on night one might need confirmation through a second night.",9.474389094274162e-08,0.028846854123974364,0.10013717421124832,0.0072537058591274906,0.000285285112508582,0.0507015306122449,0.007243206163811466,0.04755733706628362,0.017236072637734686,9.474389094274162e-08,0.07275935428242919,0.0
20,0.5,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night impact sleep bruxism? The results showed no general first night effect on RMMA frequency severity in young, healthy SB patients. Clinically, one night of sleep recording may be adequate for moderate to high frequency SB patients. Yet, low RMMA frequency on the first night could be confirmed by a second night recording.",1.1842986367842703e-07,0.0752015011972742,0.005802469135802485,0.009067132323909363,0.04373597135420404,0.03218960465994872,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
20,0.5,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night effect on sleep bruxism? The study found no overall first night effect on RMMA frequency severity in young, healthy patients with SB. For clinical use, a single night sleep recording may be sufficient for patients with moderate to high frequency SB. However, low RMMA frequency on the first night might be validated by a second night.",0.0,4.440892098500626e-16,0.0,0.0,0.023496514595251483,0.016844959359551777,0.0,0.0,0.0,0.0,0.0,0.0
21,0.5,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns cause less pain? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not lead to lower cumulative opioid usage.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.5,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain reduced in newborns undergoing minimal access major surgery? The use of minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair is not linked to decreased cumulative opioid doses.,2.36859727356853e-08,0.033146172468933255,0.0010047404324198955,0.0018134264647818796,0.0327898228229917,0.0,0.0018108015409528735,0.03390155167568176,0.0,2.3685972735685406e-08,0.035091319811269006,0.0
21,0.5,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery result in less pain for newborns? Minimal access procedures for repairing esophageal atresia or congenital diaphragmatic hernia do not correspond with reduced cumulative opioid consumption.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.5,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain with minimal access major surgery in newborn patients? Performing minimal access surgery to fix esophageal atresia or congenital diaphragmatic hernia does not reduce the total opioid dosage required.,2.36859727356853e-08,0.033146172468933255,0.0010047404324198955,0.0018134264647818796,0.0327898228229917,0.0,0.0018108015409528735,0.03390155167568176,0.0,2.3685972735685406e-08,0.035091319811269006,0.0
21,0.5,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns reduce pain levels? Minimal access surgical repair of esophageal atresia or congenital diaphragmatic hernia is not associated with lower cumulative opioid doses.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.5,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns lead to less pain? The cumulative opioid doses are not decreased when minimal access surgery is used for esophageal atresia or congenital diaphragmatic hernia repair.,2.36859727356853e-08,0.033146172468933255,0.0010047404324198955,0.0018134264647818796,0.0327898228229917,0.0,0.0018108015409528735,0.03390155167568176,0.0,2.3685972735685406e-08,0.035091319811269006,0.0
21,0.5,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is minimal access major surgery less painful for newborns? Repairing esophageal atresia or congenital diaphragmatic hernia with minimal access surgery does not result in less cumulative opioid use.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.5,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does undergoing minimal access major surgery cause less pain in newborns? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia does not diminish cumulative opioid requirements.,1.421158364141118e-07,0.21763667988247315,0.007182518210197705,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,0.5,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain lessened by minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not correspond with reduced total opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.5,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery reduce pain in newborn major surgery cases? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia is not linked to lower cumulative opioid use.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
22,0.5,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites mirror community practice? Family practice at residency teaching sites strives to closely mirror community practice, though some differences exist due to the focus on education. Residency programs aim to...",1.184298636784265e-07,0.1632377003628065,0.0187616488856156,0.00906713232390937,0.15811053872494485,0.01433106575963719,0.009054007704764347,0.1576610666943541,0.011632653061224532,1.1842986367842703e-07,0.1568905770836877,0.00834467120181405
22,0.5,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Is family practice at residency teaching sites representative of community practice? Family practice at residency teaching sites is designed to represent community practice closely, but variations may occur because of the teaching and learning emphasis. Residency programs endeavor to...",4.73719454713706e-08,0.02575629299850002,0.016770409346691245,0.0036268529295637453,0.060329357109093706,0.00529525308746083,0.003621603081905733,0.06014745969624036,0.004277281160398036,4.737194547137081e-08,0.059851841459428456,0.003055415003466927
22,0.5,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice in residency teaching sites accurately reflect community practice? Family practice in residency teaching sites attempts to accurately reflect community practice; however, differences can arise from the priority given to teaching. Residency programs work to...",9.47438909427412e-08,0.16697359837426573,0.037786619159099505,0.0072537058591274906,0.16407159919085057,0.037664399092970466,0.007243206163811473,0.12410143412991248,0.009041602072670907,9.474389094274162e-08,0.12349336091481211,0.006476247106542904
22,0.5,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","How well does family practice at residency teaching sites reflect community practice? Family practice at residency teaching sites aims to reflect community practice closely, though some distinctions exist due to educational priorities. Residency programs seek to...",1.184298636784265e-07,0.1632377003628065,0.0187616488856156,0.00906713232390937,0.15811053872494485,0.01433106575963719,0.009054007704764347,0.1576610666943541,0.011632653061224532,1.1842986367842703e-07,0.1568905770836877,0.00834467120181405
22,0.5,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Is the family practice at residency teaching sites similar to community practice? Family practice at residency teaching sites aims for similarity with community practice, yet some differences occur because of the focus on training. Residency programs strive to...",7.10579182070559e-08,0.05735446312874082,0.013492782223183425,0.005440279394345618,0.0918913774266974,0.008150510204081599,0.0054324046228586,0.09161903752274592,0.006593590561224494,7.105791820705622e-08,0.09116928482195785,0.004716198979591822
22,0.5,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites align with community practice? Family practice at residency teaching sites aligns closely with community practice, but differences may be present due to the emphasis on instruction. Residency programs endeavor to...",9.47438909427412e-08,0.1284654216764909,0.014671280276816606,0.0072537058591274906,0.12446318887313934,0.011158444647369814,0.007243206163811473,0.12410143412991248,0.009041602072670907,9.474389094274162e-08,0.12349336091481211,0.006476247106542904
22,0.5,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","To what extent does family practice at residency teaching sites reflect community practice? Family practice at residency teaching sites seeks to reflect community practice as closely as possible, though some differences exist due to the teaching focus. Residency programs aim to...",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.5,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Is family practice at residency teaching sites comparable to community practice? Family practice at residency teaching sites is comparable to community practice, but some differences arise from the focus on education and training. Residency programs strive to...",9.47438909427412e-08,0.16697359837426573,0.037786619159099505,0.0072537058591274906,0.16407159919085057,0.037664399092970466,0.007243206163811473,0.12410143412991248,0.009041602072670907,9.474389094274162e-08,0.12349336091481211,0.006476247106542904
22,0.5,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites emulate community practice? Family practice at residency teaching sites attempts to emulate community practice closely, yet some differences are present because of the emphasis on teaching. Residency programs work to...",9.47438909427412e-08,0.1284654216764909,0.014671280276816606,0.0072537058591274906,0.12446318887313934,0.011158444647369814,0.007243206163811473,0.12410143412991248,0.009041602072670907,9.474389094274162e-08,0.12349336091481211,0.006476247106542904
22,0.5,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","How closely does family practice at residency teaching sites match community practice? Family practice at residency teaching sites matches community practice closely, although some differences exist due to the focus on learning and teaching. Residency programs aim to...",7.10579182070559e-08,0.05735446312874082,0.013492782223183425,0.005440279394345618,0.0918913774266974,0.008150510204081599,0.0054324046228586,0.09161903752274592,0.006593590561224494,7.105791820705622e-08,0.09116928482195785,0.004716198979591822
23,0.5,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the length of psychological treatment for depression connected to the chance of seeking treatment again? The length of psychological treatment for depression does not directly influence the probability of returning for treatment. More important factors include treatment effectiveness, the individual's personal situation and support network, and their readiness to continue treatment.",3.316036182995957e-07,0.27768945808656786,0.024202496089884784,0.025387970506946217,0.29884611647352255,0.036543209876543234,0.025351221573340132,0.2984672977067544,0.033487654320987645,3.316036182995957e-07,0.297857598767842,0.03000000000000002
23,0.5,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does the duration of psychological treatment for depression affect the likelihood of re-entering treatment? The duration itself is not directly linked to returning to treatment. Instead, factors like how effective the treatment is, the person's circumstances and support system, and their willingness to continue treatment are more crucial.",4.263475092423373e-07,0.22576965955611428,0.0700865188229487,0.03264167636607371,0.24359828930058436,0.06222222222222222,0.0325944277371516,0.2704582194250298,0.047500000000000014,4.263475092423373e-07,0.2982255781874783,0.0322222222222222
23,0.5,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is there a relationship between how long psychological treatment for depression lasts and the chance of returning to treatment? The duration is not directly related to the likelihood of returning. Key influences include the treatment's success, the individual's life situation and support, and their motivation to keep receiving treatment.",4.026615365066519e-07,0.17522062565360264,0.0913530594656708,0.030828249901291835,0.222092084079621,0.06222222222222222,0.030783626196198732,0.24847931270625478,0.047500000000000014,4.026615365066519e-07,0.2757527223354206,0.0322222222222222
23,0.5,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does the time spent in psychological treatment for depression impact the chance of returning to treatment? The duration does not have a direct correlation with returning. More significant are factors such as treatment efficacy, the individual's personal context and support network, and their willingness to continue treatment.",4.500334819780227e-07,0.21778024007239916,0.0913530594656708,0.03445510283085558,0.26557719601935936,0.06222222222222222,0.034405229278104466,0.2929310752770875,0.047500000000000014,4.500334819780227e-07,0.3212150964121778,0.0322222222222222
23,0.5,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the length of psychological treatment for depression associated with the likelihood of returning for more treatment? The length of treatment is not directly connected to the chance of returning. Factors like treatment effectiveness, the person's circumstances and support system, and their willingness to pursue further treatment play a larger role.",3.552895910352811e-07,0.1898504055781438,0.05142250391011523,0.02720139697172809,0.20871110933456016,0.04182291666666667,0.027162023114293,0.20591969828745826,0.047500000000000014,3.552895910352811e-07,0.23226761039568222,0.0322222222222222
23,0.5,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the duration of psychological treatment for depression linked to the probability of re-entering treatment? The duration itself is not directly related to returning. Instead, the effectiveness of the treatment, the individual's personal situation and support network, and their readiness to continue treatment are more influential.",4.737194547137081e-07,0.27056568814939386,0.0691423156640179,0.03626852929563745,0.2880500518714171,0.06222222222222222,0.03621603081905733,0.31592059350178703,0.047500000000000014,4.737194547137081e-07,0.34474559382237224,0.0322222222222222
23,0.5,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does how long psychological treatment for depression lasts relate to the likelihood of returning to treatment? The duration is not directly connected to returning. More important are factors such as treatment success, the individual's circumstances and support system, and their willingness to continue treatment.",5.210914001850789e-07,0.2852215208679314,0.0913530594656708,0.0398953822252012,0.334570067506311,0.06222222222222222,0.039837633900963065,0.36354864249104146,0.047500000000000014,5.210914001850789e-07,0.39353575799180396,0.0322222222222222
23,0.5,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is there a connection between the duration of psychological treatment for depression and the chance of returning to treatment? The duration does not directly affect the likelihood of returning. Instead, factors like treatment effectiveness, the individual's personal circumstances and support, and their willingness to continue treatment are more significant.",4.026615365066519e-07,0.20410175817693332,0.07052915724747251,0.030828249901291835,0.222092084079621,0.06222222222222222,0.030783626196198732,0.24847931270625478,0.047500000000000014,4.026615365066519e-07,0.2757527223354206,0.0322222222222222
23,0.5,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the length of time in psychological treatment for depression related to the chance of needing treatment again? The length of treatment does not directly influence the likelihood of returning. More critical are factors like the treatment's effectiveness, the person's situation and support system, and their willingness to keep receiving treatment.",3.552895910352811e-07,0.1898504055781438,0.05142250391011523,0.02720139697172809,0.20871110933456016,0.04182291666666667,0.027162023114293,0.20591969828745826,0.047500000000000014,3.552895910352811e-07,0.23226761039568222,0.0322222222222222
23,0.5,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does the duration of psychological treatment for depression have a direct impact on the probability of returning to treatment? The duration itself is not directly linked to returning. Factors such as how effective the treatment is, the individual's personal circumstances and support network, and their willingness to continue treatment play a more important role.",2.8423167282822487e-07,0.1022862203889936,0.07249211272010866,0.02176111757738247,0.12099596720825101,0.06222222222222222,0.0217296184914344,0.14529507647102413,0.047500000000000014,2.8423167282822487e-07,0.1703922066775947,0.0322222222222222
24,0.5,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it possible for a new surgical technique for the temporomandibular joint to enhance access and minimize complications? Answer: The VMPA offers direct access and excellent visibility to the TMJ area, resulting in favorable aesthetic and functional outcomes. It is regarded as the preferred approach for routine TMJ surgeries.",2.3685972735685406e-08,0.10785209564055176,0.062245322543618004,0.0018134264647818726,0.05054903390251164,0.021266540642722105,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
24,0.5,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a novel surgical method for the temporomandibular joint improve accessibility and reduce complications? Answer: The VMPA provides direct access and optimal visibility to the TMJ region, producing good cosmetic and functional results. It is considered the approach of choice for standard TMJ surgeries.",9.474389094274162e-08,0.028513153103694844,0.08264462809917356,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Does a new surgical approach to the temporomandibular joint improve access and decrease complications? Answer: The VMPA allows direct access and clear visibility to the TMJ area, leading to positive aesthetic and functional outcomes. It is regarded as the preferred technique for common TMJ procedures.",7.105791820705622e-08,0.010627073760686834,0.038296331722753874,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.5,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can an innovative surgical technique for the temporomandibular joint enhance access and lower complication rates? Answer: The VMPA grants direct access and favorable visualization of the TMJ region, yielding excellent aesthetic and functional results. It is considered the preferred approach for typical TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is a novel surgical approach to the temporomandibular joint effective in improving access and reducing complications? Answer: The VMPA offers direct access and good visibility to the TMJ area, resulting in satisfactory aesthetic and functional outcomes. It is viewed as the approach of choice for common TMJ operations.",0.0,0.057762265046662264,0.041056726397850296,0.0,0.02949562470467848,0.021266540642722105,0.0,0.0,0.0,0.0,0.0,0.0
24,0.5,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a new surgical technique for the temporomandibular joint provide better access and fewer complications? Answer: The VMPA enables direct access and clear visibility to the TMJ region, achieving favorable aesthetic and functional results. It is considered the preferred method for routine TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Does a novel surgical approach to the temporomandibular joint enhance accessibility and minimize complications? Answer: The VMPA ensures direct access and optimal visibility to the TMJ area, producing good cosmetic and functional outcomes. It is regarded as the approach of choice for standard TMJ surgeries.",7.105791820705622e-08,0.020179467597532863,0.06043388429752067,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.5,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can an innovative surgical method improve access to the temporomandibular joint and reduce complications? Answer: The VMPA provides direct access and excellent visualization of the TMJ region, leading to positive aesthetic and functional results. It is considered the preferred approach for common TMJ surgeries.",9.474389094274162e-08,0.028513153103694844,0.08264462809917356,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it possible for a new surgical approach to the temporomandibular joint to facilitate access and lower complication risks? Answer: The VMPA offers direct access and favorable visibility to the TMJ area, yielding good aesthetic and functional outcomes. It is seen as the approach of choice for typical TMJ procedures.",4.737194547137081e-08,0.10089475016878291,0.04271407254361799,0.0036268529295637453,0.0711683211052474,0.021266540642722105,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
24,0.5,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a novel surgical technique for the temporomandibular joint improve surgical access and decrease complications? Answer: The VMPA allows direct access and clear visualization of the TMJ region, resulting in satisfactory cosmetic and functional results. It is regarded as the preferred technique for routine TMJ surgeries.",4.737194547137081e-08,0.012691247799749839,0.03925619834710743,0.0036268529295637453,0.013989487235059883,0.021266540642722105,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
25,0.5,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypersons and healthcare professionals consider it acceptable to break confidentiality to safeguard a patient's wife from a sexually transmitted infection? Most French individuals base their decision on situational factors when determining if a doctor should breach confidentiality to protect the spouse of a patient with an STD.,7.105791820705622e-08,0.007959027215065362,0.037769847781801716,0.005440279394345618,0.006423629273291986,0.039930555555555566,0.0054324046228586,0.034887179966024195,0.020399305555555556,7.105791820705622e-08,0.06453852113757153,0.0
25,0.5,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Are French non-professionals and health workers agreeable to violating confidentiality to shield a patient's wife from an STD? In France, most people are influenced by the context when deciding whether a physician should disclose confidential information to protect the spouse of an infected patient.",1.8948778188548325e-07,0.08907878990606344,0.05859375,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
25,0.5,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health professionals and laypeople approve of breaching confidentiality to protect a patient's wife from sexually transmitted diseases? The majority in France take situational factors into account when deciding if a doctor should break confidentiality to safeguard the patient's spouse.,2.6054570009253947e-07,0.19605681051368595,0.03361018655489808,0.0199476911126006,0.19300958485370545,0.039930555555555566,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
25,0.5,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it acceptable to French laypeople and medical professionals to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Most French citizens weigh situational circumstances when deciding if a physician should disclose confidential information to protect the spouse of an STD-infected patient.,1.6580180914979784e-07,0.0975959617068165,0.03587876892915089,0.012693985253473108,0.09537111528978759,0.039930555555555566,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
25,0.5,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health care providers and laypersons find it permissible to violate confidentiality to protect a patient's wife from STDs? Most people in France consider situational factors when determining if a doctor should breach confidentiality for the spouse's protection.,3.0791764556391007e-07,0.21269274587323928,0.05859375,0.023574544042164344,0.2456533183391243,0.039930555555555566,0.023540420032387266,0.28000963799900846,0.020399305555555556,3.079176455639103e-07,0.31585294941847764,0.0
25,0.5,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French non-experts and health professionals find breaching confidentiality acceptable to protect a patient's wife from a sexually transmitted infection? In France, most individuals are influenced by the situation when deciding if a physician should break confidentiality to protect the spouse of a patient with an STD.",1.1842986367842703e-07,0.051774343047919835,0.0368653549382716,0.009067132323909363,0.04990874121303035,0.039930555555555566,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
25,0.5,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French laypeople and medical professionals willing to breach confidentiality to protect a patient's wife from an STD? Most French people rely on situational factors when deciding if a doctor should disclose confidential information to safeguard the patient's spouse.,3.0791764556391007e-07,0.21269274587323928,0.05859375,0.023574544042164344,0.2456533183391243,0.039930555555555566,0.023540420032387266,0.28000963799900846,0.020399305555555556,3.079176455639103e-07,0.31585294941847764,0.0
25,0.5,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health professionals and laypersons agree on breaching confidentiality to protect a patient's wife from sexually transmitted diseases? The majority in France consider situational factors when deciding if a physician should break confidentiality to protect the spouse of an infected patient.,2.3685972735685406e-07,0.2043309540718976,0.00994154750164366,0.018134264647818726,0.2023491358974101,0.014946992110453645,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
25,0.5,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease acceptable to French laypeople and health professionals? Most individuals in France base their decision on situational factors when determining if a doctor should breach confidentiality for the spouse's protection.,2.3685972735685406e-07,0.13670683889531787,0.05859375,0.018134264647818726,0.16769177686941372,0.039930555555555566,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
25,0.5,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and health workers find it acceptable to violate confidentiality to protect a patient's wife from an STD? Most people in France are influenced by the context when deciding whether a physician should breach confidentiality to safeguard the spouse of an infected patient.,1.6580180914979784e-07,0.0975959617068165,0.03587876892915089,0.012693985253473108,0.09537111528978759,0.039930555555555566,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
26,0.5,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? The ACE gene I/D polymorphism might be a candidate gene for insulin resistance because it participates in the renin-angiotensin-aldosterone system, which influences glucose metabolism. Nevertheless, more studies are required to confirm this.",7.105791820705622e-08,0.1314850780211283,0.045282029547763794,0.005440279394345618,0.13083301862383356,0.04651234567901234,0.0054324046228586,0.1300024215237885,0.04645492994650541,7.105791820705622e-08,0.1289713478427008,0.045351473922902494
26,0.5,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? The ACE gene I/D polymorphism is considered a potential candidate gene for insulin resistance due to its role in the renin-angiotensin-aldosterone system, which affects glucose metabolism. Further investigation is necessary.",1.4211583641411244e-07,0.08750480827730556,0.027768595041322272,0.010880558788691236,0.11417150703595569,0.011612654320987667,0.0108648092457172,0.1417831447740454,0.0059120982986767545,1.4211583641411244e-07,0.1703875925940399,0.024375
26,0.5,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to",Does the insertion allele of the ACE gene I/D polymorphism represent a candidate gene for insulin resistance? This polymorphism in the ACE gene is a possible candidate gene for insulin resistance because it is involved in the renin-angiotensin-aldosterone system that regulates glucose metabolism. Additional research is needed to validate this.,2.3685972735685406e-08,0.023597713916179153,0.002296304904594454,0.0018134264647818726,0.005904201849303181,0.018765432098765453,0.0018108015409528666,0.007213231144150178,0.020321361058601158,2.3685972735685406e-08,0.02150620522096336,0.0
26,0.5,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Is the ACE gene I/D polymorphism insertion allele a candidate gene for insulin resistance? The ACE gene I/D polymorphism is potentially associated with insulin resistance as it functions within the renin-angiotensin-aldosterone system, which has a role in glucose metabolism. However, further studies are required.",1.6580180914979784e-07,0.11342518138809243,0.025723887611999438,0.012693985253473108,0.1400048189995058,0.009981737161224358,0.012675610786670066,0.16749079433350111,0.007064300797033081,1.6580180914979784e-07,0.19592550662411812,0.02498356344510192
26,0.5,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The insertion allele of the ACE gene I/D polymorphism: could it be a candidate gene for insulin resistance? This polymorphism is a potential candidate gene due to its involvement in the renin-angiotensin-aldosterone system, which influences glucose metabolism, although more research is needed.",2.1317375462116866e-07,0.06590767297774036,0.09339359504132227,0.016320838183036854,0.08977395737465876,0.08098765432098766,0.0162972138685758,0.1498770997315848,0.04158790170132326,2.1317375462116866e-07,0.21256144198367144,0.0
26,0.5,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Might the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? The ACE gene I/D polymorphism is considered a candidate gene for insulin resistance because it participates in the renin-angiotensin-aldosterone system, involved in glucose metabolism. Further research is necessary to establish this.",1.1842986367842703e-07,0.06223135775631761,0.029725763393493615,0.009067132323909363,0.08898384764668998,0.013170878592254728,0.009054007704764333,0.11671743766161535,0.004813050113072946,1.1842986367842703e-07,0.1454849920247816,0.023795359904818555
26,0.5,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Is the insertion allele of the ACE gene I/D polymorphism implicated as a candidate gene for insulin resistance? Given its role in the renin-angiotensin-aldosterone system affecting glucose metabolism, the ACE gene I/D polymorphism is a potential candidate gene, but additional studies are needed.",1.8948778188548325e-07,0.14002609820276168,0.023585769556557765,0.014507411718254981,0.16651751754915667,0.008272972880544432,0.014486412327622933,0.19387400980328717,0.008273594143552075,1.8948778188548325e-07,0.2221319648398974,0.025623268698060954
26,0.5,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to",Could the ACE gene I/D polymorphism insertion allele be a candidate gene for insulin resistance? This polymorphism is a possible candidate because it is involved in the renin-angiotensin-aldosterone system that plays a role in glucose metabolism. More research is required to confirm this.,1.8948778188548325e-07,0.007998063810390477,0.11776859504132227,0.014507411718254981,0.06508134478428707,0.08098765432098766,0.014486412327622933,0.12455929174729308,0.04158790170132326,1.8948778188548325e-07,0.18658595558041347,0.0
26,0.5,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Is the insertion allele of the ACE gene I/D polymorphism a potential candidate gene for insulin resistance? Due to its function in the renin-angiotensin-aldosterone system, which regulates glucose metabolism, the ACE gene I/D polymorphism is considered a candidate gene, though further investigation is warranted.",1.6580180914979784e-07,0.11342518138809243,0.025723887611999438,0.012693985253473108,0.1400048189995058,0.009981737161224358,0.012675610786670066,0.16749079433350111,0.007064300797033081,1.6580180914979784e-07,0.19592550662411812,0.02498356344510192
26,0.5,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Does the ACE gene I/D polymorphism insertion allele serve as a candidate gene for insulin resistance? The polymorphism may be a candidate due to its involvement in the renin-angiotensin-aldosterone system impacting glucose metabolism. However, more research is needed to verify this.",2.3685972735685406e-07,0.09144558700781857,0.09278503159622034,0.018134264647818726,0.11509176535895049,0.08098765432098766,0.018108015409528666,0.17585258613484278,0.04158790170132326,2.3685972735685406e-07,0.2392296890658323,0.0
27,0.5,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there a link between androgens and sexual desire in women? Evidence indicates that androgens like testosterone might influence sexual desire in women, though this relationship is complex and affected by hormone levels, individual differences, and psychological factors.",4.500334819780224e-07,0.297394379575866,0.15020408163265303,0.03445510283085558,0.326782060758426,0.10224489795918368,0.034405229278104466,0.35661963167931177,0.05536332179930796,4.500334819780227e-07,0.39161839417671773,0.037677816224529016
27,0.5,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Does a correlation exist between androgens and female sexual desire? Research suggests that androgens such as testosterone could impact sexual desire in women, but this connection is complex and shaped by hormone levels, personal differences, and psychological influences.",4.500334819780224e-07,0.22245954924506028,0.2040816326530612,0.03445510283085558,0.28827388406065113,0.13,0.034405229278104466,0.35661963167931177,0.05536332179930796,4.500334819780227e-07,0.39161839417671773,0.037677816224529016
27,0.5,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Are androgens related to sexual desire in women? There is evidence that androgens, including testosterone, may contribute to sexual desire in women, although this relationship is multifaceted and affected by hormone levels, individual variability, and psychological factors.",4.737194547137077e-07,0.36538305352650013,0.12143700455388766,0.03626852929563745,0.39566158166277,0.0730670339761249,0.03621603081905734,0.426380532114913,0.025978565141824023,4.737194547137081e-07,0.4214713573263995,0.037677816224529016
27,0.5,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there an association between androgens and women's sexual desire? Studies suggest that androgens like testosterone may be involved in sexual desire in women; however, this relationship is complex and influenced by hormone concentrations, individual differences, and psychological components.",4.263475092423371e-07,0.19579130216289942,0.2040816326530612,0.03264167636607371,0.2608749098725358,0.13,0.0325944277371516,0.3284487547126149,0.05536332179930796,4.263475092423373e-07,0.3626308573034662,0.037677816224529016
27,0.5,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Do androgens correlate with sexual desire in women? Evidence points to a possible role of androgens such as testosterone in female sexual desire, but the relationship is intricate and affected by hormone levels, individual differences, and psychological factors.",4.500334819780224e-07,0.22245954924506028,0.2040816326530612,0.03445510283085558,0.28827388406065113,0.13,0.034405229278104466,0.35661963167931177,0.05536332179930796,4.500334819780227e-07,0.39161839417671773,0.037677816224529016
27,0.5,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there a connection between androgens and sexual desire among women? Research shows that androgens, including testosterone, might affect sexual desire in women, though this link is complex and influenced by hormone levels, personal factors, and psychological aspects.",4.500334819780224e-07,0.2599269644104627,0.17707545981355505,0.03445510283085558,0.28827388406065113,0.13,0.034405229278104466,0.35661963167931177,0.05536332179930796,4.500334819780227e-07,0.39161839417671773,0.037677816224529016
27,0.5,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Can androgens influence sexual desire in women? Evidence suggests that androgens like testosterone may play a role in women's sexual desire, but the relationship is complex and shaped by hormone levels, individual differences, and psychological factors.",4.97405427449393e-07,0.27802940039987245,0.2040816326530612,0.03808195576041933,0.3454322979005995,0.13,0.03802683236001021,0.41546013170224505,0.05536332179930796,4.974054274493935e-07,0.4522430159931532,0.037677816224529016
27,0.5,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is sexual desire in women correlated with androgens? There is evidence indicating that androgens such as testosterone could be involved in sexual desire in women, yet this relationship is complex and affected by hormone levels, individual variability, and psychological factors.",4.026615365066518e-07,0.24090783427860973,0.15294941935868575,0.030828249901291835,0.2706880933461613,0.10370343316289263,0.030783626196198732,0.3010497805244996,0.05536332179930796,4.026615365066519e-07,0.3344599803367694,0.037677816224529016
27,0.5,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Are androgens connected to sexual desire in women? Studies indicate that androgens like testosterone may influence sexual desire in women, although the relationship is complex and modulated by hormone levels, individual differences, and psychological factors.",5.210914001850783e-07,0.38856366439782386,0.1454878826530612,0.03989538222520121,0.417294181084217,0.0997265625,0.039837633900963086,0.44623179036899874,0.05536332179930796,5.210914001850789e-07,0.483991714307733,0.037677816224529016
27,0.5,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there a relationship between androgens and sexual desire in women? Evidence suggests that androgens such as testosterone might contribute to sexual desire in women, but this relationship is complicated by hormone levels, individual differences, and psychological factors.",4.500334819780224e-07,0.297394379575866,0.15020408163265303,0.03445510283085558,0.326782060758426,0.10224489795918368,0.034405229278104466,0.35661963167931177,0.05536332179930796,4.500334819780227e-07,0.39161839417671773,0.037677816224529016
28,0.5,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals useful and pertinent to both practitioners and athletes? Yes, they offer current research, information, and guidelines on injury prevention, diagnosis, treatment, and other sports medicine topics.",3.5528959103527993e-07,0.24415022758534421,0.11895786437292223,0.027201396971728138,0.26779858678348756,0.11426592797783926,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
28,0.5,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Do sports medicine journals hold relevance and practical value for practitioners and athletes? Indeed, they deliver the latest research, data, and protocols related to injury prevention, diagnosis, treatment, and more in sports medicine.",2.84231672828224e-07,0.0979069009403708,0.15339663988312632,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,0.5,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals applicable and meaningful to practitioners and athletes? Absolutely, these journals provide up-to-date studies, insights, and recommendations on injury prevention, diagnosis, treatment, and various sports medicine areas.",3.5528959103527993e-07,0.24415022758534421,0.11895786437292223,0.027201396971728138,0.26779858678348756,0.11426592797783926,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
28,0.5,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Is the content of sports medicine journals relevant and usable by practitioners and athletes? Yes, as they supply current research, information, and guidelines covering injury prevention, diagnosis, treatment, and other facets of sports medicine.",2.605457000925387e-07,0.10914416230755286,0.12312320238312632,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.2046613880039425,0.0710059171597633,2.6054570009253947e-07,0.2447505698655732,0.04865220249835634
28,0.5,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Can practitioners and athletes benefit from sports medicine journals? Certainly, because these journals present the latest research, data, and guidelines on injury prevention, diagnosis, treatment, and related sports medicine topics.",3.5528959103527993e-07,0.24415022758534421,0.11895786437292223,0.027201396971728138,0.26779858678348756,0.11426592797783926,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
28,0.5,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals important and practical for practitioners and athletes? Yes, they contain up-to-date research findings, information, and guidance on injury prevention, diagnosis, treatment, and more within sports medicine.",3.5528959103527993e-07,0.1963469737536241,0.15339663988312632,0.027201396971728138,0.26779858678348756,0.11426592797783926,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
28,0.5,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Do sports medicine journals provide relevant and applicable knowledge to practitioners and athletes? Yes, as they offer recent research, information, and protocols concerning injury prevention, diagnosis, treatment, and other sports medicine matters.",3.0791764556390933e-07,0.17437477219430164,0.12117441766090412,0.02357454404216438,0.1988057152965368,0.11426592797783926,0.023540420032387308,0.271352762502616,0.0710059171597633,3.079176455639103e-07,0.31374344135252397,0.04865220249835634
28,0.5,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals valuable and pertinent to practitioners and athletes? Indeed, they provide current research, information, and recommendations on injury prevention, diagnosis, treatment, and various aspects of sports medicine.",3.5528959103527993e-07,0.1963469737536241,0.15339663988312632,0.027201396971728138,0.26779858678348756,0.11426592797783926,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
28,0.5,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals significant and useful for practitioners and athletes? Yes, they deliver up-to-date research, information, and guidelines on injury prevention, diagnosis, treatment, and other sports medicine topics.",3.7897556377096523e-07,0.28094880646203224,0.11773134495857215,0.029014823436510018,0.30416623095436224,0.11426592797783926,0.028972824655245928,0.38055205446760665,0.0710059171597633,3.789755637709665e-07,0.4270721266595281,0.04865220249835634
28,0.5,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Is the information in sports medicine journals relevant and applicable to practitioners and athletes? Yes, these journals provide the latest research, data, and guidelines on injury prevention, diagnosis, treatment, and various aspects of sports medicine.",2.3685972735685343e-07,0.037282279123935336,0.15339663988312632,0.01813426464781874,0.10349553549221158,0.11426592797783926,0.018108015409528687,0.1729126896893627,0.0710059171597633,2.3685972735685406e-07,0.2119607470425815,0.04865220249835634
29,0.5,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does the quantity of needles influence acupuncture treatment for neck pain? Answer: The amount of needles applied during acupuncture for neck pain can differ based on the patient's condition and the practitioner's method. Although studies on the exact effect of needle count are scarce, the",2.3685972735685406e-08,0.03628563889351,0.040752588959438646,0.0018134264647818726,0.03914022686438168,0.04434829637641968,0.0018108015409528666,0.008517171800753065,0.02271498107084911,2.3685972735685406e-08,0.023530497410194418,0.0
29,0.5,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: In acupuncture for neck pain, is the number of needles significant? Answer: The number of needles utilized in acupuncture for neck pain varies according to the individual's needs and the practitioner's technique. Research specifically addressing the impact of needle quantity is limited, but the",4.737194547137081e-08,0.08280773303659972,0.02588486934798409,0.0036268529295637453,0.11280690634821422,0.04769641105290315,0.003621603081905733,0.0810273428056254,0.024785018929150904,4.737194547137081e-08,0.047628048989254435,0.0
29,0.5,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does the number of needles used in acupuncture affect neck pain treatment? Answer: The needle count in acupuncture for neck pain depends on the patient's condition and the practitioner's style. Limited research exists on how needle quantity influences treatment outcomes, however, the",9.474389094274162e-08,0.006301625714966619,0.05957911957168352,0.0072537058591274906,0.03147734034957228,0.04434829637641968,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
29,0.5,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Is the quantity of acupuncture needles important in treating neck pain? Answer: The number of needles used in acupuncture therapy for neck pain may change based on individual conditions and the practitioner's approach. Although there is limited research on the precise effect of needle numbers, the",0.0,0.1506841696869441,0.10707911957168353,0.0,0.061613082716439393,0.04434829637641968,0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0
29,0.5,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: How does the number of needles affect acupuncture treatment for neck pain? Answer: The number of needles employed in acupuncture for neck pain treatment varies according to the patient's condition and the practitioner's method. Research on the specific influence of needle quantity is limited, but the",0.0,0.03013683393738864,0.020911319118168778,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
29,0.5,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does acupuncture needle count impact neck pain therapy? Answer: The quantity of needles used in acupuncture for neck pain is variable depending on the individual's condition and the practitioner's technique. While there is limited research on the direct impact of needle number, the",7.105791820705622e-08,0.01876408139746344,0.060678167757287335,0.005440279394345618,0.007379788770512263,0.04434829637641968,0.0054324046228586,0.03911087718850137,0.02271498107084911,7.105791820705622e-08,0.07232066157962613,0.0
29,0.5,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Is the number of needles a factor in acupuncture treatment for neck pain? Answer: The number of needles applied during acupuncture for neck pain depends on the patient's condition and the practitioner's approach. Research specifically on the effect of needle quantity is limited, though the",2.3685972735685406e-08,0.025327443822929396,0.0022958804283164658,0.0018134264647818726,0.023873153186523055,0.0010031775464828113,0.0018108015409528666,0.02372223194622114,0.0005276493146384141,2.3685972735685406e-08,0.023530497410194418,0.0
29,0.5,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: What role does needle quantity play in acupuncture for neck pain? Answer: The number of needles used in acupuncture for neck pain treatment can vary based on individual patient conditions and the practitioner's style. Limited research exists on the effect of needle count, but the",2.3685972735685406e-08,0.03628563889351,0.040752588959438646,0.0018134264647818726,0.023873153186523055,0.0010031775464828113,0.0018108015409528666,0.02372223194622114,0.0005276493146384141,2.3685972735685406e-08,0.023530497410194418,0.0
29,0.5,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: In treating neck pain with acupuncture, does needle number matter? Answer: The amount of needles used during acupuncture treatment for neck pain depends on the patient's condition and the practitioner's method. There is limited research on the specific impact of needle quantity, however, the",4.737194547137081e-08,0.04321902706520664,0.06172764564878104,0.0036268529295637453,0.016150708639682154,0.04434829637641968,0.003621603081905733,0.015013325609441353,0.02271498107084911,4.737194547137081e-08,0.047628048989254435,0.0
29,0.5,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does the number of acupuncture needles influence neck pain relief? Answer: The number of needles used in acupuncture for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific effect of needle quantity is limited, the",4.737194547137081e-08,0.01979435298569765,0.017079119571683538,0.0036268529295637453,0.01608869510729205,0.02110566599093216,0.003621603081905733,0.015013325609441353,0.02271498107084911,4.737194547137081e-08,0.047628048989254435,0.0
30,0.5,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are we adhering to guidelines when preparing high fall-risk patients for discharge after rehabilitation? Answer: Evidence shows minimal systematic fall risk assessments for high-risk patients during rehab. When risks were found, strategies were usually applied. However, failure to",2.6054570009253926e-07,0.14106725176220847,0.08098765432098766,0.0199476911126006,0.17363970069367252,0.06222222222222222,0.019918816950481533,0.20763741384459067,0.04246913580246913,2.6054570009253947e-07,0.24315650106229247,0.021728395061728398
30,0.5,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we follow guidelines in preparing patients at high fall risk for discharge post-rehabilitation? Answer: There is scant evidence that systematic fall risk assessments are conducted during rehab for high-risk individuals. When risks were identified, strategies were typically implemented. However, failure to",1.6580180914979784e-07,0.07399080180331863,0.057192294416169104,0.012693985253473108,0.07098554663359025,0.06222222222222222,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.13494291642206147,0.021728395061728398
30,0.5,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Preparing high fall-risk patients for discharge after rehabilitation: Are guidelines being met? Answer: Little evidence exists that systematic fall risk assessments occur during rehabilitation for those at high risk. When risks were detected, strategies were generally put in place. However, failure to",1.6580180914979784e-07,0.04098379320522705,0.08098765432098766,0.012693985253473108,0.07098554663359025,0.06222222222222222,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.13494291642206147,0.021728395061728398
30,0.5,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are guidelines followed when preparing patients at high risk of falls for discharge after rehab? Answer: There is limited evidence that systematic falls risk assessments are performed during rehabilitation for high-risk patients. When a risk was identified, a strategy was usually implemented. However, failure to",9.474389094274162e-08,0.02800907828172461,0.08098765432098766,0.0072537058591274906,0.00036797941963628844,0.06222222222222222,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.06083494426833802,0.021728395061728398
30,0.5,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we meet guidelines in preparing patients at high risk of falls for home discharge after rehabilitation? Answer: Evidence indicates that systematic falls risk assessments during rehabilitation for high-risk patients are rare. When risks were identified, strategies were generally applied. However, failure to",1.4211583641411244e-07,0.01745329579503263,0.08098765432098766,0.010880558788691236,0.04688799505453023,0.06222222222222222,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
30,0.5,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are patients at high risk of falls properly prepared for discharge home after rehabilitation according to guidelines? Answer: There is little evidence that systematic falls risk assessments happen during rehab for high-risk patients. When risks were found, strategies were typically implemented. However, failure to",1.1842986367842703e-07,0.005536222429666893,0.08098765432098766,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
30,0.5,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Following guidelines in preparing high fall-risk patients for discharge after rehabilitation: Are we compliant? Answer: There is minimal evidence that systematic falls risk assessments are conducted during rehabilitation for high-risk patients. When risks were identified, strategies were usually put in place. However, failure to",1.1842986367842703e-07,0.005536222429666893,0.08098765432098766,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
30,0.5,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Is the preparation of patients at high risk of falls for discharge home after rehabilitation meeting guidelines? Answer: Little evidence shows that systematic falls risk assessment is done during rehabilitation for high-risk patients. When a risk was found, strategies were generally implemented. However, failure to",9.474389094274162e-08,0.02800907828172461,0.08098765432098766,0.0072537058591274906,0.00036797941963628844,0.06222222222222222,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.06083494426833802,0.021728395061728398
30,0.5,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are guidelines met when preparing high fall-risk patients for discharge after rehabilitation? Answer: There is scarce evidence that systematic falls risk assessments are performed during rehab for those at high risk. When risks were identified, a strategy was typically implemented. However, failure to",1.4211583641411244e-07,0.01745329579503263,0.08098765432098766,0.010880558788691236,0.04688799505453023,0.06222222222222222,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
30,0.5,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Preparing patients at high risk of falls for home discharge post-rehabilitation: Are guidelines followed? Answer: Evidence suggests that systematic falls risk assessments during rehabilitation for high-risk individuals are infrequent. When a risk was recognized, strategies were usually applied. However, failure to",1.8948778188548325e-07,0.06508134478428707,0.08098765432098766,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
31,0.5,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Yes, symptoms are important when selecting patients for phase I clinical trials.",4.73719454713706e-08,0.1111454657755857,0.009527552262554029,0.003626852929563759,0.11231296951894443,0.012307220427685561,0.003621603081905747,0.11326695201084025,0.01370663957288959,4.737194547137081e-08,0.1139331754913564,0.013725809698166364
31,0.5,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Should symptoms be taken into account when choosing patients for phase I clinical trials? Answer: Yes, symptoms should be considered when choosing patients for phase I clinical trials.",4.73719454713706e-08,0.15027799199547376,0.03433987317140172,0.003626852929563759,0.15295050981973812,0.04044664728371594,0.003621603081905747,0.1555779773499415,0.045145486596002926,4.737194547137081e-08,0.15812095710377383,0.04843639110826224
31,0.5,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Do symptoms play a role in the selection of patients for phase I clinical trials? Answer: Yes, symptoms play a significant role in the selection of patients for phase I clinical trials.",1.421158364141118e-07,0.10433377536786592,0.016746125966545372,0.010880558788691277,0.14534946983155805,0.025669055195622764,0.010864809245717241,0.18848619228621155,0.01781440966858497,1.4211583641411244e-07,0.18607676256611283,0.026611649011095917
31,0.5,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Is it necessary to consider symptoms when evaluating patients for phase I clinical trials? Answer: Yes, it is necessary to consider symptoms when evaluating patients for phase I clinical trials.",9.47438909427412e-08,0.05423582049196085,0.01731301939058169,0.007253705859127518,0.05090136730156347,0.03143351800554017,0.007243206163811494,0.046877901883457085,0.046094182825484775,9.474389094274162e-08,0.04202767239506011,0.06129501385041558
31,0.5,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Are symptoms a factor in deciding patient eligibility for phase I clinical trials? Answer: Yes, symptoms are a factor in deciding patient eligibility for phase I clinical trials.",4.73719454713706e-08,0.001746453304056761,0.016620498614958484,0.003626852929563759,0.001082196971361249,0.02770083102493079,0.003621603081905747,0.004379064317738823,0.03878116343490304,4.737194547137081e-08,0.008234366230611467,0.049861495844875287
31,0.5,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Should patient symptoms be evaluated for phase I clinical trial inclusion? Answer: Yes, patient symptoms should be evaluated for phase I clinical trial inclusion.",4.73719454713706e-08,0.1111454657755857,0.009527552262554029,0.003626852929563759,0.05203930164416626,0.015449198043842538,0.003621603081905747,0.05025357195993596,0.021066311001675775,4.737194547137081e-08,0.04791915829517146,0.027316097260695643
31,0.5,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Do symptoms influence the consideration of patients for phase I clinical trials? Answer: Yes, symptoms influence the consideration of patients for phase I clinical trials.",2.36859727356853e-08,0.16505358593185626,0.013406769390581691,0.0018134264647818796,0.1702094682247779,0.0339335180055402,0.0018108015409528735,0.1756639643089315,0.05218793282548473,2.3685972735685406e-08,0.1814373713771471,0.06817001385041549
31,0.5,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Is symptom assessment important in the selection process for phase I clinical trials? Answer: Yes, symptom assessment is important in the selection process for phase I clinical trials.",4.73719454713706e-08,0.001746453304056761,0.016620498614958484,0.003626852929563759,0.05026203862567158,0.011433518005540294,0.003621603081905747,0.04893994957148795,0.016094182825484693,4.737194547137081e-08,0.04721740821418363,0.02129501385041549
31,0.5,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Are symptoms relevant when assessing patients for phase I clinical trials? Answer: Yes, symptoms are relevant when assessing patients for phase I clinical trials.",4.73719454713706e-08,0.1111454657755857,0.009527552262554029,0.003626852929563759,0.11231296951894443,0.012307220427685561,0.003621603081905747,0.11326695201084025,0.01370663957288959,4.737194547137081e-08,0.1139331754913564,0.013725809698166364
31,0.5,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Must symptoms be taken into consideration when recruiting patients for phase I clinical trials? Answer: Yes, symptoms must be taken into consideration when recruiting patients for phase I clinical trials.",9.47438909427412e-08,0.05423582049196085,0.01731301939058169,0.007253705859127518,0.05090136730156347,0.03143351800554017,0.007243206163811494,0.046877901883457085,0.046094182825484775,9.474389094274162e-08,0.04202767239506011,0.06129501385041558
32,0.5,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might improve blood lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, offering significant metabolic and cardiovascular benefits. Further prospective studies are needed.",1.6580180914979753e-07,0.04724496117222721,0.09,0.012693985253473108,0.11320236974350362,0.046400951814396206,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
32,0.5,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can airway surgery decrease serum lipid levels in obstructive sleep apnea patients? Surgical intervention may enhance lipid levels in OSA patients, especially those who have dyslipidemia before surgery, potentially providing important metabolic and cardiovascular advantages. Prospective research should investigate this.",1.1842986367842692e-07,0.06569324620577666,0.038867786705624546,0.009067132323909363,0.09561657902901377,0.020104384977288833,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
32,0.5,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients? Surgery could improve blood lipid levels in OSA patients, notably in those with preoperative dyslipidemia, which might lead to considerable metabolic and cardiovascular improvements. This warrants further prospective studies.",0.0,0.09452007007635643,0.06728501892915088,0.0,0.06447880749394841,0.046400951814396206,0.0,0.0,0.0,0.0,0.0,0.0
32,0.5,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does performing airway surgery affect serum lipid levels in obstructive sleep apnea patients? Airway surgery may positively impact lipid levels in OSA patients, particularly those with existing dyslipidemia, potentially resulting in significant metabolic and cardiovascular benefits. Prospective studies should explore this further.",7.105791820705622e-08,0.046026979877014984,0.01728531855955677,0.005440279394345618,0.042499213113674106,0.021417388369294285,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
32,0.5,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can serum lipid levels be lowered by airway surgery in patients with obstructive sleep apnea? Surgery may help improve lipid profiles in OSA patients, especially among those with preoperative dyslipidemia, possibly offering major metabolic and cardiovascular benefits. This should be studied prospectively.",7.105791820705622e-08,0.05540919288785506,0.09,0.005440279394345618,0.007841854085677724,0.046400951814396206,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
32,0.5,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is airway surgery effective in lowering serum lipid levels in obstructive sleep apnea patients? Surgical treatment might improve blood lipid levels, particularly in OSA patients with dyslipidemia before surgery, potentially yielding substantial metabolic and cardiovascular benefits. Prospective studies are recommended.",1.1842986367842692e-07,0.005398772313191635,0.09,0.009067132323909363,0.05913514847322743,0.046400951814396206,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
32,0.5,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery contribute to lowering serum lipid levels in obstructive sleep apnea patients? Surgery may enhance lipid levels in patients with OSA, especially those with preoperative dyslipidemia, possibly providing significant metabolic and cardiovascular advantages. Further prospective studies should be conducted.",9.474389094274162e-08,0.03859813775851073,0.04013850415512466,0.0072537058591274906,0.06870567132945338,0.020777683116335252,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
32,0.5,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can airway surgery lead to a decrease in serum lipid levels among obstructive sleep apnea patients? Surgery might improve lipid profiles in OSA patients, particularly those with dyslipidemia prior to surgery, which could result in notable metabolic and cardiovascular benefits. Prospective research is necessary.",2.3685972735685406e-08,0.1030372418771095,0.09,0.0018134264647818726,0.04094831008375399,0.046400951814396206,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
32,0.5,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is there evidence that airway surgery lowers serum lipid levels in obstructive sleep apnea patients? Surgical intervention may improve blood lipid levels in patients with OSA, especially those with preoperative dyslipidemia, potentially leading to important metabolic and cardiovascular benefits. This requires prospective study.",4.737194547137081e-08,0.01349272727073103,0.04249999999999998,0.0036268529295637453,0.016961299083595893,0.022025951814396205,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
32,0.5,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery have an impact on serum lipid levels in obstructive sleep apnea patients? Surgery may improve lipid levels in OSA patients, particularly those with preoperative dyslipidemia, potentially offering major benefits in metabolism and cardiovascular outcomes. Prospective studies should examine this.",7.105791820705622e-08,0.012214922288724672,0.041347797501643656,0.005440279394345618,0.042499213113674106,0.021417388369294285,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
33,0.5,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography a viable alternative to bone scintigraphy for detecting bone metastases in breast cancer? Answer: Our results indicate that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.5,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans substitute bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our findings imply that routine bone scintigraphy is not needed for metastatic breast cancer patients when CT imaging of the thorax, abdomen, and pelvis is performed.",1.184298636784265e-07,0.09887403359652636,0.02498356344510192,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
33,0.5,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Does computerized tomography replace bone scintigraphy for detecting bone metastases in breast cancer cases? Answer: Our study suggests that routine bone scintigraphy is unnecessary in metastatic breast cancer patients if CT of the thorax, abdomen, and pelvis is done.",9.47438909427412e-08,0.03712156612126272,0.05113221329437545,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
33,0.5,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT imaging be used instead of bone scintigraphy to detect bone metastases from breast cancer? Answer: Our evidence suggests that routine bone scintigraphy is not required for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are carried out.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.5,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is bone scintigraphy essential when computerized tomography is performed for detecting bone metastases in breast cancer? Answer: Our data suggest that routine bone scintigraphy is not necessary for metastatic breast cancer patients if CT imaging of the thorax, abdomen, and pelvis is available.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.5,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerized tomography replace bone scintigraphy in the detection of bone metastases in breast cancer patients? Answer: Our findings indicate that routine bone scintigraphy is not needed for patients presenting with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are performed.",2.3685972735685353e-07,0.18970134556446672,0.04434829637641968,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.5,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it possible to replace bone scintigraphy with CT for detecting bone metastases from breast cancer? Answer: Our results suggest that routine bone scintigraphy is unnecessary for metastatic breast cancer patients when CT imaging of the thorax, abdomen, and pelvis is done.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.5,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans serve as a replacement for bone scintigraphy in identifying bone metastases in breast cancer? Answer: Our findings recommend that routine bone scintigraphy is not required for patients with metastatic breast cancer if CT of the thorax, abdomen, and pelvis is performed.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.5,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is routine bone scintigraphy needed if computerized tomography is used to detect bone metastases from breast cancer? Answer: Our study suggests it is not necessary for patients presenting with metastatic breast cancer when CT scans of the thorax, abdomen, and pelvis are conducted.",1.8948778188548272e-07,0.20585205420414887,0.0,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.5,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerized tomography be used in place of bone scintigraphy for detecting bone metastases from breast cancer? Answer: Our evidence suggests that routine bone scintigraphy is not required for metastatic breast cancer patients if CT imaging of the thorax, abdomen, and pelvis is performed.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
34,0.5,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain considered a clinically significant issue in general adult psychiatry? Yes, pain is indeed a clinically relevant concern in general adult psychiatry because it frequently coexists with mental health disorders like depression, anxiety, and post-traumatic stress disorder. Addressing pain in conjunction with psychiatric symptoms is essential for thorough patient care and better outcomes.",2.3685972735685406e-08,0.10053574449951075,0.057021550094517974,0.0018134264647818726,0.1286697907869887,0.07765753174764106,0.0018108015409528666,0.13070617618577085,0.07939508506616257,2.3685972735685406e-08,0.10507787228404242,0.060964083175803374
34,0.5,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Does pain represent a clinically important problem in general adult psychiatry? Yes, pain is a clinically important problem in general adult psychiatry as it is commonly linked with mental health conditions such as depression, anxiety, and PTSD. Managing pain alongside psychiatric symptoms is vital for comprehensive treatment and patient improvement.",7.105791820705622e-08,0.0692167087361697,0.006643349851398694,0.005440279394345618,0.06911907255858996,0.005877340329059455,0.0054324046228586,0.06895435364721036,0.004974844625562691,7.105791820705622e-08,0.06871423846717528,0.003935862740908375
34,0.5,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain a relevant clinical issue in the field of general adult psychiatry? Yes, pain is a relevant clinical issue in general adult psychiatry since it is often connected to mental health disorders including depression, anxiety, and post-traumatic stress disorder. Treating pain together with psychiatric symptoms is key to providing holistic patient care and enhancing recovery.",7.105791820705622e-08,0.09001974821691405,0.023421550094518018,0.005440279394345618,0.11605327231889895,0.041517585573092805,0.0054324046228586,0.11685946225432531,0.04171726884163355,7.105791820705622e-08,0.11763907849271149,0.041740707551043664
34,0.5,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain recognized as a clinically pertinent problem in general adult psychiatry? Yes, pain is recognized as a clinically pertinent problem in general adult psychiatry because it frequently accompanies mental health issues such as depression, anxiety, and PTSD. Effective treatment of pain alongside psychiatric symptoms is crucial for comprehensive patient management.",4.737194547137081e-08,0.1010707692647852,0.04077346124335045,0.0036268529295637453,0.10213617432775512,0.0420079815164881,0.003621603081905733,0.10320524077064963,0.043053894525674194,4.737194547137081e-08,0.10427565495743751,0.043911200270908654
34,0.5,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain an important clinical concern in general adult psychiatry? Yes, pain is an important clinical concern in general adult psychiatry as it is often associated with mental illnesses like depression, anxiety, and post-traumatic stress disorder. Addressing pain in parallel with psychiatric symptoms is essential for complete patient care and improved outcomes.",2.3685972735685406e-08,0.022554498438822623,0.0021340054610375775,0.0018134264647818726,0.02252085153366945,0.0018845247263646892,0.0018108015409528666,0.022466045049959416,0.0015925692548250936,2.3685972735685406e-08,0.022387519806204903,0.0012581390464188463
34,0.5,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain a clinically relevant issue within general adult psychiatry? Yes, pain is a clinically relevant issue in general adult psychiatry since it commonly co-occurs with mental health disorders such as depression, anxiety, and PTSD. Treating pain in combination with psychiatric symptoms is fundamental for comprehensive patient care.",1.1842986367842703e-07,0.05912157402240448,0.029051620402792744,0.009067132323909363,0.027546692235508985,0.05349247762033464,0.009054007704764333,0.025263508126454504,0.05718434126450968,1.1842986367842703e-07,0.02275549922584119,0.060964083175803374
34,0.5,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Does pain pose a clinically significant problem in general adult psychiatry? Yes, pain poses a clinically significant problem in general adult psychiatry because it is frequently linked to mental health conditions including depression, anxiety, and post-traumatic stress disorder. Managing pain alongside psychiatric symptoms is critical for holistic patient treatment.",9.474389094274162e-08,0.09337246114584374,0.009027429497318759,0.0072537058591274906,0.0932449426631603,0.007994376074311263,0.007243206163811466,0.09302539579901525,0.006772715387352191,9.474389094274162e-08,0.09270226744844257,0.005362447436441514
34,0.5,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain a problem of clinical relevance in general adult psychiatry? Yes, pain is a problem of clinical relevance in general adult psychiatry as it is often associated with mental health disorders like depression, anxiety, and PTSD. Addressing pain in conjunction with psychiatric symptoms is vital for thorough patient care and enhanced recovery.",0.0,0.026659506944613387,0.017936474596839988,0.0,0.027182242374899968,0.018674648183154813,0.0,0.027725887222397994,0.01937034703260289,0.0,0.028291721655508084,0.020023571145184285
34,0.5,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain considered a clinically meaningful problem in general adult psychiatry? Yes, pain is considered a clinically meaningful problem in general adult psychiatry because it often occurs alongside mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Effective treatment of pain along with psychiatric symptoms is essential for comprehensive care.",2.3685972735685406e-08,0.04973674081372215,0.020359441641019202,0.0018134264647818726,0.050246738756067,0.020887687668921504,0.0018108015409528666,0.0507577667054675,0.02132805542970516,2.3685972735685406e-08,0.051268652329536035,0.021680544923370196
34,0.5,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain a clinically significant issue in general adult psychiatry? Yes, pain is a clinically significant issue in general adult psychiatry since it is frequently associated with mental health disorders including depression, anxiety, and PTSD. Treating pain together with psychiatric symptoms is crucial for holistic patient care and better health outcomes.",4.737194547137081e-08,0.045618994819989656,0.004347044946804268,0.0036268529295637453,0.045552731016738957,0.0038422331234669593,0.003621603081905733,0.04544297572398737,0.0032495430330110042,4.737194547137081e-08,0.04528440554808055,0.002568974675436278
35,0.5,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do preoperative statins decrease the incidence of atrial fibrillation following coronary artery bypass grafting? Answer: Our research suggests that statin use before surgery appears to lower the risk of AF after CABG.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
35,0.5,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can preoperative statins help prevent atrial fibrillation post-coronary artery bypass grafting? Answer: Findings from our study indicate that administering statins before surgery may reduce the occurrence of AF after CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,0.5,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Are statins given preoperatively effective in reducing atrial fibrillation after CABG? Answer: Our study showed that preoperative statin therapy likely diminishes the development of AF following CABG.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.5,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Question: Does the use of statins before coronary artery bypass grafting reduce atrial fibrillation? Answer: According to our study, preoperative statin treatment seems to decrease AF incidence after CABG.",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.5,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is there a reduction in atrial fibrillation after CABG with preoperative statin therapy? Answer: Our findings suggest that statins administered before surgery reduce the likelihood of AF post-CABG.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.5,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do statins administered before surgery lower the risk of atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicates that preoperative statin use appears to reduce AF occurrence following CABG.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
35,0.5,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does preoperative statin use impact atrial fibrillation rates after coronary artery bypass grafting? Answer: The study demonstrated that statin therapy before surgery seems to lessen AF development post-CABG.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.5,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Are patients given statins before CABG less likely to develop atrial fibrillation? Answer: Our research suggests that preoperative statin therapy reduces the chance of AF after CABG.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.5,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can preoperative statin therapy decrease the frequency of atrial fibrillation after coronary artery bypass grafting? Answer: Our study found that statins used before CABG appear to reduce AF development.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
35,0.5,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does preoperative administration of statins reduce atrial fibrillation following coronary artery bypass graft surgery? Answer: Our findings indicate that preoperative statin therapy tends to lower AF incidence after CABG.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
36,0.5,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and useful to practitioners and athletes? There is a shortage of research focusing on diagnostic and treatment methods in sports medicine literature. The evidence supporting sports medicine needs to grow both in quantity and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.5,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold relevance and applicability for practitioners and athletes? The sports medicine literature lacks sufficient studies on diagnostic and therapeutic interventions. It is essential to expand the evidence base for sports medicine in both volume and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.5,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals valuable and applicable to practitioners and athletes? Few studies address diagnostic and treatment interventions within the sports medicine literature. The evidence base in sports medicine must be enhanced in terms of both quantity and quality.,1.4211583641411222e-07,0.15843063997897167,0.015054169816074561,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.5,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals significant and practical for practitioners and athletes? There is a scarcity of research on diagnostic and treatment approaches in sports medicine literature. Increasing the volume and quality of evidence in sports medicine is necessary.,1.6580180914979753e-07,0.22491042517533,0.04630283485943398,0.012693985253473108,0.21618935393522687,0.02775510204081633,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.5,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and useful for practitioners and athletes? The literature in sports medicine shows a deficiency of studies on diagnostic and treatment interventions. The evidence base for sports medicine should continue to expand in both volume and quality.,9.474389094274162e-08,0.10280071813615255,0.00952255325029372,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,0.5,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals provide relevant and applicable information to practitioners and athletes? There is a lack of studies addressing diagnostic and treatment interventions in sports medicine literature. The evidence supporting sports medicine must grow in quantity and quality.,1.4211583641411222e-07,0.15843063997897167,0.015054169816074561,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.5,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and relevant to practitioners and athletes? The sports medicine literature has a limited number of studies on diagnostic and treatment interventions. The evidence base for sports medicine needs ongoing growth in both volume and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.5,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals important and relevant for practitioners and athletes? There is an insufficient amount of research on diagnostic and treatment interventions in sports medicine literature. The evidence base must increase in both quantity and quality.,1.8948778188548283e-07,0.1642734888416455,0.06521541950113377,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.5,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals useful and relevant to practitioners and athletes? The sports medicine literature contains few studies on diagnostic and treatment interventions. The evidence base for sports medicine must continue to increase in volume and quality.,1.8948778188548283e-07,0.2173163361995467,0.02121632966912254,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.5,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and applicable for practitioners and athletes? There is a shortage of studies in the sports medicine literature addressing diagnostic and treatment interventions. The evidence base must grow in both volume and quality.,1.8948778188548283e-07,0.1642734888416455,0.06521541950113377,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
37,0.5,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? This study revealed for the first time that RALP causes less tissue damage than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.5,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy result in less invasiveness than retropubic radical prostatectomy? The study demonstrated for the first time that RALP leads to reduced tissue trauma compared to RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.5,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP less invasive than RRP? This research showed for the first time that robotically assisted laparoscopic radical prostatectomy produces lower tissue injury than retropubic radical prostatectomy.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
37,0.5,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the robotically assisted laparoscopic radical prostatectomy procedure less invasive than retropubic radical prostatectomy? The study indicated for the first time that RALP results in less tissue trauma than RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.5,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy associated with less invasiveness than retropubic radical prostatectomy? This study found for the first time that RALP causes less tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.5,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy cause less tissue trauma than retropubic radical prostatectomy? This study showed for the first time that RALP is less invasive than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.5,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? This study demonstrated for the first time that RALP induces less tissue trauma than RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.5,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy a less invasive option than retropubic radical prostatectomy? The study revealed for the first time that RALP results in reduced tissue trauma compared to RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.5,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP less invasive than retropubic radical prostatectomy? This study for the first time showed that robotically assisted laparoscopic radical prostatectomy induces less tissue trauma than RRP.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
37,0.5,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the robotically assisted laparoscopic radical prostatectomy technique less invasive than retropubic radical prostatectomy? This study showed for the first time that RALP causes lower tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
38,0.5,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","What is the optimal duration of acid suppression for maximum healing in Los Angeles grades C and D reflux oesophagitis? After 4 weeks of acid-suppressive treatment for LA grade C or D oesophagitis, healing seems to plateau, with little further improvement despite longer periods of intragastric pH above 4.",3.316036182995957e-07,0.2559333741372005,0.0,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
38,0.5,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Is there an ideal length of acid suppression therapy for optimal healing of Los Angeles grades C and D reflux oesophagitis? Following 4 weeks of acid suppression in LA grade C or D oesophagitis, healing reaches a limit beyond which additional hours with intragastric pH >4 do not enhance recovery.",3.079176455639103e-07,0.2918975302454805,0.040742417383431435,0.023574544042164344,0.26855398578875,0.020823902218198284,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,0.5,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","For Los Angeles grades C and D reflux oesophagitis, what is the best time frame for acid suppression to maximize healing? After 4 weeks of acid-suppressive therapy, healing in LA grade C or D oesophagitis hits a threshold where further increases in intragastric pH >4 duration don’t yield significant benefits.",3.079176455639103e-07,0.23531408693446476,0.0,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,0.5,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Regarding healing of Los Angeles grade C and D reflux oesophagitis, when is acid suppression most effective? Healing after 4 weeks of acid-suppressive therapy appears to plateau, with minimal gains despite more hours of intragastric pH above 4.",5.921493183921348e-07,0.516216472400866,0.0,0.045335661619546816,0.5273549257172001,0.0,0.045270038523821665,0.538996500732686,0.0,5.921493183921352e-07,0.5511769192895568,0.0
38,0.5,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","When treating Los Angeles grades C and D reflux oesophagitis, is there an optimal acid suppression period for maximal healing? After 4 weeks of therapy, healing seems to reach a ceiling, and extending the duration of intragastric pH >4 does not significantly improve outcomes.",4.500334819780227e-07,0.3659342693515293,0.0,0.03445510283085558,0.3732042458899425,0.0,0.034405229278104466,0.3807724955177916,0.0,4.500334819780227e-07,0.38865798979178257,0.0
38,0.5,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.",What is the optimal acid suppression duration for healing Los Angeles grade C and D reflux oesophagitis? Successful healing after 4 weeks of acid suppression reaches a threshold beyond which increased intragastric pH >4 hours offer little additional improvement.,5.684633456564495e-07,0.5260296558744915,0.026296566837107373,0.04352223515476494,0.4999559515290848,0.0,0.0434592369828688,0.5108256237659892,0.0,5.684633456564497e-07,0.5221893824163053,0.0
38,0.5,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Is there a best time to suppress acid for maximum healing in Los Angeles grades C and D reflux oesophagitis? After 4 weeks of acid-suppressive treatment, healing plateaus and further increases in intragastric pH >4 time do not enhance recovery.",5.447773729207642e-07,0.46357273891544715,0.0,0.04170880868998307,0.4732877044469239,0.0,0.04164843544191593,0.48342664957787385,0.0,5.447773729207643e-07,0.49401850544960846,0.0
38,0.5,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","In Los Angeles grade C and D reflux oesophagitis, does an optimal acid suppression duration exist for maximal healing? Healing after 4 weeks of therapy appears to reach a plateau despite more hours with intragastric pH above 4.",5.921493183921348e-07,0.516216472400866,0.0,0.045335661619546816,0.5273549257172001,0.0,0.045270038523821665,0.538996500732686,0.0,5.921493183921352e-07,0.5511769192895568,0.0
38,0.5,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","What duration of acid suppression yields the best healing results in Los Angeles grades C and D reflux oesophagitis? After 4 weeks, healing reaches a threshold beyond which additional intragastric pH >4 time does not improve outcomes.",6.158352911278201e-07,0.5436154465889813,0.0,0.04714908808432869,0.555525802683897,0.0,0.04708084006477454,0.5679840376059375,0.0,6.158352911278206e-07,0.5810298824392386,0.0
38,0.5,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Is there an ideal acid suppression timeframe for maximal healing in Los Angeles grade C and D reflux oesophagitis? After 4 weeks of treatment, healing plateaus, and increasing intragastric pH >4 hours does not significantly enhance healing.",6.158352911278201e-07,0.5436154465889813,0.0,0.04714908808432869,0.555525802683897,0.0,0.04708084006477454,0.5679840376059375,0.0,6.158352911278206e-07,0.5810298824392386,0.0
39,0.5,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, especially in spring and autumn. Viral infections may trigger BPPV episodes by causing vestibulopathy or lead to secondary BPPV through neurolabyrinthitis caused by the infection.",1.8948778188548325e-07,0.2028649207777371,0.023242630385487524,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
39,0.5,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections contribute to benign paroxysmal positional vertigo? BPPV shows an association with positive viral serology, notably during spring and autumn months. Viral infections might cause BPPV attacks by developing vestibulopathy or induce secondary BPPV due to viral neurolabyrinthitis.",2.8423167282822477e-07,0.3038099958541647,0.025623268698060954,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
39,0.5,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections influence benign paroxysmal positional vertigo? Positive viral serology is correlated with BPPV, particularly in spring and autumn. Viral infections may facilitate BPPV attacks through vestibulopathy or result in secondary BPPV via neurolabyrinthitis linked to the infection.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.5,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections involved in benign paroxysmal positional vertigo? BPPV is connected with positive viral serology, mainly during spring and autumn. Viral infections could trigger BPPV episodes by causing vestibulopathy or induce secondary BPPV through infection-related neurolabyrinthitis.",3.5528959103528067e-07,0.38681487096598977,0.02775510204081633,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,0.5,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections play a role in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially in certain months like spring and autumn. Viral infections might provoke BPPV attacks by developing vestibulopathy or cause secondary BPPV due to viral neurolabyrinthitis.",2.1317375462116866e-07,0.2271630230390489,0.023795359904818555,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
39,0.5,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is benign paroxysmal positional vertigo linked to viral infections? Positive viral serology is observed in BPPV cases, particularly in spring and autumn. Viral infections may promote BPPV attacks by causing vestibulopathy or induce secondary BPPV via neurolabyrinthitis related to the infection.",2.6054570009253947e-07,0.24294617861038903,0.0,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.5,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Could viral infections be a factor in benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, especially during spring and autumn months. Viral infections might initiate BPPV attacks through vestibulopathy or lead to secondary BPPV via viral neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.5,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Does benign paroxysmal positional vertigo have an association with viral infections? BPPV is linked to positive viral serology, mainly in spring and autumn. Viral infections may trigger BPPV attacks by causing vestibulopathy or induce secondary BPPV through neurolabyrinthitis caused by the virus.",2.3685972735685406e-07,0.21825356602001733,0.0,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
39,0.5,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections a cause of benign paroxysmal positional vertigo? Positive viral serology is found in BPPV, particularly in spring and autumn months. Viral infections might promote BPPV episodes due to vestibulopathy or cause secondary BPPV via viral neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.5,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a role for viral infections in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially in spring and autumn. Viral infections may lead to BPPV attacks by developing vestibulopathy or induce secondary BPPV through viral infection-related neurolabyrinthitis.",2.3685972735685406e-07,0.2520656236083072,0.024375,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
40,0.5,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk for Type 2 diabetes? In this at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not lower than that of healthy controls. However, among the at-risk individuals, those with higher aerobic fitness showed improved microvascular and endothelial responsiveness.",1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
40,0.5,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an impact of aerobic fitness on microvascular function in healthy adults at risk of developing Type 2 diabetes? For this at-risk population with skin microvascular dysfunction, maximal oxygen uptake was comparable to healthy controls. Yet, within the at-risk group, higher aerobic fitness correlated with enhanced microvascular and endothelial function.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.5,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness influence microvascular function in healthy adults who are at risk for Type 2 diabetes? In individuals at risk with skin microvascular dysfunction, maximal oxygen uptake was not decreased relative to healthy controls. Still, those with greater aerobic fitness in the at-risk group exhibited superior microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.10035125020839786,0.003618700802974578,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.5,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness affect microvascular function in healthy adults at risk of Type 2 diabetes? Among this at-risk group with skin microvascular dysfunction, maximal oxygen uptake was similar to healthy controls. Nonetheless, higher aerobic fitness within the at-risk group was linked to better microvascular and endothelial responsiveness.",1.8948778188548325e-07,0.1657661288910468,0.00615728104988815,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.5,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Can aerobic fitness impact microvascular function in healthy adults at risk of Type 2 diabetes? In this at-risk cohort with skin microvascular dysfunction, maximal oxygen uptake did not differ from healthy controls. However, within this group, individuals with higher aerobic fitness demonstrated improved microvascular and endothelial responses.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.5,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is aerobic fitness associated with microvascular function in healthy adults at risk for Type 2 diabetes? This at-risk group, characterized by skin microvascular dysfunction, showed no reduction in maximal oxygen uptake compared to healthy controls. Yet, those with higher aerobic fitness had enhanced microvascular and endothelial responsiveness.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.5,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness play a role in microvascular function among healthy adults at risk of developing Type 2 diabetes? In this at-risk group exhibiting skin microvascular dysfunction, maximal oxygen uptake was not diminished compared to healthy controls. However, individuals with greater aerobic fitness in this group had better microvascular and endothelial function.",9.474389094274162e-08,0.07946133321722204,0.0028384992665777056,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
40,0.5,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","What is the effect of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? In the at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. Still, higher aerobic fitness within the at-risk group corresponded with improved microvascular and endothelial responsiveness.",9.474389094274162e-08,0.13382581796702242,0.041551431802421296,0.0072537058591274906,0.10468692835852789,0.019991670137442734,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
40,0.5,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults vulnerable to Type 2 diabetes? In this at-risk population with skin microvascular dysfunction, maximal oxygen uptake was equivalent to healthy controls. However, those with higher aerobic fitness among the at-risk individuals exhibited better microvascular and endothelial responsiveness.",2.3685972735685406e-07,0.1810665327796479,0.014101110950928097,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
40,0.5,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness influence microvascular function in healthy adults at risk for Type 2 diabetes? In this at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not reduced compared to healthy controls. Yet, higher aerobic fitness within this group was associated with improved microvascular and endothelial responsiveness.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
41,0.5,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Our data indicate that among UHR intake criteria, the risk of transition to psychosis over 6 months follows the order: Trait alone < APS < BLIPS.",9.237529366917293e-07,0.9183464090989748,0.015621063240110858,0.0707236321264931,0.9650808960435899,0.0,0.07062126009716188,0.991640169115942,0.0,9.237529366917308e-07,1.0198314108149948,0.0
41,0.5,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The findings show that UHR criteria predict psychosis transition risk within 6 months, ranked from lowest to highest as Trait alone, then APS, and finally BLIPS.",9.237529366917293e-07,0.9183464090989748,0.015621063240110858,0.0707236321264931,0.9650808960435899,0.0,0.07062126009716188,0.991640169115942,0.0,9.237529366917308e-07,1.0198314108149948,0.0
41,0.5,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","According to our data, the likelihood of transitioning to psychosis over six months varies by UHR criteria, with Trait alone being the lowest risk, APS intermediate, and BLIPS the highest.",8.29009045748988e-07,0.7699264039807017,0.015621063240110858,0.06346992626736558,0.810930216216331,0.0,0.06337805393335039,0.8312975190407621,0.0,8.290090457489892e-07,0.8527773261518279,0.0
41,0.5,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The risk of psychosis transition within 6 months, as predicted by UHR intake criteria, is lowest for Trait alone, higher for APS, and highest for BLIPS, per our data.",8.526950184846733e-07,0.8050177237919707,0.015621063240110858,0.06528335273214747,0.8472978603872057,0.0,0.06518885547430325,0.8690378470236091,0.0,8.526950184846746e-07,0.8919980393051103,0.0
41,0.5,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates",Our results reveal that UHR criteria forecast psychosis transition risk in the sequence Trait alone < APS < BLIPS over a 6-month period.,9.948108548987852e-07,1.0461797806088593,0.015621063240110858,0.07616391152083875,1.0986122886681136,0.0,0.07605366472002051,1.1314021114911013,0.0,9.94810854898787e-07,1.1664348850068702,0.0
41,0.5,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Data suggest that the probability of psychosis transition at 6 months differs by UHR status, with BLIPS patients at the greatest risk, followed by APS and then Trait alone.",8.526950184846733e-07,0.8050177237919707,0.015621063240110858,0.06528335273214747,0.8472978603872057,0.0,0.06518885547430325,0.8690378470236091,0.0,8.526950184846746e-07,0.8919980393051103,0.0
41,0.5,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The order of risk for psychosis transition over six months, based on UHR intake criteria, is Trait alone, then APS, and finally BLIPS, according to our findings.",9.00066963956044e-07,0.8791256959456923,0.015621063240110858,0.06891020566171123,0.9242589015233351,0.0,0.06881045855620901,0.9490805546971464,0.0,9.000669639560454e-07,0.9753796482441608,0.0
41,0.5,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Our study shows that BLIPS patients carry the highest short-term risk of psychosis transition, consistent with the 'early' vs. 'late' prodrome model, and that UHR criteria predict risk in the order Trait alone < APS < BLIPS.",6.63207236599191e-07,0.5537032955110646,0.015621063240110858,0.050775941013892434,0.5877866649021217,0.0,0.05070244314668027,0.6007738604289297,0.0,6.632072365991914e-07,0.6143663027068302,0.0
41,0.5,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","According to the data, UHR intake criteria predict psychosis transition risk over six months in increasing order: Trait alone, APS, and BLIPS, with BLIPS patients at greatest short-term risk.",8.526950184846733e-07,0.8050177237919707,0.015621063240110858,0.06528335273214747,0.8472978603872057,0.0,0.06518885547430325,0.8690378470236091,0.0,8.526950184846746e-07,0.8919980393051103,0.0
41,0.5,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The evidence suggests that psychosis transition risk within six months is stratified by UHR criteria, with BLIPS patients having the highest risk, supporting the early versus late prodrome framework.",8.526950184846733e-07,0.8050177237919707,0.015621063240110858,0.06528335273214747,0.8472978603872057,0.0,0.06518885547430325,0.8690378470236091,0.0,8.526950184846746e-07,0.8919980393051103,0.0
42,0.5,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is the preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? It might serve as a predictor of disease progression and survival outcomes, but more studies are required to clarify this association.",4.0266153650665116e-07,0.1832433833071918,0.20181405895691615,0.030828249901291856,0.2846257870333604,0.10072314049586772,0.03078362619619876,0.32168927632942035,0.08264462809917356,4.026615365066519e-07,0.36046334593386753,0.06353305785123965
42,0.5,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Does the platelet count before surgery predict prognosis in esophageal squamous cell carcinoma? It could reflect the chances of disease advancement and overall survival, although additional research is necessary to confirm this link.",4.2634750924233646e-07,0.2140150419739455,0.20181405895691615,0.032641676366073735,0.3163744853479402,0.10072314049586772,0.032594427737151634,0.35447909915241205,0.08264462809917356,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
42,0.5,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Can the preoperative platelet count be used as a prognostic factor in esophageal squamous cell carcinoma? It may indicate the risk of disease progression and survival rates, but further investigation is needed to understand this relationship fully.",3.3160361829959526e-07,0.09623200631756168,0.20181405895691615,0.025387970506946217,0.19501362834367342,0.10072314049586772,0.02535122157334014,0.22931595619840506,0.08264462809917356,3.316036182995957e-07,0.2651531661295423,0.06353305785123965
42,0.5,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is the platelet count prior to surgery a prognostic marker in esophageal squamous cell carcinoma? It potentially signals the likelihood of disease progression and patient survival, yet more research is required to validate this connection.",3.7897556377096586e-07,0.15339042015751003,0.20181405895691615,0.029014823436509976,0.2538541283666067,0.10072314049586772,0.028972824655245887,0.2899405780148405,0.08264462809917356,3.789755637709665e-07,0.32767352311087583,0.06353305785123965
42,0.5,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Does the preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? It might predict disease progression and overall survival, but more studies are essential to establish this association.",4.974054274493924e-07,0.3124551147871988,0.20181405895691615,0.038081955760419374,0.4181571796578827,0.10072314049586772,0.038026832360010254,0.4598396148102375,0.08264462809917356,4.974054274493935e-07,0.50356418957454,0.06353305785123965
42,0.5,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is the platelet count measured before surgery a factor in predicting outcomes for esophageal squamous cell carcinoma? It may suggest the probability of disease advancement and survival, though further research is needed to elucidate this link.",3.5528959103528056e-07,0.12440288328425853,0.20181405895691615,0.027201396971728097,0.22400116521692492,0.10072314049586772,0.027162023114293013,0.25916891934808683,0.08264462809917356,3.552895910352811e-07,0.295924824796296,0.06353305785123965
42,0.5,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Could the preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? It may indicate disease progression and survival chances, but additional studies are necessary to fully understand the correlation.",4.2634750924233646e-07,0.2140150419739455,0.20181405895691615,0.032641676366073735,0.3163744853479402,0.10072314049586772,0.032594427737151634,0.35447909915241205,0.08264462809917356,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
42,0.5,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is there prognostic significance to the preoperative platelet count in esophageal squamous cell carcinoma? It might be associated with disease progression and overall survival, but more research is required to confirm this relationship.",4.2634750924233646e-07,0.2140150419739455,0.20181405895691615,0.032641676366073735,0.3163744853479402,0.10072314049586772,0.032594427737151634,0.35447909915241205,0.08264462809917356,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
42,0.5,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Can preoperative platelet levels predict prognosis in esophageal squamous cell carcinoma? They may reflect the likelihood of disease progression and survival outcomes, although further studies are needed to clarify this connection.",4.7371945471370706e-07,0.278553563111517,0.20181405895691615,0.036268529295637494,0.3830658598466137,0.10072314049586772,0.03621603081905738,0.4234719706393628,0.08264462809917356,4.737194547137081e-07,0.465823861591693,0.06353305785123965
42,0.5,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is the platelet count before surgery indicative of prognosis in esophageal squamous cell carcinoma? It could be linked to disease progression and survival, but more research is necessary to fully comprehend this association.",4.2634750924233646e-07,0.2140150419739455,0.20181405895691615,0.032641676366073735,0.3163744853479402,0.10072314049586772,0.032594427737151634,0.35447909915241205,0.08264462809917356,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
43,0.5,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do the leadership abilities of residents correlate with their technical skill ratings? Research on general surgery residents found that intraoperative leadership skills significantly correlated with their perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions could offer an individualized metric for intraoperative evaluation. Further study is needed.,7.105791820705622e-08,0.0623235119648653,0.0012239022181982917,0.005440279394345618,0.06187540371808753,0.0,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
43,0.5,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Is there a relationship between residents' leadership skills and their technical skill ratings? Studies on general surgery research residents revealed that intraoperative leadership skills significantly relate to perceived skill decay and task difficulty in bowel repair. Evaluating residents' directional commands might serve as an additional personalized intraoperative assessment tool. More research is warranted.,9.474389094274162e-08,0.08226433325225413,0.001600526593438574,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
43,0.5,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are residents' leadership capabilities connected to their technical skill ratings? Research involving general surgery residents demonstrated significant correlations between intraoperative leadership skills and residents' perceptions of skill decay and task difficulty in bowel repair. Analyzing residents' directional instructions may provide a new individualized metric for intraoperative assessment. Further investigation is necessary.,4.737194547137081e-08,0.06970312704358506,0.020823902218198284,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
43,0.5,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Does a resident's leadership skill impact their technical skill ratings? Findings from general surgery research residents indicate that intraoperative leadership skills significantly correlate with perceived skill decay and task difficulty during bowel repair. Reviewing residents' directional instructions could add an individualized intraoperative assessment dimension. Additional evaluation is recommended.,2.3685972735685406e-08,0.007827723325497526,0.020823902218198284,0.0018134264647818726,0.02150620522096336,0.0,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
43,0.5,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,How do resident leadership skills relate to technical skill ratings? General surgery research residents' intraoperative leadership abilities showed significant correlations with their perceptions of skill decay and task difficulty in bowel repair. Assessing directional instructions of residents may provide an extra personalized intraoperative evaluation metric. Further assessment is required.,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.5,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Is there a link between residents' leadership skills and technical skill ratings? Research on general surgery residents found significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions might offer an individualized intraoperative assessment measure. Further analysis is needed.,2.3685972735685406e-08,0.007083023584949277,0.01991851516523315,0.0018134264647818726,0.007827723325497526,0.020823902218198284,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,0.5,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do leadership skills of residents influence their technical skill ratings? General surgery research residents exhibited significant correlations between intraoperative leadership skills and their perceived skill decay and task difficulty in bowel repair. Assessment of residents' directional instructions may serve as an additional personalized intraoperative evaluation metric. More research is necessary.,2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,0.5,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Can residents' leadership skills predict technical skill ratings? Studies involving general surgery research residents showed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating directional instructions given by residents could provide an individualized intraoperative assessment tool. Further study is advised.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.5,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are intraoperative leadership skills of residents associated with their technical skill ratings? Research on general surgery residents revealed significant correlations between leadership skills and perceptions of skill decay and task difficulty in bowel repair. Assessing residents' directional instructions may add another individualized intraoperative evaluation metric. Additional evaluation is needed.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.5,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do residents' leadership abilities correlate with technical skill ratings? Findings from general surgery research residents indicated significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating directional instructions from residents could provide an individualized intraoperative assessment measure. Further research is recommended.,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.5,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism associated with chronic kidney disease in patients with hypertension? Answer: The ACE-DD genotype is suggested to be a potential risk factor for causing and progressing chronic kidney failure in hypertensive individuals.,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.5,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the polymorphism of the ACE-1 gene contribute to chronic kidney disease in hypertensive patients? Answer: It is concluded that the ACE-DD genotype might increase the risk of developing chronic kidney failure among those with hypertension.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.5,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there a link between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? Answer: Findings indicate that the ACE-DD genotype may be a risk factor for the onset and progression of chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.027846328995862812,0.0013369225080936895,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.5,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can ACE-1 gene polymorphism cause chronic kidney disease in patients with hypertension? Answer: The ACE-DD genotype is concluded to potentially play a role as a risk factor in the development of chronic kidney failure among hypertensive patients.,2.36859727356853e-08,0.008827198864009844,0.025462962962962975,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,0.5,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does polymorphism in the angiotensin-converting enzyme-1 gene lead to chronic kidney disease in hypertensive individuals? Answer: It is concluded that the ACE-DD genotype could be a risk factor for chronic kidney failure development in hypertensive patients.,4.73719454713706e-08,0.058120713554252745,0.002894185996838834,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.5,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the ACE-1 gene polymorphism responsible for chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype may be considered a risk factor for causing and developing chronic kidney failure among hypertensive patients.,1.184298636784265e-07,0.11012465718226894,0.02219569830246914,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
44,0.5,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the ACE-1 gene polymorphism increase the risk of chronic kidney disease among hypertensive patients? Answer: It is concluded that the ACE-DD genotype may contribute as a risk factor to the development of chronic kidney failure in hypertensive individuals.,2.36859727356853e-08,0.027846328995862812,0.0013369225080936895,0.0018134264647818726,0.009813183473625475,0.026296566837107373,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.5,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there an association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype is concluded to be a possible risk factor for the causation and progression of chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.027846328995862812,0.0013369225080936895,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.5,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Could the ACE-1 gene polymorphism lead to chronic kidney disease in patients with hypertension? Answer: The ACE-DD genotype may be a contributing risk factor to chronic kidney failure among hypertensive patients.,1.658018091497971e-07,0.22007444000836918,0.011740138870539173,0.012693985253473143,0.2559303430194002,0.033293697978596916,0.012675610786670108,0.2162231084696371,0.0,1.6580180914979784e-07,0.22314355131420927,0.0
44,0.5,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the angiotensin-converting enzyme-1 gene polymorphism influence chronic kidney disease occurrence in hypertensive patients? Answer: It is concluded that the ACE-DD genotype may serve as a risk factor for the causation and development of chronic kidney failure in hypertensive individuals.,4.73719454713706e-08,0.05494143744312874,0.0026076399575938047,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
45,0.5,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are labs accurately reporting serum quantitative hCG results? Multiple factors lead to errors in hCG reporting, such as (a) the complexity of the hCG molecule and confusion over its various forms' nomenclature; (b) lack of awareness among laboratory staff.",9.474389094274141e-08,0.06707644995888984,0.023795359904818555,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
45,0.5,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Do laboratories correctly report serum quantitative hCG results? Errors in hCG reporting arise from several causes, including (a) the intricate nature of the hCG molecule and confusion surrounding the naming of its different forms; (b) insufficient knowledge among lab personnel.",7.105791820705611e-08,0.041100963555631864,0.023795359904818555,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
45,0.5,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are serum quantitative hCG results being reported correctly by laboratories? Many factors cause errors in hCG reporting, including (a) the complex structure of the hCG molecule and confusion about the terminology for its various forms; (b) laboratory staff's lack of awareness.",4.737194547137081e-08,0.015783155571340135,0.023795359904818555,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
45,0.5,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Is the reporting of serum quantitative hCG results by laboratories accurate? The erroneous reporting of hCG results is influenced by multiple factors, such as (a) the complexity of the hCG molecule and confusion in nomenclature for its different forms; (b) lack of awareness among lab workers.",7.105791820705622e-08,0.040386797368603844,0.020552936471601127,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
45,0.5,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are laboratories providing accurate serum quantitative hCG results? Several factors contribute to mistakes in hCG reporting, including (a) the complex hCG molecule and confusion over the nomenclature of its various forms; (b) lack of awareness among laboratory personnel.",1.1842986367842671e-07,0.0937446970410507,0.023795359904818555,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
45,0.5,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Do labs report serum quantitative hCG results correctly? Errors in hCG reporting stem from multiple factors, including (a) the complexity of the hCG molecule and confusion about the nomenclature of its various forms; (b) laboratory staff's lack of awareness.",9.474389094274141e-08,0.06707644995888984,0.023795359904818555,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
45,0.5,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are serum quantitative hCG results reported accurately by laboratories? Many reasons cause errors in hCG reporting, including (a) the complexity of the hCG molecule and confusion regarding the nomenclature of its different forms; (b) lack of awareness among laboratory personnel.",7.105791820705611e-08,0.041100963555631864,0.023795359904818555,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
45,0.5,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Is the serum quantitative hCG reporting by laboratories correct? Several factors lead to errors in hCG results reporting, such as (a) the complicated structure of the hCG molecule and confusion about the naming of its various forms; (b) laboratory personnel's lack of awareness.",0.0,0.03300700859809158,0.023795359904818555,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
45,0.5,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Are laboratories reporting serum quantitative hCG results properly? Errors in hCG reporting are caused by various factors including (a) the complex nature of the hCG molecule and confusion over the nomenclature of its different forms; (b) lack of awareness among lab staff.,2.3685972735685406e-08,0.008909457019031564,0.023795359904818555,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
45,0.5,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are serum quantitative hCG results being accurately reported by laboratories? Many factors contribute to incorrect hCG reporting, including (a) the complexity of the hCG molecule and confusion about the nomenclature of its various forms; (b) laboratory personnel's lack of awareness.",7.105791820705611e-08,0.041100963555631864,0.023795359904818555,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
46,0.5,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex found in cervical disk disease? Yes, it is present and plays a crucial role in the extracellular matrix of intervertebral discs, contributing to disc degeneration and structural breakdown.",3.3160361829959473e-07,0.15702949577763414,0.1502770083102493,0.02538797050694625,0.28847218217975,0.06781677572873293,0.025351221573340174,0.3616648819601149,0.023242630385487524,3.316036182995957e-07,0.4054651081081637,0.0
46,0.5,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Does cervical disk disease involve the fibronectin-aggrecan complex? Yes, this complex is a significant part of the extracellular matrix in intervertebral discs and participates in disc degeneration.",4.5003348197802123e-07,0.3329201622412983,0.1502770083102493,0.03445510283085565,0.4707937389737049,0.06781677572873293,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
46,0.5,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex associated with cervical disk disease? Yes, it is present and serves as an important component of the extracellular matrix, influencing the degeneration of the disc structure.",3.7897556377096533e-07,0.27152412410802773,0.11583823280004521,0.02901482343651001,0.3574650536667008,0.06781677572873293,0.02897282465524592,0.4331238459422586,0.023242630385487524,3.789755637709665e-07,0.4795730802618854,0.0
46,0.5,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Can the fibronectin-aggrecan complex be detected in cervical disk disease? Yes, it is found within the extracellular matrix of intervertebral discs and is involved in their degeneration.",4.5003348197802123e-07,0.3329201622412983,0.1502770083102493,0.03445510283085565,0.4707937389737049,0.06781677572873293,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
46,0.5,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Yes, it constitutes a key element of the extracellular matrix and contributes to the breakdown of the disc.",4.0266153650665063e-07,0.30832270298471576,0.11461171338569512,0.03082824990129189,0.39383269783757546,0.06781677572873293,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
46,0.5,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Does the fibronectin-aggrecan complex exist in cervical disk disease? Yes, it is a vital part of the extracellular matrix in intervertebral discs and plays a role in disc degeneration.",4.0266153650665063e-07,0.2588121900875766,0.1502770083102493,0.03082824990129189,0.39383269783757546,0.06781677572873293,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
46,0.5,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex involved in cervical disk disease? Yes, it is present in the extracellular matrix and is implicated in the degeneration and deterioration of the disc structure.",4.0266153650665063e-07,0.30832270298471576,0.11461171338569512,0.03082824990129189,0.39383269783757546,0.06781677572873293,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
46,0.5,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex observed in cervical disk disease? Yes, it forms a crucial component of the extracellular matrix in intervertebral discs and is linked to disc degeneration.",4.2634750924233593e-07,0.2951798342584513,0.1502770083102493,0.03264167636607377,0.43157302582042245,0.06781677572873293,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
46,0.5,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex a feature of cervical disk disease? Yes, it is present in the extracellular matrix and contributes to the structural breakdown of the intervertebral discs.",4.2634750924233593e-07,0.2951798342584513,0.1502770083102493,0.03264167636607377,0.43157302582042245,0.06781677572873293,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
46,0.5,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex found in cervical disk disease? Yes, it is a key part of the extracellular matrix and plays a role in the degeneration and breakdown of disc tissue.",3.5528959103528003e-07,0.18981931860062584,0.1502770083102493,0.02720139697172813,0.3223737338554318,0.06781677572873293,0.027162023114293048,0.39675620177138393,0.023242630385487524,3.552895910352811e-07,0.4418327522790384,0.0
47,0.5,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Can the criteria used for selecting residents predict how well they will perform in an orthopaedic surgery residency? Answer: While residency selection criteria might offer some insight into a candidate's potential success in orthopaedic surgery residency, they are not absolute predictors. Performance is also significantly influenced by factors like work ethic, commitment, and clinical skills honed during the residency.",9.474389094274162e-08,0.1475291521594424,0.05533577819927485,0.0072537058591274906,0.09713108178066054,0.01851192595229618,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
47,0.5,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Are residency selection criteria reliable indicators of performance in orthopaedic surgery residency? Answer: Residency selection criteria may suggest a candidate's potential performance in orthopaedic surgery residency but do not definitively predict it. Other elements such as dedication, work ethic, and clinical abilities developed during training also play a crucial role.",1.1842986367842703e-07,0.1331182078348676,0.026485539749668968,0.009067132323909363,0.15636679562165545,0.04245215722350719,0.009054007704764333,0.12797203516756062,0.020823902218198284,1.1842986367842703e-07,0.10109611687136999,0.0
47,0.5,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Do the criteria for selecting residents forecast their performance in orthopaedic surgery residency? Answer: The selection criteria might give some indication of a candidate’s future performance in orthopaedic surgery residency, but they are not conclusive. Factors like clinical skills, dedication, and work ethic developed during residency also significantly affect outcomes.",1.1842986367842703e-07,0.07766643339007162,0.012524346853397053,0.009067132323909363,0.12807507396614737,0.022230491431135254,0.009054007704764333,0.12797203516756062,0.020823902218198284,1.1842986367842703e-07,0.10109611687136999,0.0
47,0.5,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Is performance in orthopaedic surgery residency predictable by residency selection criteria? Answer: Residency selection criteria can provide some clues about a candidate’s potential performance, but they are not definitive predictors. Other factors such as clinical skill development, dedication, and work ethic during residency are also important.",2.1317375462116866e-07,0.10800721459931806,0.05055149728736809,0.016320838183036854,0.15664943899543893,0.01851192595229618,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
47,0.5,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Does the selection process for residency predict success in orthopaedic surgery residency? Answer: The criteria used in residency selection may hint at a candidate’s potential success in orthopaedic surgery residency, but they are not absolute predictors. Performance is also shaped by factors like work ethic, dedication, and clinical skills gained during residency.",7.105791820705622e-08,0.03524657940343623,0.01480384070394862,0.005440279394345618,0.08585078079123276,0.020638428066862512,0.0054324046228586,0.08599479534637355,0.019991670137442734,7.105791820705622e-08,0.05942342047080107,0.0
47,0.5,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Can residency selection criteria determine performance in an orthopaedic surgery residency? Answer: While these criteria might offer some insight into a candidate’s prospective performance, they do not guarantee it. Other influences such as clinical skill acquisition, dedication, and work ethic developed during residency significantly impact performance.",2.1317375462116866e-07,0.07787038066192942,0.07227989234909649,0.016320838183036854,0.15664943899543893,0.01851192595229618,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
47,0.5,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Are the criteria for selecting residents predictive of their performance in orthopaedic surgery residency? Answer: Selection criteria may provide some indication of potential performance but are not definitive predictors. Factors including work ethic, dedication, and clinical skills developed throughout residency also play a vital role.",2.3685972735685406e-07,0.09984928738070442,0.07227989234909649,0.018134264647818726,0.17912229484749664,0.01851192595229618,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
47,0.5,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Do residency selection criteria forecast a candidate’s performance in orthopaedic surgery residency? Answer: Though these criteria might suggest a candidate’s potential, they cannot definitively predict performance. Other aspects such as clinical skills, dedication, and work ethic during residency significantly influence outcomes.",3.316036182995957e-07,0.22675176803500596,0.047904892349096485,0.025387970506946217,0.2744324746518223,0.01851192595229618,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
47,0.5,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Is the performance of orthopaedic surgery residents predicted by the selection criteria? Answer: Selection criteria may offer some insight into potential performance but are not conclusive predictors. Additional factors like work ethic, dedication, and clinical skill development during residency are equally important.",3.079176455639103e-07,0.16884215886765608,0.07227989234909649,0.023574544042164344,0.2497398620614506,0.01851192595229618,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
47,0.5,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Question: Can the criteria used for residency selection predict how well a candidate will perform in orthopaedic surgery residency? Answer: The selection criteria may provide some indication of potential performance, but they are not definitive predictors. Other factors such as dedication, work ethic, and clinical skills developed during residency also greatly affect performance.",7.105791820705622e-08,0.04473194143040393,0.07227989234909649,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
48,0.5,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Amblyopia: Is the vision loss permanent? Older adults with amblyopia who later lose vision in their previously unaffected eye may regain vision in the amblyopic eye gradually over time.,3.552895910352798e-07,0.3817879071745742,0.033709705075445816,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
48,0.5,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Does amblyopia cause permanent vision loss? In elderly individuals with amblyopia, if the normal eye develops vision loss, the amblyopic eye can recover visual function over time.",3.789755637709651e-07,0.36864503844830976,0.06937499999999999,0.029014823436510025,0.4795730802618854,0.0,0.028972824655245935,0.49469624183610783,0.0,3.789755637709665e-07,0.5108256237659909,0.0
48,0.5,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Is visual loss caused by amblyopia permanent? Older patients with amblyopia who experience vision loss in their previously normal eye might see improvement in the amblyopic eye's visual function over a period.,2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
48,0.5,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Does amblyopia lead to irreversible visual loss? In older people with amblyopia, losing sight in the previously normal eye can result in a gradual recovery of vision in the amblyopic eye.",3.079176455639092e-07,0.30949433482781386,0.036081302021403076,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
48,0.5,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Amblyopia: Is the loss of vision permanent? For older individuals with a history of amblyopia, visual loss in the formerly normal eye can trigger recovery of sight in the amblyopic eye over time.",2.605457000925386e-07,0.24206770043791037,0.038157518210197694,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
48,0.5,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Is vision loss from amblyopia permanent? Older adults who have amblyopia and then lose vision in their normal eye may experience a restoration of vision in the amblyopic eye gradually.,3.316036182995945e-07,0.3449893282978862,0.0349362244897959,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
48,0.5,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Is the visual impairment from amblyopia permanent? In older people with amblyopia, visual loss in the previously unaffected eye can lead to a gradual recovery of vision in the amblyopic eye.",2.842316728282239e-07,0.2752138729068436,0.03715277777777779,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
48,0.5,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Does amblyopia cause permanent blindness? For older patients with amblyopia, if the normal eye loses vision, the amblyopic eye can regain function over time.",4.737194547137063e-07,0.5289876885234897,0.06937499999999999,0.03626852929563754,0.6466271649250523,0.0,0.03621603081905743,0.6690496289808863,0.0,4.7371945471370807e-07,0.6931471805599458,0.0
48,0.5,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Is vision loss due to amblyopia permanent? Older individuals with amblyopia who develop vision loss in the previously normal eye may see a recovery of vision in the amblyopic eye over a period.,2.605457000925386e-07,0.28538939922290707,0.007152777777777765,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
48,0.5,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Amblyopia: Is the vision loss everlasting? Older people with amblyopia who suffer vision loss in their previously normal eye might experience a progressive recovery of visual function in the amblyopic eye.,3.079176455639092e-07,0.30949433482781386,0.036081302021403076,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
49,0.5,1,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae louder than bubble CPAP for preterm infants? Research indicates that high flow nasal cannulae (HFNC) tend to be quieter than bubble continuous positive airway pressure (CPAP).,7.10579182070559e-08,0.12589820989663858,0.013489781993489935,0.005440279394345639,0.12023081208000397,0.007801783264746218,0.005432404622858621,0.11926994685466008,0.004265260631001383,7.105791820705622e-08,0.11778303565638426,0.0
49,0.5,2,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? Studies show that high flow nasal cannulae (HFNC) are usually less noisy compared to bubble CPAP.,4.73719454713706e-08,0.13342614487511506,0.0415962908692296,0.003626852929563759,0.08172497413789648,0.005382971729125552,0.003621603081905747,0.08106857998389128,0.0029483070348455126,4.737194547137081e-08,0.08004270767353727,0.0
49,0.5,3,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Is the noise level of high flow nasal cannulae higher than bubble CPAP for preterm babies? Evidence suggests that high flow nasal cannulae (HFNC) are typically quieter than bubble CPAP.,4.73719454713706e-08,0.08562289104339493,0.009267296786389406,0.003626852929563759,0.08172497413789648,0.005382971729125552,0.003621603081905747,0.08106857998389128,0.0029483070348455126,4.737194547137081e-08,0.08004270767353727,0.0
49,0.5,4,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae noisier compared to bubble CPAP in preterm infants? Research findings indicate that HFNC devices generally emit less noise than bubble CPAP.,4.73719454713706e-08,0.1284159012520023,0.14366729678638937,0.003626852929563759,0.026595320104916276,0.07638888888888888,0.003621603081905747,0.027929834494255346,0.03993055555555556,4.737194547137081e-08,0.08701137698962969,0.0
49,0.5,5,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Do preterm infants experience more noise from high flow nasal cannulae than from bubble CPAP? Studies imply that high flow nasal cannulae (HFNC) are commonly quieter than bubble CPAP.,2.36859727356853e-08,0.093213047867589,0.03806729678638934,0.0018134264647818796,0.04168988456723399,0.0027888888888888963,0.0018108015409528735,0.041353473708850785,0.001530555555555549,2.3685972735685406e-08,0.04082199452025481,0.0
49,0.5,6,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Is the sound produced by high flow nasal cannulae greater than that of bubble CPAP for preterm infants? Research suggests that HFNC tends to be less noisy than bubble CPAP.,4.73719454713706e-08,0.27683590637027544,0.14366729678638937,0.003626852929563759,0.18074599993217522,0.07638888888888888,0.003621603081905747,0.13241281558092455,0.03993055555555556,4.737194547137081e-08,0.08004270767353727,0.0
49,0.5,7,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae noisier than bubble CPAP in preterm infants? Studies indicate that HFNC are usually quieter than bubble CPAP.,1.421158364141118e-07,0.11195150308896107,0.09616729678638936,0.010880558788691277,0.15572623668903862,0.07638888888888888,0.010864809245717241,0.21898507125696476,0.03993055555555556,1.4211583641411228e-07,0.28768207245178035,0.0
49,0.5,8,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Do high flow nasal cannulae generate more noise than bubble CPAP for preterm infants? Evidence shows that HFNC devices are generally quieter than bubble CPAP.,7.10579182070559e-08,0.029831641685087007,0.10207939508506611,0.005440279394345639,0.015964294313879357,0.07638888888888888,0.005432404622858621,0.0723815970650894,0.03993055555555556,7.105791820705622e-08,0.13353139262452363,0.0
49,0.5,9,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae louder than bubble CPAP for preterm infants? Research suggests that HFNC are typically less noisy than bubble CPAP.,1.184298636784265e-07,0.06243085030878648,0.09831582286348686,0.009067132323909398,0.10693607251960735,0.07638888888888888,0.009054007704764368,0.1676917768694146,0.03993055555555556,1.1842986367842692e-07,0.23361485118150505,0.0
49,0.5,10,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Is the noise level of high flow nasal cannulae higher than bubble CPAP for preterm infants? Studies indicate that HFNC tend to be quieter than bubble CPAP.,2.36859727356853e-08,0.114317600516058,0.10526729678638935,0.0018134264647818796,0.06741731462517109,0.07638888888888888,0.0018108015409528735,0.014629779924540287,0.03993055555555556,2.3685972735685406e-08,0.04255961441879563,0.0
50,0.5,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is emergency double-balloon enteroscopy with real-time capsule endoscopy viewing a viable method for acute overt-obscure gastrointestinal bleeding? Answer: Yes, this combined approach is feasible in such cases.",3.316036182995943e-07,0.08944566312437141,0.24408284023668642,0.02538797050694628,0.01976275127150995,0.2496570644718793,0.025351221573340202,0.05367971940711769,0.23852040816326525,3.316036182995957e-07,0.1311994543763615,0.21403091557669443
50,0.5,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Can emergency double-balloon enteroscopy paired with live capsule endoscopy viewing be effectively used in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is a practical combined technique.",3.552895910352796e-07,0.05170533514152442,0.24408284023668642,0.02720139697172816,0.019457961881772512,0.2496570644718793,0.027162023114293075,0.0945017139273725,0.23852040816326525,3.552895910352811e-07,0.17375906879515712,0.21403091557669443
50,0.5,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is it possible to use emergency double-balloon enteroscopy along with real-time capsule endoscopy for acute overt-obscure gastrointestinal bleeding? Answer: Yes, this combination is feasible.",4.026615365066502e-07,0.02833737253201285,0.24408284023668642,0.030828249901291918,0.10283957082082296,0.2496570644718793,0.030783626196198823,0.18151309091700218,0.23852040816326525,4.026615365066519e-07,0.2647308470008851,0.21403091557669443
50,0.5,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy viewing work for acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is a feasible approach.",4.263475092423355e-07,0.07089698695080848,0.24408284023668642,0.0326416763660738,0.147291333391657,0.2496570644718793,0.032594427737151696,0.22803310655189613,0.23852040816326525,4.2634750924233726e-07,0.3135210111703164,0.21403091557669443
50,0.5,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Can emergency double-balloon enteroscopy and real-time capsule endoscopy viewing be combined effectively in cases of acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is a feasible combined method.",3.316036182995943e-07,0.08944566312437141,0.24408284023668642,0.02538797050694628,0.01976275127150995,0.2496570644718793,0.025351221573340202,0.05367971940711769,0.23852040816326525,3.316036182995957e-07,0.1311994543763615,0.21403091557669443
50,0.5,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is emergency double-balloon enteroscopy with real-time capsule endoscopy a practical combined approach for acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is feasible.",4.500334819780208e-07,0.11534874952164254,0.24408284023668642,0.03445510283085568,0.19381134902655095,0.2496570644718793,0.03440522927810457,0.2768232707213274,0.23852040816326525,4.500334819780226e-07,0.36481430555786654,0.21403091557669443
50,0.5,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Can the combination of emergency double-balloon enteroscopy and live capsule endoscopy viewing be used in acute overt-obscure gastrointestinal bleeding? Answer: Yes, this combined approach is feasible.",3.552895910352796e-07,0.05170533514152442,0.24408284023668642,0.02720139697172816,0.019457961881772512,0.2496570644718793,0.027162023114293075,0.0945017139273725,0.23852040816326525,3.552895910352811e-07,0.17375906879515712,0.21403091557669443
50,0.5,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is the combined use of emergency double-balloon enteroscopy and real-time capsule endoscopy effective in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is a viable approach.",3.789755637709649e-07,0.012484621988241962,0.24408284023668642,0.02901482343651004,0.060279956402027324,0.2496570644718793,0.02897282465524595,0.13706132834616813,0.23852040816326525,3.789755637709665e-07,0.21821083136599118,0.21403091557669443
50,0.5,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Does emergency double-balloon enteroscopy combined with real-time capsule endoscopy provide a feasible approach for acute overt-obscure gastrointestinal bleeding? Answer: Yes, it does.",4.500334819780208e-07,0.11534874952164254,0.24408284023668642,0.03445510283085568,0.19381134902655095,0.2496570644718793,0.03440522927810457,0.2768232707213274,0.23852040816326525,4.500334819780226e-07,0.36481430555786654,0.21403091557669443
50,0.5,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is emergency double-balloon enteroscopy together with real-time capsule endoscopy viewing a feasible method in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is a feasible combined approach.",3.552895910352796e-07,0.0016136787477023518,0.2056828402366864,0.02720139697172816,0.019457961881772512,0.2496570644718793,0.027162023114293075,0.0945017139273725,0.23852040816326525,3.552895910352811e-07,0.17375906879515712,0.21403091557669443
51,0.5,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does misclassification of gestational age account for the birthweight differences between Australian Aborigines and whites? It is unlikely that gestational age misclassification explains the observed birthweight disparity between Aborigines and whites. These findings may assist in interpreting other population-based comparisons.,1.1842986367842692e-07,0.0971999362312288,0.01668456243435748,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
51,0.5,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is gestational age misclassification responsible for the birthweight differences seen in Australian Aborigines versus whites? Gestational age misclassification probably does not explain the reported differences in average birthweights between Aborigines and whites. The results could aid in understanding other comparisons across populations.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.5,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Could errors in gestational age classification explain the birthweight differences between Australian Aborigines and whites? Misclassification of gestational age is an improbable cause for the noted variation in birthweights between Aborigines and whites. These outcomes might help clarify other population comparisons.,9.474389094274162e-08,0.07010482778396288,0.017955279883857596,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.5,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does incorrect gestational age classification explain the difference in birthweights for Australian Aborigines compared to whites? It is unlikely that gestational age misclassification accounts for the reported birthweight differences between Aborigines and whites. The findings may assist in interpreting other inter-population comparisons.,7.105791820705622e-08,0.009909554725886949,0.04344177572873293,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.5,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is the misclassification of gestational age the reason for the birthweight gap between Australian Aborigines and whites? Gestational age misclassification is an unlikely reason for the observed divergence in average birthweights between Aborigines and whites. These results might help interpret other comparisons between populations.,2.3685972735685406e-08,0.05742706313623902,0.0242279317005899,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.5,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Can gestational age misclassification explain the difference in birthweights between Australian Aborigines and whites? It appears unlikely that gestational age misclassification is responsible for the reported birthweight differences between Aborigines and whites. The findings may be useful for interpreting other population-level comparisons.,7.105791820705622e-08,0.07753366990246668,0.004897905711710296,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.5,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does gestational age misclassification account for the differences in birthweights between Australian Aborigines and whites? Misclassification of gestational age is unlikely to explain the reported birthweight divergence between Aborigines and whites. These results could help with interpreting other between-population comparisons.,1.1842986367842692e-07,0.0971999362312288,0.01668456243435748,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
51,0.5,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is gestational age misclassification a plausible explanation for the birthweight differences observed between Australian Aborigines and whites? Gestational age misclassification is an unlikely explanation for the reported differences in average birthweights between Aborigines and whites. The findings might assist in the interpretation of other population comparisons.,2.3685972735685406e-08,0.03703978086268389,0.04155822427126707,0.0018134264647818726,0.007784458079231005,0.02210884353741497,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
51,0.5,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Could gestational age misclassification be the cause of the birthweight differences between Australian Aborigines and whites? It is improbable that gestational age misclassification explains the reported divergence in birthweights for Aborigines and whites. These results may help interpret other comparisons between populations.,7.105791820705622e-08,0.07753366990246713,0.004897905711710296,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.5,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does misclassification of gestational age explain the birthweight differences between Australian Aborigines and whites? Gestational age misclassification is unlikely to explain the observed differences in average birthweights between Aborigines and whites. The outcomes might aid in interpreting other between-population comparisons.,1.1842986367842692e-07,0.13274594549071272,0.008572113160155964,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
52,0.5,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Is maintaining a zero rate of central line-associated bloodstream infections achievable?,9.948108548987845e-07,1.5153610908643165,0.09506564056134,0.0761639115208388,1.6258720858885058,0.07786328655500228,0.07605366472002058,1.7494038020811167,0.05975554549569943,9.948108548987862e-07,1.8893267057442973,0.040742417383431435
52,0.5,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Can a zero central line-associated bloodstream infection rate be maintained over time?,9.711248821630991e-07,1.4200509110599913,0.09506564056134,0.07435048505605693,1.52051157023068,0.07786328655500228,0.07424286317906771,1.6316207664247329,0.05975554549569943,9.71124882163101e-07,1.7557953131197754,0.040742417383431435
52,0.5,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Is it possible to sustain a zero incidence of central line-associated bloodstream infections?,9.474389094274137e-07,1.3330395340703611,0.09506564056134,0.07253705859127504,1.4252013904263547,0.07786328655500228,0.07243206163811483,1.526260250766907,0.05975554549569943,9.474389094274156e-07,1.6380122774633916,0.040742417383431435
52,0.5,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Can healthcare facilities consistently keep central line-associated bloodstream infections at zero?,9.948108548987845e-07,1.5153610908643165,0.09506564056134,0.0761639115208388,1.6258720858885058,0.07786328655500228,0.07605366472002058,1.7494038020811167,0.05975554549569943,9.948108548987862e-07,1.8893267057442973,0.040742417383431435
52,0.5,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Is the goal of zero central line-associated bloodstream infections realistically sustainable?,9.948108548987845e-07,1.5153610908643165,0.09506564056134,0.0761639115208388,1.6258720858885058,0.07786328655500228,0.07605366472002058,1.7494038020811167,0.05975554549569943,9.948108548987862e-07,1.8893267057442973,0.040742417383431435
52,0.5,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Is sustaining a zero central line-associated bloodstream infection rate feasible?,1.0184968276344697e-06,1.6207216065221424,0.09506564056134,0.07797733798562068,1.7436551215448897,0.07786328655500228,0.07786446626097346,1.8829351947056385,0.05975554549569943,1.0184968276344716e-06,2.0434773855715562,0.040742417383431435
52,0.5,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Can the zero rate of central line-associated bloodstream infections be upheld continuously?,9.711248821630991e-07,1.4200509110599913,0.09506564056134,0.07435048505605693,1.52051157023068,0.07786328655500228,0.07424286317906771,1.6316207664247329,0.05975554549569943,9.71124882163101e-07,1.7557953131197754,0.040742417383431435
52,0.5,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Is it achievable to maintain zero central line-associated bloodstream infections?,1.0184968276344697e-06,1.6207216065221424,0.09506564056134,0.07797733798562068,1.7436551215448897,0.07786328655500228,0.07786446626097346,1.8829351947056385,0.05975554549569943,1.0184968276344716e-06,2.0434773855715562,0.040742417383431435
52,0.5,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Is it realistic to sustain a zero central line-associated bloodstream infection rate?,9.711248821630991e-07,1.4200509110599913,0.09506564056134,0.07435048505605693,1.52051157023068,0.07786328655500228,0.07424286317906771,1.6316207664247329,0.05975554549569943,9.71124882163101e-07,1.7557953131197754,0.040742417383431435
52,0.5,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective",Can a zero central line-associated bloodstream infection rate be effectively sustained?,9.948108548987845e-07,1.5153610908643165,0.09506564056134,0.0761639115208388,1.6258720858885058,0.07786328655500228,0.07605366472002058,1.7494038020811167,0.05975554549569943,9.948108548987862e-07,1.8893267057442973,0.040742417383431435
53,0.5,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism characterized following injury and hemorrhagic shock, and do hormonal differences play a role? Answer: The female gender independently offers protection against multiple organ failure and nosocomial infections, a benefit seen in both premenopausal and postmenopausal women compared to age-matched men. This finding contrasts with prior experimental research and established knowledge.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
53,0.5,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What defines gender dimorphism after injury and hemorrhagic shock, and are hormones the cause? Answer: Female gender shows a significant independent protective effect against multiple organ failure and hospital-acquired infections in both premenopausal and postmenopausal women relative to men of similar age. This contradicts earlier experimental findings and accepted theories.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
53,0.5,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How does gender dimorphism manifest after injury and hemorrhagic shock, and could hormones be responsible? Answer: Female sex independently reduces the risk of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to men of the same age group, opposing previous experimental studies and known data.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
53,0.5,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: In the context of injury and hemorrhagic shock, how is gender dimorphism characterized, and are hormonal factors involved? Answer: The protective effect of being female on multiple organ failure and nosocomial infection rates remains significant in both pre- and postmenopausal women when compared to similarly aged men, which is contrary to earlier experimental studies and established knowledge.",7.105791820705622e-08,0.05406722127027486,0.0,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
53,0.5,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What is the characterization of gender dimorphism after injury and hemorrhagic shock, and do hormones play a role? Answer: Female gender independently confers protection against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women relative to men of comparable age, challenging previous experimental results and accepted understanding.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
53,0.5,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism characterized following injury and hemorrhagic shock, and are hormonal differences the cause? Answer: The independent protective effect of female gender on the incidence of multiple organ failure and nosocomial infections is significant in both premenopausal and postmenopausal women compared with similarly aged men, contradicting prior experimental studies and known information.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
53,0.5,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What characterizes gender dimorphism after injury and hemorrhagic shock, and are hormones responsible? Answer: Female gender independently protects against multiple organ failure and hospital-acquired infections in both premenopausal and postmenopausal women when compared with men of similar age, which is at odds with previous experimental findings and established knowledge.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
53,0.5,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How can gender dimorphism be described after injury and hemorrhagic shock, and do hormonal differences explain it? Answer: The female gender shows a significant independent protective effect against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to age-matched men, opposing earlier experimental studies and known data.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
53,0.5,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What is the nature of gender dimorphism after injury and hemorrhagic shock, and are hormones the underlying cause? Answer: Female gender independently reduces rates of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women relative to men of similar age, which contradicts previous experimental research and accepted knowledge.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
53,0.5,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism characterized post-injury and hemorrhagic shock, and are hormonal differences to blame? Answer: The protective effect of female gender against multiple organ failure and nosocomial infections remains significant in both premenopausal and postmenopausal women compared to similarly aged men, contrary to earlier experimental studies and established understanding.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
54,0.5,1,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women need fewer calories to maintain their weight? Answer: There is no clear answer since caloric requirements depend on factors like age, height, weight, activity level, and metabolism. However, research",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.5,2,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Is it true that African American women require fewer calories to maintain weight? Answer: There isn’t a definitive answer because calorie needs vary with age, height, weight, activity level, and metabolism. Nevertheless, research",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.5,3,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women have lower calorie needs to maintain their weight? Answer: No definitive answer exists as caloric needs differ based on age, height, weight, activity level, and metabolism. However, studies show",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.5,4,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Are fewer calories required by African American women to maintain weight? Answer: There’s no conclusive answer since calorie requirements depend on age, height, weight, activity level, and metabolism. Yet, research indicates",9.47438909427412e-08,0.1213608570042668,0.0,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
54,0.5,5,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women need fewer calories for weight maintenance? Answer: The answer is not definitive because calorie needs vary according to age, height, weight, activity level, and metabolism. Still, research suggests",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.5,6,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Is it accurate that African American women require fewer calories to keep their weight? Answer: No definitive answer exists as caloric needs depend on factors like age, height, weight, activity level, and metabolism. However, research",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
54,0.5,7,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women consume fewer calories to maintain weight? Answer: There is no clear-cut answer since caloric needs vary based on age, height, weight, activity level, and metabolism. Nevertheless, research",9.47438909427412e-08,0.1213608570042668,0.0,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
54,0.5,8,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Are African American women’s calorie needs lower for weight maintenance? Answer: No definitive conclusion can be drawn because calorie requirements change with age, height, weight, activity level, and metabolism. However, research",9.47438909427412e-08,0.1213608570042668,0.0,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
54,0.5,9,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women require a lower caloric intake to sustain their weight? Answer: There is no definitive answer as calorie needs differ due to age, height, weight, activity level, and metabolism. Yet, research",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,0.5,10,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Is it necessary for African American women to consume fewer calories to maintain weight? Answer: There is no certain answer because caloric requirements depend on age, height, weight, activity level, and metabolism. However, research",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
55,0.5,1,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Could heightened neutrophil migration following severe trauma play a role in causing acute respiratory distress syndrome? Answer: Evidence indicates that elevated neutrophil migratory activity after major trauma may be involved in the onset of acute respiratory distress syndrome (ARDS).,7.105791820705611e-08,0.11885607811204935,0.12879858255337545,0.005440279394345618,0.0904050079960319,0.11574424948942327,0.0054324046228586,0.06066789464227762,0.09876543209876547,7.105791820705622e-08,0.008950689154565872,0.05113221329437545
55,0.5,2,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Is increased neutrophil migratory activity post-major trauma a factor in the development of acute respiratory distress syndrome? Answer: There is supporting evidence that enhanced neutrophil migration after major trauma might contribute to acute respiratory distress syndrome (ARDS).,1.1842986367842671e-07,0.06236953281479307,0.12605324482734273,0.009067132323909363,0.034311040583767216,0.11428571428571432,0.009054007704764333,0.0050980434874654534,0.09876543209876547,1.1842986367842703e-07,0.06610910299451422,0.05113221329437545
55,0.5,3,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Does augmented neutrophil migration after significant trauma influence the etiology of acute respiratory distress syndrome? Answer: Data suggest that increased neutrophil migratory activity following major trauma could be a contributing factor to acute respiratory distress syndrome (ARDS).,1.1842986367842671e-07,0.06236953281479307,0.12605324482734273,0.009067132323909363,0.034311040583767216,0.11428571428571432,0.009054007704764333,0.0050980434874654534,0.09876543209876547,1.1842986367842703e-07,0.06610910299451422,0.05113221329437545
55,0.5,4,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Can increased neutrophil migratory activity after major trauma be implicated in the cause of acute respiratory distress syndrome? Answer: Evidence supports that heightened neutrophil migration post-major trauma may play a role in the development of acute respiratory distress syndrome (ARDS).,4.737194547137081e-08,0.07663646850332118,0.08116536374898545,0.0036268529295637453,0.08176990643610793,0.0909086030321552,0.003621603081905733,0.050854711168652145,0.07246886526165809,4.737194547137081e-08,0.01844828503354945,0.05113221329437545
55,0.5,5,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Is the rise in neutrophil migratory activity after severe trauma linked to acute respiratory distress syndrome? Answer: There is evidence suggesting that increased neutrophil migration after major trauma may contribute to the pathogenesis of acute respiratory distress syndrome (ARDS).,7.105791820705611e-08,0.11885607811204935,0.12879858255337545,0.005440279394345618,0.0904050079960319,0.11574424948942327,0.0054324046228586,0.06066789464227762,0.09876543209876547,7.105791820705622e-08,0.008950689154565872,0.05113221329437545
55,0.5,6,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Could the increase in neutrophil migratory activity following major trauma be a factor in acute respiratory distress syndrome? Answer: Evidence points to the possibility that elevated neutrophil migratory activity after major trauma contributes to acute respiratory distress syndrome (ARDS).,7.105791820705611e-08,0.01221805033359713,0.05449826989619386,0.005440279394345618,0.05392357744024512,0.0895716805240615,0.0054324046228586,0.06066789464227762,0.09876543209876547,7.105791820705622e-08,0.008950689154565872,0.05113221329437545
55,0.5,7,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Does enhanced neutrophil migration after major trauma contribute to the etiology of acute respiratory distress syndrome? Answer: There is evidence indicating that increased neutrophil migratory activity post-major trauma may be involved in acute respiratory distress syndrome (ARDS).,1.1842986367842671e-07,0.06236953281479307,0.12605324482734273,0.009067132323909363,0.034311040583767216,0.11428571428571432,0.009054007704764333,0.0050980434874654534,0.09876543209876547,1.1842986367842703e-07,0.06610910299451422,0.05113221329437545
55,0.5,8,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Is increased neutrophil migratory activity after significant trauma a contributing factor to acute respiratory distress syndrome? Answer: Evidence suggests that the rise in neutrophil migration following major trauma could play a role in the development of acute respiratory distress syndrome (ARDS).,2.3685972735685406e-08,0.17233440202910133,0.13127859334939457,0.0018134264647818726,0.14352237391137157,0.11705725288142874,0.0018108015409528666,0.11331162812769646,0.09876543209876547,2.3685972735685406e-08,0.04511653211571032,0.05113221329437545
55,0.5,9,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Might increased neutrophil migratory activity after major trauma be involved in causing acute respiratory distress syndrome? Answer: There is evidence to suggest that elevated neutrophil migration post-major trauma may contribute to the onset of acute respiratory distress syndrome (ARDS).,7.105791820705611e-08,0.11885607811204935,0.12879858255337545,0.005440279394345618,0.0904050079960319,0.11574424948942327,0.0054324046228586,0.06066789464227762,0.09876543209876547,7.105791820705622e-08,0.008950689154565872,0.05113221329437545
55,0.5,10,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Could the increased neutrophil migratory activity seen after major trauma be a factor in acute respiratory distress syndrome? Answer: Evidence suggests that heightened neutrophil migration after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,7.105791820705611e-08,0.047764059593081054,0.07870630605183251,0.005440279394345618,0.05392357744024512,0.0895716805240615,0.0054324046228586,0.06066789464227762,0.09876543209876547,7.105791820705622e-08,0.008950689154565872,0.05113221329437545
56,0.5,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in such cases is unclear. Early diagnosis of sarcoidosis in other organs and steroid treatment is necessary.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.5,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery work for spinal cord sarcoidosis when compressive cervical myelopathy is present? The impact of decompression is not apparent. Early detection of sarcoidosis in other organs and steroid therapy are required.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.5,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery an effective treatment for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The benefits of decompression are not evident. Early diagnosis from other organs and steroid treatment are essential.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.5,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery help in cases of spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression is not clear. Early identification of sarcoidosis in other organs and steroid therapy should be considered.,1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
56,0.5,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective in managing spinal cord sarcoidosis with compressive cervical myelopathy? The decompression effect is not obvious. Early diagnosis of sarcoidosis from other organs and steroid treatment is necessary.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.5,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery provide benefit for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression is uncertain. Early diagnosis of sarcoidosis in other organs and steroid therapy are needed.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.5,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a useful approach for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The benefit of decompression is not evident. Early diagnosis from other organ involvement and steroid therapy are important.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.5,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression remains unclear. Early diagnosis of sarcoidosis in other organs and steroid treatment should be initiated.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.5,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery show efficacy in spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression is not clearly demonstrated. Early diagnosis from other organs and steroid therapy are necessary.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.5,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The effect of decompression is not evident. Early diagnosis of sarcoidosis in other organs and steroid therapy is required.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
57,0.5,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a contraindication for GERD laparoscopic surgery? Laparoscopic antireflux surgery remains a safe and effective option for treating GERD in elderly patients, with low morbidity and mortality and symptom improvement similar to younger individuals.",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.5,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Does advanced age contraindicate GERD laparoscopic surgery? Even in elderly patients, laparoscopic antireflux surgery is a safe, effective treatment for GERD, showing low morbidity, mortality, and symptom relief comparable to younger patients.",2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
57,0.5,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is laparoscopic surgery for GERD contraindicated in older adults? Laparoscopic antireflux surgery is safe and effective for elderly patients with GERD, featuring low morbidity and mortality and symptom improvement on par with younger patients.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,0.5,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a reason to avoid GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe, effective treatment for GERD in elderly individuals, with low morbidity and mortality and symptom improvement similar to that seen in younger patients.",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.5,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Does advanced age prevent the use of laparoscopic surgery for GERD? Laparoscopic antireflux surgery is safe and effective in elderly GERD patients, showing low morbidity, mortality, and symptom improvement comparable to younger patients.",2.3685972735685321e-07,0.2719337154836414,0.0,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
57,0.5,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is elderly age a contraindication for GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe and effective treatment for GERD in older patients, with low morbidity and mortality rates and symptom improvement similar to younger patients.",1.6580180914979731e-07,0.22192996711166568,0.02854671280276816,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.5,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a limitation for GERD laparoscopic surgery? Laparoscopic antireflux surgery is effective and safe for elderly patients with GERD, resulting in low morbidity and mortality and symptom improvement comparable to younger patients.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,0.5,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Does old age exclude patients from GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity, mortality, and symptom relief similar to younger individuals.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,0.5,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a contraindication to laparoscopic surgery for GERD? Laparoscopic antireflux surgery is a safe and effective approach in elderly GERD patients, with low morbidity and mortality and improvements in symptoms comparable to younger patients.",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.5,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is being elderly a contraindication for GERD laparoscopic surgery? Laparoscopic antireflux surgery is safe and effective in elderly patients with GERD, showing low morbidity, mortality, and significant symptom improvement similar to younger patients.",2.3685972735685321e-07,0.2719337154836414,0.0,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
58,0.5,1,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Do French laypeople and healthcare professionals consider it acceptable to violate confidentiality in order to protect a wife from a sexually transmitted infection?,6.868932093348749e-07,0.4874140284923114,0.22506925207756232,0.052589367478674404,0.5625158082583477,0.20249835634451027,0.052513244687633236,0.6414625296570646,0.174375,6.868932093348767e-07,0.7245941040781334,0.14158239143367046
58,0.5,2,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Is it considered acceptable by French non-professionals and health workers to break confidentiality to safeguard a patient's spouse from an STD?,7.342651548062455e-07,0.5827242082966366,0.22506925207756232,0.05621622040823816,0.6625992668153291,0.20249835634451027,0.05613484776953898,0.7468230453148901,0.174375,7.342651548062474e-07,0.8358197391883575,0.14158239143367046
58,0.5,3,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,How do French lay individuals and medical professionals view the breach of confidentiality to protect a patient's wife from a sexually transmitted disease?,6.868932093348749e-07,0.4874140284923114,0.22506925207756232,0.052589367478674404,0.5625158082583477,0.20249835634451027,0.052513244687633236,0.6414625296570646,0.174375,6.868932093348767e-07,0.7245941040781334,0.14158239143367046
58,0.5,4,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Do French health professionals and laypeople find it permissible to disclose confidential information to protect a patient's wife from an STD?,7.342651548062455e-07,0.5827242082966366,0.22506925207756232,0.05621622040823816,0.6625992668153291,0.20249835634451027,0.05613484776953898,0.7468230453148901,0.174375,7.342651548062474e-07,0.8358197391883575,0.14158239143367046
58,0.5,5,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Is breaching confidentiality to protect a patient's wife from a sexually transmitted infection deemed acceptable by French health workers and the general public?,6.868932093348749e-07,0.4874140284923114,0.22506925207756232,0.052589367478674404,0.5625158082583477,0.20249835634451027,0.052513244687633236,0.6414625296570646,0.174375,6.868932093348767e-07,0.7245941040781334,0.14158239143367046
58,0.5,6,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,What is the stance of French laypersons and healthcare providers on violating confidentiality to shield a patient's wife from an STD?,7.342651548062455e-07,0.5827242082966366,0.22506925207756232,0.05621622040823816,0.6625992668153291,0.20249835634451027,0.05613484776953898,0.7468230453148901,0.174375,7.342651548062474e-07,0.8358197391883575,0.14158239143367046
58,0.5,7,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Are French laypeople and health professionals agreeable to breaking confidentiality to protect a patient's wife against a sexually transmitted disease?,7.579511275419309e-07,0.6340175026841868,0.22506925207756232,0.05802964687302004,0.7166664880856044,0.20249835634451027,0.057945649310491856,0.8039814591548389,0.174375,7.579511275419328e-07,0.8964443610047925,0.14158239143367046
58,0.5,8,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Do French medical staff and lay individuals accept breaching confidentiality to protect a patient's wife from an STD?,8.053230730133016e-07,0.7452431377944109,0.22506925207756232,0.061656499802583795,0.8344495237419882,0.20249835634451027,0.0615672523923976,0.9291446021088445,0.174375,8.053230730133034e-07,1.0299757536293153,0.14158239143367046
58,0.5,9,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,How acceptable is it among French health professionals and laypeople to breach confidentiality to protect a patient's wife from a sexually transmitted disease?,6.868932093348749e-07,0.4874140284923114,0.22506925207756232,0.052589367478674404,0.5625158082583477,0.20249835634451027,0.052513244687633236,0.6414625296570646,0.174375,6.868932093348767e-07,0.7245941040781334,0.14158239143367046
58,0.5,10,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Do French laypeople and health professionals approve of breaching patient confidentiality to protect the patient's wife from a sexually transmitted infection?,7.342651548062455e-07,0.5827242082966366,0.22506925207756232,0.05621622040823816,0.6625992668153291,0.20249835634451027,0.05613484776953898,0.7468230453148901,0.174375,7.342651548062474e-07,0.8358197391883575,0.14158239143367046
59,0.5,1,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors by distinguishing pleomorphic adenoma and myoepithelial adenomas from other entities, despite some overlap between benign and malignant lesions.",4.0266153650665106e-07,0.42608439531090037,0.0,0.030828249901291863,0.43721380642274443,0.0,0.030783626196198767,0.44895022004790297,0.0,4.026615365066519e-07,0.4613455665026214,0.0
59,0.5,2,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Using diffusion-weighted echo-planar MRI, it may be possible to differentiate pleomorphic adenoma and myoepithelial adenomas from other primary parotid gland tumors, although overlap exists among benign and malignant groups.",4.974054274493923e-07,0.5596157879354227,0.0,0.03808195576041938,0.5753641449035616,0.0,0.03802683236001026,0.5920510636885754,0.0,4.974054274493935e-07,0.6097655716208945,0.0
59,0.5,3,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Echo-planar diffusion-weighted MR imaging shows promise in identifying pleomorphic adenoma and myoepithelial adenomas among primary parotid gland tumors, but some benign and malignant lesions overlap.",5.921493183921335e-07,0.7137664677626816,0.0,0.0453356616195469,0.7357067949787415,0.0,0.045270038523821755,0.7591051483517424,0.0,5.921493183921352e-07,0.784118958765673,0.0
59,0.5,4,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Primary parotid gland tumors can be partly distinguished by diffusion-weighted echo-planar MRI, which helps separate pleomorphic adenoma and myoepithelial adenomas from other types, although benign and malignant lesions sometimes overlap.",4.7371945471370696e-07,0.5245244681241537,0.0,0.0362685292956375,0.5389965007326869,0.0,0.03621603081905739,0.5543107357057284,0.0,4.737194547137081e-07,0.570544858467612,0.0
59,0.5,5,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Diffusion-weighted echo-planar MR imaging offers potential in differentiating pleomorphic adenoma and myoepithelial adenomas from other primary parotid gland tumor subtypes, despite overlaps in benign and malignant lesions.",5.447773729207629e-07,0.6337237600891443,0.0,0.04170880868998314,0.652325186039691,0.0,0.04164843544191601,0.6720937713621127,0.0,5.447773729207643e-07,0.693147180559945,0.0
59,0.5,6,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"The use of diffusion-weighted echo-planar MRI may allow prediction of histologic subtypes in primary parotid gland tumors by distinguishing pleomorphic adenoma and myoepithelial adenomas, with some overlap between benign and malignant groups.",4.2634750924233636e-07,0.4578330936254802,0.0,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
59,0.5,7,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Echo-planar diffusion-weighted MR imaging could differentiate pleomorphic adenoma and myoepithelial adenomas from other primary parotid gland tumors, although overlaps occur within benign and malignant lesions.",5.921493183921335e-07,0.7137664677626816,0.0,0.0453356616195469,0.7357067949787415,0.0,0.045270038523821755,0.7591051483517424,0.0,5.921493183921352e-07,0.784118958765673,0.0
59,0.5,8,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Diffusion-weighted echo-planar MR imaging has the ability to separate pleomorphic adenoma and myoepithelial adenomas from other primary parotid gland tumors, despite some overlap between benign and malignant entities.",5.210914001850776e-07,0.5959834321062973,0.0,0.03989538222520126,0.6131044728864086,0.0,0.039837633900963135,0.6312717768418579,0.0,5.210914001850789e-07,0.6505875661411493,0.0
59,0.5,9,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Primary parotid gland tumors may be classified by diffusion-weighted echo-planar MRI, which differentiates pleomorphic adenoma and myoepithelial adenomas from others, though overlap exists between benign and malignant lesions.",5.210914001850776e-07,0.5959834321062973,0.0,0.03989538222520126,0.6131044728864086,0.0,0.039837633900963135,0.6312717768418579,0.0,5.210914001850789e-07,0.6505875661411493,0.0
59,0.5,10,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"The potential of diffusion-weighted echo-planar MR imaging lies in differentiating pleomorphic adenoma and myoepithelial adenomas from other primary parotid gland tumors, despite overlaps in benign and malignant lesion groups.",4.974054274493923e-07,0.5596157879354227,0.0,0.03808195576041938,0.5753641449035616,0.0,0.03802683236001026,0.5920510636885754,0.0,4.974054274493935e-07,0.6097655716208945,0.0
60,0.5,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Is it possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Correlated results can be achieved with homebrew assays if they are carefully designed, validated, and performed according to established protocols and guidelines. Nonetheless, using commercially available kits that have been rigorously tested is recommended for accuracy and reliability.",2.1317375462116866e-07,0.02867380702793776,0.08613712483925579,0.016320838183036854,0.044127317833616786,0.07877526753864449,0.0162972138685758,0.06740412561426679,0.06420927467300831,2.1317375462116866e-07,0.09145173438926513,0.049048751486325794
60,0.5,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Can homebrew assays yield correlated results for BCRABL transcript detection by quantitative real-time PCR? Yes, provided the assay is properly designed, validated, and executed following standard protocols and guidelines. However, it is advisable to use commercially available kits that have undergone thorough testing for dependable results.",4.500334819780227e-07,0.17893379844936597,0.12244897959183677,0.03445510283085558,0.2489217304796303,0.07877526753864449,0.034405229278104466,0.2764959234728255,0.06420927467300831,4.500334819780227e-07,0.30502583468732514,0.049048751486325794
60,0.5,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Are correlated results achievable with homebrew assays for BCRABL transcript detection via quantitative real-time PCR? Such results are possible if the assay is well-designed, validated, and conducted according to established protocols and guidelines. Still, the use of commercially tested kits is recommended for accurate and reliable outcomes.",4.263475092423373e-07,0.15695489173059096,0.12244897959183677,0.03264167636607371,0.22644887462757257,0.07877526753864449,0.0325944277371516,0.25350640524812595,0.06420927467300831,4.263475092423373e-07,0.2814953372771307,0.049048751486325794
60,0.5,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Is it feasible to get correlated outcomes from homebrew assays in BCRABL transcript detection by quantitative real-time PCR? Yes, if the assay is designed, validated, and executed properly following established protocols and guidelines. However, commercially available kits with rigorous testing are preferred for reliable and accurate results.",4.263475092423373e-07,0.15695489173059096,0.12244897959183677,0.03264167636607371,0.22644887462757257,0.07877526753864449,0.0325944277371516,0.25350640524812595,0.06420927467300831,4.263475092423373e-07,0.2814953372771307,0.049048751486325794
60,0.5,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Can quantitative real-time PCR homebrew assays produce correlated results for BCRABL transcript detection? Correlated results are attainable if the assay is carefully designed, validated, and performed in line with established protocols and guidelines. Nonetheless, commercially available kits that have been rigorously tested are recommended for accuracy and reliability.",4.026615365066519e-07,0.16494431121430608,0.10118243894911468,0.030828249901291835,0.20446996790879757,0.07877526753864449,0.030783626196198732,0.23103354939606824,0.06420927467300831,4.026615365066519e-07,0.2585058190524312,0.049048751486325794
60,0.5,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Do homebrew assays provide correlated results for BCRABL transcript detection using quantitative real-time PCR? They can, if the assay is properly designed, validated, and executed according to established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone extensive testing for precise and reliable results.",3.552895910352811e-07,0.09377599010905868,0.12244897959183677,0.02720139697172809,0.16191035349000105,0.07877526753864449,0.027162023114293,0.18754843745632988,0.06420927467300831,3.552895910352811e-07,0.21405405648159848,0.049048751486325794
60,0.5,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Is it possible to obtain consistent results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR? Yes, if the assay is correctly designed, validated, and performed following established protocols and guidelines. Still, using commercially available kits that have been rigorously tested is advised for accuracy and reliability.",3.789755637709665e-07,0.11439527731179444,0.12244897959183677,0.029014823436509962,0.1829637626878342,0.07877526753864449,0.028972824655245866,0.20905464267729323,0.06420927467300831,3.789755637709665e-07,0.23603296320037348,0.049048751486325794
60,0.5,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Can homebrew assays generate correlated results in BCRABL transcript detection via quantitative real-time PCR? Correlated results are possible when the assay is well-designed, validated, and executed according to established protocols and guidelines. However, for reliable and accurate results, commercially available kits that have undergone thorough testing are recommended.",4.026615365066519e-07,0.16494431121430608,0.10118243894911468,0.030828249901291835,0.20446996790879757,0.07877526753864449,0.030783626196198732,0.23103354939606824,0.06420927467300831,4.026615365066519e-07,0.2585058190524312,0.049048751486325794
60,0.5,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Are consistent results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR achievable? Yes, if the assay is properly designed, validated, and carried out following established protocols and guidelines. Nevertheless, it is best to use commercially available kits that have been rigorously tested for accurate and reliable outcomes.",3.552895910352811e-07,0.09377599010905868,0.12244897959183677,0.02720139697172809,0.16191035349000105,0.07877526753864449,0.027162023114293,0.18754843745632988,0.06420927467300831,3.552895910352811e-07,0.21405405648159848,0.049048751486325794
60,0.5,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Is it feasible to get reliable results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Reliable results can be obtained if the assay is well-designed, validated, and executed according to established protocols and guidelines. However, using commercially available kits that have undergone extensive testing is recommended for accuracy and reliability.",2.8423167282822487e-07,0.061012076582871,0.10322560396707706,0.02176111757738247,0.10128573167356691,0.07877526753864449,0.0217296184914344,0.12567303373824235,0.06420927467300831,2.8423167282822487e-07,0.1508751548600662,0.049048751486325794
61,0.5,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging necessary to diagnose appendicitis in children? Clinical evaluation remains the primary method for diagnosing appendicitis. However, for girls over 10 years old, targeted imaging should be used to prevent unnecessary surgeries. In uncertain cases, the preferred imaging technique is...",9.474389094274162e-08,0.032296799753420924,0.045351473922902494,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
61,0.5,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Do we require imaging to confirm appendicitis in pediatric patients? Diagnosis mainly relies on clinical examination. Still, in girls older than 10, selective imaging is recommended to reduce unnecessary appendectomies. The imaging method of choice in ambiguous cases is...",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
61,0.5,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Should imaging be used to diagnose appendicitis in children? The diagnosis is primarily clinical. Yet, for girls above 10 years, imaging should be selectively employed to avoid unwarranted appendectomies. The preferred imaging modality in doubtful cases is...",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
61,0.5,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging needed for diagnosing appendicitis in children? Clinical assessment is crucial for diagnosis. Nevertheless, in girls older than 10, imaging should be selectively applied to prevent unnecessary surgery. The imaging technique favored in equivocal cases is...",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
61,0.5,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Do we need to perform imaging to diagnose appendicitis in children? Diagnosis depends mostly on clinical evaluation. However, in girls over 10 years, selective imaging is advisable to avoid needless appendectomies. The imaging choice in uncertain cases is...",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
61,0.5,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging essential for diagnosing appendicitis in children? Clinical assessment is the cornerstone of diagnosis. Still, in girls older than 10 years, selective imaging use is recommended to prevent unnecessary appendectomies. The imaging method preferred in ambiguous cases is...",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
61,0.5,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Should we use imaging to diagnose appendicitis in children? Clinical evaluation is key for diagnosis. However, in girls above 10 years, selective imaging should be implemented to avoid unnecessary appendectomies. The imaging of choice in equivocal cases is...",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
61,0.5,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging required to diagnose appendicitis in children? Diagnosis is primarily clinical. Nonetheless, in girls older than 10 years, selective imaging should be used to avoid unnecessary appendectomies. The preferred imaging modality in uncertain cases is...",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
61,0.5,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Do children with suspected appendicitis need imaging? Clinical assessment is fundamental for diagnosis. Yet, in girls over 10 years old, selective imaging should be applied to prevent unnecessary appendectomies. The imaging technique chosen in equivocal cases is...",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
61,0.5,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging indicated to diagnose appendicitis in children? Diagnosis mainly relies on clinical evaluation. However, in girls older than 10, selective use of imaging is advised to avoid unnecessary appendectomies. The imaging method of choice in ambiguous cases is...",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
62,0.5,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries unnecessary? Answer: Using MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, leading to low rates of immediate and delayed paraplegia. This suggests routine surgical reimplantation of segmental vessels may be unnecessary.",1.1842986367842703e-07,0.11630759437391891,0.018860946745562133,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
62,0.5,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: In thoracic and thoracoabdominal aneurysm repair, is reimplanting spinal cord arteries futile? Answer: Monitoring MEP and SSEP allows safe sacrifice of as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair, with acceptably low immediate and delayed paraplegia rates. This experience indicates routine segmental vessel reimplantation might not be needed.",1.1842986367842703e-07,0.09015109699429802,0.0,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
62,0.5,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair a pointless effort? Answer: With MEP and SSEP monitoring, up to 15 intercostal and lumbar arteries can be safely sacrificed without reimplantation during TAA/A repair, resulting in low rates of immediate and delayed paraplegia. This suggests routine surgical reimplantation of segmental vessels may be unnecessary.",2.3685972735685406e-08,0.04171269641572639,0.017538265306122455,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
62,0.5,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: does reimplanting spinal cord arteries have value? Answer: Monitoring MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low immediate and delayed paraplegia rates. This experience implies routine reimplantation of segmental vessels might be redundant.",1.4211583641411244e-07,0.10919929196499112,0.0,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
62,0.5,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Is it worthwhile to reimplant spinal cord arteries during thoracic and thoracoabdominal aneurysm aneurysm repair? Answer: Using MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with acceptably low rates of immediate and delayed paraplegia. This suggests routine reimplantation of segmental vessels may be unnecessary.",4.737194547137081e-08,0.03509131981126945,0.0,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
62,0.5,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Question: In thoracic and thoracoabdominal aneurysm repair, is reimplantation of spinal cord arteries effective? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, resulting in low immediate and delayed paraplegia rates. This experience suggests that routine surgical reimplantation of segmental vessels may be unnecessary.",4.737194547137081e-08,0.059846576259839246,0.017851239669421492,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
62,0.5,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries beneficial? Answer: Monitoring MEP and SSEP indicates that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with acceptably low rates of immediate and delayed paraplegia. This suggests routine reimplantation of segmental vessels may not be required.",7.105791820705622e-08,0.07831517733430982,0.0181755829903978,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
62,0.5,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair a waste? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, resulting in low immediate and delayed paraplegia rates. This experience suggests routine reimplantation of segmental vessels might be unnecessary.",1.1842986367842703e-07,0.09015109699429802,0.0,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
62,0.5,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: does reimplantation of spinal cord arteries matter? Answer: Using MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low immediate and delayed paraplegia rates. This suggests routine surgical reimplantation of segmental vessels may be redundant.",1.4211583641411244e-07,0.1358587989096045,0.01922337562475971,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
62,0.5,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: In thoracic and thoracoabdominal aneurysm repair, is reimplantation of spinal cord arteries justified? Answer: Monitoring MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine reimplantation of segmental vessels is not necessary.",4.737194547137081e-08,0.059846576259839246,0.017851239669421492,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
63,0.5,1,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? There is no direct connection between cervical cord plaques and discopathy in these patients.,7.10579182070559e-08,0.048881856501088894,0.0173979591836734,0.005440279394345639,0.04668734464658675,0.02582766439909298,0.005432404622858621,0.04401396725101003,0.0347222222222221,7.105791820705622e-08,0.040766682260833687,0.044081632653061226
63,0.5,2,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Does a relationship exist between cervical cord plaques and discopathy in patients with multiple sclerosis? There is no direct relationship between cervical cord plaques and discopathy in such patients.,4.73719454713706e-08,0.04983235946618336,0.0465508517456569,0.003626852929563759,0.054245888686454524,0.06020782968834909,0.003621603081905747,0.059189562569345266,0.07346189164370975,4.737194547137081e-08,0.06474904911168045,0.08631303761173899
63,0.5,3,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Are cervical cord plaques related to discopathy in individuals with multiple sclerosis? No direct relation exists between cervical cord plaques and discopathy in these individuals.,1.421158364141118e-07,0.019457961881772956,0.12244897959183679,0.010880558788691277,0.09035074872166104,0.1924392346470268,0.010864809245717241,0.10541153346308363,0.2222222222222221,1.4211583641411244e-07,0.05675098530128997,0.20408163265306126
63,0.5,4,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there an association between cervical cord plaques and discopathy in multiple sclerosis patients? There is no direct association between cervical cord plaques and discopathy in these patients.,7.10579182070559e-08,0.048881856501088894,0.0173979591836734,0.005440279394345639,0.04668734464658675,0.02582766439909298,0.005432404622858621,0.04401396725101003,0.0347222222222221,7.105791820705622e-08,0.040766682260833687,0.044081632653061226
63,0.5,5,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Can cervical cord plaques be linked to discopathy in patients suffering from multiple sclerosis? There is no direct link between cervical cord plaques and discopathy in these patients.,7.10579182070559e-08,0.15649508588704242,0.1355229591836735,0.005440279394345639,0.21990772479954535,0.19742766439909293,0.005432404622858621,0.23324490497296813,0.2222222222222221,7.105791820705622e-08,0.1902823779258136,0.20408163265306126
63,0.5,6,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Do cervical cord plaques have any relation to discopathy in multiple sclerosis patients? There is no direct relation between cervical cord plaques and discopathy in these patients.,9.47438909427412e-08,0.11283042302761626,0.13147640908915553,0.007253705859127518,0.17855425109069456,0.1958971088435374,0.007243206163811494,0.1924229104527133,0.2222222222222221,9.474389094274162e-08,0.14772276350701796,0.20408163265306126
63,0.5,7,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is a correlation present between cervical cord plaques and discopathy in patients with multiple sclerosis? There is no direct correlation between cervical cord plaques and discopathy in these patients.,4.73719454713706e-08,0.04983235946618336,0.0465508517456569,0.003626852929563759,0.054245888686454524,0.06020782968834909,0.003621603081905747,0.059189562569345266,0.07346189164370975,4.737194547137081e-08,0.06474904911168045,0.08631303761173899
63,0.5,8,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there any connection between cervical cord plaques and discopathy in multiple sclerosis patients? There is no direct connection between cervical cord plaques and discopathy in these patients.,7.10579182070559e-08,0.048881856501088894,0.0173979591836734,0.005440279394345639,0.04668734464658675,0.02582766439909298,0.005432404622858621,0.04401396725101003,0.0347222222222221,7.105791820705622e-08,0.040766682260833687,0.044081632653061226
63,0.5,9,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Are cervical cord plaques and discopathy related in patients with multiple sclerosis? There is no direct relation between cervical cord plaques and discopathy in these patients.,1.184298636784265e-07,0.011759653762829725,0.09070294784580499,0.009067132323909398,0.01989723587524983,0.11337868480725624,0.009054007704764368,0.029315960284361786,0.13605442176870736,1.1842986367842703e-07,0.04025762088527962,0.15873015873015875
63,0.5,10,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there any link between cervical cord plaques and discopathy in multiple sclerosis patients? There is no direct link between cervical cord plaques and discopathy in these patients.,7.10579182070559e-08,0.048881856501088894,0.0173979591836734,0.005440279394345639,0.04668734464658675,0.02582766439909298,0.005432404622858621,0.04401396725101003,0.0347222222222221,7.105791820705622e-08,0.040766682260833687,0.044081632653061226
64,0.5,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the 30-day and 1-year mortality rates in emergency general surgery laparotomies worrisome and in need of enhancement? Answer: Yes, these mortality rates are concerning and highlight the necessity for advancements in this area.",2.3685972735685343e-07,0.04654895266083292,0.14345474951535556,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.27958486221916123,0.0
64,0.5,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Is there a concern regarding 30-day and 1-year mortality following emergency general surgery laparotomies, suggesting a need for improvement? Answer: Yes, the mortality rates at 30 days and 1 year post-surgery are alarming and call for improvements.",1.6580180914979753e-07,0.07878179892958048,0.1728395061728395,0.012693985253473108,0.04872356224955565,0.09204470742932283,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.18721154208814594,0.0
64,0.5,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Do the 30-day and 1-year mortality statistics for emergency general surgery laparotomies indicate a problem and the need for better outcomes? Answer: Yes, these mortality figures are troubling and demonstrate the need for progress.",2.3685972735685343e-07,0.0873223162231831,0.1142457561728395,0.01813426464781874,0.17774385927312153,0.06177126992932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.27958486221916123,0.0
64,0.5,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the mortality rates within 30 days and 1 year after emergency general surgery laparotomies a significant concern requiring improvement? Answer: Yes, the rates are concerning and point to the necessity for enhanced care.",2.3685972735685343e-07,0.0057755890984831915,0.1728395061728395,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.27958486221916123,0.0
64,0.5,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Is the 30-day and 1-year mortality in emergency general surgery laparotomies an issue that demands attention and improvement? Answer: Yes, these mortality rates are a matter of concern and indicate the need for better practices.",2.1317375462116813e-07,0.023211947774768316,0.1728395061728395,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.2478361639045814,0.0
64,0.5,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the 30-day and 1-year mortality rates after emergency general surgery laparotomies problematic and in need of improvement? Answer: Yes, these rates raise concerns and emphasize the need for advancements in treatment.",2.84231672828224e-07,0.06640021091491866,0.1728395061728395,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.3462762367178347,0.0
64,0.5,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Do the 30-day and 1-year mortality outcomes in emergency general surgery laparotomies highlight an area needing improvement? Answer: Yes, the mortality rates are concerning and suggest the need for enhanced interventions.",3.0791764556390933e-07,0.09814890922949848,0.1728395061728395,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.3813675565291037,0.0
64,0.5,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Is there a need to improve due to the concerning 30-day and 1-year mortality rates in emergency general surgery laparotomies? Answer: Yes, these mortality rates are troubling and call for improvement.",3.0791764556390933e-07,0.1428680821688495,0.1406172839506173,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.3813675565291037,0.0
64,0.5,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the 30-day and 1-year mortality rates in emergency general surgery laparotomies an area of concern that requires improvement? Answer: Yes, these rates are cause for concern and indicate a need for better outcomes.",2.3685972735685343e-07,0.0057755890984831915,0.1728395061728395,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.27958486221916123,0.0
64,0.5,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Does the 30-day and 1-year mortality in emergency general surgery laparotomies represent a challenge that necessitates improvement? Answer: Yes, the mortality rates are worrisome and highlight the need for progress.",3.3160361829959463e-07,0.13093873205249018,0.1728395061728395,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.33945109091197967,0.047500000000000014,3.316036182995957e-07,0.4177352006999784,0.0
65,0.5,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Is emergency double-balloon enteroscopy combined with real-time capsule endoscopy a practical method for acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe, feasible, and effective procedure for acute OGIB, potentially preventing major surgery by diagnosing and treating most cases successfully.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
65,0.5,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Emergency double-balloon enteroscopy alongside real-time capsule endoscopy: is it a viable approach for acute overt-obscure gastrointestinal bleeding? Emergency DBE proves to be effective, safe, and feasible in acute OGIB, often avoiding the need for major surgery through accurate diagnosis and treatment.",2.3685972735685406e-08,0.009119444997918169,0.024375,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
65,0.5,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Can emergency double-balloon enteroscopy with real-time capsule endoscopy be effectively used in acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe, feasible, and effective technique for acute OGIB, capable of diagnosing and treating most patients while potentially preventing major surgery.",4.7371945471370706e-08,0.01619836298637356,0.024375,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
65,0.5,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Is the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy a feasible approach for acute overt-obscure gastrointestinal bleeding? Emergency DBE is an effective, safe, and feasible option in acute OGIB that may help avoid major surgery by diagnosing and treating most patients.",2.3685972735685406e-08,0.057909609167349885,0.024375,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
65,0.5,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Does emergency double-balloon enteroscopy combined with real-time capsule endoscopy represent a feasible strategy for acute overt-obscure gastrointestinal bleeding? Emergency DBE is safe, effective, and feasible in acute OGIB, often circumventing the need for major surgery by diagnosing and successfully treating the majority of patients.",4.737194547137081e-08,0.0814401065775443,0.024375,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
65,0.5,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Is emergency double-balloon enteroscopy with real-time capsule endoscopy a practical combined method for acute overt-obscure gastrointestinal bleeding? Emergency DBE is feasible, safe, and effective in acute OGIB, potentially avoiding major surgery by diagnosing and treating most patients successfully.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
65,0.5,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Emergency double-balloon enteroscopy combined with real-time capsule endoscopy: is this a feasible combined approach for acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe, effective, and feasible procedure that can diagnose and treat most acute OGIB cases, possibly preventing major surgery.",2.3685972735685406e-08,0.009119444997918169,0.024375,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
65,0.5,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Can emergency double-balloon enteroscopy together with real-time capsule endoscopy be a feasible approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is a feasible, safe, and effective method in acute OGIB that may avoid major surgery by diagnosing and treating most patients.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
65,0.5,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Is it feasible to use emergency double-balloon enteroscopy combined with real-time capsule endoscopy in acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe, effective, and feasible technique for acute OGIB, often preventing the need for major surgery through diagnosis and treatment.",2.3685972735685406e-08,0.009119444997918169,0.024375,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
65,0.5,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy offer a feasible approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is effective, safe, and feasible in acute OGIB and may avoid major surgery by diagnosing and successfully treating most patients.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
66,0.5,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex affect the outcome of intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis might alter the typical survival and recovery benefits seen in men after ischemic stroke.,1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
66,0.5,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is there an influence of sex on the response to intravenous thrombolysis in ischemic stroke? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis could change the usual survival and recovery advantage men experience in ischemic stroke.,7.105791820705622e-08,0.10178325435209201,0.02467255675266781,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
66,0.5,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does gender impact the effectiveness of intravenous thrombolysis in ischemic stroke? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register shows that intravenous thrombolysis may modify the survival and recovery benefits normally observed in men during ischemic stroke.,1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
66,0.5,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the response to intravenous thrombolysis in ischemic stroke affected by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest intravenous thrombolysis may influence the typical survival and recovery advantage men have in ischemic stroke.,1.6580180914979774e-07,0.20603493494102976,0.029403818232647053,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
66,0.5,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,","Does intravenous thrombolysis response in ischemic stroke vary by sex? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis might alter the expected survival and recovery benefits men usually have in ischemic stroke.",2.1317375462116834e-07,0.26252148023828603,0.03214915595867978,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
66,0.5,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is sex a factor in the response to intravenous thrombolysis for ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register imply that intravenous thrombolysis could modify the natural survival and recovery advantage seen in men with ischemic stroke.,9.474389094274162e-08,0.0938419528664296,0.0020669648430901577,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
66,0.5,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex influence outcomes after intravenous thrombolysis in ischemic stroke? Research from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests intravenous thrombolysis may change the expected survival and recovery benefits men typically experience in ischemic stroke.,1.8948778188548304e-07,0.23388126393689257,0.030740740740740742,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
66,0.5,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the effect of intravenous thrombolysis on ischemic stroke outcomes influenced by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis may alter the survival and recovery advantage generally observed in men.,1.6580180914979774e-07,0.1704889256815454,0.003894873636332556,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
66,0.5,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex alter the response to intravenous thrombolysis in ischemic stroke? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis might affect the usual survival and recovery advantage men have in ischemic stroke.,1.6580180914979774e-07,0.20603493494102976,0.029403818232647053,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
66,0.5,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the survival and recovery benefit from intravenous thrombolysis in ischemic stroke affected by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the natural advantage men experience.,2.1317375462116834e-07,0.22505406507288273,0.005277777777777767,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
67,0.5,1,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers secrete GABA? No, mossy fibers do not secrete gamma-aminobutyric acid (GABA). They are cerebellar nerve fibers that release glutamate as their neurotransmitter. GABA is mainly released by inhibitory neurons in the brain.",1.8948778188548261e-07,0.14060314229802584,0.09290321178433068,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
67,0.5,2,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Are mossy fibers responsible for releasing GABA? No, mossy fibers do not release gamma-aminobutyric acid (GABA). Instead, these fibers in the cerebellum release glutamate. GABA is predominantly released by inhibitory neurons.",2.842316728282238e-07,0.27120273372701265,0.0889942704632177,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
67,0.5,3,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Is GABA released by mossy fibers? No, mossy fibers do not release gamma-aminobutyric acid (GABA). They are nerve fibers in the cerebellum that release glutamate. GABA is chiefly released by inhibitory neurons.",2.605457000925385e-07,0.23692227180604242,0.09006574621959243,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
67,0.5,4,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers emit GABA? No, mossy fibers do not emit gamma-aminobutyric acid (GABA). These cerebellar nerve fibers release glutamate, while GABA is primarily released by inhibitory neurons.",3.552895910352797e-07,0.3816976729445418,0.08530571992110458,0.027201396971728152,0.45547552868282537,0.0,0.02716202311429307,0.47000362924573613,0.0,3.552895910352811e-07,0.4855078157816992,0.0
67,0.5,5,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Are mossy fibers a source of GABA? No, mossy fibers do not release gamma-aminobutyric acid (GABA). They are known to release glutamate in the cerebellum. GABA is mainly released by inhibitory neurons in the brain.",1.8948778188548261e-07,0.181376505860376,0.06369421844181462,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
67,0.5,6,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers discharge GABA? No, mossy fibers do not discharge gamma-aminobutyric acid (GABA). They are cerebellar nerve fibers that release glutamate. GABA is chiefly released by inhibitory neurons in the brain.",2.605457000925385e-07,0.23692227180604242,0.09006574621959243,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
67,0.5,7,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Is GABA secreted by mossy fibers? No, mossy fibers do not secrete gamma-aminobutyric acid (GABA). Instead, they release glutamate in the cerebellum. GABA is predominantly released by inhibitory neurons.",3.316036182995944e-07,0.29398579317663387,0.12228796844181462,0.025387970506946272,0.4177352006999784,0.0,0.025351221573340195,0.43078291609245367,0.0,3.316036182995957e-07,0.4446858212614444,0.0
67,0.5,8,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers produce GABA? No, mossy fibers do not produce gamma-aminobutyric acid (GABA). They are nerve fibers in the cerebellum that release glutamate. GABA is mainly released by inhibitory neurons in the brain.",2.1317375462116791e-07,0.21370058195323027,0.06193417031486354,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
67,0.5,9,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Are mossy fibers involved in GABA release? No, mossy fibers are not involved in releasing gamma-aminobutyric acid (GABA). They release glutamate in the cerebellum, while GABA is primarily released by inhibitory neurons.",2.605457000925385e-07,0.2816414447453939,0.05807869376880631,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
67,0.5,10,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers contain GABA? No, mossy fibers do not contain or release gamma-aminobutyric acid (GABA). They are cerebellar nerve fibers that release glutamate, whereas GABA is primarily released by inhibitory neurons.",2.605457000925385e-07,0.23692227180604242,0.09006574621959243,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
68,0.5,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Marital status, living arrangement, and mortality: does the link differ by gender? Assessing living arrangements is key to understanding and explaining gender disparities in mortality risks related to marital status. The effects of living alone versus living with a partner appear to",4.737194547137081e-08,0.01538864524228023,0.023242630385487524,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
68,0.5,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Does the relationship between marital status, living arrangements, and mortality change based on gender? Examining living arrangements is essential to uncover and clarify gender differences in mortality risk according to marital status. The influence of living alone compared to living with a partner seems to",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
68,0.5,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","How do marital status, living arrangements, and mortality interrelate, and does this vary by gender? Analyzing living arrangements is vital for identifying and explaining gender-specific mortality risks associated with marital status. The role of living alone versus cohabiting with a partner appears to",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
68,0.5,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Is there a gender variation in the association between marital status, living arrangements, and mortality? Evaluating living arrangements is important for revealing and explaining gender differences in mortality risks linked to marital status. The impact of living alone and living with a partner seems to",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
68,0.5,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Does the association between marital status, living arrangements, and mortality differ between genders? Understanding living arrangements is critical for identifying and explaining gender disparities in mortality risk by marital status. The effect of living alone versus living with a partner appears to",4.737194547137081e-08,0.01538864524228023,0.023242630385487524,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
68,0.5,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Marital status, living arrangements, and mortality: does gender influence their association? Assessing living arrangements is fundamental to explaining and identifying gender differences in mortality risks related to marital status. The consequences of living alone compared to living with a partner seem to",4.737194547137081e-08,0.01538864524228023,0.023242630385487524,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
68,0.5,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Is the relationship between marital status, living arrangements, and mortality influenced by gender? Evaluating living arrangements plays a crucial role in identifying and explaining gender disparities in mortality risks tied to marital status. The impact of living alone versus living with a partner appears to",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
68,0.5,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Do marital status, living arrangements, and mortality associations vary by gender? Analyzing living arrangements is essential for understanding and explaining gender differences in mortality risks according to marital status. The effect of living alone compared to living with a partner seems to",4.737194547137081e-08,0.01538864524228023,0.023242630385487524,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
68,0.5,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Does gender alter the association between marital status, living arrangements, and mortality? Assessing living arrangements is key to identifying and explaining gender-specific mortality risks linked to marital status. The influence of living alone versus living with a partner appears to",9.474389094274152e-08,0.06539906581694366,0.023242630385487524,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
68,0.5,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","How does gender affect the relationship between marital status, living arrangements, and mortality? Examining living arrangements is critical for uncovering and explaining gender differences in mortality risks associated with marital status. The impact of living alone and living with a partner seems to",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
69,0.5,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is preventing osteoporosis the main way to eliminate musculoskeletal symptoms caused by aromatase inhibitors? Preventing osteoporosis alone might not be enough to fully resolve these symptoms. Besides bone health, factors like inflammation, hormonal changes, and individual patient differences are crucial in managing these symptoms.",3.316036182995957e-07,0.2490461448195047,0.023374769082720202,0.025387970506946217,0.2629268160032119,0.017851239669421492,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
69,0.5,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Could stopping osteoporosis be the key to getting rid of aromatase inhibitor-related musculoskeletal symptoms? While bone health is important, it may not be the only factor. Managing inflammation, hormonal imbalances, and patient-specific traits also plays a vital role.",4.737194547137078e-07,0.3723169555402954,0.04276954805761024,0.03626852929563745,0.4170774958304695,0.017851239669421492,0.03621603081905733,0.45198512374305766,0.0,4.737194547137081e-07,0.4626235219481134,0.0
69,0.5,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is the prevention of osteoporosis essential to eradicate musculoskeletal symptoms linked to aromatase inhibitors? Preventing osteoporosis might not be the only solution; addressing inflammation, hormone levels, and individual patient factors is also important.",5.921493183921343e-07,0.48003155021939214,0.06977572089711641,0.045335661619546844,0.5666092298014331,0.017851239669421492,0.0452700385238217,0.6061358035703162,0.0,5.921493183921352e-07,0.6216882165778022,0.0
69,0.5,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Does preventing osteoporosis hold the key to eliminating musculoskeletal symptoms caused by aromatase inhibitors? Though bone health maintenance is important, other factors like inflammation, hormonal imbalances, and patient-specific characteristics must also be considered.",5.921493183921343e-07,0.48003155021939214,0.06977572089711641,0.045335661619546844,0.5666092298014331,0.017851239669421492,0.0452700385238217,0.6061358035703162,0.0,5.921493183921352e-07,0.6216882165778022,0.0
69,0.5,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is stopping osteoporosis the critical factor in removing aromatase inhibitor-related musculoskeletal symptoms? Maintaining bone health is necessary but not sufficient; inflammation, hormonal issues, and individual patient factors are also significant.",6.632072365991902e-07,0.5784716230326454,0.06977572089711641,0.05077594101389248,0.6683919241113756,0.017851239669421492,0.05070244314668032,0.7114963192281416,0.0,6.632072365991914e-07,0.7308875085427928,0.0
69,0.5,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is preventing osteoporosis the main approach to eliminate musculoskeletal symptoms related to aromatase inhibitors? While important, bone health alone does not address all factors such as inflammation, hormonal imbalances, and individual patient differences.",5.921493183921343e-07,0.48003155021939214,0.06977572089711641,0.045335661619546844,0.5666092298014331,0.017851239669421492,0.0452700385238217,0.6061358035703162,0.0,5.921493183921352e-07,0.6216882165778022,0.0
69,0.5,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Could managing osteoporosis be the solution to aromatase inhibitor-induced musculoskeletal symptoms? Maintaining bone health helps, but other elements including inflammation, hormones, and patient-specific characteristics are also key.",7.342651548062461e-07,0.6876709149976361,0.06977572089711641,0.05621622040823812,0.7817206094183797,0.017851239669421492,0.05613484776953894,0.8292793548845259,0.0,7.342651548062476e-07,0.8534898306351257,0.0
69,0.5,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is osteoporosis prevention the key to resolving musculoskeletal symptoms from aromatase inhibitors? Bone health is vital, yet inflammation, hormonal imbalances, and individual patient factors also play crucial roles.",7.105791820705608e-07,0.6499305870147891,0.06977572089711641,0.05440279394345624,0.7424998962650973,0.017851239669421492,0.05432404622858607,0.788457360364271,0.0,7.105791820705622e-07,0.8109302162163301,0.0
69,0.5,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is preventing osteoporosis the primary method to eliminate aromatase inhibitor-related musculoskeletal symptoms? Although important, other factors like inflammation, hormonal changes, and patient-specific traits must be addressed.",7.579511275419314e-07,0.7268916281509186,0.06977572089711641,0.05802964687302,0.8225426039386345,0.017851239669421492,0.057945649310491815,0.8718389693033215,0.0,7.57951127541933e-07,0.8979415932059598,0.0
69,0.5,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is the prevention of osteoporosis the sole key to eliminating musculoskeletal symptoms caused by aromatase inhibitors? While important, managing inflammation, hormonal imbalances, and individual patient characteristics is also essential.",6.868932093348755e-07,0.6135629428439144,0.06977572089711641,0.05258936747867436,0.7047595682822503,0.017851239669421492,0.052513244687633194,0.7492366472109886,0.0,6.868932093348768e-07,0.7701082216960753,0.0
70,0.5,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in younger individuals might represent a unique clinical entity. Additional studies are required to confirm these findings and establish the best treatment strategy for this group.,0.0,0.03554600925948348,0.024835600907029506,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0
70,0.5,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a separate clinical entity? Answer: Colorectal cancer occurring in young patients could be considered a separate clinical entity. More research is necessary to verify our results and determine the ideal management for this population.,4.7371945471370706e-08,0.012411839588333251,0.043209876543209916,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
70,0.5,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer among young patients a distinct clinical condition? Answer: Colorectal cancer in the young may be a distinct clinical condition. Further investigation is needed to validate these observations and identify the optimal approach for this demographic.,2.36859727356853e-08,0.028781750292165675,0.001978458049886611,0.0018134264647818726,0.027654231691776943,0.000709606002398791,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
70,0.5,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young individuals be a distinct clinical entity? Answer: Colorectal cancer in young individuals may constitute a distinct clinical entity. Additional research is needed to substantiate our findings and define the best approach for this patient group.,2.36859727356853e-08,0.07598831840523879,0.06893983083429453,0.0018134264647818726,0.07972712007889182,0.07492792295881102,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
70,0.5,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a separate clinical entity? Answer: Colorectal cancer in young patients might be a separate clinical entity. Further studies are required to confirm these findings and establish the optimal treatment approach for this population.,0.0,0.10663802777845177,0.07237144168962348,0.0,0.1094442916673608,0.07750966153659505,0.0,0.07493483033080572,0.05387755102040818,0.0,0.03850817669777484,0.02775510204081633
70,0.5,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young people represent a distinct clinical entity? Answer: Colorectal cancer among young people may represent a distinct clinical entity. More research is needed to validate our findings and determine the best clinical approach for this group.,2.36859727356853e-08,0.04133095937724107,0.04606009070294784,0.0018134264647818726,0.008635101559923974,0.024835646457268077,0.0018108015409528666,0.009813183473625475,0.026296566837107373,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.5,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in younger patients a unique clinical entity? Answer: Colorectal cancer occurring in younger patients could be a unique clinical entity. Further research is essential to confirm these findings and define the optimal management strategy for this population.,2.36859727356853e-08,0.04133095937724107,0.04606009070294784,0.0018134264647818726,0.008635101559923974,0.024835646457268077,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.5,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be considered a distinct clinical entity? Answer: Colorectal cancer in young patients might be considered a distinct clinical entity. Additional studies are necessary to verify our results and determine the best approach for this group.,4.7371945471370706e-08,0.11384801235320374,0.10726584022038566,0.0036268529295637453,0.12016942922464713,0.11903215288607605,0.003621603081905733,0.0895403035525173,0.1012244897959184,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
70,0.5,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young individuals a distinct clinical entity? Answer: Colorectal cancer in young individuals may be a distinct clinical entity. Further research is required to substantiate our findings and establish the optimal treatment plan for this population.,0.0,0.10663802777845177,0.07237144168962348,0.0,0.1094442916673608,0.07750966153659505,0.0,0.07493483033080572,0.05387755102040818,0.0,0.03850817669777484,0.02775510204081633
70,0.5,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer among young patients a separate clinical entity? Answer: Colorectal cancer among young patients might constitute a separate clinical entity. More investigation is needed to confirm these observations and define the best approach for this demographic.,2.36859727356853e-08,0.1382260419595256,0.0759548611111111,0.0018134264647818726,0.14005647718798553,0.08022317604627185,0.0018108015409528666,0.10441532758366501,0.055363321799307974,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
71,0.5,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Answer: Findings from the current study indicate that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after one year.",0.0,0.08154672712469857,0.05696180555555559,0.0,0.12602676010180813,0.09000000000000004,0.0,0.08664339756999428,0.06222222222222223,0.0,0.044719172939351015,0.0322222222222222
71,0.5,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is the compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: The results of this study suggest that septoplasty does not affect compensatory hypertrophy of the middle turbinate, even after a year.",2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.03470999491993654,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
71,0.5,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty influence the dimensions of compensatory hypertrophy in the middle turbinate? Answer: According to the present study, compensatory hypertrophy of the middle turbinate remains unchanged following septoplasty, even after one year.",4.73719454713706e-08,0.015825434862968724,0.053333333333333365,0.003626852929563759,0.06350640312047462,0.09000000000000004,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.5,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Can septoplasty modify the size of compensatory hypertrophy in the middle turbinate? Answer: The study's findings imply that compensatory hypertrophy of the middle turbinate is not altered by septoplasty, even after one year.",2.36859727356853e-08,0.04922265103184431,0.05520175742860451,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.5,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty affect the extent of compensatory hypertrophy in the middle turbinate? Answer: This study suggests that compensatory hypertrophy of the middle turbinate is unaffected by septoplasty, even after one year.",7.10579182070559e-08,0.018718211760319292,0.05134628088254728,0.005440279394345639,0.03071658029748292,0.09000000000000004,0.005432404622858621,0.011796675243259003,0.06222222222222223,7.105791820705622e-08,0.05706352137059145,0.0322222222222222
71,0.5,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is there a change in compensatory hypertrophy of the middle turbinate after septoplasty? Answer: The current study indicates no change in compensatory hypertrophy of the middle turbinate post-septoplasty, even after one year.",4.73719454713706e-08,0.200783059062013,0.08604444444444444,0.003626852929563759,0.2048086345156337,0.09239999999999994,0.003621603081905747,0.2089441837542254,0.0977777777777778,4.737194547137081e-08,0.21318521688620296,0.10217777777777776
71,0.5,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty impact the size of the middle turbinate's compensatory hypertrophy? Answer: Findings from this study show that septoplasty does not influence compensatory hypertrophy of the middle turbinate, even one year later.",4.73719454713706e-08,0.015825434862968724,0.053333333333333365,0.003626852929563759,0.018787230181123604,0.05777777777777784,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.5,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty result in changes to the compensatory hypertrophy of the middle turbinate? Answer: The present study reveals that septoplasty does not affect compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.034709994919936094,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
71,0.5,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is compensatory hypertrophy of the middle turbinate altered by septoplasty? Answer: Results from this study suggest no alteration in compensatory hypertrophy of the middle turbinate following septoplasty, even one year post-operation.",7.10579182070559e-08,0.15287573057837367,0.039769888231426645,0.005440279394345639,0.1541226678518357,0.040177514792899396,0.005432404622858621,0.15520643673841938,0.039848783694937544,7.105791820705622e-08,0.1560845471648702,0.03878369493754113
71,0.5,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty cause any changes in the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The study findings indicate that compensatory hypertrophy of the middle turbinate remains unaffected by septoplasty, even after one year.",2.36859727356853e-08,0.03364734985180551,0.0031726211122673764,0.0018134264647818796,0.03355963256444161,0.0025910509885536254,0.0018108015409528735,0.03339721616887559,0.0018684240952711456,2.3685972735685406e-08,0.033146172468933255,0.0010047404324198955
72,0.5,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Does the nature of general practice affect the adoption of IT innovations in primary care? Yes, elements like practice size, existing IT infrastructure, and healthcare professionals' attitudes significantly influence the uptake of new technology in primary care.",6.158352911278201e-07,0.44796610446870133,0.06790816326530615,0.04714908808432869,0.4873473914812796,0.049048751486325794,0.04708084006477454,0.5679840376059375,0.0,6.158352911278206e-07,0.5810298824392386,0.0
72,0.5,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Can general practice traits impact the acceptance of IT innovations in primary care? Indeed, factors such as the size of the practice, available IT resources, and the beliefs and attitudes of medical staff play a role in adopting new technology.",5.447773729207642e-07,0.3294152200973923,0.09566326530612247,0.04170880868998307,0.40510929324430656,0.049048751486325794,0.04164843544191593,0.48342664957787385,0.0,5.447773729207643e-07,0.49401850544960846,0.0
72,0.5,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Are general practice characteristics a factor in the adoption of IT innovations within primary care? Yes, the size of the practice, IT infrastructure, and healthcare professionals' perspectives all affect how new technology is embraced.",6.86893209334876e-07,0.4964693047605566,0.09566326530612247,0.05258936747867433,0.5769595501709666,0.049048751486325794,0.05251324468763316,0.6603573577369528,0.0,6.868932093348768e-07,0.6763400622435638,0.0
72,0.5,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Do features of general practice influence how IT innovations are adopted in primary care? Absolutely, aspects like practice size, IT setup, and healthcare workers' attitudes can determine the uptake of new technologies.",7.342651548062466e-07,0.5589896617418901,0.09566326530612247,0.056216220408238086,0.6414980713085381,0.049048751486325794,0.056134847769538906,0.7270487322356263,0.0,7.342651548062476e-07,0.7453329337305146,0.0
72,0.5,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Is the uptake of IT innovations in primary care affected by general practice characteristics? Yes, variables including practice size, IT infrastructure, and the attitudes and beliefs of healthcare providers impact adoption.",7.579511275419319e-07,0.5917794845648818,0.09566326530612247,0.058029646873019966,0.6753996229842198,0.049048751486325794,0.05794564931049178,0.7621400520468953,0.0,7.57951127541933e-07,0.7817005779013892,0.0
72,0.5,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Do general practice attributes affect the implementation of IT innovations in primary care? Yes, factors such as the size of the practice, existing IT infrastructure, and healthcare professionals’ mindset influence technology adoption.",7.342651548062466e-07,0.5589896617418901,0.09566326530612247,0.056216220408238086,0.6414980713085381,0.049048751486325794,0.056134847769538906,0.7270487322356263,0.0,7.342651548062476e-07,0.7453329337305146,0.0
72,0.5,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Can the characteristics of general practices influence the acceptance of IT innovations in primary care? Yes, considerations like practice size, IT resources, and healthcare professionals' attitudes affect the adoption process.",7.816371002776172e-07,0.6256810362405636,0.09566326530612247,0.059843073337801846,0.7104909427954889,0.049048751486325794,0.059756450851444654,0.79850769621777,0.0,7.816371002776184e-07,0.8194409058842362,0.0
72,0.5,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Are the traits of general practices influential in the uptake of IT innovations in primary care? Yes, elements such as practice size, IT infrastructure, and the attitudes and beliefs of healthcare staff play a crucial role.",6.395212638635054e-07,0.43762880473762333,0.09566326530612247,0.04896251454911057,0.5163349283545311,0.049048751486325794,0.04889164160572741,0.5978370007556193,0.0,6.39521263863506e-07,0.6118015411059923,0.0
72,0.5,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Do general practice features impact the adoption of IT innovations in primary care? Yes, the size of the practice, presence of IT infrastructure, and healthcare professionals' attitudes significantly influence technology uptake.",7.579511275419319e-07,0.6379892966022114,0.062369567327525556,0.058029646873019966,0.6753996229842198,0.049048751486325794,0.05794564931049178,0.7621400520468953,0.0,7.57951127541933e-07,0.7817005779013892,0.0
72,0.5,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Is the adoption of IT innovations in primary care influenced by general practice characteristics? Yes, factors like practice size, IT infrastructure availability, and healthcare professionals' attitudes and beliefs affect the implementation of new technology.",6.86893209334876e-07,0.4964693047605566,0.09566326530612247,0.05258936747867433,0.5769595501709666,0.049048751486325794,0.05251324468763316,0.6603573577369528,0.0,6.868932093348768e-07,0.6763400622435638,0.0
73,0.5,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Is the fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? The fragility observed in the esophageal mucosa could represent an important endoscopic marker of primary eosinophilic esophagitis, suggesting possible esophageal damage and inflammation. Nonetheless, additional diagnostic procedures are required to establish a conclusive diagnosis.",4.737194547137081e-08,0.008853553419875038,0.03353163872363443,0.0036268529295637453,0.040794662467614096,0.05825400469339861,0.003621603081905733,0.04408378315119643,0.06222222222222221,4.737194547137081e-08,0.013989487235059883,0.0212665406427221
73,0.5,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Could esophageal mucosal fragility be a hallmark endoscopic sign of primary eosinophilic esophagitis? Fragility in the esophageal mucosa might serve as a key endoscopic sign pointing to primary eosinophilic esophagitis, reflecting underlying esophageal inflammation and injury. Still, confirmation demands further diagnostic assessments.",2.1317375462116866e-07,0.07199384334363268,0.08763768392673832,0.016320838183036854,0.06148223571915068,0.10072314049586774,0.0162972138685758,0.12099596720825367,0.06222222222222221,2.1317375462116866e-07,0.18306581727899296,0.0212665406427221
73,0.5,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Is mucosal fragility in the esophagus pathognomonic for primary eosinophilic esophagitis on endoscopy? The presence of fragile esophageal mucosa may be a noteworthy endoscopic sign of primary eosinophilic esophagitis, indicating inflammation and tissue damage. However, definitive diagnosis requires additional testing.",2.6054570009253936e-07,0.0899261580012003,0.1106666177270337,0.0199476911126006,0.11277553010670038,0.10072314049586774,0.019918816950481533,0.17363970069367252,0.06222222222222221,2.6054570009253947e-07,0.23713303854926915,0.0212665406427221
73,0.5,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Does fragility of the esophageal mucosa indicate primary eosinophilic esophagitis in endoscopic exams? Fragile mucosa in the esophagus could be a significant endoscopic sign of primary eosinophilic esophagitis, signaling potential inflammation and injury. Further diagnostic evaluation is necessary to confirm this condition.",2.1317375462116866e-07,0.03818178575534281,0.11191488642509465,0.016320838183036854,0.06148223571915068,0.10072314049586774,0.0162972138685758,0.12099596720825367,0.06222222222222221,2.1317375462116866e-07,0.18306581727899296,0.0212665406427221
73,0.5,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Is esophageal mucosal fragility an endoscopic hallmark of primary eosinophilic esophagitis? The fragility seen in the esophageal mucosa might be an important endoscopic feature of primary eosinophilic esophagitis, suggesting esophageal inflammation and damage. Confirmation requires further diagnostic investigations.",3.0791764556390996e-07,0.18195871255794094,0.08241233540468648,0.023574544042164344,0.20535092807475142,0.07296803845505141,0.023540420032387266,0.22920955184848468,0.06222222222222221,3.079176455639103e-07,0.2942914523892175,0.0212665406427221
73,0.5,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Can fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Fragility of the esophageal mucosa may indicate primary eosinophilic esophagitis during endoscopy, reflecting possible mucosal damage and inflammation. Nonetheless, additional diagnostic tests are essential for a definitive diagnosis.",1.6580180914979784e-07,0.11793869791266909,0.022023958447255396,0.012693985253473108,0.1117130973439977,0.029717223336104437,0.012675610786670066,0.13860966181016998,0.013570019723865866,1.6580180914979784e-07,0.16642988191943964,0.0037170228023798192
73,0.5,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Is the fragile state of the esophageal mucosa a diagnostic endoscopic sign of primary eosinophilic esophagitis? Fragility of the esophageal mucosa might represent a critical endoscopic sign of primary eosinophilic esophagitis, pointing to inflammation and injury. Further diagnostic workup is needed to confirm the diagnosis.",1.4211583641411244e-07,0.1542989911312631,0.01710675345803167,0.010880558788691236,0.15035859287439512,0.013542787481971519,0.0108648092457172,0.14590902084880897,0.008783694937541095,1.4211583641411244e-07,0.14089196788936142,0.003108459357277899
73,0.5,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Does the fragility of the esophageal mucosa serve as a pathognomonic endoscopic marker for primary eosinophilic esophagitis? Fragile esophageal mucosa could be a significant endoscopic indication of primary eosinophilic esophagitis, suggestive of esophageal inflammation and damage. Additional tests are required for diagnosis confirmation.",1.8948778188548325e-07,0.04628619378417698,0.08878988642509464,0.014507411718254981,0.03678962312877898,0.10072314049586774,0.014486412327622933,0.09567815922396194,0.06222222222222221,1.8948778188548325e-07,0.15709033087573498,0.0212665406427221
73,0.5,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Is mucosal fragility in the esophagus a definitive endoscopic sign of primary eosinophilic esophagitis? The fragility of the esophageal mucosa may be an important endoscopic feature indicating primary eosinophilic esophagitis, with potential esophageal damage and inflammation. However, confirming the diagnosis necessitates further evaluation.",1.8948778188548325e-07,0.013279185186084508,0.1124945265202761,0.014507411718254981,0.03678962312877898,0.10072314049586774,0.014486412327622933,0.09567815922396194,0.06222222222222221,1.8948778188548325e-07,0.15709033087573498,0.0212665406427221
73,0.5,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Could fragile esophageal mucosa be a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Fragility of the esophageal mucosa might be a key endoscopic sign of primary eosinophilic esophagitis, reflecting inflammation and injury in the esophagus. Yet, additional diagnostic testing is essential to confirm the diagnosis.",1.4211583641411244e-07,0.12279230110581096,0.003325897505427028,0.010880558788691236,0.0858797853804476,0.031348140495867746,0.0108648092457172,0.11290201225071428,0.014722222222222192,1.4211583641411244e-07,0.14089196788936142,0.003108459357277899
74,0.5,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is it necessary to perform untethering before scoliosis correction in a patient with myelomeningocele? The study indicates that spinal cord untethering might not be required for patients with MM undergoing scoliosis surgery if they lack clinical signs of tethered cord, despite radiographic evidence of tethering.",1.4211583641411244e-07,0.1278333715098836,0.0,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
74,0.5,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For a patient with myelomeningocele, is untethering required before scoliosis correction? According to the study, spinal cord untethering may be unnecessary in MM patients having scoliosis surgery who do not show clinical symptoms of tethered cord, even if imaging shows tethering.",2.3685972735685406e-07,0.22314355131420927,0.0,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
74,0.5,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does a patient with myelomeningocele need untethering before scoliosis corrective surgery? Study findings suggest that untethering the spinal cord may not be needed for MM patients undergoing scoliosis correction who have no clinical tethered cord symptoms, despite radiographic tethering.",2.8423167282822466e-07,0.27443684570175897,0.0,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,0.5,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In patients with myelomeningocele, is untethering necessary prior to scoliosis correction? The research suggests that spinal cord untethering could be unnecessary for MM patients undergoing scoliosis surgery if they exhibit no clinical signs of tethered cord, even when tethering is visible on imaging.",1.8948778188548325e-07,0.17435338714477755,0.0,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
74,0.5,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering required before scoliosis correction in myelomeningocele patients? The study suggests that untethering may not be necessary for MM patients without clinical symptoms of tethered cord undergoing scoliosis surgery, despite radiographic evidence.",3.7897556377096586e-07,0.3856624808119835,0.0,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
74,0.5,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Should untethering be done before scoliosis corrective surgery in patients with myelomeningocele? The study results imply that spinal cord untethering might be unnecessary in MM patients who lack clinical tethered cord symptoms but have radiographic tethering, when undergoing scoliosis correction.",2.6054570009253936e-07,0.248461359298501,0.0,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
74,0.5,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For scoliosis correction in patients with myelomeningocele, is untethering essential? Study data indicate that spinal cord untethering may not be required if the patient shows no clinical signs of tethered cord, even if tethering is seen on radiographs.",3.0791764556390996e-07,0.30110509278391984,0.0,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
74,0.5,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering mandatory before scoliosis surgery in myelomeningocele patients? Findings suggest that patients with MM undergoing scoliosis correction without clinical tethered cord symptoms may not need spinal cord untethering, despite radiographic tethering.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
74,0.5,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Do patients with myelomeningocele need spinal cord untethering prior to scoliosis correction? The study suggests untethering may be unnecessary if there are no clinical symptoms of tethered cord, even when imaging shows tethering.",4.2634750924233646e-07,0.446287102628419,0.0,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
74,0.5,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is it necessary to untether the spinal cord before scoliosis correction in myelomeningocele patients? The research indicates that spinal cord untethering might not be required for those undergoing scoliosis surgery who do not have clinical signs of tethered cord, despite radiographic evidence.",2.1317375462116866e-07,0.23226299631212743,0.024375,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
75,0.5,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What is the clinical importance of bile duct sludge, and how does it differ from bile duct stones? Answer: Bile duct sludge is a combination of thickened bile, cholesterol crystals, and other materials that build up in the bile ducts. Although it resembles bile duct stones in some ways, it is distinct.",2.1317375462116866e-07,0.16005294408625703,0.08474359161771036,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
75,0.5,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile",Question: How clinically significant is bile duct sludge compared to bile duct stones? Answer: Bile duct sludge consists of thickened bile mixed with cholesterol crystals and other substances that can collect in the bile ducts. It shares some characteristics with bile duct stones but is not the same.,9.474389094274162e-08,0.01811673146994819,0.1287233737933813,0.0072537058591274906,0.06083494426833802,0.021728395061728398,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
75,0.5,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What distinguishes the clinical relevance of bile duct sludge from that of bile duct stones? Answer: Bile duct sludge is an accumulation of thickened bile, cholesterol crystals, and other components within the bile ducts. While similar to bile duct stones, it is a different entity.",4.737194547137081e-08,0.06272950509571595,0.1641935603807258,0.0036268529295637453,0.01649336441601079,0.045351473922902494,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
75,0.5,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: Can you explain the clinical significance of bile duct sludge and how it differs from bile duct stones? Answer: Bile duct sludge is made up of thickened bile, cholesterol crystals, and other substances that gather in the bile ducts. It has similarities to bile duct stones but is distinct.",1.4211583641411244e-07,0.06580894311636953,0.11913954803504687,0.010880558788691236,0.1046502601011925,0.020823902218198284,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.5,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What is the clinical difference between bile duct sludge and bile duct stones? Answer: Bile duct sludge is a mixture of thickened bile, cholesterol crystals, and other materials that accumulate in the bile ducts. Though it shares features with bile duct stones, it is different.",4.737194547137081e-08,0.03192296373749626,0.1392028554431885,0.0036268529295637453,0.015013325609441353,0.02271498107084911,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
75,0.5,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: How does the clinical significance of bile duct sludge compare to that of bile duct stones? Answer: Bile duct sludge comprises thickened bile, cholesterol crystals, and other substances that can build up in the bile ducts. It is similar but not identical to bile duct stones.",7.105791820705622e-08,0.036732353851955946,0.15823914336704342,0.005440279394345618,0.007379788770512263,0.04434829637641968,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.5,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What clinical implications does bile duct sludge have, and how is it distinct from bile duct stones? Answer: Bile duct sludge refers to a blend of thickened bile, cholesterol crystals, and other elements that accumulate in the bile ducts. It shares some traits with bile duct stones but differs.",1.4211583641411244e-07,0.06580894311636953,0.11913954803504684,0.010880558788691236,0.1046502601011925,0.020823902218198284,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.5,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What is the clinical importance of bile duct sludge versus bile duct stones? Answer: Bile duct sludge is an aggregation of thickened bile, cholesterol crystals, and other substances in the bile ducts. While it resembles bile duct stones, it is different.",4.737194547137081e-08,0.14004096795385967,0.16340146761228158,0.0036268529295637453,0.0834475231974281,0.02498356344510192,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
75,0.5,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: How significant is bile duct sludge clinically, and how does it differ from bile duct stones? Answer: Bile duct sludge consists of thickened bile, cholesterol crystals, and other materials that can collect in the bile ducts. It shares similarities with bile duct stones but is distinct.",7.105791820705622e-08,0.006595519914566861,0.13384350369138331,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.5,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What are the clinical differences between bile duct sludge and bile duct stones? Answer: Bile duct sludge is a combination of thickened bile, cholesterol crystals, and other substances that accumulate in the bile ducts. Although it is similar to bile duct stones, it is a separate condition.",9.474389094274162e-08,0.04087451793940877,0.1760856632956574,0.0072537058591274906,0.06083494426833802,0.021728395061728398,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
76,0.5,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Do quantitative real-time PCR assays for BCRABL transcript detection yield comparable results from homebrew assays? The findings indicate that despite methodological differences, comparable results can be achieved if the same positive control cell line and quality control gene are employed, highlighting the need for assay standardization across labs.",4.026615365066519e-07,0.29490940756929707,0.009950941147080193,0.030828249901291835,0.2924886575037129,0.01586888657648284,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
76,0.5,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Are correlated results achievable from homebrew quantitative real-time PCR assays for BCRABL transcript detection? The data suggest that consistent results are possible between labs using different methods, provided they use the same positive control cell line and quality control gene, emphasizing the importance of assay standardization.",4.500334819780227e-07,0.30889889480435695,0.031217481789802295,0.03445510283085558,0.3369404200745456,0.01586888657648284,0.034405229278104466,0.3659342693515293,0.0,4.500334819780227e-07,0.3732042458899425,0.0
76,0.5,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can homebrew assays for BCRABL transcript detection by quantitative real-time PCR produce correlated results? The evidence shows that despite varied methodologies, comparable outcomes are attainable if the same positive control cell line and quality control gene are utilized, underscoring the necessity for assay standardization among laboratories.",4.500334819780227e-07,0.30889889480435695,0.031217481789802295,0.03445510283085558,0.3369404200745456,0.01586888657648284,0.034405229278104466,0.3659342693515293,0.0,4.500334819780227e-07,0.3732042458899425,0.0
76,0.5,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Is it possible to obtain correlated results from homebrew quantitative real-time PCR assays for BCRABL detection? Results imply that assays can be comparable across labs with differing methods when the same positive control cell line and quality control gene are applied, making assay standardization essential.",4.737194547137081e-07,0.33137175065641467,0.031217481789802295,0.03626852929563745,0.35992993829924513,0.01586888657648284,0.03621603081905733,0.3894647667617237,0.0,4.737194547137081e-07,0.3973017974690025,0.0
76,0.5,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Do homebrew quantitative real-time PCR assays for BCRABL transcript detection provide comparable results? Findings indicate that despite significant methodological differences, results can be consistent if the same positive control cell line and quality control gene are used, stressing the need for standardized assays between labs.",4.737194547137081e-07,0.33137175065641467,0.031217481789802295,0.03626852929563745,0.35992993829924513,0.01586888657648284,0.03621603081905733,0.3894647667617237,0.0,4.737194547137081e-07,0.3973017974690025,0.0
76,0.5,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Are quantitative real-time PCR assays for BCRABL detection from homebrew methods able to yield correlated results? The studies suggest comparability across laboratories with divergent methodologies if the same positive control cell line and quality control gene are employed, highlighting the critical role of assay standardization.",4.737194547137081e-07,0.33137175065641467,0.031217481789802295,0.03626852929563745,0.35992993829924513,0.01586888657648284,0.03621603081905733,0.3894647667617237,0.0,4.737194547137081e-07,0.3973017974690025,0.0
76,0.5,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can quantitative real-time PCR assays for BCRABL transcript detection be correlated between labs using homebrew assays? The results indicate that comparable findings are possible despite methodological differences when the same positive control cell line and quality control gene are used, pointing to the importance of assay standardization.",4.263475092423373e-07,0.28691998808558195,0.031217481789802295,0.03264167636607371,0.3144675642224879,0.01586888657648284,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
76,0.5,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Is correlation feasible in results from homebrew quantitative real-time PCR assays for BCRABL detection? Evidence suggests that despite different methodologies, comparable results can be obtained if the same positive control cell line and quality control gene are used, emphasizing the imperative of assay standardization.",4.974054274493935e-07,0.3543612688811142,0.031217481789802295,0.038081955760419325,0.38346043570943955,0.01586888657648284,0.0380268323600102,0.4135623183407837,0.0,4.974054274493935e-07,0.4219944100593742,0.0
76,0.5,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Are consistent results possible from homebrew quantitative real-time PCR assays detecting BCRABL transcripts? Data show that assays can be comparable across labs with different methods if the same positive control cell line and quality control gene are used, underlining the necessity of assay standardization.",4.974054274493935e-07,0.3543612688811142,0.031217481789802295,0.038081955760419325,0.38346043570943955,0.01586888657648284,0.0380268323600102,0.4135623183407837,0.0,4.974054274493935e-07,0.4219944100593742,0.0
76,0.5,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can homebrew quantitative real-time PCR assays for BCRABL detection achieve correlated results? The findings propose that despite significant methodological variation, comparable results are attainable when the same positive control cell line and quality control gene are applied, making assay standardization a critical requirement.",5.210914001850789e-07,0.3778917662913086,0.031217481789802295,0.0398953822252012,0.40755798728849957,0.01586888657648284,0.039837633900963065,0.4382549309311554,0.0,5.210914001850789e-07,0.44731221804366594,0.0
77,0.5,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex found in cervical disk disease? Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a link with pH levels. Additional analysis of FAC is ongoing.",1.4211583641411233e-07,0.1122943022824554,0.02221074380165289,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
77,0.5,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does cervical disk disease involve the fibronectin-aggrecan complex? Injured cervical intervertebral disks exhibit biochemical signs including inflammatory markers like MCP, structural protein fragments such as FAC, and a relationship to pH. Further examination of FAC is underway.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
77,0.5,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex detected in cervical disk disease? Biochemical assessment of injured cervical intervertebral disks identifies inflammatory markers such as MCP, fragments of matrix proteins like FAC, and an association with pH. FAC is being further studied.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,0.5,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Biochemical analysis of damaged cervical intervertebral disks reveals inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and a correlation with pH. FAC requires further evaluation.",1.4211583641411233e-07,0.1122943022824554,0.02221074380165289,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
77,0.5,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","In cervical disk disease, is the fibronectin-aggrecan complex present? Biochemical analysis of injured cervical intervertebral disks shows inflammatory markers including MCP, fragments of structural matrix proteins such as FAC, and a pH correlation. FAC is subject to further study.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
77,0.5,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does the fibronectin-aggrecan complex appear in cervical disk disease? Biochemical evaluation of damaged cervical intervertebral disks reveals inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a link with pH. FAC is being further evaluated.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,0.5,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex involved in cervical disk disease? Biochemical studies of injured cervical intervertebral disks reveal inflammatory markers including MCP, fragments of structural proteins like FAC, and a correlation with pH. FAC is under further investigation.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
77,0.5,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex found in cervical disk disease? Biochemical analysis of injured cervical intervertebral disks identifies inflammatory markers such as MCP, fragments of matrix proteins like FAC, and a relationship with pH. Further study of FAC is ongoing.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
77,0.5,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex detected in cervical disk disease? Biochemical evaluation of damaged cervical intervertebral disks shows inflammatory markers including MCP, fragments of structural matrix proteins like FAC, and a pH correlation. FAC is being further analyzed.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
77,0.5,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cervical disk disease? Biochemical studies of injured cervical intervertebral disks reveal inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and a link with pH. Further investigation of FAC is needed.",1.4211583641411233e-07,0.1122943022824554,0.02221074380165289,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
78,0.5,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis a precursor to bronchiectasis? A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi might play a role in neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. However, it is still unclear if this mechanism drives the progression from PBB to bronchiectasis.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
78,0.5,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Could alveolar macrophage phagocytic dysfunction in children suffering from protracted bacterial bronchitis be an early indicator of bronchiectasis? A weakened phagocytic response of alveolar macrophages to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization observed in PBB and bronchiectasis. The role of this mechanism in advancing PBB to bronchiectasis is yet to be determined.,4.737194547137081e-08,0.08612878664280244,0.03631185475258099,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
78,0.5,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis signal the onset of bronchiectasis? A reduced host phagocytic response by alveolar macrophages to apoptotic cells or NTHi could be involved in neutrophilic inflammation and NTHi colonization seen in both PBB and bronchiectasis. Whether this contributes to PBB progressing into bronchiectasis remains unknown.,4.737194547137081e-08,0.013369432360373246,0.03631185475258099,0.0036268529295637453,0.012068210184330574,0.01851192595229618,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
78,0.5,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is the dysfunction of alveolar macrophage phagocytosis in children with protracted bacterial bronchitis a precursor to the development of bronchiectasis? A compromised phagocytic response to apoptotic cells or NTHi by alveolar macrophages may lead to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. It is still uncertain if this mechanism causes PBB to progress to bronchiectasis.,2.3685972735685406e-08,0.06842920954340181,0.03631185475258099,0.0018134264647818726,0.04402125646671262,0.01851192595229618,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.5,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Can alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be considered a forerunner of bronchiectasis? A lowered alveolar macrophage phagocytic response to apoptotic cells or NTHi might contribute to neutrophilic inflammation and colonization by NTHi in both PBB and bronchiectasis. Whether this mechanism influences the transition from PBB to bronchiectasis is unknown.,4.737194547137081e-08,0.03894356239886809,0.0013659614719480281,0.0036268529295637453,0.03872771712894396,0.0007114496724635287,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
78,0.5,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is alveolar macrophage phagocytic impairment in children with protracted bacterial bronchitis an early step toward bronchiectasis? A diminished phagocytic host response by alveolar macrophages to apoptotic cells or NTHi could promote neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. The impact of this mechanism on the progression of PBB to bronchiectasis is yet to be established.,2.3685972735685406e-08,0.06842920954340181,0.03631185475258099,0.0018134264647818726,0.04402125646671262,0.01851192595229618,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.5,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis precede bronchiectasis? A reduced phagocytic response of alveolar macrophages to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this process also facilitates PBB's progression to bronchiectasis is still unknown.,1.6580180914979784e-07,0.08572147028385668,0.03631185475258099,0.012693985253473108,0.11316432705570056,0.01851192595229618,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
78,0.5,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is the impaired phagocytic function of alveolar macrophages in children with protracted bacterial bronchitis a precursor to bronchiectasis? A decreased alveolar macrophage phagocytic response to apoptotic cells or NTHi may be involved in neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. It remains unclear if this mechanism contributes to bronchiectasis development from PBB.,2.3685972735685406e-08,0.03206156537252758,0.03631185475258099,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.5,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Could dysfunction in alveolar macrophage phagocytosis in children with protracted bacterial bronchitis be a preliminary factor leading to bronchiectasis? A reduced phagocytic response to apoptotic cells or NTHi by alveolar macrophages may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. The role of this dysfunction in the progression from PBB to bronchiectasis is not yet known.,7.105791820705622e-08,0.0796189024388112,0.019075782114846302,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
78,0.5,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis linked as an early event to bronchiectasis? A lowered phagocytic response by alveolar macrophages to apoptotic cells or NTHi might contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also leads to the advancement of PBB into bronchiectasis remains uncertain.,2.3685972735685406e-08,0.06842920954340181,0.03631185475258099,0.0018134264647818726,0.04402125646671262,0.01851192595229618,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
79,0.5,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Yes, the study results show that these markers accurately represent bone histomorphometry in this group.",2.36859727356853e-07,0.016136021573160075,0.35804883401920434,0.018134264647818782,0.0666859609137096,0.1627799393508714,0.01810801540952873,0.09437334024797961,0.16000000000000003,2.3685972735685406e-07,0.17803859535036892,0.11238293444328822
79,0.5,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Do biochemical markers of bone turnover reflect bone histomorphometry in 370 postmenopausal women? Yes, according to the study, these markers are representative of bone histomorphometry in the sample of 370 postmenopausal women.",1.658018091497971e-07,0.05530151967079444,0.3374485596707819,0.012693985253473143,0.04380897830381958,0.16646848989298454,0.012675610786670108,0.014825951717011066,0.16000000000000003,1.6580180914979784e-07,0.0647099100433648,0.11238293444328822
79,0.5,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Can biochemical markers of bone turnover serve as indicators of bone histomorphometry in 370 postmenopausal women? Yes, the study demonstrates that these markers correspond well with bone histomorphometric data in 370 postmenopausal women.",1.421158364141118e-07,0.13596181338778868,0.3709021039359701,0.010880558788691264,0.07808944022478981,0.16753996564935925,0.010864809245717234,0.04872750339269283,0.16000000000000003,1.4211583641411244e-07,0.029618590232095787,0.11238293444328822
79,0.5,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Are biochemical markers of bone turnover reliable indicators of bone histomorphometry in 370 postmenopausal women? Yes, the findings confirm that these markers represent bone histomorphometry in this population.",2.605457000925383e-07,0.05800483384371713,0.35427383401920437,0.01994769111260066,0.10640106718875009,0.16136218787158144,0.019918816950481602,0.13359405340126207,0.16000000000000003,2.6054570009253947e-07,0.21886058987062373,0.11238293444328822
79,0.5,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Is there a correlation between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women? Yes, the study indicates that biochemical markers accurately reflect bone histomorphometry in 370 postmenopausal women.",1.658018091497971e-07,0.010582346731443426,0.3083233902322221,0.012693985253473143,0.04861064577083951,0.100996755772816,0.012675610786670108,0.08078055594642919,0.09141289437585737,1.6580180914979784e-07,0.11422042294050394,0.07671763951873403
79,0.5,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? Yes, the study results support that these markers are representative of bone histomorphometry.",2.842316728282236e-07,0.004968531075308924,0.4252488340192044,0.02176111757738254,0.09230276645280577,0.19976218787158145,0.021729618491434476,0.17441604792151688,0.16000000000000003,2.8423167282822487e-07,0.26142020428941937,0.11238293444328822
79,0.5,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? Yes, the study confirms that these markers are representative of bone histomorphometry in the group studied.",2.131737546211677e-07,0.041769217837511086,0.2492488340192044,0.016320838183036902,0.07799510694008038,0.1287562707118181,0.016297213868575855,0.10797724786216589,0.12301775147928998,2.1317375462116866e-07,0.13881788219708646,0.11238293444328822
79,0.5,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Can biochemical markers of bone turnover be used to represent bone histomorphometry in 370 postmenopausal women? Yes, evidence from the study shows these markers are representative of bone histomorphometry.",2.36859727356853e-07,0.08288500422111822,0.4279835390946502,0.018134264647818782,0.015341725316676325,0.19976218787158145,0.01810801540952873,0.09437334024797961,0.16000000000000003,2.3685972735685406e-07,0.17803859535036892,0.11238293444328822
79,0.5,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Are biochemical markers of bone turnover valid representatives of bone histomorphometry in 370 postmenopausal women? Yes, the study results indicate that these markers accurately reflect bone histomorphometry.",2.842316728282236e-07,0.004968531075308924,0.4252488340192044,0.02176111757738254,0.09230276645280577,0.19976218787158145,0.021729618491434476,0.17441604792151688,0.16000000000000003,2.8423167282822487e-07,0.26142020428941937,0.11238293444328822
79,0.5,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? Yes, the study findings affirm that these markers are representative of bone histomorphometry in this cohort.",2.131737546211677e-07,0.02407707543436599,0.3615778281020446,0.016320838183036902,0.028484594042940792,0.16409689294702728,0.016297213868575855,0.05663301226513262,0.16000000000000003,2.1317375462116866e-07,0.13881788219708646,0.11238293444328822
80,0.5,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Yes, both opioid dependence and MMT must be documented as they are crucial elements of the patient's medical history and treatment plan.",2.1317375462116802e-07,0.02623168447933244,0.13604292820069205,0.016320838183036868,0.05212191666417487,0.12972656250000003,0.01629721386857582,0.07877587596313207,0.11959876543209881,2.1317375462116866e-07,0.15092017254479861,0.07450693937180423
80,0.5,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is opioid dependence along with methadone maintenance treatment (MMT) noted in the medical record? Yes, these should be included since they are significant for the patient's medical history and ongoing care.",3.079176455639092e-07,0.06984810030863953,0.19463667820069205,0.023574544042164386,0.1393247281102461,0.16000000000000003,0.023540420032387314,0.21230726858765436,0.11959876543209881,3.079176455639103e-07,0.28907051102561576,0.07450693937180423
80,0.5,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Does the medical record include documentation of opioid dependence and methadone maintenance treatment (MMT)? Yes, these are essential to note in the medical record as part of the patient's history and treatment.",2.842316728282239e-07,0.1264966233643503,0.13042740352768373,0.021761117577382506,0.15163298847189388,0.12670630202140312,0.02172961849143444,0.17721594877638536,0.11959876543209881,2.8423167282822487e-07,0.2527028668547411,0.07450693937180423
80,0.5,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) captured in the medical record? Yes, they should be documented because they play a vital role in the patient's medical history and treatment plan.",2.842316728282239e-07,0.08177745042499884,0.16241445597846985,0.021761117577382506,0.10542317643456434,0.16000000000000003,0.02172961849143444,0.17721594877638536,0.11959876543209881,2.8423167282822487e-07,0.2527028668547411,0.07450693937180423
80,0.5,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Yes, it is important to record these as they are key factors in the patient's ongoing treatment and history.",2.3685972735685332e-07,0.016546840538250063,0.16436324070069205,0.018134264647818747,0.04088465529699281,0.16000000000000003,0.018108015409528694,0.1105245742777119,0.11959876543209881,2.3685972735685406e-07,0.1837099953677903,0.07450693937180423
80,0.5,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) documented within the medical record? Yes, these must be recorded as they are important components of the patient's medical history and treatment strategy.",3.079176455639092e-07,0.06984810030863953,0.19463667820069205,0.023574544042164386,0.1393247281102461,0.16000000000000003,0.023540420032387314,0.21230726858765436,0.11959876543209881,3.079176455639103e-07,0.28907051102561576,0.07450693937180423
80,0.5,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is opioid dependence and methadone maintenance treatment (MMT) included in the medical record? Yes, it should be documented since it is a critical part of the patient's medical history and treatment plan.",2.842316728282239e-07,0.03705827748564783,0.19463667820069205,0.021761117577382506,0.10542317643456434,0.16000000000000003,0.02172961849143444,0.17721594877638536,0.11959876543209881,2.8423167282822487e-07,0.2527028668547411,0.07450693937180423
80,0.5,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Yes, documenting these is necessary because they significantly impact the patient's medical history and ongoing treatment.",3.552895910352798e-07,0.1388409717955903,0.19463667820069205,0.027201396971728145,0.21078369209238978,0.16000000000000003,0.02716202311429306,0.28641524074137603,0.11959876543209881,3.552895910352811e-07,0.3660315521617452,0.07450693937180423
80,0.5,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Does the medical record document opioid dependence and methadone maintenance treatment (MMT)? Yes, it is essential to include these as they are important aspects of the patient's medical history and treatment plan.",2.842316728282239e-07,0.03705827748564783,0.19463667820069205,0.021761117577382506,0.10542317643456434,0.16000000000000003,0.02172961849143444,0.17721594877638536,0.11959876543209881,2.8423167282822487e-07,0.2527028668547411,0.07450693937180423
80,0.5,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the patient's medical record? Yes, they should be documented as they are vital to understanding the patient's medical history and treatment approach.",2.842316728282239e-07,0.1264966233643503,0.13042740352768373,0.021761117577382506,0.15163298847189388,0.12670630202140312,0.02172961849143444,0.17721594877638536,0.11959876543209881,2.8423167282822487e-07,0.2527028668547411,0.07450693937180423
81,0.5,1,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Are the existing prediction formulas suitable for estimating basal metabolic rate in Chinese people? Further research is required to confirm their accuracy.,3.079176455639089e-07,0.2779712690809921,0.14268727705112957,0.023574544042164434,0.3747485278106817,0.09000000000000004,0.023540420032387356,0.4779752248482887,0.031217481789802305,3.079176455639101e-07,0.5436154465889818,0.0
81,0.5,2,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Do the current basal metabolic rate prediction equations apply to Chinese individuals? Additional studies are necessary to verify their validity.,3.552895910352796e-07,0.37805472763797354,0.14268727705112957,0.027201396971728194,0.48010904346850714,0.09000000000000004,0.0271620231142931,0.5892008599585128,0.031217481789802305,3.5528959103528083e-07,0.6613984822453656,0.0
81,0.5,3,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Is it appropriate to use present prediction equations for basal metabolic rate estimation in the Chinese population? More investigation is needed to ensure precision.,2.605457000925383e-07,0.18699949087526413,0.14268727705112957,0.019947691112600675,0.2794383480063565,0.09000000000000004,0.01991881695048161,0.3778917662913073,0.031217481789802305,2.605457000925394e-07,0.4382549309311563,0.0
81,0.5,4,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Can the existing basal metabolic rate prediction models accurately estimate rates in Chinese subjects? Further evaluation is needed.,4.026615365066503e-07,0.48928036274819764,0.14268727705112957,0.030828249901291946,0.597892079124891,0.09000000000000004,0.030783626196198847,0.7143640029125184,0.031217481789802305,4.0266153650665153e-07,0.7949298748698883,0.0
81,0.5,5,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,The suitability of current basal metabolic rate prediction equations for Chinese individuals requires more research to validate accuracy.,4.026615365066503e-07,0.48928036274819764,0.14268727705112957,0.030828249901291946,0.597892079124891,0.09000000000000004,0.030783626196198847,0.7143640029125184,0.031217481789802305,4.0266153650665153e-07,0.7949298748698883,0.0
81,0.5,6,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Are the standard basal metabolic rate prediction equations valid for use with Chinese people? This question demands further study to confirm.,3.3160361829959426e-07,0.3267614332504234,0.14268727705112957,0.025387970506946314,0.42604182219823183,0.09000000000000004,0.02535122157334023,0.532042446118564,0.031217481789802305,3.316036182995955e-07,0.6007738604289306,0.0
81,0.5,7,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,"It remains to be determined if current basal metabolic rate prediction formulas are applicable to the Chinese population, necessitating additional research.",3.3160361829959426e-07,0.3267614332504234,0.14268727705112957,0.025387970506946314,0.42604182219823183,0.09000000000000004,0.02535122157334023,0.532042446118564,0.031217481789802305,3.316036182995955e-07,0.6007738604289306,0.0
81,0.5,8,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Further investigation is essential to assess whether existing basal metabolic rate prediction equations are accurate for Chinese individuals.,4.026615365066503e-07,0.48928036274819764,0.14268727705112957,0.030828249901291946,0.597892079124891,0.09000000000000004,0.030783626196198847,0.7143640029125184,0.031217481789802305,4.0266153650665153e-07,0.7949298748698883,0.0
81,0.5,9,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,The accuracy of current prediction equations for estimating basal metabolic rate in Chinese people needs to be tested through more research.,3.3160361829959426e-07,0.3267614332504234,0.14268727705112957,0.025387970506946314,0.42604182219823183,0.09000000000000004,0.02535122157334023,0.532042446118564,0.031217481789802305,3.316036182995955e-07,0.6007738604289306,0.0
81,0.5,10,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,More research is needed to establish if the present basal metabolic rate prediction equations are applicable to Chinese individuals.,3.7897556377096496e-07,0.43212194890824884,0.14268727705112957,0.02901482343651007,0.5372674573084559,0.09000000000000004,0.028972824655245973,0.6498254817749478,0.031217481789802305,3.789755637709662e-07,0.7259370033829362,0.0
82,0.5,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, prevent colon cancer in patients with coronary artery disease? Our findings from coronary artery disease patients support the idea that bezafibrate may help prevent colon cancer.",1.8948778188548272e-07,0.18835066359864783,0.01244203397612488,0.014507411718254988,0.1452950764710219,0.047500000000000014,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
82,0.5,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer among coronary artery disease patients? Data from patients with coronary artery disease suggest a potential protective effect of bezafibrate against colon cancer.",2.1317375462116802e-07,0.21966810696117722,0.010781249999999992,0.016320838183036868,0.21715695965463944,0.017226562500000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
82,0.5,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can bezafibrate, a ligand for peroxisome proliferator-activated receptors that lowers lipids, prevent colon cancer in individuals with coronary artery disease? Our study data from such patients indicate a possible preventive role of bezafibrate in colon cancer development.",1.6580180914979742e-07,0.11947114269430381,0.041619897959183666,0.012693985253473108,0.1163075395977704,0.047500000000000014,0.012675610786670073,0.15339948449985608,0.024375,1.6580180914979784e-07,0.19237189264745602,0.0
82,0.5,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the use of bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, reduce the risk of colon cancer in patients suffering from coronary artery disease? Evidence from patients with coronary artery disease supports the hypothesis that bezafibrate might prevent colon cancer.",7.105791820705622e-08,0.010259809366699457,0.04439143655489808,0.005440279394345618,0.008093954957539395,0.047500000000000014,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
82,0.5,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is the peroxisome proliferator-activated receptor ligand bezafibrate, known for lowering lipids, capable of preventing colon cancer in those with coronary artery disease? Our data from coronary artery disease patients back the hypothesis of bezafibrate’s preventive effect on colon cancer.",1.1842986367842682e-07,0.06337717528203912,0.043078433162892615,0.009067132323909363,0.06073768844295824,0.047500000000000014,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.5,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, a lipid-lowering ligand targeting peroxisome proliferator-activated receptors, prevent colon cancer in coronary artery disease patients? Data collected from these patients support the possible protective impact of bezafibrate against colon cancer.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,0.5,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Findings from patients with coronary artery disease favor the hypothesis that bezafibrate may have a preventive effect on colon cancer.,1.6580180914979742e-07,0.1964874960898535,0.01326962809917355,0.012693985253473108,0.19552436023319242,0.00943296602387509,0.012675610786670073,0.1941728480622058,0.005009756657483936,1.6580180914979784e-07,0.19237189264745602,0.0
82,0.5,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is there evidence that bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, prevents colon cancer in coronary artery disease patients? Our data from such patients support the notion that bezafibrate could prevent colon cancer development.",2.1317375462116802e-07,0.17889474339882705,0.03999024334251605,0.016320838183036868,0.1751480396207037,0.047500000000000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
82,0.5,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the peroxisome proliferator-activated receptor ligand bezafibrate, which lowers lipids, have a preventive effect on colon cancer in patients with coronary artery disease? Data from these patients support this possible protective role of bezafibrate.",2.3685972735685332e-07,0.1679743429861591,0.06937499999999999,0.018134264647818747,0.20591969828745738,0.047500000000000014,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
82,0.5,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer among patients with coronary artery disease? Our patient data support the hypothesis of bezafibrate’s potential to prevent colon cancer.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
83,0.5,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do UK radiologists feel content with the training and support provided for suspected child abuse cases? Answer: The survey reveals considerable dissatisfaction among consultant radiologists with the existing service, highlights a low count of paediatric radiologists handling these cases, and indicates that the number of radiology child abuse specialists could grow by 27% with enhanced training.",0.0,0.024755256448569796,0.017814055255132685,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
83,0.5,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are radiologists in the UK happy with the training and support they receive regarding suspected child abuse? Answer: Survey results demonstrate notable dissatisfaction among consultant radiologists with the current service, show a limited number of paediatric radiologists involved, and suggest a 27% increase in child abuse radiology experts is possible with better training.",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
83,0.5,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: How satisfied are UK radiologists with their training and support for suspected child abuse cases? Answer: The survey points to significant dissatisfaction among consultant radiologists about the current service, confirms few paediatric radiologists undertake this work, and proposes that improved training could boost the number of child abuse radiology specialists by 27%.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
83,0.5,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK consultant radiologists content with the support and training they get for suspected child abuse? Answer: Findings show marked dissatisfaction among consultant radiologists with the present service, a low number of paediatric radiologists involved, and potential to increase child abuse radiology experts by 27% through enhanced training.",1.8948778188548325e-07,0.18715768842535052,0.023736662031901768,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
83,0.5,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do consultant radiologists in the UK feel adequately supported and trained for suspected child abuse cases? Answer: The survey highlights significant dissatisfaction with the current service, a small number of paediatric radiologists engaged in this work, and suggests that improved training could raise the number of child abuse radiology experts by 27%.",9.474389094274162e-08,0.10267172959437865,0.02054876033057852,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
83,0.5,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists satisfied with the level of training and support for suspected child abuse? Answer: Survey data reveals substantial dissatisfaction among consultant radiologists with the existing service, confirms few paediatric radiologists working in this area, and indicates that a 27% increase in child abuse radiology specialists is feasible with better training.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
83,0.5,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: How do UK radiologists rate their training and support in suspected child abuse cases? Answer: The survey uncovers significant dissatisfaction among consultant radiologists with current services, a low number of paediatric radiologists involved, and the possibility of increasing child abuse radiology experts by 27% with improved training.",2.1317375462116866e-07,0.17994445728120034,0.00341530097330061,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
83,0.5,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are radiologists in the UK satisfied with their support and training regarding suspected child abuse? Answer: Results show notable dissatisfaction among consultant radiologists with the current service, limited paediatric radiologists working in this field, and the potential to boost child abuse radiology experts by 27% if training is enhanced.",1.6580180914979784e-07,0.10877613617595294,0.017851239669421492,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
83,0.5,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do UK consultant radiologists feel the training and support for suspected child abuse is adequate? Answer: The survey indicates significant dissatisfaction among consultant radiologists, confirms a low number of paediatric radiologists in this work, and suggests a 27% increase in child abuse radiology specialists could be achieved with better training.",1.4211583641411244e-07,0.11629931608083233,0.002140430468021242,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
83,0.5,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists content with the training and support they receive for suspected child abuse? Answer: Survey findings reveal considerable dissatisfaction among consultant radiologists with current services, a low number of paediatric radiologists involved, and the potential to increase the number of child abuse radiology experts by 27% with improved training.",1.1842986367842703e-07,0.09595304393715409,0.001748760330578504,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
84,0.5,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Does the Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? We discovered that USMLE Step 2 scores, the count of honors during medical school clerkships, and AOA membership showed the strongest correlations with resident performance. Our aim in analyzing these data was to give residency programs an understanding of which criteria might be considered ""high"".",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
84,0.5,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Is Residency Selection Criteria a Predictor of Performance in Orthopaedic Surgery Residency? Our findings indicated that USMLE Step 2 results, the number of honors earned in medical school clerkships, and AOA membership were most strongly correlated with resident performance. The purpose of this analysis was to help residency programs identify which criteria could be deemed ""high"".",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
84,0.5,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Does the selection criteria for residency predict how well one performs in Orthopaedic Surgery Residency? We found that USMLE Step 2 scores, honors received during medical school clerkships, and AOA membership had the strongest links to resident performance. Our goal was to provide residency programs with insight into which criteria might be considered ""high"".",4.737194547137081e-08,0.037041271680350096,0.0,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
84,0.5,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Can Residency Selection Criteria forecast performance in Orthopaedic Surgery Residency? We observed that USMLE Step 2, the number of honors in medical school clerkships, and AOA membership correlated most strongly with resident performance. Our objective was to inform residency programs about which criteria may be ""high"".",2.3685972735685406e-07,0.20067069546215155,0.0,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
84,0.5,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Does the Residency Selection Criteria serve as a predictor for Orthopaedic Surgery Residency performance? We identified USMLE Step 2 scores, honors obtained in medical school clerkships, and AOA membership as having the strongest correlations with resident performance. Our intent was to offer residency programs a sense of which criteria might be classified as ""high"".",4.737194547137081e-08,0.037041271680350096,0.0,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
84,0.5,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Is there a predictive relationship between Residency Selection Criteria and performance in Orthopaedic Surgery Residency? Our analysis showed that USMLE Step 2 scores, number of honors in medical school clerkships, and AOA membership were the strongest indicators of resident performance. Our goal was to help residency programs understand which criteria could be considered ""high"".",4.737194547137081e-08,0.037041271680350096,0.0,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
84,0.5,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Does Residency Selection Criteria predict success in Orthopaedic Surgery Residency? We found that USMLE Step 2 scores, honors earned in medical school clerkships, and AOA membership were the strongest predictors of resident performance. Our aim in analyzing these data was to provide residency programs with a sense of which criteria may be ""high"".",7.105791820705622e-08,0.056089466651043196,0.0,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
84,0.5,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Are Residency Selection Criteria indicative of performance in Orthopaedic Surgery Residency? We discovered that USMLE Step 2, the number of honors in medical school clerkships, and AOA membership had the strongest correlations with resident performance. Our goal was to give residency programs insight into which criteria might be considered ""high"".",1.4211583641411244e-07,0.11551288712184427,0.0,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
84,0.5,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Does the Residency Selection Criteria effectively predict performance in Orthopaedic Surgery Residency? Our findings showed that USMLE Step 2 results, honors in medical school clerkships, and AOA membership were closely linked with resident performance. The purpose of analyzing these data was to inform residency programs about which criteria may be ""high"".",1.1842986367842703e-07,0.09531017980432566,0.0,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
84,0.5,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Can Residency Selection Criteria reliably predict performance in Orthopaedic Surgery Residency? We found that USMLE Step 2 scores, the number of honors during medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal was to help residency programs identify which criteria might be considered ""high"".",1.4211583641411244e-07,0.11551288712184427,0.0,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
85,0.5,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy effective for treating gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, though more research is needed to clarify its role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.5,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external palliative radiotherapy work well for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative option for gallbladder carcinoma, but additional studies are required to define its role in palliative or adjuvant treatment.",2.1317375462116813e-07,0.2054366026956549,0.016804761120134334,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.5,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy an effective palliative treatment for gallbladder carcinoma? External radiotherapy seems safe and effective for palliative care in gallbladder carcinoma, yet further research is necessary to establish its role in palliative or adjuvant therapy.",2.1317375462116813e-07,0.2054366026956549,0.016804761120134334,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.5,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy is regarded as a safe and effective palliative treatment for gallbladder carcinoma; however, more studies are needed to determine its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.5,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative approach for gallbladder carcinoma, but further investigation is needed to assess its role in palliative or adjuvant therapy.",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.5,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a safe and effective palliative treatment for gallbladder carcinoma? External radiotherapy seems to be a safe and effective method of palliation for gallbladder carcinoma, though more research is required to understand its role in palliative or adjuvant treatment.",9.474389094274162e-08,0.20558359489340639,0.07709750566893424,0.0072537058591274906,0.13649108433591195,0.027889582908887926,0.007243206163811466,0.13656488911276776,0.026296566837107373,9.474389094274162e-08,0.10265415406008227,0.0
85,0.5,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","What is the effectiveness of external palliative radiotherapy for gallbladder carcinoma? External radiotherapy is considered both safe and effective for palliative management of gallbladder carcinoma, but additional studies are necessary to define its role in palliative or adjuvant therapy.",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.5,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy provide effective palliative care for gallbladder carcinoma? External radiotherapy appears safe and effective for palliative treatment of gallbladder carcinoma; however, further studies are needed to clarify its role in palliative or adjuvant treatment.",2.1317375462116813e-07,0.2054366026956549,0.016804761120134334,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.5,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy a viable treatment for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative treatment for gallbladder carcinoma, though more research is necessary to determine its role in palliative or adjuvant therapy.",1.6580180914979753e-07,0.18519317155393722,0.008526077097505684,0.012693985253473108,0.18394995018825266,0.004512471655328806,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.5,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How reliable is external palliative radiotherapy in treating gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative method for gallbladder carcinoma, but further studies are required to establish its role in palliative or adjuvant treatment.",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
86,0.5,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure be used to predict fluid responsiveness? Answer: Current evidence does not support the common use of central venous pressure for guiding fluid therapy. This method of fluid resuscitation ought to be discontinued.,2.36859727356853e-08,0.030371344206569173,0.0015696442245671308,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
86,0.5,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a reliable predictor of fluid responsiveness? Answer: There is no data backing the routine use of central venous pressure in directing fluid therapy. This practice should be stopped.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
86,0.5,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does measuring central venous pressure help predict fluid responsiveness? Answer: No data supports the widespread use of central venous pressure to guide fluid treatment. This approach to fluid resuscitation should be abandoned.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
86,0.5,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure indicate fluid responsiveness? Answer: The existing evidence does not support using central venous pressure as a guide for fluid therapy. This method should be discontinued.,1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.5,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a valid tool for predicting fluid responsiveness? Answer: There is a lack of data supporting the common practice of using central venous pressure to guide fluid therapy. This approach should be stopped.,2.36859727356853e-08,0.030371344206569173,0.0015696442245671308,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
86,0.5,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure effectively predict fluid responsiveness? Answer: No evidence supports the widespread use of central venous pressure for fluid management. This fluid resuscitation method should be abandoned.,1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.5,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure be used to guide fluid responsiveness? Answer: Data do not support the routine use of central venous pressure in fluid therapy. This practice should be discontinued.,1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,0.5,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is the central venous pressure measurement useful for predicting fluid responsiveness? Answer: There are no data endorsing the widespread use of central venous pressure to direct fluid therapy. This approach should be abandoned.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.5,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure serve as a predictor for fluid responsiveness? Answer: The practice of using central venous pressure to guide fluid therapy is not supported by data and should be stopped.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
86,0.5,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure reliably guide fluid responsiveness prediction? Answer: There is no evidence to justify the common use of central venous pressure in fluid resuscitation. This approach should be discontinued.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
87,0.5,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG an effective surrogate tracer for measuring tumor hypoxia? This study demonstrated that FDG does not serve well as a surrogate tracer for tumor hypoxia in either normal or low oxygen conditions. Only specialized hypoxia...,4.73719454713706e-08,0.02163259942144702,0.026659528523875105,0.003626852929563759,0.019851258254085735,0.029384756657483937,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
87,0.5,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Can (18)F-FDG be used as a surrogate tracer to assess tumor hypoxia? The findings indicate that FDG is not a reliable surrogate tracer for tumor hypoxia under both ambient and hypoxic environments. Only particular hypoxia...,2.36859727356853e-08,0.031088519621267796,0.0008886808425160632,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
87,0.5,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Does (18)F-FDG function as a surrogate tracer for tumor hypoxia? Research shows FDG is not suitable as a surrogate tracer for tumor hypoxia in ambient or hypoxic states. Only specific hypoxia...,7.10579182070559e-08,0.28435031995703763,0.12972656250000003,0.005440279394345639,0.2896530881401338,0.13439999999999996,0.005432404622858621,0.2503142330013599,0.10560000000000003,7.105791820705622e-08,0.208048986851892,0.07359999999999998
87,0.5,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG suitable as a surrogate tracer to evaluate tumor hypoxia? This study found that FDG fails to be an effective surrogate tracer for tumor hypoxia under normal or low oxygen conditions. Only certain hypoxia...,2.36859727356853e-08,0.031088519621267796,0.0008886808425160632,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
87,0.5,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Can (18)F-FDG act as a surrogate tracer for tumor hypoxia measurement? The study revealed that FDG is not a good surrogate tracer for tumor hypoxia in either ambient or hypoxic conditions. Only specific hypoxia...,0.0,0.12602676010180858,0.0886326267092747,0.0,0.12996509635499054,0.09274673008323425,0.0,0.08943834587870247,0.06420927467300831,0.0,0.046209812037329545,0.033293697978596916
87,0.5,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG a valid surrogate tracer for detecting tumor hypoxia? Results from this study indicated that FDG is not an appropriate surrogate tracer for tumor hypoxia under both normal and hypoxic conditions. Only particular hypoxia...,2.36859727356853e-08,0.009684843941082377,0.0283203125,0.0018134264647818796,0.011237261367182061,0.0302734375,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
87,0.5,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Does (18)F-FDG serve as a surrogate tracer to measure tumor hypoxia? Evidence suggests that FDG is ineffective as a surrogate tracer for tumor hypoxia in ambient and hypoxic environments. Only specific hypoxia...,4.73719454713706e-08,0.1546689557654517,0.06538982780612247,0.003626852929563759,0.15695814521223062,0.06632653061224487,0.003621603081905747,0.11449462833039359,0.03443877551020409,4.737194547137081e-08,0.06899287148695077,0.0
87,0.5,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG reliable as a surrogate tracer for tumor hypoxia? The study demonstrated that FDG does not reliably serve as a surrogate tracer for tumor hypoxia under ambient or hypoxic states. Only certain hypoxia...,0.0,0.16803568013574477,0.11641023596938771,0.0,0.17328679513998724,0.12244897959183673,0.0,0.13415751881805393,0.09566326530612247,0.0,0.09241962407465909,0.06632653061224487
87,0.5,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG considered a surrogate tracer for tumor hypoxia? Findings show FDG is not a good surrogate tracer for tumor hypoxia whether in ambient or hypoxic conditions. Only specific hypoxia...,9.47438909427412e-08,0.2306125729412316,0.07179756841715977,0.007253705859127518,0.23255241841880103,0.07100591715976333,0.007243206163811494,0.18949457407785042,0.03698224852071005,9.474389094274162e-08,0.14310084364067244,0.0
87,0.5,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Can (18)F-FDG be considered a surrogate tracer for tumor hypoxia? This research indicates that FDG is not effective as a surrogate tracer for tumor hypoxia under both ambient and hypoxic conditions. Only particular hypoxia...,0.0,0.12602676010180858,0.0886326267092747,0.0,0.12996509635499054,0.09274673008323425,0.0,0.08943834587870247,0.06420927467300831,0.0,0.046209812037329545,0.033293697978596916
88,0.5,1,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is specialized breast pathology evaluation essential for handling ductal carcinoma in situ? Answer: Specialized breast pathology evaluations remain essential in managing DCIS.,1.658018091497971e-07,0.21106712140308526,0.04439999999999997,0.012693985253473157,0.25467506385368877,0.023505917159763315,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,0.5,2,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert evaluation in breast pathology required for managing ductal carcinoma in situ? Answer: Expert evaluations in breast pathology are still required for DCIS management.,9.47438909427412e-08,0.12356231312578059,0.016631404958677695,0.007253705859127518,0.11289191907964069,0.02941801545844007,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
88,0.5,3,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is professional breast pathology assessment needed for the treatment of ductal carcinoma in situ? Answer: Professional breast pathology assessments continue to be needed in DCIS treatment.,7.10579182070559e-08,0.024624304416563714,0.05801111111111108,0.005440279394345639,0.06975943395752049,0.03107536160420777,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
88,0.5,4,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,"Question: Does the management of ductal carcinoma in situ require expert breast pathology assessment? Answer: Yes, expert breast pathology assessment remains necessary for managing DCIS.",1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.5,5,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is an expert breast pathology review important for managing ductal carcinoma in situ? Answer: An expert breast pathology review is still important for the management of DCIS.,4.73719454713706e-08,0.13696712664042776,0.04121983471074389,0.003626852929563759,0.13504398802712148,0.042415632934754616,0.003621603081905747,0.18786459002572142,0.0793950850661626,4.737194547137081e-08,0.13780497272019776,0.04158790170132326
88,0.5,6,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is the involvement of expert breast pathologists necessary in the care of ductal carcinoma in situ? Answer: The involvement of expert breast pathologists continues to be necessary in DCIS care.,2.36859727356853e-08,0.05214430522141589,0.053100000000000036,0.0018134264647818796,0.057100669721332764,0.06339408284023663,0.0018108015409528735,0.11216389452054276,0.10560000000000003,2.3685972735685406e-08,0.06494814321121956,0.07359999999999998
88,0.5,7,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology analysis crucial for the management of ductal carcinoma in situ? Answer: Expert breast pathology analysis remains crucial for managing DCIS.,1.184298636784265e-07,0.22907804449829472,0.025600000000000067,0.009067132323909398,0.21823660420133173,0.0151618832937514,0.009054007704764368,0.26780779269691823,0.04535147392290251,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.5,8,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is it necessary to have expert breast pathology assessment for ductal carcinoma in situ management? Answer: It is necessary to have expert breast pathology assessment for the management of DCIS.,2.36859727356853e-08,0.09835411725874543,0.07732022684310028,0.0018134264647818796,0.15270717738477435,0.1218107180009171,0.0018108015409528735,0.21118492031482017,0.17013232514177698,2.3685972735685406e-08,0.16763661440528477,0.14366729678638937
88,0.5,9,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert evaluation in breast pathology indispensable for managing ductal carcinoma in situ? Answer: Expert evaluation in breast pathology remains indispensable in DCIS management.,1.184298636784265e-07,0.22907804449829472,0.025600000000000067,0.009067132323909398,0.27851027207610946,0.05649408284023667,0.009054007704764368,0.3308211727478221,0.09,1.1842986367842703e-07,0.27958811749424584,0.047500000000000014
88,0.5,10,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is specialized breast pathology assessment vital for the treatment of ductal carcinoma in situ? Answer: Specialized breast pathology assessment continues to be vital in treating DCIS.,7.10579182070559e-08,0.07794331830578871,0.02097844990548202,0.005440279394345639,0.12521120840231736,0.008389167906399264,0.005432404622858621,0.17554530070304475,0.04158790170132326,7.105791820705622e-08,0.1226023220923329,0.0
89,0.5,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple childbirths? Our research indicates that pregnancy-related glomerular hyperfiltration does not negatively impact the kidneys in women with higher parity. Pregnancy may offer protective effects for the kidneys against the harmful consequences of glomerular hyperfiltration.,1.4211583641411244e-07,0.09692359066558609,0.021267763897151196,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.5,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney damage caused by glomerular hyperfiltration in pregnant women with numerous births? According to our study, glomerular hyperfiltration from pregnancy does not adversely affect the kidneys in women with more parities. Pregnancy might provide protective mechanisms for the kidneys against the negative effects of glomerular hyperfiltration.",1.1842986367842703e-07,0.030501283797998102,0.050655609638843815,0.009067132323909363,0.0221828539906328,0.05975554549569943,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
89,0.5,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnant women with many children lead to kidney damage? Our findings suggest that pregnancy-induced glomerular hyperfiltration does not harm the kidneys in women with multiple parities. There may be protective factors during pregnancy that shield the kidneys from the adverse effects of glomerular hyperfiltration.,9.474389094274162e-08,0.007071450878903374,0.05202249770431591,0.0072537058591274906,0.00020394727185779615,0.05975554549569943,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.5,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration during pregnancy cause kidney damage in women with higher parity? Our study proposes that glomerular hyperfiltration caused by pregnancy does not have detrimental effects on the kidneys of women with several childbirths. Pregnancy may have protective mechanisms that guard the kidneys against the harmful impact of glomerular hyperfiltration.,2.3685972735685406e-08,0.06011316528602606,0.055800010059856145,0.0018134264647818726,0.06297495434967448,0.05975554549569943,0.0018108015409528666,0.035964156108279965,0.040742417383431435,2.3685972735685406e-08,0.007827723325497526,0.020823902218198284
89,0.5,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does increased glomerular filtration in pregnancy damage kidneys in women with more pregnancies? The study suggests that pregnancy-related glomerular hyperfiltration does not negatively affect kidney function in women with higher parity. Pregnancy might confer protective effects on the kidneys against glomerular hyperfiltration's adverse consequences.,1.8948778188548325e-07,0.07201087027531194,0.06915460374115937,0.014507411718254981,0.12418273407567604,0.03596018559088088,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.5,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there kidney damage from glomerular hyperfiltration in pregnant women with multiple births? Our research suggests that glomerular hyperfiltration due to pregnancy does not cause kidney damage in women with greater parity. Pregnancy may have protective roles that prevent kidney harm from glomerular hyperfiltration.,1.8948778188548325e-07,0.1364896777692599,0.023510848126232733,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.5,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys of women who have had many pregnancies? Our data indicate that pregnancy-induced glomerular hyperfiltration does not adversely affect kidney health in women with increased parity. Pregnancy may provide protective mechanisms to the kidneys against the negative effects of glomerular hyperfiltration.,9.474389094274162e-08,0.022424173825775107,0.07308641975308644,0.0072537058591274906,0.00020394727185779615,0.05975554549569943,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.5,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy result in kidney damage in women with numerous parities? Our study suggests that pregnancy-related glomerular hyperfiltration does not damage the kidneys in women with more childbirths. Protective mechanisms during pregnancy may shield the kidneys from the harmful effects of glomerular hyperfiltration.,1.4211583641411244e-07,0.08529585413748508,0.027512723907726896,0.010880558788691236,0.0761623998681431,0.03704056442485032,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.5,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration caused by pregnancy damage kidneys in women with multiple parities? Findings from our study indicate that such hyperfiltration does not adversely impact the kidneys in women with higher parity. Pregnancy might have protective effects that counteract the adverse consequences of glomerular hyperfiltration.,1.6580180914979784e-07,0.07906261463302089,0.04773877982682263,0.012693985253473108,0.13212403556133845,0.013354593681303227,0.012675610786670066,0.1305742451143348,0.01694705747861288,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.5,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is kidney damage linked to glomerular hyperfiltration in pregnant women with increased parity? Our study proposes that glomerular hyperfiltration during pregnancy does not harm the kidneys of women with more parities. Pregnancy may offer protective mechanisms that defend the kidneys from the negative effects of glomerular hyperfiltration.,1.1842986367842703e-07,0.030501283797998102,0.050655609638843815,0.009067132323909363,0.0221828539906328,0.05975554549569943,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
90,0.5,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Are stroke patients' self-reported home blood pressure readings dependable? The dependability of these reports can differ, so healthcare providers should verify their accuracy by comparing them with clinical measurements or employing automated home monitoring devices.",5.447773729207637e-07,0.2794425758919301,0.23567708333333334,0.041708808689983085,0.3462136172757444,0.16326530612244897,0.04164843544191595,0.41557052233093605,0.08999999999999998,5.447773729207643e-07,0.4523083708850617,0.07359999999999998
90,0.5,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Can stroke patients' home blood pressure readings be trusted? The trustworthiness of these reports varies, making it essential for medical professionals to validate them against in-clinic readings or through automated home blood pressure monitors.",5.68463345656449e-07,0.3933133791094843,0.17532328520638227,0.043522235154764964,0.4203069747274957,0.13204782433264667,0.043459236982868826,0.4473192206455159,0.08999999999999998,5.684633456564497e-07,0.4850981937080534,0.07359999999999998
90,0.5,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Do stroke patients provide reliable home blood pressure readings? The reliability may fluctuate, thus healthcare practitioners need to confirm the readings' accuracy by cross-checking with clinical data or using automated devices at home.",5.921493183921343e-07,0.3400671977083656,0.23567708333333334,0.045335661619546844,0.4087339742570779,0.16326530612244897,0.0452700385238217,0.4801090434685076,0.08999999999999998,5.921493183921352e-07,0.5189997453837352,0.07359999999999998
90,0.5,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Is the reporting of home blood pressure readings by stroke patients accurate? Accuracy can vary, so it is crucial for healthcare workers to validate these readings by comparing them to those taken in a clinical setting or by using automated home monitors.",3.789755637709665e-07,0.12604309139207404,0.21130208333333333,0.029014823436509962,0.15384172462828838,0.16326530612244897,0.028972824655245866,0.21774477900101807,0.08999999999999998,3.789755637709665e-07,0.24870941564382187,0.07359999999999998
90,0.5,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","How reliable are stroke patients' home blood pressure reports? Their reliability can differ, requiring healthcare professionals to assess their accuracy through validation against in-clinic measurements or automated home monitoring tools.",6.632072365991902e-07,0.43850727052161886,0.23567708333333334,0.05077594101389248,0.5105166685670204,0.16326530612244897,0.05070244314668032,0.585469559126333,0.08999999999999998,6.632072365991914e-07,0.6281990373487258,0.07359999999999998
90,0.5,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Are the home blood pressure readings reported by stroke patients consistent? Consistency may vary, so it is important for healthcare providers to verify these readings by comparing them with clinical measurements or using automated monitoring devices at home.",4.737194547137078e-07,0.19488518786386644,0.23567708333333334,0.03626852929563745,0.25920224028611427,0.16326530612244897,0.03621603081905733,0.3259583636412491,0.08999999999999998,4.737194547137081e-07,0.3599350507540464,0.07359999999999998
90,0.5,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Can the home blood pressure readings reported by stroke patients be considered accurate? Accuracy varies, thus healthcare professionals should validate these readings through comparison with in-clinic measurements or automated home devices.",6.395212638635049e-07,0.4046057188459371,0.23567708333333334,0.0489625145491106,0.4754253487557514,0.16326530612244897,0.04889164160572745,0.5491019149554583,0.08999999999999998,6.39521263863506e-07,0.5904587093658789,0.07359999999999998
90,0.5,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Is the information stroke patients provide about their home blood pressure readings reliable? Reliability may fluctuate, making it necessary for healthcare providers to confirm accuracy by validating against clinical measurements or automated home monitoring systems.",5.447773729207637e-07,0.2794425758919301,0.23567708333333334,0.041708808689983085,0.3462136172757444,0.16326530612244897,0.04164843544191595,0.41557052233093605,0.08999999999999998,5.447773729207643e-07,0.4523083708850617,0.07359999999999998
90,0.5,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Do stroke patients give dependable reports of their home blood pressure readings? Dependability can vary, so healthcare professionals must assess the accuracy of these reports by comparing them with clinical measurements or using automated monitoring devices.",5.210914001850784e-07,0.2504550390186786,0.23567708333333334,0.039895382225201205,0.3163606541260626,0.16326530612244897,0.03983763390096308,0.38479886366418237,0.08999999999999998,5.210914001850789e-07,0.4205596725704819,0.07359999999999998
90,0.5,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Are stroke patients' reports of home blood pressure measurements trustworthy? Trustworthiness varies, and healthcare providers should validate these readings by comparing them to in-clinic measurements or employing automated home blood pressure monitors.",6.158352911278196e-07,0.4612542419016479,0.17146780866032502,0.04714908808432872,0.48773360911739916,0.12997160814385206,0.04708084006477457,0.5140105951441893,0.08999999999999998,6.158352911278206e-07,0.5540910651950042,0.07359999999999998
91,0.5,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Our findings indicate that reduced vessel compliance and heightened vascular resistance characterize young, obese, normotensive individuals regardless of other cardiovascular risk factors. Alterations in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.5,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? The data suggests that young, obese, normotensive subjects exhibit decreased vessel compliance and increased vascular resistance independently of cardiovascular risk factors. Changes in arterial wall properties might...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.5,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is the rise in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Our study shows that depressed vessel compliance and elevated vascular resistance are evident in young, obese, normotensive subjects beyond traditional cardiovascular risk factors. Modifications in arterial wall properties could...",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
91,0.5,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are higher carotid artery pulsatility and resistance indexes indicative of early vascular abnormalities in young obese males? Results demonstrate that reduced vessel compliance and increased vascular resistance are present in young, obese, normotensive individuals independent of cardiovascular risk factors. Arterial wall property changes may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.5,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Can increased carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Findings suggest that young, obese, normotensive subjects have diminished vessel compliance and heightened vascular resistance, independent of cardiovascular risk factors. Altered arterial wall properties may...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.5,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do young obese males exhibit early vascular abnormalities through increased carotid artery pulsatility and resistance indexes? Our results imply that depressed vessel compliance and elevated vascular resistance are characteristics of young, obese, normotensive individuals, separate from cardiovascular risk factors. Changes in arterial wall properties might...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.5,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is increased carotid artery pulsatility and resistance indexes a precursor to vascular abnormalities in young obese males? The evidence indicates that young, obese, normotensive subjects show reduced vessel compliance and increased vascular resistance beyond cardiovascular risk factors. Arterial wall changes may...",2.8423167282822487e-07,0.2623642644674917,0.0,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
91,0.5,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are elevated carotid artery pulsatility and resistance indexes early manifestations of vascular abnormalities in young obese males? The study suggests that depressed vessel compliance and increased vascular resistance exist in young, obese, normotensive individuals independently of cardiovascular risk factors. Alterations in arterial wall properties could...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.5,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Could increased carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Our findings propose that young, obese, normotensive subjects present with reduced vessel compliance and increased vascular resistance apart from cardiovascular risk factors. Changes in arterial wall properties may...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.5,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is there evidence that increased carotid artery pulsatility and resistance indexes are early indicators of vascular abnormalities in young obese males? Results support that young, obese, normotensive individuals have depressed vessel compliance and increased vascular resistance independent of cardiovascular risk factors. Arterial wall property changes may...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
92,0.5,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does having an optimistic perspective correlate with improved survival rates in very old age? Answer: An optimistic outlook seems to be a strong indicator of survival for the oldest-old women. It might also predict survival for men, though the male sample size is limited.",0.0,0.09452007007635466,0.06641709938413236,0.0,0.09671821124092306,0.06937499999999999,0.0,0.03300700859809158,0.023795359904818555,0.0,0.0,0.0
92,0.5,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is optimism linked to better longevity in advanced age? Answer: Optimism appears to significantly predict survival among the oldest-old women and could be important for men as well, despite a small sample size.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.5,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can an optimistic attitude forecast better survival in the elderly? Answer: Optimism seems to be a key predictor of survival in the oldest-old women and possibly for men, though the male group is small.",2.3685972735685343e-07,0.18184238629954041,0.05317482330703485,0.01813426464781874,0.20998326302009485,0.03910156249999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.5,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does an optimistic mindset enhance survival chances at very old ages? Answer: An optimistic outlook is a significant survival predictor for the oldest-old women and may also be for men, but the male sample is small.",1.8948778188548283e-07,0.081645422032667,0.08401347126621853,0.014507411718254981,0.10913384296322581,0.06937499999999999,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
92,0.5,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is there a connection between optimism and survival in advanced age? Answer: Optimism appears to be a significant survival predictor among the oldest-old women and potentially for men, though the sample size for men is small.",1.8948778188548283e-07,0.04313724533489216,0.11176857330703485,0.014507411718254981,0.10913384296322581,0.06937499999999999,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
92,0.5,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does optimism predict greater survival in the oldest age groups? Answer: An optimistic perspective seems to be an important survival predictor for oldest-old women and possibly men, albeit with a small male sample.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.5,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is a positive outlook associated with better survival rates in very elderly individuals? Answer: Optimism is a significant predictor of survival among the oldest-old women and may also be for men, though the male sample is limited.",1.6580180914979753e-07,0.05320568631217926,0.08476240046752868,0.012693985253473108,0.08096296599652897,0.06937499999999999,0.012675610786670066,0.14931454819586287,0.023795359904818555,1.6580180914979784e-07,0.18721154208814594,0.0
92,0.5,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does having an optimistic view forecast improved longevity in advanced age? Answer: Optimistic outlooks appear to significantly predict survival in oldest-old women and might do so for men, but the male sample size is small.",2.1317375462116813e-07,0.071308122301589,0.11176857330703485,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
92,0.5,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can optimism be used to predict survival among the oldest-old? Answer: An optimistic outlook is a significant predictor of survival in oldest-old women and may also be for men, though the sample size for men is small.",1.6580180914979753e-07,0.01573827114677684,0.11176857330703485,0.012693985253473108,0.08096296599652897,0.06937499999999999,0.012675610786670066,0.14931454819586287,0.023795359904818555,1.6580180914979784e-07,0.18721154208814594,0.0
92,0.5,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is an optimistic attitude linked to better survival at advanced ages? Answer: Optimism appears to be a significant predictor of survival among the oldest-old women and possibly men, despite the small male sample size.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
93,0.5,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Does the radiographic transition zone align with the aganglionosis level found in Hirschsprung's disease specimens?,5.447773729207622e-07,0.6346538465403451,0.21811224489795913,0.04170880868998321,0.8260286975056998,0.13527575442247655,0.041648435441916085,0.9516161807482795,0.0849609375,5.447773729207638e-07,1.0876918882554416,0.029384756657483937
93,0.5,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","In Hirschsprung's disease, is there a correlation between the radiographic transition zone and the specimen's aganglionosis level?",4.974054274493916e-07,0.5011224539158223,0.21811224489795913,0.03808195576041945,0.6829278538650265,0.13527575442247655,0.03802683236001034,0.7974655009210219,0.0849609375,4.974054274493931e-07,0.9206378035922751,0.029384756657483937
93,0.5,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Is the level of aganglionosis on the specimen reflected by the radiographic transition zone in Hirschsprung's disease?,4.974054274493916e-07,0.5011224539158223,0.21811224489795913,0.03808195576041945,0.6829278538650265,0.13527575442247655,0.03802683236001034,0.7974655009210219,0.0849609375,4.974054274493931e-07,0.9206378035922751,0.029384756657483937
93,0.5,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Does the radiographic transition zone correspond to the extent of aganglionosis seen in Hirschsprung's disease specimens?,5.210914001850769e-07,0.565660975053393,0.21811224489795913,0.03989538222520133,0.7519207253519786,0.13527575442247655,0.03983763390096322,0.8715734730747431,0.0849609375,5.210914001850785e-07,1.0006805112658115,0.029384756657483937
93,0.5,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","In Hirschsprung's disease, does the radiographic transition zone match the aganglionosis level present on the specimen?",5.210914001850769e-07,0.565660975053393,0.21811224489795913,0.03989538222520133,0.7519207253519786,0.13527575442247655,0.03983763390096322,0.8715734730747431,0.0849609375,5.210914001850785e-07,1.0006805112658115,0.029384756657483937
93,0.5,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Is there a relationship between the radiographic transition zone and the aganglionosis level on specimens in Hirschsprung's disease?,4.737194547137062e-07,0.4404978320993873,0.21811224489795913,0.03626852929563758,0.6183893327274559,0.13527575442247655,0.03621603081905747,0.7284726294340698,0.0849609375,4.7371945471370775e-07,0.8465298314385539,0.029384756657483937
93,0.5,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Does the radiographic transition zone in Hirschsprung's disease indicate the level of aganglionosis on the specimen?,5.210914001850769e-07,0.565660975053393,0.21811224489795913,0.03989538222520133,0.7519207253519786,0.13527575442247655,0.03983763390096322,0.8715734730747431,0.0849609375,5.210914001850785e-07,1.0006805112658115,0.029384756657483937
93,0.5,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","In cases of Hirschsprung's disease, does the radiographic transition zone correlate with the specimen's aganglionosis level?",5.210914001850769e-07,0.565660975053393,0.21811224489795913,0.03989538222520133,0.7519207253519786,0.13527575442247655,0.03983763390096322,0.8715734730747431,0.0849609375,5.210914001850785e-07,1.0006805112658115,0.029384756657483937
93,0.5,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Is the radiographic transition zone a reliable marker for the level of aganglionosis on Hirschsprung's disease specimens?,4.974054274493916e-07,0.5011224539158223,0.21811224489795913,0.03808195576041945,0.6829278538650265,0.13527575442247655,0.03802683236001034,0.7974655009210219,0.0849609375,4.974054274493931e-07,0.9206378035922751,0.029384756657483937
93,0.5,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Does the radiographic transition zone typically reflect the level of aganglionosis found on the specimen in Hirschsprung's disease?,4.737194547137062e-07,0.4404978320993873,0.21811224489795913,0.03626852929563758,0.6183893327274559,0.13527575442247655,0.03621603081905747,0.7284726294340698,0.0849609375,4.7371945471370775e-07,0.8465298314385539,0.029384756657483937
94,0.5,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic indicator for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.5,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer serve as a novel diagnostic tool for acute appendicitis? Answer: Increased D-dimer values are not reliable for diagnosing acute appendicitis.,1.184298636784265e-07,0.15345017704898067,0.03698224852071005,0.009067132323909398,0.2135741002980609,0.0,0.009054007704764368,0.2231435513142097,0.0,1.1842986367842692e-07,0.23361485118150505,0.0
94,0.5,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be utilized as a new parameter to diagnose acute appendicitis? Answer: Raised D-dimer levels should not be regarded as a diagnostic criterion for acute appendicitis.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
94,0.5,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a viable new diagnostic parameter for acute appendicitis? Answer: Higher D-dimer concentrations should not be considered diagnostic for acute appendicitis.,1.184298636784265e-07,0.21646355709988496,0.00836922540219246,0.009067132323909398,0.2135741002980609,0.0,0.009054007704764368,0.2231435513142097,0.0,1.1842986367842692e-07,0.23361485118150505,0.0
94,0.5,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could elevated D-dimer levels indicate acute appendicitis as a new diagnostic parameter? Answer: Increased D-dimer should not be used to diagnose acute appendicitis.,9.47438909427412e-08,0.10899841447814662,0.03698224852071005,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.5,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer act as a new marker in diagnosing acute appendicitis? Answer: Elevated D-dimer levels are not appropriate as a diagnostic parameter for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.5,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to become a new diagnostic criterion for acute appendicitis? Answer: Raised D-dimer levels should not be considered diagnostic in acute appendicitis cases.,0.0,0.05134423559703327,0.03698224852071005,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
94,0.5,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer levels be used as a new diagnostic tool for acute appendicitis? Answer: Increased D-dimer should not be relied upon for diagnosing acute appendicitis.,4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.5,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be introduced as a new diagnostic measure for acute appendicitis? Answer: Elevated D-dimer values are not suitable as a diagnostic parameter for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.5,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic factor for acute appendicitis? Answer: Higher D-dimer levels should not be treated as a diagnostic marker for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
95,0.5,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? The study found higher expression of TGF-β1 and VEGF in polyps compared to nearby normal endometrial tissue, indicating these cytokines may contribute to polyp development. Additionally, steroid receptor expression showed a significant correlation with VEGF and TGF-β1 levels.",1.6580180914979784e-07,0.00775967366274255,0.07877526753864447,0.012693985253473108,0.09744161334294432,0.016124697661918846,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
95,0.5,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Does endometrial polyp development correlate with increased expression of VEGF and TGF-β1? Results demonstrated that TGF-β1 and VEGF were more highly expressed in polyps than in adjacent normal endometrium, suggesting a role for these cytokines in polyp formation. There was also a notable relationship between steroid receptor expression and the expression of VEGF and TGF-β1.",2.1317375462116866e-07,0.12114367122916736,0.023411945739336512,0.016320838183036854,0.18679587978253576,0.02155311856261017,0.0162972138685758,0.18628965253649588,0.01922337562475971,2.1317375462116866e-07,0.16251892949777424,0.0
95,0.5,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is there an association between endometrial polyp formation and heightened expression of vascular endothelial growth factor and transforming growth factor-beta1? Findings revealed elevated TGF-β1 and VEGF in polyps relative to normal endometrial tissue nearby, implying these cytokines might be involved in polyp formation. Moreover, steroid receptor expression correlated significantly with VEGF and TGF-β1 expression.",2.3685972735685406e-07,0.06281945084577112,0.07877526753864447,0.018134264647818726,0.15353107999398752,0.016124697661918846,0.018108015409528666,0.17904823144898518,0.0,2.3685972735685406e-07,0.182321556793954,0.0
95,0.5,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Are increased levels of VEGF and TGF-β1 linked to the formation of endometrial polyps? The data showed that TGF-β1 and VEGF expression was greater in polyps than in adjacent normal endometrium, suggesting these cytokines may play a role in polyp development. A significant correlation was also found between steroid receptor expression and VEGF and TGF-β1 levels.",1.8948778188548325e-07,0.10139423522650626,0.02441136221320067,0.014507411718254981,0.14146286980965694,0.002387228290377335,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
95,0.5,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is the expression of vascular endothelial growth factor and transforming growth factor-beta1 elevated in endometrial polyps? There was a rise in TGF-β1 and VEGF expression in polyps compared to nearby normal endometrial tissue, indicating a potential role for these cytokines in polyp formation. Additionally, steroid receptor expression was significantly correlated with VEGF and TGF-β1 expression.",2.1317375462116866e-07,0.044127317833616786,0.07877526753864447,0.016320838183036854,0.13448288502329442,0.016124697661918846,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
95,0.5,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Does the formation of endometrial polyps involve increased expression of VEGF and TGF-β1? Increased TGF-β1 and VEGF were observed in polyps relative to adjacent normal endometrium, suggesting these cytokines might contribute to polyp development. Steroid receptor expression was also significantly associated with VEGF and TGF-β1 expression.",4.263475092423373e-07,0.25725541598579227,0.056564523736991584,0.03264167636607371,0.3205851646571536,0.016124697661918846,0.0325944277371516,0.3496737484797481,0.0,4.263475092423373e-07,0.35667494393873156,0.0
95,0.5,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is there a relationship between endometrial polyp formation and the upregulation of vascular endothelial growth factor and transforming growth factor-beta1? The study observed increased expression of TGF-β1 and VEGF in polyps compared to normal endometrial tissue nearby, suggesting these cytokines may be involved in polyp formation. Steroid receptor expression also showed a significant correlation with VEGF and TGF-β1.",1.4211583641411244e-07,0.00993990343665807,0.07877526753864447,0.010880558788691236,0.07942310784026585,0.016124697661918846,0.0108648092457172,0.10354067894083929,0.0,1.4211583641411244e-07,0.10536051565782412,0.0
95,0.5,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions increased in endometrial polyps? Findings indicated elevated TGF-β1 and VEGF in polyps versus adjacent normal endometrial tissue, implying these cytokines could play a role in polyp formation. There was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.",3.079176455639103e-07,0.14881424619214467,0.05878359740120174,0.023574544042164344,0.2129545004647886,0.016124697661918846,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
95,0.5,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is the increased expression of VEGF and TGF-β1 associated with the development of endometrial polyps? Results showed higher levels of TGF-β1 and VEGF in polyps compared to adjacent normal endometrium, suggesting these cytokines might participate in polyp formation. A significant correlation was also noted between steroid receptor expression and VEGF and TGF-β1.",2.8423167282822487e-07,0.1556502164233664,0.03962491351948578,0.02176111757738247,0.19275179314726998,0.016124697661918846,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
95,0.5,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Does endometrial polyp formation associate with elevated VEGF and TGF-β1 expression? The expression of TGF-β1 and VEGF was increased in polyps relative to nearby normal endometrial tissue, indicating these cytokines may have a role in polyp development. Additionally, steroid receptor expression was significantly correlated with VEGF and TGF-β1 expression.",3.552895910352811e-07,0.21967261853666287,0.03718736583732121,0.02720139697172809,0.284122821570036,0.005141842980803255,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
96,0.5,1,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is sternal fracture in growing children a rare and frequently missed injury? Answer: Sternal fractures in growing children are uncommon and often go unnoticed. Diagnosing them can be difficult because the sternum is mostly cartilage at this age. Nonetheless, early detection and correct management are important.",9.474389094274162e-08,0.005025840701839535,0.05537700234669933,0.0072537058591274906,0.031089184732003172,0.038753339374150486,0.007243206163811466,0.02924911194296742,0.04158790170132326,9.474389094274162e-08,0.05945186131181712,0.0212665406427221
96,0.5,2,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Are sternal fractures in growing children rare and commonly overlooked? Answer: In growing children, sternal fractures are rare and frequently overlooked. This is partly due to the cartilaginous composition of the sternum, which complicates diagnosis. Early recognition and appropriate treatment are crucial.",1.8948778188548325e-07,0.1347449768270672,0.027759514939002153,0.014507411718254981,0.09337306643979515,0.060964083175803374,0.014486412327622933,0.12455929174729308,0.04158790170132326,1.8948778188548325e-07,0.15709033087573498,0.0212665406427221
96,0.5,3,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is a sternal fracture in children a rare and often missed diagnosis? Answer: Sternal fractures in growing children are infrequent and often not diagnosed promptly. The cartilaginous sternum in children makes it challenging to identify. However, timely diagnosis and proper care are essential.",1.6580180914979784e-07,0.07667226111654246,0.05236448028436925,0.012693985253473108,0.06927551486073513,0.060964083175803374,0.012675610786670066,0.09986667915692138,0.04158790170132326,1.6580180914979784e-07,0.13177252289144326,0.0212665406427221
96,0.5,4,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Are sternal fractures in children rare injuries that are often overlooked? Answer: Yes, sternal fractures in growing children are rare and commonly missed because the sternum is largely cartilage, making diagnosis difficult. Early detection and management are important for better outcomes.",2.1317375462116866e-07,0.12744561778842822,0.050113229600409114,0.016320838183036854,0.15272303805816323,0.03598051973070145,0.0162972138685758,0.1498770997315848,0.04158790170132326,2.1317375462116866e-07,0.18306581727899296,0.0212665406427221
96,0.5,5,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is a sternal fracture in the pediatric population a rare and often undetected injury? Answer: Sternal fractures in children are rare and often overlooked due to the cartilaginous nature of their sternum, which complicates diagnosis. Early identification and appropriate treatment are necessary.",1.8948778188548325e-07,0.10173796822897252,0.05126543209876544,0.014507411718254981,0.12718512402808502,0.03658908317580337,0.014486412327622933,0.12455929174729308,0.04158790170132326,1.8948778188548325e-07,0.15709033087573498,0.0212665406427221
96,0.5,6,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Are sternal fractures uncommon and frequently overlooked in growing children? Answer: Sternal fractures in growing children are uncommon and often missed because the sternum is mostly cartilage, making diagnosis challenging. Early diagnosis and management are vital.",3.3160361829959526e-07,0.3053991609533706,0.016120803999591912,0.025387970506946217,0.2515970716546896,0.060964083175803374,0.02535122157334014,0.2870782212450673,0.04158790170132326,3.316036182995957e-07,0.3241444155388993,0.0212665406427221
96,0.5,7,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is the occurrence of sternal fractures in children rare and often unnoticed? Answer: Sternal fractures in children are rare and often go unnoticed due to the cartilaginous sternum, which makes detection difficult. Early recognition and proper treatment are critical.",2.6054570009253936e-07,0.2875619694839324,0.02666709385279159,0.0199476911126006,0.2788032650850769,0.017403263762972132,0.019918816950481533,0.23998824838240607,0.014581728861817096,2.6054570009253947e-07,0.23713303854926915,0.0212665406427221
96,0.5,8,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Are sternal fractures in children a rare injury that is often missed? Answer: Yes, sternal fractures are rare in growing children and frequently overlooked because the sternum is cartilaginous, complicating diagnosis. Timely identification and management are important.",3.0791764556390996e-07,0.19994307183733318,0.07175925925925929,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.2580906843718158,0.04158790170132326,3.079176455639103e-07,0.2942914523892175,0.0212665406427221
96,0.5,9,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is a sternal fracture in growing children a rare and underdiagnosed injury? Answer: Sternal fractures in the pediatric population are rare and often underdiagnosed due to the cartilaginous sternum, which hinders easy detection. Early diagnosis and appropriate care are essential.",2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.17585258613484278,0.04158790170132326,2.3685972735685406e-07,0.20973406436115383,0.0212665406427221
96,0.5,10,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper",Question: Are sternal fractures in children rare and often not detected early? Answer: Sternal fractures in growing children are rare and commonly not detected early because the sternum is largely cartilage. Early identification and proper management are key.,3.0791764556390996e-07,0.31234531733354176,0.007754310784613777,0.023574544042164344,0.2619343713857676,0.03320898113498705,0.023540420032387266,0.2580906843718158,0.04158790170132326,3.079176455639103e-07,0.2942914523892175,0.0212665406427221
97,0.5,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women are more prone to obesity due to needing fewer calories for weight maintenance.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.5,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it true that African American women require less caloric intake to maintain their weight? Answer: The data does not support the claim that African American women have a higher obesity risk because they need fewer calories to maintain their weight.,1.421158364141119e-07,0.14759735854428913,0.007215830988810595,0.010880558788691243,0.18086694310083162,0.012902009639642179,0.010864809245717214,0.21552591547155275,0.03473052942889013,1.4211583641411244e-07,0.2151719557116576,0.031217481789802305
97,0.5,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have lower calorie requirements to maintain their weight? Answer: These results do not confirm that African American women are at increased obesity risk due to lower calorie needs for weight maintenance.,0.0,0.03960841031771123,0.027421996943288215,0.0,0.08154672712469857,0.05802419235396247,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,0.5,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are African American women’s calorie needs for weight maintenance lower? Answer: The evidence does not support the notion that African American women are more susceptible to obesity because they require fewer calories to maintain weight.,0.0,0.11882523095313324,0.08383622164052006,0.0,0.1223200906870483,0.08740894901144641,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,0.5,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to sustain their weight? Answer: The study’s results do not support the view that African American women are more likely to become obese due to lower calorie requirements for weight maintenance.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.5,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the calorie requirement for weight maintenance lower in African American women? Answer: The findings do not endorse the belief that African American women face a greater obesity risk because they require fewer calories to maintain their weight.,7.10579182070559e-08,0.20419030895203116,0.08608636760618084,0.005440279394345625,0.20687747871511197,0.08740894901144641,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.5,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require less energy intake to maintain their weight? Answer: These results do not support the idea that African American women are at higher risk of obesity because they need fewer calories to keep their weight stable.,1.184298636784265e-07,0.22265031583937311,0.06252143859841289,0.00906713232390937,0.2239752029410469,0.06178568031338546,0.009054007704764347,0.2250964383277787,0.06035379812695108,1.1842986367842703e-07,0.18850370862949672,0.031217481789802305
97,0.5,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight? Answer: The results do not back the perspective that African American women are more vulnerable to obesity due to reduced calorie needs for weight maintenance.,2.36859727356853e-08,0.10958816484199163,0.05701961264398024,0.0018134264647818796,0.11169921724258858,0.058862236208678254,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.5,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is there a lower caloric need for African American women to maintain weight? Answer: The data does not support the hypothesis that African American women have an increased risk of obesity because they require fewer calories to maintain weight.,9.47438909427412e-08,0.16000919813262326,0.03599404555439932,0.0072537058591274975,0.1970642952414865,0.061112382174339036,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.5,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require fewer calories to maintain their body weight? Answer: These findings do not support the assumption that African American women are at greater risk for obesity because they need fewer calories to sustain their weight.,9.47438909427412e-08,0.12446318887313934,0.011158444647369814,0.0072537058591274975,0.1605828646856997,0.03493981320897727,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
98,0.5,1,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Are UK radiologists content with the training and support provided for suspected child abuse? Answer: Research specifically focusing on UK radiologists' satisfaction with training and support in suspected child abuse is scarce. More studies are necessary to collect detailed data and feedback about their experiences and satisfaction.,2.1317375462116866e-07,0.13991468089627945,0.024894470022655005,0.016320838183036854,0.15841791864004184,0.01458345969085259,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
98,0.5,2,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Do UK radiologists feel adequately trained and supported in cases of suspected child abuse? Answer: There is a lack of focused research on UK radiologists' satisfaction with training and support in suspected child abuse. Additional research is required to obtain thorough insights and feedback from radiologists about their satisfaction.,1.6580180914979784e-07,0.038046832037183176,0.0680282223183391,0.012693985253473108,0.08572147028385668,0.03631185475258099,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
98,0.5,3,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: How satisfied are UK radiologists with the training and support related to suspected child abuse? Answer: Limited research exists on this topic for UK radiologists. More comprehensive studies are needed to understand their experiences and satisfaction with training and support in suspected child abuse.,2.8423167282822487e-07,0.21190584465039697,0.020610752145161726,0.02176111757738247,0.22796176924515965,0.013069224367093464,0.0217296184914344,0.25131442828090744,0.0,2.8423167282822487e-07,0.2567198468478131,0.0
98,0.5,4,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Are UK radiologists pleased with the training and support they receive when dealing with suspected child abuse? Answer: There is insufficient research specifically addressing UK radiologists' satisfaction in this area. Further investigation is needed to gather detailed feedback and data.,3.789755637709665e-07,0.21269595437836575,0.08842752787389466,0.029014823436509962,0.2933608350621033,0.03631185475258099,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
98,0.5,5,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,"Question: What is the level of satisfaction among UK radiologists regarding training and support for suspected child abuse? Answer: Research focusing on this is limited, and more studies are required to comprehensively assess radiologists' experiences and satisfaction.",4.737194547137077e-07,0.31805647003619164,0.08842752787389466,0.03626852929563745,0.4015744197023343,0.03631185475258099,0.03621603081905734,0.4626235219481134,0.0,4.737194547137081e-07,0.47378435208564085,0.0
98,0.5,6,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,"Question: Do UK radiologists express satisfaction with training and support in suspected child abuse cases? Answer: Available research is limited, and more extensive studies are necessary to collect data and feedback on their satisfaction and experiences.",4.97405427449393e-07,0.3462273470028885,0.08842752787389466,0.03808195576041933,0.4305619565755858,0.03631185475258099,0.03802683236001021,0.4924764850977952,0.0,4.974054274493935e-07,0.5045560107523945,0.0
98,0.5,7,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,"Question: Are UK radiologists happy with the training and support they get for suspected child abuse cases? Answer: There is little research specifically on this, highlighting the need for further studies to gather comprehensive feedback and satisfaction data.",4.500334819780224e-07,0.2906574958480763,0.08842752787389466,0.03445510283085558,0.3734035427356375,0.03631185475258099,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
98,0.5,8,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,"Question: How do UK radiologists rate their training and support in suspected child abuse scenarios? Answer: Research in this area is limited, and further studies are essential to understand radiologists' levels of satisfaction and experiences.",5.210914001850783e-07,0.37521488387614,0.08842752787389466,0.03989538222520121,0.4604149197252676,0.03631185475258099,0.039837633900963086,0.5232481437645489,0.0,5.210914001850789e-07,0.5363047090669744,0.0
98,0.5,9,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Is the training and support for suspected child abuse satisfactory to UK radiologists? Answer: There is a lack of focused research on this topic; more studies are necessary to gain comprehensive insights into radiologists' satisfaction.,4.97405427449393e-07,0.3462273470028885,0.08842752787389466,0.03808195576041933,0.4305619565755858,0.03631185475258099,0.03802683236001021,0.4924764850977952,0.0,4.974054274493935e-07,0.5045560107523945,0.0
98,0.5,10,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,"Question: Are UK radiologists content with the support and training they receive for suspected child abuse? Answer: Limited research exists, indicating a need for additional studies to collect detailed feedback on their satisfaction and experiences.",5.210914001850783e-07,0.37521488387614,0.08842752787389466,0.03989538222520121,0.4604149197252676,0.03631185475258099,0.039837633900963086,0.5232481437645489,0.0,5.210914001850789e-07,0.5363047090669744,0.0
99,0.5,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Enhancing hospital efficiency by reducing the length of stay does not seem to lead to higher readmission rates or more physician visits within 30 days post-discharge. Further research is necessary to determine the ideal length of stay and expected readmission rates.,9.474389094274162e-08,0.10075139533781297,0.020139550918406572,0.0072537058591274906,0.10076747909833506,0.01922337562475971,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
99,0.5,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier discharge from Winnipeg hospitals compromise care quality? Shortening hospital stays to improve efficiency appears not to increase readmission rates or physician visits within 30 days after discharge. Additional studies are required to find optimal stay durations and anticipated readmission rates.,3.789755637709665e-07,0.30515824742638475,0.01753826530612245,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
99,0.5,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is the quality of care affected by earlier discharge of patients from Winnipeg hospitals? Reducing length of hospital stay to boost efficiency does not seem to raise readmission or physician visit rates within 30 days after discharge. Research is needed to establish the best length of stay and expected readmission rates.,1.6580180914979784e-07,0.13443319592494518,0.0024534048313202828,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
99,0.5,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients sooner from Winnipeg hospitals harm the quality of care? Improving hospital efficiency by decreasing length of stay does not appear to cause higher readmission rates or more physician visits within 30 days post-discharge. Further investigation is needed to identify optimal stay lengths and readmission expectations.,2.3685972735685406e-07,0.16858271242063472,0.01753826530612245,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
99,0.5,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier patient discharge from Winnipeg hospitals adversely affect care quality? Enhancing hospital efficiency through shorter stays does not seem to increase readmission rates or physician visits within 30 days after discharge. Research must identify optimal lengths of stay and expected readmission rates.,3.552895910352811e-07,0.28106069584732474,0.01753826530612245,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
99,0.5,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is earlier discharge from Winnipeg hospitals detrimental to quality of care? Shortening hospital stays to improve efficiency does not appear to result in increased readmission or physician visit rates within 30 days after discharge. Additional research is necessary to determine ideal stay durations and readmission rates.,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
99,0.5,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients earlier in Winnipeg hospitals negatively influence care quality? Boosting hospital efficiency by reducing length of stay does not seem to elevate readmission rates or physician visits within 30 days post-discharge. Research is required to find optimal stay lengths and expected readmission rates.,3.079176455639103e-07,0.2345406802124308,0.01753826530612245,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
99,0.5,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier discharge from Winnipeg hospitals reduce quality of care? Improving hospital efficiency by shortening stays does not appear to increase readmission or physician visit rates within 30 days after discharge. More research is needed to establish optimal lengths of stay and expected readmission rates.,3.079176455639103e-07,0.2345406802124308,0.01753826530612245,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
99,0.5,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is quality of care compromised by earlier discharge from Winnipeg hospitals? Shortening length of stay to improve hospital efficiency does not seem to raise rates of readmission or physician visits within 30 days post-discharge. Further research is required to determine optimal stay durations and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.5,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier discharge of patients from Winnipeg hospitals adversely impact care quality? Enhancing hospital efficiency by reducing length of stay does not appear to increase readmission or physician visit rates within 30 days after discharge. Research is needed to identify ideal lengths of stay and expected readmission rates.,2.3685972735685406e-07,0.1980783371253132,0.003728275336599654,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
100,0.5,1,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is there an initial night impact on sleep bruxism? Evidence indicates a possible first night effect, where individuals might grind or clench their teeth more on the first night in a new setting or with a sleep monitoring device, though further study is required.",4.026615365066519e-07,0.2180336117674475,0.11255983875031497,0.030828249901291835,0.2458817672413427,0.06743801652892563,0.030783626196198732,0.27516606309453007,0.05157024793388431,4.026615365066519e-07,0.305529906312898,0.035041322314049606
100,0.5,2,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Does sleep bruxism show a first night effect? Research suggests that tooth grinding and clenching may increase during the first night in a new environment or when using sleep monitoring equipment, but additional research is necessary to clarify this.",5.210914001850787e-07,0.3458895945434355,0.10950590229869511,0.0398953822252012,0.372633472880485,0.06743801652892563,0.039837633900963065,0.40521919134272766,0.05157024793388431,5.210914001850789e-07,0.43906129893742074,0.035041322314049606
100,0.5,3,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is sleep bruxism influenced by the first night effect? There is some evidence that individuals experience heightened tooth grinding and clenching on the first night in unfamiliar surroundings or while using sleep monitoring devices, although more investigation is needed.",5.210914001850787e-07,0.3823710250992223,0.08333333333333334,0.0398953822252012,0.4101008880458874,0.04043184368941946,0.039837633900963065,0.40521919134272766,0.05157024793388431,5.210914001850789e-07,0.43906129893742074,0.035041322314049606
100,0.5,4,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Can the first night effect impact sleep bruxism? Studies suggest that during the initial night in a new environment or when monitored for sleep, individuals may show increased bruxism, but more research is needed to confirm this.",5.684633456564493e-07,0.36347538525792533,0.1358024691358025,0.04352223515476494,0.42820332403529715,0.06743801652892563,0.043459236982868805,0.462377605182676,0.05157024793388431,5.684633456564497e-07,0.497901798960354,0.035041322314049606
100,0.5,5,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is there a first night effect associated with sleep bruxism? Evidence points to increased tooth grinding and clenching on the first night in new environments or with sleep monitoring devices, but further research is essential to fully understand this.",5.210914001850787e-07,0.3823710250992223,0.08333333333333334,0.0398953822252012,0.372633472880485,0.06743801652892563,0.039837633900963065,0.40521919134272766,0.05157024793388431,5.210914001850789e-07,0.43906129893742074,0.035041322314049606
100,0.5,6,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Does the first night effect affect sleep bruxism? There is indication that tooth grinding and clenching may be elevated on the first night in a novel setting or when using sleep tracking devices, though more study is required.",5.44777372920764e-07,0.41101124140061573,0.08192491811539432,0.04170880868998307,0.43854062376637515,0.0396829144881093,0.04164843544191593,0.4333900683094245,0.05157024793388431,5.447773729207643e-07,0.46804883581067225,0.035041322314049606
100,0.5,7,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is sleep bruxism subject to a first night effect? Some evidence suggests increased bruxism during the first night in new surroundings or while using sleep monitoring technology, but additional research is needed.",6.868932093348758e-07,0.55772629216824,0.10358024691358028,0.05258936747867434,0.5823540038625556,0.06743801652892563,0.05251324468763317,0.6214422998123648,0.05157024793388431,6.868932093348768e-07,0.66220485025163,0.035041322314049606
100,0.5,8,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is there a phenomenon of first night effect in sleep bruxism? Data suggests that tooth grinding and clenching may increase on the first night in unfamiliar environments or with sleep monitoring devices, but more research is necessary.",5.684633456564493e-07,0.4019835619557002,0.10804736709498616,0.04352223515476494,0.42820332403529715,0.06743801652892563,0.043459236982868805,0.462377605182676,0.05157024793388431,5.684633456564497e-07,0.497901798960354,0.035041322314049606
100,0.5,9,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is the first night effect present in sleep bruxism? Research shows a potential increase in tooth grinding and clenching during the first night in a new setting or when sleep is monitored, although further studies are required.",5.684633456564493e-07,0.440491738653475,0.08043914733649452,0.04352223515476494,0.4678117343530084,0.03889130372615747,0.043459236982868805,0.462377605182676,0.05157024793388431,5.684633456564497e-07,0.497901798960354,0.035041322314049606
100,0.5,10,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Does sleep bruxism exhibit a first night effect? Evidence suggests individuals may experience more tooth grinding and clenching on the first night in a new environment or with sleep monitoring devices, but more research is needed to understand fully.",5.210914001850787e-07,0.3458895945434355,0.10950590229869511,0.0398953822252012,0.372633472880485,0.06743801652892563,0.039837633900963065,0.40521919134272766,0.05157024793388431,5.210914001850789e-07,0.43906129893742074,0.035041322314049606
101,0.5,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Grandmultiparous women experienced higher rates of maternal and neonatal complications and mortality, even after adjusting for confounding factors, indicating the necessity for closer monitoring compared to regular multiparous women during labor and delivery.",2.3685972735685406e-08,0.057909609167349885,0.024375,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.5,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Women with grandmultiparity showed elevated maternal and neonatal morbidity and mortality rates despite controlling for confounders, implying that they require more careful observation than typical multiparous patients during labor and delivery.",2.3685972735685406e-08,0.009119444997918169,0.024375,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.5,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is being grandmultiparous an independent risk factor for poor perinatal outcomes? Grandmultiparous women had greater maternal and neonatal health issues and higher neonatal death rates after adjusting for confounders, suggesting the need for enhanced monitoring compared to regular multiparous women during childbirth.",0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.5,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Can grandmultiparity be considered an independent risk factor for unfavorable perinatal outcomes? Even after accounting for confounding variables, grandmultiparous women had increased maternal and neonatal complications and mortality, highlighting the importance of closer surveillance than that given to standard multiparous patients during labor and delivery.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,0.5,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity associated independently with adverse perinatal outcomes? The data indicate that grandmultiparous women faced higher maternal and neonatal morbidity and neonatal mortality, despite controlling for confounders, which suggests they need more intensive observation than regular multiparous women during delivery.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.5,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently contribute to the risk of poor perinatal outcomes? Grandmultiparous women exhibited increased maternal and neonatal morbidity and mortality rates after confounder adjustment, pointing to the necessity for more vigilant monitoring during labor and delivery compared to standard multiparous patients.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.5,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor of adverse perinatal outcomes? Findings show grandmultiparous women have higher maternal and neonatal morbidity and neonatal mortality even when accounting for confounders, indicating a need for closer observation than that of usual multiparous women during labor and delivery.",2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.5,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity itself a risk factor for negative perinatal outcomes? Even after controlling for other variables, grandmultiparous women experienced increased maternal and neonatal complications and neonatal death, suggesting they require closer monitoring than regular multiparous women during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.5,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the likelihood of adverse perinatal outcomes? Grandmultiparous women had more maternal and neonatal morbidity and higher neonatal mortality despite adjustments for confounders, implying a need for more attentive observation compared to regular multiparous patients during childbirth.",4.7371945471370706e-08,0.01619836298637356,0.024375,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.5,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently linked to worse perinatal outcomes? Grandmultiparous women showed increased maternal and neonatal morbidity and neonatal mortality after controlling for confounders, which suggests they should be monitored more closely than typical multiparous women during labor and delivery.",7.1057918207056e-08,0.07865527994541788,0.0019215668371073726,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
102,0.5,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are doctors adequately supporting family caregivers of frail elderly patients? Possible reasons for dissatisfaction include physicians' lack of interest in assisting caregivers, insufficient compensation for counseling sessions typically provided to caregivers, and the challenges of serving as professional caregivers to family caregivers.",4.026615365066519e-07,0.3229693169262511,0.017236072637734686,0.030828249901291835,0.354171813720614,0.0,0.030783626196198732,0.3617900446055051,0.0,4.026615365066519e-07,0.3697470255060846,0.0
102,0.5,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Do physicians fulfill the needs of family caregivers for the frail elderly? The dissatisfaction may stem from physicians' disinterest in helping caregivers, inadequate payment for counseling sessions common to caregivers, and the role of being a professional caregiver to family caregivers.",4.263475092423373e-07,0.3476619295166228,0.017236072637734686,0.03264167636607371,0.37948962170490574,0.0,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
102,0.5,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are medical professionals addressing the needs of family caregivers of frail elderly individuals? The hypotheses for this dissatisfaction include physicians' possible lack of interest in assisting caregivers, poor remuneration for usual caregiver counseling, and the complexities of being professional caregivers to family caregivers.",3.789755637709665e-07,0.29887176534719107,0.017236072637734686,0.029014823436509962,0.3294792011302423,0.0,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
102,0.5,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Is the medical community meeting the needs of family caregivers of frail elderly patients? The dissatisfaction might be due to physicians' lack of willingness to help caregivers, low compensation for typical counseling sessions for caregivers, and the burden of acting as professional caregivers to family caregivers.",3.079176455639103e-07,0.2298788938602394,0.017236072637734686,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
102,0.5,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians adequately meeting the needs of family caregivers of frail elderly people? Possible explanations for dissatisfaction include physicians' disinterest in helping caregivers, limited reimbursement for common caregiver counseling sessions, and the difficulty of serving as professional caregivers to family caregivers.",4.263475092423373e-07,0.3476619295166228,0.017236072637734686,0.03264167636607371,0.37948962170490574,0.0,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
102,0.5,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Do physicians meet the needs of family caregivers of frail elderly individuals? Hypotheses for dissatisfaction include physicians possibly being uninterested in aiding caregivers, poor payment for the usual caregiver counseling, and the role of professional caregivers to family caregivers.",4.737194547137079e-07,0.3989552239041725,0.017236072637734686,0.03626852929563745,0.4321333551903246,0.0,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
102,0.5,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are doctors fulfilling the needs of family caregivers of frail elderly patients? The dissatisfaction may be explained by physicians' lack of interest in helping caregivers, insufficient remuneration for counseling sessions typical for caregivers, and the challenge of being professional caregivers to family caregivers.",3.789755637709665e-07,0.29887176534719107,0.017236072637734686,0.029014823436509962,0.3294792011302423,0.0,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
102,0.5,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians addressing the needs of family caregivers of frail elderly individuals? Reasons for dissatisfaction might include physicians' disinterest in assisting caregivers, inadequate payment for usual caregiver counseling, and the responsibilities of being professional caregivers to family caregivers.",4.974054274493932e-07,0.42562347098633335,0.017236072637734686,0.038081955760419325,0.4595323293784399,0.0,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
102,0.5,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are medical doctors meeting the needs of family caregivers of the frail elderly? Hypotheses for dissatisfaction include physicians' possible lack of interest in helping caregivers, poor compensation for typical counseling sessions for caregivers, and the role of professional caregivers to family caregivers.",4.026615365066519e-07,0.3229693169262511,0.017236072637734686,0.030828249901291835,0.354171813720614,0.0,0.030783626196198732,0.3617900446055051,0.0,4.026615365066519e-07,0.3697470255060846,0.0
102,0.5,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians satisfying the needs of family caregivers for frail elderly patients? Dissatisfaction hypotheses include physicians' disinterest in aiding caregivers, low remuneration for typical caregiver counseling, and the challenge of acting as professional caregivers to family caregivers.",5.210914001850785e-07,0.4530224451744487,0.017236072637734686,0.0398953822252012,0.48770320634513675,0.0,0.03983763390096307,0.49899116611898764,0.0,5.210914001850789e-07,0.5108256237659909,0.0
103,0.5,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Can airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Answer: Current evidence is limited but indicates that airway surgery might reduce serum lipid levels in obstructive sleep apnea patients; however, more research is necessary to confirm this relationship.",4.737194547137081e-08,0.007491452980166624,0.03395061728395063,0.0036268529295637453,0.04437220072772119,0.06315091388461157,0.003621603081905733,0.046930160765037865,0.06701213454226854,4.737194547137081e-08,0.04969180051901212,0.0707974763713328
103,0.5,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does airway surgery impact serum lipid levels in obstructive sleep apnea patients? Answer: There is some limited evidence that airway surgery could lower serum lipid levels in those with obstructive sleep apnea, but additional studies are required to verify this link.",7.105791820705622e-08,0.012375665048213413,0.053240740740740686,0.005440279394345618,0.051801042846225,0.08600409948017945,0.0054324046228586,0.05538106157725631,0.09125036168908293,7.105791820705622e-08,0.05926232337523807,0.09642074506939374
103,0.5,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients? Answer: Limited data suggest airway surgery may decrease serum lipid levels in obstructive sleep apnea patients, though further investigation is needed to establish a definitive connection.",4.737194547137081e-08,0.007491452980166624,0.0339506172839506,0.0036268529295637453,0.04437220072772119,0.06315091388461157,0.003621603081905733,0.08158751979303558,0.09189006694204196,4.737194547137081e-08,0.08523780977849604,0.09642074506939374
103,0.5,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.",Question: Does undergoing airway surgery affect serum lipid levels in patients with obstructive sleep apnea? Answer: Evidence is scarce but suggests that airway surgery might reduce serum lipid levels in obstructive sleep apnea patients; more research is needed to confirm this effect.,7.105791820705622e-08,0.012375665048213413,0.053240740740740686,0.005440279394345618,0.051801042846225,0.08600409948017945,0.0054324046228586,0.05538106157725631,0.09125036168908293,7.105791820705622e-08,0.05926232337523807,0.09642074506939374
103,0.5,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Can airway surgery lead to lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence pointing toward a potential reduction in serum lipid levels after airway surgery in obstructive sleep apnea patients, but further research is necessary to confirm this association.",2.3685972735685406e-08,0.08968712790635536,0.042661991379940034,0.0018134264647818726,0.12190587063018787,0.06804881959632186,0.0018108015409528666,0.1563261366536839,0.09363100000165636,2.3685972735685406e-08,0.1593457819322195,0.09642074506939374
103,0.5,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Is there evidence that airway surgery decreases serum lipid levels in obstructive sleep apnea patients? Answer: While evidence is limited, it suggests airway surgery may lower serum lipid levels in patients with obstructive sleep apnea; however, more research is required to clarify this connection.",0.0,0.09452007007635732,0.061070932865804645,0.0,0.12895761498789682,0.08946464351065858,0.0,0.1320280343923721,0.09307827048232532,0.0,0.13524823035315947,0.09642074506939374
103,0.5,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does airway surgery have an effect on serum lipid levels in obstructive sleep apnea patients? Answer: Limited evidence indicates airway surgery might reduce serum lipid levels in obstructive sleep apnea patients, but additional studies are needed to establish a clear relationship.",7.105791820705622e-08,0.05524845012836721,0.009344696484258175,0.005440279394345618,0.05217103423776637,0.013416615733218062,0.0054324046228586,0.05125696620119591,0.015649140591225477,7.105791820705622e-08,0.05018196829212229,0.018053398130618237
103,0.5,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Can serum lipid levels be lowered by airway surgery in obstructive sleep apnea patients? Answer: There is some limited evidence that airway surgery could decrease serum lipid levels in obstructive sleep apnea patients, yet further research is essential to confirm this link.",4.737194547137081e-08,0.007491452980166624,0.0339506172839506,0.0036268529295637453,0.04437220072772119,0.06315091388461157,0.003621603081905733,0.08158751979303558,0.09189006694204196,4.737194547137081e-08,0.08523780977849604,0.09642074506939374
103,0.5,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Is airway surgery associated with reduced serum lipid levels in obstructive sleep apnea patients? Answer: Limited data suggest a possible reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients; however, more research is needed to verify this association.",4.737194547137081e-08,0.007491452980166624,0.0339506172839506,0.0036268529295637453,0.044372200727720745,0.06315091388461157,0.003621603081905733,0.08158751979303558,0.09189006694204196,4.737194547137081e-08,0.08523780977849604,0.09642074506939374
103,0.5,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does airway surgery result in lower serum lipid levels among obstructive sleep apnea patients? Answer: Although evidence is limited, it suggests airway surgery may reduce serum lipid levels in obstructive sleep apnea patients, but further studies are necessary to confirm this relationship.",4.737194547137081e-08,0.04049846157825909,0.05596587578569562,0.0036268529295637453,0.07818425831601106,0.08721339282669846,0.003621603081905733,0.11624487882103196,0.11687363038714388,4.737194547137081e-08,0.08523780977849604,0.09642074506939374
104,0.5,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Does the use of audits to identify maternal mortality vary solely between wealthy and impoverished settings? Answer: Audits used to detect maternal mortality are not limited to differences between affluent and poor areas. Although socioeconomic status affects healthcare access and maternal health, audit systems can uncover and tackle systemic problems in both well-resourced and under-resourced environments.",4.026615365066519e-07,0.01398233256172654,0.1840570398011848,0.03082824990129189,0.00022430310084065042,0.18311533888228299,0.030783626196198746,0.0393925581750878,0.16202240735420861,4.026615365066519e-07,0.08016127690868347,0.13888888888888895
104,0.5,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Is the identification of maternal mortality through audits merely a distinction between rich and poor settings? Answer: Identifying maternal mortality via audits transcends the rich-poor divide. Socioeconomic factors impact healthcare access and maternal outcomes, but audits serve to reveal and address systemic challenges across all settings, regardless of wealth.",5.684633456564497e-07,0.12308552526973449,0.18150897391505072,0.043522235154765,0.13590787122373937,0.18311533888228299,0.04345923698286881,0.17822900302930522,0.16202240735420861,5.684633456564497e-07,0.22181179397170991,0.13888888888888895
104,0.5,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Does auditing maternal mortality only reflect disparities between rich and poor environments? Answer: Auditing maternal mortality is not just about differences between wealthier and poorer areas. While socioeconomic conditions influence healthcare and maternal health, audit processes help detect and resolve systemic issues in both resource-rich and resource-poor contexts.",5.921493183921352e-07,0.17317535586362398,0.160320377769283,0.04533566161954687,0.18645690512625102,0.1618487982395609,0.04527003852382168,0.19973520825026858,0.16202240735420861,5.921493183921352e-07,0.24379070069048492,0.13888888888888895
104,0.5,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Is the use of audits for maternal mortality identification simply a matter of economic disparity? Answer: The use of audits to identify maternal mortality goes beyond economic disparities. Socioeconomic factors affect access to care and outcomes, yet audits are valuable tools for identifying and addressing systemic problems in all settings, rich or poor.",4.737194547137081e-07,0.12094817769121446,0.12693951645519602,0.03626852929563751,0.10918417743942932,0.14471533888228297,0.036216030819057346,0.12373321438993745,0.14242240735420864,4.737194547137081e-07,0.13843018503265903,0.13888888888888895
104,0.5,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Does maternal mortality auditing only highlight the gap between rich and poor regions? Answer: Auditing maternal mortality is more than a reflection of the rich-poor gap. Although socioeconomic status affects healthcare access and maternal health, audits can pinpoint and remediate systemic issues in both affluent and disadvantaged settings.",5.921493183921352e-07,0.14429422334029285,0.181084377252408,0.04533566161954687,0.15696128042157254,0.18311533888228299,0.04527003852382168,0.19973520825026858,0.16202240735420861,5.921493183921352e-07,0.24379070069048492,0.13888888888888895
104,0.5,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Is the difference in maternal mortality audits solely between wealthy and impoverished areas? Answer: The difference in maternal mortality audits is not confined to wealth disparities. While socioeconomic factors influence healthcare access and maternal health, audits help identify and tackle systemic issues in both high- and low-resource settings.",5.921493183921352e-07,0.2598187534336174,0.09915003176914605,0.04533566161954687,0.27494377924028646,0.09874540919055773,0.04527003852382168,0.2901457100624354,0.09712246143749687,5.921493183921352e-07,0.3054037834069243,0.09454059251246927
104,0.5,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Are audits for maternal mortality identification just about economic differences? Answer: Audits for identifying maternal mortality are not merely about economic differences. Socioeconomic status impacts healthcare and maternal outcomes, but audit processes are essential for uncovering and addressing systemic issues across all environments.",7.105791820705622e-07,0.322132197272214,0.13253327947060628,0.054402793943456235,0.26943926384826256,0.18311533888228299,0.05432404622858601,0.31480453803505526,0.16202240735420861,7.105791820705622e-07,0.3615737363468683,0.13888888888888895
104,0.5,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Does auditing maternal mortality only distinguish between the rich and the poor? Answer: Auditing maternal mortality is not solely a distinction between rich and poor. Although socioeconomic factors influence healthcare access and maternal health outcomes, audits can identify and address systemic problems in both resource-rich and resource-poor settings.",5.921493183921352e-07,0.2020564883869551,0.13968605724838407,0.04533566161954687,0.18645690512625102,0.1618487982395609,0.04527003852382168,0.19973520825026858,0.16202240735420861,5.921493183921352e-07,0.24379070069048492,0.13888888888888895
104,0.5,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Is the use of audits in maternal mortality identification limited to disparities between rich and poor? Answer: The use of audits to identify maternal mortality is not limited to disparities between rich and poor. While socioeconomic factors affect healthcare access and maternal outcomes, audits help reveal and solve systemic issues in all settings.",4.737194547137081e-07,0.2517306645893176,0.03920166790035837,0.03626852929563751,0.21582220521788198,0.06969378878776498,0.036216030819057346,0.2052799415146378,0.08415912079920633,4.737194547137081e-07,0.19388195947745457,0.09895833333333338
104,0.5,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Question: Is maternal mortality identification through audits just a reflection of wealth differences? Answer: Identifying maternal mortality through audits is not just a reflection of wealth differences. Socioeconomic factors influence healthcare and maternal health, but audits are crucial for identifying and addressing systemic challenges in both affluent and resource-limited settings.",5.684633456564497e-07,0.26454413354727446,0.08184337952468958,0.043522235154765,0.22255126879373233,0.12089311666006076,0.04345923698286881,0.23722025243866218,0.11955327155173948,5.684633456564497e-07,0.25194862790909855,0.11716049382716055
105,0.5,1,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,The study of gender differences following injury and hemorrhagic shock indicates that hormones might play a key role. Additional investigation is required to clarify how hormones influence these conditions and affect treatment and outcomes.,4.974054274493928e-07,0.31277166050818117,0.12675418741511993,0.038081955760419346,0.3999300212339123,0.07496876301541025,0.038026832360010226,0.4372779932624411,0.057476051645147866,4.974054274493935e-07,0.4762637663123708,0.039150354019158694
105,0.5,2,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Gender dimorphism observed after injury and hemorrhagic shock appears to be linked to hormonal variations. More research is necessary to comprehensively understand hormones' effects on these states and their implications for therapy and prognosis.,4.974054274493928e-07,0.31277166050818117,0.12675418741511993,0.038081955760419346,0.3999300212339123,0.07496876301541025,0.038026832360010226,0.4372779932624411,0.057476051645147866,4.974054274493935e-07,0.4762637663123708,0.039150354019158694
105,0.5,3,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,"After injury and hemorrhagic shock, gender differences seem to be influenced by hormonal factors. Further studies are essential to determine the exact role hormones have in these conditions and their impact on clinical results and treatment approaches.",4.263475092423369e-07,0.22576028351855104,0.12675418741511993,0.03264167636607371,0.31031786254422533,0.07496876301541025,0.032594427737151606,0.3449046731314258,0.057476051645147866,4.263475092423373e-07,0.38095358650804556,0.039150354019158694
105,0.5,4,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,The analysis of gender dimorphism post-injury and hemorrhagic shock points to hormonal differences as a possible cause. Continued research is needed to fully grasp how hormones affect these conditions and their treatment outcomes.,5.210914001850781e-07,0.34354331917493486,0.12675418741511993,0.039895382225201226,0.43167871954849213,0.07496876301541025,0.0398376339009631,0.4700678160854328,0.057476051645147866,5.210914001850789e-07,0.5101653179880525,0.039150354019158694
105,0.5,5,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Hormonal differences may underlie the gender dimorphism seen after injury and hemorrhagic shock. More research is required to understand the hormonal role in these conditions and how it influences patient outcomes and therapeutic strategies.,4.974054274493928e-07,0.31277166050818117,0.12675418741511993,0.038081955760419346,0.3999300212339123,0.07496876301541025,0.038026832360010226,0.4372779932624411,0.057476051645147866,4.974054274493935e-07,0.4762637663123708,0.039150354019158694
105,0.5,6,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Gender-specific responses after injury and hemorrhagic shock are possibly due to hormonal variations. Further investigation is warranted to elucidate the role of hormones in these scenarios and their effect on treatment and prognosis.,5.210914001850781e-07,0.34354331917493486,0.12675418741511993,0.039895382225201226,0.43167871954849213,0.07496876301541025,0.0398376339009631,0.4700678160854328,0.057476051645147866,5.210914001850789e-07,0.5101653179880525,0.039150354019158694
105,0.5,7,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,The characterization of gender differences following injury and hemorrhagic shock suggests hormones could be responsible. Additional research is needed to better understand hormones' influence on these conditions and their impact on treatment and outcomes.,4.974054274493928e-07,0.31277166050818117,0.12675418741511993,0.038081955760419346,0.3999300212339123,0.07496876301541025,0.038026832360010226,0.4372779932624411,0.057476051645147866,4.974054274493935e-07,0.4762637663123708,0.039150354019158694
105,0.5,8,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Hormonal distinctions may explain the gender dimorphism observed after injury and hemorrhagic shock. More studies are needed to fully understand how hormones affect these conditions and their treatment implications.,6.158352911278193e-07,0.47707471179945715,0.12675418741511993,0.047149088084328744,0.5698290580293093,0.07496876301541025,0.047080840064774594,0.6131686597261052,0.057476051645147866,6.158352911278206e-07,0.6585853231063257,0.039150354019158694
105,0.5,9,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Gender dimorphism after injury and hemorrhagic shock is potentially driven by hormonal differences. Further research is essential to clarify the role hormones play in these conditions and their effects on treatment and clinical outcomes.,4.974054274493928e-07,0.31277166050818117,0.12675418741511993,0.038081955760419346,0.3999300212339123,0.07496876301541025,0.038026832360010226,0.4372779932624411,0.057476051645147866,4.974054274493935e-07,0.4762637663123708,0.039150354019158694
105,0.5,10,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,The gender-based differences seen after injury and hemorrhagic shock may be attributed to hormonal factors. Continued research is necessary to comprehend the influence of hormones on these conditions and their impact on therapeutic strategies and outcomes.,4.500334819780222e-07,0.2539311604852479,0.12675418741511993,0.03445510283085559,0.33930539941747684,0.07496876301541025,0.03440522927810448,0.3747576362811076,0.057476051645147866,4.500334819780227e-07,0.41172524517479925,0.039150354019158694
106,0.5,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? The answer reveals significant influence at multiple levels; graduates are seen as key contributors to their workplaces and frequently hold sway at the national level. The impacts align closely with public health education goals. A qualitative study provided deeper insights into the graduates' influence.,1.8948778188548325e-07,0.12715517548524602,0.0,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.5,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs affect health system strengthening in low- and middle-income countries? Results show considerable effects across various levels; graduates are recognized for their substantial contributions to their work environments and often have national-level influence. Much of the impact corresponds with the objectives of public health education. Qualitative research offered a more detailed understanding of graduates' effects.,2.3685972735685406e-07,0.16164135155641457,0.0,0.018134264647818726,0.16430305129127465,0.0,0.018108015409528666,0.16705408466316563,0.0,2.3685972735685406e-07,0.16989903679539609,0.0
106,0.5,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the contribution of MPH programs to health system strengthening in low- and middle-income countries? There was notable impact on several levels; graduates were viewed as able to make important contributions to their workplaces and frequently influenced national policies. The impact largely matched the goals of public health education. A qualitative study uncovered deeper insights into the graduates' influence.,1.8948778188548325e-07,0.12715517548524602,0.0,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.5,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs contribute to strengthening health systems in low- and middle-income countries? The impact was significant at multiple levels; graduates were perceived to contribute meaningfully to their workplaces and often had influence at the national stage. The described impacts aligned well with public health educational objectives. The qualitative study provided a more nuanced understanding of graduates' impact.,2.1317375462116866e-07,0.14424960884454574,0.0,0.016320838183036854,0.14660347419187403,0.0,0.0162972138685758,0.14903557916048715,0.0,2.1317375462116866e-07,0.15154989812720032,0.0
106,0.5,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the effect of MPH programs on health system strengthening in low- and middle-income countries? There was a considerable impact at various levels; graduates were considered capable of significant contributions to their workplaces and often held influence nationally. Much of the impact reflected the aims of public health education. The qualitative method study revealed deeper insights into the graduates' impact.,1.6580180914979784e-07,0.11034805716886531,0.0,0.012693985253473108,0.11211729812070548,0.0,0.012675610786670066,0.1139442593492177,0.0,1.6580180914979784e-07,0.11583181552512123,0.0
106,0.5,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How have MPH programs impacted health system strengthening in low- and middle-income countries? Significant effects were observed at multiple levels; graduates were seen as valuable contributors to their workplaces and often exerted influence at the national level. The impacts corresponded with the goals of public health education. A qualitative study provided an in-depth understanding of the graduates' impact.,2.3685972735685406e-07,0.16164135155641457,0.0,0.018134264647818726,0.16430305129127465,0.0,0.018108015409528666,0.16705408466316563,0.0,2.3685972735685406e-07,0.16989903679539609,0.0
106,0.5,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the influence of MPH programs on health system strengthening in low- and middle-income countries? There was a substantial impact at many levels; graduates were perceived as able to contribute significantly to their workplaces and frequently influenced national policies. Much of the impact aligned with public health education objectives. The qualitative study offered a deeper comprehension of graduates' impact.,1.8948778188548325e-07,0.12715517548524602,0.0,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.5,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs affect health system strengthening in low- and middle-income countries? Considerable impact was noted at various levels; graduates were regarded as significant contributors to their workplaces and often had influence at the national level. The described impact was consistent with public health educational aims. Qualitative research revealed a more detailed understanding of the graduates' impact.,2.3685972735685406e-07,0.18596230526027213,0.017538265306122455,0.018134264647818726,0.16430305129127465,0.0,0.018108015409528666,0.16705408466316563,0.0,2.3685972735685406e-07,0.16989903679539609,0.0
106,0.5,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the role of MPH programs in strengthening health systems in low- and middle-income countries? There was notable impact on multiple levels; graduates were perceived to contribute effectively to their workplaces and often held influence nationally. Much of the impact was aligned with the aims of public health education. The qualitative study provided deeper insights into the graduates' impact.,1.8948778188548325e-07,0.12715517548524602,0.0,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.5,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs contribute to health system strengthening in low- and middle-income countries? The impact was considerable across many levels; graduates were seen as able to make significant contributions to their workplaces and often influenced national policies. The impact largely reflected the goals of public health education. A qualitative study revealed a more comprehensive understanding of graduates' impact.,2.1317375462116866e-07,0.1681512357604058,0.017236072637734686,0.016320838183036854,0.14660347419187403,0.0,0.0162972138685758,0.14903557916048715,0.0,2.1317375462116866e-07,0.15154989812720032,0.0
107,0.5,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can neoadjuvant chemotherapy alter the scope of lymphadenectomy in cervical cancer? The occurrence and location of lymph node metastases remain unchanged by neoadjuvant chemotherapy, with clinical non-responders exhibiting a higher number of affected lymph nodes. Therefore, a thorough and systemic lymphadenectomy is recommended for patients undergoing neoadjuvant chemotherapy followed by surgery.",2.3685972735685406e-08,0.0207685417506287,0.0004076354181128221,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
107,0.5,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is it possible for neoadjuvant chemotherapy to change the extent of lymphadenectomy in cervical cancer? The frequency and anatomical distribution of lymph node metastases are not affected by neoadjuvant chemotherapy, and patients who do not respond clinically have more involved lymph nodes. Hence, a comprehensive systemic lymphadenectomy should be conducted in patients receiving neoadjuvant chemotherapy plus surgery.",1.6580180914979784e-07,0.13706785783146103,0.002548065886134064,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
107,0.5,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Does neoadjuvant chemotherapy influence the degree of lymphadenectomy needed in cervical cancer? The rate and distribution of lymph node metastases do not change with neoadjuvant chemotherapy, and clinical non-responders tend to have more lymph nodes involved. Consequently, patients treated with neoadjuvant chemotherapy and surgery should undergo an extensive systemic lymphadenectomy.",0.0,0.02829172165550764,0.02034311182787588,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
107,0.5,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Could the range of lymphadenectomy be adjusted by neoadjuvant chemotherapy in cervical cancer cases? Neoadjuvant chemotherapy does not alter the frequency or location of lymph node metastases, and patients who fail to respond clinically show greater lymph node involvement. Therefore, an extensive systemic lymphadenectomy is advised for those treated with neoadjuvant chemotherapy plus surgery.",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
107,0.5,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is the extent of lymphadenectomy modifiable by neoadjuvant chemotherapy in cervical cancer? The incidence and topographic spread of lymph node metastases remain unaffected by neoadjuvant chemotherapy; clinical non-responders have more lymph nodes involved. As a result, systemic and broad lymphadenectomy should be performed in patients undergoing neoadjuvant chemotherapy followed by surgery.",2.3685972735685406e-08,0.00695734547176885,0.01953125000000001,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
107,0.5,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can neoadjuvant chemotherapy modify how extensive lymphadenectomy should be in cervical cancer? The frequency and anatomical distribution of lymph node metastases are not changed by neoadjuvant chemotherapy, and patients who do not respond clinically have increased lymph node involvement. Thus, a systemic and comprehensive lymphadenectomy is necessary for patients treated with neoadjuvant chemotherapy plus surgery.",1.1842986367842703e-07,0.07411123451212331,0.016582942965154498,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
107,0.5,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Does neoadjuvant chemotherapy impact the extent of lymphadenectomy in cervical cancer? The rate and location of lymph node metastases are not affected by neoadjuvant chemotherapy; however, clinical non-responders exhibit more involved lymph nodes. Therefore, systemic and extensive lymphadenectomy is recommended for patients receiving neoadjuvant chemotherapy and surgery.",7.105791820705622e-08,0.06502401390341284,0.0013290895061728418,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
107,0.5,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Could neoadjuvant chemotherapy alter the necessary extent of lymphadenectomy in cervical cancer? The frequency and distribution of lymph node metastases remain unchanged by neoadjuvant chemotherapy, with clinical non-responders showing more lymph node involvement. Hence, patients treated with neoadjuvant chemotherapy plus surgery should undergo a systemic and extensive lymphadenectomy.",4.737194547137081e-08,0.0723722241544178,0.022069830246913582,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,0.5,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is the scope of lymphadenectomy influenced by neoadjuvant chemotherapy in cervical cancer? Neoadjuvant chemotherapy does not modify the frequency or topographic distribution of lymph node metastases, and clinical non-responders have a higher number of involved lymph nodes. Therefore, a systemic and wide lymphadenectomy should be performed in patients treated with neoadjuvant chemotherapy and surgery.",9.474389094274162e-08,0.04457773585163727,0.05649419694348329,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
107,0.5,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can the extent of lymphadenectomy be changed by neoadjuvant chemotherapy in cervical cancer? The occurrence and anatomical distribution of lymph node metastases are not altered by neoadjuvant chemotherapy; clinical non-responders tend to have more involved lymph nodes. Thus, systemic and extensive lymphadenectomy is advised for patients undergoing neoadjuvant chemotherapy plus surgery.",2.3685972735685406e-08,0.00695734547176885,0.01953125000000001,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
108,0.5,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are doctors effectively supporting family caregivers of frail elderly patients? Opinions differ on whether physicians sufficiently meet the needs of these caregivers. Some suggest healthcare professionals fall short in providing support, while others feel that initiatives to enhance caregiver education and resources are underway.",3.552895910352811e-07,0.13193150644183538,0.1184159938485198,0.02720139697172809,0.15945592732803604,0.10380622837370242,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
108,0.5,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Do physicians adequately address the needs of family caregivers for the frail elderly? There is debate about whether medical providers are doing enough. Some believe caregivers are underserved, whereas others argue that steps are being taken to improve education and resources for caregivers.",3.789755637709665e-07,0.1554620038520298,0.1184159938485198,0.029014823436509962,0.18355347890709606,0.10380622837370242,0.028972824655245866,0.21269595437836575,0.08842752787389466,3.789755637709665e-07,0.24295013102137952,0.07227989234909649
108,0.5,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are the needs of family caregivers of frail elderly patients being met by physicians? This remains a contested issue with some asserting that healthcare providers do not offer enough support, while others maintain that efforts to improve caregiver support and education are in progress.",3.552895910352811e-07,0.13193150644183538,0.1184159938485198,0.02720139697172809,0.15945592732803604,0.10380622837370242,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
108,0.5,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","To what extent are physicians meeting the needs of family caregivers of frail elderly individuals? Opinions vary; some say caregivers lack sufficient support from healthcare providers, while others claim that improvements in caregiver education and resources are being made.",4.737194547137079e-07,0.2555454624090112,0.1184159938485198,0.03626852929563745,0.2862076329671783,0.10380622837370242,0.03621603081905733,0.31805647003619164,0.08842752787389466,4.737194547137081e-07,0.35116371566161053,0.07227989234909649
108,0.5,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are family caregivers of the frail elderly receiving adequate support from physicians? The question is debated, with some arguing that healthcare professionals are not providing enough assistance, and others believing that caregiver education and resource provision are improving.",4.974054274493932e-07,0.2822137094911721,0.1184159938485198,0.038081955760419325,0.31360660715529365,0.10380622837370242,0.0380268323600102,0.3462273470028885,0.08842752787389466,4.974054274493935e-07,0.38015125253486204,0.07227989234909649
108,0.5,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Is physician support sufficient for family caregivers of frail elderly patients? There is ongoing discussion about this, with some contending that caregivers are inadequately supported, and others noting that efforts to enhance caregiver education and resources exist.",5.210914001850785e-07,0.3096126836792874,0.1184159938485198,0.0398953822252012,0.3417774841219905,0.10380622837370242,0.03983763390096307,0.37521488387614,0.08842752787389466,5.210914001850789e-07,0.4100042156845438,0.07227989234909649
108,0.5,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Do physicians fulfill the needs of family caregivers caring for frail elderly patients? This issue is debated; some think caregivers do not get enough help from healthcare providers, while others believe that support and educational resources for caregivers are being enhanced.",4.263475092423373e-07,0.2042521680214615,0.1184159938485198,0.03264167636607371,0.23356389948175948,0.10380622837370242,0.0325944277371516,0.26398924876591545,0.08842752787389466,4.263475092423373e-07,0.29559386450679836,0.07227989234909649
108,0.5,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are the needs of family caregivers for frail elderly individuals being properly met by physicians? There is disagreement, with some suggesting a lack of adequate support, and others pointing to ongoing improvements in caregiver education and resources.",5.210914001850785e-07,0.3096126836792874,0.1184159938485198,0.0398953822252012,0.3417774841219905,0.10380622837370242,0.03983763390096307,0.37521488387614,0.08842752787389466,5.210914001850789e-07,0.4100042156845438,0.07227989234909649
108,0.5,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are physicians properly addressing the needs of family caregivers of frail elderly patients? Opinions differ, with some arguing that caregivers receive insufficient support, and others asserting that efforts to improve education and resources for caregivers are ongoing.",5.210914001850785e-07,0.3096126836792874,0.1184159938485198,0.0398953822252012,0.3417774841219905,0.10380622837370242,0.03983763390096307,0.37521488387614,0.08842752787389466,5.210914001850789e-07,0.4100042156845438,0.07227989234909649
108,0.5,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Is the medical community adequately supporting family caregivers of the frail elderly? This remains a topic of debate, as some feel caregivers are not sufficiently helped by physicians, while others believe that measures to improve caregiver education and resources are being implemented.",4.026615365066519e-07,0.1795595554310898,0.1184159938485198,0.030828249901291835,0.20824609149746776,0.10380622837370242,0.030783626196198732,0.23801376236265748,0.08842752787389466,4.026615365066519e-07,0.2689256174246375,0.07227989234909649
109,0.5,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Is neck pain linked to a decline in health-related quality of life six months later? Our findings show that neck pain negatively impacts physical but not mental health-related quality of life. This suggests that neck pain could lead to poorer physical HRQoL in the future population.,4.737194547137081e-08,0.0800301172111908,0.028493442401297975,0.0036268529295637453,0.07732830868434881,0.023623078861174096,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
109,0.5,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does neck pain correlate with worse health-related quality of life after six months? We discovered that neck pain is associated with reduced physical, but not mental, HRQoL. This indicates neck pain might contribute to future physical HRQoL deterioration in the population.",1.6580180914979784e-07,0.11454863119848246,0.0283884828064582,0.012693985253473108,0.13494291642206147,0.021728395061728398,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
109,0.5,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is there an association between neck pain and diminished health-related quality of life six months later? Our study found neck pain to be negatively related to physical health-related quality of life, but not mental. This implies neck pain may cause poorer physical HRQoL in the future.",4.737194547137081e-08,0.0492235758529711,0.005941761854004718,0.0036268529295637453,0.04582161865889667,0.0009865860091207122,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
109,0.5,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain connected to poorer health-related quality of life six months afterward? The results show neck pain adversely affects physical, but not mental, HRQoL, suggesting it could be a factor in future physical HRQoL decline in the population.",2.1317375462116844e-07,0.11992743449171073,0.10458499076159464,0.016320838183036854,0.1875866499074803,0.021728395061728398,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
109,0.5,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does experiencing neck pain lead to worse health-related quality of life six months later? We observed a negative association between neck pain and physical HRQoL, but no effect on mental HRQoL, indicating neck pain may contribute to future physical health quality decline.",1.4211583641411244e-07,0.08784636198249851,0.030947303818294344,0.010880558788691236,0.10962510843776974,0.021728395061728398,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
109,0.5,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain associated with a reduction in health-related quality of life six months later? Our analysis revealed neck pain negatively influences physical, but not mental, HRQoL, suggesting it may be a predictor of future poor physical HRQoL.",2.3685972735685374e-07,0.14758166618348767,0.10387538475919585,0.018134264647818726,0.21498562409559563,0.021728395061728398,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
109,0.5,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is there a link between neck pain and worse health-related quality of life after six months? Findings indicate neck pain is negatively linked to physical HRQoL but not mental, implying it might contribute to future physical HRQoL issues.",2.3685972735685374e-07,0.18504908134889098,0.07700400657829384,0.018134264647818726,0.21498562409559563,0.021728395061728398,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
109,0.5,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does neck pain impact health-related quality of life six months later? We found a negative correlation between neck pain and physical HRQoL, but no significant effect on mental HRQoL, suggesting neck pain could lead to future physical HRQoL decline.",2.1317375462116844e-07,0.17017855304130158,0.022856866240677357,0.016320838183036854,0.1875866499074803,0.021728395061728398,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
109,0.5,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain related to poorer health-related quality of life six months later? Our data suggests neck pain adversely affects physical HRQoL, without impacting mental HRQoL, indicating it may be a factor in future physical health quality reduction.",2.3685972735685374e-07,0.14758166618348767,0.10387538475919585,0.018134264647818726,0.21498562409559563,0.021728395061728398,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
109,0.5,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain a factor in decreased health-related quality of life six months later? The study shows neck pain negatively associates with physical HRQoL but not mental, suggesting it may contribute to future declines in physical health-related quality of life.",1.8948778188548314e-07,0.16410854531111863,0.05449266870981312,0.014507411718254981,0.19739983338110578,0.004568171775378976,0.014486412327622933,0.19574457712609394,0.0,1.8948778188548325e-07,0.20067069546215155,0.0
110,0.5,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical importance of bile duct sludge compared to bile duct stones? Answer: The results suggest that symptomatic bile duct sludge has clinical significance comparable to common bile duct stones. Bile duct sludge appears to represent an initial phase of choledocholithiasis.,0.0,0.09042573206536808,0.34734646677822545,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.5,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does the clinical relevance of bile duct sludge differ from that of bile duct stones? Answer: Findings show that the clinical impact of symptomatic bile duct sludge is similar to that of common bile duct stones. Bile duct sludge may be an early form of choledocholithiasis.,9.474389094274162e-08,0.06751479571327978,0.38227146814404456,0.0072537058591274906,0.05520033394268875,0.06391157382368849,0.007243206163811466,0.12690248065430154,0.024375,9.474389094274162e-08,0.09531017980432566,0.0
110,0.5,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical significance of bile duct sludge versus bile duct stones? Answer: The evidence indicates that symptomatic bile duct sludge shares similar clinical importance with common bile duct stones. It seems that bile duct sludge is an early stage in the development of choledocholithiasis.,7.105791820705622e-08,0.005780670033979085,0.3106024930747925,0.005440279394345618,0.061766069438595306,0.043359924283396425,0.0054324046228586,0.10442962480224383,0.024375,7.105791820705622e-08,0.07232066157962613,0.0
110,0.5,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical significance of bile duct sludge different from that of bile duct stones? Answer: The data reveal that symptomatic bile duct sludge has a clinical significance akin to common bile duct stones. Bile duct sludge likely represents an initial stage of choledocholithiasis.,2.3685972735685406e-08,0.12445433679422901,0.3948308881365208,0.0018134264647818726,0.01934225811744117,0.07187500000000002,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
110,0.5,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How significant is bile duct sludge clinically compared to bile duct stones? Answer: The findings demonstrate that symptomatic bile duct sludge carries clinical significance comparable to that of common bile duct stones. Bile duct sludge appears to be an early phase of choledocholithiasis.,0.0,0.09042573206536808,0.34734646677822545,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.5,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What clinical implications does bile duct sludge have relative to bile duct stones? Answer: The study findings indicate that symptomatic bile duct sludge has clinical significance similar to common bile duct stones. Bile duct sludge seems to constitute an early stage of choledocholithiasis.,0.0,0.09042573206536808,0.34734646677822545,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.5,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Does bile duct sludge differ clinically from bile duct stones? Answer: The findings suggest that the clinical significance of symptomatic bile duct sludge is on par with that of common bile duct stones. Bile duct sludge appears to be an early stage of choledocholithiasis.,2.3685972735685406e-08,0.06144095674332384,0.33448753462603864,0.0018134264647818726,0.01289714562953348,0.04768143961927421,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
110,0.5,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical difference between bile duct sludge and bile duct stones? Answer: The evidence points to symptomatic bile duct sludge having similar clinical significance as common bile duct stones. Bile duct sludge seems to be an initial phase of choledocholithiasis.,2.3685972735685406e-08,0.1202369750061143,0.36088027085257024,0.0018134264647818726,0.0384697994073715,0.052434253780407655,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
110,0.5,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does bile duct sludge compare to bile duct stones in clinical significance? Answer: The data suggest that symptomatic bile duct sludge is clinically as significant as common bile duct stones. Bile duct sludge appears to be an early stage in the progression of choledocholithiasis.,4.737194547137081e-08,0.033239299664916455,0.3222543668420508,0.0036268529295637453,0.0376286495127971,0.04547052154195008,0.003621603081905733,0.0814401065775443,0.024375,4.737194547137081e-08,0.048790164169431716,0.0
110,0.5,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What clinical role does bile duct sludge play compared to bile duct stones? Answer: The findings indicate that symptomatic bile duct sludge holds clinical significance similar to that of common bile duct stones. Bile duct sludge seems to represent an early stage of choledocholithiasis.,2.3685972735685406e-08,0.06144095674332384,0.33448753462603875,0.0018134264647818726,0.01289714562953348,0.04768143961927421,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
111,0.5,1,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Is a previous benign prostate biopsy indicative of the outcome for patients receiving radical perineal prostatectomy? Answer: Current evidence is limited and suggests that a prior benign prostate biopsy might not reliably predict the outcome for these patients.,7.1057918207056e-08,0.0190392836713289,0.03823458795282822,0.005440279394345618,0.048924294716525374,0.020629388351396057,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
111,0.5,2,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Can a prior benign prostate biopsy forecast the results for patients treated with radical perineal prostatectomy? Answer: Limited data indicates that a previous benign prostate biopsy may not be a significant predictor of the outcome in such cases.,7.1057918207056e-08,0.05392357744024512,0.0895716805240615,0.005440279394345618,0.011456879551122068,0.04750076653229807,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
111,0.5,3,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Does having a benign prostate biopsy beforehand help predict outcomes for patients undergoing radical perineal prostatectomy? Answer: There is scarce evidence implying that a prior benign prostate biopsy is not a strong outcome predictor for these patients.,9.474389094274131e-08,0.025283361138851657,0.08816326530612248,0.0072537058591274906,0.039896615271609814,0.04675183733098791,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
111,0.5,4,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Is the outcome for patients treated with radical perineal prostatectomy influenced by a prior benign prostate biopsy? Answer: Evidence is limited but suggests that prior benign biopsies may not strongly predict patient outcomes.,1.894877818854825e-07,0.05620107974202382,0.11176737882653065,0.014507411718255002,0.11917147423021879,0.07450693937180423,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
111,0.5,5,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Does a history of benign prostate biopsy affect the prognosis for patients receiving radical perineal prostatectomy? Answer: The available evidence is limited and suggests that a previous benign prostate biopsy might not be a reliable predictor of prognosis.,7.1057918207056e-08,0.05392357744024512,0.0895716805240615,0.005440279394345618,0.011456879551122068,0.04750076653229807,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
111,0.5,6,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Can outcomes of radical perineal prostatectomy be predicted by a previous benign prostate biopsy? Answer: There is limited evidence indicating that prior benign prostate biopsy may not be a strong predictor of outcomes.,1.894877818854825e-07,0.05620107974202382,0.11176737882653065,0.014507411718255002,0.11917147423021879,0.07450693937180423,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
111,0.5,7,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Is prior benign prostate biopsy a predictor of outcomes in patients treated with radical perineal prostatectomy? Answer: Limited evidence suggests that it may not serve as a strong predictor for patient outcomes.,2.131737546211678e-07,0.04496381837484176,0.14204081632653065,0.01632083818303688,0.15092017254479861,0.07450693937180423,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
111,0.5,8,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Does a prior benign prostate biopsy serve as a reliable indicator of outcomes for radical perineal prostatectomy patients? Answer: Evidence is limited and suggests it may not be a strong indicator.,2.368597273568531e-07,0.07671251668942158,0.14204081632653065,0.01813426464781876,0.1837099953677903,0.07450693937180423,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
111,0.5,9,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Is there a link between prior benign prostate biopsy and outcomes in radical perineal prostatectomy treatment? Answer: The evidence is limited and suggests that prior benign biopsy may not strongly correlate with patient outcomes.,1.658018091497972e-07,0.025112560120756022,0.11265605966904671,0.012693985253473122,0.0883998155634651,0.07450693937180423,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
111,0.5,10,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Does a previous benign prostate biopsy predict the results for patients undergoing radical perineal prostatectomy? Answer: Limited evidence suggests that prior benign prostate biopsy is not a strong predictor of treatment outcomes.,2.131737546211678e-07,0.13160721594483604,0.07981859410430842,0.01632083818303688,0.19563934548414963,0.042284717149582034,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.5,1,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: should second-look laparotomy still be recommended? Answer: Second-look laparotomy does not improve overall or disease-free survival. Tumor grade remains the sole independent prognostic factor for patient survival.,1.658018091497972e-07,0.22798490565049567,0.029384756657483937,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.5,2,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy continue to be performed for advanced epithelial ovarian carcinoma in Thai women? Answer: The procedure does not positively affect overall or disease-free survival rates. Tumor grade is the only independent predictor of survival.,1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.5,3,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In Thai women with advanced epithelial ovarian carcinoma, is second-look laparotomy still advisable? Answer: Second-look laparotomy shows no beneficial effect on overall or disease-free survival. Tumor grade is the only independent prognostic indicator for survival.",1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,0.5,4,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy be maintained? Answer: This surgery does not improve overall survival or disease-free survival. Tumor grade is the sole independent prognostic factor for patient outcomes.",1.421158364141119e-07,0.15822400521489444,0.0,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,0.5,5,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: is continuing second-look laparotomy justified? Answer: Second-look laparotomy has no favorable impact on overall or disease-free survival. Tumor grade is the only independent variable predicting survival.,1.894877818854825e-07,0.25907342527176347,0.0302734375,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.5,6,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy be offered for advanced epithelial ovarian carcinoma in Thai women? Answer: The procedure does not enhance overall or disease-free survival. Tumor grade stands as the only independent prognostic factor for survival.,1.658018091497972e-07,0.18721154208814594,0.0,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.5,7,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Is it appropriate to continue second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women? Answer: Second-look laparotomy fails to improve overall and disease-free survival. Tumor grade is the only independent prognostic factor for patient survival.,1.1842986367842661e-07,0.16856130494597243,0.02775510204081633,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.5,8,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still beneficial? Answer: Second-look laparotomy does not positively influence overall or disease-free survival. Tumor grade is the only independent factor predicting survival.,2.131737546211678e-07,0.291157862689579,0.031217481789802305,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.5,9,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy be continued? Answer: This procedure does not improve overall or disease-free survival. Tumor grade remains the only independent prognostic variable for survival.",1.894877818854825e-07,0.21706450523782772,0.0,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.5,10,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should we persist with second-look laparotomy in advanced epithelial ovarian carcinoma cases among Thai women? Answer: Second-look laparotomy has no advantageous effect on overall or disease-free survival. Tumor grade is the only independent prognostic factor for patient survival.,7.1057918207056e-08,0.11246733753370775,0.026296566837107373,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
113,0.5,1,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is bedside assessment sufficient to rule out aspiration after an acute stroke? Answer: Bedside assessment by itself might not reliably exclude aspiration after an acute stroke. Additional evaluations like swallowing tests or imaging may be needed for accurate diagnosis in stroke patients.,4.737194547137081e-08,0.09004892491704597,0.028266154107072214,0.0036268529295637453,0.08902433317653591,0.027736686390532554,0.003621603081905733,0.08959879647112645,0.02748557235736722,4.737194547137081e-08,0.09011114865082126,0.027006172839506164
113,0.5,2,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Can aspiration be reliably excluded using only bedside assessment after an acute stroke? Answer: Bedside assessment alone may not be enough to reliably rule out aspiration following an acute stroke. Further tests, such as swallow assessments or imaging studies, might be required to confirm aspiration in stroke patients.",1.8948778188548325e-07,0.29784608688727854,0.08086107789051347,0.014507411718254981,0.2932239833588657,0.0763888888888889,0.014486412327622933,0.2640180978742812,0.05246913580246914,1.8948778188548325e-07,0.23321199229149636,0.027006172839506164
113,0.5,3,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Does bedside assessment reliably rule out aspiration post-acute stroke? Answer: Bedside assessment on its own may not reliably exclude aspiration after an acute stroke. Additional diagnostic procedures, including swallow evaluations or imaging, may be necessary for accurate detection.",4.73719454713706e-08,0.08551207019664941,0.09615241275472936,0.0036268529295637453,0.053994294293033374,0.0763888888888889,0.003621603081905733,0.01889563984129694,0.05246913580246914,4.737194547137081e-08,0.01810243598940975,0.027006172839506164
113,0.5,4,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is bedside assessment a reliable method to exclude aspiration after an acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following an acute stroke. Other assessments such as swallowing tests or imaging studies could be required for precise diagnosis.,2.3685972735685406e-08,0.09654323496548756,0.049734298151393505,0.0018134264647818726,0.13195583576274394,0.0763888888888889,0.0018108015409528666,0.0989383475148311,0.05246913580246914,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
113,0.5,5,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Can aspiration be ruled out reliably by bedside assessment after an acute stroke? Answer: Bedside assessment alone may not be sufficient to reliably exclude aspiration after an acute stroke. Supplementary tests like swallow evaluations or imaging may be needed for accurate diagnosis.,4.737194547137081e-08,0.12305593351513844,0.05144306243207343,0.0036268529295637453,0.12283639076482578,0.052013888888888894,0.003621603081905733,0.12425615549912283,0.05246913580246914,4.737194547137081e-08,0.09011114865082126,0.027006172839506164
113,0.5,6,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is bedside assessment adequate to exclude aspiration following an acute stroke? Answer: Bedside assessment alone may not adequately exclude aspiration following an acute stroke. Additional diagnostic tools such as swallowing evaluations or imaging studies might be necessary.,7.10579182070559e-08,0.09201182215673853,0.009386957908163268,0.005440279394345618,0.08892920998840648,0.006255739210284647,0.0054324046228586,0.08849205776082192,0.004463830221405965,7.105791820705622e-08,0.08786333642501098,0.0023785838179777724
113,0.5,7,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Can bedside assessment alone reliably exclude aspiration after acute stroke? Answer: Bedside assessment alone may not be reliable enough to exclude aspiration after an acute stroke, and further tests like swallow studies or imaging may be required.",7.10579182070559e-08,0.054544406991336114,0.0159292367084575,0.005440279394345618,0.050421033290631634,0.02102556708958092,0.0054324046228586,0.009275237125399904,0.05246913580246914,7.105791820705622e-08,0.047089972862661256,0.027006172839506164
113,0.5,8,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Does bedside assessment alone suffice to rule out aspiration post-acute stroke? Answer: Bedside assessment alone may not suffice to reliably exclude aspiration after an acute stroke; additional tests such as swallow evaluations or imaging studies may be needed.,4.73719454713706e-08,0.012549209085075397,0.044081632653061226,0.0036268529295637453,0.016526879127630956,0.04938271604938273,0.003621603081905733,0.01889563984129694,0.05246913580246914,4.737194547137081e-08,0.01810243598940975,0.027006172839506164
113,0.5,9,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is it possible to exclude aspiration using only bedside assessment after an acute stroke? Answer: Using bedside assessment alone may not reliably exclude aspiration after an acute stroke; additional swallow assessments or imaging might be necessary.,9.47438909427412e-08,0.0861064273089398,0.013073979591836732,0.0072537058591274906,0.04118396717949002,0.047842176086120736,0.007243206163811473,0.03826277399865141,0.05246913580246914,9.474389094274162e-08,0.07694293601234303,0.027006172839506164
113,0.5,10,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Can aspiration be confidently excluded with bedside assessment alone following acute stroke? Answer: Bedside assessment alone may not confidently exclude aspiration following acute stroke, and further diagnostic tests like swallowing evaluations or imaging studies may be required.",7.10579182070559e-08,0.017076991825933696,0.041999152602217385,0.005440279394345618,0.011912856592856791,0.04863378684807257,0.0054324046228586,0.009275237125399904,0.05246913580246914,7.105791820705622e-08,0.047089972862661256,0.027006172839506164
114,0.5,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the Catholic bishops' boycott call influence polio vaccination rates in Kenya in 2015? Yes, it did affect the coverage.",5.210914001850768e-07,0.3295763388900981,0.24872448979591835,0.039895382225201316,0.4172767469098022,0.23543400713436385,0.03983763390096319,0.5104342187380695,0.20999999999999996,5.210914001850787e-07,0.6096274235960992,0.1748178980228928
114,0.5,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Was the polio vaccination coverage in Kenya in 2015 impacted by the Catholic bishops' boycott call? Yes, it was.",5.447773729207622e-07,0.3836435601603734,0.24872448979591835,0.041708808689983196,0.474435160749751,0.23543400713436385,0.04164843544191606,0.5710588405545045,0.20999999999999996,5.44777372920764e-07,0.6741659447336699,0.1748178980228928
114,0.5,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the boycott urged by Catholic bishops change polio vaccine coverage in Kenya during 2015? Yes, it caused an effect.",5.210914001850768e-07,0.3295763388900981,0.24872448979591835,0.039895382225201316,0.4172767469098022,0.23543400713436385,0.03983763390096319,0.5104342187380695,0.20999999999999996,5.210914001850787e-07,0.6096274235960992,0.1748178980228928
114,0.5,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","In 2015, did the Catholic bishops' call for a boycott affect polio vaccination coverage in Kenya? Yes, it had an impact.",4.974054274493914e-07,0.2782830445025479,0.24872448979591835,0.038081955760419436,0.3632095256395269,0.23543400713436385,0.03802683236001032,0.4532758048981207,0.20999999999999996,4.974054274493933e-07,0.5490028017796642,0.1748178980228928
114,0.5,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the Catholic bishops' boycott call alter the polio vaccination coverage in Kenya in 2015? Yes, it influenced the rates.",5.210914001850768e-07,0.3295763388900981,0.24872448979591835,0.039895382225201316,0.4172767469098022,0.23543400713436385,0.03983763390096319,0.5104342187380695,0.20999999999999996,5.210914001850787e-07,0.6096274235960992,0.1748178980228928
114,0.5,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Was there an effect on polio vaccination coverage in Kenya in 2015 due to the Catholic bishops' boycott call? Yes, there was.",4.737194547137061e-07,0.22949288033311666,0.24872448979591835,0.03626852929563756,0.31191623125197676,0.23543400713436385,0.03621603081905744,0.3992085836278454,0.20999999999999996,4.7371945471370796e-07,0.4918443879397154,0.1748178980228928
114,0.5,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the 2015 boycott call by Catholic bishops impact polio vaccination coverage in Kenya? Yes, it did.",5.921493183921328e-07,0.5014265958167572,0.24872448979591835,0.04533566161954694,0.5995983037037567,0.23543400713436385,0.045270038523821804,0.7045902331790272,0.20999999999999996,5.921493183921347e-07,0.8172667883743432,0.1748178980228928
114,0.5,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the call for a boycott by Catholic bishops affect Kenya's polio vaccination coverage in 2015? Yes, it did have an effect.",4.737194547137061e-07,0.22949288033311666,0.24872448979591835,0.03626852929563756,0.31191623125197676,0.23543400713436385,0.03621603081905744,0.3992085836278454,0.20999999999999996,4.7371945471370796e-07,0.4918443879397154,0.1748178980228928
114,0.5,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","In 2015, did the Catholic bishops' boycott call influence polio vaccine coverage in Kenya? Yes, it impacted the coverage.",5.447773729207622e-07,0.3836435601603734,0.24872448979591835,0.041708808689983196,0.474435160749751,0.23543400713436385,0.04164843544191606,0.5710588405545045,0.20999999999999996,5.44777372920764e-07,0.6741659447336699,0.1748178980228928
114,0.5,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the Catholic bishops' call for boycott impact polio vaccination coverage in Kenya in 2015? Yes, it did affect it.",5.210914001850768e-07,0.3295763388900981,0.24872448979591835,0.039895382225201316,0.4172767469098022,0.23543400713436385,0.03983763390096319,0.5104342187380695,0.20999999999999996,5.210914001850787e-07,0.6096274235960992,0.1748178980228928
115,0.5,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy achievable? Answer: Performing transgastric endoscopic splenectomy in a pig model seems technically possible. Further long-term survival studies are scheduled.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
115,0.5,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be done? Answer: Transgastric endoscopic splenectomy in a porcine model is technically feasible. Additional experiments focusing on long-term survival are planned.,4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.5,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is it possible to perform transgastric endoscopic splenectomy? Answer: The procedure appears technically feasible in a porcine model. Plans are underway for further long-term survival experiments.,7.10579182070559e-08,0.18287598996711107,0.04338842975206613,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
115,0.5,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Transgastric endoscopic splenectomy: is it achievable? Answer: It seems technically feasible to perform this procedure in a pig model. More long-term survival trials are planned.,4.73719454713706e-08,0.14365527681382861,0.04338842975206613,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.5,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can transgastric endoscopic splenectomy be performed? Answer: In a porcine model, the procedure appears technically feasible. Additional long-term survival studies are being planned.",0.0,0.06027366787477817,0.04338842975206613,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
115,0.5,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy feasible? Answer: Technically, it can be done in a pig model. Further experiments on long-term survival are planned.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.5,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it possible to do transgastric endoscopic splenectomy? Answer: The technique is feasible in a porcine model, and more long-term survival experiments are planned.",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
115,0.5,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Transgastric endoscopic splenectomy: is it doable? Answer: It appears technically feasible in a pig model. Additional long-term survival experiments will be conducted.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.5,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy practically possible? Answer: The procedure is technically feasible in a porcine model, with further long-term survival studies planned.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.5,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can transgastric endoscopic splenectomy be technically achieved? Answer: It seems feasible in a pig model, and more long-term survival experiments are planned.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
116,0.5,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux used for perioperative bridging? Answer: Fondaparinux's role in perioperative bridging has not been defined, and it has significant limitations preventing routine use.",2.842316728282236e-07,0.32844875471261537,0.055363321799307974,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.5,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux have a role in perioperative bridging? Answer: The use of fondaparinux for perioperative bridging is not established, with notable restrictions on its routine application.",2.36859727356853e-07,0.2484060470390781,0.055363321799307974,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.5,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Can fondaparinux be used for perioperative bridging? Answer: Fondaparinux is not a well-established option for perioperative bridging and has important limitations for regular use.,2.842316728282236e-07,0.38621101975927585,0.013775420097984714,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.5,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux recommended for perioperative bridging? Answer: Fondaparinux's function in perioperative bridging remains unclear, and it is limited in its routine use.",3.316036182995942e-07,0.41546013170224505,0.055363321799307974,0.025387970506946314,0.4712172134482806,0.02854671280276816,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
116,0.5,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: What is the role of fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging therapy is not confirmed and it has key limitations for standard bridging.,1.658018091497971e-07,0.3782230242326885,0.1095672337562476,0.012693985253473157,0.3815771925850546,0.11034217608612071,0.012675610786670115,0.38455636540293225,0.109375,1.6580180914979784e-07,0.3450490512234512,0.07638888888888888
116,0.5,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Is fondaparinux suitable for perioperative bridging? Answer: Fondaparinux has not been established as a perioperative bridging agent and has significant drawbacks for routine use.,2.842316728282236e-07,0.32844875471261537,0.055363321799307974,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.5,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux serve a role in perioperative bridging? Answer: Its role in perioperative bridge therapy is unestablished, with important limitations to its routine use.",2.842316728282236e-07,0.4439732848059381,0.027281306299865568,0.021761117577382555,0.4405191031173308,0.014841716949297971,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.5,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Is there an established role for fondaparinux in perioperative bridging? Answer: Fondaparinux is not established for perioperative bridging and has important restrictions for regular application.,2.605457000925383e-07,0.28762676019236055,0.055363321799307974,0.019947691112600675,0.337685820823757,0.02854671280276816,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
116,0.5,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Should fondaparinux be used in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging is not defined, and it carries limitations that affect its routine use.",2.131737546211677e-07,0.2620099546532644,0.018381073278597927,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
116,0.5,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux effective for perioperative bridging? Answer: Its effectiveness and role in perioperative bridging have not been established, with significant limitations for routine use.",2.842316728282236e-07,0.32844875471261537,0.055363321799307974,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
117,0.5,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do individuals with episodic migraines focus specifically on headache-related visual cues?,9.000669639560428e-07,1.4819725203438527,0.06222222222222221,0.06891020566171131,1.6529230243738384,0.0,0.06881045855620911,1.7491998548092589,0.0,9.000669639560447e-07,1.8607523407150057,0.0
117,0.5,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Are people who suffer from episodic migraines more attentive to visual stimuli associated with headaches?,8.053230730133015e-07,1.1455002837226398,0.06222222222222221,0.06165649980258381,1.2851982442485208,0.0,0.06156725239239762,1.3437347467010938,0.0,8.053230730133033e-07,1.408767216971949,0.0
117,0.5,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do episodic migraine sufferers tend to selectively notice headache-related visual information?,9.000669639560428e-07,1.4819725203438527,0.06222222222222221,0.06891020566171131,1.6529230243738384,0.0,0.06881045855620911,1.7491998548092589,0.0,9.000669639560447e-07,1.8607523407150057,0.0
117,0.5,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Is there a selective attention towards headache-related visuals among those with episodic migraines?,8.526950184846721e-07,1.2996509635498974,0.06222222222222221,0.06528335273214755,1.4522523289116873,0.0,0.06518885547430336,1.5260563034950492,0.0,8.52695018484674e-07,1.6094379124341,0.0
117,0.5,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do episodic migraine patients prioritize processing of headache-related visual stimuli?,9.237529366917282e-07,1.5873330360016786,0.06222222222222221,0.07072363212649319,1.7707060600302222,0.0,0.07062126009716199,1.8827312474337807,0.0,9.2375293669173e-07,2.0149030205422647,0.0
117,0.5,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Are visual stimuli linked to headaches more likely to capture the attention of episodic migraineurs?,8.053230730133015e-07,1.1455002837226398,0.06222222222222221,0.06165649980258381,1.2851982442485208,0.0,0.06156725239239762,1.3437347467010938,0.0,8.053230730133033e-07,1.408767216971949,0.0
117,0.5,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do those with episodic migraines show a bias in attending to headache-related visual cues?,8.290090457489868e-07,1.219608255876361,0.06222222222222221,0.06346992626736568,1.3652409519220572,0.0,0.0633780539333505,1.430746123690724,0.0,8.290090457489886e-07,1.5040773967762742,0.0
117,0.5,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Is selective attention to headache-related visuals a characteristic of episodic migraine sufferers?,8.763809912203575e-07,1.3866623405395275,0.06222222222222221,0.06709677919692944,1.5475625087160125,0.0,0.06699965701525624,1.631416819152875,0.0,8.763809912203594e-07,1.7272209480904839,0.0
117,0.5,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do episodic migraineurs have an attentional preference for headache-related visual stimuli?,9.000669639560428e-07,1.4819725203438527,0.06222222222222221,0.06891020566171131,1.6529230243738384,0.0,0.06881045855620911,1.7491998548092589,0.0,9.000669639560447e-07,1.8607523407150057,0.0
117,0.5,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Are headache-related visual stimuli more salient to individuals experiencing episodic migraines?,9.000669639560428e-07,1.4819725203438527,0.06222222222222221,0.06891020566171131,1.6529230243738384,0.0,0.06881045855620911,1.7491998548092589,0.0,9.000669639560447e-07,1.8607523407150057,0.0
118,0.5,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is a surgeon's past experience a factor in their ability to perform transurethral resection of the prostate? Yes, previous experience impacts the surgeon's capability to carry out transurethral resection of the prostate. Experience helps the surgeon acquire the necessary skills, knowledge, and expertise essential for the procedure's success and reducing complications.",1.1842986367842703e-07,0.1239763827728213,0.14143428684610687,0.009067132323909363,0.10297398622050125,0.13487741732731234,0.009054007704764333,0.08127994386940429,0.12534893728797458,1.1842986367842703e-07,0.058860924796309444,0.113421550094518
118,0.5,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does a surgeon's prior experience affect their proficiency in performing transurethral resection of the prostate? Indeed, the surgeon's prior experience influences their ability to perform the procedure effectively. Experience enables the surgeon to gain the skills, knowledge, and expertise needed for successful outcomes and fewer complications.",2.3685972735685406e-07,0.04018044606574911,0.15684153596538664,0.018134264647818726,0.020420075313699382,0.15290485363989467,0.018108015409528666,0.0001601811784062157,0.14617283950617285,2.3685972735685406e-07,0.053617058630380576,0.113421550094518
118,0.5,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the surgeon's experience a determinant in their ability to perform transurethral resection of the prostate? Yes, the surgeon's previous experience plays a significant role in their ability to perform the procedure. Through experience, the surgeon develops critical skills, knowledge, and expertise necessary for success and minimizing risks.",1.8948778188548325e-07,0.0021994828014655354,0.09631454889509429,0.014507411718254981,0.00596802609781788,0.11071988879403202,0.014486412327622933,0.01599052746127594,0.10182454312975317,1.8948778188548325e-07,0.038603733020939224,0.09070656902366889
118,0.5,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does previous surgical experience impact the ability to perform transurethral resection of the prostate? Yes, a surgeon's previous experience affects their ability to execute the transurethral resection of the prostate. Experience equips the surgeon with the skills, knowledge, and expertise vital for a successful procedure and complication reduction.",1.8948778188548325e-07,0.027296141903212945,0.11681990265008106,0.014507411718254981,0.036104860035206965,0.13223140495867763,0.014486412327622933,0.014816013896943758,0.12396209570451996,1.8948778188548325e-07,0.007097042995486635,0.113421550094518
118,0.5,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the capability to perform transurethral resection of the prostate influenced by the surgeon's experience? Yes, the surgeon's experience significantly influences their ability to perform the procedure. Experience allows the development of essential skills, knowledge, and expertise to ensure success and limit complications.",3.079176455639103e-07,0.033213359900947204,0.1536898323418063,0.023574544042164344,0.018690801874801988,0.17561983471074377,0.023540420032387266,0.07216048040121992,0.14617283950617285,3.079176455639103e-07,0.12772503078410402,0.113421550094518
118,0.5,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does the surgeon's prior experience influence their skill in performing transurethral resection of the prostate? Yes, prior experience impacts the surgeon's skill in carrying out the transurethral resection of the prostate. This experience builds the necessary skills, knowledge, and expertise for effective and safe performance.",2.6054570009253947e-07,0.10971946722258119,0.0682258434221387,0.0199476911126006,0.03554156037949596,0.12921888289634756,0.019918816950481533,0.05637732482987978,0.1223774796013543,2.6054570009253947e-07,0.0777146102094406,0.113421550094518
118,0.5,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the ability to conduct transurethral resection of the prostate dependent on the surgeon's previous experience? Yes, the surgeon's previous experience is crucial for their ability to perform the procedure. Experience helps in acquiring the skills, knowledge, and expertise needed to perform successfully and reduce complications.",2.3685972735685406e-07,0.021432636650690284,0.11314700069397765,0.018134264647818726,0.020420075313699382,0.15290485363989467,0.018108015409528666,0.0001601811784062157,0.14617283950617285,2.3685972735685406e-07,0.053617058630380576,0.113421550094518
118,0.5,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does the surgeon's experience affect their ability to perform transurethral resection of the prostate? Yes, experience influences the surgeon's ability to perform the procedure well. It allows them to develop the skills, knowledge, and expertise necessary for success and minimizing complications.",3.552895910352811e-07,0.11996158395818579,0.12668289297000207,0.02720139697172809,0.10424723170894934,0.14999656601268282,0.027162023114293,0.12345377478876962,0.14617283950617285,3.552895910352811e-07,0.18036876426952286,0.113421550094518
118,0.5,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is previous experience a key factor in a surgeon's ability to perform transurethral resection of the prostate? Yes, previous experience is a key factor affecting the surgeon's ability to perform the procedure. Experience contributes to gaining the skills, knowledge, and expertise essential for a successful operation and fewer complications.",1.6580180914979784e-07,0.006954745220226322,0.07874085274996957,0.012693985253473108,0.02939785901691261,0.11208677685950412,0.012675610786670066,0.03746462803654982,0.12444444444444445,1.6580180914979784e-07,0.01537581285657108,0.113421550094518
118,0.5,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the skill to perform transurethral resection of the prostate shaped by the surgeon's prior experience? Yes, the surgeon's prior experience shapes their skill in performing the procedure. Experience helps develop the skills, knowledge, and expertise critical for success and complication prevention.",3.316036182995957e-07,0.05892100946040291,0.15253762984344998,0.025387970506946217,0.07804077349317007,0.15063627126564186,0.025351221573340132,0.09747828838551165,0.14617283950617285,3.316036182995957e-07,0.153700517187362,0.113421550094518
119,0.5,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The link between marital status, living arrangement, and mortality might differ based on gender. Additional studies are necessary to identify the exact differences and influencing factors.",9.474389094274152e-08,0.0720122768419631,0.018242786705624542,0.0072537058591274906,0.10355788051467618,0.002501206932288818,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
119,0.5,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Gender may influence how marital status and living arrangements relate to mortality. More research is required to clarify these distinctions and their underlying causes.",1.4211583641411212e-07,0.05356399180841365,0.06937499999999999,0.010880558788691236,0.12114367122916603,0.023795359904818555,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
119,0.5,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The relationship between marital status, living arrangements, and mortality could change according to gender. Further investigation is needed to understand the specific variations and contributing factors.",9.474389094274152e-08,0.0720122768419631,0.018242786705624542,0.0072537058591274906,0.10355788051467618,0.002501206932288818,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
119,0.5,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Associations between marital status, living arrangement, and mortality may differ across genders. Further research is essential to pinpoint these differences and the factors involved.",1.4211583641411212e-07,0.12849882213921937,0.015497448979591814,0.010880558788691236,0.15965184792694087,0.003959742135997774,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
119,0.5,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The connection between marital status, living arrangement, and mortality may vary with gender. More detailed research is needed to explore the particular differences and factors that play a role.",2.3685972735685406e-08,0.007173696634544591,0.021874999999999978,0.0018134264647818726,0.024902600569258304,0.0005796400951814454,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
119,0.5,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Gender may affect the association between marital status, living arrangement, and mortality. Additional research is necessary to determine the precise differences and contributing elements.",1.4211583641411212e-07,0.16596623730462223,0.011074826989619355,0.010880558788691236,0.15965184792694087,0.003959742135997774,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
119,0.5,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association of marital status and living arrangement with mortality might differ by gender. Further studies are required to identify the specific differences and underlying factors.",9.474389094274152e-08,0.0720122768419631,0.018242786705624542,0.0072537058591274906,0.06707644995888984,0.023795359904818555,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
119,0.5,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: How marital status and living arrangement relate to mortality could vary depending on gender. More research is needed to understand the exact differences and influencing factors.",9.474389094274152e-08,0.03646626758247873,0.04375173130193904,0.0072537058591274906,0.06707644995888984,0.023795359904818555,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
119,0.5,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The relationship between marital status, living arrangement, and mortality may be gender-dependent. Additional investigation is needed to clarify these differences and contributing factors.",1.6580180914979742e-07,0.15797931939207865,0.014011678200692018,0.012693985253473108,0.1889229585135741,0.004751352897949604,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
119,0.5,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The link between marital status, living arrangement, and mortality appears to vary by gender. Further research is required to explore the specific differences and factors involved.",9.474389094274152e-08,0.10755828610144702,0.007013888888888903,0.0072537058591274906,0.10355788051467618,0.002501206932288818,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
120,0.5,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does the timing of living in an urban environment affect the risk of non-communicable diseases in Thailand? Answer: Urban living was linked to higher behavioral and physiological risk factors, but these links may not directly cause higher biological risk factors. The biological risks probably stem from a complex interplay of long-term exposure and early life experiences.",1.6580180914979784e-07,0.05176901846019977,0.0475,0.012693985253473108,0.1198011998126205,0.0,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
120,0.5,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: How does living in an urban area influence non-communicable disease risk in Thailand, and does timing play a role? Answer: Urbanicity correlated with increased behavioral and physiological risk factors, yet this may not directly increase biological risk factors, which likely result from a complex interaction of prolonged exposure and early life conditions.",2.6054570009253947e-07,0.15253649755853482,0.02827662437524029,0.0199476911126006,0.1953087523207664,0.0,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
120,0.5,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Is the timing of urban living important for non-communicable disease risk in Thailand? Answer: Urban living was associated with rises in behavioral and physiological risks, but these do not necessarily lead to higher biological risks, which probably arise from a complex mix of long-term exposure and early life factors.",3.316036182995957e-07,0.2135921327402306,0.027100694444444445,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
120,0.5,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does the timing of residing in urban areas impact non-communicable disease risk in Thailand? Answer: Urbanicity was linked to increased behavioral and physiological risk factors; however, these may not directly increase biological risk factors, which are likely due to complex interactions between long-term exposure and early life.",3.789755637709665e-07,0.22697310748529143,0.0475,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
120,0.5,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: What role does timing play in the relationship between urban living and non-communicable disease risk in Thailand? Answer: Urban living increased behavioral and physiological risk factors, but these associations may not directly cause biological risk factors, which are probably the result of complex interactions involving both long-term exposure and early life.",2.8423167282822487e-07,0.19965956122082362,0.008349645980841307,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
120,0.5,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does timing affect the link between urban living and non-communicable disease risk in Thailand? Answer: Urbanicity was connected to higher behavioral and physiological risk factors, but this may not translate directly to biological risk factors, which likely arise from complex interactions of long-term exposure and early life.",3.789755637709665e-07,0.2564687321899699,0.026233459357277895,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
120,0.5,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: How does timing influence the association between urban living and non-communicable disease risk in Thailand? Answer: Urban living was associated with increases in behavioral and physiological risks, yet these may not directly lead to biological risk factors that likely result from complex interactions between long-term exposure and early life.",3.316036182995957e-07,0.2135921327402306,0.027100694444444445,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
120,0.5,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Is there an impact of timing on the risk of non-communicable diseases from urban living in Thailand? Answer: Urbanicity increased behavioral and physiological risk factors, though these may not directly cause biological risk factors, which likely emerge from complex interactions involving long-term exposure and early life.",4.026615365066519e-07,0.2786161466436434,0.025771604938271603,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
120,0.5,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does the timing of urban residence matter for non-communicable disease risk in Thailand? Answer: Urban living was linked to rises in behavioral and physiological risk factors, but these may not directly increase biological risk factors, which probably result from complex interactions between long-term exposure and early life.",3.789755637709665e-07,0.2564687321899699,0.026233459357277895,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
120,0.5,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: What is the effect of timing on the relationship between urban living and non-communicable disease risk in Thailand? Answer: Urbanicity was associated with increased behavioral and physiological risks; however, these may not directly cause biological risk factors, which likely stem from complex interactions of long-term exposure and early life.",3.316036182995957e-07,0.1853004110847225,0.0475,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
121,0.5,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does sex affect the response to intravenous thrombolysis in ischemic stroke? According to research, sex does not seem to impact the effectiveness of intravenous thrombolysis in ischemic stroke, with both men and women exhibiting comparable recanalization rates and functional outcomes after treatment.",1.1842986367842703e-07,0.005547664987933576,0.07455685044647327,0.009067132323909363,0.0022585055630583994,0.08031601894802412,0.009054007704764333,0.0013594530791576354,0.0861453046089739,1.1842986367842703e-07,0.005343659020720537,0.09204470742932283
121,0.5,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? A study indicates that sex does not influence the response, as males and females have similar recanalization rates and functional outcomes following this therapy.",2.6054570009253894e-07,0.062335497437957965,0.1472715318869165,0.019947691112600606,0.09546271700483855,0.13017751479289946,0.019918816950481547,0.13014862232452273,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
121,0.5,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does gender play a role in the response to intravenous thrombolysis for ischemic stroke? Evidence suggests that sex does not affect the treatment response, with both sexes showing equivalent recanalization and functional recovery.",3.3160361829959484e-07,0.15194765612764494,0.1472715318869165,0.025387970506946245,0.18783603713585384,0.13017751479289946,0.025351221573340167,0.22545880212884795,0.11176857330703485,3.316036182995957e-07,0.26494667071919276,0.09204470742932283
121,0.5,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is there a difference in intravenous thrombolysis response in ischemic stroke patients based on sex? Research shows no significant difference, with men and women achieving similar rates of recanalization and functional outcomes.",3.5528959103528014e-07,0.18369635444222476,0.1472715318869165,0.027201396971728124,0.22062585995884554,0.13017751479289946,0.02716202311429304,0.2593603538045297,0.11176857330703485,3.552895910352811e-07,0.30003799053046176,0.09204470742932283
121,0.5,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does the patient's sex impact the effectiveness of intravenous thrombolysis in ischemic stroke? Studies reveal that sex does not alter the treatment response, as both males and females have alike outcomes and recanalization rates.",3.0791764556390954e-07,0.12117599746089125,0.1472715318869165,0.023574544042164365,0.156087338821274,0.13017751479289946,0.023540420032387294,0.19266897930585625,0.11176857330703485,3.079176455639103e-07,0.231045119043511,0.09204470742932283
121,0.5,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does sex influence outcomes after intravenous thrombolysis in ischemic stroke? Findings suggest that sex does not affect the response, with comparable recanalization and functional results in both genders.",4.5003348197802134e-07,0.3218466929230419,0.1472715318869165,0.03445510283085564,0.363726703599518,0.13017751479289946,0.034405229278104535,0.40778035892280284,0.11176857330703485,4.500334819780227e-07,0.4541886703577207,0.09204470742932283
121,0.5,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is the effectiveness of intravenous thrombolysis in ischemic stroke affected by sex? According to a study, sex does not seem to change the response, with similar outcomes and recanalization rates observed in men and women.",2.8423167282822424e-07,0.09132303431120947,0.1472715318869165,0.021761117577382486,0.12531568015452033,0.13017751479289946,0.02172961849143442,0.16092028099127642,0.11176857330703485,2.8423167282822487e-07,0.1982552962205193,0.09204470742932283
121,0.5,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does intravenous thrombolysis response in ischemic stroke vary by sex? Research indicates no variation, showing men and women respond similarly in terms of recanalization and functional outcome.",4.7371945471370664e-07,0.3595870209058889,0.1472715318869165,0.03626852929563752,0.40294741675280044,0.13017751479289946,0.03621603081905741,0.44860235344305766,0.11176857330703485,4.737194547137081e-07,0.49674828477651634,0.09204470742932283
121,0.5,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is the response to intravenous thrombolysis in ischemic stroke dependent on sex? Data suggests sex does not influence treatment response, with equal recanalization and functional outcomes for both sexes.",4.2634750924233604e-07,0.28547904875216723,0.1472715318869165,0.03264167636607376,0.325986375616671,0.13017751479289946,0.03259442773715166,0.3685596457695204,0.11176857330703485,4.263475092423373e-07,0.4133666758374659,0.09204470742932283
121,0.5,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does sex alter the response to intravenous thrombolysis in ischemic stroke patients? A study found no influence of sex on treatment response, with both males and females demonstrating similar recanalization and functional results.",3.3160361829959484e-07,0.15194765612764494,0.1472715318869165,0.025387970506946245,0.18783603713585384,0.13017751479289946,0.025351221573340167,0.22545880212884795,0.11176857330703485,3.316036182995957e-07,0.26494667071919276,0.09204470742932283
122,0.5,1,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Is withdrawal-related anxiety in alcoholism linked to a deficiency in beta-endorphins? Withdrawal anxiety in alcoholism might be connected to a lack of beta-endorphins, natural peptides involved in mood regulation.",1.184298636784265e-07,0.1868078298808853,0.015599999999999989,0.009067132323909398,0.13459987482243596,0.02523997370151218,0.009054007704764368,0.13117149352431312,0.0322222222222222,1.1842986367842703e-07,0.1823215567939549,0.0
122,0.5,2,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Could beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Anxiety during alcohol withdrawal may be due to insufficient beta-endorphins, which help regulate mood.",2.842316728282236e-07,0.3259583636412504,0.09000000000000004,0.021761117577382555,0.38336023167574185,0.06222222222222223,0.021729618491434483,0.44482905237935544,0.0322222222222222,2.842316728282247e-07,0.5108256237659901,0.0
122,0.5,3,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Is the anxiety caused by alcohol withdrawal related to a shortage of beta-endorphins? Withdrawal anxiety in alcoholics could stem from a beta-endorphin deficiency, peptides that influence mood.",1.658018091497971e-07,0.11238426334318952,0.09000000000000004,0.012693985253473157,0.16021668036153214,0.06222222222222223,0.012675610786670115,0.2112142011978504,0.0322222222222222,1.6580180914979784e-07,0.26570316573300534,0.0
122,0.5,4,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Does withdrawal anxiety in alcoholism result from beta-endorphin deficiency? The anxiety experienced during alcohol withdrawal may be associated with lower beta-endorphin levels, natural mood-regulating peptides.",2.131737546211677e-07,0.1924269710167268,0.09000000000000004,0.016320838183036916,0.24359828930058258,0.06222222222222223,0.016297213868575862,0.2982255781874801,0.0322222222222222,2.1317375462116866e-07,0.35667494393873334,0.0
122,0.5,5,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Is there a link between beta-endorphin deficiency and withdrawal anxiety in alcoholism? Withdrawal-induced anxiety might be related to a deficit in beta-endorphins, which play a key role in mood control.",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
122,0.5,6,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Is withdrawal anxiety in alcoholism due to a lack of beta-endorphins? Anxiety during alcohol withdrawal could be connected to beta-endorphin deficiency, peptides important for mood regulation.",1.894877818854824e-07,0.15160497649647198,0.09000000000000004,0.014507411718255037,0.20103867488178695,0.06222222222222223,0.014486412327622988,0.253773815616646,0.0322222222222222,1.8948778188548325e-07,0.3101549283038394,0.0
122,0.5,7,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Might beta-endorphin deficiency cause withdrawal anxiety in alcoholic patients? Anxiety linked to alcohol withdrawal may be associated with lower beta-endorphin levels, natural mood modulators.",2.36859727356853e-07,0.23498658543552242,0.09000000000000004,0.018134264647818796,0.28805005187141663,0.06222222222222223,0.018108015409528735,0.344745593822374,0.0322222222222222,2.36859727356854e-07,0.4054651081081646,0.0
122,0.5,8,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Is the anxiety seen in alcohol withdrawal connected to beta-endorphin deficiency? Withdrawal-induced anxiety in alcoholism may arise from a deficiency in beta-endorphins, which regulate mood.",2.131737546211677e-07,0.1924269710167268,0.09000000000000004,0.016320838183036916,0.24359828930058258,0.06222222222222223,0.016297213868575862,0.2982255781874801,0.0322222222222222,2.1317375462116866e-07,0.35667494393873334,0.0
122,0.5,9,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Could a deficiency in beta-endorphins explain withdrawal anxiety in alcoholism? Anxiety during alcohol withdrawal might be caused by a lack of beta-endorphins, natural peptides involved in mood regulation.",1.421158364141118e-07,0.07464393536034253,0.09000000000000004,0.010880558788691277,0.12099596720824968,0.06222222222222223,0.010864809245717241,0.17039220667759558,0.0322222222222222,1.4211583641411244e-07,0.2231435513142097,0.0
122,0.5,10,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,"Is withdrawal anxiety in alcoholism associated with a beta-endorphin shortage? The anxiety experienced during withdrawal may be linked to beta-endorphin deficiency, peptides that help regulate mood.",1.894877818854824e-07,0.15160497649647198,0.09000000000000004,0.014507411718255037,0.20103867488178695,0.06222222222222223,0.014486412327622988,0.253773815616646,0.0322222222222222,1.8948778188548325e-07,0.3101549283038394,0.0
123,0.5,1,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It remains uncertain if patients at high risk of falls receive sufficient preparation for discharge home following rehabilitation. Additional assessment is required to verify compliance with existing guidelines.,7.105791820705622e-08,0.047802965939191644,0.009777843484885945,0.005440279394345618,0.04528443278868366,0.01307397959183676,0.0054324046228586,0.042495539049439035,0.016553153962992326,7.105791820705622e-08,0.07164642041470293,0.003012522062330082
123,0.5,2,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There is a lack of clarity on whether patients at high risk of falls are properly prepared for discharge home after rehabilitation. More evaluation is necessary to confirm adherence to the guidelines.,2.3685972735685406e-08,0.024729382782400222,0.0028543640339339926,0.0018134264647818726,0.024155752409674047,0.0023840796459200647,0.0018108015409528666,0.023511377923222998,0.0017253015925517007,2.3685972735685406e-08,0.022788623686384124,0.0009192939495969929
123,0.5,3,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is not clear if the preparation for discharge home after rehabilitation adequately addresses the needs of patients at high risk of falls. Further investigation is needed to assess guideline compliance.,0.0,0.028291721655508084,0.018160486482913574,0.0,0.028881132523331132,0.01969073189037654,0.0,0.02949562470467848,0.020836871840485605,0.0,0.030136833937389085,0.021660034690337726
123,0.5,4,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: The adequacy of discharge preparation for patients at high risk of falls after rehabilitation is uncertain. Additional review is needed to determine if current procedures follow the recommended guidelines.,4.737194547137081e-08,0.03718295332010246,0.05217409192509041,0.0036268529295637453,0.010179844971634378,0.036281179138322,0.003621603081905733,0.017922237195683532,0.01804339907948037,4.737194547137081e-08,0.04719147474695973,0.00196304417083637
123,0.5,5,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Uncertainty exists regarding whether patients at high risk of falls are sufficiently prepared for discharge home post-rehabilitation. Further evaluation is essential to ensure alignment with established guidelines.,9.474389094274162e-08,0.07446982460378226,0.006772367061553153,0.0072537058591274906,0.07125803197690228,0.010680406284801908,0.007243206163811466,0.06768319843870474,0.014994929691725264,9.474389094274162e-08,0.09671212752713298,0.004111570247933891
123,0.5,6,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear if current discharge preparations for patients at high risk of falls after rehabilitation meet the recommended standards. More thorough evaluation is required to confirm guideline adherence.,4.737194547137081e-08,0.007687328615423983,0.03212373587150498,0.0036268529295637453,0.010179844971634378,0.036281179138322,0.003621603081905733,0.017922237195683532,0.01804339907948037,4.737194547137081e-08,0.04719147474695973,0.00196304417083637
123,0.5,7,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation remains unclear. Additional analysis is needed to verify if current practices comply with guidelines.,4.737194547137081e-08,0.05130392079393298,0.006001249217283622,0.0036268529295637453,0.05009382290314335,0.005051020408163243,0.003621603081905733,0.04872877855390323,0.003672901956103397,4.737194547137081e-08,0.04719147474695973,0.00196304417083637
123,0.5,8,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: The extent to which patients at high risk of falls are prepared for discharge home following rehabilitation is uncertain. Further assessment is necessary to determine conformity with guidelines.,7.105791820705622e-08,0.047802965939191644,0.009777843484885945,0.005440279394345618,0.04528443278868366,0.01307397959183676,0.0054324046228586,0.042495539049439035,0.016553153962992326,7.105791820705622e-08,0.07164642041470293,0.003012522062330082
123,0.5,9,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is not definitively known whether patients at high risk of falls are well-prepared for discharge home after rehabilitation. More evaluation is needed to establish if current practices align with guidelines.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
123,0.5,10,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There is uncertainty about whether discharge preparations for patients at high risk of falls after rehabilitation are adequate. Additional investigation is required to ensure practices meet the established guidelines.,4.737194547137081e-08,0.007687328615423983,0.03212373587150498,0.0036268529295637453,0.010179844971634378,0.036281179138322,0.003621603081905733,0.017922237195683532,0.01804339907948037,4.737194547137081e-08,0.04719147474695973,0.00196304417083637
124,0.5,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective method for managing postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage appears to be a safe and effective approach both for preventing CSF fistula in patients with large dural tears or those who are debilitated or irradiated, and for treating existing CSF leaks.",1.8948778188548325e-07,0.1880977832986206,0.004159661226903637,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
124,0.5,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage effectively address postoperative cerebrospinal fluid fistula after spine surgery? Evidence suggests lumbar drainage is both safe and effective in preventing CSF fistulas in cases involving large dural tears and in patients who are debilitated or irradiated, as well as in treating CSF leaks.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.5,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a reliable treatment for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage seems to provide a safe and effective means of preventing CSF fistula in patients with significant dural tears or those who are debilitated or irradiated, and also aids in the treatment of CSF leaks.",2.1317375462116866e-07,0.20930648136917895,0.004584257889546365,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
124,0.5,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage effectively prevent and treat postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage appears to be both a safe and effective method for preventing CSF fistula in cases of large dural tears and in debilitated or irradiated patients, as well as for managing CSF leaks.",1.6580180914979784e-07,0.16642988191943964,0.0037170228023798192,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
124,0.5,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage beneficial for postoperative cerebrospinal fluid fistula following spine surgery? It seems that lumbar drainage is a safe and effective strategy for both preventing CSF fistulas in patients with large dural tears or compromised health status, and for treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.5,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"How effective is lumbar drainage for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage is considered safe and effective for preventing CSF fistula in patients with large dural tears or those debilitated or irradiated, and also for treating CSF leaks.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
124,0.5,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage provide effective prevention and treatment for postoperative cerebrospinal fluid fistula after spine surgery? It appears to be a safe and effective option for preventing CSF fistula in cases of large dural tears and in debilitated or irradiated patients, as well as for treating CSF leaks.",1.6580180914979784e-07,0.19592550662411812,0.02498356344510192,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
124,0.5,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a safe and effective intervention for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage has shown effectiveness in preventing CSF fistula in patients with large dural tears or those debilitated or irradiated, and in treating CSF leaks.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
124,0.5,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"What is the efficacy of lumbar drainage in managing postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage seems to be both effective and safe in preventing CSF fistula in cases of significant dural tears and in debilitated or irradiated patients, as well as in treating CSF leaks.",1.6580180914979784e-07,0.16642988191943964,0.0037170228023798192,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
124,0.5,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective and safe treatment for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage appears to effectively prevent CSF fistula in patients with large dural tears or compromised health, and is also useful in treating CSF leaks.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
125,0.5,1,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? Answer: Using a neuroendoscope at the same time does not significantly impact the incidence of ventriculoperitoneal shunt infections.,9.47438909427412e-08,0.05695788095782195,0.10022248520710056,0.007253705859127518,0.06924420109410567,0.12815845650603483,0.007243206163811494,0.0830771013004612,0.1508916323731139,9.474389094274162e-08,0.003992819662763214,0.09566326530612247
125,0.5,2,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Is the incidence of ventriculoperitoneal shunt infection affected by the concurrent use of a neuroendoscope? Answer: The concurrent use of a neuroendoscope does not significantly alter the incidence of ventriculoperitoneal shunt infections.,4.73719454713706e-08,0.0402379400352606,0.008177777777777756,0.003626852929563759,0.03677295437988892,0.014345562130177486,0.003621603081905747,0.03276927536190666,0.020714117580214464,4.737194547137081e-08,0.028140363344059782,0.02707615968197981
125,0.5,3,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Does simultaneous neuroendoscope use influence ventriculoperitoneal shunt infection rates? Answer: The simultaneous use of a neuroendoscope has no significant effect on the rate of ventriculoperitoneal shunt infections.,1.658018091497971e-07,0.08509237785228185,0.19341775147928994,0.012693985253473157,0.05565141679255525,0.1967455621301775,0.012675610786670115,0.03025158400654293,0.1508916323731139,1.6580180914979784e-07,0.12177585531914747,0.09566326530612247
125,0.5,4,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Does the use of a neuroendoscope at the same time change the incidence of ventriculoperitoneal shunt infection? Answer: Using a neuroendoscope simultaneously does not significantly influence the occurrence of ventriculoperitoneal shunt infections.,4.73719454713706e-08,0.17637055388972156,0.13765326991676574,0.003626852929563759,0.18682291031686837,0.16452333990795528,0.003621603081905747,0.15206997278741197,0.1508916323731139,4.737194547137081e-08,0.06746614431938047,0.09566326530612247
125,0.5,5,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Is the incidence of ventriculoperitoneal shunt infection impacted by the simultaneous use of a neuroendoscope? Answer: There is no significant impact on ventriculoperitoneal shunt infection incidence from the simultaneous use of a neuroendoscope.,2.36859727356853e-08,0.08505378870784908,0.0575604938271605,0.0018134264647818796,0.09000398643081198,0.07429658253834076,0.0018108015409528735,0.09542144973170119,0.08668235770010559,2.3685972735685406e-08,0.05515788395773269,0.062369567327525556
125,0.5,6,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Does the simultaneous application of a neuroendoscope affect the frequency of ventriculoperitoneal shunt infections? Answer: The simultaneous application of a neuroendoscope does not significantly affect the frequency of ventriculoperitoneal shunt infections.,7.10579182070559e-08,0.172604777463381,0.019033106575963687,0.005440279394345639,0.17092623586541,0.03465939654750838,0.005432404622858621,0.1686511018785919,0.04192500278756653,7.105791820705622e-08,0.16566722708044512,0.043225623582766395
125,0.5,7,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Does using a neuroendoscope during the procedure influence ventriculoperitoneal shunt infection rates? Answer: Using a neuroendoscope during the procedure does not significantly influence the rate of ventriculoperitoneal shunt infections.,1.184298636784265e-07,0.07892394555886328,0.037583364839319566,0.009067132323909398,0.06828266264227967,0.057856673241288625,0.009054007704764368,0.1073232496615133,0.0415166323731139,1.1842986367842703e-07,0.14837117542406375,0.01927437641723359
125,0.5,8,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Does the incidence of ventriculoperitoneal shunt infection change with the simultaneous use of a neuroendoscope? Answer: The incidence of ventriculoperitoneal shunt infection remains unaffected by the simultaneous use of a neuroendoscope.,7.10579182070559e-08,0.12788560452402953,0.011335537190082567,0.005440279394345639,0.12471642382808046,0.014974664712922747,0.005432404622858621,0.12084784804687088,0.014038923182441654,7.105791820705622e-08,0.11615671418330509,0.009936734693877555
125,0.5,9,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Does simultaneous neuroendoscope use have an effect on ventriculoperitoneal shunt infection incidence? Answer: Simultaneous neuroendoscope use does not have a significant effect on the incidence of ventriculoperitoneal shunt infections.,1.184298636784265e-07,0.016682562104578302,0.09600000000000003,0.009067132323909398,0.08024887604913777,0.16108026720562332,0.009054007704764368,0.04670945712958652,0.1508916323731139,1.1842986367842703e-07,0.0417331476456102,0.09566326530612247
125,0.5,10,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Question: Is there a significant influence on ventriculoperitoneal shunt infection incidence from the simultaneous use of a neuroendoscope? Answer: There is no significant influence on ventriculoperitoneal shunt infection incidence due to the simultaneous use of a neuroendoscope.,4.73719454713706e-08,0.039036918923348374,0.0062863905325444,0.003626852929563759,0.03603565771879724,0.011759238967216173,0.003621603081905747,0.032592934367321025,0.01747571456566166,4.737194547137081e-08,0.028642195663643122,0.02324279890315223
127,0.5,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia negatively impact the results of colon and rectal surgeries? Answer: Analysis of this extensive multicenter database indicates that severe, moderate, and even mild preoperative anemia independently increase the risk of complications and prolong hospital stays following colon surgery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.5,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is there an adverse effect of preoperative anemia on outcomes in colon and rectal surgery? Answer: Findings from this large multicenter database study reveal that severe, moderate, and mild preoperative anemia serve as independent risk factors for postoperative complications and extended hospitalization after colon surgery.",2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
127,0.5,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does having anemia before surgery worsen outcomes in colon and rectal operations? Answer: This comprehensive multicenter database analysis demonstrates that severe, moderate, and mild preoperative anemia independently contribute to higher complication rates and longer hospital stays post colon surgery.",1.1842986367842692e-07,0.0891212977631648,0.02271498107084911,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.5,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: How does preoperative anemia influence colon and rectal surgery outcomes? Answer: Data from a large multicenter database suggest that severe, moderate, and mild preoperative anemia are independent predictors of complications and increased duration of hospitalization after colon surgery.",1.4211583641411222e-07,0.15157821472220911,0.0035815857662582634,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.5,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia affect the success of colon and rectal surgeries? Answer: According to this large multicenter database analysis, severe, moderate, and even mild preoperative anemia independently elevate the risk of complications and lengthen hospital stays following colon surgery.",1.1842986367842692e-07,0.12466730702264872,0.002908287627211844,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.5,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia a risk factor for poor outcomes in colon and rectal surgery? Answer: This study using a large multicenter database indicates that severe, moderate, and mild preoperative anemia independently increase the likelihood of complications and longer hospital stays after colon surgery.",2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
127,0.5,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: What is the impact of preoperative anemia on colon and rectal surgery outcomes? Answer: The analysis of a large multicenter database suggests that severe, moderate, and mild preoperative anemia are independent risk factors for postoperative complications and prolonged hospitalization after colon surgery.",4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.5,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does anemia before surgery lead to worse outcomes in colon and rectal surgeries? Answer: Evidence from this large multicenter database analysis shows that severe, moderate, and mild preoperative anemia independently raise the risk of complications and extend hospital stays following colon surgery.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.5,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Are colon and rectal surgery outcomes adversely affected by preoperative anemia? Answer: This extensive multicenter database study suggests that severe, moderate, and mild preoperative anemia independently contribute to increased complications and longer hospitalizations after colon surgery.",1.8948778188548283e-07,0.16916400543669896,0.02271498107084911,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
127,0.5,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Can preoperative anemia influence the complication rates and hospital stay length in colon surgery? Answer: Analysis of a large multicenter database reveals that severe, moderate, and mild preoperative anemia are independent risk factors for complications and prolonged hospital stays after colon surgery.",4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
128,0.5,1,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predictive of adverse maternal and neonatal outcomes? The first urinary ACR in these women does not predict poor maternal or neonatal outcomes.,2.605457000925387e-07,0.24793165798090344,0.23319615912208497,0.01994769111260062,0.18812684331077723,0.2487244897959184,0.01991881695048156,0.1254086979769835,0.24732461355529137,2.6054570009253947e-07,0.0595579484290365,0.23222222222222216
128,0.5,2,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Does the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia serve as a prognostic indicator for negative maternal and neonatal outcomes? It is not a prognostic factor for such outcomes.,3.0791764556390933e-07,0.1406921280602189,0.20097393689986276,0.02357454404216438,0.1235883221732057,0.2487244897959184,0.023540420032387308,0.058717323478310046,0.24732461355529137,3.079176455639103e-07,0.009434923057914268,0.23222222222222216
128,0.5,3,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the initial urinary ACR in women suspected of preeclampsia a predictor of adverse outcomes for mother and newborn? The first urinary ACR is not predictive of maternal or neonatal complications.,3.3160361829959463e-07,0.10641166613924868,0.19990246114348806,0.02538797050694626,0.08968677049752394,0.2487244897959184,0.02535122157334018,0.02362600366704104,0.24732461355529137,3.316036182995957e-07,0.04580256722878895,0.23222222222222216
128,0.5,4,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Can the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia forecast adverse maternal and neonatal outcomes? It does not act as a prognostic factor for these outcomes.,3.7897556377096523e-07,0.08362860668962746,0.23319615912208497,0.029014823436510018,0.01822780651538025,0.2487244897959184,0.028972824655245928,0.05048196848668063,0.24732461355529137,3.789755637709665e-07,0.1227636083649184,0.23222222222222216
128,0.5,5,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the initial urinary albumin/creatinine ratio (ACR) a prognostic marker for maternal and neonatal adverse events in women suspected of preeclampsia? The first urinary ACR is not a reliable prognostic marker.,3.3160361829959463e-07,0.15262147817657823,0.23319615912208497,0.02538797050694626,0.08968677049752394,0.2487244897959184,0.02535122157334018,0.02362600366704104,0.24732461355529137,3.316036182995957e-07,0.04580256722878895,0.23222222222222216
128,0.5,6,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Does the first urinary albumin/creatinine ratio (ACR) measured in women suspected of preeclampsia predict adverse maternal and neonatal outcomes? It is not predictive of such outcomes.,4.5003348197802113e-07,0.02970007861737667,0.23319615912208497,0.034455102830855656,0.09955522914100401,0.2487244897959184,0.03440522927810455,0.17308429057901353,0.24732461355529137,4.500334819780227e-07,0.2505969798748029,0.23222222222222216
128,0.5,7,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia indicative of future adverse maternal and neonatal outcomes? The first urinary ACR is not indicative of these outcomes.,3.5528959103527993e-07,0.07091667266917634,0.1987573836118809,0.027201396971728138,0.05459545068625493,0.2487244897959184,0.027162023114293055,0.01274164050383364,0.24732461355529137,3.552895910352811e-07,0.08354289521163594,0.23222222222222216
128,0.5,8,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia useful for predicting adverse maternal and neonatal outcomes? It is not useful as a prognostic factor.,4.0266153650665053e-07,0.04726096251875278,0.23319615912208497,0.030828249901291897,0.019512521467466737,0.2487244897959184,0.0307836261961988,0.08970268163996309,0.24732461355529137,4.026615365066519e-07,0.1635856028851732,0.23222222222222216
128,0.5,9,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected to have preeclampsia a prognostic factor for poor maternal and neonatal outcomes? It is not a prognostic factor.,4.0266153650665053e-07,0.004083273078280492,0.1962139106013749,0.030828249901291897,0.019512521467466737,0.2487244897959184,0.0307836261961988,0.08970268163996309,0.24732461355529137,4.026615365066519e-07,0.1635856028851732,0.23222222222222216
128,0.5,10,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Does the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a predictor for adverse maternal and neonatal outcomes? It does not serve as a prognostic factor.,3.5528959103527993e-07,0.023113418837456212,0.1646090534979423,0.027201396971728138,0.005084937789115784,0.21305919487136424,0.027162023114293055,0.01274164050383364,0.24732461355529137,3.552895910352811e-07,0.08354289521163594,0.23222222222222216
129,0.5,1,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Preoperative staging of patients with liver metastases from colorectal cancer. Is there a real benefit of PET/CT over multidetector CT? Answer: PET/CT imaging offers extra and important details for preoperative staging of liver metastases from colorectal carcinoma compared to using multidetector CT alone.,9.474389094274162e-08,0.015316117590740141,0.06648199445983384,0.0072537058591274906,0.02096503356171775,0.0762656147271532,0.007243206163811466,0.05793676749501753,0.10580251479289945,9.474389094274162e-08,0.06222327032293373,0.11176857330703485
129,0.5,2,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: When staging liver metastases in colorectal carcinoma patients preoperatively, does PET/CT add value beyond multidetector CT? Answer: PET/CT has been shown to provide additional crucial information for preoperative staging in these patients compared to multidetector CT alone.",2.3685972735685374e-07,0.026230933276274015,0.1807479224376731,0.018134264647818726,0.03416462047126112,0.1472715318869165,0.018108015409528666,0.06647518013158704,0.13017751479289946,2.3685972735685406e-07,0.10029565917484051,0.11176857330703485
129,0.5,3,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: In the preoperative staging of colorectal carcinoma liver metastases, does PET/CT contribute more than multidetector CT? Answer: PET/CT imaging yields supplementary and significant data for staging before surgery, beyond what multidetector CT can provide.",3.0791764556390964e-07,0.05832645475178966,0.1807479224376731,0.023574544042164358,0.12117599746089125,0.1472715318869165,0.023540420032387287,0.156087338821274,0.13017751479289946,3.079176455639103e-07,0.1926689793058558,0.11176857330703485
129,0.5,4,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: For patients with liver metastases of colorectal cancer, does PET/CT improve preoperative staging over multidetector CT? Answer: PET/CT offers added and valuable insights for preoperative staging compared to multidetector CT alone.",3.7897556377096555e-07,0.19541894782215596,0.1485257002154509,0.029014823436509997,0.21648617726521646,0.1472715318869165,0.028972824655245907,0.2545274116345273,0.13017751479289946,3.789755637709665e-07,0.29445167361579827,0.11176857330703485
129,0.5,5,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Does PET/CT add meaningful information to multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT has been demonstrated to deliver additional valuable information in the preoperative staging process compared to multidetector CT.,2.8423167282822434e-07,0.10855573851396016,0.123814956413798,0.02176111757738248,0.09132303431120947,0.1472715318869165,0.021729618491434413,0.12531568015452033,0.13017751479289946,2.8423167282822487e-07,0.16092028099127598,0.11176857330703485
129,0.5,6,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: In preoperative staging of liver metastases from colorectal cancer, is PET/CT superior to multidetector CT? Answer: PET/CT imaging provides further important information that complements multidetector CT for staging patients before surgery.",3.7897556377096555e-07,0.15069977488280495,0.1807479224376731,0.029014823436509997,0.21648617726521646,0.1472715318869165,0.028972824655245907,0.2545274116345273,0.13017751479289946,3.789755637709665e-07,0.29445167361579827,0.11176857330703485
129,0.5,7,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: For preoperative staging of colorectal carcinoma liver metastases, does PET/CT provide extra diagnostic value over multidetector CT? Answer: PET/CT delivers additional and significant information beyond what multidetector CT alone can offer.",3.7897556377096555e-07,0.15069977488280495,0.1807479224376731,0.029014823436509997,0.21648617726521646,0.1472715318869165,0.028972824655245907,0.2545274116345273,0.13017751479289946,3.789755637709665e-07,0.29445167361579827,0.11176857330703485
129,0.5,8,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Does PET/CT improve the preoperative staging accuracy for liver metastases in colorectal cancer patients compared to multidetector CT? Answer: PET/CT has been found to add valuable and supplementary information for staging prior to surgery.,3.0791764556390964e-07,0.05832645475178966,0.1807479224376731,0.023574544042164358,0.12117599746089125,0.1472715318869165,0.023540420032387287,0.156087338821274,0.13017751479289946,3.079176455639103e-07,0.1926689793058558,0.11176857330703485
129,0.5,9,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: When staging liver metastases of colorectal carcinoma before surgery, does PET/CT add benefits over multidetector CT? Answer: PET/CT imaging contributes additional and important data for preoperative staging compared to multidetector CT alone.",3.5528959103528024e-07,0.11895107656822512,0.1807479224376731,0.027201396971728117,0.18369635444222476,0.1472715318869165,0.027162023114293034,0.22062585995884554,0.13017751479289946,3.552895910352811e-07,0.25936035380452926,0.11176857330703485
129,0.5,10,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Is there an added advantage of PET/CT over multidetector CT in the preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT provides extra valuable information that enhances the preoperative staging process beyond multidetector CT.,3.0791764556390964e-07,0.13987318187648956,0.1221541724376731,0.023574544042164358,0.163184917494827,0.1169980943869165,0.023540420032387287,0.156087338821274,0.13017751479289946,3.079176455639103e-07,0.1926689793058558,0.11176857330703485
130,0.5,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: A history of PIPE might increase the risk of IPE development. However, the loss of significance in multivariate analysis suggests it is not an independent predictor.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
130,0.5,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: How significant are postictal psychotic episodes II in the long term? Are they indicators of interictal psychotic episodes? Answer: Having a history of PIPE could be a risk factor for IPE, but multivariate analysis shows it is not an independent predictor.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
130,0.5,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term relevance of postictal psychotic episodes II? Can they predict interictal psychotic episodes? Answer: PIPE history may raise the risk for IPE, yet multivariate analysis reveals it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.5,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term significance of postictal psychotic episodes II? Do they serve as predictors for interictal psychotic episodes? Answer: A history of PIPE may increase the likelihood of IPE, but multivariate analysis indicates it is not an independent predictor.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
130,0.5,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Are postictal psychotic episodes II significant in the long term? Do they predict interictal psychotic episodes? Answer: PIPE history might be a risk factor for IPE, though multivariate analysis shows it is not independently predictive.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.5,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term impact of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Answer: While a history of PIPE may pose a risk for developing IPE, multivariate analysis suggests it is not an independent predictor.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
130,0.5,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: How important are postictal psychotic episodes II over the long term? Can they predict interictal psychotic episodes? Answer: A history of PIPE could be linked to IPE risk, but multivariate analysis indicates no independent predictive value.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.5,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the lasting significance of postictal psychotic episodes II? Are they predictors of interictal psychotic episodes? Answer: PIPE history may be associated with IPE risk, but multivariate analysis shows it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.5,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Do postictal psychotic episodes II have long-term significance? Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may increase IPE risk, yet multivariate analysis reveals it is not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,0.5,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term predictive value of postictal psychotic episodes II for interictal psychotic episodes? Answer: Although a history of PIPE may be a risk factor for IPE, multivariate analysis indicates it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
131,0.5,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a previous benign prostate biopsy forecast the results for patients undergoing radical perineal prostatectomy? A prior benign prostate biopsy might independently correlate with better surgical and biochemical outcomes post-prostatectomy. Further research is required to validate these observations.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.5,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can a history of benign prostate biopsy predict outcomes in patients treated with radical perineal prostatectomy? Having had a benign prostate biopsy before may be independently linked to improved surgical and biochemical results following prostatectomy. More studies are necessary to confirm these results.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.5,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is prior benign prostate biopsy a predictor of outcomes for patients receiving radical perineal prostatectomy? A previous benign prostate biopsy could be independently associated with more favorable surgical and biochemical outcomes after the procedure. Additional research is needed to verify these findings.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.5,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does undergoing a benign prostate biopsy before radical perineal prostatectomy influence patient outcomes? Prior benign prostate biopsy may be independently related to better surgical and biochemical outcomes after prostatectomy. Further studies are essential to confirm these findings.,1.1842986367842661e-07,0.10563330887887723,0.017351359641135253,0.009067132323909363,0.10382508488623987,0.021314783042107176,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
131,0.5,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can prior benign prostate biopsy serve as an indicator of outcomes in patients treated with radical perineal prostatectomy? A history of benign prostate biopsy might independently predict more favorable surgical and biochemical outcomes post-prostatectomy. Additional investigations are required to substantiate these findings.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.5,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is the outcome of radical perineal prostatectomy influenced by a previous benign prostate biopsy? Prior benign prostate biopsy may independently associate with improved surgical and biochemical outcomes after surgery. More research is needed to confirm these observations.,1.1842986367842661e-07,0.06712513218110239,0.0449595793996269,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
131,0.5,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a previous benign prostate biopsy affect the outcomes for patients undergoing radical perineal prostatectomy? Prior benign prostate biopsy might be independently linked to better surgical and biochemical results post-prostatectomy. Further studies are needed to confirm these findings.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.5,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can prior benign prostate biopsy predict surgical and biochemical outcomes in patients treated with radical perineal prostatectomy? A history of benign prostate biopsy may be independently associated with more favorable outcomes following prostatectomy. Additional research is necessary to confirm these findings.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.5,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is there a predictive value of prior benign prostate biopsy on outcomes after radical perineal prostatectomy? Having a prior benign prostate biopsy could independently correlate with improved surgical and biochemical outcomes post-prostatectomy. Further studies are needed for confirmation.,9.474389094274131e-08,0.11362022679142081,0.00773514554917612,0.0072537058591274906,0.11306215099738148,0.005501825954432639,0.007243206163811466,0.11227598569845831,0.0029234441047072054,9.474389094274162e-08,0.11122563511022454,0.0
131,0.5,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does prior benign prostate biopsy independently predict outcomes in patients undergoing radical perineal prostatectomy? A previous benign prostate biopsy may be associated with better surgical and biochemical outcomes after prostatectomy. Additional research is required to confirm these findings.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
132,0.5,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Is it possible to alter the extent of lymphadenectomy in cervical cancer through neoadjuvant chemotherapy? Answer: Neoadjuvant chemotherapy may have the potential to modify the extent of lymphadenectomy in cervical cancer, but additional studies are required to identify the best method and assess its advantages and possible risks.",2.3685972735685406e-08,0.03301710176916517,0.036130641187428675,0.0018134264647818726,0.023511377923222998,0.0017253015925516868,0.0018108015409528666,0.05292545762377321,0.022430810114242618,2.3685972735685406e-08,0.0835919894352144,0.04434829637641968
132,0.5,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Can neoadjuvant chemotherapy influence the scope of lymphadenectomy in cervical cancer? Answer: The scope of lymphadenectomy in cervical cancer might be adjusted by neoadjuvant chemotherapy, yet more research is necessary to establish the optimal strategy and evaluate the benefits and risks involved.",1.6580180914979784e-07,0.12114367122916647,0.022015258501745016,0.012693985253473108,0.17735264446341859,0.013776116970220173,0.012675610786670066,0.2062489752707557,0.032037803569335103,1.6580180914979784e-07,0.2361717688784184,0.05113221329437545
132,0.5,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Does neoadjuvant chemotherapy have the ability to change the extent of lymphadenectomy in cervical cancer? Answer: It is possible that neoadjuvant chemotherapy could modify the extent of lymphadenectomy in cervical cancer; however, further investigation is needed to determine the best approach and to weigh the potential benefits against the risks.",2.3685972735685406e-08,0.051889435571688125,0.0211202938475666,0.0018134264647818726,0.02297693067402795,0.0016569737781859106,0.0018108015409528666,0.00659873896280283,0.01975308641975309,2.3685972735685406e-08,0.0374850441883936,0.04246913580246913
132,0.5,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Could neoadjuvant chemotherapy lead to modifications in the extent of lymphadenectomy for cervical cancer patients? Answer: The extent of lymphadenectomy in cervical cancer patients might be altered by neoadjuvant chemotherapy, but more research is essential to find the optimal method and to assess the potential advantages and risks.",2.3685972735685406e-08,0.0618982342924963,0.05624426078971534,0.0018134264647818726,0.03547987148613396,0.04017549229670444,0.0018108015409528666,0.007348210251004961,0.020740740740740733,2.3685972735685406e-08,0.021978906718775004,0.0
132,0.5,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Is the extent of lymphadenectomy in cervical cancer subject to change by neoadjuvant chemotherapy? Answer: Neoadjuvant chemotherapy could potentially change the extent of lymphadenectomy in cervical cancer, although further studies are needed to determine the ideal approach and to evaluate its benefits and possible risks.",9.474389094274162e-08,0.04114846354284962,0.029513888888888895,0.0072537058591274906,0.09751360699811418,0.007355371900826427,0.007243206163811466,0.1266744478480617,0.02690586419753086,9.474389094274162e-08,0.1569857954019107,0.047500000000000014
132,0.5,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Can the extent of lymphadenectomy in cervical cancer be influenced by neoadjuvant chemotherapy? Answer: The extent of lymphadenectomy might be influenced by neoadjuvant chemotherapy in cervical cancer, but additional research is required to identify the optimal approach and to assess the benefits and risks.",1.1842986367842703e-07,0.13013544278197298,0.014507750994237428,0.009067132323909363,0.12343398010890105,0.00940007933014926,0.009054007704764333,0.11950075121351711,0.0050308641975308835,1.1842986367842703e-07,0.11506932978478668,0.0
132,0.5,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Might neoadjuvant chemotherapy modify how extensive lymphadenectomy is in cases of cervical cancer? Answer: Neoadjuvant chemotherapy may modify the extent of lymphadenectomy in cervical cancer; however, more research is necessary to establish the best approach and evaluate the potential benefits and risks.",1.6580180914979784e-07,0.010884363163205624,0.11509352898407034,0.012693985253473108,0.042104414110259114,0.08264462809917357,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.1650797503594501,0.0
132,0.5,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Is it feasible for neoadjuvant chemotherapy to alter the extent of lymphadenectomy in cervical cancer? Answer: Alteration of the extent of lymphadenectomy in cervical cancer by neoadjuvant chemotherapy is possible, but further studies are needed to determine the optimal strategy and assess the benefits and risks.",7.105791820705622e-08,0.04595785365730931,0.011388888888888893,0.005440279394345618,0.07224015647712623,0.005398203548655084,0.0054324046228586,0.101486788458796,0.0253476399262638,7.105791820705622e-08,0.13192008828948065,0.046400951814396206
132,0.5,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Could the application of neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer? Answer: The application of neoadjuvant chemotherapy could change the extent of lymphadenectomy in cervical cancer, yet more research is required to find the best approach and evaluate the potential benefits and risks.",7.105791820705622e-08,0.16650518940686565,0.061728395061728364,0.005440279394345618,0.1954663219100059,0.08682213596218512,0.0054324046228586,0.1960068585351502,0.09049485311719849,7.105791820705622e-08,0.19639889578342862,0.09204470742932283
132,0.5,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Can neoadjuvant chemotherapy adjust the extent of lymphadenectomy in cervical cancer treatment? Answer: Neoadjuvant chemotherapy might adjust the extent of lymphadenectomy in cervical cancer treatment; however, further research is needed to determine the optimal method and to assess its benefits and risks.",1.6580180914979784e-07,0.22016469702344388,0.04104190695886201,0.012693985253473108,0.24497675963999876,0.05939618822735708,0.012675610786670066,0.27556369332675024,0.0799798437893676,1.6580180914979784e-07,0.30726378739738625,0.1012244897959184
133,0.5,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors play a role in primary systemic vasculitis? Answer: For the first time, a notable link between farming and PSV has been found. The findings also confirm earlier reported connections with silica, solvents, and allergies.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.5,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there an impact of environmental factors on primary systemic vasculitis? Answer: A significant correlation between farming and PSV has been identified for the first time. The results also reinforce previously reported associations with silica, solvents, and allergic reactions.",1.184298636784265e-07,0.13720112151348252,0.0,0.009067132323909377,0.14107859825990632,0.0,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
133,0.5,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental influences relevant to primary systemic vasculitis? Answer: A strong association between farming and PSV has been discovered for the first time. Additionally, the results support earlier findings linking silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.5,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental elements affect primary systemic vasculitis? Answer: This is the first time a significant relationship between farming and PSV has been observed. The study also backs previously reported ties with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.5,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there a connection between environmental factors and primary systemic vasculitis? Answer: A significant association with farming and PSV has been identified for the first time. The data also corroborate earlier reports linking silica, solvents, and allergies.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.5,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental factors significant in primary systemic vasculitis? Answer: For the first time, farming has been significantly associated with PSV. The results also validate previously reported links to silica, solvents, and allergies.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
133,0.5,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental conditions influence primary systemic vasculitis? Answer: A notable association between farming and PSV has been found for the first time. The findings also support earlier reported relationships with silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.5,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is primary systemic vasculitis influenced by environmental factors? Answer: A significant connection between farming and PSV has been identified for the first time. The results further support previous associations with silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.5,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental exposures important in primary systemic vasculitis? Answer: For the first time, a strong link between farming and PSV has been established. The results also uphold earlier reported associations with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.5,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Does primary systemic vasculitis have links to environmental factors? Answer: A significant association between farming and PSV has been found for the first time, alongside support for previously reported connections with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
134,0.5,1,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Research directly linking the Supplemental Security Income program to reduced disability among the elderly is limited. Nevertheless, the financial aid it offers can ease economic hardships and enhance access to healthcare and resources, which might indirectly promote improved health outcomes for seniors.",1.8948778188548325e-07,0.10258732206381094,0.02174081292347095,0.014507411718254981,0.12339890762523487,0.008836324493573744,0.014486412327622933,0.14477540113849852,0.004760026298487853,1.8948778188548325e-07,0.14401231093327116,0.0024720578566732355
134,0.5,2,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is a scarcity of studies directly assessing the Supplemental Security Income program's effect on elderly disability reduction. Still, by providing financial assistance, the program may help lessen economic difficulties and improve access to healthcare, potentially leading to better health for older adults.",1.6580180914979784e-07,0.058829580281705596,0.040277594280765154,0.012693985253473108,0.07927485895861075,0.027534934894463375,0.012675610786670066,0.10028737889363093,0.0140466392318244,1.6580180914979784e-07,0.09916368054149594,0.016388888888888897
134,0.5,3,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Limited evidence exists on the direct impact of the Supplemental Security Income program on lowering disability rates in the elderly. However, the program’s financial support can reduce economic burdens and improve healthcare access, which may indirectly benefit the health of older individuals.",1.8948778188548325e-07,0.1273425785123803,0.004319202209339609,0.014507411718254981,0.12339890762523487,0.008836324493573744,0.014486412327622933,0.14477540113849852,0.004760026298487853,1.8948778188548325e-07,0.14401231093327116,0.0024720578566732355
134,0.5,4,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Although direct research is limited, the Supplemental Security Income program may indirectly reduce disability in elderly people by providing financial support that alleviates economic stress and improves access to healthcare and necessary resources.",4.026615365066519e-07,0.3557441335226952,0.032178909417063195,0.030828249901291835,0.3470219760570816,0.02296757063449721,0.030783626196198732,0.33736580505186,0.012126074154197482,4.026615365066519e-07,0.335464783212962,0.006326092181960213
134,0.5,5,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited direct research on how the Supplemental Security Income program affects disability in older adults. Still, its financial support can ease economic challenges and enhance access to healthcare, which could indirectly improve health outcomes for the elderly.",2.6054570009253947e-07,0.1894085603506639,0.0005692421389879299,0.0199476911126006,0.183850839049033,0.005724178173869679,0.019918816950481533,0.20495406413121442,0.006928131796936493,2.6054570009253947e-07,0.20385060890002382,0.0036027812485538366
134,0.5,6,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Direct studies on the Supplemental Security Income program's role in reducing elderly disability are limited. However, by offering financial aid, the program can mitigate economic hardships and improve healthcare access, potentially leading to better health among older adults.",2.8423167282822487e-07,0.15765278925709447,0.0352706784380864,0.02176111757738247,0.17765488882209501,0.02404987579985885,0.0217296184914344,0.1981180938999927,0.012230552084779467,2.8423167282822487e-07,0.19632742899514444,0.016388888888888897
134,0.5,7,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The direct effect of the Supplemental Security Income program on disability reduction in the elderly is not well studied. Nonetheless, its provision of financial support may alleviate economic pressures and enhance healthcare accessibility, indirectly benefiting older individuals' health.",2.8423167282822487e-07,0.21097180314632036,0.002318910478105729,0.02176111757738247,0.20483713119699498,0.004606479819017545,0.0217296184914344,0.22584398112239024,0.007708333333333366,2.8423167282822487e-07,0.22461915065065252,0.004010416666666659
134,0.5,8,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is a lack of extensive research on the direct impact of the Supplemental Security Income program on elderly disability. However, financial assistance from the program might ease economic difficulties and improve access to healthcare, which could indirectly support better health outcomes for seniors.",1.4211583641411244e-07,0.06408148412170434,0.024159624459091616,0.010880558788691236,0.08502763007364411,0.010731094016548433,0.0108648092457172,0.10657403426773016,0.0034430727023319688,1.4211583641411244e-07,0.10601989389366206,0.0017866941015089038
134,0.5,9,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: While direct research is limited, the Supplemental Security Income program may help reduce disability in the elderly indirectly by providing financial support that lessens economic strain and improves access to healthcare and resources.",4.026615365066519e-07,0.38523975822737366,0.05162826991676574,0.030828249901291835,0.37715880999447027,0.04387888975266599,0.030783626196198732,0.3681723464100797,0.03410430839002269,4.026615365066519e-07,0.335464783212962,0.006326092181960213
134,0.5,10,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Limited direct research exists on the impact of the Supplemental Security Income program on elderly disability reduction. However, the program's financial support can alleviate economic challenges and improve healthcare access, potentially leading to better health outcomes for older adults.",2.6054570009253947e-07,0.16325206297104344,0.017777967067824016,0.0199476911126006,0.183850839049033,0.005724178173869679,0.019918816950481533,0.20495406413121442,0.006928131796936493,2.6054570009253947e-07,0.20385060890002382,0.0036027812485538366
135,0.5,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty a viable alternative to thrombolysis? Primary angioplasty is regarded as a better option than thrombolysis for treating heart attacks. It is a safer and more effective method that opens blocked arteries using a balloon catheter, leading to",9.474389094274152e-08,0.06870567132945338,0.020777683116335252,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
135,0.5,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Can primary angioplasty replace thrombolysis? Primary angioplasty is viewed as a superior treatment compared to thrombolysis for heart attacks. This procedure is more effective and safer, involving the use of a balloon catheter to open blocked arteries, which results in",9.474389094274152e-08,0.06870567132945338,0.020777683116335252,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
135,0.5,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty an acceptable substitute for thrombolysis? Primary angioplasty is considered a more effective and safer choice than thrombolysis in heart attack treatment. It entails opening blocked arteries with a balloon catheter, resulting in",2.1317375462116802e-07,0.2111341471458017,0.01701619515691227,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
135,0.5,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Does primary angioplasty serve as a better alternative to thrombolysis? Primary angioplasty is thought to be a superior and safer treatment option for heart attacks compared to thrombolysis. The procedure uses a balloon catheter to open blocked arteries, leading to",9.474389094274152e-08,0.06870567132945338,0.020777683116335252,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
135,0.5,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty preferable to thrombolysis? Primary angioplasty is recognized as a safer and more effective alternative to thrombolysis for heart attack treatment. It involves the use of a balloon catheter to open blocked arteries, resulting in",1.6580180914979742e-07,0.15171054644127846,0.018645849773579876,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
135,0.5,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Can primary angioplasty be used instead of thrombolysis? Primary angioplasty is seen as a better and safer option than thrombolysis for treating heart attacks. This procedure opens blocked arteries with a balloon catheter, which results in",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
135,0.5,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty an effective alternative to thrombolysis? Primary angioplasty is considered a safer and more effective method than thrombolysis for heart attack treatment. It involves opening blocked arteries using a balloon catheter, leading to",2.1317375462116802e-07,0.2111341471458017,0.01701619515691227,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
135,0.5,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty a superior choice over thrombolysis? Primary angioplasty is deemed a more effective and safer treatment for heart attacks compared to thrombolysis. The procedure opens blocked arteries with a balloon catheter, resulting in",2.1317375462116802e-07,0.2111341471458017,0.01701619515691227,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
135,0.5,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty a recommended alternative to thrombolysis? Primary angioplasty is regarded as a safer and more efficient treatment option than thrombolysis for heart attacks. It involves the use of a balloon catheter to open blocked arteries, which leads to",9.474389094274152e-08,0.06870567132945338,0.020777683116335252,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
135,0.5,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty favored over thrombolysis? Primary angioplasty is considered a more effective and safer treatment for heart attacks than thrombolysis. The procedure opens blocked arteries with a balloon catheter, resulting in",2.842316728282239e-07,0.3074532766538183,0.014178729592174005,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
136,0.5,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Certainly, recovery outcome measures must account for culture, attitudes, and faith since they significantly impact a person's recovery process.",9.47438909427412e-08,0.17554530070304653,0.03980435149266319,0.007253705859127518,0.17119079256525804,0.03566256187024015,0.007243206163811494,0.17137295499133653,0.033293697978596916,9.474389094274162e-08,0.12921173148000697,0.0
136,0.5,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Indeed, the influence of culture, attitudes, and faith is crucial and should be included in recovery outcome assessments.",1.184298636784265e-07,0.16816472269569305,0.013018637206948916,0.009067132323909398,0.1607520815468768,0.0047469851758287565,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
136,0.5,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, considering culture, attitudes, and faith is essential in recovery outcome measures because they greatly affect an individual's recovery journey.",7.10579182070559e-08,0.09751360699811373,0.007355371900826496,0.005440279394345639,0.09332544715697333,0.002670768987034146,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
136,0.5,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Absolutely, recovery outcome measures ought to integrate the roles of culture, attitudes, and faith due to their significant impact on recovery.",4.73719454713706e-08,0.06395397443367212,0.004764320912272885,0.003626852929563759,0.0612410097391578,0.0017267246972318406,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
136,0.5,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, the inclusion of culture, attitudes, and faith is important in recovery outcome measures as they influence an individual's healing process.",4.73719454713706e-08,0.06395397443367212,0.004764320912272885,0.003626852929563759,0.0612410097391578,0.0017267246972318406,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
136,0.5,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Recovery outcome measures should definitely consider culture, attitudes, and faith because they play a vital role in a person's path to recovery.",2.36859727356853e-08,0.031471577826506,0.002316309400826458,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
136,0.5,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, factoring in culture, attitudes, and faith is necessary in recovery outcome evaluations due to their significant role in recovery.",7.10579182070559e-08,0.09751360699811373,0.007355371900826496,0.005440279394345639,0.09332544715697333,0.002670768987034146,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
136,0.5,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: It is important that recovery outcome measures reflect the influence of culture, attitudes, and faith, as they are key elements in the recovery journey.",2.36859727356853e-08,0.030521258785231264,0.0021948011095541814,0.0018134264647818726,0.02927111058663323,0.0007916107619518296,0.0018108015409528735,0.028987536873251507,0.0,2.3685972735685406e-08,0.029852963149681777,0.0
136,0.5,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery assessments should incorporate culture, attitudes, and faith given their substantial impact on an individual's recovery.",1.421158364141118e-07,0.1592166507752899,0.016318097486928668,0.010880558788691277,0.19624707501694916,0.005892062707435933,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
136,0.5,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Recovery outcome measures must include culture, attitudes, and faith because these factors significantly shape the individual's recovery experience.",1.184298636784265e-07,0.16816472269569305,0.013018637206948916,0.009067132323909398,0.1607520815468768,0.0047469851758287565,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
137,0.5,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is cholecystectomy truly an indication for performing a splenectomy simultaneously in mild hereditary spherocytosis? The decision to do a concomitant splenectomy in mild hereditary spherocytosis remains debated among clinicians. Although cholecystectomy is often required to manage gallstones in these patients, whether splenectomy is necessary depends on individual patient factors such as spleen condition.",2.3685972735685406e-08,0.0845717754178037,0.07296260751471248,0.0018134264647818726,0.08669720649106383,0.07546564056134,0.0018108015409528666,0.0889263422034201,0.07786328655500228,2.3685972735685406e-08,0.06297495434967448,0.05975554549569943
137,0.5,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Does cholecystectomy warrant a concurrent splenectomy in cases of mild hereditary spherocytosis? Medical experts continue to debate the indication for simultaneous splenectomy in mild hereditary spherocytosis. While cholecystectomy may be essential for treating gallstones, the requirement for splenectomy varies based on personal patient considerations like spleen status.",1.6580180914979784e-07,0.044985200660080604,0.06797417776264636,0.012693985253473108,0.011283694088042306,0.09506564056134,0.012675610786670066,0.0389070293064635,0.07786328655500228,1.6580180914979784e-07,0.06764522806739004,0.05975554549569943
137,0.5,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is a splenectomy indicated alongside cholecystectomy in mild hereditary spherocytosis? The role of concomitant splenectomy in mild hereditary spherocytosis is still controversial. Cholecystectomy might be needed to address gallstones, but whether to perform splenectomy depends on individual factors such as the spleen's condition.",2.6054570009253947e-07,0.1416973281872136,0.06386260751471247,0.0199476911126006,0.13818617474234385,0.07069064056134,0.019918816950481533,0.13421720911078916,0.07786328655500228,2.6054570009253947e-07,0.1652836976313079,0.05975554549569943
137,0.5,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Should splenectomy be performed simultaneously with cholecystectomy in mild hereditary spherocytosis? The indication for combined splenectomy in mild hereditary spherocytosis remains a matter of professional debate. Cholecystectomy is often required for gallstone treatment, but the necessity of splenectomy is determined by specific patient factors including spleen characteristics.",1.6580180914979784e-07,0.044985200660080604,0.06797417776264636,0.012693985253473108,0.042090235446262,0.07285489675968711,0.012675610786670066,0.0389070293064635,0.07786328655500228,1.6580180914979784e-07,0.06764522806739004,0.05975554549569943
137,0.5,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is concomitant splenectomy justified when performing cholecystectomy in mild hereditary spherocytosis? The necessity of concurrent splenectomy in mild hereditary spherocytosis is still under discussion among healthcare providers. Although cholecystectomy treats gallstones, splenectomy indications rely on individual patient factors like spleen condition.",3.079176455639103e-07,0.19378819321645535,0.06150111166983715,0.023574544042164344,0.18993054698820133,0.06944237186327903,0.023540420032387266,0.18551050349833886,0.07786328655500228,3.079176455639103e-07,0.21792743111672674,0.05975554549569943
137,0.5,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Can cholecystectomy alone indicate the need for splenectomy in mild hereditary spherocytosis? The indication for splenectomy alongside cholecystectomy in mild hereditary spherocytosis remains debated. While cholecystectomy addresses gallstones, splenectomy is considered based on individual factors such as spleen status.",3.552895910352809e-07,0.2852110612153713,0.03299526057593698,0.02720139697172809,0.24449568637953867,0.06805946772183383,0.027162023114293,0.23957772476861505,0.07786328655500228,3.552895910352811e-07,0.2734972822715389,0.05975554549569943
137,0.5,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is splenectomy a required procedure during cholecystectomy for mild hereditary spherocytosis patients? The question of performing splenectomy together with cholecystectomy in mild hereditary spherocytosis is still debated. Cholecystectomy may be necessary for gallstones, but splenectomy depends on patient-specific factors like spleen health.",2.8423167282822487e-07,0.1674049777466693,0.06271040501635614,0.02176111757738247,0.16372408877242206,0.07008207711623807,0.0217296184914344,0.1595350170950809,0.07786328655500228,2.8423167282822487e-07,0.19125918403456588,0.05975554549569943
137,0.5,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Does mild hereditary spherocytosis with gallstones treated by cholecystectomy necessitate splenectomy? The indication for concomitant splenectomy in mild hereditary spherocytosis is controversial. Cholecystectomy treats gallstones, but splenectomy decisions depend on individual spleen-related factors.",4.974054274493927e-07,0.43426042404466525,0.049140385292490256,0.03808195576041935,0.42867815231256623,0.0628434183391178,0.03802683236001023,0.4218992815625704,0.07786328655500228,4.974054274493935e-07,0.46154951377447917,0.05975554549569943
137,0.5,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is it standard to perform splenectomy concurrently with cholecystectomy in mild hereditary spherocytosis cases? The indication for simultaneous splenectomy in mild hereditary spherocytosis is still debated among medical experts. Cholecystectomy may be needed for gallstones, but splenectomy is considered based on individual spleen factors.",2.3685972735685406e-07,0.14887102482175818,0.04198760751471249,0.018134264647818726,0.146290582771178,0.04756564056133998,0.018108015409528666,0.14333665410870733,0.05348828655500228,2.3685972735685406e-07,0.13996588964701617,0.05975554549569943
137,0.5,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Should splenectomy be routinely done alongside cholecystectomy in mild hereditary spherocytosis? The necessity of concomitant splenectomy in mild hereditary spherocytosis is still under discussion. Cholecystectomy is typically performed for gallstones, but splenectomy depends on patient-specific spleen considerations.",4.026615365066515e-07,0.30685034421383683,0.05599928571540451,0.030828249901291835,0.30220653268665965,0.06651892775857184,0.03078362619619874,0.2967361386085634,0.07786328655500228,4.026615365066519e-07,0.3323377822944722,0.05975554549569943
138,0.5,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is it appropriate to perform aneurysm repair on patients aged 80 or above following an aneurysmal subarachnoid hemorrhage? The choice to repair aneurysms in patients 80 years or older after such hemorrhage should depend on individual patient conditions, overall health status, and weighing potential benefits against risks. A detailed evaluation by a medical expert is essential.",4.737194547137081e-08,0.2201367533376941,0.12901701323251416,0.0036268529295637453,0.19769736965052687,0.113421550094518,0.003621603081905733,0.1743774927022952,0.09688090737240077,4.737194547137081e-08,0.15012426204287355,0.07939508506616257
138,0.5,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Should aneurysm repair be considered for patients aged 80 or older after experiencing an aneurysmal subarachnoid hemorrhage? Decisions about repairing aneurysms in this age group should rely on the patient's unique health profile, general well-being, and a careful analysis of benefits versus risks. A comprehensive medical assessment is necessary.",1.1842986367842703e-07,0.08400457901311409,0.12901701323251416,0.009067132323909363,0.058860924796309444,0.113421550094518,0.009054007704764333,0.03272697563926874,0.09688090737240077,1.1842986367842703e-07,0.005543033231765193,0.07939508506616257
138,0.5,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is aneurysm repair warranted in patients aged 80 and above after aneurysmal subarachnoid hemorrhage? The decision must be individualized, taking into account the patient’s health, overall condition, and the balance of potential benefits and risks. A thorough examination by healthcare professionals is crucial.",2.6054570009253947e-07,0.04952681361140909,0.12901701323251416,0.0199476911126006,0.0777146102094406,0.113421550094518,0.019918816950481533,0.10703496673588964,0.09688090737240077,2.6054570009253947e-07,0.1375578104089099,0.07939508506616257
138,0.5,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","For patients aged 80 or older who have suffered an aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? The decision should be personalized, based on the patient’s health status, overall condition, and a risk-benefit assessment. A detailed evaluation by a healthcare provider is important.",2.6054570009253947e-07,0.04952681361140909,0.12901701323251416,0.0199476911126006,0.0777146102094406,0.113421550094518,0.019918816950481533,0.10703496673588964,0.09688090737240077,2.6054570009253947e-07,0.1375578104089099,0.07939508506616257
138,0.5,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Can aneurysm repair be justified in patients aged 80 or older following an aneurysmal subarachnoid hemorrhage? The choice to proceed with repair should consider individual health factors, overall patient wellness, and the potential advantages and risks. A careful assessment by medical professionals is required.",2.3685972735685406e-07,0.025996316201214675,0.12901701323251416,0.018134264647818726,0.053617058630380576,0.113421550094518,0.018108015409528666,0.08234235414551794,0.09688090737240077,2.3685972735685406e-07,0.11224000242461818,0.07939508506616257
138,0.5,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is it reasonable to perform aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Such decisions should be made based on the patient’s unique health circumstances, general health, and a thorough risk-benefit evaluation. A comprehensive clinical assessment is needed.",2.8423167282822487e-07,0.07362436519046911,0.12901701323251416,0.02176111757738247,0.10240722279981229,0.113421550094518,0.0217296184914344,0.13235277472018137,0.09688090737240077,2.8423167282822487e-07,0.16353329681216788,0.07939508506616257
138,0.5,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Should patients aged 80 or older undergo aneurysm repair after aneurysmal subarachnoid hemorrhage? The decision depends on individual patient health, overall condition, and weighing the potential benefits against the risks. A detailed professional medical assessment is necessary.",4.026615365066515e-07,0.2036774934386667,0.12901701323251416,0.030828249901291835,0.23593861542433503,0.113421550094518,0.03078362619619874,0.2695538962336639,0.09688090737240077,4.026615365066519e-07,0.3046118950720742,0.07939508506616257
138,0.5,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is aneurysm repair advisable for patients aged 80 or above after an aneurysmal subarachnoid hemorrhage? The decision should be individualized, considering the patient's health, overall status, and a careful evaluation of benefits and risks. A thorough healthcare professional assessment is essential.",3.079176455639103e-07,0.09831697778084081,0.12901701323251416,0.023574544042164344,0.12772503078410402,0.113421550094518,0.023540420032387266,0.15832826112343934,0.09688090737240077,3.079176455639103e-07,0.19020154389432875,0.07939508506616257
138,0.5,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is aneurysm repair indicated for patients 80 years or older following aneurysmal subarachnoid hemorrhage? The decision should be based on the patient's specific health factors, overall condition, and the balance between potential benefits and risks. A detailed evaluation by healthcare providers is critical.",2.6054570009253947e-07,0.04952681361140909,0.12901701323251416,0.0199476911126006,0.0777146102094406,0.113421550094518,0.019918816950481533,0.10703496673588964,0.09688090737240077,2.6054570009253947e-07,0.1375578104089099,0.07939508506616257
138,0.5,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","For patients aged 80 or older who have had an aneurysmal subarachnoid hemorrhage, is aneurysm repair appropriate? The decision should be personalized, taking into account individual health status, overall wellness, and a careful consideration of risks and benefits. A comprehensive assessment by medical professionals is necessary.",1.8948778188548325e-07,0.019466057875542564,0.12901701323251416,0.014507411718254981,0.007097042995486635,0.113421550094518,0.014486412327622933,0.0347143051562635,0.09688090737240077,1.8948778188548325e-07,0.06344983825518646,0.07939508506616257
139,0.5,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during",Does blood pressure vary in treated hypertensive patients when measured by a physician versus a nurse? Systolic BP readings taken by nurses are significantly lower than those by physicians and closely match ambulatory BP monitoring. Nurse-measured BP is preferred for diagnosis and monitoring control levels.,6.868932093348768e-07,0.3210212382217992,0.183349609375,0.05258936747867436,0.45770373827583066,0.041587901701323246,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
139,0.5,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, is there a difference in blood pressure readings depending on whether a physician or nurse measures it? Nurses record significantly lower systolic BP than physicians, aligning closely with ambulatory BP monitoring, making nurse measurements ideal for diagnosis and control assessment.",7.105791820705622e-07,0.3440107564464987,0.183349609375,0.054402793943456235,0.4812342356860251,0.041587901701323246,0.05432404622858601,0.5295825376451795,0.014081632653061225,7.105791820705622e-07,0.5596157879354222,0.0
139,0.5,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","For patients with treated hypertension, does blood pressure differ based on measurement by a physician or nurse? Nurse-measured systolic BP is notably lower than physician readings and nearly identical to ambulatory monitoring, supporting nurse measurement for diagnosis and control evaluation.",8.053230730133037e-07,0.44164922601041656,0.183349609375,0.061656499802583725,0.5813176942430065,0.041587901701323246,0.06156725239239748,0.6322366917052618,0.014081632653061225,8.053230730133038e-07,0.6649763035932481,0.0
139,0.5,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Is blood pressure in treated hypertensive patients affected by whether a physician or nurse takes the measurement? Nurses obtain significantly lower systolic BP values than physicians, matching ambulatory BP monitoring, thus nurse measurements are recommended for diagnosis and control assessment.",8.053230730133037e-07,0.44164922601041656,0.183349609375,0.061656499802583725,0.5813176942430065,0.041587901701323246,0.06156725239239748,0.6322366917052618,0.014081632653061225,8.053230730133038e-07,0.6649763035932481,0.0
139,0.5,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does the blood pressure reading in treated hypertensive patients change depending on if a nurse or physician measures it? Systolic BP measured by nurses is significantly lower than by physicians and closely resembles ambulatory BP monitoring, making nurse measurements preferable for diagnosis and control evaluation.",6.868932093348768e-07,0.3210212382217992,0.183349609375,0.05258936747867436,0.45770373827583066,0.041587901701323246,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
139,0.5,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, does blood pressure measurement differ when taken by a nurse versus a physician? Nurses record systolic BP significantly lower than physicians, nearly matching ambulatory BP monitoring, suggesting nurse measurements are beneficial for diagnosis and monitoring control.",8.053230730133037e-07,0.44164922601041656,0.183349609375,0.061656499802583725,0.5813176942430065,0.041587901701323246,0.06156725239239748,0.6322366917052618,0.014081632653061225,8.053230730133038e-07,0.6649763035932481,0.0
139,0.5,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Is there a difference in blood pressure readings for treated hypertensive patients when measured by a nurse compared to a physician? Nurse-measured systolic BP is significantly lower than physician readings and aligns with ambulatory BP monitoring, indicating nurse measurements are desirable for diagnosis and control.",6.868932093348768e-07,0.3210212382217992,0.183349609375,0.05258936747867436,0.45770373827583066,0.041587901701323246,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
139,0.5,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","For treated hypertensive patients, does blood pressure vary when measured by a physician versus a nurse? Nurses obtain lower systolic BP readings than physicians, closely matching ambulatory BP monitoring, supporting the use of nurse measurements for diagnosis and control assessment.",8.053230730133037e-07,0.44164922601041656,0.183349609375,0.061656499802583725,0.5813176942430065,0.041587901701323246,0.06156725239239748,0.6322366917052618,0.014081632653061225,8.053230730133038e-07,0.6649763035932481,0.0
139,0.5,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does blood pressure in treated hypertensive patients differ based on whether it is measured by a nurse or physician? Systolic BP measured by nurses is significantly lower than physician measurements and nearly identical to ambulatory BP monitoring, making nurse measurements preferable for diagnosis and control evaluation.",6.632072365991914e-07,0.32935492372796116,0.1611388655733471,0.05077594101389249,0.43471422005113114,0.041587901701323246,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
139,0.5,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, does the method of measurement by nurse or physician affect blood pressure readings? Nurses record significantly lower systolic BP than physicians, closely resembling ambulatory BP monitoring, thus nurse measurements are desirable for diagnosis and control monitoring.",8.053230730133037e-07,0.44164922601041656,0.183349609375,0.061656499802583725,0.5813176942430065,0.041587901701323246,0.06156725239239748,0.6322366917052618,0.014081632653061225,8.053230730133038e-07,0.6649763035932481,0.0
140,0.5,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the use of audit to detect maternal mortality in various environments merely a disparity between wealth and poverty? Answer: Maternal mortality differences extend beyond just economic status. Recognizing the scale of maternal deaths and leveraging robust political commitment are crucial. Yet, no single universal solution exists to lower maternal mortality, and problem identification must be tailored.",3.789755637709665e-07,0.16960967565654617,0.07999633677000212,0.029014823436510018,0.2128062515831317,0.027755102040816333,0.02897282465524588,0.23582141911701626,0.014081632653061225,3.789755637709665e-07,0.25951119548508306,0.0
140,0.5,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality in different contexts only highlight the gap between rich and poor? Answer: The variation in maternal mortality surpasses simple economic divides. It is vital to acknowledge the severity of maternal mortality and to mobilize strong political will to address it. Nonetheless, reducing maternal mortality requires multiple approaches, as no one-size-fits-all solution exists.",4.026615365066519e-07,0.26200932484636796,0.06907273149454113,0.03082824990129189,0.23082475708581018,0.027755102040816333,0.030783626196198746,0.254170557785212,0.014081632653061225,4.026615365066519e-07,0.2782033284972374,0.0
140,0.5,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the disparity in maternal mortality audits between rich and poor settings the sole factor? Answer: Maternal mortality differences are more complex than just economic disparities. Recognizing the extent of the issue and committing politically are key. However, there is no universal fix for reducing maternal mortality, and problem identification must be context-specific.",4.737194547137081e-07,0.24420457361473868,0.07867365533056245,0.03626852929563751,0.2869142237368534,0.027755102040816333,0.036216030819057346,0.31132897162516215,0.014081632653061225,4.737194547137081e-07,0.33647223662121295,0.0
140,0.5,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality merely reflect economic differences between affluent and impoverished areas? Answer: Differences in maternal mortality involve more than economic status. Understanding the scale of the problem and harnessing political will are essential. Still, there is no single solution to reduce maternal mortality; identifying issues requires careful analysis.",5.447773729207643e-07,0.30404287158149135,0.07754293193868184,0.041708808689983126,0.34633764420765445,0.027755102040816333,0.041648435441915946,0.3719535934415963,0.014081632653061225,5.447773729207643e-07,0.3983476403393005,0.0
140,0.5,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the use of audits to identify maternal mortality just highlighting economic inequalities? Answer: Maternal mortality disparities involve more than wealth differences. Acknowledging the problem's magnitude and strong political commitment are important. However, there is no one-size-fits-all solution to maternal mortality reduction, and problem identification is necessary.",6.158352911278206e-07,0.408316576715571,0.010621021829210986,0.047149088084328744,0.40951654582918673,0.027755102040816333,0.047080840064774546,0.4364921145791678,0.014081632653061225,6.158352911278206e-07,0.46430560813109656,0.0
140,0.5,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does maternal mortality auditing only show the divide between rich and poor populations? Answer: Variations in maternal mortality are not solely economic. Recognizing the seriousness of maternal deaths and political will are critical. Yet, no single general solution exists to decrease maternal mortality; identifying problems is essential.",6.158352911278206e-07,0.36768801278185936,0.07626806143340248,0.047149088084328744,0.40951654582918673,0.027755102040816333,0.047080840064774546,0.4364921145791678,0.014081632653061225,6.158352911278206e-07,0.46430560813109656,0.0
140,0.5,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is auditing maternal mortality across different settings simply a reflection of rich versus poor? Answer: The differences in maternal mortality go beyond economic factors. Acknowledging the scale and applying strong political will are vital. Nonetheless, there is no single solution to reduce maternal mortality, and problem identification must be thorough.",5.447773729207643e-07,0.30404287158149135,0.07754293193868184,0.041708808689983126,0.34633764420765445,0.027755102040816333,0.041648435441915946,0.3719535934415963,0.014081632653061225,5.447773729207643e-07,0.3983476403393005,0.0
140,0.5,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the difference in maternal mortality audits just a matter of wealth disparity? Answer: Disparities in maternal mortality exceed economic differences. Recognizing the issue's magnitude and political will are important. However, reducing maternal mortality requires multiple approaches; problem identification is necessary.",7.57951127541933e-07,0.5889662456957163,0.027811658311687,0.05802964687301998,0.5839358472323415,0.0027715385957144123,0.057945649310491745,0.5795929582198429,0.014081632653061225,7.57951127541933e-07,0.6109090823229719,0.0
140,0.5,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does the audit of maternal mortality only reveal disparities between rich and poor communities? Answer: Maternal mortality differences are more complex than just economic status. Acknowledging the scale and political commitment are crucial. Still, no universal solution exists to reduce maternal mortality; identifying the problems is key.",6.158352911278206e-07,0.36768801278185936,0.07626806143340248,0.047149088084328744,0.40951654582918673,0.027755102040816333,0.047080840064774546,0.4364921145791678,0.014081632653061225,6.158352911278206e-07,0.46430560813109656,0.0
140,0.5,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the use of auditing to detect maternal mortality simply a reflection of economic differences? Answer: Differences in maternal mortality involve more than wealth gaps. Recognizing the problem's magnitude and strong political will are important. However, there is no single general solution to reduce maternal mortality; problem identification is essential.",5.447773729207643e-07,0.30404287158149135,0.07754293193868184,0.041708808689983126,0.34633764420765445,0.027755102040816333,0.041648435441915946,0.3719535934415963,0.014081632653061225,5.447773729207643e-07,0.3983476403393005,0.0
141,0.5,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is measuring visceral adipose tissue area at one level sufficient to represent visceral adipose tissue volume? Measuring VAT area 3 cm above the lower edge of the L3 vertebra is practical and can indicate changes in VAT volume and body weight. New insights: VAT area on a CT slice 3 cm above,1.6580180914979784e-07,0.06429405464963356,0.0775190926275992,0.012693985253473108,0.08919622203576916,0.02984516534156085,0.012675610786670066,0.08402087972738315,0.03566529492455417,1.6580180914979784e-07,0.11092682230421813,0.0181755829903978
141,0.5,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can a single-level measurement of visceral adipose tissue area accurately represent visceral adipose tissue volume? Measuring VAT area at a single level 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Knowledge advancement: VAT area at a CT slice 3 cm above,1.1842986367842703e-07,0.07301204360468283,0.04538298676748584,0.009067132323909363,0.10116176221614426,0.006613167991772473,0.009054007704764333,0.0711977874885843,0.016065294924554174,1.1842986367842703e-07,0.07010482778396376,0.0181755829903978
141,0.5,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Does measuring visceral adipose tissue area at one specific level correspond to visceral adipose tissue volume? VAT area measurement 3 cm above the lower margin of the L3 vertebra is practical and can reflect changes in VAT volume and body weight. Advances in understanding: VAT area at a CT slice 3 cm above,1.4211583641411244e-07,0.0689217985857109,0.06097844990548197,0.010880558788691236,0.0683063050445929,0.030625366877957715,0.0108648092457172,0.06381817240986454,0.03566529492455417,1.4211583641411244e-07,0.09030753510148237,0.0181755829903978
141,0.5,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is it possible for visceral adipose tissue area measured at a single level to represent visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is feasible and correlates with changes in VAT volume and body weight. Knowledge progress: VAT area at a CT slice 3 cm above,9.474389094274162e-08,0.02525713572628474,0.06502499999999997,0.0072537058591274906,0.027788534226238948,0.03209790467258739,0.007243206163811466,0.024597459256582077,0.03566529492455417,9.474389094274162e-08,0.050302200487784,0.0181755829903978
141,0.5,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can a single measurement of visceral adipose tissue area serve as a proxy for visceral adipose tissue volume? VAT area measurement at 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: VAT area at a CT slice 3 cm above,7.105791820705622e-08,0.02109794963120315,0.08439999999999999,0.005440279394345618,0.008127642051876549,0.03279347237640635,0.0054324046228586,0.005549264285888977,0.03566529492455417,7.105791820705622e-08,0.030884114630681303,0.0181755829903978
141,0.5,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is a single-level measurement of visceral adipose tissue area indicative of visceral adipose tissue volume? Measuring VAT area 3 cm above the lower edge of the L3 vertebra is practical and can mirror changes in VAT volume and body weight. Knowledge update: VAT area at a CT slice 3 cm above,1.8948778188548325e-07,0.114540793405701,0.0566314049586777,0.014507411718254981,0.1388223198750156,0.008811637721313034,0.014486412327622933,0.1335212994534496,0.014841392706355885,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
141,0.5,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can visceral adipose tissue area assessed at one level represent the volume of visceral adipose tissue? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Advances in knowledge: VAT area at a CT slice 3 cm above,7.105791820705622e-08,0.02109794963120315,0.08439999999999999,0.005440279394345618,0.017544475746639865,0.051263794944820223,0.0054324046228586,0.005549264285888977,0.03566529492455417,7.105791820705622e-08,0.030884114630681303,0.0181755829903978
141,0.5,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Does a single-level VAT area measurement correspond to visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is practical and can indicate changes in VAT volume and body weight. Knowledge advancement: VAT area at a CT slice 3 cm above,2.6054570009253947e-07,0.13917631183714851,0.04351844240129796,0.0199476911126006,0.1472628904674127,0.04804732583538801,0.019918816950481533,0.16917868806769043,0.03566529492455417,2.6054570009253947e-07,0.19793819929384737,0.0181755829903978
141,0.5,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is measuring VAT area at one level enough to represent visceral adipose tissue volume? VAT area measurement 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Advances in knowledge: VAT area at a CT slice 3 cm above,2.1317375462116866e-07,0.12052531921258769,0.02822231404958675,0.016320838183036854,0.13232870715788936,0.02818781919579315,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
141,0.5,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can VAT area measured at a single level represent visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is practical and can reflect changes in VAT volume and body weight. Knowledge progress: VAT area at a CT slice 3 cm above,2.3685972735685406e-07,0.1443141302033184,0.025130124391563008,0.018134264647818726,0.12511547601373918,0.0485091802543943,0.018108015409528666,0.14719978134891543,0.03566529492455417,2.3685972735685406e-07,0.17546534344178966,0.0181755829903978
142,0.5,1,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Does the menopausal transition influence quality of life? Yes, it can impact quality of life because of symptoms like hot flashes, mood swings, sleep problems, and decreased sexual desire, though the effect differs among women.",1.658018091497972e-07,0.0927366752973362,0.0670359884119098,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.5,2,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Is quality of life affected by menopausal transition? Indeed, menopausal transition may affect quality of life due to symptoms including hot flashes, mood changes, sleep disruptions, and lower sexual desire, with variations for each woman.",1.658018091497972e-07,0.13351003885968638,0.03782699506939374,0.012693985253473122,0.16506609462539767,0.019588058344875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.5,3,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Can the menopausal transition alter quality of life? Yes, it can influence quality of life through symptoms such as hot flashes, mood swings, sleep disturbances, and diminished sexual desire, but the degree varies among women.",1.658018091497972e-07,0.0927366752973362,0.0670359884119098,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.5,4,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Does going through menopause impact quality of life? Yes, menopausal transition can affect it because of symptoms like hot flashes, mood swings, sleep issues, and reduced sexual desire, although the impact varies for every woman.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.5,5,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Is the quality of life influenced by menopausal transition? Yes, it can be affected due to symptoms such as hot flashes, mood swings, sleep disturbances, and lessened sexual desire, but the extent varies between women.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.5,6,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Does the menopausal transition have an effect on quality of life? Yes, it can affect quality of life owing to symptoms like hot flashes, mood swings, sleep problems, and a decline in sexual desire, though this varies among women.",7.1057918207056e-08,0.022780892819451726,0.07012417823228637,0.005440279394345618,0.008646823413716476,0.049861495844875335,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
142,0.5,7,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Is quality of life impacted by menopausal transition? Yes, menopausal transition may impact it because of symptoms including hot flashes, mood swings, sleep disturbances, and reduced sexual desire, with differences for each woman.",2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
142,0.5,8,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Can menopausal transition affect quality of life? Yes, it can due to symptoms such as hot flashes, mood swings, sleep problems, and decreased sexual desire, but the effects differ for each woman.",2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
142,0.5,9,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Does the transition through menopause affect quality of life? Yes, it can influence quality of life because of symptoms like hot flashes, mood swings, sleep disturbances, and reduced sexual desire, though the impact varies among women.",1.421158364141119e-07,0.0625841851794462,0.06787403226662558,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.5,10,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Is quality of life changed by menopausal transition? Yes, it can be impacted due to symptoms such as hot flashes, mood swings, sleep disruptions, and lower sexual desire, but the effect differs for each woman.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
143,0.5,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis of low-tone sudden deafness—does it always lead to Meniere's disease? We conclude that not all patients with low-tone sudden deafness (SD) experience endolymphatic hydrops, even if they have vertigo attacks at onset, and that electrocochleography (ECochG) serves as a valuable prognostic tool.",2.3685972735685406e-08,0.0074882197977830245,0.021177685950413232,0.0018134264647818726,0.00833368550616198,0.02221074380165289,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
143,0.5,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably develop into Meniere's disease? Our findings indicate that not every low-tone sudden deafness (SD) patient has endolymphatic hydrops despite vertigo attacks at onset, and electrocochleography (ECochG) is a useful tool for prognosis.",2.3685972735685364e-07,0.26186514355375623,0.01197489204724185,0.018134264647818726,0.26011629724039764,0.006335969001115268,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,0.5,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression to Meniere's disease unavoidable in low-tone sudden deafness? We found that endolymphatic hydrops is not present in all low-tone sudden deafness (SD) patients even if vertigo attacks occur initially, and that electrocochleography (ECochG) is an effective prognostic method.",1.6580180914979774e-07,0.1403520917441563,0.01776516105400517,0.012693985253473108,0.13826978868571338,0.02221074380165289,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
143,0.5,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always progress to Meniere's disease? Our conclusion is that endolymphatic hydrops does not affect all low-tone sudden deafness (SD) patients, even those with vertigo at onset, and electrocochleography (ECochG) is a beneficial prognostic tool.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.5,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is it certain that low-tone sudden deafness leads to Meniere's disease? We conclude that not all patients with low-tone sudden deafness (SD) develop endolymphatic hydrops despite vertigo attacks at the beginning, and electrocochleography (ECochG) is a useful prognostic indicator.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.5,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the likelihood that low-tone sudden deafness progresses to Meniere's disease? Our study shows that endolymphatic hydrops is not found in all low-tone sudden deafness (SD) patients even if vertigo attacks occur initially, and electrocochleography (ECochG) is a helpful prognostic tool.",1.1842986367842703e-07,0.12241977708658869,0.005263772746290217,0.009067132323909363,0.12163385332616006,0.0027728196434490295,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
143,0.5,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness necessarily lead to Meniere's disease? We conclude that some low-tone sudden deafness (SD) patients do not have endolymphatic hydrops even when vertigo attacks are present at onset, and electrocochleography (ECochG) is a useful prognostic method.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.5,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression from low-tone sudden deafness to Meniere's disease unavoidable? Findings indicate that not all low-tone sudden deafness (SD) patients have endolymphatic hydrops despite vertigo at onset, and electrocochleography (ECochG) is a valuable prognostic tool.",2.8423167282822424e-07,0.3235539311228548,0.015205320247933876,0.021761117577382486,0.32135730697955545,0.008062693698347109,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
143,0.5,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always result in Meniere's disease? We conclude that endolymphatic hydrops does not occur in every low-tone sudden deafness (SD) patient, even those with vertigo attacks initially, and that electrocochleography (ECochG) is a useful prognostic tool.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.5,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is it inevitable that low-tone sudden deafness leads to Meniere's disease? Our conclusion is that not all low-tone sudden deafness (SD) patients suffer from endolymphatic hydrops despite vertigo attacks at onset, and electrocochleography (ECochG) provides useful prognostic information.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
144,0.5,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Is there a connection between a resident's leadership abilities and their technical skill ratings? Answer: No, there is no direct link between a resident's leadership abilities and their technical skill ratings. Leadership and technical skills are separate attributes that both contribute to overall competence, but one does not directly influence the other.",9.474389094274162e-08,0.050954450251711414,0.021307696632371947,0.0072537058591274906,0.02011079149599615,0.07024793388429755,0.007243206163811466,0.08297371439533574,0.11776859504132227,9.474389094274162e-08,0.05630079993723269,0.10072314049586772
144,0.5,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Are a resident's leadership skills associated with their technical skill ratings? Answer: There is no direct association between a resident's leadership skills and their technical skill ratings. Leadership and technical skills are independent traits that both play a role in overall proficiency, but one does not necessarily affect the other.",4.737194547137081e-08,0.08638035654334608,0.07130259511211887,0.0036268529295637453,0.04528440554808055,0.002568974675436278,0.003621603081905733,0.013678481895465833,0.020823902218198284,4.737194547137081e-08,0.04348511193973836,0.0
144,0.5,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Do leadership skills in residents correlate with their technical skill ratings? Answer: There is no direct correlation between residents' leadership skills and their technical skill ratings. These two skill sets are distinct and both contribute to overall capability, but one does not inherently impact the other.",4.737194547137081e-08,0.05121768190411791,0.10516808129417257,0.0036268529295637453,0.01419522081607738,0.041322314049586764,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
144,0.5,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Does a resident's leadership skill level relate to their technical skill ratings? Answer: No direct relationship exists between a resident's leadership skills and their technical skill ratings. Leadership and technical skills are different competencies that both influence overall performance, yet one does not necessarily affect the other.",2.3685972735685406e-08,0.04515189011853371,0.08569809751915906,0.0018134264647818726,0.006707001018294356,0.020144628099173528,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
144,0.5,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Is there a relationship between residents' leadership skills and their technical skill evaluations? Answer: There is no direct relationship between leadership skills and technical skill evaluations in residents. Both skill sets are unique qualities that contribute to overall ability, but one does not directly impact the other.",2.3685972735685406e-08,0.04515189011853371,0.08569809751915906,0.0018134264647818726,0.03684383495568344,0.041804662789511254,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
144,0.5,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Are a resident's leadership capabilities linked to their technical skill ratings? Answer: There is no direct link between a resident's leadership capabilities and their technical skill ratings. Leadership and technical skills are separate competencies that together contribute to overall effectiveness, but one does not directly influence the other.",0.0,0.039782135518425576,0.0673097795094241,0.0,0.0,0.0,0.0,0.03013683393738864,0.021728395061728398,0.0,0.0,0.0
144,0.5,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Do residents' leadership skills influence their technical skill ratings? Answer: Leadership skills do not directly influence residents' technical skill ratings. These are distinct qualities that both contribute to overall competence, but one does not necessarily affect the other.",2.3685972735685385e-07,0.12238991415799694,0.11759889140841517,0.018134264647818726,0.15074281495179687,0.06353305785123965,0.018108015409528666,0.24512245803298427,0.0,2.3685972735685406e-07,0.2513144282809061,0.0
144,0.5,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Is there a correlation between a resident's leadership abilities and technical skill ratings? Answer: No, leadership abilities and technical skill ratings in residents do not have a direct correlation. Both are separate skills that contribute to overall proficiency, but one does not inherently impact the other.",4.737194547137081e-08,0.021080847966728822,0.08390022675736956,0.0036268529295637453,0.04741786190036201,0.0027934727610052362,0.003621603081905733,0.10746514262173745,0.045351473922902494,4.737194547137081e-08,0.07770177782373144,0.023242630385487524
144,0.5,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Does the leadership skill of a resident affect their technical skill ratings? Answer: There is no effect of a resident's leadership skill on their technical skill ratings. Leadership and technical skills are distinct qualities that both contribute to overall competency, but one does not necessarily influence the other.",0.0,0.06866326804175671,0.08742339911171076,0.0,0.05899124940935696,0.042266517208517554,0.0,0.0,0.0,0.0,0.0,0.0
144,0.5,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Are the leadership skills of residents related to their technical skill ratings? Answer: The leadership skills of residents are not directly related to their technical skill ratings. These skills are independent attributes that both contribute to overall ability, but one does not necessarily impact the other.",4.737194547137081e-08,0.09946648778282752,0.0038630410612998656,0.0036268529295637453,0.139837485975022,0.06664445694165981,0.003621603081905733,0.17047852267264174,0.09,4.737194547137081e-08,0.10994118157070565,0.046400951814396206
145,0.5,1,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Question: Can student examiners serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies provided they receive proper training and possess adequate skills.,9.474389094274162e-08,0.061532502650274434,0.01288258614906998,0.0072537058591274906,0.05750215177378282,0.020112456747404833,0.007243206163811466,0.05630590065753838,0.02373824070069208,9.474389094274162e-08,0.054915973106960614,0.027587045847750902
145,0.5,2,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Question: Are student examiners suitable replacements for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may act as suitable substitutes for faculty in an undergraduate OSCE on medical emergencies if they have undergone proper training and demonstrate competence.,1.1842986367842703e-07,0.025363411581724282,0.04390495867768596,0.009067132323909363,0.01883714309100082,0.05885212616889246,0.009054007704764333,0.015866475023341486,0.0660783678241999,1.1842986367842703e-07,0.012565297516012208,0.07341105296437167
145,0.5,3,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Question: Is it acceptable for student examiners to replace faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may reasonably replace faculty in an undergraduate OSCE on medical emergencies, given that they are well-trained and capable.",1.8948778188548293e-07,0.12580540215067648,0.0316427708061045,0.014507411718254981,0.11665285539427872,0.0476124567474048,0.014486412327622933,0.11373947206993629,0.055747789311803214,1.8948778188548325e-07,0.11034647913186335,0.06437524029219531
145,0.5,4,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Question: Could student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners might be reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies as long as they have received adequate training and have good proficiency.,2.3685972735685406e-08,0.032138740192058535,0.023792501930281124,0.0018134264647818726,0.03416215205402784,0.03128592613515993,0.0018108015409528666,0.03557507612592481,0.03463667820069205,2.3685972735685406e-08,0.037086171675941415,0.03788997952122025
145,0.5,5,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Question: May student examiners act as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies if they are properly trained and competent.,1.4211583641411233e-07,0.12888243993688064,0.005483436680064152,0.010880558788691236,0.12338801838364732,0.012056901191849323,0.0108648092457172,0.12239947548438623,0.015747789311803234,1.4211583641411244e-07,0.1211436712291647,0.01993079584775087
145,0.5,6,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Question: Is it reasonable for student examiners to substitute for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies provided they have been sufficiently trained and are skilled.,4.737194547137081e-08,0.06630089224608637,0.055078428065441054,0.0036268529295637453,0.07050483303107091,0.06872356785851597,0.003621603081905733,0.07346629679206407,0.07503791276859327,4.737194547137081e-08,0.07663646850332118,0.08116536374898543
145,0.5,7,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Question: Are student examiners reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies as long as they have proper training and adequate ability.,1.1842986367842703e-07,0.09467812963771838,0.009182736455463802,0.009067132323909363,0.08992916160997089,0.016145235103284028,0.009054007704764333,0.08882933613491417,0.019818780177799228,1.1842986367842703e-07,0.08750012784681571,0.02384338689873941
145,0.5,8,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Question: Can student examiners reasonably substitute for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can reasonably substitute for faculty in an undergraduate OSCE on medical emergencies if they receive proper training and demonstrate good capability.,1.6580180914979763e-07,0.16421213930316192,0.0018131219429920464,0.012693985253473108,0.15794414234273502,0.007850268875823407,0.012675610786670066,0.1570837803991072,0.011521339318409152,1.6580180914979784e-07,0.1559159499154803,0.015840427238951876
145,0.5,9,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Question: Could student examiners reasonably replace faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners might reasonably replace faculty in an undergraduate OSCE on medical emergencies as long as they have good training and competence.,2.1317375462116823e-07,0.20003864529554471,0.009182736455463802,0.016320838183036854,0.1910335443983051,0.020112456747404833,0.016297213868575806,0.18932513872873047,0.026269331261916495,2.1317375462116866e-07,0.18715058820182717,0.03324712237836319
145,0.5,10,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Question: Is it feasible for student examiners to be reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be feasible substitutes for faculty in an undergraduate OSCE on medical emergencies provided they have been adequately trained and are proficient.,2.3685972735685406e-08,0.06364543021751068,0.04038455051442058,0.0018134264647818726,0.06640155580100204,0.05097665427826903,0.0018108015409528666,0.06858208472401728,0.055747789311803214,2.3685972735685406e-08,0.07089822926423173,0.06033203041565209
146,0.5,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream interventions: does the supplemental security income program decrease disability among the elderly? Answer: Income support policies could be a powerful tool for enhancing public health, particularly for low-income groups. Although the results are strong, additional studies are necessary to verify their accuracy. Future investigations should explore various income support policies and consider a wider spectrum.",1.8948778188548325e-07,0.16138105612916487,0.02004423168444331,0.014507411718254981,0.16100689317942596,0.0181755829903978,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
146,0.5,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: can the supplemental security income program lower disability rates in older adults? Answer: Income support initiatives may serve as an important approach to boost population health, especially for those with lower incomes. Despite robust findings, further research is required to confirm their validity. Upcoming studies should assess different income support policies and a broader range of factors.",1.1842986367842703e-07,0.08318130465670848,0.0013230509097107834,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
146,0.5,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream strategies: does the supplemental security income program reduce disability among seniors? Answer: Income support policies might represent a key lever to improve health outcomes for the general population, particularly low-income individuals. Even with strong evidence, more analysis is needed to ensure reliability. Future research should investigate various income support programs and a wider array of related policies.",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
146,0.5,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream approaches: does the supplemental security income program diminish disability in elderly populations? Answer: Income support measures may be a crucial new method for enhancing public health, especially for economically disadvantaged groups. While findings are consistent, further studies are needed to confirm their dependability. Future work should examine multiple income support policies and a broader scope of interventions.",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
146,0.5,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Question: Upstream solutions: does the supplemental security income program lessen disability in the elderly? Answer: Income support policies could be an effective mechanism for improving health across populations, particularly among lower-income individuals. Despite robust results, additional research is necessary to validate these findings. Future studies should explore a variety of income support policies and a wider range of related strategies.",9.474389094274162e-08,0.0890874837824045,0.017672634738486057,0.0072537058591274906,0.08909379708106879,0.01694411414982164,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
146,0.5,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Question: Upstream interventions: does the supplemental security income program decrease disability in older adults? Answer: Income support programs may provide a significant tool for enhancing population health, especially for low-income groups. Although findings are strong, further analysis is required to confirm their reliability. Future research should focus on different income support policies and a broader range of approaches.",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
146,0.5,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Question: Upstream solutions: does the supplemental security income program reduce disability among elderly individuals? Answer: Income support policies might be an important new lever to improve health outcomes, particularly for those with lower incomes. Even though the results are robust, more research is needed to confirm their validity. Future studies should examine a variety of income support policies and broader strategies.",7.105791820705622e-08,0.0718006439289427,0.01712814675701641,0.005440279394345618,0.07189507018810026,0.016661878770468257,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
146,0.5,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Question: Upstream strategies: does the supplemental security income program lower disability rates in the elderly? Answer: Income support initiatives may be a vital lever for improving population health, especially for low-income persons. Despite strong findings, additional research is needed to verify their reliability. Future investigations should consider various income support policies and a wider range of factors.",1.6580180914979784e-07,0.11849191983648222,0.0019172020660115936,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
146,0.5,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Question: Upstream approaches: does the supplemental security income program reduce disability in older adults? Answer: Income support policies could be a key method for enhancing health outcomes, particularly among economically disadvantaged populations. While findings are robust, further studies are necessary to confirm their dependability. Future research should explore multiple income support policies and a broader spectrum of interventions.",1.4211583641411244e-07,0.12458247725247595,0.018817712270093226,0.010880558788691236,0.12440441226084253,0.01753826530612245,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
146,0.5,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support programs may be a significant new approach to improve population health, especially for lower-income individuals. Although findings are strong, further analyses are needed to confirm their accuracy. Future research should investigate a variety of income support policies as well as a broader range of strategies.",4.737194547137081e-08,0.03244743539175943,0.0005036344218079854,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
147,0.5,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is there a correlation between the radiographic transition zone and the extent of aganglionosis in Hirschsprung's disease? The correlation between the radiographic transition zone seen on contrast enema and the length of aganglionosis is low. Systematic preoperative biopsy is recommended.,4.73719454713706e-08,0.04630867066935851,0.06437869461662077,0.0036268529295637453,0.053350324255096115,0.07605112633288609,0.003621603081905733,0.05683239434139642,0.08044982698961935,4.737194547137081e-08,0.019857939555601334,0.055363321799307974
147,0.5,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the location of the radiographic transition zone correspond to the level of aganglionosis in Hirschsprung's disease? There is a weak correlation between the radiographic transition zone on contrast enema and the length of aganglionosis. Preoperative biopsy should be performed systematically.,7.10579182070559e-08,0.12385912504733065,0.032012803511575,0.005440279394345618,0.047458865852340715,0.02337711125355912,0.0054324046228586,0.04575666768118669,0.026296566837107373,7.105791820705622e-08,0.08455738802806367,0.0
147,0.5,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"In Hirschsprung's disease, does the radiographic transition zone align with the aganglionosis level? The correlation between the transition zone on contrast enema and aganglionosis length is minimal. Systematic biopsy before surgery is advised.",1.184298636784265e-07,0.03863404796788572,0.07530226109357693,0.009067132323909391,0.1110235572731888,0.02775510204081633,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
147,0.5,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Is the radiographic transition zone on contrast enema indicative of the aganglionosis extent in Hirschsprung's disease? The correlation between these two is low, so systematic preoperative biopsy is necessary.",2.131737546211677e-07,0.12884374180741043,0.10651974288337923,0.01632083818303691,0.24917389575400595,0.02775510204081633,0.016297213868575862,0.29725152346793093,0.0,2.1317375462116866e-07,0.3074846997479619,0.0
147,0.5,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone correlate with aganglionosis level in Hirschsprung's disease specimens? The correlation remains low between the radiographic transition zone on contrast enema and aganglionosis length. Systematic biopsy before surgery is essential.,9.47438909427412e-08,0.09056745061794258,0.016519742883379193,0.007253705859127511,0.16591825652860326,0.034467120181405894,0.007243206163811494,0.1660800299436178,0.0322222222222222,9.474389094274162e-08,0.125163142954007,0.0
147,0.5,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"In Hirschsprung's disease, is the radiographic transition zone a reliable marker for the length of aganglionosis? The correlation is low, emphasizing the need for systematic preoperative biopsy.",2.605457000925383e-07,0.2029517139611321,0.10651974288337923,0.01994769111260067,0.3261349368901354,0.02775510204081633,0.01991881695048161,0.3772942311414682,0.0,2.6054570009253947e-07,0.39086630868701233,0.0
147,0.5,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"How well does the radiographic transition zone correspond to the aganglionosis level in Hirschsprung's disease? The correlation is weak, so systematic preoperative biopsy is recommended.",3.079176455639089e-07,0.28299442163466937,0.10651974288337923,0.023574544042164428,0.40951654582918584,0.02775510204081633,0.023540420032387356,0.4643056081310979,0.0,3.079176455639103e-07,0.4818380868927403,0.0
147,0.5,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Does the contrast enema radiographic transition zone match the level of aganglionosis in Hirschsprung's disease? The correlation is low, hence systematic preoperative biopsy is important.",3.079176455639089e-07,0.28299442163466937,0.10651974288337923,0.023574544042164428,0.40951654582918584,0.02775510204081633,0.023540420032387356,0.4643056081310979,0.0,3.079176455639103e-07,0.4818380868927403,0.0
147,0.5,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Is there a strong relationship between the radiographic transition zone and aganglionosis length in Hirschsprung's disease? The correlation is low, making systematic preoperative biopsy necessary.",3.079176455639089e-07,0.28299442163466937,0.10651974288337923,0.023574544042164428,0.40951654582918584,0.02775510204081633,0.023540420032387356,0.4643056081310979,0.0,3.079176455639103e-07,0.4818380868927403,0.0
147,0.5,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Can the radiographic transition zone on contrast enema predict the extent of aganglionosis in Hirschsprung's disease? The correlation is low, so systematic preoperative biopsy should be conducted.",2.605457000925383e-07,0.2029517139611321,0.10651974288337923,0.01994769111260067,0.3261349368901354,0.02775510204081633,0.01991881695048161,0.3772942311414682,0.0,2.6054570009253947e-07,0.39086630868701233,0.0
148,0.5,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in children are uncommon and frequently missed injuries, typically caused by age-specific trauma. Ultrasound is effective for detecting these fractures, while X-rays are preferred to assess the degree of displacement.",4.5003348197802176e-07,0.4503099137206008,0.01999167013744273,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
148,0.5,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In growing children, sternal fractures are rare and often go unnoticed. These isolated fractures usually result from trauma common to their age group. Ultrasonography helps in diagnosis, and radiography is best for evaluating the extent of dislocation.",3.3160361829959526e-07,0.30077817974963716,0.01999167013744273,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
148,0.5,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in pediatric patients are infrequent and often overlooked, generally stemming from trauma typical for their age. Ultrasound serves as a valuable diagnostic tool, whereas radiography is ideal for visualizing dislocation severity.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
148,0.5,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in children, although rare, are frequently missed and are generally caused by typical traumatic events related to age. Ultrasonography is useful for detecting fractures, with radiography being the preferred method to determine dislocation extent.",3.5528959103528056e-07,0.328949056716334,0.01999167013744273,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
148,0.5,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In children, sternal fractures are uncommon and often not recognized. These fractures typically arise from trauma associated with their age. Ultrasonography is a useful diagnostic method, and radiography is the standard for assessing dislocation.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
148,0.5,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Growing children rarely sustain sternal fractures, which are often overlooked. Such fractures usually result from age-related trauma. Ultrasonography is effective for fracture detection, while radiography is used to evaluate the extent of dislocation.",4.2634750924233646e-07,0.418561215406021,0.01999167013744273,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
148,0.5,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in the pediatric population are rare and frequently missed, commonly caused by trauma typical for their age group. Ultrasound is a helpful diagnostic tool, and radiography is the preferred technique to assess dislocation.",3.7897556377096586e-07,0.3579365935895855,0.01999167013744273,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
148,0.5,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In childhood, isolated sternal fractures are rare and often unnoticed injuries, typically due to trauma common in that age group. Ultrasonography aids in diagnosis, and radiography is the method of choice for viewing dislocation.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
148,0.5,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in growing children are uncommon and often overlooked, usually resulting from typical age-related trauma. Ultrasonography is beneficial for detecting fractures, while radiography is preferred to visualize dislocation.",4.974054274493924e-07,0.5170012882192743,0.01999167013744273,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
148,0.5,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in children are infrequent and often missed injuries caused by age-specific trauma. Ultrasonography is useful for detection, and radiography is the preferred method to assess the extent of dislocation.",4.7371945471370706e-07,0.4830997365435925,0.01999167013744273,0.036268529295637494,0.5245244681241537,0.0,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
149,0.5,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a newly identified risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of aripiprazole might account for the development of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.5,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be a novel risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed alongside existing case reports. The dopamine partial agonist properties of aripiprazole may explain the emergence of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.5,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Does aripiprazole represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated in the context of other published case reports. The mechanism of aripiprazole as a dopamine partial agonist could clarify the occurrence of pathological gambling.,1.658018091497971e-07,0.19237189264745602,0.0,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
149,0.5,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: is it a new risk factor for pathological gambling? Answer: Adverse drug reactions were reviewed with reference to prior case reports. The dopamine partial agonist effect of aripiprazole might explain why pathological gambling occurs.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.5,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole associated with a new risk for pathological gambling? Answer: Adverse drug reactions were compared with other documented case reports. The dopamine partial agonist mechanism of aripiprazole could explain the manifestation of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.5,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be linked to a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with previously published cases. The dopamine partial agonist action of aripiprazole may be responsible for pathological gambling.,4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.5,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a potential new risk factor for pathological gambling? Answer: Adverse drug reactions were assessed alongside other published case reports. The dopamine partial agonist mechanism of aripiprazole might explain pathological gambling occurrences.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
149,0.5,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: a potential new risk factor for pathological gambling? Answer: Adverse drug reactions were examined in relation to existing case reports. The dopamine partial agonist property of aripiprazole could account for pathological gambling.,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
149,0.5,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole represent a novel risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed with other published case studies. The dopamine partial agonist mechanism of aripiprazole may explain the development of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.5,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole implicated as a new risk factor in pathological gambling? Answer: Adverse drug reactions were reviewed alongside previously published case reports. The dopamine partial agonist effect of aripiprazole could explain pathological gambling occurrence.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
150,0.5,1,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Do preoperative statins lower the risk of atrial fibrillation following coronary artery bypass graft surgery? Evidence suggests that using statins before surgery can decrease atrial fibrillation occurrence.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
150,0.5,2,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Can taking statins before coronary artery bypass grafting reduce atrial fibrillation? Studies indicate preoperative statin therapy might lessen atrial fibrillation rates.,1.4211583641411185e-07,0.2090452505782654,0.03840000000000001,0.010880558788691277,0.27443684570175986,0.0,0.010864809245717241,0.28768207245178035,0.0,1.4211583641411222e-07,0.3022808718729335,0.0
150,0.5,3,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Is atrial fibrillation less common after coronary artery bypass grafting when patients use statins preoperatively? There is supporting evidence that pre-surgery statin use reduces atrial fibrillation.,2.36859727356853e-08,0.014098300735944314,0.03840000000000001,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.5,4,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Does administering statins prior to coronary artery bypass grafting help prevent atrial fibrillation? Research shows that preoperative statins may cut down atrial fibrillation incidence.,7.10579182070559e-08,0.06928330820310613,0.03840000000000001,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
150,0.5,5,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Are preoperative statins effective in reducing atrial fibrillation after coronary artery bypass grafting? Evidence points to a beneficial effect of statins before surgery in lowering atrial fibrillation.,0.0,0.053319013889226774,0.03840000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
150,0.5,6,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Do statins given before coronary artery bypass grafting decrease the chance of atrial fibrillation? Data indicates that preoperative statin use can reduce atrial fibrillation occurrence.,4.73719454713706e-08,0.026723693784310498,0.03840000000000001,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
150,0.5,7,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Is the occurrence of atrial fibrillation after coronary artery bypass grafting reduced by preoperative statin therapy? There is evidence supporting this reduction.,1.184298636784265e-07,0.16025508640883412,0.03840000000000001,0.009067132323909398,0.2231435513142097,0.0,0.009054007704764368,0.23361485118150505,0.0,1.1842986367842687e-07,0.2451224580329847,0.0
150,0.5,8,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Does preoperative statin treatment reduce the likelihood of atrial fibrillation post-coronary artery bypass graft surgery? Evidence suggests it does.,1.8948778188548256e-07,0.31440576623609084,0.03840000000000001,0.014507411718255033,0.38566248081198395,0.0,0.014486412327622985,0.40546510810816416,0.0,1.8948778188548293e-07,0.42744401482693917,0.0
150,0.5,9,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Can pre-surgery statin use diminish atrial fibrillation following coronary artery bypass grafting? Research supports that statins before surgery may reduce atrial fibrillation.,1.184298636784265e-07,0.16025508640883412,0.03840000000000001,0.009067132323909398,0.2231435513142097,0.0,0.009054007704764368,0.23361485118150505,0.0,1.1842986367842687e-07,0.2451224580329847,0.0
150,0.5,10,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Is there a decrease in atrial fibrillation after coronary artery bypass grafting with preoperative statin use? Evidence indicates preoperative statins may lower atrial fibrillation rates.,4.73719454713706e-08,0.08448595883097099,0.0031879017013232494,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
151,0.5,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are there discrepancies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist between clinicians and clinical pathologists regarding the clinical significance of certain RBC morphology terms. Adding interpretive comments to CBC reports is the most effective method to guarantee that RBC morphology changes are understood as intended by the clinical pathologist. Reporting methods should be critically reviewed to enhance accuracy.,9.474389094274162e-08,0.0004930230695716631,0.045351473922902494,0.0072537058591274906,0.06351340572232633,0.0,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
151,0.5,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a mismatch between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology? Clinicians and clinical pathologists differ notably in their views on the clinical importance of some RBC morphology terminology. Including explanatory notes on CBC reports ensures that RBC morphology alterations are interpreted correctly according to the clinical pathologist's intent. Reporting procedures need critical evaluation for improvement.,2.3685972735685406e-08,0.08443893207439856,0.049048751486325794,0.0018134264647818726,0.01652930195121094,0.0,0.0018108015409528666,0.01680711831638071,0.0,2.3685972735685406e-08,0.01709443335929972,0.0
151,0.5,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Do clinical pathologists and clinicians disagree in the reporting and interpretation of red blood cell morphology? There are important differences in how clinicians and clinical pathologists perceive the clinical relevance of certain RBC morphology terms. The clearest way to ensure RBC morphology changes are interpreted as the clinical pathologist intends is to include interpretive comments on CBC reports. Reporting protocols should be critically assessed to foster improvement.,9.474389094274162e-08,0.0004930230695716631,0.045351473922902494,0.0072537058591274906,0.06351340572232633,0.0,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
151,0.5,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there discordance between clinicians and clinical pathologists in reporting and interpreting red blood cell morphology? Clinicians and clinical pathologists hold differing views on the clinical significance of specific RBC morphology terms. The inclusion of interpretive comments in CBC reports is the best way to ensure RBC morphology changes are understood as intended by the clinical pathologist. Reporting practices warrant critical review for enhancement.,2.3685972735685406e-08,0.09402302064719947,0.07877526753864447,0.0018134264647818726,0.028458652067570256,0.0322222222222222,0.0018108015409528666,0.006196835116328181,0.016388888888888897,2.3685972735685406e-08,0.01680711831638071,0.0
151,0.5,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? Key differences exist between clinicians and clinical pathologists regarding the clinical relevance of certain RBC morphology terms. Providing interpretive comments on CBC reports is the most straightforward approach to ensure RBC morphology changes are interpreted as the clinical pathologist intends. Reporting methods should be critically examined to improve them.,4.737194547137081e-08,0.033233849862913445,0.04676162321956463,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,0.5,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a difference in how clinical pathologists and clinicians report and interpret red blood cell morphology? Important clinical relevance differences exist between clinicians and clinical pathologists about certain RBC morphology terms. The inclusion of interpretive comments on CBC reports clearly ensures that RBC morphology changes are interpreted as the clinical pathologist intends. Reporting practices should be critically evaluated for improvement.,4.737194547137081e-08,0.07899963486032124,0.033293697978596916,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
151,0.5,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are there inconsistencies between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Significant differences exist between clinicians and clinical pathologists concerning the clinical importance of certain RBC morphology terms. Including interpretive comments on CBC reports is the clearest method to ensure RBC morphology changes are interpreted as intended by the clinical pathologist. Reporting practices should be critically reviewed to enhance them.,9.474389094274162e-08,0.0004930230695716631,0.045351473922902494,0.0072537058591274906,0.06351340572232633,0.0,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
151,0.5,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a divergence between clinicians and clinical pathologists in reporting and interpreting red blood cell morphology? Important differences about the clinical relevance of certain RBC morphology terms exist between clinicians and clinical pathologists. The best way to ensure RBC morphology changes are interpreted as intended by the clinical pathologist is to include interpretive comments on CBC reports. Reporting procedures should be critically examined to improve them.,9.474389094274162e-08,0.04250194310350697,0.07524858908895453,0.0072537058591274906,0.020858194610945624,0.030738221214411676,0.007243206163811466,0.042877671745075396,0.015621063240110858,9.474389094274162e-08,0.06559728248581642,0.0
151,0.5,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are clinical pathologists and clinicians in agreement when reporting and interpreting red blood cell morphology? There are significant differences between clinicians and clinical pathologists regarding the clinical relevance of some RBC morphology terms. Including interpretive comments on CBC reports ensures that RBC morphology changes are understood as the clinical pathologist intends. Reporting practices should undergo critical review to foster improvement.,7.105791820705622e-08,0.12008648492512997,0.0507015306122449,0.005440279394345618,0.05043085362689137,0.0,0.0054324046228586,0.05129329438754926,0.0,7.105791820705622e-08,0.05218575317056917,0.0
151,0.5,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a gap between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Clinicians and clinical pathologists differ importantly in their views on the clinical relevance of certain RBC morphology terms. The clearest approach to ensure RBC morphology changes are interpreted as intended by the clinical pathologist is to add interpretive comments on CBC reports. Reporting methods should be critically assessed for improvement.,1.4211583641411244e-07,0.031213274787491585,0.044023668639053264,0.010880558788691236,0.09381875521765437,0.0,0.0108648092457172,0.09531017980432477,0.0,1.4211583641411244e-07,0.09684982598991798,0.0
152,0.5,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Are viral infections involved in benign paroxysmal positional vertigo? Answer: The precise cause of benign paroxysmal positional vertigo (BPPV) remains unclear, but viral infections are generally not considered a direct factor in its onset. BPPV usually results from inner ear issues, such as",1.8948778188548325e-07,0.13143251639718656,0.027505907372400773,0.014507411718254981,0.17963450852047114,0.0038036897673758216,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
152,0.5,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Can viral infections contribute to benign paroxysmal positional vertigo? Answer: While the exact cause of benign paroxysmal positional vertigo (BPPV) is not completely known, viral infections are not thought to play a direct role in causing it. BPPV is commonly linked to inner ear problems like",1.1842986367842703e-07,0.05768352617289807,0.031980961455689016,0.009067132323909363,0.1084411697936476,0.0022190736642101576,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
152,0.5,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Do viral infections play a part in benign paroxysmal positional vertigo? Answer: The exact origins of benign paroxysmal positional vertigo (BPPV) are not fully understood; however, viral infections are not believed to directly cause it. BPPV is often due to disturbances in the inner ear, including",1.1842986367842703e-07,0.08782036011028671,0.010713106918886009,0.009067132323909363,0.1084411697936476,0.0022190736642101576,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
152,0.5,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Is there a connection between viral infections and benign paroxysmal positional vertigo? Answer: The cause of benign paroxysmal positional vertigo (BPPV) is not entirely clear, but viral infections are not thought to have a direct involvement. BPPV typically arises from inner ear problems such as",1.4211583641411244e-07,0.08167155515416535,0.030554376760155877,0.010880558788691236,0.1316141743129382,0.002723310933406376,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
152,0.5,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Are viral infections responsible for benign paroxysmal positional vertigo? Answer: Although the exact cause of benign paroxysmal positional vertigo (BPPV) is not fully known, viral infections are not considered a direct cause. BPPV generally stems from issues within the inner ear, like",2.1317375462116866e-07,0.15726582836073666,0.025874990212637464,0.016320838183036854,0.20453710908972944,0.004383329862557267,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
152,0.5,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Do viral infections influence benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) remains uncertain, but viral infections are not believed to directly contribute to its development. BPPV is usually caused by inner ear problems such as",2.1317375462116866e-07,0.15726582836073666,0.025874990212637464,0.016320838183036854,0.20453710908972944,0.004383329862557267,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
152,0.5,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Could viral infections cause benign paroxysmal positional vertigo? Answer: The precise cause of benign paroxysmal positional vertigo (BPPV) is not well defined, and viral infections are not thought to be a direct cause. BPPV is typically linked to inner ear issues, including",2.1317375462116866e-07,0.15726582836073666,0.025874990212637464,0.016320838183036854,0.20453710908972944,0.004383329862557267,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
152,0.5,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Is benign paroxysmal positional vertigo caused by viral infections? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully established, but viral infections are not believed to play a direct role. BPPV usually results from inner ear problems such as",1.8948778188548325e-07,0.13143251639718656,0.027505907372400773,0.014507411718254981,0.2126415171185636,0.02750832986255728,0.014486412327622933,0.21206028899460883,0.024375,1.8948778188548325e-07,0.1823215567939549,0.0
152,0.5,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Do viral infections have any role in benign paroxysmal positional vertigo? Answer: The cause of benign paroxysmal positional vertigo (BPPV) is not completely understood, and viral infections are not considered a direct cause. BPPV is commonly caused by problems in the inner ear, like",1.6580180914979784e-07,0.10624485700792086,0.029064131643667834,0.012693985253473108,0.15533640625915934,0.0032509602480447902,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
152,0.5,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Are viral infections linked to benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully known, but viral infections are generally not thought to directly cause it. BPPV is typically due to inner ear issues such as",1.6580180914979784e-07,0.10624485700792086,0.029064131643667834,0.012693985253473108,0.15533640625915934,0.0032509602480447902,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
153,0.5,1,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Transient tachypnea of the newborn (TTN): could polymorphisms in beta-adrenergic receptor (ADRB) genes be involved? Answer: The involvement of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is under investigation.,4.73719454713706e-08,0.10802423238637537,0.03141259105098848,0.003626852929563752,0.14550070155837203,0.06004264895195603,0.003621603081905747,0.1056504394893194,0.033067033976124934,4.737194547137081e-08,0.06317295703908332,0.0018327251323183684
153,0.5,2,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Is there a role for polymorphisms in beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn (TTN)? Answer: Research is ongoing into the role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN).,4.73719454713706e-08,0.04246585885752552,0.053912591050988445,0.0036268529295637453,0.08577826252690546,0.09217326992371928,0.003621603081905733,0.05255040403677924,0.0749029714761249,4.737194547137081e-08,0.017592752691026448,0.0532598714416896
153,0.5,3,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Could polymorphisms in beta-adrenergic receptor (ADRB) genes contribute to transient tachypnea of the newborn (TTN)? Answer: The potential role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being studied.,0.0,0.03746741516540286,0.0228014799398773,0.0,0.0770163533955488,0.05263112632330301,0.0,0.03960841031771167,0.028027971476124895,0.0,0.0,0.0
153,0.5,4,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Transient tachypnea of the newborn (TTN): does it involve polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in TTN is presently under investigation.,1.421158364141118e-07,0.08628373598471839,0.06042414364288905,0.01088055878869127,0.1592166507752899,0.016318097486928668,0.010864809245717241,0.15663866469923837,0.022494190513671013,1.4211583641411244e-07,0.15338265087860803,0.029384756657483937
153,0.5,5,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Are polymorphisms in beta-adrenergic receptor (ADRB) genes linked to transient tachypnea of the newborn (TTN)? Answer: Studies are examining the involvement of polymorphisms in beta-adrenergic receptor encoding genes in TTN.,1.658018091497971e-07,0.12354547610164479,0.057321976850246065,0.01269398525347315,0.19630508603975283,0.014057522475030879,0.012675610786670115,0.1934372435759264,0.02126767109932093,1.6580180914979784e-07,0.1897502950494827,0.029384756657483937
153,0.5,6,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Transient tachypnea of the newborn (TTN): is there a connection with polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: The connection between polymorphisms in beta-adrenergic receptor encoding genes and TTN is being explored.,1.184298636784265e-07,0.05034261520707517,0.06334067886577727,0.009067132323909391,0.12344554975634159,0.01843535342616523,0.009054007704764368,0.12114367122916603,0.02363926804527819,1.1842986367842703e-07,0.11829133106733902,0.029384756657483937
153,0.5,7,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Does transient tachypnea of the newborn (TTN) have a genetic basis involving polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: The genetic role of polymorphisms in beta-adrenergic receptor encoding genes in TTN is currently being researched.,4.73719454713706e-08,0.050409408884468654,0.07112647144901152,0.003626852929563752,0.023180610871323726,0.024050878099173542,0.003621603081905747,0.02163259942144702,0.026659528523875105,4.737194547137081e-08,0.019851258254085735,0.029384756657483937
153,0.5,8,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Is transient tachypnea of the newborn (TTN) associated with polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: The association of polymorphisms in beta-adrenergic receptor encoding genes with TTN is under current study.,1.421158364141118e-07,0.08628373598471839,0.06042414364288905,0.01088055878869127,0.1592166507752899,0.016318097486928668,0.010864809245717241,0.15663866469923837,0.022494190513671013,1.4211583641411244e-07,0.15338265087860803,0.029384756657483937
153,0.5,9,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) genes influence transient tachypnea of the newborn (TTN)? Answer: Ongoing research is focused on the influence of polymorphisms in beta-adrenergic receptor encoding genes in TTN.,1.184298636784265e-07,0.0070209164220789155,0.09386518672678928,0.009067132323909391,0.034007203877639114,0.08264462809917354,0.009054007704764368,0.07493385919183648,0.056932966023875105,1.1842986367842703e-07,0.11829133106733902,0.029384756657483937
153,0.5,10,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Transient tachypnea of the newborn (TTN): is there a role for beta-adrenergic receptor (ADRB) gene polymorphisms? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in TTN is being actively investigated.,1.184298636784265e-07,0.03630078236291778,0.12486992715920922,0.009067132323909391,0.034007203877639114,0.08264462809917354,0.009054007704764368,0.07493385919183648,0.056932966023875105,1.1842986367842703e-07,0.11829133106733902,0.029384756657483937
154,0.5,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Studies indicate that parents, their children, and the children's doctors might view body image in distinct ways. Elements like social influences, individual biases, and medical knowledge can lead to these differing views. More research is required to understand this fully.",0.0,0.05041070404072334,0.03517533463965816,0.0,0.07701635339555013,0.05464623960923583,0.0,0.07846949213886134,0.05610781626984812,0.0,0.07997852083384016,0.057476051645147866
154,0.5,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Evidence shows that parents, their offspring, and their children's healthcare providers may have varying perspectives on body image. Influences such as cultural norms, subjective biases, and clinical expertise play a role in these differences. Additional investigation is necessary to explore this topic further.",7.105791820705622e-08,0.1326370566885373,0.05588497905487035,0.005440279394345618,0.15810685655900114,0.07409022282382342,0.0054324046228586,0.1596857667015108,0.07496876301541025,7.105791820705622e-08,0.13606798748488336,0.057476051645147866
154,0.5,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research indicates that perceptions of body image differ among parents, their children, and the children's physicians. These differences can be attributed to societal pressures, personal viewpoints, and medical training. Further studies are essential to deepen understanding.",9.474389094274162e-08,0.03300440988557529,0.02959194043375238,0.0072537058591274906,0.00405222658834159,0.051697932574390315,0.007243206163811466,0.0021373475785200213,0.0545694574598547,9.474389094274162e-08,6.418683969666716e-05,0.057476051645147866
154,0.5,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: It appears that parents, their children, and their children's doctors may each perceive body image differently. Various factors including societal expectations, individual biases, and professional medical insights contribute to these discrepancies. More research is needed to clarify these distinctions.",2.3685972735685406e-08,0.0468218511356393,0.019298960426365266,0.0018134264647818726,0.021114030917673166,0.0016874840922763146,0.0018108015409528666,0.005599273713948971,0.017492711370262384,2.3685972735685406e-08,0.006195950226937974,0.018325697625989172
154,0.5,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests differences in body image perception exist between parents, their children, and the children's physicians. Such variations stem from social influences, personal prejudices, and medical knowledge. Further research is warranted to better understand these differences.",9.474389094274162e-08,0.03300440988557529,0.02959194043375238,0.0072537058591274906,0.00405222658834159,0.051697932574390315,0.007243206163811466,0.0021373475785200213,0.0545694574598547,9.474389094274162e-08,6.418683969666716e-05,0.057476051645147866
154,0.5,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Studies reveal that parents, their children, and the children's medical professionals may hold differing views on body image. Factors like cultural impact, individual bias, and clinical expertise contribute to these variations. Continued research is needed to gain deeper insight.",2.3685972735685406e-08,0.055866620058424576,0.0520919051894467,0.0018134264647818726,0.057355461221188175,0.053950671905416865,0.0018108015409528666,0.058918287603175745,0.05574538739065054,2.3685972735685406e-08,0.060560434976737465,0.057476051645147866
154,0.5,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: There is evidence that parents, their children, and their children's physicians perceive body image in distinct ways. Influences including societal norms, personal biases, and medical education affect these perceptions. Additional studies are required to further explore this issue.",4.737194547137081e-08,0.12121763597476498,0.05525138458149324,0.0036268529295637453,0.1226557945471698,0.05713184244856649,0.003621603081905733,0.12411598793361245,0.05881222872012695,4.737194547137081e-08,0.12559751565382893,0.0602925433961744
154,0.5,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research findings indicate that body image perception may vary among parents, their children, and the children's doctors. These differences are influenced by social factors, subjective biases, and professional medical knowledge. More research is necessary for comprehensive understanding.",7.105791820705622e-08,0.011495382307326274,0.03106633809986578,0.005440279394345618,0.016837690402834227,0.05247813411078719,0.0054324046228586,0.018631194172108678,0.054977092877967516,7.105791820705622e-08,0.02055510036303909,0.057476051645147866
154,0.5,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: It has been suggested that parents, their children, and their children's physicians might perceive body image differently due to social influences, personal biases, and medical expertise. Further investigation is needed to fully comprehend these differences.",1.1842986367842703e-07,0.16588516546133736,0.046739784349113786,0.009067132323909363,0.13855348939411272,0.028436411815970813,0.009054007704764333,0.10998944321907178,0.00767586508376332,1.1842986367842703e-07,0.10960447015156527,0.006057006206091786
154,0.5,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research points to potential differences in how parents, their children, and their children's physicians view body image. These variations may arise from societal pressures, individual biases, and medical training. Further study is essential to better understand these perspectives.",4.737194547137081e-08,0.042748143835903196,0.003907380525957821,0.0036268529295637453,0.04267727371332963,0.0034371524313941137,0.003621603081905733,0.042569260808913434,0.002894523539592034,4.737194547137081e-08,0.04241985398663539,0.002279493850551567
155,0.5,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is there a link between neck pain and poorer health-related quality of life six months afterward? Yes, neck pain is linked to a decline in health-related quality of life six months later. Research indicates that ongoing neck pain can lead to diminished physical function and a lower overall quality of life.",7.105791820705622e-08,0.16585613039785319,0.0738693625598387,0.005440279394345618,0.16096985256122354,0.06628387756592884,0.0054324046228586,0.16273437171689764,0.06795529257067724,7.105791820705622e-08,0.16450016850969806,0.06929943750456571
155,0.5,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Does neck pain correlate with a worse health-related quality of life half a year later? Indeed, neck pain is connected to a reduced health-related quality of life six months later. Studies reveal that chronic neck pain may cause decreased physical abilities and a general decline in quality of life.",2.3685972735685406e-08,0.1726823582771866,0.1056153943058705,0.0018134264647818726,0.17347279337332955,0.10480239608444736,0.0018108015409528666,0.17668132093070543,0.10844911973117106,2.3685972735685406e-08,0.18000630597931666,0.11176857330703485
155,0.5,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain related to a poorer health-related quality of life after six months? Yes, neck pain is associated with a worse health-related quality of life six months later. Evidence shows that persistent neck pain can impair physical function and reduce overall life quality.",9.474389094274162e-08,0.08440468397526679,0.15640496221059483,0.0072537058591274906,0.05397204215981244,0.09977153188691648,0.007243206163811466,0.05793676749501753,0.10580251479289945,9.474389094274162e-08,0.06222327032293329,0.11176857330703485
155,0.5,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Can neck pain be associated with a decline in health-related quality of life six months later? Yes, neck pain is linked to a deterioration in health-related quality of life six months later. Research demonstrates that long-lasting neck pain can result in lower physical functioning and quality of life.",0.0,0.05899124940935696,0.037291388803392556,0.0,0.06027366787477906,0.04019241231523296,0.0,0.06161308271644028,0.042134683145070795,0.0,0.06301338005090207,0.04395179757830192
155,0.5,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Does experiencing neck pain lead to worse health-related quality of life six months later? Yes, neck pain leads to a poorer health-related quality of life six months afterward. Studies confirm that ongoing neck pain diminishes physical function and overall quality of life.",1.4211583641411244e-07,0.0858785451983719,0.018435618814406807,0.010880558788691236,0.06743354092542342,0.04850609978815103,0.0108648092457172,0.06489962326980825,0.05378862590401057,1.4211583641411244e-07,0.062032885176189545,0.05929943750456571
155,0.5,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is there an association between neck pain and reduced health-related quality of life six months later? Yes, neck pain is associated with a decline in health-related quality of life six months later. Research has found that persistent neck pain decreases physical functioning and overall quality of life.",2.3685972735685406e-08,0.06136695419534366,0.05183432509148117,0.0018134264647818726,0.06575276541006936,0.05922870023908784,0.0018108015409528666,0.06784632222090448,0.06236073906416653,2.3685972735685406e-08,0.07006512440861101,0.06536762149263864
155,0.5,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain linked to a worse health-related quality of life six months later? Yes, neck pain is linked to poorer health-related quality of life six months later. Studies indicate that chronic neck pain results in reduced physical capabilities and overall quality of life.",9.474389094274162e-08,0.056721492495526604,0.011018732111580998,0.0072537058591274906,0.012041975036374719,0.05308870640215199,0.007243206163811466,0.009687347681562652,0.057462833352456236,9.474389094274162e-08,0.007091447733060807,0.06190707746215952
155,0.5,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Does neck pain contribute to a decline in health-related quality of life six months down the line? Yes, neck pain contributes to a worse health-related quality of life six months later. Research shows that sustained neck pain can cause decreased physical function and lower quality of life.",2.3685972735685406e-08,0.031230120257955463,0.03111839316794257,0.0018134264647818726,0.06575276541006936,0.05922870023908783,0.0018108015409528666,0.06784632222090448,0.06236073906416653,2.3685972735685406e-08,0.07006512440861101,0.06536762149263864
155,0.5,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain connected to a reduced health-related quality of life six months later? Yes, neck pain is connected to a poorer health-related quality of life six months later. Studies suggest that ongoing neck pain leads to diminished physical functioning and overall quality of life.",7.105791820705622e-08,0.05809112437153985,0.001957046435131893,0.005440279394345618,0.017680461968679673,0.03300560390907724,0.0054324046228586,0.016825350868088673,0.05917159763313616,7.105791820705622e-08,0.01929176773672525,0.06311637080867852
155,0.5,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Can persistent neck pain affect health-related quality of life six months later? Yes, persistent neck pain affects health-related quality of life negatively six months later. Research supports that chronic neck pain reduces physical function and overall quality of life.",2.1317375462116844e-07,0.18523451220804255,0.005586419753086547,0.016320838183036854,0.11916789177935438,0.06682170489729715,0.0162972138685758,0.07681247986266504,0.10242241275208314,2.1317375462116866e-07,0.07130812230158945,0.11176857330703485
156,0.5,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Can (18)F-FDG be used as a surrogate tracer for assessing tumor hypoxia? Answer: No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia. It measures glucose metabolism in tumors rather than oxygen levels.",4.73719454713706e-08,0.16831638331220677,0.1345306458036254,0.003626852929563759,0.1115913262693744,0.03504003058039032,0.003621603081905747,0.11266003573151506,0.03530946717917139,4.737194547137081e-08,0.11363644642723303,0.03510904882244257
156,0.5,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Is (18)F-FDG suitable as a surrogate tracer to evaluate tumor hypoxia? Answer: No, (18)F-FDG is not suitable as a surrogate tracer for tumor hypoxia because it tracks glucose metabolism, not oxygenation in tumors.",0.0,0.09987384442437364,0.12800751603763894,0.0,0.043321698784996254,0.02970224950860248,0.0,0.04471917293935146,0.03145399063311416,0.0,0.046209812037329545,0.03303283263364796
156,0.5,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Does (18)F-FDG act as a surrogate tracer for tumor hypoxia measurement? Answer: No, (18)F-FDG is not used to measure tumor hypoxia; it is employed to assess tumor glucose metabolism instead.",7.10579182070559e-08,0.17259934475579275,0.24691358024691362,0.005440279394345639,0.07484672232673395,0.12244897959183673,0.005432404622858621,0.032374824508111466,0.09566326530612247,7.105791820705622e-08,0.012940891583166358,0.06632653061224487
156,0.5,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Is (18)F-FDG a valid surrogate tracer for detecting tumor hypoxia? Answer: No, (18)F-FDG is not a valid surrogate tracer for tumor hypoxia since it reflects glucose metabolism, not hypoxic conditions.",7.10579182070559e-08,0.012239903393525875,0.11673606545401419,0.005440279394345639,0.06856303916842643,0.02037797367467696,0.005432404622858621,0.06664620128616727,0.024657348146359143,7.105791820705622e-08,0.06428512718019963,0.029344282091534828
156,0.5,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Can (18)F-FDG serve as a surrogate tracer to detect hypoxia in tumors? Answer: No, (18)F-FDG cannot be used as a surrogate tracer for tumor hypoxia; it evaluates glucose metabolism rather than oxygen levels.",0.0,0.14188276445830983,0.1569135802469136,0.0,0.08664339756999295,0.060226757369614504,0.0,0.08943834587870292,0.06344104308390028,0.0,0.09241962407465909,0.06632653061224487
156,0.5,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Is (18)F-FDG utilized as a surrogate tracer for tumor hypoxia? Answer: No, (18)F-FDG is not utilized as a surrogate tracer for tumor hypoxia but is used to measure glucose metabolism within tumors.",2.36859727356853e-08,0.02279232681661547,0.06939878734750535,0.0018134264647818796,0.082057767871349,0.032876464195145505,0.0018108015409528735,0.08347155215425639,0.03451424948677696,2.3685972735685406e-08,0.08489168909618305,0.0357444753049149
156,0.5,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Does (18)F-FDG function as a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG does not function as a surrogate tracer for tumor hypoxia; it measures glucose uptake in tumors instead.",4.73719454713706e-08,0.026512475821379056,0.12071330589849114,0.003626852929563759,0.029881162109572923,0.023683547493071277,0.003621603081905747,0.028140363344059782,0.02707615968197981,4.737194547137081e-08,0.026083760309430826,0.030661235687690698
156,0.5,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Is (18)F-FDG employed as a surrogate tracer for the assessment of tumor hypoxia? Answer: No, (18)F-FDG is not employed as a surrogate tracer for tumor hypoxia but rather for assessing glucose metabolism in tumors.",2.36859727356853e-08,0.09389566989805154,0.10422630319578405,0.0018134264647818796,0.0360227736709966,0.0035429153825620313,0.0018108015409528735,0.03594112077764278,0.0029165352228882196,2.3685972735685406e-08,0.035771101018948315,0.002117255939236562
156,0.5,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Can (18)F-FDG be considered a surrogate tracer for tumor hypoxia? Answer: No, (18)F-FDG cannot be considered a surrogate tracer for tumor hypoxia since it measures glucose metabolism, not oxygen levels.",7.10579182070559e-08,0.10465952746818541,0.05941358024691362,0.005440279394345639,0.16416954683186713,0.04248157596371885,0.005432404622858621,0.16566722708044512,0.043225623582766395,7.105791820705622e-08,0.16697359837426617,0.043048469387755126
156,0.5,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Question: Is (18)F-FDG an appropriate surrogate tracer to evaluate tumor hypoxia? Answer: No, (18)F-FDG is not appropriate as a surrogate tracer for tumor hypoxia because it measures glucose metabolism, not hypoxic status.",4.73719454713706e-08,0.16066999463943343,0.21469135802469141,0.003626852929563759,0.10874827400241571,0.12244897959183673,0.003621603081905747,0.06746614431938047,0.09566326530612247,4.737194547137081e-08,0.02342675258770832,0.06632653061224487
157,0.5,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically significant issue in general adult psychiatry? Evidence suggests that pain is a notable clinical concern among psychiatric patients, often underestimated in psychiatry. Patients in general adult psychiatry exhibit unique risk factors distinct from those in other clinical subpopulations.",2.6054570009253947e-07,0.2253172462198596,0.008823849146791525,0.0199476911126006,0.2504212952634859,0.0053835634451019285,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
157,0.5,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Does pain represent a clinically important problem in general adult psychiatry? Research indicates that pain can be a major clinical issue for psychiatric patients and is frequently underrecognized in the field. The patients studied in general adult psychiatry have specific risk factors that differ from those in other medical specialties.,7.105791820705622e-08,0.03602834294797663,0.01673363426171643,0.005440279394345618,0.0623235119648653,0.0012239022181982917,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
157,0.5,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a relevant clinical problem in the context of general adult psychiatry? Findings show that pain constitutes a significant clinical challenge in psychiatric patients, which appears to be undervalued in psychiatric practice. The patients examined in general adult psychiatry possess distinct risk factors unlike those in other clinical groups.",7.105791820705622e-08,0.03602834294797663,0.01673363426171643,0.005440279394345618,0.03344237944153461,0.019599999999999992,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
157,0.5,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Can pain be considered a clinically pertinent problem in general adult psychiatry? Evidence reveals that pain is a considerable clinical problem among psychiatric patients and is often underestimated within psychiatry. The patient population in general adult psychiatry is marked by particular risk factors that differ from other clinical subpopulations.,9.474389094274162e-08,0.05782645188635849,0.015888149943824606,0.0072537058591274906,0.08399141334404625,0.0016665406427221093,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
157,0.5,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain an important clinical issue in general adult psychiatry? We identified that pain can be a substantial clinical problem for psychiatric patients, which seems to be underappreciated in psychiatry. Patients in general adult psychiatry have unique risk factors that set them apart from other clinical disciplines.",1.4211583641411244e-07,0.10289746913327091,0.014087621893081742,0.010880558788691236,0.12878744193732583,0.002610743801652899,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
157,0.5,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically relevant concern in general adult psychiatry? The evidence points to pain being a significant clinical problem in psychiatric patients, often overlooked in psychiatry. Patients treated in general adult psychiatry show specific risk factors different from those in other clinical subpopulations.",2.1317375462116866e-07,0.17454388954797384,0.01107509983075166,0.016320838183036854,0.19998078066414937,0.004195359904818563,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
157,0.5,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Does pain pose a clinically significant problem in general adult psychiatry? Our findings indicate that pain can be an important clinical issue among psychiatric patients and tends to be underestimated in psychiatry. The patients in general adult psychiatry are characterized by particular risk factors distinct from other clinical groups.,9.474389094274162e-08,0.05782645188635849,0.015888149943824606,0.0072537058591274906,0.08399141334404625,0.0016665406427221093,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
157,0.5,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically meaningful problem in general adult psychiatry? Research found that pain may be a major clinical concern in psychiatric patients, which appears to be underestimated in psychiatry. The patients in general adult psychiatry have specific risk factors that differ from those in other clinical disciplines.",1.1842986367842703e-07,0.08010884544688679,0.015006915842678735,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
157,0.5,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a clinically noteworthy problem in general adult psychiatry? Evidence shows that pain can be a significant clinical issue for psychiatric patients and is often underrecognized in psychiatry. Patients in general adult psychiatry possess distinct risk factors unlike those in other clinical subpopulations.,2.1317375462116866e-07,0.17454388954797384,0.01107509983075166,0.016320838183036854,0.19998078066414937,0.004195359904818563,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
157,0.5,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically important issue in general adult psychiatry? We found that pain may be a considerable clinical problem in psychiatric patients, which seems to be underestimated in psychiatry. The patients in general adult psychiatry exhibit specific risk factors different from other clinical areas.",1.8948778188548325e-07,0.15008894388023064,0.012124577722245372,0.014507411718254981,0.17568267840283758,0.0036426303854875317,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
158,0.5,1,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Are clinical predictors sufficient for identifying cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: The sufficiency of clinical predictors for cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms is,4.73719454713706e-08,0.07981028248569855,0.0063691650230111585,0.003626852929563759,0.07804457775273299,0.009095198902606322,0.003621603081905747,0.07846296837496336,0.00955610425240061,4.737194547137081e-08,0.07878187441382511,0.009560493827160482
158,0.5,2,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Can clinical predictors reliably detect cervical spine fractures in geriatric blunt trauma patients after low-energy trauma? Answer: The reliability of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy trauma is,2.36859727356853e-08,0.1198538899550603,0.034550754458161886,0.0018134264647818796,0.1212841420470725,0.04923265306122443,0.0018108015409528735,0.12397894999204917,0.05491632653061232,2.3685972735685406e-08,0.1267769408107009,0.05995102040816325
158,0.5,3,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: How effective are clinical predictors for cervical spine fractures in older adults experiencing low-energy blunt trauma? Answer: The effectiveness of clinical predictors for cervical spine fractures in older adults with low-energy blunt trauma is,0.0,0.04077336356235017,0.012655555555555559,0.0,0.04200892003393575,0.020854437869822523,0.0,0.043321698784996254,0.024085207100591755,0.0,0.0447191729393519,0.027074556213017742
158,0.5,4,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Are clinical predictors adequate for diagnosing cervical spine fractures in elderly patients with low-energy blunt trauma? Answer: The adequacy of clinical predictors in diagnosing cervical spine fractures in elderly patients with low-energy blunt trauma is,2.36859727356853e-08,0.040637069319638286,0.0030555555555555614,0.0018134264647818796,0.039737414922372594,0.004582248520710125,0.0018108015409528735,0.039961109924176785,0.0048544378698225366,2.3685972735685406e-08,0.04013354324070839,0.004885207100591704
158,0.5,5,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Do clinical predictors provide sufficient accuracy for cervical spine fractures in geriatric patients with low-energy blunt trauma? Answer: The accuracy of clinical predictors for cervical spine fractures in geriatric patients with low-energy blunt trauma is,2.36859727356853e-08,0.040637069319638286,0.0030555555555555614,0.0018134264647818796,0.039737414922372594,0.004582248520710125,0.0018108015409528735,0.039961109924176785,0.0048544378698225366,2.3685972735685406e-08,0.04013354324070839,0.004885207100591704
158,0.5,6,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Is the use of clinical predictors appropriate for detecting cervical spine fractures in geriatric blunt trauma cases involving low-energy mechanisms? Answer: The appropriateness of clinical predictors for detecting cervical spine fractures in geriatric blunt trauma cases with low-energy mechanisms is,1.421158364141118e-07,0.1890216158133029,0.007621548421191671,0.01088055878869125,0.18321136159929408,0.007600000000000051,0.01086480924571722,0.21973213453112983,0.026782101977107176,1.4211583641411244e-07,0.22044125480277277,0.026312591050988487
158,0.5,7,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: How adequate are clinical predictors in identifying cervical spine fractures among elderly patients after low-energy blunt trauma? Answer: The adequacy of clinical predictors in identifying cervical spine fractures among elderly patients after low-energy blunt trauma is,4.73719454713706e-08,0.002793929090148861,0.0069444444444444475,0.003626852929563759,0.040780653200400696,0.030663888888888824,0.003621603081905747,0.04385712231208627,0.04145555555555552,4.737194547137081e-08,0.047244885687982574,0.05197500000000002
158,0.5,8,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Are clinical predictors sufficient to assess cervical spine fractures in geriatric patients following low-energy blunt trauma? Answer: The sufficiency of clinical predictors to assess cervical spine fractures in geriatric patients after low-energy blunt trauma is,2.36859727356853e-08,0.08024547963734907,0.01672419460881,0.0018134264647818796,0.1212841420470725,0.04923265306122443,0.0018108015409528735,0.12397894999204917,0.05491632653061232,2.3685972735685406e-08,0.1267769408107009,0.05995102040816325
158,0.5,9,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Can clinical predictors be trusted to evaluate cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: The trustworthiness of clinical predictors to evaluate cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms is,9.47438909427412e-08,0.08118210406428261,0.005465154503616038,0.007253705859127504,0.07580755979520903,0.015596159122085007,0.007243206163811487,0.07446133687138712,0.020622222222222125,9.474389094274162e-08,0.07280861209868617,0.026104801097393715
158,0.5,10,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: What is the adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients experiencing low-energy mechanisms? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients experiencing low-energy mechanisms is,9.47438909427412e-08,0.02826218760307686,0.016212455366519662,0.007253705859127504,0.0740621008664002,0.020585255198487667,0.007243206163811487,0.07957136991971137,0.04414669187145548,9.474389094274162e-08,0.0856250291721583,0.06712741020793947
159,0.5,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does the interfractional motion of the prostate bed target, assessed using RTOG consensus definitions and daily CT on rails, differ between the superior and inferior parts of the clinical target volume? Answer: No significant motion differences are observed between the superior (SUP-CTV) and inferior (INF-CTV) clinical target volumes. The existing uniform planning target volume (PTV) margins sufficiently cover both regions of the CTV.",1.4211583641411244e-07,0.008391805480828296,0.09422922246896054,0.010880558788691236,0.10417836428883565,0.0017265420075026489,0.0108648092457172,0.10354067894083929,0.0,1.4211583641411244e-07,0.10536051565782412,0.0
159,0.5,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior sections of the prostate bed clinical target volume? Answer: There are no statistically significant differences in motion between the superior (SUP-CTV) and inferior (INF-CTV) portions. The current uniform PTV margins adequately encompass both parts of the CTV.",2.3685972735685406e-08,0.053474484459716365,0.05039833592731744,0.0018134264647818726,0.006187073859745595,0.017190082644628107,0.0018108015409528666,0.006736750945891323,0.017851239669421492,2.3685972735685406e-08,0.018349138668195764,0.0
159,0.5,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When evaluating prostate bed target interfractional motion with RTOG consensus criteria and daily CT on rails, does motion vary between the superior and inferior clinical target volume areas? Answer: No statistically significant motion differences exist between the SUP-CTV and INF-CTV. Uniform PTV margins currently in use are sufficient to cover both CTV regions.",9.474389094274162e-08,0.05027394425433407,0.016180375568487466,0.0072537058591274906,0.04935271570515187,0.017851239669421492,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
159,0.5,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does interfractional motion differ between the superior and inferior segments of the prostate bed clinical target volume as defined by RTOG consensus and assessed with daily CT on rails? Answer: There is no statistically meaningful difference in motion between the superior (SUP-CTV) and inferior (INF-CTV) parts. The uniform PTV margins effectively cover both CTV sections.,4.737194547137081e-08,0.06269223125544832,0.01932258301139421,0.0036268529295637453,0.0372845055208213,0.0006606862828746896,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
159,0.5,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, is there a difference in motion between the superior and inferior parts of the prostate bed clinical target volume? Answer: No statistically significant differences in motion were found between SUP-CTV and INF-CTV. The current uniform planning target volume margins are adequate for both portions of the CTV.",2.3685972735685406e-08,0.0185681825888242,0.0006239726105045779,0.0018134264647818726,0.006736750945891323,0.017851239669421492,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
159,0.5,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does the prostate bed target exhibit different interfractional motion in the superior versus inferior clinical target volume portions, based on RTOG consensus and daily CT on rails? Answer: There are no statistically significant motion differences between the superior (SUP-CTV) and inferior (INF-CTV) parts. The uniform PTV margins currently applied are sufficient to cover both CTV areas.",2.3685972735685406e-08,0.006187073859745595,0.017190082644628107,0.0018134264647818726,0.006736750945891323,0.017851239669421492,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
159,0.5,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Is there a difference in interfractional motion between the superior and inferior clinical target volume areas of the prostate bed target, using RTOG consensus definitions and daily CT on rails? Answer: No statistically significant motion difference is observed between SUP-CTV and INF-CTV. The prevailing uniform PTV margins adequately cover both portions of the CTV.",7.105791820705622e-08,0.031097431661075703,0.016529396361753414,0.005440279394345618,0.030304520734458773,0.017851239669421492,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
159,0.5,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: According to RTOG consensus definitions and daily CT on rails, does the interfractional motion of the prostate bed target differ between the superior and inferior clinical target volume regions? Answer: There are no statistically significant differences in motion between the SUP-CTV and INF-CTV. The uniform planning target volume margins currently used are sufficient to cover both parts of the CTV.",7.105791820705622e-08,0.03062048373927162,0.014820173530825743,0.005440279394345618,0.07694100961913897,0.017851239669421492,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
159,0.5,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the interfractional motion vary between superior and inferior parts of the prostate bed clinical target volume when assessed by RTOG consensus and daily CT on rails? Answer: No statistically significant motion differences exist between the superior (SUP-CTV) and inferior (INF-CTV) regions. Current uniform PTV margins adequately encompass both portions of the CTV.,9.474389094274162e-08,0.07643044163395452,0.0026364939104794177,0.0072537058591274906,0.04935271570515187,0.017851239669421492,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
159,0.5,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using daily CT on rails and RTOG consensus definitions, is there a difference in interfractional motion between the superior and inferior clinical target volume of the prostate bed? Answer: No statistically apparent differences in motion between SUP-CTV and INF-CTV are found. The uniform planning target volume margins in place sufficiently cover both CTV portions.",7.105791820705622e-08,0.05676954945959212,0.0019409262066604552,0.005440279394345618,0.030304520734458773,0.017851239669421492,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
160,0.5,1,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Are laboratories accurately reporting serum quantitative hCG results? It's essential that labs provide precise serum quantitative hCG data to guarantee dependable diagnostic insights. Consistent quality control and following set guidelines and protocols aid in maintaining accuracy.,1.6580180914979731e-07,0.16251735163509773,0.014072951135888197,0.012693985253473115,0.16036079047391594,0.019267445840872404,0.01267561078667008,0.15771453361945964,0.02498356344510192,1.6580180914979784e-07,0.19782574332991798,0.0
160,0.5,2,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Do laboratories report serum quantitative hCG results correctly? Accurate reporting of serum quantitative hCG by laboratories is vital for reliable diagnostic information. Implementing regular quality checks and adhering to established protocols ensures precision.,2.3685972735685321e-07,0.25955608725935697,0.008783694937541074,0.018134264647818754,0.2566799199819325,0.01642998027613414,0.0181080154095287,0.25302471342378485,0.02498356344510192,2.3685972735685406e-07,0.29626581614317127,0.0
160,0.5,3,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Are serum quantitative hCG results being reported correctly by laboratories? For dependable diagnostics, labs must report serum quantitative hCG results accurately. Regular quality control and compliance with guidelines support this accuracy.",2.842316728282238e-07,0.3760806469389233,0.027759514939002153,0.021761117577382513,0.3742586292046952,0.019934903125786323,0.021729618491434448,0.37152809780787477,0.010681731479452256,2.8423167282822487e-07,0.36772478012531495,0.0
160,0.5,4,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Is the reporting of serum quantitative hCG results by laboratories accurate? Accurate serum quantitative hCG reporting is critical for trustworthy diagnostic data. Laboratories can ensure this by following protocols and performing consistent quality control.,2.1317375462116791e-07,0.22615887109048138,0.01065211903281222,0.016320838183036875,0.22353374751299926,0.017434720708554036,0.016297213868575827,0.22023489060079315,0.02498356344510192,2.1317375462116866e-07,0.2623642644674895,0.0
160,0.5,5,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Do labs correctly report serum quantitative hCG results? Precise reporting of serum quantitative hCG is crucial for reliable diagnostics, achievable through routine quality assessments and adherence to established protocols.",3.316036182995944e-07,0.4054651081081637,2.7755575615628914e-17,0.025387970506946272,0.4014553211204319,0.011669953977646294,0.025351221573340195,0.3961255570644573,0.02498356344510192,3.316036182995957e-07,0.4446858212614444,0.0
160,0.5,6,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Are laboratories providing correct serum quantitative hCG results? Accurate serum quantitative hCG reporting is essential for dependable diagnostic information, maintained by regular quality control and strict protocol compliance.",3.552895910352797e-07,0.4455001976788262,0.0025940828402366833,0.027201396971728152,0.4411704273954724,0.01025220249835633,0.02716202311429307,0.43534627021773975,0.02498356344510192,3.552895910352811e-07,0.4855078157816992,0.0
160,0.5,7,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Are serum quantitative hCG results reported accurately by labs? To ensure reliable diagnostics, labs must report serum quantitative hCG results precisely, supported by routine quality control and guideline adherence.",3.316036182995944e-07,0.45497562100530153,0.03459408284023674,0.025387970506946272,0.4527995567174652,0.024947797501643644,0.025351221573340195,0.44944457095368406,0.01341643655489809,3.316036182995957e-07,0.4446858212614444,0.0
160,0.5,8,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Is the serum quantitative hCG reporting by laboratories accurate? Reliable diagnostic information depends on precise serum quantitative hCG results, which laboratories can ensure through quality control and following protocols.",3.316036182995944e-07,0.4054651081081637,2.7755575615628914e-17,0.025387970506946272,0.4014553211204319,0.011669953977646294,0.025351221573340195,0.3961255570644573,0.02498356344510192,3.316036182995957e-07,0.4446858212614444,0.0
160,0.5,9,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Do laboratories provide accurate serum quantitative hCG results? Accurate reporting of serum quantitative hCG is fundamental for trustworthy diagnostics, achieved by regular quality control and adherence to established procedures.",3.316036182995944e-07,0.4054651081081637,2.7755575615628914e-17,0.025387970506946272,0.4014553211204319,0.011669953977646294,0.025351221573340195,0.3961255570644573,0.02498356344510192,3.316036182995957e-07,0.4446858212614444,0.0
160,0.5,10,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Are serum quantitative hCG results from laboratories reported correctly? For reliable diagnostics, it's imperative labs report serum quantitative hCG accurately, supported by consistent quality control and protocol compliance.",3.552895910352797e-07,0.4455001976788262,0.0025940828402366833,0.027201396971728152,0.4411704273954724,0.01025220249835633,0.02716202311429307,0.43534627021773975,0.02498356344510192,3.552895910352811e-07,0.4855078157816992,0.0
161,0.5,1,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: are we overlooking some prognostic indicators? Answer: Recent studies indicate that there might be prognostic factors for hepatorenal syndrome that remain undiscovered. More research is necessary to investigate these possible factors and enhance our knowledge and treatment of this syndrome.,9.474389094274162e-08,0.09097177820572666,0.0,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
161,0.5,2,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: could there be unknown prognostic factors? Answer: Current evidence points to the existence of additional prognostic factors for hepatorenal syndrome that have not been identified yet. Further investigation is required to uncover these factors and advance the understanding and management of the disease.,2.3685972735685406e-08,0.021978906718775004,0.0,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
161,0.5,3,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: are there prognostic factors we haven't recognized? Answer: Ongoing research suggests that some prognostic factors for hepatorenal syndrome may still be unknown. Additional studies are essential to identify these factors and improve disease management and comprehension.,1.8948778188548304e-07,0.22753666731849442,0.026296566837107373,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
161,0.5,4,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: might we be missing some key prognostic factors? Answer: Present research implies that there could be extra prognostic factors for hepatorenal syndrome that have not been detected. More detailed studies are needed to explore these and enhance care strategies for the condition.,4.737194547137081e-08,0.04445176257083272,0.0,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
161,0.5,5,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: are unknown prognostic factors being missed? Answer: Research to date suggests potential prognostic factors for hepatorenal syndrome remain unidentified. Further exploration is needed to better understand and manage the syndrome by identifying these factors.,2.3685972735685364e-07,0.2836306347307591,0.02775510204081633,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
161,0.5,6,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,"Question: Hepatorenal syndrome: do we lack knowledge of certain prognostic factors? Answer: Studies indicate that there may be additional, yet unidentified, prognostic factors influencing hepatorenal syndrome. Continued research is required to discover these factors and improve clinical outcomes.",2.1317375462116834e-07,0.21772348384486895,0.0,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
161,0.5,7,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: are there prognostic factors we have yet to find? Answer: Current findings suggest that some prognostic factors related to hepatorenal syndrome have not been fully recognized. Further research is necessary to uncover these factors and enhance treatment approaches.,1.4211583641411244e-07,0.17441930140315476,0.02498356344510192,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
161,0.5,8,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: could some prognostic factors be missing from current knowledge? Answer: Evidence shows that additional prognostic factors for hepatorenal syndrome might exist but remain unknown. More comprehensive studies are needed to identify them and improve disease management.,1.8948778188548304e-07,0.22753666731849442,0.026296566837107373,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
161,0.5,9,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: might some prognostic factors still be undiscovered? Answer: Present research suggests the existence of further prognostic factors for hepatorenal syndrome that have not yet been identified. Continued investigation is essential to improve understanding and patient care.,1.8948778188548304e-07,0.22753666731849442,0.026296566837107373,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
161,0.5,10,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: is there a gap in identifying prognostic factors? Answer: Current research highlights the possibility of missing prognostic factors in hepatorenal syndrome. Further studies are required to explore these potential factors and enhance knowledge and treatment of the condition.,1.4211583641411244e-07,0.13976194237515838,0.0,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
162,0.5,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Question: Does cup-cage reconstruction using oversized cups ensure initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Answer: Most acetabular components in this group remained stable despite limited contact area between the component and pelvic bone. However, 3 out of 10 showed migration beyond thresholds predictive of future loosening.",2.3685972735685406e-08,0.019802627296179764,0.0,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
162,0.5,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,Question: Is initial stability achieved in THA for osteoporotic acetabular fractures with cup-cage reconstruction using oversized cups? Answer: The majority of acetabular components in this study were stable even though the contact surface with the pelvic bone was minimal. Three of the ten components migrated beyond the limits associated with potential loosening later on.,4.737194547137081e-08,0.038466280827795796,0.0,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
162,0.5,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Question: Does using oversized cups in cup-cage reconstruction provide initial stability in THA for patients with osteoporotic acetabular fractures? Answer: Despite the small contact area between the implant and pelvic bone, most acetabular components remained stable. However, 3 out of 10 implants migrated more than the limits that indicate possible future loosening.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
162,0.5,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Question: Can cup-cage reconstruction with oversized cups provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Answer: Most acetabular components were stable in this cohort, despite limited contact between the implant and pelvic bone. Three of ten implants migrated beyond thresholds that predict subsequent loosening.",1.1842986367842703e-07,0.10318423623523065,0.0,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
162,0.5,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Question: Does cup-cage reconstruction using oversized cups offer initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of components were stable despite the minimal contact surface with the pelvic bone. However, three out of ten migrated beyond the limits that suggest future loosening.",1.6580180914979784e-07,0.14763599880606337,0.0,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
162,0.5,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Question: Is initial stability ensured by cup-cage reconstruction with oversized cups in total hip arthroplasty for osteoporotic acetabular fractures? Answer: Most acetabular components maintained stability despite the small contact area with pelvic bone, though three of ten migrated beyond the limits predictive of loosening.",1.8948778188548325e-07,0.1706255170307629,0.0,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
162,0.5,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Question: Does the use of oversized cups in cup-cage reconstruction provide initial stability in THA for osteoporotic acetabular fractures? Answer: In this cohort, most acetabular components were stable despite minimal contact with the pelvic bone, but three out of ten migrated beyond thresholds indicating potential loosening.",1.4211583641411244e-07,0.12516314295400566,0.0,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
162,0.5,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Question: Can oversized cups in cup-cage reconstruction achieve initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Answer: Most components remained stable despite limited contact with the pelvic bone, though three of ten migrated beyond limits that predict later loosening.",2.6054570009253947e-07,0.24294617861038903,0.0,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
162,0.5,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Question: Does cup-cage reconstruction with oversized cups confer initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components stayed stable despite the small contact surface with pelvic bone, but three of ten migrated beyond the limits associated with future loosening.",1.8948778188548325e-07,0.1706255170307629,0.0,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
162,0.5,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Question: Is initial stability provided by cup-cage reconstruction using oversized cups in total hip arthroplasty for osteoporotic acetabular fractures? Answer: Most acetabular components were stable despite the small contact area with the pelvic bone; however, three of ten implants migrated beyond the limits that predict later loosening.",1.1842986367842703e-07,0.10318423623523065,0.0,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
163,0.5,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study indicates a potential link between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.15021004549256967,0.005106302021403095,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.5,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does a relationship exist between cervical cord plaques and discopathy in individuals with multiple sclerosis? Study findings suggest a possible association between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.5,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques related to discopathy in patients with multiple sclerosis? The research data implies a possible correlation between cervical discopathy and cervical MS plaques.,1.184298636784265e-07,0.13611174475662535,0.033293697978596916,0.009067132323909398,0.18924199963852795,0.0,0.009054007704764368,0.19671029424605457,0.0,1.1842986367842703e-07,0.20479441264601395,0.0
163,0.5,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any association between cervical cord plaques and discopathy in multiple sclerosis sufferers? The study data points to a possible connection between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.5,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Do cervical cord plaques correlate with discopathy in multiple sclerosis patients? The study results suggest a potential relationship between cervical discopathy and cervical MS plaques.,1.421158364141118e-07,0.17693373927688016,0.033293697978596916,0.010880558788691277,0.23180161405732358,0.0,0.010864809245717241,0.24116205681688863,0.0,1.4211583641411244e-07,0.2513144282809079,0.0
163,0.5,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a link between cervical cord plaques and discopathy in patients diagnosed with multiple sclerosis? Study findings indicate a possible correlation between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.5,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques connected to discopathy in multiple sclerosis cases? The study data suggests a potential association between cervical discopathy and cervical MS plaques.,1.421158364141118e-07,0.17693373927688016,0.033293697978596916,0.010880558788691277,0.23180161405732358,0.0,0.010864809245717241,0.24116205681688863,0.0,1.4211583641411244e-07,0.2513144282809079,0.0
163,0.5,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any relation between cervical cord plaques and discopathy in multiple sclerosis patients? The study suggests a possible correlation between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.15021004549256967,0.005106302021403095,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.5,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does cervical cord plaque presence relate to discopathy in multiple sclerosis patients? The study data shows a possible link between cervical discopathy and cervical MS plaques.,1.184298636784265e-07,0.13611174475662535,0.033293697978596916,0.009067132323909398,0.18924199963852795,0.0,0.009054007704764368,0.19671029424605457,0.0,1.1842986367842703e-07,0.20479441264601395,0.0
163,0.5,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there an observed relationship between cervical cord plaques and discopathy in multiple sclerosis patients? The study suggests a potential correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
164,0.5,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to perform aneurysm repair on patients aged 80 or above following aneurysmal subarachnoid hemorrhage? Repairing the ruptured aneurysm in elderly patients yielded a better prognosis compared to conservative treatment. Based on this study's results, definitive surgery should be confidently offered to elderly patients with aSAH.",1.4211583641411244e-07,0.09732694178750023,0.016411275581806918,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
164,0.5,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should aneurysm repair be considered for patients aged 80 and older after aneurysmal subarachnoid hemorrhage? The study showed improved outcomes when ruptured aneurysms were repaired in elderly patients rather than managed conservatively. Therefore, definitive surgery should not be withheld from elderly individuals with aSAH.",2.3685972735685406e-07,0.15677880309931735,0.03767781622452902,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.5,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.",Is aneurysm repair justified in patients aged 80 or older after experiencing aneurysmal subarachnoid hemorrhage? Repairing the ruptured aneurysm in elderly patients led to better prognoses than conservative treatment. This study suggests we should not hesitate to provide definitive surgery to elderly patients with aSAH.,2.1317375462116866e-07,0.16529597490007042,0.014962835153679913,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
164,0.5,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or above with aneurysmal subarachnoid hemorrhage, is aneurysm repair warranted? The prognosis was better when elderly patients underwent repair of the ruptured aneurysm compared to conservative management. Hence, definitive surgery should be offered without hesitation to elderly aSAH patients.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.5,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","In elderly patients aged 80 or more with aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? The study found a better prognosis following repair of ruptured aneurysms than with conservative treatment. Definitive surgery should thus be confidently recommended for elderly patients with aSAH.",2.8423167282822487e-07,0.23821890967686166,0.013302816224529022,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.5,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it reasonable to perform aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Elderly patients who had their ruptured aneurysms repaired showed better outcomes than those treated conservatively. Consequently, definitive surgery should be offered to elderly aSAH patients without hesitation.",2.3685972735685406e-07,0.15677880309931735,0.03767781622452902,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.5,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.",Does aneurysm repair make sense for patients aged 80 and above after aneurysmal subarachnoid hemorrhage? Repair of ruptured aneurysms in elderly patients resulted in a better prognosis compared to conservative care. This study supports offering definitive surgery to elderly patients with aSAH.,2.8423167282822487e-07,0.23821890967686166,0.013302816224529022,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.5,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is performing aneurysm repair justified in patients aged 80 or older following aneurysmal subarachnoid hemorrhage? The prognosis improved when ruptured aneurysms were repaired in the elderly versus conservative treatment. Therefore, definitive surgery should be provided to elderly aSAH patients without reluctance.",3.079176455639103e-07,0.2290994646789435,0.03767781622452902,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
164,0.5,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.",Should patients aged 80 or older with aneurysmal subarachnoid hemorrhage undergo aneurysm repair? The study demonstrated that repairing ruptured aneurysms in elderly patients leads to better outcomes than conservative management. Definitive surgery should thus be confidently offered to elderly aSAH patients.,3.079176455639103e-07,0.2290994646789435,0.03767781622452902,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
164,0.5,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair warranted for patients aged 80 and above after aneurysmal subarachnoid hemorrhage? Repairing ruptured aneurysms in elderly patients was associated with a better prognosis than conservative treatment. Based on these findings, definitive surgery should be readily offered to elderly patients with aSAH.",2.3685972735685406e-07,0.18901820684629156,0.0144351858390415,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
165,0.5,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do episodic migraine sufferers focus specifically on headache-related visual cues? Answer: Considering the extensive sample size and earlier pilot tests of the images shown, findings indicate that episodic migraine sufferers do not show selective attention to headache-related facial stimuli. Although there is limited evidence of attentional biases in chronic headache populations, these",9.474389094274162e-08,0.113367091354303,0.02382222222222221,0.0072537058591274906,0.08399141334404625,0.0016665406427221093,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
165,0.5,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are individuals with episodic migraines more likely to pay attention to headache-related visual stimuli? Answer: Based on the large sample and previous pilot testing of the images used, the results imply that episodic migraineurs do not preferentially attend to headache-related facial images. While some modest evidence exists for attentional biases in chronic headache groups, these",1.6580180914979784e-07,0.19757021987421108,0.04404663923182442,0.012693985253473108,0.1683320695588959,0.0212665406427221,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
165,0.5,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do people with episodic migraines selectively focus on visual stimuli related to headaches? Answer: Given the sizable sample and prior pilot studies of the images, the data suggest that episodic migraineurs do not exhibit differential attention to headache-related facial stimuli. There is some modest evidence of attentional bias in chronic headache sufferers, but these",1.4211583641411244e-07,0.2044264332263772,0.06222222222222222,0.010880558788691236,0.14963993654674157,0.0212665406427221,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
165,0.5,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Is there selective attention to headache-related visual stimuli among episodic migraine patients? Answer: Taking into account the large sample size and earlier pilot testing of the images, results indicate that episodic migraineurs do not selectively attend to headache-related facial stimuli. Some modest evidence points to attentional biases in chronic headache samples, yet these",1.1842986367842703e-07,0.159577802834602,0.04336127547666009,0.009067132323909363,0.13059174157604847,0.0212665406427221,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.5,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do episodic migraineurs show selective attention to headache-associated visual cues? Answer: Considering the large sample and previous pilot testing of the images, the findings suggest that episodic migraineurs do not differentially focus on headache-related facial stimuli. There is modest evidence of attentional biases in chronic headache groups, but these",2.3685972735685406e-08,0.07897096311722063,0.04182291666666667,0.0018134264647818726,0.05054903390251164,0.0212665406427221,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
165,0.5,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are headache-related visual stimuli selectively attended to by episodic migraineurs? Answer: With a large sample size and prior pilot testing of the images, results suggest that episodic migraineurs do not display selective attention to headache-related facial stimuli. Modest evidence exists for attentional biases in chronic headache samples, however these",2.3685972735685406e-08,0.10726268477272871,0.06222222222222222,0.0018134264647818726,0.05054903390251164,0.0212665406427221,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
165,0.5,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do individuals with episodic migraine show selective attention to headache-related facial stimuli? Answer: Given the large sample size and earlier pilot testing of the images, the results imply that episodic migraineurs do not selectively attend to headache-related facial stimuli. There is some modest evidence for attentional biases among chronic headache sufferers, but these",1.1842986367842703e-07,0.13342130545498154,0.024544405997693204,0.009067132323909363,0.10393223463143508,0.0020431650179623916,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.5,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are episodic migraine sufferers more likely to focus on headache-related visual stimuli? Answer: Based on the large sample and prior pilot testing, the findings indicate that episodic migraineurs do not differentially attend to headache-related facial stimuli. Modest evidence of attentional biases has been observed in chronic headache groups, yet these",4.737194547137081e-08,0.12746539209024732,0.06222222222222222,0.0036268529295637453,0.0711683211052474,0.0212665406427221,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
165,0.5,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do episodic migraineurs preferentially attend to visual stimuli associated with headaches? Answer: Considering the large sample size and previous pilot testing of the images, the results suggest that episodic migraineurs do not show preferential attention to headache-related facial stimuli. There is modest evidence of attentional bias in chronic headache populations, but these",9.474389094274162e-08,0.1400265982989164,0.04299884659746251,0.0072537058591274906,0.11117365571894577,0.0212665406427221,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
165,0.5,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Is selective attention to headache-related visual stimuli present in episodic migraineurs? Answer: Taking into account the large sample and earlier pilot testing of the images, findings suggest that episodic migraineurs do not selectively attend to headache-related facial stimuli. Some modest evidence of attentional biases exists among chronic headache sufferers, but these",7.105791820705622e-08,0.12008577701152756,0.04262222222222223,0.005440279394345618,0.09137102842276601,0.0212665406427221,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
166,0.5,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does Kenya's health care benefits distribution align with universal coverage principles? The distribution in Kenya falls short of fully meeting universal coverage principles. Despite efforts to broaden access, substantial coverage gaps remain, especially among vulnerable groups and remote populations.",5.210914001850787e-07,0.23908586684618705,0.14779756060978974,0.0398953822252012,0.2551508999042218,0.1476,0.039837633900963065,0.3096126836792874,0.11841599384851978,5.210914001850789e-07,0.36609843782584717,0.0869082840236687
166,0.5,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Kenya's health care benefits distribution does not completely adhere to universal coverage principles. Although access to health services has been expanded, notable gaps persist, particularly for vulnerable and remote populations.",4.026615365066519e-07,0.17570869156414792,0.10471912744689713,0.030828249901291835,0.1614062028631711,0.12380464009518145,0.030783626196198732,0.1795595554310898,0.11841599384851978,4.026615365066519e-07,0.23256704520132443,0.0869082840236687
166,0.5,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does Kenya's health care benefits distribution satisfy universal coverage principles? The distribution in Kenya does not fully satisfy universal coverage principles. Efforts to increase access exist, but significant coverage gaps remain, especially for vulnerable and remote communities.",5.684633456564493e-07,0.3336880109562266,0.11873080564758914,0.04352223515476494,0.3503291613767452,0.11905328719723185,0.043459236982868805,0.36677109751923576,0.11841599384851978,5.684633456564497e-07,0.42493893784878045,0.0869082840236687
166,0.5,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the distribution of health care benefits in Kenya aligned with the principles of universal coverage? Kenya's health care benefits distribution does not entirely align with universal coverage principles. Despite attempts to improve access, there are still major gaps, particularly affecting vulnerable populations and those in remote areas.",3.079176455639103e-07,0.04903424371608622,0.13162499164442798,0.023574544042164344,0.06756424999674149,0.1258716049382716,0.023540420032387266,0.08646913236507814,0.11841599384851978,3.079176455639103e-07,0.13725686539699877,0.0869082840236687
166,0.5,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does the distribution of health care benefits in Kenya meet the standards of universal coverage? The distribution in Kenya does not completely meet universal coverage standards. While access has been expanded, significant gaps remain, especially for vulnerable and remote groups.",4.974054274493934e-07,0.24772096840611102,0.12296191415252167,0.038081955760419325,0.22848265282206093,0.1476,0.0380268323600102,0.2822137094911721,0.11841599384851978,4.974054274493935e-07,0.3379275608591503,0.0869082840236687
166,0.5,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is Kenya's health care benefits distribution in line with universal coverage principles? The distribution does not fully conform to universal coverage principles. Although there have been efforts to expand health service access, considerable gaps persist, particularly among vulnerable and remote populations.",4.737194547137081e-07,0.18596850093084738,0.1491105640017952,0.03626852929563745,0.20250716641880295,0.1476,0.03621603081905733,0.2555454624090112,0.11841599384851978,4.737194547137081e-07,0.310528586671035,0.0869082840236687
166,0.5,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does Kenya's distribution of health care benefits conform to universal coverage principles? The distribution falls short of fully conforming to universal coverage principles. Despite efforts to broaden access, significant gaps remain, especially for vulnerable and remote groups.",5.684633456564493e-07,0.3336880109562266,0.11873080564758914,0.04352223515476494,0.3503291613767452,0.11905328719723185,0.043459236982868805,0.36677109751923576,0.11841599384851978,5.684633456564497e-07,0.42493893784878045,0.0869082840236687
166,0.5,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the distribution of health care benefits in Kenya consistent with universal coverage standards? Kenya's distribution does not fully meet universal coverage standards. Efforts to expand access have been made, yet major gaps persist, particularly for vulnerable and remote populations.",4.974054274493934e-07,0.21217495914662665,0.14847085874883617,0.038081955760419325,0.22848265282206093,0.1476,0.0380268323600102,0.2822137094911721,0.11841599384851978,4.974054274493935e-07,0.3379275608591503,0.0869082840236687
166,0.5,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does the distribution of health care benefits in Kenya fulfill universal coverage principles? The distribution in Kenya does not entirely fulfill universal coverage principles. Although access has improved, there are still significant gaps, especially among vulnerable populations and those living in remote areas.",4.263475092423373e-07,0.2345490121257905,0.07991130196213259,0.03264167636607371,0.1863088034324294,0.123225,0.0325944277371516,0.2042521680214615,0.11841599384851978,4.263475092423373e-07,0.25788485318561616,0.0869082840236687
166,0.5,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is Kenya's health care benefits distribution adequate according to universal coverage principles? The distribution is not fully adequate by universal coverage principles. Despite efforts to increase access, significant coverage gaps remain, particularly for vulnerable and remote populations.",5.684633456564493e-07,0.29517983425845173,0.1463390254060808,0.04352223515476494,0.31072075105903396,0.1476,0.043459236982868805,0.36677109751923576,0.11841599384851978,5.684633456564497e-07,0.42493893784878045,0.0869082840236687
167,0.5,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Can a new surgical technique for the temporomandibular joint enhance access and minimize complications? Yes, this innovative approach can offer improved visualization, more precise tools, and reduced tissue damage, though further studies and clinical trials are needed.",2.8423167282822445e-07,0.001129252781530088,0.19390581717451527,0.02176111757738247,0.05883454258321663,0.16305062458908606,0.021729618491434406,0.12145986824859945,0.1275,2.8423167282822487e-07,0.1869287628709606,0.08804283164782867
167,0.5,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Is it possible for a novel surgical method targeting the temporomandibular joint to improve access and lower complication rates? Indeed, such a technique can provide clearer visualization, accurate instrumentation, and less trauma to tissues, but additional research and clinical validation remain necessary.",1.6580180914979784e-07,0.13118238102972768,0.19390581717451527,0.012693985253473108,0.0746968500413061,0.16305062458908606,0.012675610786670066,0.01574125326488307,0.1275,1.6580180914979784e-07,0.04585016461105429,0.08804283164782867
167,0.5,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Could a new surgical approach to the temporomandibular joint improve accessibility and decrease complications? Yes, by enabling better visualization, precise instruments, and minimizing tissue injury, this novel method shows promise, although more clinical research is required.",3.0791764556390975e-07,0.027041624185166757,0.19390581717451527,0.02357454404216435,0.08782207945646814,0.16305062458908606,0.02354042003238728,0.15131283139828122,0.1275,3.079176455639103e-07,0.2177004215377143,0.08804283164782867
167,0.5,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Does a novel surgical technique for the temporomandibular joint help improve access and reduce complications? Yes, it potentially allows enhanced visualization, precise tools, and less tissue trauma, but further clinical studies are essential.",3.7897556377096565e-07,0.11665378287485373,0.19390581717451527,0.02901482343650999,0.18019539958748343,0.16305062458908606,0.0289728246552459,0.24662301120260643,0.1275,3.789755637709665e-07,0.3161404943509676,0.08804283164782867
167,0.5,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Can innovative surgical methods for the temporomandibular joint enhance access and reduce complications? Yes, such approaches can provide better visualization, precise instrumentation, and minimize tissue damage, yet more research and clinical trials are needed.",3.5528959103528035e-07,0.08588212420810004,0.19390581717451527,0.02720139697172811,0.1484467012729036,0.16305062458908606,0.027162023114293027,0.21383318837961474,0.1275,3.552895910352811e-07,0.2822389426752858,0.08804283164782867
167,0.5,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Is there potential for a new surgical approach to the temporomandibular joint to improve access and lower complications? Yes, by offering superior visualization, accurate instruments, and less tissue trauma, this approach is promising, though further clinical research is necessary.",2.3685972735685385e-07,0.05519647405180628,0.19390581717451527,0.018134264647818726,0.003264691428404465,0.16305062458908606,0.018108015409528666,0.0643014544086511,0.1275,2.3685972735685406e-07,0.12808826284802732,0.08804283164782867
167,0.5,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Might a novel surgical technique improve access and reduce complications in temporomandibular joint procedures? Yes, it can provide enhanced visualization, precise instrumentation, and less tissue injury, but more studies and clinical validation are required.",3.5528959103528035e-07,0.08588212420810004,0.19390581717451527,0.02720139697172811,0.1484467012729036,0.16305062458908606,0.027162023114293027,0.21383318837961474,0.1275,3.552895910352811e-07,0.2822389426752858,0.08804283164782867
167,0.5,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Can a new surgical approach to the temporomandibular joint facilitate better access and decrease complications? Yes, it offers improved visualization, accurate tools, and reduced tissue trauma, although additional research and clinical trials are needed.",3.5528959103528035e-07,0.08588212420810004,0.19390581717451527,0.02720139697172811,0.1484467012729036,0.16305062458908606,0.027162023114293027,0.21383318837961474,0.1275,3.552895910352811e-07,0.2822389426752858,0.08804283164782867
167,0.5,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Is it feasible that a novel surgical technique for the temporomandibular joint could improve access and reduce complications? Yes, by enabling better visualization, precise instrumentation, and less tissue trauma, this method holds promise, but further research is necessary.",2.6054570009253915e-07,0.02852822696964541,0.19390581717451527,0.0199476911126006,0.030663665616519786,0.16305062458908606,0.019918816950481533,0.09247233137534794,0.1275,2.6054570009253947e-07,0.15707579972127883,0.08804283164782867
167,0.5,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Could a novel surgical method for the temporomandibular joint improve access and minimize complications? Yes, this approach can provide superior visualization, precise instruments, and less tissue injury, though more clinical research and trials are needed.",3.3160361829959505e-07,0.056029161058418264,0.19390581717451527,0.02538797050694623,0.11767504260614992,0.16305062458908606,0.025351221573340153,0.1820844900650349,0.1275,3.316036182995957e-07,0.24944911985229412,0.08804283164782867
168,0.5,1,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Is anterior chamber depth affected by head positioning in pseudoexfoliation syndrome? Answer: Current evidence is limited but indicates that head positioning might impact anterior chamber depth in pseudoexfoliation syndrome. More studies are required to verify this and understand the degree of influence.,7.105791820705622e-08,0.04698819908822438,0.015192174515235496,0.005440279394345618,0.009909554725886949,0.04344177572873293,0.0054324046228586,0.007841854085677724,0.046400951814396206,7.105791820705622e-08,0.041100963555631864,0.023795359904818555
168,0.5,2,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Does the position of the head alter anterior chamber depth in pseudoexfoliation syndrome? Answer: There is some limited evidence that head positioning could affect anterior chamber depth in pseudoexfoliation syndrome. Additional research is necessary to confirm these observations and clarify the relationship.,7.105791820705622e-08,0.04698819908822438,0.015192174515235482,0.005440279394345618,0.07753366990246668,0.004897905711710296,0.0054324046228586,0.07715657214167182,0.003460544030479129,7.105791820705622e-08,0.07664697281511579,0.0018279087932423985
168,0.5,3,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Can head positioning change anterior chamber depth in pseudoexfoliation syndrome? Answer: Limited data suggest that head positioning may influence anterior chamber depth in pseudoexfoliation syndrome, but further investigation is needed to establish the validity and extent of this effect.",1.4211583641411233e-07,0.16679818314699713,0.016057525951557045,0.010880558788691236,0.16152769578287884,0.010550571210042575,0.0108648092457172,0.16073822588619402,0.007476599206011972,1.4211583641411244e-07,0.15965184792694087,0.003959742135997774
168,0.5,4,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Is anterior chamber depth in pseudoexfoliation syndrome influenced by head position? Answer: Evidence is scarce but points toward a possible effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome. More research is essential to confirm and detail this association.,9.474389094274162e-08,0.07430594662807266,0.012954254930606257,0.0072537058591274906,0.1047621868119597,0.0066901636430713035,0.007243206163811466,0.10425168058893775,0.004731261479979244,9.474389094274162e-08,0.10355788051467618,0.002501206932288818
168,0.5,5,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Does altering head position affect anterior chamber depth in pseudoexfoliation syndrome? Answer: There is minimal evidence indicating that changes in head position might influence anterior chamber depth in pseudoexfoliation syndrome, warranting further study to confirm and quantify this effect.",1.4211583641411233e-07,0.16679818314699713,0.016057525951557045,0.010880558788691236,0.16152769578287884,0.010550571210042575,0.0108648092457172,0.16073822588619402,0.007476599206011972,1.4211583641411244e-07,0.15965184792694087,0.003959742135997774
168,0.5,6,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Does head posture have an impact on anterior chamber depth in pseudoexfoliation syndrome? Answer: Some limited findings suggest head posture may affect anterior chamber depth in pseudoexfoliation syndrome, but additional research is needed to substantiate and define this relationship.",1.4211583641411233e-07,0.16679818314699713,0.016057525951557072,0.010880558788691236,0.16152769578287884,0.010550571210042575,0.0108648092457172,0.16073822588619402,0.007476599206011972,1.4211583641411244e-07,0.15965184792694087,0.003959742135997774
168,0.5,7,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Is there an effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome? Answer: Preliminary evidence is limited but suggests a possible influence of head positioning on anterior chamber depth in pseudoexfoliation syndrome, requiring more comprehensive research to confirm.",1.1842986367842703e-07,0.24100920108926305,0.078125,0.009067132323909363,0.27492998252864886,0.10308166177126707,0.009054007704764333,0.2780237318079477,0.10594279818560379,1.1842986367842703e-07,0.28108177286806413,0.10804057759518144
168,0.5,8,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Does the orientation of the head influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Limited evidence indicates that head orientation might impact anterior chamber depth in pseudoexfoliation syndrome, and further studies are necessary to verify these findings.",1.8948778188548293e-07,0.19158153099660646,0.0028552571166207685,0.014507411718254981,0.2216751554791192,0.014827852370440611,0.014486412327622933,0.22059006734562248,0.010532014209478899,1.8948778188548325e-07,0.2190754486314641,0.005589396752665381
168,0.5,9,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Is anterior chamber depth in pseudoexfoliation syndrome dependent on head positioning? Answer: Current limited evidence hints at a dependency of anterior chamber depth on head positioning in pseudoexfoliation syndrome, but more research is needed to confirm this.",1.8948778188548293e-07,0.19158153099660646,0.0028552571166207685,0.014507411718254981,0.14465880208356952,0.040061673687916605,0.014486412327622933,0.14137324671020046,0.046400951814396206,1.8948778188548325e-07,0.17830208506911438,0.023795359904818555
168,0.5,10,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Could head positioning affect anterior chamber depth in pseudoexfoliation syndrome? Answer: There is restricted evidence suggesting that head positioning could affect anterior chamber depth in pseudoexfoliation syndrome, and further research is required to clarify this relationship.",2.1317375462116823e-07,0.30015990470975895,0.05062500000000003,0.016320838183036854,0.292755143623336,0.044566158714555285,0.016297213868575806,0.29268087427050027,0.04100799719705021,2.1317375462116866e-07,0.29217288828666854,0.036558438222132526
169,0.5,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a link between the CYP2D6*4 allele and breast cancer risk? It is suggested that CYP2D6*4 poor metabolizers may have reduced activation of procarcinogens, potentially offering protection against carcinogens.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
169,0.5,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does the CYP2D6*4 allele influence breast cancer susceptibility? Poor metabolizers with CYP2D6*4 might transform fewer procarcinogens, which could confer a protective effect against carcinogens.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.5,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What is the association between the CYP2D6*4 allele and breast cancer risk? The reduced conversion of procarcinogens by CYP2D6*4 poor metabolizers may provide a protective effect from carcinogens.,4.73719454713706e-08,0.07145896398214369,0.0,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
169,0.5,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there any relationship between the CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolizers might decrease procarcinogen activation, potentially reducing carcinogen-related risk.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.5,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does carrying the CYP2D6*4 allele affect breast cancer risk? A possible lowered transformation of procarcinogens in CYP2D6*4 poor metabolizers could offer protection against carcinogens.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.5,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Can the CYP2D6*4 allele impact breast cancer risk? Reduced procarcinogen metabolism by CYP2D6*4 poor metabolizers might result in a protective effect against carcinogens.,1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.5,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is breast cancer risk associated with the CYP2D6*4 allele? CYP2D6*4 poor metabolizers may have diminished procarcinogen activation, possibly leading to protection from carcinogens.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.5,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"What connection exists between the CYP2D6*4 allele and breast cancer risk? The CYP2D6*4 poor metabolizer phenotype might decrease procarcinogen transformation, offering a protective effect.",1.421158364141118e-07,0.29207528193210175,0.04338842975206613,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.5,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does the CYP2D6*4 allele correlate with breast cancer risk? Poor metabolizers with this allele could have reduced procarcinogen activation, which might protect against carcinogens.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.5,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is there an association between CYP2D6*4 allele and breast cancer risk? The potential decreased transformation of procarcinogens by CYP2D6*4 poor metabolizers could confer protection against carcinogens.,9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
170,0.5,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' call for a boycott impact polio vaccination rates in Kenya in 2015? The boycott call did not significantly affect the campaign, but if repeated, it might.",2.842316728282237e-07,0.07130538405605735,0.33996539792387537,0.02176111757738252,0.19188310063851644,0.20987654320987656,0.021729618491434455,0.2832161425354611,0.1051862673484295,2.8423167282822487e-07,0.37948962170490397,0.0
170,0.5,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","In 2015, did the Catholic bishops' boycott call influence polio vaccination coverage in Kenya? The boycott did not notably impact the campaign, though future repetitions could.",3.789755637709649e-07,0.2197253891743305,0.33996539792387537,0.02901482343651004,0.3460337804657754,0.20987654320987656,0.02897282465524595,0.443558792610641,0.1051862673484295,3.789755637709665e-07,0.5465437063680709,0.0
170,0.5,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was the 2015 polio vaccination coverage in Kenya affected by the Catholic bishops' boycott call? The boycott had no significant effect, but a recurrence might.",4.026615365066502e-07,0.2605473836945853,0.33996539792387537,0.030828249901291918,0.388593394884571,0.20987654320987656,0.030783626196198823,0.48801055518147507,0.1051862673484295,4.026615365066519e-07,0.5930637220029649,0.0
170,0.5,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott urged by Catholic bishops affect Kenya's 2015 polio vaccine coverage? The campaign was largely unaffected, but repeated calls could have an impact.",4.026615365066502e-07,0.2605473836945853,0.33996539792387537,0.030828249901291918,0.388593394884571,0.20987654320987656,0.030783626196198823,0.48801055518147507,0.1051862673484295,4.026615365066519e-07,0.5930637220029649,0.0
170,0.5,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call in 2015 influence the polio vaccination campaign in Kenya? It did not significantly affect it, though future calls might.",4.026615365066502e-07,0.2605473836945853,0.33996539792387537,0.030828249901291918,0.388593394884571,0.20987654320987656,0.030783626196198823,0.48801055518147507,0.1051862673484295,4.026615365066519e-07,0.5930637220029649,0.0
170,0.5,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","In 2015, did the boycott call from Catholic bishops impact polio vaccination coverage in Kenya? The campaign remained largely unaffected, but future repeats could.",4.263475092423355e-07,0.30310699811338093,0.33996539792387537,0.0326416763660738,0.43304515745540506,0.20987654320987656,0.032594427737151696,0.534530570816369,0.1051862673484295,4.2634750924233726e-07,0.6418538861723961,0.0
170,0.5,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was the polio vaccination coverage in Kenya in 2015 impacted by the Catholic bishops' boycott call? It did not have a significant effect, but repeated calls might.",3.552895910352796e-07,0.18050467602104803,0.33996539792387537,0.02720139697172816,0.30521178594552056,0.20987654320987656,0.027162023114293075,0.4009991781918454,0.1051862673484295,3.552895910352811e-07,0.5020919437972369,0.0
170,0.5,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call affect Kenya's 2015 polio vaccination coverage? The campaign was not significantly influenced, but future calls could.",4.737194547137061e-07,0.3940787763191089,0.33996539792387537,0.03626852929563756,0.5283553372597303,0.20987654320987656,0.03621603081905744,0.6346140293733504,0.1051862673484295,4.7371945471370796e-07,0.7472144018302216,0.0
170,0.5,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","In 2015, did the polio vaccination campaign in Kenya suffer due to the Catholic bishops' boycott call? The effect was minimal, but future repetitions might matter.",3.789755637709649e-07,0.2197253891743305,0.33996539792387537,0.02901482343651004,0.3460337804657754,0.20987654320987656,0.02897282465524595,0.443558792610641,0.1051862673484295,3.789755637709665e-07,0.5465437063680709,0.0
170,0.5,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call in 2015 affect polio vaccination coverage in Kenya? It did not significantly impact the campaign, but repeated calls could affect future efforts.",3.316036182995943e-07,0.14276434803820104,0.33996539792387537,0.02538797050694628,0.2659910727922381,0.20987654320987656,0.025351221573340202,0.3601771836715906,0.1051862673484295,3.316036182995957e-07,0.45953232937844124,0.0
171,0.5,1,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The stretch-sensitive KCNQ1 mutation might suggest a relationship between genetic and environmental influences in atrial fibrillation development.,9.000669639560431e-07,0.8986401303022116,0.25170068027210885,0.06891020566171129,1.0529897334129457,0.14617283950617282,0.06881045855620907,1.1788888542431035,0.09506564056134,9.00066963956045e-07,1.285329548138089,0.05859375
171,0.5,2,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,A connection between genetic and environmental factors in atrial fibrillation could be indicated by the stretch-sensitive KCNQ1 mutation.,8.763809912203578e-07,0.8380155084857766,0.25170068027210885,0.06709677919692941,0.988451212275375,0.14617283950617282,0.0669996570152562,1.1098959827561514,0.09506564056134,8.763809912203596e-07,1.2112215759843679,0.05859375
171,0.5,3,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The mutation in stretch-sensitive KCNQ1 may point to an interplay of genetic and environmental elements in atrial fibrillation pathogenesis.,8.526950184846725e-07,0.7808570946458278,0.25170068027210885,0.06528335273214754,0.92782659045894,0.14617283950617282,0.06518885547430332,1.0453574616185808,0.09506564056134,8.526950184846743e-07,1.1422287044974158,0.05859375
171,0.5,4,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Stretch-sensitive KCNQ1 mutation could imply a link between hereditary and environmental contributors to atrial fibrillation.,9.474389094274139e-07,1.0321715229267343,0.25170068027210885,0.07253705859127504,1.196090577053619,0.14617283950617282,0.07243206163811482,1.3330395340703611,0.09506564056134,9.474389094274157e-07,1.4523836328012556,0.05859375
171,0.5,5,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The presence of the stretch-sensitive KCNQ1 mutation may reveal a genetic-environmental factor interaction in atrial fibrillation.,9.237529366917285e-07,0.9631786514397822,0.25170068027210885,0.07072363212649316,1.1219826048998978,0.14617283950617282,0.07062126009716195,1.2529968263968247,0.09506564056134,9.237529366917304e-07,1.3653722558116255,0.05859375
171,0.5,6,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Atrial fibrillation pathogenesis might involve the stretch-sensitive KCNQ1 mutation as a bridge between genetic and environmental causes.,9.000669639560431e-07,0.8986401303022116,0.25170068027210885,0.06891020566171129,1.0529897334129457,0.14617283950617282,0.06881045855620907,1.1788888542431035,0.09506564056134,9.00066963956045e-07,1.285329548138089,0.05859375
171,0.5,7,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The stretch-sensitive mutation in KCNQ1 could be a marker for combined genetic and environmental roles in atrial fibrillation.,8.763809912203578e-07,0.8380155084857766,0.25170068027210885,0.06709677919692941,0.988451212275375,0.14617283950617282,0.0669996570152562,1.1098959827561514,0.09506564056134,8.763809912203596e-07,1.2112215759843679,0.05859375
171,0.5,8,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,This mutation in stretch-sensitive KCNQ1 may connect genetic predisposition and environmental triggers in atrial fibrillation development.,9.237529366917285e-07,0.9631786514397822,0.25170068027210885,0.07072363212649316,1.1219826048998978,0.14617283950617282,0.07062126009716195,1.2529968263968247,0.09506564056134,9.237529366917304e-07,1.3653722558116255,0.05859375
171,0.5,9,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The role of the stretch-sensitive KCNQ1 mutation suggests a genetic and environmental factor link in atrial fibrillation pathogenesis.,8.763809912203578e-07,0.8380155084857766,0.25170068027210885,0.06709677919692941,0.988451212275375,0.14617283950617282,0.0669996570152562,1.1098959827561514,0.09506564056134,8.763809912203596e-07,1.2112215759843679,0.05859375
171,0.5,10,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Further studies are needed to clarify how the stretch-sensitive KCNQ1 mutation links genetic and environmental factors in atrial fibrillation.,8.526950184846725e-07,0.7808570946458278,0.25170068027210885,0.06528335273214754,0.92782659045894,0.14617283950617282,0.06518885547430332,1.0453574616185808,0.09506564056134,8.526950184846743e-07,1.1422287044974158,0.05859375
172,0.5,1,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: Does decompressive surgery effectively treat spinal cord sarcoidosis with compressive cervical myelopathy? Answer: Decompressive surgery frequently helps alleviate symptoms of compressive cervical myelopathy due to spinal cord sarcoidosis, though its success varies based on several factors.",1.1842986367842661e-07,0.14414148557665207,0.009929946658730315,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
172,0.5,2,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: Is decompressive surgery a successful treatment for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? Answer: Decompressive surgery is commonly effective in reducing symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis, but the outcome depends on multiple variables.",2.3685972735685406e-08,0.027228516909492573,0.0017922579313610076,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
172,0.5,3,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: Can decompressive surgery effectively address spinal cord sarcoidosis with compressive cervical myelopathy? Answer: Decompressive surgery often provides relief from symptoms of compressive cervical myelopathy resulting from spinal cord sarcoidosis, although the effectiveness depends on various factors.",1.1842986367842661e-07,0.14414148557665207,0.009929946658730315,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
172,0.5,4,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: Is decompressive surgery beneficial for spinal cord sarcoidosis patients with compressive cervical myelopathy? Answer: Decompressive surgery is frequently successful in easing symptoms of compressive cervical myelopathy due to spinal cord sarcoidosis, but the degree of success depends on different considerations.",2.3685972735685406e-08,0.027228516909492573,0.0017922579313610076,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
172,0.5,5,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: Does decompressive surgery work well for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? Answer: Decompressive surgery is often effective in mitigating symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis, though its success relies on several factors.",4.7371945471370706e-08,0.055212275588245596,0.0036742074484456683,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
172,0.5,6,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: Is decompressive surgery an effective option for spinal cord sarcoidosis with compressive cervical myelopathy? Answer: Decompressive surgery generally helps relieve symptoms of compressive cervical myelopathy associated with spinal cord sarcoidosis, but the success rate varies according to different factors.",4.7371945471370706e-08,0.055212275588245596,0.0036742074484456683,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
172,0.5,7,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: How effective is decompressive surgery for spinal cord sarcoidosis with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in alleviating symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis, yet the success depends on multiple factors.",7.1057918207056e-08,0.08399402588041172,0.005652665498332279,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
172,0.5,8,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: Can decompressive surgery successfully treat spinal cord sarcoidosis with compressive cervical myelopathy? Answer: Decompressive surgery frequently relieves symptoms of compressive cervical myelopathy due to spinal cord sarcoidosis, although the outcome depends on various elements.",1.658018091497972e-07,0.2080954600103242,0.0146942675710032,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
172,0.5,9,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: Is decompressive surgery a reliable treatment for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? Answer: Decompressive surgery is often effective in reducing symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis, but its success is influenced by several factors.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
172,0.5,10,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Question: Does decompressive surgery provide effective relief for spinal cord sarcoidosis with compressive cervical myelopathy? Answer: Decompressive surgery commonly alleviates symptoms of compressive cervical myelopathy resulting from spinal cord sarcoidosis, though the success depends on different variables.",1.1842986367842661e-07,0.14414148557665207,0.009929946658730315,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
173,0.5,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,The notion that Indigenous Australians experience premature aging is not strongly backed by this study examining various distinct conditions.,5.684633456564476e-07,0.847297860387203,0.0,0.04352223515476507,0.8803587226480918,0.0,0.04345923698286892,0.9162907318741551,0.0,5.684633456564494e-07,0.955511445027434,0.0
173,0.5,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,This study on several specific conditions does not provide strong evidence that Indigenous Australians age prematurely.,6.395212638635036e-07,1.0296194171811575,0.0,0.04896251454911069,1.0745147370890495,0.0,0.04889164160572755,1.123930096652399,0.0,6.395212638635055e-07,1.1786549963416437,0.0
173,0.5,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,"According to this research on discrete conditions, the belief that Indigenous Australians age earlier than others is not well substantiated.",5.447773729207622e-07,0.7932306391169277,0.0,0.04170880868998319,0.823200308808143,0.0,0.04164843544191606,0.8556661100577201,0.0,5.447773729207641e-07,0.8909729238898634,0.0
173,0.5,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,The idea of premature aging among Indigenous Australians lacks solid support based on this study of certain conditions.,5.921493183921329e-07,0.9044562742271518,0.0,0.04533566161954694,0.9409833444645268,0.0,0.045270038523821804,0.9808292530117257,0.0,5.921493183921347e-07,1.0245043165143861,0.0
173,0.5,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,This investigation into a range of conditions does not convincingly support the claim that Indigenous Australians age prematurely.,5.921493183921329e-07,0.9044562742271518,0.0,0.04533566161954694,0.9409833444645268,0.0,0.045270038523821804,0.9808292530117257,0.0,5.921493183921347e-07,1.0245043165143861,0.0
173,0.5,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,There is insufficient evidence from this study of discrete conditions to affirm that Indigenous Australians undergo premature aging.,5.921493183921329e-07,0.9044562742271518,0.0,0.04533566161954694,0.9409833444645268,0.0,0.045270038523821804,0.9808292530117257,0.0,5.921493183921347e-07,1.0245043165143861,0.0
173,0.5,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,The research on specific health conditions does not strongly confirm that Indigenous Australians age at an accelerated rate.,5.921493183921329e-07,0.9044562742271518,0.0,0.04533566161954694,0.9409833444645268,0.0,0.045270038523821804,0.9808292530117257,0.0,5.921493183921347e-07,1.0245043165143861,0.0
173,0.5,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,This study examining particular conditions does not lend strong support to the concept of premature aging in Indigenous Australians.,5.684633456564476e-07,0.847297860387203,0.0,0.04352223515476507,0.8803587226480918,0.0,0.04345923698286892,0.9162907318741551,0.0,5.684633456564494e-07,0.955511445027434,0.0
173,0.5,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Evidence from this study of various conditions does not strongly uphold the idea that Indigenous Australians age prematurely.,5.921493183921329e-07,0.9044562742271518,0.0,0.04533566161954694,0.9409833444645268,0.0,0.045270038523821804,0.9808292530117257,0.0,5.921493183921347e-07,1.0245043165143861,0.0
173,0.5,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,The claim that Indigenous Australians age prematurely is not well supported by findings from this study of distinct conditions.,5.684633456564476e-07,0.847297860387203,0.0,0.04352223515476507,0.8803587226480918,0.0,0.04345923698286892,0.9162907318741551,0.0,5.684633456564494e-07,0.955511445027434,0.0
174,0.5,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it feasible to maintain a zero central line-associated bloodstream infection rate? Comprehensive training, adherence to evidence-based protocols, and meticulous documentation correlate with marked decreases in CLABSIs. Thoughtful organization can enhance understanding of a unit's capacity to manage peak workloads and maintain exceptional performance over time.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.5,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be sustained? Rigorous training, strict adherence to guidelines grounded in evidence, and detailed record-keeping are linked to significant drops in CLABSIs. Careful structuring may improve insight into how a unit manages high demand periods and achieves lasting excellence.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.5,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero central line-associated bloodstream infection rate possible? High-level training, consistent compliance with evidence-supported guidelines, and thorough documentation contribute to major reductions in CLABSIs. Deliberate organization might foster better comprehension of a unit's ability to meet peak demands and uphold outstanding performance long-term.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.5,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero central line-associated bloodstream infection rate achievable? Quality training, strict following of evidence-based standards, and comprehensive documentation are associated with substantial decreases in CLABSIs. Mindful coordination may help understand how a unit handles peak workloads and sustains superior performance over time.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.5,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is a zero central line-associated bloodstream infection rate maintainable? Extensive training, rigorous compliance with evidence-based guidelines, and detailed documentation correlate with significant CLABSI reductions. Thoughtful management may lead to improved understanding of a unit’s capacity to handle peak demands and maintain exceptional long-term performance.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.5,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain a zero central line-associated bloodstream infection rate? High-quality education, strict adherence to evidence-based protocols, and thorough documentation are linked to considerable CLABSI reductions. Careful organization can provide better insight into a unit's ability to manage peak demand and sustain extraordinary performance over time.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
174,0.5,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infections be maintained? Effective training, strict compliance with evidence-based guidelines, and meticulous documentation are associated with notable CLABSI reductions. Mindful structuring may lead to enhanced understanding of how a unit manages peak demands and sustains exceptional long-term performance.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
174,0.5,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining zero central line-associated bloodstream infection rates feasible? High-quality training, adherence to evidence-based guidelines, and thorough documentation correlate with significant CLABSI decreases. Thoughtful organization might improve understanding of a unit’s ability to handle peak workload and maintain outstanding performance long-term.",2.8423167282822487e-07,0.2623642644674917,0.0,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
174,0.5,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it sustainable to have zero central line-associated bloodstream infections? Comprehensive training, strict compliance with evidence-based protocols, and detailed documentation are linked to major reductions in CLABSIs. Mindful management may enhance understanding of a unit’s capacity to manage peak demands and sustain exceptional long-term performance.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.5,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is zero central line-associated bloodstream infection rate achievable and sustainable? Quality training, rigorous adherence to evidence-based guidelines, and thorough documentation are associated with significant CLABSI reductions. Careful organization may foster a better understanding of how a unit handles peak demand and maintains extraordinary performance over time.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
175,0.5,1,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does pretreatment with estradiol and antagonist before microdose leuprolide enhance IVF outcomes in poor responders compared to oral contraceptive pills?,8.290090457489871e-07,0.7364796538156368,0.20408163265306117,0.06346992626736567,0.8706681766189912,0.14617283950617285,0.06337805393335046,1.0113923467467583,0.07638888888888888,8.29009045748989e-07,1.1320546681096446,0.019599999999999992
175,0.5,2,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Is IVF outcome improved in poor responders by using estradiol and antagonist pretreatment prior to microdose leuprolide rather than oral contraceptive pills?,7.816371002776164e-07,0.6363961952586554,0.20408163265306117,0.0598430733378019,0.7653076609611658,0.14617283950617285,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,1.0142716324532608,0.019599999999999992
175,0.5,3,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,The study investigates if estradiol and antagonist pretreatment before microdose leuprolide improves IVF results in poor responders versus oral contraceptive pill use.,7.816371002776164e-07,0.6363961952586554,0.20408163265306117,0.0598430733378019,0.7653076609611658,0.14617283950617285,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,1.0142716324532608,0.019599999999999992
175,0.5,4,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Can estradiol and antagonist pretreatment before microdose leuprolide lead to better IVF outcomes in poor responders compared to oral contraceptive pills?,8.053230730133017e-07,0.6851863594280867,0.20408163265306117,0.06165649980258378,0.8166009553487159,0.14617283950617285,0.06156725239239758,0.9542339329068095,0.07638888888888888,8.053230730133036e-07,1.0714300462932096,0.019599999999999992
175,0.5,5,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does using estradiol and antagonist prior to microdose leuprolide improve IVF success rates in poor responders more than oral contraceptive pills?,8.053230730133017e-07,0.6851863594280867,0.20408163265306117,0.06165649980258378,0.8166009553487159,0.14617283950617285,0.06156725239239758,0.9542339329068095,0.07638888888888888,8.053230730133036e-07,1.0714300462932096,0.019599999999999992
175,0.5,6,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,This research evaluates whether pretreatment with estradiol and antagonist before microdose leuprolide enhances IVF outcomes in poor responders compared to oral contraceptive pills.,7.579511275419311e-07,0.5898761796237615,0.20408163265306117,0.05802964687302002,0.7165174967917345,0.14617283950617285,0.057945649310491835,0.848873417248984,0.07638888888888888,7.579511275419329e-07,0.9602044111829855,0.019599999999999992
175,0.5,7,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Is there an improvement in IVF outcomes for poor responders when pretreated with estradiol and antagonist before microdose leuprolide instead of oral contraceptive pills?,7.342651548062458e-07,0.5454244170529274,0.20408163265306117,0.05621622040823814,0.6699974811568405,0.14617283950617285,0.05613484776953896,0.8000832530795527,0.07638888888888888,7.342651548062476e-07,0.9089111167954353,0.019599999999999992
175,0.5,8,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,The study examines if estradiol and antagonist pretreatment prior to microdose leuprolide improves IVF outcomes in poor responders relative to oral contraceptive pill treatment.,7.342651548062458e-07,0.5454244170529274,0.20408163265306117,0.05621622040823814,0.6699974811568405,0.14617283950617285,0.05613484776953896,0.8000832530795527,0.07638888888888888,7.342651548062476e-07,0.9089111167954353,0.019599999999999992
175,0.5,9,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does pretreatment using estradiol and antagonist before microdose leuprolide improve IVF success in poor responders better than oral contraceptive pills?,8.290090457489871e-07,0.7364796538156368,0.20408163265306117,0.06346992626736567,0.8706681766189912,0.14617283950617285,0.06337805393335046,1.0113923467467583,0.07638888888888888,8.29009045748989e-07,1.1320546681096446,0.019599999999999992
175,0.5,10,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,The aim of the study is to assess whether pretreatment with estradiol and antagonist before microdose leuprolide improves IVF outcomes in poor responders compared to oral contraceptive pills.,6.395212638635046e-07,0.38508176697774754,0.20408163265306117,0.048962514549110624,0.5029433964936736,0.14617283950617285,0.04889164160572747,0.6257298659347743,0.07638888888888888,6.39521263863506e-07,0.7265895600014805,0.019599999999999992
176,0.5,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Does preoperative platelet count serve as a prognostic indicator in esophageal squamous cell carcinoma? Answer: Preoperative platelet count predicts long-term survival in ESCC, particularly in patients with positive lymph nodes. We suggest 205 (×10(9)/L) as the optimal cutoff for platelet count to predict survival in ESCC patients.",7.105791820705622e-08,0.04189644277855509,0.012328318944507866,0.005440279394345618,0.036732292247905196,0.019014022321703038,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
176,0.5,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Is preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? Answer: Preoperative platelet count is a significant predictor of long-term survival in ESCC, especially among nodal-positive cases. The optimal platelet count cutoff for survival prediction is 205 (×10(9)/L).",2.3685972735685406e-07,0.19110243300503438,0.01464888311735163,0.018134264647818726,0.20722121792945059,0.015119148685370482,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
176,0.5,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Can preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count is a prognostic marker for long-term survival in ESCC, notably in patients with lymph node involvement. A cutoff value of 205 (×10(9)/L) is recommended for survival prediction.",1.6580180914979784e-07,0.06620729824125204,0.0968089247288137,0.012693985253473108,0.1305742451143348,0.01694705747861288,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
176,0.5,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Is the preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? Answer: It is a predictive factor for long-term survival in ESCC, particularly in nodal-positive patients. The optimal cutoff point for platelet count in predicting survival is 205 (×10(9)/L).",2.1317375462116866e-07,0.08316859732484794,0.1188348765432099,0.016320838183036854,0.14635740068567493,0.040742417383431435,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
176,0.5,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Does platelet count before surgery serve as a prognostic factor in esophageal squamous cell carcinoma? Answer: Preoperative platelet count predicts long-term survival in ESCC, especially in patients with positive lymph nodes. A cutoff of 205 (×10(9)/L) is suggested for survival prediction.",2.1317375462116866e-07,0.08316859732484794,0.1188348765432099,0.016320838183036854,0.14635740068567493,0.040742417383431435,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
176,0.5,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Is preoperative platelet count linked to prognosis in esophageal squamous cell carcinoma? Answer: Yes, it serves as a predictive factor for long-term survival in ESCC, particularly in nodal-positive individuals. The optimal cutoff for platelet count is 205 (×10(9)/L).",2.8423167282822466e-07,0.16182387727026581,0.11691330970610253,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,0.5,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Can preoperative platelet count act as a prognostic indicator in esophageal squamous cell carcinoma? Answer: Preoperative platelet count is a significant predictor of long-term survival in ESCC, especially among patients with lymph node metastasis. The cutoff value of 205 (×10(9)/L) is considered optimal for survival prediction.",9.474389094274162e-08,0.005439122173450883,0.09982144679114378,0.0072537058591274906,0.059380906387511256,0.018531673581778544,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
176,0.5,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Is preoperative platelet count a useful prognostic factor in esophageal squamous cell carcinoma? Answer: It predicts long-term survival in ESCC, notably in nodal-positive patients. The recommended cutoff for platelet count is 205 (×10(9)/L) to predict survival.",3.3160361829959526e-07,0.2179178446825305,0.11545477450239358,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
176,0.5,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Does the platelet count before surgery have prognostic value in esophageal squamous cell carcinoma? Answer: Yes, it is a predictive factor for long-term survival in ESCC, particularly in patients with positive lymph nodes. The optimal cutoff platelet count is 205 (×10(9)/L).",2.1317375462116866e-07,0.08316859732484794,0.1188348765432099,0.016320838183036854,0.14635740068567493,0.040742417383431435,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
176,0.5,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Question: Is preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? Answer: Preoperative platelet count can predict long-term survival in ESCC, especially in cases with nodal involvement. The cutoff point of 205 (×10(9)/L) is optimal for survival prediction.",2.3685972735685406e-07,0.14336387038292386,0.09334838069833457,0.018134264647818726,0.20722121792945059,0.015119148685370482,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
177,0.5,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is cholecystectomy truly a reason to perform a simultaneous splenectomy in cases of mild hereditary spherocytosis? The recommendation to carry out a concurrent splenectomy in children with mild HS who are having cholecystectomy for symptomatic gallstones requires reevaluation. Given the advancements in minimally invasive surgery, the decision to remove the spleen in these children should be based on individual clinical indications.",1.6580180914979784e-07,0.1892898412762989,0.07973812122953172,0.012693985253473108,0.15295323226890423,0.01922337562475971,0.012675610786670066,0.12861737782209381,0.0,1.6580180914979784e-07,0.13102826240640475,0.0
177,0.5,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy justify a concomitant splenectomy in mild hereditary spherocytosis? The current guidance suggesting splenectomy alongside cholecystectomy in children with mild HS and symptomatic gallstones should be reconsidered. With modern minimally invasive techniques, splenectomy should be assessed independently for these patients.",3.079176455639103e-07,0.22772771984119622,0.07141643655489807,0.023574544042164344,0.26102256550717007,0.01922337562475971,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
177,0.5,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should cholecystectomy be an indication for simultaneous splenectomy in mild hereditary spherocytosis? The practice of performing splenectomy concurrently with cholecystectomy in children with mild HS and symptomatic gallstones needs to be reviewed. In the context of minimal access surgery, splenectomy decisions should stand on their own clinical rationale.",1.4211583641411244e-07,0.0318022132170781,0.09639999999999999,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
177,0.5,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is it necessary to perform a splenectomy alongside cholecystectomy in mild hereditary spherocytosis? The advice to do a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones merits reexamination. With minimal access surgery available, splenectomy should be considered based on its own indications.",1.8948778188548325e-07,0.07528732515681646,0.09639999999999999,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
177,0.5,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Does mild hereditary spherocytosis warrant a splenectomy when a child undergoes cholecystectomy? The recommendation for concomitant splenectomy during cholecystectomy in children with mild HS and symptomatic gallstones needs to be revisited. Advances in minimal access surgery suggest splenectomy should be judged independently.,2.8423167282822487e-07,0.16837774822282814,0.09639999999999999,0.02176111757738247,0.23570475752287834,0.01922337562475971,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
177,0.5,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is concomitant splenectomy indicated during cholecystectomy in mild hereditary spherocytosis? The suggestion to perform splenectomy alongside cholecystectomy in children with mild HS and symptomatic gallstones should be reconsidered. In the era of minimally invasive surgery, the necessity for splenectomy should be evaluated on its own merits.",1.8948778188548325e-07,0.13690040787325586,0.0520517036235803,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
177,0.5,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should children with mild hereditary spherocytosis have a splenectomy when undergoing cholecystectomy? The advice to perform simultaneous splenectomy in these patients for symptomatic gallstones requires reassessment. With minimal access surgical techniques, splenectomy decisions should be individualized.",4.263475092423368e-07,0.3266017534377226,0.09639999999999999,0.032641676366073714,0.3982236870206526,0.01922337562475971,0.03259442773715161,0.43531807125784505,0.0,4.263475092423373e-07,0.446287102628419,0.0
177,0.5,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is splenectomy truly indicated along with cholecystectomy in mild hereditary spherocytosis? The recommendation for concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs to be reviewed. Modern minimal access surgery calls for splenectomy to be considered independently.,3.079176455639103e-07,0.22772771984119622,0.07141643655489807,0.023574544042164344,0.26102256550717007,0.01922337562475971,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
177,0.5,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is it appropriate to perform a splenectomy during cholecystectomy in children with mild hereditary spherocytosis? The guidance to do a concurrent splenectomy in mild HS patients with symptomatic gallstones should be reexamined. With the availability of minimal access surgery, the need for splenectomy should be judged separately.",1.6580180914979784e-07,0.0834452523754301,0.07467160493827159,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
177,0.5,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does the presence of mild hereditary spherocytosis justify simultaneous splenectomy when performing cholecystectomy? The advice to conduct a splenectomy alongside cholecystectomy in children with mild HS and symptomatic gallstones warrants reconsideration. In the current era of minimal access surgery, splenectomy should be evaluated on its own clinical grounds.",1.4211583641411244e-07,0.0318022132170781,0.09639999999999999,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
178,0.5,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Question: Can measuring visceral adipose tissue area at a single level represent the total visceral adipose tissue volume? Answer: Measuring visceral adipose tissue area at one level might estimate the volume, but it does not fully capture the entire volume. For a thorough evaluation, multiple level measurements or other imaging methods are necessary.",1.4211583641411244e-07,0.0052196192774296435,0.2143388718430212,0.010880558788691236,0.03850803117479984,0.11869955728906267,0.0108648092457172,0.07273006473134958,0.028671982378195224,1.4211583641411244e-07,0.07127492235141286,0.03153747496566505
178,0.5,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Question: Is a single-level measurement of visceral adipose tissue area sufficient to represent visceral adipose tissue volume? Answer: A single-level measurement can provide an estimate of visceral adipose tissue volume; however, it may not fully represent the total volume. Comprehensive assessment requires multiple measurements or additional imaging techniques.",2.6054570009253947e-07,0.1283095103209937,0.19021078542326814,0.0199476911126006,0.1274435834073464,0.1252718774584663,0.019918816950481533,0.12571946008020207,0.06621678407224177,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
178,0.5,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Question: Does measuring visceral adipose tissue area at a single level accurately reflect visceral adipose tissue volume? Answer: While a single-level measurement may estimate visceral adipose tissue volume, it may not accurately represent the whole volume. More extensive measurement across multiple levels or supplementary imaging is needed for accuracy.",2.3685972735685406e-07,0.01584738581585876,0.26103206641500365,0.018134264647818726,0.04413927142816254,0.17214514528411506,0.018108015409528666,0.07293401200320737,0.08842752787389466,2.3685972735685406e-07,0.09984928738070442,0.07227989234909649
178,0.5,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Question: Can visceral adipose tissue area measured at one level serve as a proxy for visceral adipose tissue volume? Answer: Measuring at a single level can give an estimate but might not accurately reflect the entire visceral adipose tissue volume. Multiple level assessments or advanced imaging are required for a complete evaluation.,1.6580180914979784e-07,0.05285526753489922,0.2716161158895424,0.012693985253473108,0.02194358360822868,0.17746150330880645,0.012675610786670066,0.009755110381675092,0.08842752787389466,1.6580180914979784e-07,0.035310766243132896,0.07227989234909649
178,0.5,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Question: Is it possible to represent visceral adipose tissue volume by measuring its area at a single level? Answer: Measuring visceral adipose tissue area at one level may estimate volume but is unlikely to fully represent the entire volume. A more comprehensive approach involves multiple level measurements or additional imaging techniques.,1.8948778188548325e-07,0.07912348312071638,0.3748302399275687,0.014507411718254981,0.03936589195528839,0.2386594199754731,0.014486412327622933,0.03037439758441085,0.08842752787389466,1.8948778188548325e-07,0.05636417544096606,0.07227989234909649
178,0.5,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Question: Does a single-level measurement of visceral adipose tissue area provide an accurate representation of visceral adipose tissue volume? Answer: Such a measurement can estimate volume but might not accurately represent the full visceral adipose tissue volume. For thorough assessment, multiple measurements or other imaging methods are necessary.",2.6054570009253947e-07,0.06931826091163673,0.23447240673846093,0.0199476911126006,0.09730674946995777,0.14764715170734016,0.019918816950481533,0.12571946008020207,0.06621678407224177,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
178,0.5,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Question: Can the visceral adipose tissue volume be estimated by measuring its area at a single level? Answer: Estimation is possible with a single-level measurement, but it may not fully capture the entire volume. Comprehensive evaluation requires multiple level measurements or supplementary imaging techniques.",3.552895910352811e-07,0.011478255053326336,0.43458578542326814,0.02720139697172809,0.08649306621646247,0.25905872553102866,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
178,0.5,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Question: Is a single-level visceral adipose tissue area measurement enough to represent the volume of visceral adipose tissue? Answer: It may provide an estimate but is insufficient to accurately represent the entire volume. More detailed assessment through multiple levels or additional imaging is needed.,3.552895910352811e-07,0.05300055244062207,0.38818483360887196,0.02720139697172809,0.08649306621646247,0.25905872553102866,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
178,0.5,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Question: Can measuring visceral adipose tissue area at a single level accurately estimate visceral adipose tissue volume? Answer: It might offer an estimate but does not fully represent the total volume. A more complete assessment requires measurements at multiple levels or other imaging methods.,3.552895910352811e-07,0.05300055244062207,0.38818483360887196,0.02720139697172809,0.11950007481455405,0.23526336562621009,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
178,0.5,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Question: Does measuring visceral adipose tissue area at one level suffice to represent the entire visceral adipose tissue volume? Answer: Although it can estimate volume, it may not accurately reflect the whole volume. Multiple measurements or additional imaging techniques are necessary for a comprehensive evaluation.",3.316036182995957e-07,0.028545606772878873,0.38923431150036564,0.025387970506946217,0.09520197255324225,0.23581609514554114,0.025351221573340132,0.16390579020893403,0.08842752787389466,3.316036182995957e-07,0.1929397104467161,0.07227989234909649
179,0.5,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can locoregional opening of the rodent blood-brain barrier for paclitaxel be achieved using Nd:YAG laser-induced thermo therapy as a novel adjuvant glioma treatment? Answer: LITT facilitates localized entry of chemotherapy drugs into brain tissue, offering promising potential for brain tumor therapy.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.5,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is it possible to use Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents for paclitaxel delivery as a new adjuvant glioma treatment? Answer: LITT enables targeted penetration of chemotherapeutic agents into the brain, which may benefit brain tumor treatment.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
179,0.5,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermo therapy allow locoregional opening of the rodent blood-brain barrier for paclitaxel as a novel adjuvant therapy for glioma? Answer: LITT promotes localized passage of chemotherapy drugs into brain tissue, which could be valuable in treating brain tumors.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.5,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can the rodent blood-brain barrier be locally opened for paclitaxel delivery using Nd:YAG laser-induced thermo therapy as a new concept in adjuvant glioma therapy? Answer: LITT induces selective entry of chemotherapeutic agents into brain tissue, presenting potential for brain tumor treatments.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.5,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is Nd:YAG laser-induced thermo therapy a viable method for locoregional opening of the rodent blood-brain barrier to deliver paclitaxel in adjuvant glioma therapy? Answer: LITT allows localized chemotherapeutic drug passage into the brain, which holds promise for brain tumor therapy.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.5,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Could Nd:YAG laser-induced thermo therapy enable locoregional blood-brain barrier opening in rodents for paclitaxel as a novel adjuvant glioma treatment? Answer: LITT facilitates targeted delivery of chemotherapy agents into brain tissue, potentially improving brain tumor treatment.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
179,0.5,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does locoregional opening of the rodent blood-brain barrier for paclitaxel via Nd:YAG laser-induced thermo therapy represent a new adjuvant glioma therapy concept? Answer: LITT permits localized passage of chemotherapeutics into brain tissue, which may be beneficial for brain tumor therapy.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.5,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is the use of Nd:YAG laser-induced thermo therapy effective for locoregional opening of the rodent blood-brain barrier to enhance paclitaxel delivery in glioma treatment? Answer: LITT induces passage of chemotherapy drugs into brain tissue locally, offering potential advantages in brain tumor therapy.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
179,0.5,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy be used to locally open the rodent blood-brain barrier for paclitaxel as a novel glioma adjuvant therapy? Answer: LITT enables localized chemotherapeutic agent penetration into brain tissue, which could be of interest for brain tumor treatment.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.5,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is Nd:YAG laser-induced thermo therapy a new approach to achieve locoregional opening of the rodent blood-brain barrier for paclitaxel in adjuvant glioma therapy? Answer: LITT induces targeted passage of chemotherapy drugs into brain tissue, presenting potential for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
180,0.5,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? Yes, it can. This specialized consultation considers the unique needs and conditions of older adults, including their overall health, comorbidities, and functional status.",3.5528959103528056e-07,0.10714195893715184,0.17132659131469363,0.027201396971728097,0.1674177219059092,0.13888888888888887,0.027162023114293013,0.2302877868247557,0.10275824770146022,3.552895910352811e-07,0.295924824796296,0.06353305785123965
180,0.5,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Can a geriatric oncology consultation alter the cancer treatment plan for elderly patients? Yes, such consultations can modify treatment plans by addressing the specific health needs, comorbidities, and functional abilities of older adults.",4.2634750924233646e-07,0.1967541176268388,0.17132659131469363,0.032641676366073735,0.2597910420369245,0.13888888888888887,0.032594427737151634,0.3255979666290809,0.10275824770146022,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
180,0.5,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation? Yes, because this consultation evaluates the unique health status, comorbidities, and functional capacities of older adults.",4.974054274493924e-07,0.2951941904400921,0.17132659131469363,0.038081955760419374,0.36157373634686696,0.13888888888888887,0.038026832360010254,0.43095848228690636,0.10275824770146022,4.974054274493935e-07,0.50356418957454,0.06353305785123965
180,0.5,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Does consulting a geriatric oncologist impact the cancer treatment plan for elderly patients? Yes, it can lead to modifications by taking into account the older patients' overall health, comorbidities, and functional condition.",4.5003348197802176e-07,0.22850281594141864,0.17132659131469363,0.034455102830855615,0.2925808648599162,0.13888888888888887,0.03440522927810451,0.3594995183047627,0.10275824770146022,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
180,0.5,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Can a geriatric oncology consultation influence the cancer treatment approach for elderly patients? Yes, as it assesses older adults’ unique health circumstances, including comorbidities and functional status, to tailor the treatment plan.",4.5003348197802176e-07,0.22850281594141864,0.17132659131469363,0.034455102830855615,0.2925808648599162,0.13888888888888887,0.03440522927810451,0.3594995183047627,0.10275824770146022,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
180,0.5,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Is the cancer treatment plan for elderly patients adjusted after a geriatric oncology consultation? Yes, this specialized consultation modifies plans by considering the older patients’ overall health, comorbidities, and functionality.",4.974054274493924e-07,0.2951941904400921,0.17132659131469363,0.038081955760419374,0.36157373634686696,0.13888888888888887,0.038026832360010254,0.43095848228690636,0.10275824770146022,4.974054274493935e-07,0.50356418957454,0.06353305785123965
180,0.5,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Does a consultation in geriatric oncology lead to changes in the cancer treatment plan for elderly patients? Yes, because it factors in the distinct health needs, comorbidities, and functional abilities of older adults.",4.2634750924233646e-07,0.2400758164118364,0.14010910952489133,0.032641676366073735,0.2597910420369245,0.13888888888888887,0.032594427737151634,0.3255979666290809,0.10275824770146022,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
180,0.5,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Can a geriatric oncology consultation result in modifications to the cancer treatment plan for elderly patients? Yes, it accounts for the unique health profile, comorbidities, and functional status of elderly patients.",4.7371945471370706e-07,0.26129263876441033,0.17132659131469363,0.036268529295637494,0.32648241653559795,0.13888888888888887,0.03621603081905738,0.3945908381160317,0.10275824770146022,4.737194547137081e-07,0.465823861591693,0.06353305785123965
180,0.5,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Is the cancer treatment plan for elderly patients revised following a geriatric oncology consultation? Yes, this consultation modifies the plan by considering the older adults’ health, comorbidities, and functional capacity.",4.974054274493924e-07,0.2951941904400921,0.17132659131469363,0.038081955760419374,0.36157373634686696,0.13888888888888887,0.038026832360010254,0.43095848228690636,0.10275824770146022,4.974054274493935e-07,0.50356418957454,0.06353305785123965
180,0.5,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Does a geriatric oncology consultation adjust the cancer treatment plan for elderly patients? Yes, since it evaluates the specific health needs, comorbidities, and functional status of older adults to guide treatment decisions.",4.5003348197802176e-07,0.22850281594141864,0.17132659131469363,0.034455102830855615,0.2925808648599162,0.13888888888888887,0.03440522927810451,0.3594995183047627,0.10275824770146022,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
181,0.5,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is it possible to implement an advance care planning model in community palliative care? Yes, an advance care planning model can be effectively applied in community palliative care services. Integral to this model are quality audit procedures, with the documentation of advance care planning discussions serving as a key outcome indicator.",7.105791820705622e-08,0.04787363157913793,0.0050581065759637,0.005440279394345618,0.04296405519438773,0.012390837877850835,0.0054324046228586,0.0683893388073491,0.0027603946750964226,7.105791820705622e-08,0.06796903311257019,0.0014484404281270083
181,0.5,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can an advance care planning model be successfully integrated into community palliative care? The answer is yes; such a model is viable within community palliative care settings. Essential to this approach are quality audits, and recording advance care planning conversations is recognized as a critical outcome metric.",2.3685972735685406e-08,0.11681854435768457,0.17947505408328832,0.0018134264647818726,0.0791368473196159,0.11157610427090947,0.0018108015409528666,0.03914022686438168,0.04434829637641968,2.3685972735685406e-08,0.008517171800753065,0.02271498107084911
181,0.5,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is implementing an advance care planning model practical in community palliative care? Indeed, it is feasible to use an advance care planning model in community palliative care services. A vital part of this model includes quality audits, with the documentation of advance care planning discussions being a significant measure of success.",7.105791820705622e-08,0.04787363157913749,0.0050581065759637,0.005440279394345618,0.04296405519438773,0.012390837877850835,0.0054324046228586,0.0683893388073491,0.0027603946750964226,7.105791820705622e-08,0.06796903311257019,0.0014484404281270083
181,0.5,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the use of an advance care planning model achievable in community palliative care? An advance care planning model is indeed feasible for community palliative care. Quality audit processes form a crucial element of the model, with the recording of advance care planning discussions established as an important outcome measure.",4.737194547137081e-08,0.05100882911039717,0.010248015873015964,0.0036268529295637453,0.04805637672698815,0.005687674518843333,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
181,0.5,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can community palliative care adopt an advance care planning model? Yes, community palliative care services can feasibly adopt an advance care planning model. Quality audits are a key component of this model, and documenting advance care planning discussions is an important outcome metric.",1.1842986367842703e-07,0.17271537909511947,0.053202854671280275,0.009067132323909363,0.1649694721775412,0.04136747291509199,0.009054007704764333,0.12548467099593807,0.005513199468455653,1.1842986367842703e-07,0.12466730702264872,0.002908287627211844
181,0.5,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is an advance care planning model workable within community palliative care? The model is feasible for community palliative care services. Quality audit procedures are essential, and documenting advance care planning discussions is a significant outcome indicator.",2.8423167282822434e-07,0.18488951978296386,0.15941406250000006,0.02176111757738248,0.21113194003867175,0.10440209141507842,0.021729618491434413,0.2485418455874,0.04434829637641968,2.8423167282822487e-07,0.2869470410930828,0.02271498107084911
181,0.5,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the application of an advance care planning model feasible in community palliative care? Yes, it is feasible to apply an advance care planning model in community palliative care services. Quality audits are essential, and the documentation of advance care planning discussions is a key outcome measure.",2.3685972735685406e-08,0.056615544623371594,0.02709314404432117,0.0018134264647818726,0.055717054641363895,0.02558815192743763,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
181,0.5,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can an advance care planning model be implemented in community palliative care? Implementation is feasible within community palliative care services. Quality audit processes are vital, with documentation of advance care planning discussions recognized as an important outcome measure.",2.3685972735685374e-07,0.1228966831712266,0.16392517301038073,0.018134264647818726,0.1517083393341485,0.10603174603174603,0.018108015409528666,0.18970134556446672,0.04434829637641968,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
181,0.5,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is it practical to use an advance care planning model in community palliative care? Yes, an advance care planning model is practical and feasible in community palliative care. Quality audits play an essential role, with documenting advance care planning discussions as a key outcome measure.",7.105791820705622e-08,0.11306024313935081,0.03957561728395059,0.005440279394345618,0.1088845656166888,0.03311065885264533,0.0054324046228586,0.07339380596669631,0.003151703623580332,7.105791820705622e-08,0.07292293477679124,0.0016600189291508909
181,0.5,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the advance care planning model a viable approach in community palliative care? The model is viable and feasible for community palliative care services. Quality audit processes are fundamental, with the documentation of advance care planning discussions serving as an important outcome metric.",1.1842986367842703e-07,0.01723624216984554,0.17336908284023678,0.009067132323909363,0.016959091976465945,0.10941184807256235,0.009054007704764333,0.05616995293994398,0.04434829637641968,1.1842986367842703e-07,0.0891212977631648,0.02271498107084911
182,0.5,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Does central venous pressure indicate fluid responsiveness? Central venous pressure (CVP) is not a reliable indicator of fluid responsiveness. Research suggests that parameters like stroke volume variation (SVV) and pulse pressure are better predictors.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
182,0.5,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Can central venous pressure predict fluid responsiveness? Central venous pressure (CVP) poorly predicts fluid responsiveness. Studies have demonstrated that other measures such as stroke volume variation (SVV) and pulse pressure are more accurate.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
182,0.5,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Is fluid responsiveness predicted by central venous pressure? Central venous pressure (CVP) is an inadequate predictor of fluid responsiveness. Evidence shows that alternative parameters like stroke volume variation (SVV) and pulse pressure perform better.,4.73719454713706e-08,0.02163259942144702,0.026659528523875105,0.003626852929563759,0.019851258254085735,0.029384756657483937,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
182,0.5,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Does central venous pressure serve as a predictor for fluid responsiveness? Central venous pressure (CVP) is not effective in predicting fluid responsiveness. Multiple studies highlight that stroke volume variation (SVV) and pulse pressure are superior indicators.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
182,0.5,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Can fluid responsiveness be predicted by central venous pressure? Central venous pressure (CVP) fails to reliably predict fluid responsiveness. Research indicates that stroke volume variation (SVV) and pulse pressure are more dependable.,9.47438909427412e-08,0.0868632093081958,0.024710743801652904,0.007253705859127518,0.08438977939165726,0.029384756657483937,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
182,0.5,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Is central venous pressure a reliable predictor of fluid responsiveness? Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Other parameters like stroke volume variation (SVV) and pulse pressure have been shown to be better predictors.,4.73719454713706e-08,0.015082988871376823,0.04958677685950413,0.003626852929563752,0.020915424006748395,0.025978565141824037,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
182,0.5,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Does central venous pressure accurately predict fluid responsiveness? Central venous pressure (CVP) does not accurately predict fluid responsiveness. Studies reveal that stroke volume variation (SVV) and pulse pressure are preferable measures.,1.184298636784265e-07,0.2597731073411551,0.07324454876902434,0.009067132323909398,0.21389783873077928,0.03920234896665872,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
182,0.5,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Is central venous pressure useful to predict fluid responsiveness? Central venous pressure (CVP) is not useful for predicting fluid responsiveness. Evidence supports that stroke volume variation (SVV) and pulse pressure are more effective predictors.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
182,0.5,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Can central venous pressure forecast fluid responsiveness? Central venous pressure (CVP) is a poor forecast tool for fluid responsiveness. Research supports that stroke volume variation (SVV) and pulse pressure offer better prediction.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
182,0.5,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Does central venous pressure help in predicting fluid responsiveness? Central venous pressure (CVP) is ineffective at predicting fluid responsiveness. Multiple studies suggest that stroke volume variation (SVV) and pulse pressure are more reliable predictors.,4.73719454713706e-08,0.1056504394893194,0.033067033976124934,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
183,0.5,1,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is it essential to routinely place a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients suffering from choledocholithiasis-induced cholangitis? There is no agreement on this practice after the procedure.,4.50033481978022e-07,0.0815030598903621,0.23268698060941817,0.0344551028308556,0.13990282142580046,0.21301775147928995,0.03440522927810449,0.20077692871902064,0.1875,4.500334819780227e-07,0.2642891432044081,0.15704937537180247
183,0.5,2,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Should a nasobiliary drainage tube be routinely inserted after endoscopic removal of stones from the common bile duct in patients with cholangitis caused by choledocholithiasis? No consensus exists on this matter.,5.210914001850779e-07,0.17681323969468732,0.23268698060941817,0.03989538222520124,0.23834289423905375,0.21301775147928995,0.039837633900963114,0.3025596230289631,0.1875,5.210914001850789e-07,0.36964965886223355,0.15704937537180247
183,0.5,3,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,"Is routine insertion of a nasobiliary drainage tube necessary after endoscopic clearance of the common bile duct in choledocholithiasis-related cholangitis patients? Currently, there is no consensus.",6.395212638635044e-07,0.3591347964886422,0.23268698060941817,0.04896251454911064,0.4275848938775817,0.21301775147928995,0.04889164160572748,0.4992699172750177,0.1875,6.39521263863506e-07,0.5744440715082475,0.15704937537180247
183,0.5,4,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Do patients with choledocholithiasis-induced cholangitis require routine nasobiliary drainage tube placement after endoscopic common bile duct clearance? There is no established agreement on this approach.,6.632072365991897e-07,0.39995679100889703,0.23268698060941817,0.05077594101389252,0.47014450829637733,0.21301775147928995,0.050702443146680355,0.5437216798458517,0.1875,6.632072365991914e-07,0.6209640871431414,0.15704937537180247
183,0.5,5,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is the routine use of a nasobiliary drainage tube recommended after endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis? No consensus has been reached.,5.447773729207632e-07,0.21071479137036908,0.23268698060941817,0.04170880868998312,0.27343421405032275,0.21301775147928995,0.04164843544191599,0.3389272671998378,0.1875,5.447773729207643e-07,0.40738998684508054,0.15704937537180247
183,0.5,6,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,"After endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis, is it standard to insert a nasobiliary drainage tube? Opinions differ, and no consensus is present.",5.684633456564485e-07,0.2458061111816381,0.23268698060941817,0.043522235154765,0.30980185822119743,0.21301775147928995,0.04345923698286886,0.3766675951826848,0.1875,5.684633456564497e-07,0.446610699998363,0.15704937537180247
183,0.5,7,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is it standard practice to routinely insert a nasobiliary drainage tube post-endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis? There is no universal agreement.,6.395212638635044e-07,0.3591347964886422,0.23268698060941817,0.04896251454911064,0.4275848938775817,0.21301775147928995,0.04889164160572748,0.4992699172750177,0.1875,6.39521263863506e-07,0.5744440715082475,0.15704937537180247
183,0.5,8,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Should a nasobiliary drainage tube be routinely placed after endoscopic stone removal from the common bile duct in choledocholithiasis-related cholangitis? This remains a debated issue without consensus.,6.158352911278191e-07,0.31991408333535976,0.23268698060941817,0.04714908808432876,0.3867628993573269,0.21301775147928995,0.04708084006477461,0.45671030285622205,0.1875,6.158352911278206e-07,0.5299923089374134,0.15704937537180247
183,0.5,9,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is routine nasobiliary drainage tube insertion necessary after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? No consensus exists on this protocol.,5.921493183921338e-07,0.28217375535251277,0.23268698060941817,0.04533566161954688,0.3475421862040444,0.21301775147928995,0.045270038523821735,0.41588830833596724,0.1875,5.921493183921352e-07,0.4874326945186178,0.15704937537180247
183,0.5,10,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is the insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients a routine procedure? There is no consensus on this practice.,5.447773729207632e-07,0.21071479137036908,0.23268698060941817,0.04170880868998312,0.27343421405032275,0.21301775147928995,0.04164843544191599,0.3389272671998378,0.1875,5.447773729207643e-07,0.40738998684508054,0.15704937537180247
184,0.5,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the length of psychological treatment for depression linked to the likelihood of returning to treatment? Answer: Findings indicate that extended treatment duration might reduce the chance of returning to mental health services in certain groups. However, due to the study's design, no causal conclusions can be made. Additional research, ideally through a randomized controlled trial (RCT), is necessary to confirm if lower intensity treatments are related to this trend.",1.1842986367842703e-07,0.07867817334422611,0.0032745671057636816,0.009067132323909377,0.055132198612660055,0.014489619377162638,0.009054007704764333,0.0763729787845735,0.0,1.1842986367842703e-07,0.07755823434587317,0.0
184,0.5,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of psychological treatment for depression influence the probability of re-entering treatment? Answer: The results imply that longer treatment periods may help prevent relapse into mental health care for some populations. Nevertheless, the study's design does not allow for causal claims. Further investigation, preferably via an RCT, is required to establish whether reduced treatment intensity correlates with these findings.",9.474389094274162e-08,0.00046941094474473033,0.046045785639958384,0.0072537058591274906,0.06453852113757197,0.0,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
184,0.5,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is there a relationship between how long psychological treatment for depression lasts and the chance of returning to treatment? Answer: The study suggests that longer treatments might reduce the risk of returning to mental health care in certain groups, but no causal link can be confirmed due to the study design. More research, ideally randomized controlled trials, is needed to explore whether lower intensity treatments are connected to this pattern.",1.1842986367842703e-07,0.07867817334422611,0.0032745671057636816,0.009067132323909377,0.055132198612660055,0.014489619377162637,0.009054007704764333,0.0763729787845735,0.0,1.1842986367842703e-07,0.07755823434587317,0.0
184,0.5,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of depression treatment affect the likelihood of patients returning to care? Answer: Results indicate that longer treatment durations may prevent some patients from returning to mental health services, though causal relationships cannot be established given the study design. Further studies, preferably RCTs, are needed to determine if the trend towards less intense treatments is related.",1.6580180914979784e-07,0.0738630695980067,0.028809713002223698,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
184,0.5,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the length of psychological treatment for depression associated with the probability of re-entry into treatment? Answer: The findings suggest that longer treatment duration might reduce return rates to mental health care in some groups. However, the study design precludes causal inference. Additional research, ideally randomized controlled trials, is necessary to assess whether lower intensity treatments are linked to this trend.",9.474389094274162e-08,0.00046941094474473033,0.046045785639958384,0.0072537058591274906,0.06453852113757197,0.0,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
184,0.5,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of psychological therapy for depression relate to the chance of returning for treatment? Answer: The data suggest that extended treatment duration may help prevent return to mental health care in certain populations, but causality cannot be inferred due to study design. Further research, preferably RCTs, is needed to confirm if the observed trend towards lower intensity treatments is associated.",7.105791820705622e-08,0.016729931816525934,0.046045785639958384,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
184,0.5,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is there an association between treatment length for depression and the likelihood of returning to treatment? Answer: The results indicate that longer treatment may reduce the risk of returning to mental health services in some groups. However, no causal conclusions can be drawn because of the study design. Further research, preferably randomized controlled trials, is necessary to investigate the link to lower intensity treatments.",2.3685972735685406e-08,0.005156931346110838,0.014828303850156089,0.0018134264647818726,0.03775302936686398,0.01586888657648284,0.0018108015409528666,0.01600034134644357,0.0,2.3685972735685406e-08,0.016260520871781203,0.0
184,0.5,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of psychological treatment influence the chance of patients returning to treatment for depression? Answer: Findings suggest that longer treatment might prevent return to mental health care in some groups, but causal inference is not possible due to study design. More research, ideally RCTs, is needed to explore if the trend towards less intensive treatments is related.",1.4211583641411244e-07,0.03286700932284692,0.046045785639958384,0.010880558788691236,0.0984400728132524,0.0,0.0108648092457172,0.10008345855698497,0.0,1.4211583641411244e-07,0.10178269430994202,0.0
184,0.5,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the time spent in psychological treatment for depression connected to the likelihood of returning to treatment? Answer: The study results suggest that longer treatment durations may reduce the chance of returning to mental health care in certain groups, though causality cannot be established due to the study design. Further investigation, preferably randomized controlled trials, is required to determine if lower intensity treatments are involved.",0.0,0.021327605555690354,0.01522806547533323,0.0,0.021660849392496573,0.015621063240110858,0.0,0.0,0.0,0.0,0.0,0.0
184,0.5,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the length of treatment for depression affect the probability of patients returning for further treatment? Answer: The findings imply that longer treatment durations could prevent return to mental health services in some groups; however, no causal inference can be made because of the study design. Additional research, preferably through RCTs, is needed to assess whether the trend towards lower intensity treatments is related.",2.3685972735685406e-08,0.04847863013110576,0.046045785639958384,0.0018134264647818726,0.015748356968136257,0.0,0.0018108015409528666,0.01600034134644357,0.0,2.3685972735685406e-08,0.016260520871781203,0.0
185,0.5,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is it possible to predict discordance between TEOAE and AABR results in newborns? Discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not reliably predictable, as it depends on factors like gestational age, middle ear fluid presence, and individual auditory system development variability.",1.1842986367842703e-07,0.09783071500636176,0.0018160871470449327,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
185,0.5,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can discordance in TEOAE and AABR test results be anticipated in newborns? The discordance in outcomes from Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) in newborns is not consistently predictable due to influences such as gestational age, middle ear effusion, and differences in auditory maturation.",1.6580180914979784e-07,0.13980795482754882,0.002648319227800483,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
185,0.5,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is discordance between TEOAE and AABR results in newborns predictable? Predicting discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is challenging, as it varies with factors including gestational age, middle ear fluid, and individual differences in auditory system development.",2.1317375462116866e-07,0.1836232706604033,0.0035528120713305966,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
185,0.5,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can we foresee discordance in TEOAE and AABR outcomes in newborn infants? Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes among newborns is not always foreseeable, since it depends on gestational age, presence of middle ear fluid, and unique auditory system maturation.",1.8948778188548325e-07,0.16147585620672977,0.0030909576523243006,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
185,0.5,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is it feasible to predict discordance between TEOAE and AABR results in newborns? Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not always predictable in newborns, as it can be influenced by gestational age, middle ear fluid, and individual auditory maturation variability.",1.6580180914979784e-07,0.11092682230421813,0.0181755829903978,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
185,0.5,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Are discordant results between TEOAE and AABR in newborns predictable? The discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot always be predicted, due to factors like gestational age, middle ear fluid, and individual differences in auditory system maturation.",2.1317375462116866e-07,0.1836232706604033,0.0035528120713305966,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
185,0.5,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is it possible to anticipate discordance in TEOAE and AABR outcomes in newborns? Discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it depends on various factors such as gestational age, presence of middle ear fluid, and individual auditory development.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
185,0.5,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can discordance in TEOAE and AABR outcomes be predicted in newborns? Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is not always predictable because it can vary based on gestational age, middle ear fluid, and individual auditory system maturation.",2.1317375462116866e-07,0.1836232706604033,0.0035528120713305966,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
185,0.5,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is predicting discordance in TEOAE and AABR outcomes in newborns possible? Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes among newborns is not consistently predictable due to factors like gestational age, middle ear fluid presence, and individual variability in auditory maturation.",2.1317375462116866e-07,0.1836232706604033,0.0035528120713305966,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
185,0.5,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can we predict discordance in newborns' TEOAE and AABR results? The discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it depends on gestational age, middle ear fluid, and individual differences in auditory system maturation.",2.1317375462116866e-07,0.15348643672301465,0.0181755829903978,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
186,0.5,1,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Answer: Evidence is limited but suggests laparoscopic cholecystectomy might impact peri-sinusoidal cell activity. More studies are necessary to clarify its effects on liver function.,1.894877818854824e-07,0.21237475974474807,0.012179614215880583,0.014507411718255016,0.1999073475084452,0.026296566837107373,0.014486412327622974,0.24362208265775243,0.0,1.8948778188548325e-07,0.2513144282809061,0.0
186,0.5,2,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Answer: There is scarce evidence indicating that laparoscopic cholecystectomy could affect peri-sinusoidal cell activity. Additional research is required to fully understand its influence on liver function.,1.184298636784265e-07,0.07133645729738003,0.047004132231404955,0.009067132323909377,0.10459716770411998,0.026296566837107373,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
186,0.5,3,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Question: Can laparoscopic cholecystectomy alter peri-sinusoidal cell activity? Answer: Limited data suggest that laparoscopic cholecystectomy may have an effect on peri-sinusoidal cell activity, but further investigation is needed to determine its impact on liver function.",1.184298636784265e-07,0.1121098208597302,0.017795138888888895,0.009067132323909377,0.10459716770411998,0.026296566837107373,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
186,0.5,4,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Does the procedure of laparoscopic cholecystectomy impact peri-sinusoidal cell activity? Answer: Current evidence is limited but points to a possible effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity. More research is needed to understand its full impact on liver function.,2.36859727356853e-08,0.027983758678753023,0.0018819495170846606,0.0018134264647818726,0.026910907699560394,0.0006732981390464195,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
186,0.5,5,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Question: Is there an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Answer: Although evidence is limited, laparoscopic cholecystectomy may influence peri-sinusoidal cell activity, and further studies are necessary to assess its effect on liver function.",9.47438909427412e-08,0.0807923774972008,0.01945592286501379,0.0072537058591274975,0.0747442045544382,0.026296566837107373,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
186,0.5,6,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Question: Does undergoing laparoscopic cholecystectomy change peri-sinusoidal cell activity? Answer: There is limited evidence suggesting a potential influence of laparoscopic cholecystectomy on peri-sinusoidal cell activity; however, additional research is needed to fully comprehend its impact on liver function.",4.73719454713706e-08,0.02094053603777235,0.022511337868480717,0.0036268529295637453,0.017585790714489846,0.026296566837107373,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
186,0.5,7,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Question: Could laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Answer: Limited evidence hints that laparoscopic cholecystectomy might influence peri-sinusoidal cell activity, but more research is essential to understand its effects on liver function.",1.894877818854824e-07,0.21237475974474807,0.012179614215880583,0.014507411718255016,0.1999073475084452,0.026296566837107373,0.014486412327622974,0.24362208265775243,0.0,1.8948778188548325e-07,0.2513144282809061,0.0
186,0.5,8,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Question: Is peri-sinusoidal cell activity modified by laparoscopic cholecystectomy? Answer: Evidence is sparse but indicates laparoscopic cholecystectomy may affect peri-sinusoidal cell activity, warranting further studies to determine its impact on liver function.",1.894877818854824e-07,0.1676555868053966,0.044166666666666694,0.014507411718255016,0.1999073475084452,0.026296566837107373,0.014486412327622974,0.24362208265775243,0.0,1.8948778188548325e-07,0.2513144282809061,0.0
186,0.5,9,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Does laparoscopic cholecystectomy have an impact on peri-sinusoidal cell activity? Answer: There is limited information suggesting that laparoscopic cholecystectomy could influence peri-sinusoidal cell activity; further research is needed to clarify its effects on liver function.,9.47438909427412e-08,0.0807923774972008,0.01945592286501379,0.0072537058591274975,0.0747442045544382,0.026296566837107373,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
186,0.5,10,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Question: Is there a relationship between laparoscopic cholecystectomy and peri-sinusoidal cell activity? Answer: Although evidence is limited, laparoscopic cholecystectomy might affect peri-sinusoidal cell activity, and more research is required to fully understand its impact on liver function.",7.10579182070559e-08,0.050421033290631634,0.02102556708958092,0.005440279394345618,0.04575666768118669,0.026296566837107373,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
187,0.5,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? Case-mix based reimbursement can promote process-oriented care by motivating healthcare providers to deliver care efficiently and effectively. By tying reimbursement to patient complexity and outcomes, healthcare organizations are driven to enhance their care processes, coordination, and quality to secure proper payment.",2.1317375462116866e-07,0.08233131449182052,0.05603779147383414,0.016320838183036854,0.07575775272371121,0.06402753425213195,0.0162972138685758,0.09691783168821066,0.051570247933884296,2.1317375462116866e-07,0.1232083495189431,0.035041322314049606
187,0.5,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Is the development of process-oriented care delivery encouraged by case-mix based reimbursement? Case-mix based reimbursement incentivizes healthcare providers to focus on efficient and effective care delivery. Linking payment to patient complexity and outcomes pushes healthcare organizations to improve their processes, coordination, and care quality to obtain suitable reimbursement.",3.079176455639103e-07,0.11195824308606683,0.09336500083111204,0.023574544042164344,0.1314134744403641,0.08401920438957468,0.023540420032387266,0.18207564002851795,0.051570247933884296,3.079176455639103e-07,0.21021972650857235,0.035041322314049606
187,0.5,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Can case-mix based reimbursement foster the growth of process-oriented care delivery? By associating reimbursement with patient complexity and outcomes, case-mix based reimbursement motivates healthcare providers to deliver efficient and effective care. This encourages healthcare organizations to refine their processes, coordination, and quality to earn appropriate compensation.",3.552895910352811e-07,0.1875608130375661,0.07028324509741446,0.02720139697172809,0.20737192703664942,0.061304223318725565,0.027162023114293,0.2275380141052752,0.051570247933884296,3.552895910352811e-07,0.2567397421434663,0.035041322314049606
187,0.5,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does reimbursement based on case-mix promote the evolution of process-oriented care delivery? Case-mix based reimbursement can drive healthcare providers to prioritize efficient and effective care. By connecting payment to patient complexity and outcomes, it pushes healthcare organizations to enhance their care processes, coordination, and quality to receive proper reimbursement.",2.8423167282822487e-07,0.06140920918355519,0.11463154147383414,0.02176111757738247,0.10990726921940075,0.08401920438957468,0.0217296184914344,0.16009673330974294,0.051570247933884296,2.8423167282822487e-07,0.18774687065651463,0.035041322314049606
187,0.5,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Is process-oriented care delivery development stimulated by case-mix based reimbursement? Case-mix based reimbursement encourages healthcare providers to focus on delivering care that is both efficient and effective. Linking reimbursement to patient complexity and outcomes motivates healthcare organizations to improve processes, coordination, and quality of care to gain appropriate payment.",2.8423167282822487e-07,0.09029034170688588,0.09380763925563586,0.02176111757738247,0.10990726921940075,0.08401920438957468,0.0217296184914344,0.16009673330974294,0.051570247933884296,2.8423167282822487e-07,0.18774687065651463,0.035041322314049606
187,0.5,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does the use of case-mix based reimbursement incentivize the development of process-oriented care delivery? By tying reimbursement to patient complexity and outcomes, case-mix based reimbursement encourages healthcare providers to deliver care more efficiently and effectively. This leads healthcare organizations to improve their processes, coordination, and care quality to obtain suitable reimbursement.",2.3685972735685406e-07,0.07603898910809637,0.07470098591827858,0.018134264647818726,0.09652629447433991,0.06361989883401913,0.018108015409528666,0.11753711889094642,0.051570247933884296,2.3685972735685406e-07,0.14426175871677627,0.035041322314049606
187,0.5,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Can process-oriented care delivery be advanced through case-mix based reimbursement? Case-mix based reimbursement incentivizes healthcare providers to focus on efficient and effective care delivery. By linking payment to patient complexity and outcomes, healthcare organizations are encouraged to enhance their processes, coordination, and quality of care to secure proper reimbursement.",2.8423167282822487e-07,0.09029034170688588,0.09380763925563586,0.02176111757738247,0.10990726921940075,0.08401920438957468,0.0217296184914344,0.16009673330974294,0.051570247933884296,2.8423167282822487e-07,0.18774687065651463,0.035041322314049606
187,0.5,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does case-mix based reimbursement encourage the improvement of process-oriented care delivery? By associating reimbursement with patient complexity and outcomes, case-mix based reimbursement motivates healthcare providers to deliver care efficiently and effectively. This drives healthcare organizations to optimize their processes, coordination, and quality to receive appropriate reimbursement.",3.552895910352811e-07,0.1875608130375661,0.07028324509741446,0.02720139697172809,0.20737192703664942,0.061304223318725565,0.027162023114293,0.2275380141052752,0.051570247933884296,3.552895910352811e-07,0.2567397421434663,0.035041322314049606
187,0.5,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Is the development of process-oriented care delivery driven by case-mix based reimbursement? Case-mix based reimbursement links payment to patient complexity and outcomes, incentivizing healthcare providers to focus on efficient and effective care. This encourages healthcare organizations to improve their processes, coordination, and care quality to obtain suitable reimbursement.",3.079176455639103e-07,0.11195824308606683,0.09336500083111204,0.023574544042164344,0.1314134744403641,0.08401920438957468,0.023540420032387266,0.18207564002851795,0.051570247933884296,3.079176455639103e-07,0.21021972650857235,0.035041322314049606
187,0.5,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Can case-mix based reimbursement stimulate improvements in process-oriented care delivery? By connecting reimbursement to patient complexity and outcomes, it motivates healthcare providers to deliver care efficiently and effectively. This pushes healthcare organizations to enhance their processes, coordination, and quality of care to secure proper reimbursement.",3.789755637709665e-07,0.14842058617318443,0.11463154147383414,0.029014823436509962,0.19885475523589635,0.08401920438957468,0.028972824655245866,0.2510685115154696,0.051570247933884296,3.789755637709665e-07,0.2808372937225263,0.035041322314049606
188,0.5,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside assessment a reliable method to rule out aspiration after an acute stroke? Answer: Bedside swallowing assessments do not have adequate sensitivity to serve as a screening tool in acute stroke cases, and there are also concerns regarding the reliance on videofluoroscopy as the definitive standard.",1.6580180914979784e-07,0.23058286565211583,0.049861495844875335,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
188,0.5,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can aspiration be reliably excluded after acute stroke using bedside assessment? Answer: Bedside swallowing assessments lack sufficient sensitivity to be effective screening tools in acute stroke, and the use of videofluoroscopy as the gold standard is also problematic.",4.73719454713706e-08,0.018021423668444392,0.049861495844875335,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
188,0.5,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Does bedside assessment effectively exclude aspiration following an acute stroke? Answer: Bedside swallowing assessments are not sensitive enough to be used for screening in acute stroke, and there are issues with considering videofluoroscopy as the gold standard.",7.10579182070559e-08,0.008646823413716476,0.049861495844875335,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
188,0.5,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is it possible to reliably exclude aspiration after an acute stroke through bedside assessment? Answer: Bedside swallowing assessments do not have the necessary sensitivity for screening acute stroke patients, and videofluoroscopy as the gold standard raises concerns.",7.10579182070559e-08,0.046114238579118894,0.02285532300536917,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
188,0.5,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can bedside evaluation reliably rule out aspiration after an acute stroke? Answer: Bedside swallowing assessments lack the sensitivity required for screening in acute stroke, and videofluoroscopy's role as the gold standard is questionable.",1.658018091497971e-07,0.12305717459146193,0.049861495844875335,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
188,0.5,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside assessment a dependable way to exclude aspiration following an acute stroke? Answer: Bedside swallowing assessments are insufficiently sensitive to be used as screening tools in acute stroke, and there are doubts about videofluoroscopy being the gold standard.",2.36859727356853e-08,0.043996910071702366,0.049861495844875335,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
188,0.5,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can aspiration be excluded reliably after acute stroke using bedside assessment? Answer: Bedside swallowing assessments do not possess the needed sensitivity for screening acute stroke patients, and there are concerns about using videofluoroscopy as the definitive test.",7.10579182070559e-08,0.046114238579118894,0.02285532300536917,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
188,0.5,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside assessment reliable for excluding aspiration post-acute stroke? Answer: Bedside swallowing assessment lacks adequate sensitivity for screening in acute stroke, and the use of videofluoroscopy as the gold standard is controversial.",1.894877818854824e-07,0.1538288332582156,0.049861495844875335,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
188,0.5,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can bedside assessment effectively exclude aspiration after an acute stroke? Answer: Bedside swallowing assessments are not sensitive enough for screening acute stroke patients, and videofluoroscopy as the gold standard is under scrutiny.",1.894877818854824e-07,0.1538288332582156,0.049861495844875335,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
188,0.5,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside assessment sufficient to rule out aspiration following acute stroke? Answer: Bedside swallowing assessments lack the sensitivity required for screening in acute stroke, and there are concerns regarding videofluoroscopy as the gold standard.",1.421158364141118e-07,0.09320421144178015,0.049861495844875335,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
189,0.5,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Are aromatase inhibitor-related musculoskeletal symptoms primarily prevented by addressing osteoporosis? Patients using AIs who develop osteoporosis have a higher risk of musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates lowers this risk. Those previously treated with tamoxifen are less prone to AI-induced musculoskeletal issues. Our recommendation is,2.3685972735685406e-07,0.1980783371253132,0.0037282753365996506,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
189,0.5,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is preventing osteoporosis the essential factor in eliminating musculoskeletal symptoms related to aromatase inhibitors? Osteoporosis in AI patients increases the chance of musculoskeletal pain and fractures. Supplementing with calcium and bisphosphonates decreases these risks. Prior tamoxifen use also reduces the likelihood of AI-associated musculoskeletal symptoms. We suggest,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
189,0.5,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Does stopping osteoporosis prevent musculoskeletal symptoms caused by aromatase inhibitors? Patients on AIs who develop osteoporosis face more musculoskeletal symptoms and fractures. Using calcium and bisphosphonates together lowers the risk. Those who had tamoxifen before AIs are less likely to experience these symptoms. Our advice is,2.8423167282822487e-07,0.24287436571859278,0.00467247849553044,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
189,0.5,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is the key to avoiding aromatase inhibitor-related musculoskeletal symptoms through osteoporosis prevention? AI patients with osteoporosis have a greater risk of bone pain and fractures. Co-administration of calcium and bisphosphonates reduces these risks. Patients who used tamoxifen prior to AIs show fewer musculoskeletal problems. We recommend,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
189,0.5,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Could preventing osteoporosis be the main strategy to eliminate musculoskeletal symptoms linked to aromatase inhibitors? Osteoporosis in patients on AIs raises the risk of musculoskeletal symptoms and fractures. Combining calcium and bisphosphonate therapy reduces this risk. Prior tamoxifen therapy is associated with fewer AI-related musculoskeletal symptoms. Our recommendation is,2.1317375462116866e-07,0.17641043574613224,0.003285636912075833,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
189,0.5,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is managing osteoporosis the key approach to stop musculoskeletal symptoms caused by aromatase inhibitors? Patients treated with AIs who develop osteoporosis are more prone to musculoskeletal symptoms and fractures. Co-medication with calcium and bisphosphonates reduces these chances. Those previously on tamoxifen are less likely to develop these symptoms. We recommend,1.8948778188548325e-07,0.15520173767557388,0.002861040249433105,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
189,0.5,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Does preventing osteoporosis hold the key to resolving aromatase inhibitor-related musculoskeletal symptoms? AI patients with osteoporosis are at increased risk for musculoskeletal issues and bone fractures. The use of calcium and bisphosphonates lowers this risk. Patients who received tamoxifen before AIs have lower incidence of these symptoms. We suggest,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
189,0.5,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is the prevention of osteoporosis crucial to eliminating musculoskeletal symptoms associated with aromatase inhibitors? Patients on AIs who develop osteoporosis face higher risks of musculoskeletal symptoms and fractures. Calcium and bisphosphonate co-treatment reduces these risks. Prior tamoxifen treatment decreases the likelihood of AI-related musculoskeletal symptoms. We recommend,2.6054570009253947e-07,0.22022575157898672,0.004190129755605947,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
189,0.5,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Could the prevention of osteoporosis be fundamental to stopping musculoskeletal symptoms from aromatase inhibitors? Patients on AIs with osteoporosis have increased risk of musculoskeletal symptoms and fractures. Co-administration of calcium and bisphosphonates reduces this risk. Tamoxifen use before AIs correlates with fewer musculoskeletal symptoms. Our advice is,2.6054570009253947e-07,0.22022575157898672,0.004190129755605947,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
189,0.5,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is osteoporosis prevention the key to avoiding musculoskeletal symptoms caused by aromatase inhibitors? Patients treated with AIs who develop osteoporosis are more likely to suffer musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates lowers these risks. Those who had tamoxifen prior to AIs show reduced musculoskeletal symptoms. We recommend,1.8948778188548325e-07,0.15520173767557388,0.002861040249433105,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
190,0.5,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Do differences in symptom reporting explain the higher rates of depression in women? Answer: In this community sample, men and women reported similar depressive symptom patterns, with no evidence of gender-based differences in symptom presentation.",1.184298636784265e-07,0.17809085423194837,0.031949402578773184,0.00906713232390937,0.17797448507583224,0.029384756657483937,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.5,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Is the higher depression rate in women due to differences in how symptoms are reported? Answer: Both men and women in this community sample showed similar depressive symptom patterns, with no gender differences found in symptom presentation.",7.10579182070559e-08,0.04330418244171419,0.024983563445101917,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
190,0.5,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are women's higher depression rates explained by different symptom reporting? Answer: Men and women in this community sample reported depressive symptoms similarly, with no evidence of gender differences in symptom presentation.",2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.5,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Could differential symptom reporting account for higher depression rates in women? Answer: In this community sample, depressive symptom patterns were similar between men and women, with no gender-based differences observed.",2.36859727356853e-07,0.25302471342378485,0.024983563445101917,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
190,0.5,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Do women report depressive symptoms differently, explaining higher depression rates? Answer: Men and women in this community sample showed similar depressive symptom patterns, with no evidence of gender differences in symptom presentation.",1.894877818854824e-07,0.18848619228621333,0.024983563445101917,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
190,0.5,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Is the higher incidence of depression in women due to how symptoms are reported? Answer: This community sample revealed similar depressive symptom patterns for men and women, with no gender differences found in symptom presentation.",1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.5,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are gender differences in symptom reporting responsible for higher depression rates in women? Answer: Men and women in this community sample reported depressive symptoms in similar ways, showing no gender-based differences in symptom presentation.",1.421158364141118e-07,0.20940829759447777,0.033610186554898086,0.01088055878869125,0.20906300469710004,0.0302734375,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.5,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Does differential symptom reporting explain why women have higher depression rates? Answer: In this community sample, men and women exhibited similar patterns of depressive symptoms, with no evidence of gender differences in symptom presentation.",1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.5,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are women's higher depression rates linked to how they report symptoms? Answer: Men and women in this community sample reported similar depressive symptom patterns, with no gender differences in symptom presentation found.",1.894877818854824e-07,0.18848619228621333,0.024983563445101917,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
190,0.5,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Could the higher depression rates in women be due to reporting differences in symptoms? Answer: This community sample found that men and women reported depressive symptoms similarly, with no evidence of gender-based differences in symptom presentation.",9.47438909427412e-08,0.10921133332760435,0.0027715385957144123,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
191,0.5,1,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can an advance care planning model be implemented in community palliative care? Answer: Yes, implementing an advance care planning model in community palliative care is feasible. It assists individuals in making decisions about their future healthcare and guarantees their wishes are honored, even if they cannot express them.",2.3685972735685406e-08,0.054235986990596174,0.021926020408163244,0.0018134264647818726,0.05420787608919353,0.022709189879958278,0.0018108015409528666,0.05412486291865637,0.022938100860178764,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
191,0.5,2,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is it possible to use an advance care planning model in community palliative care? Answer: Yes, an advance care planning model can be used in community palliative care. It supports individuals in deciding their future healthcare and ensures their preferences are respected if they become unable to communicate.",2.3685972735685406e-08,0.054235986990596174,0.021926020408163244,0.0018134264647818726,0.05420787608919353,0.022709189879958278,0.0018108015409528666,0.05412486291865637,0.022938100860178764,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
191,0.5,3,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Could an advance care planning model work within community palliative care? Answer: Yes, an advance care planning model is practical in community palliative care. It enables individuals to make choices about their future healthcare and ensures their wishes are followed, even if they cannot communicate them.",2.3685972735685406e-08,0.03427899802484191,0.03729588042831647,0.0018134264647818726,0.03628563889351,0.040752588959438646,0.0018108015409528666,0.006933388171696642,0.020975056689342395,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
191,0.5,4,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is an advance care planning model applicable in community palliative care? Answer: Yes, an advance care planning model is applicable in community palliative care. It helps people plan their future healthcare decisions and ensures their preferences are honored when they cannot communicate.",1.1842986367842703e-07,0.13705767068058927,0.015625000000000028,0.009067132323909363,0.13344544803929193,0.012519645860415277,0.009054007704764333,0.1293354886657152,0.008180408759559346,1.1842986367842703e-07,0.12466730702264872,0.002908287627211844
191,0.5,5,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can community palliative care incorporate an advance care planning model? Answer: Yes, community palliative care can incorporate an advance care planning model. It facilitates individuals in making decisions regarding their future healthcare and respects their wishes if they are unable to express them.",9.474389094274162e-08,0.07591453556559147,0.008509404674945209,0.0072537058591274906,0.07231564291115378,0.01289629408691903,0.007243206163811466,0.06829491416793232,0.017674328113888547,9.474389094274162e-08,0.09846084880686945,0.002268582374252811
191,0.5,6,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is the use of an advance care planning model feasible in community palliative care? Answer: Yes, using an advance care planning model in community palliative care is feasible. It aids individuals in planning their future healthcare and ensures their preferences are upheld even if they can't communicate.",0.0,0.02949562470467848,0.019449360499702542,0.0,0.03013683393738864,0.020911319118168778,0.0,0.030806541358219697,0.021978234235825206,0.0,0.0,0.0
191,0.5,7,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is implementing an advance care planning model in community palliative care achievable? Answer: Yes, implementing an advance care planning model in community palliative care is achievable. It supports individuals in making healthcare decisions for the future and guarantees their wishes are respected if they lose the ability to communicate.",4.737194547137081e-08,0.006483425566253587,0.03,0.0036268529295637453,0.037805276080908,0.052920880428316525,0.003621603081905733,0.07056463691835191,0.07804846938775512,4.737194547137081e-08,0.10486255102804787,0.10478501892915089
191,0.5,8,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is an advance care planning model viable for community palliative care? Answer: Yes, an advance care planning model is viable for community palliative care. It assists individuals in deciding on future healthcare and ensures their preferences are maintained even if they cannot communicate.",9.474389094274162e-08,0.10815393931256567,0.0122608024691358,0.0072537058591274906,0.10532265150924625,0.009794510815460344,0.007243206163811466,0.10210697175622263,0.0063881508281983385,9.474389094274162e-08,0.09846084880686945,0.002268582374252811
191,0.5,9,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is it feasible to adopt an advance care planning model in community palliative care? Answer: Yes, adopting an advance care planning model in community palliative care is feasible. It helps individuals make future healthcare decisions and ensures their wishes are honored if they are unable to communicate them.",2.3685972735685406e-08,0.025354854467265042,0.002792608566329541,0.0018134264647818726,0.004783373320163431,0.017846519928613927,0.0018108015409528666,0.03628563889351,0.040752588959438646,2.3685972735685406e-08,0.06924661955536848,0.06532785057697955
191,0.5,10,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can an advance care planning model be effectively used in community palliative care? Answer: Yes, an advance care planning model can be effectively used in community palliative care. It enables individuals to decide on their future healthcare and ensures their preferences are respected even if they cannot communicate.",2.3685972735685406e-08,0.032407410579396334,0.033139792899408216,0.0018134264647818726,0.03427899802484191,0.03729588042831647,0.0018108015409528666,0.03628563889351,0.040752588959438646,2.3685972735685406e-08,0.038440078197148786,0.043611549541395775
192,0.5,1,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","Should second-look laparotomy still be offered for advanced epithelial ovarian carcinoma in Thai women? The choice to proceed with second-look laparotomy must be made cautiously, balancing benefits with potential risks.",2.842316728282237e-07,0.15739508743152486,0.12905603417837724,0.02176111757738252,0.18338814879874654,0.12244897959183673,0.021729618491434455,0.26108675234686274,0.0763888888888889,2.8423167282822487e-07,0.30652676059333084,0.05246913580246914
192,0.5,2,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","In cases of advanced epithelial ovarian carcinoma in Thai women, is it advisable to continue second-look laparotomy? The decision requires careful evaluation of the pros and cons.",3.552895910352796e-07,0.2187911255647954,0.16349480968858132,0.02720139697172816,0.29671683410575067,0.12244897959183673,0.027162023114293075,0.378869788003247,0.0763888888888889,3.552895910352811e-07,0.42912908268566374,0.05246913580246914
192,0.5,3,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","For Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy remain a treatment option? One must carefully weigh the advantages against the associated risks.",4.026615365066502e-07,0.2988338332383327,0.16349480968858132,0.030828249901291918,0.3800984430448011,0.12244897959183673,0.030783626196198823,0.4658811649928767,0.0763888888888889,4.026615365066519e-07,0.5201008608913917,0.05246913580246914
192,0.5,4,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Is continuing second-look laparotomy justified for advanced epithelial ovarian carcinoma in Thai women? The decision should involve a thorough assessment of benefits versus risks.,4.263475092423355e-07,0.3413934476571283,0.16349480968858132,0.0326416763660738,0.42455020561563517,0.12244897959183673,0.032594427737151696,0.5124011806277706,0.0763888888888889,4.2634750924233726e-07,0.568891025060823,0.05246913580246914
192,0.5,5,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","When treating advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy still be performed? The choice demands careful consideration of potential benefits and risks.",4.026615365066502e-07,0.2988338332383327,0.16349480968858132,0.030828249901291918,0.3800984430448011,0.12244897959183673,0.030783626196198823,0.4658811649928767,0.0763888888888889,4.026615365066519e-07,0.5201008608913917,0.05246913580246914
192,0.5,6,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Should we persist in offering second-look laparotomy for advanced epithelial ovarian carcinoma among Thai women? This decision calls for a balanced evaluation of risks and benefits.,3.789755637709649e-07,0.25801183871807787,0.16349480968858132,0.02901482343651004,0.3375388286260055,0.12244897959183673,0.02897282465524595,0.42142940242204263,0.0763888888888889,3.789755637709665e-07,0.4735808452564978,0.05246913580246914
192,0.5,7,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","In Thai women with advanced epithelial ovarian carcinoma, is it appropriate to continue second-look laparotomy? The decision should be made after carefully weighing the potential benefits and risks.",3.316036182995943e-07,0.18105079758194842,0.16349480968858132,0.02538797050694628,0.2574961209524682,0.12244897959183673,0.025351221573340202,0.3380477934829922,0.0763888888888889,3.316036182995957e-07,0.3865694682668681,0.05246913580246914
192,0.5,8,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","For advanced epithelial ovarian carcinoma in Thai women, is the continuation of second-look laparotomy warranted? A careful consideration of the risks and benefits is essential.",4.026615365066502e-07,0.2988338332383327,0.16349480968858132,0.030828249901291918,0.3800984430448011,0.12244897959183673,0.030783626196198823,0.4658811649928767,0.0763888888888889,4.026615365066519e-07,0.5201008608913917,0.05246913580246914
192,0.5,9,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Is it prudent to keep offering second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women? The decision must weigh the possible benefits against the risks involved.,3.552895910352796e-07,0.2187911255647954,0.16349480968858132,0.02720139697172816,0.29671683410575067,0.12244897959183673,0.027162023114293075,0.378869788003247,0.0763888888888889,3.552895910352811e-07,0.42912908268566374,0.05246913580246914
192,0.5,10,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Should second-look laparotomy be maintained as a treatment for advanced epithelial ovarian carcinoma in Thai women? The decision should be based on a careful balance of potential benefits and risks.,2.842316728282237e-07,0.10959183359980473,0.16349480968858132,0.02176111757738252,0.18338814879874654,0.12244897959183673,0.021729618491434455,0.26108675234686274,0.0763888888888889,2.8423167282822487e-07,0.30652676059333084,0.05246913580246914
193,0.5,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea impact aerobic fitness? Yes, it does. This condition involves repeated breathing interruptions during sleep, which reduce oxygen levels in the body. As a result, individuals may experience fatigue, lower endurance, and diminished aerobic capacity. Treating sleep apnea can enhance aerobic fitness.",2.3685972735685406e-07,0.07257861544028099,0.12832668559581756,0.018134264647818726,0.1567788030993178,0.03767781622452903,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
193,0.5,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Is aerobic fitness affected by obstructive sleep apnea? Indeed, obstructive sleep apnea can impair aerobic fitness. It causes frequent breathing disruptions during sleep, leading to a drop in oxygen supply to the body. This often causes tiredness, decreased stamina, and poorer aerobic performance. Managing sleep apnea can improve aerobic fitness.",1.1842986367842703e-07,0.046608147844495296,0.070054012345679,0.009067132323909363,0.07565904040831972,0.016853914006330746,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
193,0.5,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Can obstructive sleep apnea influence aerobic fitness? Yes, it can. The disorder is marked by repeated breathing pauses during sleep, which decrease oxygen delivery to the body. This leads to tiredness, reduced endurance, and compromised aerobic ability. Treating sleep apnea may help restore aerobic fitness.",2.3685972735685406e-07,0.07257861544028099,0.12832668559581756,0.018134264647818726,0.1567788030993178,0.03767781622452903,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
193,0.5,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea have an effect on aerobic fitness? Yes, obstructive sleep apnea negatively affects aerobic fitness. It involves recurring breathing interruptions during sleep, resulting in lower oxygen levels in the body. This condition can cause fatigue, reduced endurance, and impaired aerobic performance. Addressing sleep apnea can improve aerobic fitness.",9.474389094274162e-08,0.034607065669827186,0.02816832073093886,0.0072537058591274906,0.05445034233776136,0.017278510668973474,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
193,0.5,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Is aerobic fitness compromised by obstructive sleep apnea? Yes, obstructive sleep apnea can compromise aerobic fitness. It is characterized by repeated breathing stoppages during sleep, causing decreased oxygen supply to the body. This can lead to fatigue, diminished stamina, and reduced aerobic capacity. Treatment of sleep apnea can enhance aerobic fitness.",9.474389094274162e-08,0.02414210279453588,0.07164658160050408,0.0072537058591274906,0.05445034233776136,0.017278510668973474,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
193,0.5,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea reduce aerobic fitness? Yes, it can reduce aerobic fitness. The condition involves frequent breathing interruptions during sleep, which lower oxygen availability to the body. This results in fatigue, decreased endurance, and impaired aerobic function. Proper treatment can help improve aerobic fitness.",2.3685972735685406e-07,0.10408530546573314,0.10569019274376416,0.018134264647818726,0.1567788030993178,0.03767781622452903,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
193,0.5,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Can obstructive sleep apnea impair aerobic fitness? Yes, it can impair aerobic fitness. It is defined by repeated breathing pauses during sleep, leading to a reduction in oxygen supply to the body. This may cause fatigue, reduced endurance, and poorer aerobic performance. Treating the condition can improve aerobic fitness.",1.4211583641411244e-07,0.011822813471860982,0.1094537649653434,0.010880558788691236,0.0678313170828222,0.03767781622452903,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
193,0.5,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea impact aerobic capacity? Yes, obstructive sleep apnea impacts aerobic capacity. It features repeated breathing interruptions during sleep that reduce oxygen delivery to the body. This leads to tiredness, lower stamina, and impaired aerobic function. Treatment can help restore aerobic fitness.",2.6054570009253947e-07,0.12854025113347634,0.10464071485227044,0.0199476911126006,0.2133163091076038,0.013882456319710475,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
193,0.5,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Is aerobic fitness affected by obstructive sleep apnea? Yes, it is affected. The condition involves repeated breathing disruptions during sleep, which decrease oxygen supply to the body. This can cause fatigue, reduced endurance, and diminished aerobic performance. Managing sleep apnea can improve aerobic fitness.",2.6054570009253947e-07,0.06406144363952793,0.15104166666666666,0.0199476911126006,0.18030930050951222,0.03767781622452903,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
193,0.5,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Can obstructive sleep apnea influence aerobic capacity? Yes, obstructive sleep apnea can influence aerobic capacity. It is marked by repeated interruptions in breathing during sleep, resulting in decreased oxygen delivery to the body. This can lead to fatigue, lowered endurance, and impaired aerobic performance. Treatment can aid in improving aerobic fitness.",9.474389094274162e-08,0.0035837844278621134,0.09128612117096722,0.0072537058591274906,0.05445034233776136,0.017278510668973474,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
194,0.5,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is advanced age a contraindication for laparoscopic surgery of GERD? Advanced age does not automatically disqualify a patient from undergoing GERD laparoscopic surgery. The choice to proceed with surgery should be individualized, taking into account the patient's general health and other factors.",2.3685972735685406e-08,0.10712543382311379,0.09249863038714387,0.0018134264647818726,0.0767435601744979,0.07271468144044323,0.0018108015409528666,0.043996910071702366,0.049861495844875335,2.3685972735685406e-08,0.00957052285622595,0.025623268698060954
194,0.5,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Does advanced age contraindicate laparoscopic surgery for GERD? Being elderly is not inherently a contraindication for GERD laparoscopic surgery. Surgical decisions should be personalized based on the patient's overall medical condition and other considerations.,2.1317375462116791e-07,0.07612701382642406,0.11687363038714388,0.016320838183036875,0.1463999911397118,0.07271468144044323,0.016297213868575827,0.18557753157279544,0.049861495844875335,2.1317375462116866e-07,0.22681825520800558,0.025623268698060954
194,0.5,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Is elderly age a reason to avoid GERD laparoscopic surgery? Advanced age alone is not a contraindication for laparoscopic surgery in GERD patients. The decision should be tailored to each patient’s health status and other relevant aspects.,1.42115836414112e-07,0.010884363163206068,0.11687363038714388,0.010880558788691236,0.05678783245002483,0.07271468144044323,0.010864809245717207,0.09320421144178015,0.049861495844875335,1.4211583641411244e-07,0.13150807540368037,0.025623268698060954
194,0.5,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Can advanced age prevent one from having laparoscopic surgery for GERD? Older age is not necessarily a barrier to GERD laparoscopic surgery. The decision must be individualized, reflecting the patient's overall health and circumstances.",2.1317375462116791e-07,0.07612701382642406,0.11687363038714388,0.016320838183036875,0.1463999911397118,0.07271468144044323,0.016297213868575827,0.18557753157279544,0.049861495844875335,2.1317375462116866e-07,0.22681825520800558,0.025623268698060954
194,0.5,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is laparoscopic surgery for GERD contraindicated due to advanced age? Advanced age by itself does not contraindicate GERD laparoscopic surgery. The decision should be made on a case-by-case basis, assessing the patient’s overall health.",2.1317375462116791e-07,0.07612701382642406,0.11687363038714388,0.016320838183036875,0.1463999911397118,0.07271468144044323,0.016297213868575827,0.18557753157279544,0.049861495844875335,2.1317375462116866e-07,0.22681825520800558,0.025623268698060954
194,0.5,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Does being of advanced age exclude a patient from laparoscopic GERD surgery? Advanced age is not an automatic contraindication for laparoscopic surgery to treat GERD. Surgical choices should consider the individual’s comprehensive health profile.,2.1317375462116791e-07,0.11813593386035981,0.08660019288714388,0.016320838183036875,0.1463999911397118,0.07271468144044323,0.016297213868575827,0.18557753157279544,0.049861495844875335,2.1317375462116866e-07,0.22681825520800558,0.025623268698060954
194,0.5,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is advanced age a limiting factor for GERD laparoscopic surgery? Advanced age is not necessarily a limiting factor for undergoing laparoscopic surgery for GERD. The decision should be individualized, based on the patient’s overall health condition.",1.6580180914979731e-07,0.17572015507433525,0.004490695943855663,0.012693985253473115,0.16732209644797624,0.014120931440443227,0.01267561078667008,0.16506609462539767,0.019588058344875335,1.6580180914979784e-07,0.16227973407043406,0.025623268698060954
194,0.5,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is GERD laparoscopic surgery contraindicated in elderly patients? Elderly age is not inherently a contraindication for GERD laparoscopic surgery. Each case should be evaluated individually, taking into account the patient’s general health.",2.605457000925385e-07,0.1833665437471086,0.08465140816492167,0.019947691112600634,0.21093851227728333,0.07271468144044323,0.019918816950481574,0.2522689060714689,0.049861495844875335,2.6054570009253947e-07,0.29581112669495635,0.025623268698060954
194,0.5,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Does advanced age contraindicate surgery for GERD using laparoscopic methods? Advanced age does not automatically contraindicate laparoscopic surgery for GERD. Decisions should be personalized, considering the patient’s overall health and other relevant factors.",2.3685972735685321e-07,0.19354207006317203,0.05465140816492165,0.018134264647818754,0.17814868945429163,0.07271468144044323,0.0181080154095287,0.21836735439578714,0.049861495844875335,2.3685972735685406e-07,0.26071980688368734,0.025623268698060954
194,0.5,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is advanced age a reason to avoid laparoscopic surgery for GERD? Advanced age is not necessarily a reason to avoid GERD laparoscopic surgery. The choice should be individualized, based on the patient’s overall health and other considerations.",1.42115836414112e-07,0.1431483436278933,0.007498630387143879,0.010880558788691236,0.13600465308544685,0.015781715416568122,0.010864809245717207,0.13397757500412988,0.0204767391873914,1.4211583641411244e-07,0.13150807540368037,0.025623268698060954
195,0.5,1,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT showed a strong correlation with conventional factors.,4.73719454713706e-08,0.026723693784310498,0.03840000000000001,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
195,0.5,2,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"Does high-sensitivity C-reactive protein relate to carotid atherosclerosis in healthy Korean individuals? The study found a strong correlation between hsCRP levels, carotid IMT, and conventional markers.",2.36859727356853e-08,0.04082199452025481,0.0,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,0.5,3,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"In healthy Koreans, is high-sensitivity C-reactive protein connected to carotid atherosclerosis? Both hsCRP and carotid IMT were highly correlated with traditional indicators.",7.10579182070559e-08,0.13353139262452363,0.0,0.005440279394345639,0.13976194237515926,0.0,0.005432404622858621,0.14660347419187536,0.0,7.105791820705606e-08,0.15415067982725672,0.0
195,0.5,4,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"Is high-sensitivity C-reactive protein associated with carotid atherosclerosis among healthy Korean subjects? There was a strong association between hsCRP levels, carotid IMT, and conventional variables.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
195,0.5,5,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"Among healthy Koreans, does high-sensitivity C-reactive protein correlate with carotid atherosclerosis? Both hsCRP and carotid IMT were strongly linked to conventional risk factors.",4.73719454713706e-08,0.08701137698962969,0.0,0.003626852929563759,0.090971778205728,0.0,0.003621603081905747,0.09531017980432521,0.0,4.7371945471370706e-08,0.10008345855698142,0.0
195,0.5,6,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean people? The hsCRP levels and carotid IMT were closely correlated with standard measures.,4.73719454713706e-08,0.026723693784310498,0.03840000000000001,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
195,0.5,7,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Does high-sensitivity C-reactive protein have a relationship with carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT correlated strongly with conventional parameters.,2.36859727356853e-08,0.04255961441879563,0.0,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
195,0.5,8,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"In healthy Korean individuals, is high-sensitivity C-reactive protein related to carotid atherosclerosis? Strong correlations were observed between hsCRP, carotid IMT, and conventional factors.",4.73719454713706e-08,0.08701137698962969,0.0,0.003626852929563759,0.090971778205728,0.0,0.003621603081905747,0.09531017980432521,0.0,4.7371945471370706e-08,0.10008345855698142,0.0
195,0.5,9,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Koreans? The levels of hsCRP and carotid IMT were strongly associated with conventional markers.,2.36859727356853e-08,0.04255961441879563,0.0,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
195,0.5,10,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"Among healthy Koreans, is there a connection between high-sensitivity C-reactive protein and carotid atherosclerosis? Both hsCRP and carotid IMT demonstrated strong correlations with conventional indicators.",0.0,0.05776226504666049,0.04158790170132326,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
196,0.5,1,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Is fondaparinux useful for perioperative bridging? It has proven effective for high-risk thromboembolic patients, with a favorable safety profile and ease of administration.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
196,0.5,2,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Does fondaparinux have a role in perioperative bridging? Studies show it works well for patients at high thromboembolic risk, being safe and easy to use.",2.842316728282236e-07,0.3669569314103902,0.02775510204081633,0.021761117577382555,0.41985384556026384,0.0,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
196,0.5,3,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Can fondaparinux be used in perioperative bridging? It is effective for patients at high thromboembolic risk, offering both safety and convenience.",3.7897556377096486e-07,0.5492784882043451,0.02775510204081633,0.029014823436510073,0.6109090823229733,0.0,0.028972824655245977,0.635988766719997,0.0,3.789755637709663e-07,0.6632942174102641,0.0
196,0.5,4,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,What is the role of fondaparinux in perioperative bridging? It is effective and safe for high-risk thromboembolic patients and easy to administer.,3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
196,0.5,5,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,Is fondaparinux indicated for perioperative bridging? It has demonstrated efficacy and safety in high thromboembolic risk cases and is user-friendly.,4.026615365066502e-07,0.6005717825918953,0.02775510204081633,0.030828249901291953,0.6649763035932486,0.0,0.030783626196198847,0.6931471805599458,0.0,4.0266153650665164e-07,0.7239188392266991,0.0
196,0.5,6,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Does fondaparinux serve in perioperative bridging? It shows effectiveness and a good safety profile in patients at high thromboembolic risk, with simple usage.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
196,0.5,7,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Is there an application for fondaparinux in perioperative bridging? It effectively manages high thromboembolic risk patients, being both safe and easy to handle.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
196,0.5,8,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"How does fondaparinux fit into perioperative bridging? It is effective for high thromboembolic risk patients, with a favorable safety and usability profile.",3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
196,0.5,9,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Is fondaparinux appropriate for perioperative bridging? It has been proven effective and safe for patients at high risk of thromboembolism, with ease of use.",3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
196,0.5,10,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,What role does fondaparinux play in perioperative bridging? It is effective and safe for high thromboembolic risk patients and easy to use.,3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
197,0.5,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Do environmental factors matter in primary systemic vasculitis? Answer: Yes, environmental factors are known to influence the onset and course of primary systemic vasculitis. These may involve exposure to",1.184298636784265e-07,0.1731244751684291,0.009993355624142664,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
197,0.5,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Is there an impact of environmental factors on primary systemic vasculitis? Answer: Indeed, environmental factors contribute to the emergence and advancement of primary systemic vasculitis. Such factors can include exposure to",7.10579182070559e-08,0.10026493888501786,0.0056155246730083125,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
197,0.5,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Are environmental influences significant in primary systemic vasculitis? Answer: Yes, environmental influences have been shown to affect the development and progression of primary systemic vasculitis. These influences might involve exposure to",7.10579182070559e-08,0.10026493888501786,0.0056155246730083125,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
197,0.5,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Do environmental conditions affect primary systemic vasculitis? Answer: Yes, environmental conditions play a role in the initiation and progression of primary systemic vasculitis. These conditions may include exposure to",1.184298636784265e-07,0.1731244751684291,0.009993355624142664,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
197,0.5,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Is the role of environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors are implicated in the development and worsening of primary systemic vasculitis. These factors can encompass exposure to",4.73719454713706e-08,0.06572129226172985,0.0036284722222222274,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
197,0.5,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Are environmental elements relevant to primary systemic vasculitis? Answer: Yes, environmental elements have been identified as contributing to the development and progression of primary systemic vasculitis. These elements can involve exposure to",4.73719454713706e-08,0.06572129226172985,0.0036284722222222274,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
197,0.5,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Do environmental aspects influence primary systemic vasculitis? Answer: Yes, environmental aspects have a role in the onset and progression of primary systemic vasculitis. These aspects may include exposure to",1.184298636784265e-07,0.1731244751684291,0.009993355624142664,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
197,0.5,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Is there a significance of environmental factors in primary systemic vasculitis? Answer: Yes, environmental factors have a significant impact on the development and course of primary systemic vasculitis. These factors can include exposure to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
197,0.5,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Are environmental factors key in primary systemic vasculitis? Answer: Yes, environmental factors are key contributors to the development and advancement of primary systemic vasculitis. These factors might involve exposure to",9.47438909427412e-08,0.13603603990396618,0.0077327806122448745,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
197,0.5,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Question: Do environmental triggers affect primary systemic vasculitis? Answer: Yes, environmental triggers have been found to influence the development and progression of primary systemic vasculitis. These triggers can include exposure to",9.47438909427412e-08,0.13603603990396618,0.0077327806122448745,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
198,0.5,1,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does menopausal transition impact quality of life? This longitudinal research showed no significant effect of menopausal transition on quality of life in Taiwanese women, though vasomotor symptoms were linked to reduced role functioning due to emotional issues.",1.1842986367842661e-07,0.13944536646716754,0.006711119300951633,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
198,0.5,2,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Is quality of life influenced by menopausal transition? A longitudinal study found no notable impact of menopausal transition on Taiwanese women's quality of life, with declines in role limitations from emotional problems associated with vasomotor symptoms.",1.421158364141119e-07,0.13020830035602593,0.02010548969558818,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
198,0.5,3,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does going through menopause affect quality of life? According to this longitudinal study, menopausal transition did not significantly affect quality of life among Taiwanese women; however, vasomotor symptoms contributed to decreased role functioning related to emotional problems.",1.1842986367842661e-07,0.13944536646716754,0.006711119300951633,0.009067132323909363,0.17313980294223397,0.02854671280276816,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
198,0.5,4,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Is there an effect of menopausal transition on quality of life? This longitudinal study observed no significant impact on quality of life in Taiwanese women during menopausal transition, but vasomotor symptoms were linked to reductions in role limitations due to emotional issues.",0.0,0.0,0.0,0.0,0.03465735902799638,0.02498356344510192,0.0,0.0,0.0,0.0,0.0,0.0
198,0.5,5,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does the menopausal transition alter quality of life? The longitudinal study found no significant effect on quality of life among Taiwanese women, although vasomotor symptoms were related to a decline in role limitations caused by emotional problems.",1.1842986367842661e-07,0.1009371897693927,0.02089710045754001,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
198,0.5,6,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does menopausal transition influence quality of life? Findings from this longitudinal study indicate no significant effect on quality of life in Taiwanese women, with vasomotor symptoms associated with decreased role limitations from emotional problems.",1.894877818854825e-07,0.19144931009518373,0.01837876499835634,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
198,0.5,7,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Is quality of life affected by menopausal transition? This longitudinal study reported no significant impact on quality of life for Taiwanese women during menopausal transition, but vasomotor symptoms were linked to declines in role limitations due to emotional difficulties.",7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.11542895663511299,0.027006172839506164,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.5,8,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"How does menopausal transition affect quality of life? The study found no significant effect on Taiwanese women's quality of life longitudinally, though vasomotor symptoms corresponded with reduced role functioning from emotional problems.",2.368597273568531e-07,0.2566799199819325,0.01642998027613414,0.01813426464781876,0.28768207245178123,0.0,0.018108015409528708,0.29626581614317127,0.0,2.3685972735685406e-07,0.3053816495511823,0.0
198,0.5,9,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does menopausal transition have an impact on quality of life? This longitudinal research found no significant effect on quality of life among Taiwanese women, with vasomotor symptoms related to declines in role limitations caused by emotional issues.",1.1842986367842661e-07,0.13944536646716754,0.006711119300951633,0.009067132323909363,0.17313980294223397,0.02854671280276816,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
198,0.5,10,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Is there a significant effect of menopausal transition on quality of life? According to this longitudinal study, menopausal transition did not significantly influence quality of life in Taiwanese women, but vasomotor symptoms were linked to decreased role functioning due to emotional problems.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
199,0.5,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Yes, grandmultiparity, meaning having five or more children, is recognized as an independent risk factor for adverse perinatal results such as preterm birth and low birth weight.",1.1842986367842661e-07,0.08121348950955731,0.03266581632653065,0.009067132323909363,0.07906982843767052,0.03748804209183673,0.00905400770476434,0.07656381160024628,0.0426307397959184,1.1842986367842703e-07,0.0736432266264817,0.048093909438775506
199,0.5,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Indeed, grandmultiparity—defined as delivering five or more children—has been shown to be an independent risk factor for negative perinatal outcomes, including preterm delivery and low birth weight.",1.1842986367842661e-07,0.07281921728154206,0.14204081632653065,0.009067132323909363,0.03975540251546272,0.12244897959183673,0.00905400770476434,0.004982915524453624,0.1012244897959184,1.1842986367842703e-07,0.03163430659254596,0.0783673469387755
199,0.5,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is giving birth to five or more children an independent risk factor for poor perinatal outcomes? Yes, grandmultiparity (having 5+ births) is identified as an independent risk factor for adverse perinatal events like preterm birth and low birth weight.",7.1057918207056e-08,0.0190392836713289,0.03823458795282822,0.005440279394345618,0.017076991825933696,0.041999152602217385,0.0054324046228586,0.01487502403114771,0.04586116799661043,7.105791820705622e-08,0.012402216887323902,0.04982063413600735
199,0.5,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Can grandmultiparity be considered an independent risk factor for adverse perinatal outcomes? Yes, grandmultiparity, which is defined as delivering five or more offspring, is independently linked to negative perinatal outcomes such as preterm birth and low birth weight.",9.474389094274131e-08,0.10021819146965738,0.14204081632653065,0.0072537058591274906,0.06792627948215957,0.12244897959183673,0.007243206163811466,0.03397045239770513,0.1012244897959184,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
199,0.5,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity a standalone risk factor for unfavorable perinatal outcomes? Yes, having five or more children, known as grandmultiparity, is an independent risk factor associated with adverse perinatal outcomes including preterm birth and low birth weight.",1.421158364141119e-07,0.005039929997133985,0.11349410352376249,0.010880558788691243,0.010767865642211216,0.12244897959183673,0.010864809245717214,0.024870047625228153,0.1012244897959184,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
199,0.5,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Does having five or more children independently increase the risk of adverse perinatal outcomes? Yes, grandmultiparity, defined as giving birth to at least five children, is an independent risk factor for outcomes like preterm birth and low birth weight.",7.1057918207056e-08,0.12688643855181825,0.14204081632653065,0.005440279394345618,0.09532525367027489,0.12244897959183673,0.0054324046228586,0.062141329364401976,0.1012244897959184,7.105791820705622e-08,0.027206193430387327,0.0783673469387755
199,0.5,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity an independent predictor of adverse perinatal outcomes? Yes, grandmultiparity, meaning childbirth of five or more children, is identified as an independent risk factor for negative perinatal results including preterm birth and low birth weight.",1.421158364141119e-07,0.005039929997133985,0.11349410352376249,0.010880558788691243,0.010767865642211216,0.12244897959183673,0.010864809245717214,0.024870047625228153,0.1012244897959184,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
199,0.5,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is the condition of grandmultiparity an independent risk factor for poor perinatal outcomes? Yes, grandmultiparity (five or more births) is independently associated with adverse perinatal outcomes such as preterm birth and low birth weight.",1.894877818854825e-07,0.01419215970808807,0.14204081632653065,0.014507411718255002,0.04985675617422425,0.12244897959183673,0.01448641232762296,0.08739040460656167,0.1012244897959184,1.8948778188548325e-07,0.12694448639687117,0.0783673469387755
199,0.5,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity independently linked to adverse perinatal outcomes? Yes, grandmultiparity—defined as having five or more children—is an independent risk factor for unfavorable perinatal outcomes including preterm birth and low birth weight.",2.605457000925384e-07,0.10950233951241328,0.14204081632653065,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.18917309891650413,0.1012244897959184,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
199,0.5,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity an independent risk factor contributing to adverse perinatal outcomes? Yes, having five or more children, termed grandmultiparity, has been identified as an independent risk factor for negative perinatal outcomes like preterm birth and low birth weight.",9.474389094274131e-08,0.012184054026551205,0.0615909893369113,0.0072537058591274906,0.009090073913390118,0.06708565779252876,0.007243206163811466,0.005637957920006098,0.07267777699315024,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
200,0.5,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Currently, the newly developed Singapore equation stands as the most precise BMR prediction formula for the Chinese population and is suitable for use.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
200,0.5,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: At present, the Singapore equation, recently developed, is the most accurate tool for predicting BMR in Chinese individuals and is applicable for this group.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
200,0.5,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for",Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The newly formulated Singapore equation is currently the best and most accurate method for estimating BMR in Chinese people and can be applied accordingly.,9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
200,0.5,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the Singapore equation, which was recently created, provides the most accurate BMR predictions for the Chinese population and is appropriate for use.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
200,0.5,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: So far, the newly introduced Singapore equation is the most reliable for predicting basal metabolic rate in Chinese individuals and is applicable for this purpose.",1.184298636784265e-07,0.0305630937350303,0.0763888888888889,0.009067132323909377,0.06811573714833319,0.05246913580246914,0.009054007704764354,0.10771459467909672,0.027006172839506164,1.1842986367842703e-07,0.14953173397096364,0.0
200,0.5,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Up to now, the Singapore equation developed recently is the most precise BMR prediction equation for Chinese people and can be applied effectively.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
200,0.5,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The Singapore equation, newly devised, is currently the most accurate for estimating basal metabolic rate in the Chinese population and is suitable for use.",9.47438909427412e-08,0.0017813434428641806,0.0783673469387755,0.007253705859127504,0.03947552084693973,0.05387755102040818,0.007243206163811487,0.07927485895860897,0.02775510204081633,9.474389094274162e-08,0.1213608570042668,0.0
200,0.5,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: At this time, the newly developed Singapore equation remains the most accurate BMR prediction model for Chinese individuals and is applicable for them.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
200,0.5,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Presently, the Singapore equation, which has been newly developed, offers the most accurate estimation of basal metabolic rate for Chinese people and is applicable for use.",1.421158364141118e-07,0.023889493385786054,0.09876543209876547,0.01088055878869125,0.06041605688471208,0.0763888888888889,0.01086480924571722,0.09888739581508688,0.05246913580246914,1.4211583641411244e-07,0.13946329299367655,0.027006172839506164
200,0.5,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To this day, the recently developed Singapore equation is recognized as the most accurate prediction equation for basal metabolic rate in the Chinese population and is applicable for this group.",2.3685972735685343e-07,0.16330903922574302,0.06781677572873293,0.01813426464781874,0.20021374673313375,0.046400951814396206,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
201,0.5,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to routinely place a nasobiliary drainage tube after endoscopic removal of common bile duct stones in patients with cholangitis caused by choledocholithiasis? The routine use of an ENBD tube did not enhance the clinical outcome, although it led to longer procedure times and greater patient discomfort, making its insertion unnecessary.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
201,0.5,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in patients with choledocholithiasis-related cholangitis? Routine ENBD tube placement did not improve patient outcomes and caused increased procedure duration and discomfort, thus it is not required.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.5,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine insertion of a nasobiliary drainage tube needed after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients? The routine ENBD tube insertion did not benefit the clinical course and resulted in longer procedures and more discomfort, indicating it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.5,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Do patients with choledocholithiasis-induced cholangitis require routine nasobiliary drainage tube insertion after endoscopic clearance of the common bile duct? The routine use of an ENBD tube did not improve clinical outcomes but increased procedure time and patient discomfort, so the insertion is unwarranted.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.5,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it necessary to routinely insert a nasobiliary drainage tube post-endoscopic clearance of the common bile duct in patients suffering from cholangitis due to choledocholithiasis? Routine ENBD tube insertion failed to improve the clinical progress and caused longer procedures and more discomfort, thus it is unnecessary.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
201,0.5,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should nasobiliary drainage tubes be routinely inserted after endoscopic clearance of the common bile duct in patients with cholangitis induced by choledocholithiasis? Routine insertion of an ENBD tube did not enhance the clinical course, despite increased procedure time and patient discomfort, making it unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.5,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is the routine placement of a nasobiliary drainage tube required after endoscopic removal of common bile duct stones in patients with choledocholithiasis-related cholangitis? Routine ENBD tube insertion did not improve clinical outcomes and led to longer procedure times and increased discomfort, so it is not necessary.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
201,0.5,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion indicated after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients? The routine use of an ENBD tube did not improve the clinical course but caused longer procedures and more discomfort, thus it is unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.5,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it advisable to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? Routine ENBD tube placement did not improve clinical outcomes and resulted in increased procedure time and discomfort, making the insertion unnecessary.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
201,0.5,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion necessary following endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? The routine insertion of an ENBD tube did not improve the clinical course and caused longer procedure times and more discomfort, therefore it is unnecessary.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
202,0.5,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are glandular cell abnormalities in Pap smears detected through rapid prescreening? Yes, rapid prescreening (RPS) frequently identifies Pap smears with glandular cell abnormalities as abnormal, achieving a sensitivity of 36.4% at the AGC threshold. Notably, RPS does detect some cases of AGC on Pap smears.",1.6580180914979784e-07,0.09598508948312556,0.07254239251323305,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
202,0.5,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Pap smears showing glandular cell abnormalities are often marked abnormal by rapid prescreening, with a sensitivity rate of 36.4% at the AGC cutoff. Crucially, RPS identifies certain AGC cases on Pap smears.",2.1317375462116866e-07,0.11399905223784668,0.09285916824196597,0.016320838183036854,0.14908533464493434,0.03538054549569943,0.0162972138685758,0.14635740068567493,0.040742417383431435,2.1317375462116866e-07,0.17875823225491594,0.020823902218198284
202,0.5,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are commonly flagged as abnormal by rapid prescreening, yielding a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC cases are detected by RPS on Pap smears.",1.4211583641411244e-07,0.040605246271150364,0.0960108718655463,0.010880558788691236,0.0761623998681431,0.03704056442485032,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
202,0.5,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Can rapid prescreening detect glandular cell abnormalities in Pap smears? Yes, Pap smears exhibiting glandular cell abnormalities are often detected as abnormal by rapid prescreening, with a sensitivity of 36.4% at the AGC threshold. Significantly, RPS identifies some AGC cases on Pap smears.",2.1317375462116866e-07,0.11399905223784668,0.09285916824196597,0.016320838183036854,0.14908533464493434,0.03538054549569943,0.0162972138685758,0.14635740068567493,0.040742417383431435,2.1317375462116866e-07,0.17875823225491594,0.020823902218198284
202,0.5,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are Pap smears with glandular cell abnormalities identified by rapid prescreening? Rapid prescreening frequently flags Pap smears with glandular cell abnormalities as abnormal, showing a sensitivity of 36.4% at the AGC level. Importantly, RPS detects certain AGC cases in Pap smears.",2.6054570009253947e-07,0.2700619943510798,0.01791018865012925,0.0199476911126006,0.30746773466924404,0.04146894430021897,0.019918816950481533,0.307094986740585,0.03762492955534407,2.6054570009253947e-07,0.3063367960711405,0.033053648802209894
202,0.5,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Does rapid prescreening detect glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are often classified as abnormal by rapid prescreening, with a sensitivity of 36.4% at the AGC threshold. Notably, some AGC cases are detected by RPS on Pap smears.",1.8948778188548325e-07,0.08893334512541662,0.09395821642756977,0.014507411718254981,0.12418273407567604,0.03596018559088088,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
202,0.5,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Is the detection of glandular cell abnormalities in Pap smears possible via rapid prescreening? Yes, rapid prescreening often flags Pap smears with glandular cell abnormalities as abnormal, achieving 36.4% sensitivity at the AGC cutoff. Crucially, some AGC cases are identified by RPS.",2.3685972735685406e-07,0.1735187593855927,0.06764448680152275,0.018134264647818726,0.17462324867501255,0.03477198205059751,0.018108015409528666,0.17167520866996666,0.040742417383431435,2.3685972735685406e-07,0.2047337186581739,0.020823902218198284
202,0.5,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are glandular cell abnormalities in Pap smears recognized through rapid prescreening? Pap smears with glandular cell abnormalities are frequently detected as abnormal by rapid prescreening, with a sensitivity rate of 36.4% at the AGC threshold. Importantly, RPS identifies some AGC cases.",2.6054570009253947e-07,0.20074727629508526,0.06585222887016175,0.0199476911126006,0.20082970689079183,0.03413227679763848,0.019918816950481533,0.19765069507322464,0.040742417383431435,2.6054570009253947e-07,0.23140196574033478,0.020823902218198284
202,0.5,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Does rapid prescreening identify glandular cell abnormalities in Pap smears? Pap smears showing glandular cell abnormalities are often flagged as abnormal by rapid prescreening, resulting in a sensitivity of 36.4% at the AGC cutoff. Significantly, some AGC cases are detected by RPS on Pap smears.",1.6580180914979784e-07,0.06447839945767342,0.09500769431906349,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
202,0.5,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Is rapid prescreening able to detect glandular cell abnormalities in Pap smears? Yes, Pap smears with glandular cell abnormalities are commonly flagged abnormal by rapid prescreening, with a sensitivity of 36.4% at the AGC threshold. Importantly, RPS detects some cases of AGC on Pap smears.",1.6580180914979784e-07,0.06447839945767342,0.09500769431906349,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
204,0.5,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does cup-cage reconstruction using oversized cups offer initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Current evidence indicates that it can provide initial stability, but more research is necessary to confirm its long-term effectiveness.",3.5528959103528067e-07,0.10366651289411699,0.16836734693877556,0.02720139697172809,0.19031962060434493,0.1177685950413223,0.027162023114293006,0.2805846085279411,0.060964083175803374,3.552895910352811e-07,0.34581231691808023,0.020823902218198284
204,0.5,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? Existing studies suggest it can, although additional investigation is required to evaluate its full efficacy and durability.",4.5003348197802187e-07,0.2214495485505008,0.16836734693877556,0.03445510283085561,0.31168047760861173,0.1177685950413223,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
204,0.5,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Can cup-cage reconstruction with oversized cups ensure initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Present data supports this, but further studies are needed to assess long-term results.",5.210914001850778e-07,0.3198896213637541,0.16836734693877556,0.03989538222520125,0.4134631719185542,0.1177685950413223,0.03983763390096312,0.5111082671397735,0.060964083175803374,5.210914001850789e-07,0.5842233403630779,0.020823902218198284
204,0.5,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does the use of oversized cups in cup-cage reconstruction provide initial stability in THA for osteoporotic acetabular fractures? Current findings imply it does, yet more research is essential to understand its long-term benefits.",4.5003348197802187e-07,0.2214495485505008,0.16836734693877556,0.03445510283085561,0.31168047760861173,0.1177685950413223,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
204,0.5,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is initial stability in total hip arthroplasty for osteoporotic acetabular fractures achieved through cup-cage reconstruction with oversized cups? Evidence to date suggests yes, but further research is needed to fully determine its effectiveness over time.",4.0266153650665127e-07,0.16082492673406534,0.16836734693877556,0.03082824990129185,0.24916012062727821,0.1177685950413223,0.030783626196198753,0.34120923034437656,0.060964083175803374,4.026615365066519e-07,0.40833267389941375,0.020823902218198284
204,0.5,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does cup-cage reconstruction with oversized cups contribute to initial stability in THA for patients with osteoporotic acetabular fractures? The available evidence supports this, although additional research is warranted to clarify long-term outcomes.",4.7371945471370717e-07,0.25319824686508063,0.16836734693877556,0.03626852929563749,0.3444703004316034,0.1177685950413223,0.036216030819057374,0.43964930315762984,0.060964083175803374,4.737194547137081e-07,0.5101153682093562,0.020823902218198284
204,0.5,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Can the initial stability in total hip arthroplasty for osteoporotic acetabular fractures be provided by cup-cage reconstruction with oversized cups? Current evidence suggests so, but further studies are necessary to confirm long-term efficacy.",4.5003348197802187e-07,0.2214495485505008,0.16836734693877556,0.03445510283085561,0.31168047760861173,0.1177685950413223,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
204,0.5,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is initial stability in THA for osteoporotic acetabular fractures possible with cup-cage reconstruction using oversized cups? Present evidence indicates it can provide stability, but more research is needed to understand its long-term impact.",4.5003348197802187e-07,0.2214495485505008,0.16836734693877556,0.03445510283085561,0.31168047760861173,0.1177685950413223,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
204,0.5,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does the technique of cup-cage reconstruction with oversized cups offer initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Current data suggests it does, though further investigation is required to evaluate long-term outcomes.",4.2634750924233657e-07,0.19067788988374712,0.16836734693877556,0.03264167636607373,0.2799317792940319,0.1177685950413223,0.03259442773715163,0.3729579286589564,0.060964083175803374,4.263475092423373e-07,0.44112249672240544,0.020823902218198284
204,0.5,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is cup-cage reconstruction with oversized cups effective in providing initial stability in THA for osteoporotic acetabular fractures? Existing evidence suggests it is, but more research is needed to fully assess its long-term effectiveness.",4.5003348197802187e-07,0.2214495485505008,0.16836734693877556,0.03445510283085561,0.31168047760861173,0.1177685950413223,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
205,0.5,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is imaging necessary for diagnosing appendicitis in children? Yes, imaging is usually essential for diagnosing appendicitis in pediatric patients. Ultrasound and CT scans are common methods used to visualize the inflamed appendix and ensure accurate diagnosis.",2.1317375462116813e-07,0.25314673330562476,0.01714416177126707,0.01632083818303686,0.25190751070815187,0.012192798185603794,0.016297213868575813,0.2501639682527319,0.0064780775951814445,2.1317375462116866e-07,0.2478361639045814,0.0
205,0.5,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Do we require imaging to identify appendicitis in children? Yes, imaging is generally needed to confirm appendicitis in children. Techniques like ultrasound and CT scans help to detect the inflamed appendix and improve diagnostic accuracy.",2.3685972735685343e-07,0.20408240278809275,0.03843201907124899,0.01813426464781874,0.20021374673313375,0.046400951814396206,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
205,0.5,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is it important to use imaging to diagnose appendicitis in children? Yes, imaging studies are often necessary to diagnose appendicitis in children. Ultrasound and computed tomography (CT) scans are commonly utilized to visualize the inflamed appendix and provide precise diagnosis.",1.1842986367842692e-07,0.13274594549071272,0.008572113160155964,0.009067132323909363,0.13209800958480056,0.006068183988072934,0.009054007704764333,0.13121211220645312,0.003210812934687609,1.1842986367842703e-07,0.1300531282481976,0.0
205,0.5,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Should imaging be used to diagnose appendicitis in children? Yes, imaging is typically required for an accurate diagnosis of appendicitis in children. Ultrasound and CT scans are frequently employed to detect the inflamed appendix.",2.605457000925387e-07,0.23517092240936055,0.03754333822873293,0.01994769111260062,0.23098540539988743,0.046400951814396206,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
205,0.5,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is imaging required to diagnose appendicitis in children? Yes, imaging is commonly needed to diagnose appendicitis in pediatric cases. Ultrasound and CT scans are standard techniques that help visualize the inflamed appendix for a reliable diagnosis.",2.1317375462116813e-07,0.25314673330562476,0.01714416177126707,0.01632083818303686,0.25190751070815187,0.012192798185603794,0.016297213868575813,0.2501639682527319,0.0064780775951814445,2.1317375462116866e-07,0.2478361639045814,0.0
205,0.5,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Do children with suspected appendicitis need imaging for diagnosis? Yes, imaging is usually necessary to diagnose appendicitis in children. Ultrasound and CT imaging are commonly used to identify the inflamed appendix and confirm the diagnosis.",2.3685972735685343e-07,0.16330903922574302,0.06781677572873293,0.01813426464781874,0.20021374673313375,0.046400951814396206,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
205,0.5,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is imaging a necessary step in diagnosing appendicitis in children? Yes, imaging is often required to accurately diagnose appendicitis in children. Ultrasound and CT scans are typical methods to visualize the inflamed appendix.",2.84231672828224e-07,0.2672553598271761,0.036599293938930626,0.0217611175773825,0.26273410371446726,0.046400951814396206,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
205,0.5,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is it standard to use imaging to diagnose appendicitis in children? Yes, imaging is generally essential for diagnosing appendicitis in children. Common imaging modalities include ultrasound and CT scans to detect the inflamed appendix.",2.605457000925387e-07,0.23517092240936055,0.03754333822873293,0.01994769111260062,0.23098540539988743,0.046400951814396206,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
205,0.5,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Do we rely on imaging to diagnose appendicitis in children? Yes, imaging is typically utilized to diagnose appendicitis in pediatric patients. Ultrasound and CT scans help visualize the inflamed appendix and provide a definitive diagnosis.",2.3685972735685343e-07,0.2856291299127913,0.019592173282713482,0.01813426464781874,0.28423158680100613,0.013952846312554876,0.018108015409528687,0.28224840567054743,0.00742212188498375,2.3685972735685406e-07,0.27958486221916123,0.0
205,0.5,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is imaging needed for diagnosing appendicitis in children? Yes, imaging is usually required to confirm appendicitis in children. Ultrasound and CT scans are common techniques that allow visualization of the inflamed appendix for accurate diagnosis.",2.3685972735685343e-07,0.20408240278809275,0.03843201907124899,0.01813426464781874,0.20021374673313375,0.046400951814396206,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
206,0.5,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Yes, research indicates that cognitive function is a predictor of frequency compressed speech recognition in individuals with normal hearing and cognition.",1.42115836414112e-07,0.09913899883043564,0.024846567138822162,0.010880558788691236,0.05195753850884044,0.06325954861111113,0.010864809245717207,0.007580147960844386,0.10009105098855359,1.4211583641411244e-07,0.039759060119288314,0.140625
206,0.5,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Is cognitive function a predictor of frequency compressed speech recognition among listeners with normal hearing and normal cognition? Studies confirm that cognitive function indeed influences frequency compressed speech recognition in such listeners.,2.605457000925385e-07,0.11948201097660682,0.1027279254434609,0.019947691112600634,0.10048579082220233,0.13582190688775514,0.019918816950481574,0.09212800573520497,0.15306122448979592,2.6054570009253947e-07,0.08253507113805192,0.1708984375
206,0.5,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Can cognitive function forecast frequency compressed speech recognition in people with normal hearing and cognition? Evidence suggests that cognitive function plays a role in predicting this ability.,3.78975563770965e-07,0.16981499957209234,0.1905281997918834,0.02901482343651003,0.19038772354149813,0.2021484375,0.028972824655245942,0.23356675154201278,0.1875,3.789755637709665e-07,0.2792453653841065,0.1708984375
206,0.5,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Does cognitive function influence the ability to recognize frequency compressed speech in listeners who have normal hearing and cognition? Research has demonstrated that it does.,4.263475092423356e-07,0.19653869335640284,0.22892819979188342,0.03264167636607379,0.2737693324805486,0.2021484375,0.03259442773715169,0.32057812853164247,0.1875,4.263475092423373e-07,0.3702171435898345,0.1708984375
206,0.5,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Is there a relationship between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition? Yes, cognitive function has been shown to predict this skill.",3.316036182995944e-07,0.09189852642628304,0.19326290486732925,0.025387970506946272,0.11342668240536868,0.2021484375,0.025351221573340195,0.1535240438684755,0.1875,3.316036182995957e-07,0.19586375644505605,0.1708984375
206,0.5,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Does cognitive function serve as a predictor for frequency compressed speech recognition in individuals with normal hearing and normal cognition? Studies have found that it does.,4.026615365066503e-07,0.15571669883614803,0.22892819979188342,0.03082824990129191,0.23120971806175294,0.2021484375,0.030783626196198816,0.2761263659608084,0.1875,4.026615365066519e-07,0.32369712795494054,0.1708984375
206,0.5,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Can cognitive function predict how well listeners with normal hearing and cognition recognize frequency compressed speech? Yes, studies support this association.",5.210914001850768e-07,0.37886025015035774,0.22892819979188342,0.03989538222520131,0.464824569243258,0.2021484375,0.03983763390096318,0.5212488239937931,0.1875,5.210914001850787e-07,0.58152623725704,0.1708984375
206,0.5,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Does cognitive function predict frequency compressed speech recognition in those with normal hearing and cognition? Research shows that cognitive function contributes to this prediction.,4.500334819780209e-07,0.29937197564997664,0.18553977003981728,0.03445510283085567,0.31822109505138263,0.2021484375,0.03440522927810456,0.3670981441665364,0.1875,4.5003348197802266e-07,0.41900730775926576,0.1708984375
206,0.5,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Is cognitive function linked to frequency compressed speech recognition in listeners with normal hearing and normal cognition? Evidence confirms that it is a predictive factor.,4.263475092423356e-07,0.19653869335640284,0.22892819979188342,0.03264167636607379,0.2737693324805486,0.2021484375,0.03259442773715169,0.32057812853164247,0.1875,4.263475092423373e-07,0.3702171435898345,0.1708984375
206,0.5,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Does cognitive function affect frequency compressed speech recognition in listeners who have normal hearing and cognition? Studies have shown that it does influence recognition in such cases.,3.78975563770965e-07,0.16981499957209234,0.1905281997918834,0.02901482343651003,0.19038772354149813,0.2021484375,0.028972824655245942,0.23356675154201278,0.1875,3.789755637709665e-07,0.2792453653841065,0.1708984375
207,0.5,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant yet modest correlation with bone turnover parameters assessed in iliac cancellous bone. The iliac crest bone might not be fully representative.,4.73719454713706e-08,0.05745399337060908,0.006949210655774363,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
207,0.5,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover reflect bone histomorphometry in 370 postmenopausal women? Bone turnover markers were found to be significantly but moderately associated with bone turnover measurements in iliac cancellous bone. The iliac crest bone may not completely represent the bone status.,9.474389094274141e-08,0.14482513188471025,0.03801020408163264,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
207,0.5,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"In 370 postmenopausal women, are biochemical markers of bone turnover representative of bone histomorphometry? Bone turnover markers had a significant but modest relationship with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone might not fully reflect bone histomorphometry.",7.1057918207056e-08,0.08500156402629955,0.010163943693821037,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
207,0.5,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical bone turnover markers reflective of bone histomorphometry in 370 postmenopausal women? Markers of bone turnover were significantly yet modestly linked to bone turnover parameters in iliac cancellous bone. The iliac crest bone may not be entirely representative.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.5,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"Does bone turnover marker data correspond to bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly, though modestly, correlated with bone turnover parameters in iliac cancellous bone. The iliac crest bone might not be fully indicative.",2.36859727356853e-08,0.007469060524830873,0.02448979591836732,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
207,0.5,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover representative of bone histomorphometric findings in 370 postmenopausal women? There was a significant but modest association between bone turnover markers and bone turnover parameters in iliac cancellous bone. The iliac crest bone may not be fully representative.,9.474389094274141e-08,0.11181812328661556,0.013222235639818017,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
207,0.5,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"In a study of 370 postmenopausal women, do biochemical markers of bone turnover represent bone histomorphometry? Bone turnover markers showed a significant yet modest association with bone turnover parameters in iliac cancellous bone. The iliac crest bone might not fully represent the bone condition.",1.1842986367842682e-07,0.17018056665149484,0.04032876446235842,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
207,0.5,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover indicative of bone histomorphometric parameters in 370 postmenopausal women? Bone turnover markers were significantly but modestly linked with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not be completely representative.,4.73719454713706e-08,0.05745399337060908,0.006949210655774363,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
207,0.5,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? Bone turnover markers had a significant yet modest association with bone turnover parameters in iliac cancellous bone. The iliac crest bone might not be fully representative.,2.36859727356853e-08,0.06468082847456813,0.030323936733203147,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
207,0.5,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover reflective of bone histomorphometric measurements in 370 postmenopausal women? Bone turnover markers were significantly but modestly correlated with bone turnover parameters in iliac cancellous bone. The iliac crest bone may not fully represent the bone histomorphometry.,7.1057918207056e-08,0.08500156402629955,0.010163943693821037,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
208,0.5,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: Can severe hypotensive episodes trigger myocardial ischemic events in patients with coronary disease? Answer: In individuals with ischemic heart disease and hypotension, both symptomatic and silent ischemia were observed in a time-related manner with hypotension, especially concerning diastolic pressures, indicating that patients with coronary disease might be vulnerable to ischemic events.",0.0,0.06462425227459523,0.08126612402520533,0.0,0.02772588722239755,0.019938885418112832,0.0,0.0,0.0,0.0,0.0,0.0
208,0.5,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: Does profound hypotension cause myocardial ischemic events in patients suffering from coronary disease? Answer: Among patients with ischemic heart disease experiencing hypotension, symptomatic and silent ischemia occurred in close temporal association with hypotension, particularly linked to diastolic blood pressure, implying susceptibility to ischemic events in this population.",9.474389094274162e-08,0.021680543399229535,0.0779473422418949,0.0072537058591274906,0.058066668431643986,0.01820216049382717,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
208,0.5,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: In coronary disease patients, can significant hypotensive episodes lead to myocardial ischemia? Answer: For patients with ischemic heart disease and hypotension, both symptomatic and silent ischemic episodes were temporally associated with hypotension, especially low diastolic pressure, suggesting these patients are prone to ischemic events.",1.6580180914979784e-07,0.028647261781668654,0.12041647804436403,0.012693985253473108,0.09537111528978759,0.039930555555555566,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
208,0.5,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: Can profound hypotension provoke myocardial ischemic events in patients with coronary artery disease? Answer: Symptomatic and silent ischemia in patients with ischemic heart disease and hypotension occurred in a time-dependent manner related to hypotension, notably diastolic pressure, indicating that coronary disease patients may be at risk for ischemic events.",4.737194547137081e-08,0.022399959099680622,0.0796740606609326,0.0036268529295637453,0.014251352598789513,0.019106653337357282,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
208,0.5,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: Does hypotension cause ischemic heart events in patients with coronary disease? Answer: In patients with ischemic heart disease and hypotension, there was a temporal causal link between hypotension and both symptomatic and silent ischemia, particularly related to diastolic blood pressure, suggesting susceptibility to ischemic episodes.",1.4211583641411244e-07,0.09859403000427003,0.054089947432119145,0.010880558788691236,0.10388828709054065,0.017215574484706456,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
208,0.5,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: Are myocardial ischemic events triggered by profound hypotension in patients with coronary disease? Answer: Patients with ischemic heart disease who experience hypotension show symptomatic and silent ischemia occurring in temporal relation to hypotension, especially at low diastolic pressures, indicating vulnerability to ischemic events.",1.8948778188548325e-07,0.08387618375334238,0.09717384765887652,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
208,0.5,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: Can profound hypotensive episodes induce myocardial ischemia in coronary disease patients? Answer: In ischemic heart disease patients with hypotension, symptomatic and silent ischemic events were temporally linked to hypotension, especially concerning diastolic pressure, suggesting these patients are susceptible to ischemic complications.",2.3685972735685406e-07,0.09926482899562261,0.12041647804436403,0.018134264647818726,0.16769177686941372,0.039930555555555566,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
208,0.5,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: In patients with coronary artery disease, can severe hypotension cause ischemic heart events? Answer: Symptomatic and silent ischemia occurred in a temporally causal relationship with hypotension in patients with ischemic heart disease, particularly related to diastolic pressures, indicating a potential risk for ischemic events.",1.6580180914979784e-07,0.12316733185802553,0.0525997023156311,0.012693985253473108,0.1276105190367618,0.016687925170068042,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
208,0.5,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: Does profound hypotension in coronary disease patients lead to myocardial ischemic events? Answer: There is a time-related causal association between hypotension and ischemic episodes, both symptomatic and silent, in patients with ischemic heart disease, notably involving diastolic blood pressure, suggesting susceptibility to ischemia.",1.8948778188548325e-07,0.05163678000636818,0.12041647804436403,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
208,0.5,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Question: Can myocardial ischemic events be caused by profound hypotension in patients with coronary disease? Answer: In patients with ischemic heart disease and hypotension, symptomatic and silent ischemia were temporally linked to hypotensive episodes, especially those involving diastolic pressure, implying that coronary disease patients may be prone to ischemic events.",4.737194547137081e-08,0.022399959099680622,0.0796740606609326,0.0036268529295637453,0.014251352598789513,0.019106653337357282,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
209,0.5,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive ability predict how well listeners with normal hearing and cognition recognize frequency compressed speech? The connection between cognitive functioning and speech-in-noise recognition with frequency compression was not statistically significant. Results might have varied if participants had different characteristics.,7.105791820705611e-08,0.041100963555631864,0.023795359904818555,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
209,0.5,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is cognitive function a predictor for recognizing frequency compressed speech in individuals with normal hearing and cognition? The study found no significant statistical link between cognitive function and recognition of frequency compressed speech in noise. Outcomes could differ with a different participant group.,0.0,0.09902102579427963,0.07038746557994598,0.0,0.06762411517657974,0.04865220249835634,0.0,0.03465735902799638,0.02498356344510192,0.0,0.0,0.0
209,0.5,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Can cognitive function forecast the recognition of frequency compressed speech in listeners with normal hearing and cognition? No statistically significant relationship was observed between cognitive functioning and frequency compressed speech recognition in noise. The results might change with a different sample.,4.737194547137081e-08,0.08509787362733423,0.02606613594005678,0.0036268529295637453,0.08555642983414735,0.025623268698060954,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
209,0.5,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive performance influence the ability to recognize frequency compressed speech among normal hearing and cognitively normal listeners? There was no significant statistical association found between cognitive function and recognition of frequency compressed speech-in-noise. Different participant profiles might yield different findings.,4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
209,0.5,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,"Is there a predictive relationship between cognitive function and frequency compressed speech recognition in normal hearing, cognitively normal listeners? The link between cognitive function and recognizing frequency compressed speech in noise was not statistically significant. The findings might differ if participant characteristics changed.",0.0,0.1320280343923721,0.09307827048232532,0.0,0.10143617276487005,0.07271468144044323,0.0,0.03465735902799638,0.02498356344510192,0.0,0.0,0.0
209,0.5,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive functioning predict recognition of frequency compressed speech in noise for listeners with normal hearing and cognition? No statistically significant relationship was found between cognitive function and speech recognition under these conditions. Different participant groups might produce other results.,7.105791820705611e-08,0.041100963555631864,0.023795359904818555,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
209,0.5,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Can cognitive abilities predict how well normal hearing and cognitively normal individuals recognize frequency compressed speech? The study did not find a statistically significant relationship between cognitive function and speech recognition in noise with frequency compression. Different participant samples might affect the findings.,0.0,0.03300700859809158,0.023795359904818555,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
209,0.5,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is cognitive function a significant predictor of frequency compressed speech recognition in listeners with normal hearing and cognition? The data showed no significant statistical correlation between cognitive functioning and speech recognition in noise with frequency compression. Results could vary with different participants.,2.3685972735685406e-08,0.05871465815754817,0.024856842593537785,0.0018134264647818726,0.05934997161836808,0.02498356344510192,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
209,0.5,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive function correlate with recognition of frequency compressed speech in individuals with normal hearing and normal cognition? No statistically significant correlation was observed between cognitive function and recognizing frequency compressed speech-in-noise. The conclusions might differ with other participant groups.,7.105791820705611e-08,0.11219298207460016,0.027336853389556895,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
209,0.5,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Can cognitive function serve as a predictor for frequency compressed speech recognition in normal hearing and cognitively normal listeners? The relationship was not statistically significant in this study. Findings might change if the participant demographics were different.,1.42115836414112e-07,0.12114367122916603,0.023795359904818555,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
210,0.5,1,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does increased neutrophil migration after major trauma contribute to the development of acute respiratory distress syndrome? Answer: The findings suggest that major blunt trauma boosts the migratory ability of circulating neutrophils. This effect appears within 2 hours of admission and might,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,0.5,2,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is the rise in neutrophil migratory activity following major trauma a factor in acute respiratory distress syndrome? Answer: Data show that major blunt trauma increases the migration capacity of circulating neutrophils. This is evident within 2 hours of hospital admission and could,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
210,0.5,3,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could enhanced neutrophil migration after major trauma play a role in acute respiratory distress syndrome? Answer: These results indicate that major blunt trauma elevates the migratory function of circulating neutrophils. This occurs within 2 hours of admission and may,7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
210,0.5,4,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does major trauma-induced increase in neutrophil migration contribute to acute respiratory distress syndrome? Answer: The data reveal that major blunt trauma augments the migratory potential of circulating neutrophils. This is observable within 2 hours of admission and might,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
210,0.5,5,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is increased neutrophil migratory activity post-major trauma linked to acute respiratory distress syndrome? Answer: Evidence indicates that major blunt trauma enhances the ability of circulating neutrophils to migrate. This is apparent within 2 hours of admission and may,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
210,0.5,6,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could the heightened migration of neutrophils after major trauma be a factor in acute respiratory distress syndrome? Answer: Findings show that major blunt trauma improves the migratory capacity of circulating neutrophils. This is noticeable within 2 hours of admission and may,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,0.5,7,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does the increased migratory activity of neutrophils following major trauma influence acute respiratory distress syndrome? Answer: The data suggest that major blunt trauma boosts the migration ability of circulating neutrophils. This manifests within 2 hours of admission and might,7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
210,0.5,8,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is the surge in neutrophil migration after major trauma a contributing factor to acute respiratory distress syndrome? Answer: These data demonstrate that major blunt trauma enhances the migratory function of circulating neutrophils. This is evident within 2 hours of admission and may,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
210,0.5,9,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does enhanced neutrophil migration post-major trauma play a role in the etiology of acute respiratory distress syndrome? Answer: The findings indicate that major blunt trauma increases the migratory capacity of circulating neutrophils. This occurs within 2 hours of admission and might,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,0.5,10,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could increased neutrophil migratory activity after major trauma be involved in acute respiratory distress syndrome? Answer: Data indicate that major blunt trauma elevates the migration ability of circulating neutrophils. This is seen within 2 hours of admission and may,7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
211,0.5,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","MPH programs in low- and middle-income countries play a crucial role in enhancing health systems by providing students with vital public health expertise, enabling them to tackle healthcare challenges effectively. Graduates support policy formulation, program execution, and research, which leads to better health outcomes and stronger health systems.",4.737194547137081e-07,0.27178117522598866,0.05946082136558325,0.03626852929563745,0.31900442550339436,0.0302734375,0.03621603081905733,0.34639717456962593,0.015380859375,4.737194547137081e-07,0.3746934494414096,0.0
211,0.5,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","The impact of MPH programs in low- and middle-income countries is significant for health system strengthening. These programs impart essential public health knowledge and skills, preparing students to address healthcare issues. Graduates contribute to policy-making, program delivery, and research, thereby improving health outcomes and reinforcing health systems.",4.974054274493935e-07,0.293287380446952,0.05946082136558325,0.038081955760419325,0.34098333222216937,0.0302734375,0.0380268323600102,0.36887003042168365,0.015380859375,4.974054274493935e-07,0.3976829676661091,0.0
211,0.5,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","MPH programs contribute substantially to health system strengthening in low- and middle-income countries by equipping students with critical public health competencies. Graduates are able to influence policy development, implement health programs, and conduct research that enhances health outcomes and fortifies health systems.",6.158352911278206e-07,0.4083567102317387,0.05946082136558325,0.04714908808432869,0.45876636787855274,0.0302734375,0.04708084006477453,0.48949801821030103,0.015380859375,6.158352911278206e-07,0.521296923633285,0.0
211,0.5,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","In low- and middle-income countries, MPH programs significantly strengthen health systems by training students in key public health knowledge and skills. This enables graduates to aid in policy creation, program implementation, and research activities, ultimately improving health outcomes.",7.105791820705619e-07,0.511010864291821,0.05946082136558325,0.05440279394345618,0.5641268835363786,0.0302734375,0.054324046228586,0.597711602850532,0.015380859375,7.105791820705622e-07,0.6325225587435095,0.0
211,0.5,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","The role of MPH programs in low- and middle-income countries is pivotal for health system strengthening. These programs provide students with necessary public health tools and knowledge, allowing graduates to contribute to policy development, program management, and research, which improves health outcomes.",6.158352911278206e-07,0.4083567102317387,0.05946082136558325,0.04714908808432869,0.45876636787855274,0.0302734375,0.04708084006477453,0.48949801821030103,0.015380859375,6.158352911278206e-07,0.521296923633285,0.0
211,0.5,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","MPH programs in low- and middle-income countries have a major impact on strengthening health systems by equipping students with essential public health skills. Graduates help advance policy, implement programs, and conduct research that enhances health outcomes and system resilience.",6.868932093348766e-07,0.4843426172096601,0.05946082136558325,0.052589367478674306,0.5367279093482633,0.0302734375,0.05251324468763313,0.5695407258838352,0.015380859375,6.868932093348768e-07,0.603535021870258,0.0
211,0.5,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","In low- and middle-income countries, MPH programs are instrumental in health system strengthening by imparting essential public health knowledge and skills to students. Graduates contribute to policy formulation, program execution, and research, improving health outcomes and reinforcing systems.",7.105791820705619e-07,0.511010864291821,0.05946082136558325,0.05440279394345618,0.5641268835363786,0.0302734375,0.054324046228586,0.597711602850532,0.015380859375,7.105791820705622e-07,0.6325225587435095,0.0
211,0.5,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","MPH programs significantly bolster health systems in low- and middle-income countries by providing students with crucial public health expertise. Graduates play a key role in policy development, program implementation, and research, which leads to improved health outcomes.",7.342651548062472e-07,0.5384098384799363,0.05946082136558325,0.05621622040823805,0.5922977605030755,0.0302734375,0.05613484776953887,0.6266991397237835,0.015380859375,7.342651548062476e-07,0.6623755218931913,0.0
211,0.5,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","The contribution of MPH programs to health system strengthening in low- and middle-income countries is profound. These programs prepare students with vital public health competencies, enabling graduates to support policy-making, program delivery, and research that improve health outcomes.",7.105791820705619e-07,0.511010864291821,0.05946082136558325,0.05440279394345618,0.5641268835363786,0.0302734375,0.054324046228586,0.597711602850532,0.015380859375,7.105791820705622e-07,0.6325225587435095,0.0
211,0.5,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","MPH programs in low- and middle-income countries enhance health systems by equipping students with essential public health knowledge and skills. Graduates contribute to policy development, program implementation, and research, thereby strengthening health outcomes and systems.",7.816371002776178e-07,0.5955682523198846,0.05946082136558325,0.05984307333780181,0.6511382605260088,0.0302734375,0.05975645085144462,0.687323761540219,0.015380859375,7.816371002776184e-07,0.7248958788745248,0.0
212,0.5,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a role for polymorphisms in beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn (TTN)? Answer: We conclude that homozygosity for beta1Gly49 and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may increase susceptibility to TTN.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.5,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes influence transient tachypnea of the newborn (TTN)? Answer: Our findings suggest that beta1Gly49 homozygosity and the ADRB2 gene's TACC haplotype, both loss-of-function mutations, might predispose individuals to TTN.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.5,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Transient tachypnea of the newborn (TTN): Is there an association with polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We conclude that the loss-of-function genetic variants beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene may contribute to TTN risk.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.5,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We determine that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, can predispose to TTN.",4.73719454713706e-08,0.0951782614725234,0.02854671280276816,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
212,0.5,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a link between transient tachypnea of the newborn (TTN) and polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: Our conclusion is that both beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, which are loss-of-function genetic variations, may increase the risk of TTN.",2.1317375462116834e-07,0.1875866499074803,0.021728395061728398,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
212,0.5,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): Are polymorphisms in beta-adrenergic receptor (ADRB) genes involved? Answer: We find that beta1Gly49 homozygosity and the ADRB2 gene's TACC haplotype, both loss-of-function variants, may predispose to TTN.",9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
212,0.5,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Can polymorphisms in the beta-adrenergic receptor (ADRB) genes play a role in transient tachypnea of the newborn (TTN)? Answer: It appears beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function mutations, may predispose individuals to TTN.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
212,0.5,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Is transient tachypnea of the newborn (TTN) influenced by polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that the loss-of-function genetic variants beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene may contribute to the development of TTN.,9.474389094274131e-08,0.10265415406008227,0.0,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.5,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) have a genetic basis involving polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may predispose to TTN.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
212,0.5,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): Could polymorphisms in beta-adrenergic receptor (ADRB) genes be a factor? Answer: Our conclusion is that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variations, might increase susceptibility to TTN.",7.10579182070559e-08,0.04330418244171419,0.02498356344510192,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
213,0.5,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are the diagnostic features of child bipolar I disorder in the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: The generalizability of the RCT sample is supported since only 7.8% of Phenomenology participants did not meet RCT criteria. However, because RCT participants exhibited more severe illness, it remains uncertain if RCT treatment results apply to children with milder mania.",9.474389094274162e-08,0.02210487643241965,0.1451222789572694,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
213,0.5,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Do the diagnostic criteria of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' cohort generalize? Answer: Generalization of the RCT sample is validated as only 7.8% of Phenomenology subjects failed to meet RCT inclusion criteria. Yet, due to the greater severity of illness in RCT subjects, applicability of RCT treatment outcomes to children with less severe mania is uncertain.",2.3685972735685406e-08,0.07089504060185536,0.1451222789572694,0.0018134264647818726,0.01600034134644357,0.0,0.0018108015409528666,0.016260520871781203,0.0,2.3685972735685406e-08,0.01652930195121094,0.0
213,0.5,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Can the diagnostic characteristics of child bipolar I disorder in the 'Treatment of Early Age Mania (TEAM)' sample be generalized? Answer: The RCT sample generalizes well because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Still, since RCT subjects were more severely affected, it is unclear if RCT treatment findings apply to children with milder mania.",1.1842986367842703e-07,0.01819875647921343,0.12817816480744776,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
213,0.5,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Is the 'Treatment of Early Age Mania (TEAM)' sample representative for diagnostic traits of child bipolar I disorder? Answer: Generalization of the RCT sample is supported given that only 7.8% of Phenomenology subjects were excluded by RCT criteria. Nevertheless, because RCT subjects had more severe illness, it is uncertain whether RCT treatment results extend to children with less severe mania.",9.474389094274162e-08,0.02210487643241965,0.1451222789572694,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
213,0.5,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Does the 'Treatment of Early Age Mania (TEAM)' sample generalize regarding diagnostic features of child bipolar I disorder? Answer: The RCT sample appears generalizable since only 7.8% of Phenomenology subjects did not meet RCT criteria. However, due to greater severity among RCT participants, it is unclear if treatment outcomes from the RCT apply to children with milder mania.",1.4211583641411244e-07,0.03569830215912084,0.1278862063195347,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
213,0.5,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are the diagnostic markers of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' study generalizable? Answer: Generalization is supported because only 7.8% of Phenomenology subjects were excluded by RCT criteria. Yet, since RCT subjects were more severely ill, the relevance of RCT treatment findings to children with less severe mania remains uncertain.",1.8948778188548325e-07,0.07164325150310002,0.12727103928784791,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.5,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Does the 'Treatment of Early Age Mania (TEAM)' RCT sample generalize to child bipolar I disorder diagnostic characteristics? Answer: The RCT sample generalizes well as only 7.8% of Phenomenology subjects did not meet RCT criteria. Nonetheless, because RCT subjects were more severely ill, it is unclear if the treatment results apply to children with less severe mania.",1.6580180914979784e-07,0.05350937165898717,0.12758401365114694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.5,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Is the sample from 'Treatment of Early Age Mania (TEAM)' representative of child bipolar I disorder diagnostic features? Answer: Generalization of the RCT sample is supported since only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, due to the increased severity in RCT subjects, it remains uncertain if RCT treatment findings are applicable to children with milder mania.",9.474389094274162e-08,0.02210487643241965,0.1451222789572694,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
213,0.5,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Can findings from the 'Treatment of Early Age Mania (TEAM)' sample be generalized for child bipolar I disorder diagnosis? Answer: The RCT sample generalizes because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Still, since RCT participants were more severely ill, applicability of RCT treatment findings to children with less severe mania is unclear.",1.6580180914979784e-07,0.05350937165898717,0.12758401365114694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.5,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are the diagnostic characteristics of child bipolar I disorder in the 'Treatment of Early Age Mania (TEAM)' study applicable more broadly? Answer: Generalization of the RCT sample is supported as only 7.8% of Phenomenology subjects did not meet RCT criteria. Nonetheless, because RCT subjects were more severely ill, it is uncertain if treatment findings from the RCT apply to children with less severe mania.",0.0,0.06498254817749505,0.12950121571715853,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
214,0.5,1,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy an effective treatment for gallbladder carcinoma? The effectiveness depends on factors like cancer stage and patient health, but it can help alleviate symptoms.",4.2634750924233583e-07,0.33705295574406735,0.13296398891966763,0.03264167636607378,0.4133666758374659,0.09204470742932283,0.032594427737151675,0.4605947621411439,0.0710059171597633,4.263475092423373e-07,0.5104537355985785,0.04865220249835634
214,0.5,2,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"How effective is external palliative radiotherapy for gallbladder carcinoma? Its success varies with the cancer's progression and the patient's condition, offering symptom relief.",5.21091400185077e-07,0.5041070404072343,0.13296398891966763,0.039895382225201295,0.5877200629822443,0.09204470742932283,0.03983763390096317,0.6429163189350988,0.0710059171597633,5.210914001850788e-07,0.701508972361288,0.04865220249835634
214,0.5,3,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Does external palliative radiotherapy work well for gallbladder carcinoma? Its efficacy varies based on cancer stage and patient health, providing symptom management.",5.447773729207623e-07,0.5506270560421282,0.13296398891966763,0.041708808689983175,0.6365102271516756,0.09204470742932283,0.04164843544191604,0.694209613322649,0.0710059171597633,5.447773729207641e-07,0.7555761936315633,0.04865220249835634
214,0.5,4,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Can external palliative radiotherapy effectively treat gallbladder carcinoma? Effectiveness depends on cancer stage and patient health, helping to ease symptoms.",5.92149318392133e-07,0.6507105145991097,0.13296398891966763,0.045335661619546934,0.741870742809501,0.09204470742932283,0.04527003852382179,0.8054352484328731,0.0710059171597633,5.921493183921349e-07,0.8733592292879471,0.04865220249835634
214,0.5,5,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy beneficial for gallbladder carcinoma? Its effectiveness is influenced by cancer stage and overall patient health, and it can reduce symptoms.",4.974054274493917e-07,0.45965527783640026,0.13296398891966763,0.038081955760419416,0.5412000473473504,0.09204470742932283,0.038026832360010296,0.5941261547656675,0.0710059171597633,4.974054274493935e-07,0.6502156779737378,0.04865220249835634
214,0.5,6,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"How well does external palliative radiotherapy perform in gallbladder carcinoma cases? Its success varies with disease stage and patient wellness, offering symptom relief.",5.21091400185077e-07,0.5041070404072343,0.13296398891966763,0.039895382225201295,0.5877200629822443,0.09204470742932283,0.03983763390096317,0.6429163189350988,0.0710059171597633,5.210914001850788e-07,0.701508972361288,0.04865220249835634
214,0.5,7,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy a useful option for gallbladder carcinoma? Its effectiveness depends on the cancer stage and patient health, and it can alleviate symptoms.",4.7371945471370643e-07,0.4170956634176046,0.13296398891966763,0.036268529295637536,0.49674828477651634,0.09204470742932283,0.03621603081905742,0.5476061391307736,0.0710059171597633,4.737194547137081e-07,0.6014255138043065,0.04865220249835634
214,0.5,8,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,Does external palliative radiotherapy provide effective symptom relief for gallbladder carcinoma? Effectiveness varies by cancer stage and patient condition.,6.158352911278184e-07,0.704777735869385,0.13296398891966763,0.047149088084328813,0.7990291566494498,0.09204470742932283,0.04708084006477466,0.8660598702493081,0.0710059171597633,6.158352911278202e-07,0.9378977504255177,0.04865220249835634
214,0.5,9,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,What is the effectiveness of external palliative radiotherapy in gallbladder carcinoma? It varies with cancer progression and patient health but can relieve symptoms.,5.21091400185077e-07,0.5041070404072343,0.13296398891966763,0.039895382225201295,0.5877200629822443,0.09204470742932283,0.03983763390096317,0.6429163189350988,0.0710059171597633,5.210914001850788e-07,0.701508972361288,0.04865220249835634
214,0.5,10,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy effective in managing gallbladder carcinoma? Its success is influenced by cancer stage and patient health, offering symptom relief.",5.447773729207623e-07,0.5506270560421282,0.13296398891966763,0.041708808689983175,0.6365102271516756,0.09204470742932283,0.04164843544191604,0.694209613322649,0.0710059171597633,5.447773729207641e-07,0.7555761936315633,0.04865220249835634
215,0.5,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral",Antral follicle assessment serves as a more reliable predictor of IVF outcomes compared to maternal age and FSH levels.,1.0421828003701558e-06,1.04944644920177,0.16323731138545947,0.07979076445040252,1.1867559718469378,0.0652508464142813,0.07967526780192626,1.2986509339636538,0.016661878770468257,1.0421828003701574e-06,1.3694872428035083,0.0
215,0.5,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","When predicting IVF success, antral follicle count outperforms both age and follicle stimulating hormone measurements.",1.1369266913128972e-06,1.3007608774826767,0.16323731138545947,0.08704447030953003,1.4550199584416168,0.0652508464142813,0.08691847396573775,1.5863330064154342,0.016661878770468257,1.136926691312899e-06,1.6796421711073481,0.0
215,0.5,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","In vitro fertilization results correlate strongly with maternal age, day 3 hormone levels, and antral follicle counts, with antral follicle assessment being the superior predictor.",9.000669639560437e-07,0.8195266417966502,0.1216494096841362,0.06891020566171124,0.8844750999740043,0.0652508464142813,0.06881045855620901,0.9801972028451194,0.016661878770468257,9.000669639560454e-07,1.0330150061822971,0.0
215,0.5,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Among age, FSH, and antral follicle count, the latter is the most effective indicator of IVF outcomes.",1.0895547458415264e-06,1.167229484858154,0.16323731138545947,0.08341761737996627,1.3119191148009435,0.0652508464142813,0.083296870883832,1.4321823265881766,0.016661878770468257,1.0895547458415283e-06,1.5125880864441816,0.0
215,0.5,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral",Antral follicle assessment has greater predictive value for IVF success than either age or basal FSH levels.,1.0895547458415264e-06,1.167229484858154,0.16323731138545947,0.08341761737996627,1.3119191148009435,0.0652508464142813,0.083296870883832,1.4321823265881766,0.016661878770468257,1.0895547458415283e-06,1.5125880864441816,0.0
215,0.5,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral",The outcome of IVF is better forecasted by antral follicle assessment than by maternal age or follicle stimulating hormone.,1.0421828003701558e-06,1.04944644920177,0.16323731138545947,0.07979076445040252,1.1867559718469378,0.0652508464142813,0.07967526780192626,1.2986509339636538,0.016661878770468257,1.0421828003701574e-06,1.3694872428035083,0.0
215,0.5,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Compared to age and FSH, antral follicle assessment provides a stronger prediction of in vitro fertilization results.",1.0895547458415264e-06,1.167229484858154,0.16323731138545947,0.08341761737996627,1.3119191148009435,0.0652508464142813,0.083296870883832,1.4321823265881766,0.016661878770468257,1.0895547458415283e-06,1.5125880864441816,0.0
215,0.5,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral",IVF outcome prediction is more accurate when using antral follicle assessment rather than relying on age or FSH.,1.065868773105841e-06,1.106604863041719,0.16323731138545947,0.0816041909151844,1.2473805936633728,0.0652508464142813,0.08148606934287914,1.3631894551012245,0.016661878770468257,1.0658687731058429e-06,1.4384801142904604,0.0
215,0.5,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral",Antral follicle count is a more precise predictor of IVF success than maternal age or follicle stimulating hormone levels.,1.0421828003701558e-06,1.04944644920177,0.16323731138545947,0.07979076445040252,1.1867559718469378,0.0652508464142813,0.07967526780192626,1.2986509339636538,0.016661878770468257,1.0421828003701574e-06,1.3694872428035083,0.0
215,0.5,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","In predicting IVF outcomes, antral follicle assessment surpasses both age and basal cycle hormone levels in accuracy.",1.0895547458415264e-06,1.167229484858154,0.16323731138545947,0.08341761737996627,1.3119191148009435,0.0652508464142813,0.083296870883832,1.4321823265881766,0.016661878770468257,1.0895547458415283e-06,1.5125880864441816,0.0
216,0.5,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are the home blood pressure readings reported by stroke patients dependable? This cohort of elderly stroke patients could accurately measure their blood pressure at home. Any bias detected was minimal and unlikely to influence treatment decisions. Given that blood pressure readings taken in a GP's office often do not reflect true blood pressure, GPs might consider employing hypertensive monitoring at home.",7.105791820705622e-08,0.07295203810184958,0.1190082644628099,0.005440279394345618,0.0286892385753168,0.01694411414982164,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
216,0.5,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Can stroke patients reliably report their home blood pressure readings? Elderly stroke patients in this study successfully recorded their blood pressure at home with reliability. The bias present was minor and would probably not impact clinical management. Since blood pressure measurements in general practice settings often poorly represent actual blood pressure, GPs may want to utilize home monitoring for hypertension.",4.737194547137081e-08,0.044871980320767335,0.08641581632653059,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
216,0.5,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are reports of home blood pressure measurements from stroke patients trustworthy? The group of elderly stroke patients demonstrated reliable home blood pressure recording. Any bias was slight and unlikely to affect medical management. Because blood pressure readings in a general practitioner's office are frequently inaccurate indicators of true blood pressure, GPs should consider home-based hypertensive monitoring.",4.737194547137081e-08,0.14605309329742688,0.11149557862360629,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
216,0.5,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Do stroke patients provide reliable reports of their home blood pressure readings? This elderly stroke patient group was capable of accurately recording their blood pressures at home. The bias found was small and unlikely to alter treatment plans. Since GP office blood pressure readings often poorly reflect true blood pressure levels, GPs might consider home-based hypertension assessments.",2.3685972735685406e-08,0.07655380684947888,0.07270233196159122,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
216,0.5,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Is the self-reporting of home blood pressure by stroke patients dependable? Elderly stroke patients in this study reliably recorded their blood pressures at home. The bias was minimal and unlikely to influence management decisions. Given that blood pressure readings obtained at GP surgeries often do not represent true blood pressure, GPs might consider home monitoring for hypertension.",2.3685972735685406e-08,0.06721008999654021,0.03566529492455417,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
216,0.5,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Can elderly stroke patients reliably record and report their home blood pressure readings? This group demonstrated dependable home blood pressure measurements. Any bias was negligible and unlikely to affect clinical management. Since blood pressure readings taken in GP clinics often poorly indicate true blood pressure, GPs might consider using home hypertensive monitoring.",1.4211583641411244e-07,0.20303212975971885,0.10026041666666667,0.010880558788691236,0.14105457252940212,0.019991670137442734,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
216,0.5,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are home blood pressure readings self-reported by stroke patients accurate? The elderly stroke patients in this study were able to reliably record their blood pressure at home. The small bias observed is unlikely to impact treatment approaches. Because blood pressure measurements in GP offices often fail to accurately represent true blood pressure, GPs might consider home monitoring for hypertension management.",4.737194547137081e-08,0.044871980320767335,0.08641581632653059,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
216,0.5,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Is it reliable to trust stroke patients' reports of their home blood pressure readings? This elderly stroke patient group reliably recorded their blood pressure at home. Any bias was minimal and unlikely to affect management decisions. Since blood pressure readings in GP surgeries often poorly reflect actual blood pressure, GPs might consider home-based hypertensive monitoring.",7.105791820705622e-08,0.11510123730739252,0.07544378698224853,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
216,0.5,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Do stroke patients provide accurate home blood pressure readings? Elderly stroke patients in this research reliably recorded their blood pressure at home. The bias was minor and unlikely to influence clinical decisions. Given that blood pressure readings in GP offices often do not accurately represent true blood pressure, GPs might consider home monitoring for hypertension.",7.105791820705622e-08,0.14077335510590938,0.09457900807381774,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
216,0.5,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are reports of home blood pressure from stroke patients trustworthy? The elderly stroke patients were able to reliably measure their blood pressure at home. The small bias present would unlikely affect treatment management. Since blood pressure readings taken at GP surgeries often poorly indicate true blood pressure, GPs might consider using home-based hypertension monitoring.",9.474389094274162e-08,0.16110145290741418,0.09639999999999999,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
217,0.5,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Is untethering required before scoliosis correction in a patient with myelomeningocele? The choice to untether depends on factors such as the severity of the tethered cord, neurological symptoms, and treatment goals, making consultation essential.",4.0266153650665116e-07,0.3046118950720742,0.07939508506616258,0.030828249901291856,0.36950095199988464,0.040742417383431435,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
217,0.5,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","For a patient with myelomeningocele, should untethering be done before scoliosis correction? This decision hinges on the tethered cord's severity, neurological signs, and therapeutic objectives, so professional consultation is crucial.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.5,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Does a patient with myelomeningocele need untethering prior to scoliosis surgery? The need is determined by the extent of the tethered cord, neurological symptoms, and treatment aims, emphasizing the importance of expert advice.",4.2634750924233646e-07,0.3353835537388279,0.07939508506616258,0.032641676366073735,0.40124965031446447,0.040742417383431435,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
217,0.5,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","When managing scoliosis in a myelomeningocele patient, is untethering necessary beforehand? It depends on the tethered cord's severity, neurological manifestations, and treatment goals, hence consultation is key.",5.684633456564483e-07,0.5430229185170719,0.07939508506616258,0.04352223515476501,0.6163610299314111,0.040742417383431435,0.043459236982868875,0.6931471805599458,0.0,5.684633456564497e-07,0.7146533857809083,0.0
217,0.5,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","In patients with myelomeningocele, is untethering mandatory before scoliosis correction? The decision is influenced by the severity of tethering, neurological symptoms, and treatment objectives, so consulting a specialist is important.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.5,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Should untethering be performed before scoliosis correction in myelomeningocele patients? This depends on factors like tethered cord severity, neurological symptoms, and treatment goals; consultation with a specialist is essential.",5.210914001850777e-07,0.4689149463633502,0.07939508506616258,0.039895382225201254,0.5393999887952816,0.040742417383431435,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
217,0.5,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Is it necessary to untether a patient with myelomeningocele before correcting scoliosis? The decision depends on the tethered cord severity, neurological signs, and treatment goals, making consultation important.",5.44777372920763e-07,0.5052825905342249,0.07939508506616258,0.04170880868998313,0.5771403167781286,0.040742417383431435,0.041648435441916,0.652325186039691,0.0,5.447773729207643e-07,0.6720937713621127,0.0
217,0.5,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","For scoliosis correction in patients with myelomeningocele, is untethering needed first? This depends on the severity of the tethered cord, neurological symptoms, and treatment goals, so professional consultation is necessary.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.5,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Prior to scoliosis correction in myelomeningocele patients, should untethering be done? This depends on the severity of tethering, neurological symptoms, and treatment aims, thus consultation is important.",5.684633456564483e-07,0.5430229185170719,0.07939508506616258,0.04352223515476501,0.6163610299314111,0.040742417383431435,0.043459236982868875,0.6931471805599458,0.0,5.684633456564497e-07,0.7146533857809083,0.0
217,0.5,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","In the context of myelomeningocele and scoliosis correction, is untethering required beforehand? The answer depends on the severity of the tethered cord, neurological symptoms, and treatment goals, highlighting the need for consultation.",4.5003348197802176e-07,0.3671322520534077,0.07939508506616258,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
218,0.5,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair pointless? No, it is a crucial step that maintains proper blood flow to the spinal cord, minimizing the risk of paralysis and other issues.",5.684633456564491e-07,0.31896784368751563,0.14993752603082053,0.04352223515476496,0.4006179841449238,0.10380622837370242,0.04345923698286882,0.48535001858971416,0.0533997864008544,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
218,0.5,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","During thoracic and thoracoabdominal aneurysm repair, reimplantation of spinal cord arteries is vital, not a waste, as it preserves spinal cord blood supply and lowers the chance of paraplegia.",7.105791820705609e-07,0.5626343710256125,0.11427223110626636,0.054402793943456235,0.6012886796070744,0.10380622837370242,0.05432404622858606,0.6929893833679581,0.0533997864008544,7.105791820705622e-07,0.7632520083439092,0.0181755829903978
218,0.5,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Reimplanting spinal cord arteries in thoracic and thoracoabdominal aneurysm surgery is essential to protect spinal cord perfusion and prevent complications like paraplegia, so it is not a futile effort.",7.105791820705609e-07,0.5626343710256125,0.11427223110626636,0.054402793943456235,0.6012886796070744,0.10380622837370242,0.05432404622858606,0.6929893833679581,0.0533997864008544,7.105791820705622e-07,0.7632520083439092,0.0181755829903978
218,0.5,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","The procedure of reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is important for maintaining spinal cord blood flow and avoiding paraplegia, thus it is not time wasted.",6.868932093348756e-07,0.5258357921489245,0.11549875052061644,0.052589367478674355,0.5649210354361998,0.10380622837370242,0.05251324468763319,0.6552490553851111,0.0533997864008544,6.868932093348768e-07,0.7240312951906267,0.0181755829903978
218,0.5,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","In thoracic and thoracoabdominal aneurysm repairs, reimplantation of spinal cord arteries plays a key role in safeguarding spinal cord circulation and reducing paraplegia risk, making it a necessary intervention.",7.105791820705609e-07,0.5626343710256125,0.11427223110626636,0.054402793943456235,0.6012886796070744,0.10380622837370242,0.05432404622858606,0.6929893833679581,0.0533997864008544,7.105791820705622e-07,0.7632520083439092,0.0181755829903978
218,0.5,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a critical measure to ensure sufficient spinal cord blood supply and prevent paraplegia; it is definitely not a waste of time.,6.158352911278197e-07,0.4229141642889487,0.11872004424101823,0.047149088084328716,0.4631383411262573,0.10380622837370242,0.047080840064774566,0.5498885397272857,0.0533997864008544,6.158352911278206e-07,0.614832003225636,0.0181755829903978
218,0.5,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Far from being pointless, reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is essential to maintain spinal cord perfusion and minimize complications such as paraplegia.",7.342651548062462e-07,0.6008357378963813,0.11295527751011047,0.056216220408238114,0.6390290075899214,0.10380622837370242,0.056134847769538934,0.7322100965212406,0.0533997864008544,7.342651548062476e-07,0.804074002864164,0.0181755829903978
218,0.5,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",The act of reimplanting spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is a valuable procedure that supports spinal cord blood flow and decreases the likelihood of paraplegia.,7.105791820705609e-07,0.5626343710256125,0.11427223110626636,0.054402793943456235,0.6012886796070744,0.10380622837370242,0.05432404622858606,0.6929893833679581,0.0533997864008544,7.105791820705622e-07,0.7632520083439092,0.0181755829903978
218,0.5,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is an indispensable step to protect spinal cord vascularization and reduce the risk of paralysis, thus it is not wasted effort.",6.39521263863505e-07,0.45606033675788193,0.11771530380859832,0.048962514549110596,0.495928163949249,0.10380622837370242,0.04889164160572744,0.5837900914029674,0.0533997864008544,6.39521263863506e-07,0.649923323036905,0.0181755829903978
218,0.5,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Ensuring adequate blood supply to the spinal cord through reimplantation of its arteries during thoracic and thoracoabdominal aneurysm repair is crucial, making this procedure far from a waste of time.",6.868932093348756e-07,0.4780325383172044,0.14993752603082053,0.052589367478674355,0.5649210354361998,0.10380622837370242,0.05251324468763319,0.6552490553851111,0.0533997864008544,6.868932093348768e-07,0.7240312951906267,0.0181755829903978
219,0.5,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised preoperative weight loss program enhance outcomes of bariatric surgery? MSWM seems not to provide extra advantages over the usual preoperative bariatric surgery protocol regarding weight loss and most behavioral results following LAGB in our patients.,1.6580180914979763e-07,0.14394467788328003,0.01805172953931231,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.5,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Is there an improvement in bariatric surgery results with a preoperative medically supervised weight loss program? In our patient group, MSWM does not seem to offer additional benefits compared to the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes after LAGB.",2.3685972735685406e-08,0.023873153186523055,0.0010031775464828044,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
219,0.5,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does undergoing a medically supervised weight loss program before surgery improve bariatric surgery outcomes? According to our data, MSWM does not appear to yield extra benefits beyond the conventional preoperative bariatric surgery protocol in weight loss and most behavioral outcomes after LAGB.",9.474389094274162e-08,0.09910145552615202,0.004303906121936658,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.5,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Can a preoperative medically supervised weight loss regimen improve the results of bariatric surgery? Our findings suggest MSWM does not provide added benefit compared to the standard preoperative protocol in terms of weight loss and most behavioral outcomes post-LAGB.,1.6580180914979763e-07,0.14394467788328003,0.01805172953931231,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.5,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative weight loss program supervised medically improve bariatric surgery outcomes? MSWM does not seem to offer additional advantages over the typical preoperative bariatric surgery protocol for weight loss and behavioral outcomes after LAGB in our patient cohort.,1.6580180914979763e-07,0.1804261084390668,0.008120839426049457,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.5,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is a medically supervised preoperative weight loss program effective in improving bariatric surgery outcomes? MSWM appears not to confer further benefit relative to the standard preoperative bariatric surgery protocol concerning weight loss and most behavioral outcomes after LAGB in our patients.,1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
219,0.5,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before surgery enhance bariatric surgery outcomes? Our patient population shows no added benefit of MSWM compared to the standard preoperative protocol in weight loss and most behavioral outcomes after LAGB.,2.1317375462116823e-07,0.20003864529554471,0.016593194335603353,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
219,0.5,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does participation in a medically supervised preoperative weight loss program improve outcomes from bariatric surgery? MSWM does not seem to provide extra benefit compared to the standard preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes post-LAGB in our patients.,9.474389094274162e-08,0.06528939793786215,0.01997329637641968,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.5,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is the outcome of bariatric surgery improved by a preoperative medically supervised weight loss program? MSWM does not appear to offer additional benefits over the standard preoperative bariatric surgery protocol in terms of weight loss and behavioral outcomes after LAGB in our patient group.,4.737194547137081e-08,0.048328098854266255,0.0020526554379765166,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,0.5,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does a preoperative medically supervised weight loss program lead to better bariatric surgery outcomes? In our patient population, MSWM does not seem to confer added benefit compared to the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes after LAGB.",7.105791820705622e-08,0.07339380596669631,0.003151703623580332,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
220,0.5,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care during a woman's first pregnancy influence her future reproductive outcomes? Answer: In Sweden, the type of care model, like birth center care, during a woman's first pregnancy does not appear to significantly impact her later reproductive behavior.",9.474389094274162e-08,0.16559631938402353,0.05197368447043213,0.0072537058591274906,0.19452659583088172,0.07271468144044323,0.007243206163811466,0.16462489786031975,0.049861495844875335,9.474389094274162e-08,0.1331844788234018,0.025623268698060954
220,0.5,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is there an effect of birth center care during a woman's initial pregnancy on her future reproduction? Answer: The care model, including birth center care, used during a woman's first pregnancy in Sweden does not seem to play a crucial role in influencing subsequent reproduction.",2.3685972735685406e-08,0.023988028981267284,0.0014265846955331396,0.0018134264647818726,0.053979545877510304,0.02271498107084911,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
220,0.5,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Can birth center care during a woman's first pregnancy affect her future reproductive patterns? Answer: In Sweden, birth center care as a model of care during the first pregnancy does not seem to be a major factor affecting later reproduction.",1.4211583641411244e-07,0.18798087667497976,0.03386548618205372,0.010880558788691236,0.17864685290015903,0.025623268698060954,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.5,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the model of care, such as birth center care, during a woman's first pregnancy impact her future reproduction? Answer: Evidence from Sweden suggests that birth center care during the first pregnancy is not an important determinant of subsequent reproduction.",1.4211583641411244e-07,0.11866615861898566,0.015038450071836414,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.5,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is birth center care during a woman's first pregnancy linked to changes in her future reproductive behavior? Answer: The model of care, including birth center care, during the first pregnancy does not appear to significantly influence later reproduction in Sweden.",1.4211583641411244e-07,0.11866615861898566,0.015038450071836414,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.5,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: How does birth center care during a woman's first pregnancy affect her future reproduction? Answer: In Sweden, the choice of birth center care during the first pregnancy does not seem to be a significant factor in future reproductive outcomes.",1.6580180914979774e-07,0.21685328558521944,0.03632454387920665,0.012693985253473108,0.2420391911555062,0.05246913580246914,0.012675610786670066,0.21073913643943865,0.027006172839506164,1.6580180914979784e-07,0.17768117723745203,0.0
220,0.5,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Does receiving birth center care in a woman’s first pregnancy influence her subsequent reproduction? Answer: Birth center care as a model during the first pregnancy does not seem to have a meaningful impact on later reproduction in Sweden.,1.8948778188548304e-07,0.21008902661790163,0.013467401022063757,0.014507411718254981,0.23321199229149636,0.027006172839506164,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.5,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is the model of care like birth center care during a woman's first pregnancy important for her future reproduction? Answer: In Sweden, birth center care during the initial pregnancy is not considered a significant factor affecting future reproduction.",1.8948778188548304e-07,0.21008902661790163,0.013467401022063757,0.014507411718254981,0.27067940745689967,0.05387755102040818,0.014486412327622933,0.2391788721599264,0.02775510204081633,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.5,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does care at a birth center during a woman's first pregnancy affect her reproductive outcomes later? Answer: The care model, such as birth center care, during the first pregnancy does not appear to be a key factor influencing subsequent reproduction in Sweden.",9.474389094274162e-08,0.0665752935897439,0.017399945916711734,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,0.5,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does birth center care during the first pregnancy have an effect on a woman’s future reproduction? Answer: According to data from Sweden, birth center care during the first pregnancy does not seem to significantly impact later reproductive behavior.",1.8948778188548304e-07,0.31953331828526155,0.08744380408328825,0.014507411718254981,0.38308165295310737,0.1318359375,0.014486412327622933,0.3547034022532509,0.109375,1.8948778188548325e-07,0.3246772851572821,0.0849609375
221,0.5,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does preoperative anemia negatively impact the results of colon and rectal surgeries? Answer: Yes, preoperative anemia is linked to a rise in complications and mortality in colon and rectal surgeries, such as increased infection rates, extended hospitalizations, and more frequent readmissions. Appropriate management and treatment are essential.",7.105791820705622e-08,0.07199116375411752,0.004283717877493279,0.005440279394345618,0.06954385060511781,0.0015142353237591263,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
221,0.5,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Is there an adverse effect of preoperative anemia on outcomes for colon and rectal surgery? Answer: Yes, preoperative anemia correlates with heightened complications and death rates in colon and rectal surgeries, including greater infection risks, prolonged hospital stays, and increased readmission incidences. Proper management and treatment are crucial.",9.474389094274162e-08,0.09488804949599317,0.0055945535065107105,0.0072537058591274906,0.09169126505879133,0.0019760897427654224,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
221,0.5,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does having anemia before surgery worsen the outcomes of colon and rectal operations? Answer: Yes, preoperative anemia is associated with higher complication and mortality rates in colon and rectal surgeries, including elevated infection rates, longer hospital stays, and increased chances of readmission. Effective management and treatment are important.",9.474389094274162e-08,0.1237691820193243,0.02622887402740967,0.0072537058591274906,0.09169126505879133,0.0019760897427654224,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
221,0.5,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Can preoperative anemia lead to poorer outcomes in colon and rectal surgery? Answer: Yes, preoperative anemia has been linked to increased complications and mortality in colon and rectal surgery, such as more infections, extended hospital stays, and higher readmission rates. Proper treatment and management are necessary.",4.737194547137081e-08,0.018424496897634146,0.018351024724781825,0.0036268529295637453,0.01608869510729205,0.02110566599093216,0.003621603081905733,0.015013325609441353,0.02271498107084911,4.737194547137081e-08,0.047628048989254435,0.0
221,0.5,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does anemia prior to surgery negatively influence colon and rectal surgery outcomes? Answer: Yes, anemia before surgery is connected to increased complication and mortality rates in colon and rectal surgeries, including higher infection rates, longer hospitalization, and more frequent readmissions. Appropriate management and treatment are vital.",4.737194547137081e-08,0.07869816477241187,0.024428345976666807,0.0036268529295637453,0.04689523646551175,0.0010318865838346326,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
221,0.5,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Is preoperative anemia associated with worse results in colon and rectal surgery? Answer: Yes, preoperative anemia has been shown to increase complications and mortality rates in colon and rectal surgeries, including higher infection occurrences, prolonged hospital stays, and elevated readmission rates. Proper management and treatment are important.",7.105791820705622e-08,0.042495539049439035,0.016553153962992326,0.005440279394345618,0.03940701666772872,0.0201457993665786,0.0054324046228586,0.03818633012873196,0.02221074380165289,7.105791820705622e-08,0.07061756721395396,0.0
221,0.5,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does anemia before colon and rectal surgery increase risks and worsen outcomes? Answer: Yes, preoperative anemia is linked to increased complications and mortality, including more infections, longer hospital stays, and higher readmission rates. Timely management and treatment are essential.",1.1842986367842692e-07,0.02610791771226051,0.06781677572873293,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
221,0.5,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does the presence of anemia before surgery adversely affect colon and rectal surgery results? Answer: Yes, anemia prior to surgery is associated with higher complication and mortality rates in colon and rectal surgeries, such as increased infections, extended hospitalizations, and greater readmission rates. Proper management and treatment are key.",1.1842986367842703e-07,0.14556729095770615,0.027074358345301495,0.009067132323909363,0.11335916643797228,0.00241872816728924,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
221,0.5,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Is there a negative impact of preoperative anemia on colon and rectal surgery outcomes? Answer: Yes, preoperative anemia correlates with increased complications and mortality in colon and rectal surgeries, including higher infection rates, longer hospital stays, and increased readmissions. Appropriate management and treatment are necessary.",2.3685972735685406e-08,0.024573301853755503,0.0014902451164880426,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
221,0.5,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does preoperative anemia contribute to worse outcomes in colon and rectal surgery? Answer: Yes, preoperative anemia has been associated with elevated risks of complications and mortality in colon and rectal surgery, including increased infections, prolonged hospital stays, and higher readmission rates. Proper management and treatment are crucial.",7.105791820705622e-08,0.042495539049439035,0.016553153962992326,0.005440279394345618,0.03940701666772872,0.0201457993665786,0.0054324046228586,0.03818633012873196,0.02221074380165289,7.105791820705622e-08,0.07061756721395396,0.0
222,0.5,1,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Could Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis Precede Bronchiectasis? Answer: The connection between Alveolar Macrophage Phagocytic Dysfunction in children suffering from Protracted Bacterial Bronchitis and the development of Bronchiectasis remains under investigation, with no conclusive evidence available yet. More studies are required to establish any causal link.",9.474389094274162e-08,0.013729728928828067,0.039058514437302294,0.0072537058591274906,0.010213534859986773,0.04490186468762403,0.007243206163811466,0.01974870124932604,0.06805293005671079,9.474389094274162e-08,0.022152068947480785,0.07183364839319474
222,0.5,2,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis a Predictor of Bronchiectasis? Answer: The association between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is currently unclear, as research is ongoing and no definitive conclusions have been drawn. Further investigation is necessary to clarify any causal relationship.",2.3685972735685406e-08,0.0026553213487718885,0.012839506172839465,0.0018134264647818726,0.022567169660986597,0.0025055427197833435,0.0018108015409528666,0.022569261925641904,0.002341011458843828,2.3685972735685406e-08,0.022554498438822623,0.0021340054610375775
222,0.5,3,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Does Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Lead to Bronchiectasis? Answer: The role of Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis as a precursor to Bronchiectasis is still being explored, with no firm answers at present. Additional research is needed to determine causality.",1.1842986367842703e-07,0.09278964460228911,0.001512914858145864,0.009067132323909363,0.11812057930958009,0.01338207858541296,0.009054007704764333,0.11816334865020339,0.012565378201156302,1.1842986367842703e-07,0.11811282343176144,0.01150408940577946
222,0.5,4,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is There a Link Between Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis and Bronchiectasis? Answer: The potential link between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis has not yet been definitively established, and more research is required to understand any causal connection.",1.1842986367842703e-07,0.17596730626948265,0.043226975821620356,0.009067132323909363,0.2029957442761039,0.06201137357372133,0.009054007704764333,0.2048067462201959,0.06488880394200111,1.1842986367842703e-07,0.20659969754579688,0.0673263723431551
222,0.5,5,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Could Dysfunction of Alveolar Macrophage Phagocytosis in Children with Protracted Bacterial Bronchitis be a Precursor to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still under study, with no clear answer available. Further studies are needed to determine if there is a direct cause-effect relationship.",0.0,0.10082140808144624,0.06538427918408483,0.0,0.10268847119406521,0.0700672967863895,0.0,0.10462598951848223,0.07261701323251413,0.0,0.10663802777845266,0.075021550094518
222,0.5,6,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis an Early Indicator of Bronchiectasis? Answer: The connection between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and the onset of Bronchiectasis remains uncertain, as research is ongoing and no definitive conclusions have been reached. More investigation is necessary to confirm any causal link.",4.737194547137081e-08,0.06888301947097597,0.020495756172839497,0.0036268529295637453,0.04370253497045029,0.004778407897500614,0.003621603081905733,0.04369928919516175,0.0044510410102919645,4.737194547137081e-08,0.04366466285942616,0.0040465500945180005
222,0.5,7,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Does Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Precede the Development of Bronchiectasis? Answer: The association between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being researched, with no conclusive evidence at this time. Further studies are essential to determine causality.",1.1842986367842703e-07,0.09278964460228911,0.001512914858145864,0.009067132323909363,0.11812057930958009,0.01338207858541296,0.009054007704764333,0.11816334865020339,0.012565378201156302,1.1842986367842703e-07,0.11811282343176144,0.01150408940577946
222,0.5,8,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis a Potential Forerunner to Bronchiectasis? Answer: The connection between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis remains to be fully understood, and more research is needed before any definitive conclusions can be made.",1.4211583641411244e-07,0.11808486181779942,0.0015354938271605056,0.010880558788691236,0.14345515345490067,0.016332703213610578,0.0108648092457172,0.14351820311746843,0.015357986767485843,1.4211583641411244e-07,0.1434662840489871,0.014078449905482002
222,0.5,9,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Could Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Signal the Onset of Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is currently unclear, with ongoing studies but no definitive answers yet. Additional research is required to clarify any causal association.",7.105791820705622e-08,0.04397150894894608,0.007344644085224561,0.005440279394345618,0.06923941045101634,0.007765910352604544,0.0054324046228586,0.06925463702341572,0.00727287319258052,7.105791820705622e-08,0.0692167087361697,0.006643349851398694
222,0.5,10,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Linked to the Development of Bronchiectasis? Answer: The link between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis has not been conclusively determined, and further research is necessary to explore any potential causal relationship.",1.4211583641411244e-07,0.11808486181779942,0.0015354938271605056,0.010880558788691236,0.14345515345490067,0.016332703213610578,0.0108648092457172,0.14351820311746843,0.015357986767485843,1.4211583641411244e-07,0.1434662840489871,0.014078449905482002
223,0.5,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","In cases where metastatic carcinoma affects the cervical nodes from an unknown head and neck primary site, neck dissection might be required to excise the involved lymph nodes and identify the cancer's origin. This surgery aids in directing subsequent treatments and enhancing patient prognosis.",6.632072365991914e-07,0.2671764890458008,0.16202240735420861,0.05077594101389246,0.29297936701858074,0.1516805515656421,0.050702443146680265,0.31962221164369176,0.14076414823326625,6.632072365991914e-07,0.3471481150315969,0.1292731973570813
223,0.5,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","When metastatic carcinoma is present in the cervical nodes without a known primary head and neck site, performing a neck dissection may be essential to remove affected lymph nodes and locate the primary tumor. This approach supports treatment planning and improves outcomes for patients.",6.632072365991914e-07,0.2671764890458008,0.16202240735420861,0.05077594101389246,0.29297936701858074,0.1516805515656421,0.050702443146680265,0.31962221164369176,0.14076414823326625,6.632072365991914e-07,0.3471481150315969,0.1292731973570813
223,0.5,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","For metastatic carcinoma in cervical lymph nodes with an unknown primary in the head and neck region, neck dissection could be necessary to extract the involved nodes and find the primary cancer source. This procedure assists in guiding further therapy and boosting patient recovery.",6.632072365991914e-07,0.2671764890458008,0.16202240735420861,0.05077594101389246,0.29297936701858074,0.1516805515656421,0.050702443146680265,0.31962221164369176,0.14076414823326625,6.632072365991914e-07,0.3471481150315969,0.1292731973570813
223,0.5,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.",Metastatic carcinoma to cervical nodes from an unidentified head and neck primary site may require neck dissection to eliminate the affected lymph nodes and identify the primary cancer location. This helps inform treatment strategies and enhances patient outcomes.,8.053230730133035e-07,0.41745869209513753,0.16202240735420861,0.0616564998025837,0.44713004684583835,0.1516805515656421,0.061567252392397465,0.4778462168585862,0.14076414823326625,8.053230730133038e-07,0.5096670445293712,0.1292731973570813
223,0.5,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","When metastatic carcinoma involves cervical nodes from an unknown primary in the head and neck, neck dissection may be indicated to remove the diseased lymph nodes and determine the origin of the cancer. This can guide subsequent treatment and improve patient prognosis.",7.105791820705622e-07,0.31480453803505526,0.16202240735420861,0.05440279394345621,0.34176953118801245,0.1516805515656421,0.054324046228586,0.3696326322183552,0.14076414823326625,7.105791820705622e-07,0.39844140941914663,0.1292731973570813
223,0.5,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","In metastatic carcinoma cases affecting cervical nodes with an unknown head and neck primary, neck dissection may be needed to excise involved lymph nodes and pinpoint the primary tumor site. This procedure supports treatment decisions and improves patient outcomes.",7.816371002776182e-07,0.39079044501297666,0.16202240735420861,0.059843073337801825,0.419731072657723,0.1516805515656421,0.0597564508514446,0.44967533989188935,0.14076414823326625,7.816371002776184e-07,0.48067950765611966,0.1292731973570813
223,0.5,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Neck dissection might be necessary in metastatic carcinoma of cervical nodes when the primary head and neck cancer site is unknown, to remove affected lymph nodes and identify the cancer's source. This aids in guiding treatment and improving outcomes.",7.816371002776182e-07,0.39079044501297666,0.16202240735420861,0.059843073337801825,0.419731072657723,0.1516805515656421,0.0597564508514446,0.44967533989188935,0.14076414823326625,7.816371002776184e-07,0.48067950765611966,0.1292731973570813
223,0.5,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","For metastatic carcinoma found in cervical lymph nodes with an unknown primary head and neck site, neck dissection can be required to remove the involved nodes and locate the primary cancer. This helps direct further treatment and enhances patient prognosis.",7.579511275419329e-07,0.3648149586097187,0.16202240735420861,0.05802964687301995,0.39306282557556216,0.1516805515656421,0.05794564931049173,0.422276365703774,0.14076414823326625,7.57951127541933e-07,0.4525086306894228,0.1292731973570813
223,0.5,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","In cases of metastatic carcinoma to cervical nodes from an unknown primary site in the head and neck, neck dissection may be performed to remove affected lymph nodes and find the primary cancer source. This procedure supports treatment planning and improves outcomes.",7.105791820705622e-07,0.31480453803505526,0.16202240735420861,0.05440279394345621,0.34176953118801245,0.1516805515656421,0.054324046228586,0.3696326322183552,0.14076414823326625,7.105791820705622e-07,0.39844140941914663,0.1292731973570813
223,0.5,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","When metastatic carcinoma is detected in cervical nodes with an unknown primary head and neck origin, neck dissection may be necessary to excise the affected lymph nodes and identify the primary tumor. This can help guide treatment and improve patient outcomes.",7.342651548062476e-07,0.33949715062542696,0.16202240735420861,0.05621622040823808,0.3670873391723042,0.1516805515656421,0.056134847769538865,0.39560811862161316,0.14076414823326625,7.342651548062476e-07,0.4251096565013075,0.1292731973570813
224,0.5,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy has a high mortality rate, particularly among patients older than 70, indicating a need for enhanced outcome measures.",1.4211583641411222e-07,0.1830849047476617,0.026296566837107373,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
224,0.5,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Is there a concern and need for improvement regarding 30-day and 1-year mortality in emergency general surgery laparotomies? Answer: Emergency laparotomy is associated with significant mortality, especially in those over 70, highlighting the necessity for better outcomes.",1.6580180914979753e-07,0.17327172127403623,0.0,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
224,0.5,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Are 30-day and 1-year mortality rates in emergency general surgery laparotomies a concern requiring improvement? Answer: Emergency laparotomy results in high mortality rates, notably in patients above 70 years, necessitating efforts to improve results.",2.3685972735685343e-07,0.2578291093020999,0.0,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
224,0.5,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Does emergency general surgery laparotomy mortality at 30 days and 1 year present an area needing improvement? Answer: Emergency laparotomy carries a substantial mortality risk, especially in elderly patients over 70, demonstrating a need for outcome enhancement.",1.6580180914979753e-07,0.17327172127403623,0.0,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
224,0.5,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Is the mortality rate within 30 days and 1 year after emergency general surgery laparotomies an issue that requires improvement? Answer: Emergency laparotomy has a high death rate, particularly among those older than 70 years, underscoring the need for better care.",7.105791820705622e-08,0.07061756721395396,0.0,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
224,0.5,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Are the 30-day and 1-year mortality statistics for emergency general surgery laparotomies concerning and in need of improvement? Answer: Emergency laparotomy shows elevated mortality, especially in patients over 70, indicating the importance of improving outcomes.",2.1317375462116813e-07,0.2288415724288484,0.0,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
224,0.5,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Is there a need to improve the high 30-day and 1-year mortality rates following emergency general surgery laparotomies? Answer: Emergency laparotomy is linked to high mortality, particularly in individuals over 70 years old, calling for improved patient outcomes.",1.4211583641411222e-07,0.14660347419187536,0.0,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
224,0.5,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Do 30-day and 1-year mortality rates in emergency general surgery laparotomies highlight an area for improvement? Answer: Emergency laparotomy carries a high risk of death, especially in patients older than 70, which demands enhanced outcome strategies.",1.8948778188548283e-07,0.20067069546215155,0.0,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
224,0.5,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Are the mortality rates at 30 days and 1 year after emergency general surgery laparotomies an area of concern that requires action? Answer: Emergency laparotomy has a notably high mortality rate, especially among those over 70, necessitating efforts to improve.",9.474389094274162e-08,0.09531017980432566,0.0,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
224,0.5,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Is the high mortality within 30 days and 1 year after emergency general surgery laparotomies an issue needing improvement? Answer: Emergency laparotomy is associated with significant mortality rates, particularly in patients aged over 70, highlighting the need for better outcomes.",9.474389094274162e-08,0.09531017980432566,0.0,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
225,0.5,1,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is visual loss from amblyopia permanent? Visual loss caused by amblyopia can become permanent if it remains untreated for a long time. Nevertheless, early detection and timely treatment, particularly in children, significantly increase the likelihood of vision improvement and minimizing permanent damage.",4.737194547137081e-08,0.0492007028305701,0.0011323696145124768,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
225,0.5,2,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Does amblyopia cause permanent vision loss? Vision loss due to amblyopia may be permanent if not addressed over an extended period. However, early diagnosis and prompt treatment, especially in pediatric cases, can greatly enhance the chances of restoring vision and preventing lasting impairment.",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
225,0.5,3,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Can amblyopia lead to irreversible visual loss? If amblyopia is left untreated for a long duration, visual loss can be permanent. But with early detection and swift intervention, particularly in children, vision can often be improved and permanent loss reduced.",9.474389094274152e-08,0.06539906581694366,0.023242630385487524,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
225,0.5,4,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is the visual impairment from amblyopia permanent? Amblyopia-related vision loss may become permanent if untreated for a prolonged time. Early identification and treatment, especially in young patients, improve the prospects of vision recovery and reduce permanent loss.",1.6580180914979742e-07,0.14544177349047782,0.023242630385487524,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
225,0.5,5,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Does amblyopia result in lasting vision loss? Visual loss from amblyopia can be permanent if treatment is delayed for too long. Early diagnosis and prompt treatment, particularly in children, increase the chances of vision improvement and lessen permanent damage.",1.1842986367842682e-07,0.09137455222020163,0.023242630385487524,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
225,0.5,6,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is vision loss caused by amblyopia irreversible? Without timely treatment, amblyopia can cause permanent visual loss. Early detection and treatment, especially in children, offer a better chance to improve vision and prevent permanent impairment.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
225,0.5,7,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Can amblyopia cause permanent vision impairment? If amblyopia goes untreated for an extended period, the resulting vision loss may be permanent. However, early and prompt treatment, mainly in children, can enhance vision recovery and reduce permanent loss.",1.6580180914979742e-07,0.14544177349047782,0.023242630385487524,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
225,0.5,8,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is the vision loss from amblyopia permanent? Prolonged untreated amblyopia can lead to permanent vision loss. Early detection and timely treatment, especially in children, improve the likelihood of restoring vision and minimizing permanent damage.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
225,0.5,9,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Does untreated amblyopia cause permanent visual loss? Visual loss from amblyopia can become permanent if not treated promptly. Early detection and treatment, particularly in children, increase the chances of improving vision and reducing lasting impairment.",2.1317375462116802e-07,0.20260018733042617,0.023242630385487524,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
225,0.5,10,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is the visual loss due to amblyopia permanent? If amblyopia is left untreated for too long, visual loss can be permanent. Early and prompt treatment, especially in children, offers a better chance to improve vision and reduce permanent loss.",1.1842986367842682e-07,0.12785598277598798,0.0030539364516198493,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
226,0.5,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it acceptable for student examiners to act as substitute examiners for faculty during an undergraduate OSCE on medical emergencies? It appears reasonable and justified to allow medical students to serve as examiners in formative OSCE assessments in emergency medicine, though this may not be appropriate for summative evaluations.",7.105791820705622e-08,0.06453852113757153,0.0,0.005440279394345618,0.06595796779179608,0.0,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
226,0.5,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners reasonably replace faculty examiners in an undergraduate OSCE focused on medical emergencies? Encouraging medical students to officiate as examiners in formative OSCE testing for emergency medicine seems justified, but their role in summative assessments is less certain.",1.4211583641411233e-07,0.17864685290015903,0.025623268698060954,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.5,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are medical students suitable as substitute examiners for faculty in an undergraduate emergency medicine OSCE? It seems quite acceptable and justified to have medical students act as examiners in formative OSCEs, but not necessarily in summative assessments.",2.1317375462116823e-07,0.2616517280119841,0.02775510204081633,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,0.5,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May student examiners be used as reasonable substitutes for faculty examiners in an undergraduate OSCE on medical emergencies? It appears both permissible and justified to involve medical students as examiners in formative emergency medicine OSCEs, though this may not extend to summative evaluations.",7.105791820705622e-08,0.10199988008504324,0.023795359904818555,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
226,0.5,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it appropriate for student examiners to substitute for faculty in an undergraduate OSCE on medical emergencies? Encouraging medical students to officiate in formative OSCE assessments in emergency medicine is justified, but their participation in summative evaluations is not necessarily warranted.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
226,0.5,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems acceptable and justified to have medical students act as examiners during formative OSCE testing, but not necessarily for summative assessment.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
226,0.5,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners acceptable substitutes for faculty in an undergraduate OSCE on medical emergencies? It is quite reasonable and justified to allow medical students to officiate in formative emergency medicine OSCEs, but not necessarily in summative assessments.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,0.5,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it justified to have student examiners replace faculty in an undergraduate OSCE on medical emergencies? Encouraging medical students to serve as examiners during formative OSCEs seems appropriate, but their involvement in summative assessments is less justified.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,0.5,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Could student examiners reasonably substitute for faculty in an undergraduate OSCE on medical emergencies? It appears justified and acceptable to have medical students act as examiners in formative OSCE testing, but not necessarily in summative evaluations.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
226,0.5,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners a reasonable substitute for faculty in an undergraduate OSCE on medical emergencies? It seems justified and reasonable to encourage medical students to officiate as examiners in formative emergency medicine OSCEs, though this may not apply to summative assessments.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
227,0.5,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? Answer: At the studied gas flow rates, HFNC are not louder than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.5,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae greater than that of bubble CPAP for preterm infants? Answer: At the gas flows examined, HFNC are not noisier than BCPAP for preterm infants.",1.421158364141118e-07,0.26135024662228146,0.043326562499999985,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
227,0.5,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae louder compared to bubble CPAP in preterm infants? Answer: Based on the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.17414743517621023,0.07359999999999998,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.5,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae generate more noise than bubble CPAP for preterm infants? Answer: At the gas flow rates evaluated, HFNC are not noisier than BCPAP for preterm infants.",7.10579182070559e-08,0.16183917481456245,0.04030630202140307,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.5,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise produced by high flow nasal cannulae higher than bubble CPAP in preterm infants? Answer: At the gas flows tested, HFNC are not noisier than BCPAP for preterm infants.",9.47438909427412e-08,0.2408388096748837,0.07359999999999998,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.5,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP in preterm infants? Answer: At the gas flow levels studied, HFNC are not noisier than BCPAP for preterm infants.",2.36859727356853e-08,0.08954560246780208,0.03793470507544581,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.5,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae create more noise than bubble CPAP in preterm infants? Answer: Based on the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.5,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the sound level of high flow nasal cannulae greater than that of bubble CPAP for preterm infants? Answer: At the gas flows analyzed, HFNC are not noisier than BCPAP for preterm infants.",1.421158364141118e-07,0.26135024662228146,0.043326562499999985,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
227,0.5,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae more noisy than bubble CPAP for preterm infants? Answer: At the gas flows investigated, HFNC are not noisier than BCPAP for preterm infants.",2.36859727356853e-08,0.08954560246780208,0.03793470507544581,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.5,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Does high flow nasal cannula produce more noise than bubble CPAP in preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.17414743517621023,0.07359999999999998,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
228,0.5,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Does having both major depression and alcohol use disorder in adolescence result in worse depression outcomes? Yes, the coexistence of these disorders can worsen depression and extend its duration, so treatment must target both conditions together for improved results.",4.974054274493933e-07,0.2414675687825949,0.13613575302961484,0.038081955760419325,0.258312082575312,0.13440000000000002,0.0380268323600102,0.31360660715529365,0.10380622837370242,4.974054274493935e-07,0.37098260345145784,0.07100591715976332
228,0.5,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","In adolescents, does comorbidity of major depression and alcohol use disorder cause poorer depression outcomes? Indeed, these conditions can mutually intensify symptoms and lengthen depressive episodes, requiring concurrent treatment for better recovery.",6.632072365991904e-07,0.4085850934680484,0.1624323198667222,0.05077594101389247,0.4680326135573827,0.13440000000000002,0.05070244314668031,0.5298297156249308,0.10380622837370242,6.632072365991914e-07,0.5941261547656671,0.07100591715976332
228,0.5,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Is the presence of both major depression and alcohol use disorder during adolescence linked to more severe depression outcomes? Yes, as each disorder may amplify the other, leading to prolonged depression, thus simultaneous treatment is essential for better prognosis.",4.974054274493933e-07,0.20498613822680856,0.1624323198667222,0.038081955760419325,0.258312082575312,0.13440000000000002,0.0380268323600102,0.31360660715529365,0.10380622837370242,4.974054274493935e-07,0.37098260345145784,0.07100591715976332
228,0.5,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Can major depression combined with alcohol use disorder in adolescence lead to worse depression outcomes? The comorbidity can indeed exacerbate symptoms and extend depressive episodes, so addressing both disorders at once is crucial for improved outcomes.",5.684633456564492e-07,0.2872242364637816,0.1624323198667222,0.04352223515476495,0.3428694706033757,0.13440000000000002,0.04345923698286881,0.4006179841449238,0.10380622837370242,5.684633456564497e-07,0.4605947621411448,0.07100591715976332
228,0.5,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Does the co-occurrence of major depression and alcohol use disorder in adolescence result in poorer depression outcomes? Yes, these two conditions can worsen each other and prolong depression, making integrated treatment necessary for better results.",5.921493183921345e-07,0.3162117733370331,0.1624323198667222,0.04533566161954683,0.37272243375305747,0.13440000000000002,0.045270038523821686,0.43138964281167747,0.10380622837370242,5.921493183921352e-07,0.49234346045572464,0.07100591715976332
228,0.5,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Is adolescent depression outcome negatively impacted by comorbid alcohol use disorder? Yes, the interplay between these disorders can intensify depression and lengthen episodes, so treating both simultaneously yields better outcomes.",7.10579182070561e-07,0.47527646796672185,0.1624323198667222,0.05440279394345623,0.5370254850443335,0.13440000000000002,0.054324046228586054,0.6012886796070744,0.10380622837370242,7.105791820705622e-07,0.6682341269193888,0.07100591715976332
228,0.5,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","When major depression and alcohol use disorder co-occur in adolescence, does it lead to poorer depression outcomes? Yes, because the disorders exacerbate each other and prolong depressive episodes, requiring combined treatment for optimal recovery.",6.158352911278198e-07,0.3460647364867149,0.1624323198667222,0.04714908808432871,0.40349409241981116,0.13440000000000002,0.04708084006477456,0.4631383411262573,0.10380622837370242,6.158352911278206e-07,0.5251332832787163,0.07100591715976332
228,0.5,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Does having both major depression and alcohol use disorder during adolescence worsen depression outcomes? The comorbidity can prolong depression and intensify symptoms, so treating both conditions simultaneously is important for better outcomes.",6.632072365991904e-07,0.4533042664073994,0.1302100976445,0.05077594101389247,0.4680326135573827,0.13440000000000002,0.05070244314668031,0.5298297156249308,0.10380622837370242,6.632072365991914e-07,0.5941261547656671,0.07100591715976332
228,0.5,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","In adolescence, does comorbidity of major depression and alcohol use disorder lead to worse depression outcomes? Yes, as the two conditions can mutually worsen each other and extend depressive episodes, concurrent treatment is necessary for improved results.",5.447773729207639e-07,0.25905335949708475,0.1624323198667222,0.04170880868998307,0.3138819337301242,0.13440000000000002,0.04164843544191594,0.370765020995242,0.10380622837370242,5.447773729207643e-07,0.4298231034743911,0.07100591715976332
228,0.5,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Are depression outcomes poorer when major depression and alcohol use disorder coexist in adolescence? Yes, the interaction between these disorders can exacerbate depression and prolong its duration, so simultaneous treatment is key to better outcomes.",5.921493183921345e-07,0.3569851368993828,0.13304756320923827,0.04533566161954683,0.37272243375305747,0.13440000000000002,0.045270038523821686,0.43138964281167747,0.10380622837370242,5.921493183921352e-07,0.49234346045572464,0.07100591715976332
229,0.5,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",Hypotensive episodes in individuals with coronary disease may trigger myocardial ischemic events due to reduced oxygen delivery to the heart.,7.579511275419309e-07,0.8786576840582851,0.07786328655500228,0.05802964687302004,0.966199473087185,0.039930555555555566,0.057945649310491856,1.0303152323989027,0.020399305555555556,7.579511275419328e-07,1.09861228866811,0.0
229,0.5,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","In patients suffering from coronary disease, significant hypotension can cause myocardial ischemia by lowering the heart's oxygen supply.",8.053230730133016e-07,0.9898833191685092,0.07786328655500228,0.061656499802583795,1.0839825087435688,0.039930555555555566,0.0615672523923976,1.1554783753529083,0.020399305555555556,8.053230730133034e-07,1.2321436812926327,0.0
229,0.5,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",Profound hypotensive events in coronary disease patients can lead to myocardial ischemia and possibly a heart attack.,8.290090457489869e-07,1.0505079409849443,0.07786328655500228,0.06346992626736567,1.1485210298811395,0.039930555555555566,0.06337805393335047,1.2244712468398604,0.020399305555555556,8.290090457489888e-07,1.306251653446354,0.0
229,0.5,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",Severe drops in blood pressure in those with coronary disease might result in myocardial ischemic incidents by restricting oxygen to the heart muscle.,6.868932093348749e-07,0.7320542098664098,0.07786328655500228,0.052589367478674404,0.8120487932599283,0.039930555555555566,0.052513244687633236,0.8677963029011284,0.020399305555555556,6.868932093348767e-07,0.9267620317414509,0.0
229,0.5,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",Myocardial ischemic events can occur in coronary disease patients when profound hypotension reduces cardiac oxygen availability.,8.526950184846723e-07,1.115046462122515,0.07786328655500228,0.06528335273214755,1.2175139013680916,0.039930555555555566,0.06518885547430335,1.2985792189935816,0.020399305555555556,8.526950184846742e-07,1.3862943611198904,0.0
229,0.5,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","In coronary disease, profound hypotension can decrease oxygen supply to the heart, causing ischemia and potential myocardial injury.",8.053230730133016e-07,0.9898833191685092,0.07786328655500228,0.061656499802583795,1.0839825087435688,0.039930555555555566,0.0615672523923976,1.1554783753529083,0.020399305555555556,8.053230730133034e-07,1.2321436812926327,0.0
229,0.5,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",Patients with coronary disease experiencing severe hypotension may develop myocardial ischemic events due to diminished oxygen flow.,8.290090457489869e-07,1.0505079409849443,0.07786328655500228,0.06346992626736567,1.1485210298811395,0.039930555555555566,0.06337805393335047,1.2244712468398604,0.020399305555555556,8.290090457489888e-07,1.306251653446354,0.0
229,0.5,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",A significant fall in blood pressure in coronary disease patients can precipitate myocardial ischemia and trigger heart attacks.,8.053230730133016e-07,0.9898833191685092,0.07786328655500228,0.061656499802583795,1.0839825087435688,0.039930555555555566,0.0615672523923976,1.1554783753529083,0.020399305555555556,8.053230730133034e-07,1.2321436812926327,0.0
229,0.5,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",Coronary disease patients are at risk of myocardial ischemic events if they undergo profound hypotensive episodes that limit oxygen delivery.,7.579511275419309e-07,0.8786576840582851,0.07786328655500228,0.05802964687302004,0.966199473087185,0.039930555555555566,0.057945649310491856,1.0303152323989027,0.020399305555555556,7.579511275419328e-07,1.09861228866811,0.0
229,0.5,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",Profound hypotensive events can induce myocardial ischemia in patients with coronary disease by lowering the heart's oxygen supply.,8.053230730133016e-07,0.9898833191685092,0.07786328655500228,0.061656499802583795,1.0839825087435688,0.039930555555555566,0.0615672523923976,1.1554783753529083,0.020399305555555556,8.053230730133034e-07,1.2321436812926327,0.0
230,0.5,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should male HIV-infected patients over 52 years old with at least two additional cardiovascular risk factors be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? In this group, myocardial SPECT screening was approximately four times more likely to detect SMI compared to the general population, suggesting that physicians might recommend more systematic SMI screening for these patients.",1.8948778188548325e-07,0.0451938914121337,0.060353798126951096,0.014507411718254981,0.08868079094970582,0.03073822121441168,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
230,0.5,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Is it advisable to screen HIV-infected male patients older than 52 years with two or more cardiovascular risk factors for silent myocardial ischemia via gated myocardial perfusion SPECT? Screening in this demographic was about four times more likely to yield positive results than in the general population, which could encourage doctors to promote regular SMI screening.",2.6054570009253947e-07,0.09830371672608162,0.060353798126951096,0.0199476911126006,0.14274801221998068,0.03073822121441168,0.019918816950481533,0.16693032041505385,0.015621063240110858,2.6054570009253947e-07,0.19189100781010726,0.0
230,0.5,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should screening for silent myocardial ischemia using gated myocardial perfusion SPECT be conducted in male HIV-infected patients above 52 years who have at least two other cardiovascular risk factors? The likelihood of a positive myocardial SPECT result was roughly four times higher in this group than in the general population, potentially motivating physicians to recommend more thorough SMI screening.",1.8948778188548325e-07,0.0451938914121337,0.060353798126951096,0.014507411718254981,0.08868079094970582,0.03073822121441168,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
230,0.5,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","For male HIV-infected patients older than 52 with at least two additional cardiovascular risk factors, is screening for silent myocardial ischemia with gated myocardial perfusion SPECT warranted? This subgroup showed about a fourfold increase in positive myocardial SPECT findings compared to the general population, which may prompt doctors to advise systematic SMI screening.",3.316036182995957e-07,0.15439318337712482,0.060353798126951096,0.025387970506946217,0.1999064260599308,0.03073822121441168,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
230,0.5,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should male HIV-positive patients over 52 years old and possessing two or more cardiovascular risk factors be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening in this group was nearly four times more likely to be positive than in the general population, suggesting a need for more systematic SMI screening recommendations.",3.079176455639103e-07,0.13534498840643172,0.060353798126951096,0.023574544042164344,0.1804883402028281,0.03073822121441168,0.023540420032387266,0.20539660124284964,0.015621063240110858,3.079176455639103e-07,0.23111172096338972,0.0
230,0.5,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Is gated myocardial perfusion SPECT screening for silent myocardial ischemia recommended in male HIV-infected patients aged over 52 with at least two other cardiovascular risk factors? In this population, the chance of a positive SMI screening was about four times higher than in the general population, which might encourage more consistent screening practices.",3.316036182995957e-07,0.15439318337712482,0.060353798126951096,0.025387970506946217,0.1999064260599308,0.03073822121441168,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
230,0.5,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should clinicians screen male HIV-infected patients older than 52 years who have at least two additional cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? This group had an approximately fourfold higher positivity rate compared to the general population, possibly motivating more systematic screening.",4.737194547137081e-07,0.27699550546945817,0.060353798126951096,0.03626852929563745,0.32506956901393647,0.03073822121441168,0.03621603081905733,0.353032600048913,0.015621063240110858,4.737194547137081e-07,0.38193461069797285,0.0
230,0.5,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Is it beneficial to perform gated myocardial perfusion SPECT screening for silent myocardial ischemia in male HIV-infected patients above 52 years with two or more cardiovascular risk factors? The screening was about four times more likely to be positive than in the general population, which could lead physicians to recommend more regular SMI screening.",3.079176455639103e-07,0.13534498840643172,0.060353798126951096,0.023574544042164344,0.1804883402028281,0.03073822121441168,0.023540420032387266,0.20539660124284964,0.015621063240110858,3.079176455639103e-07,0.23111172096338972,0.0
230,0.5,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","For male HIV-infected patients over 52 with at least two other cardiovascular risk factors, should silent myocardial ischemia screening via gated myocardial perfusion SPECT be implemented? This group showed an approximately fourfold increase in positive results compared to the general population, potentially encouraging more systematic screening.",4.974054274493935e-07,0.2989744121882332,0.060353798126951096,0.038081955760419325,0.3475424248659942,0.03073822121441168,0.0380268323600102,0.37602211827361254,0.015621063240110858,4.974054274493935e-07,0.40546510810816727,0.0
230,0.5,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should silent myocardial ischemia screening with gated myocardial perfusion SPECT be advised for male HIV-infected patients older than 52 years who have two or more cardiovascular risk factors? The likelihood of positive screening was about four times higher than in the general population, which may prompt physicians to suggest more thorough SMI screening.",3.316036182995957e-07,0.15439318337712482,0.060353798126951096,0.025387970506946217,0.1999064260599308,0.03073822121441168,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
231,0.5,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure compared to retropubic radical prostatectomy? Yes, it is usually regarded as less invasive than the retropubic approach.",4.73719454713706e-08,0.2191466042370238,0.18382222222222208,0.003626852929563759,0.17976013684903513,0.17561983471074386,0.003621603081905747,0.07991433399414127,0.11342155009451795,4.737194547137081e-08,0.027929834494255346,0.03993055555555556
231,0.5,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Does robotically assisted laparoscopic radical prostatectomy involve less invasiveness than retropubic radical prostatectomy? Yes, it is typically seen as less invasive.",1.8948778188548245e-07,0.010101353658758416,0.2222222222222221,0.014507411718255037,0.09467670885272472,0.17561983471074386,0.014486412327622988,0.20776773845763907,0.11342155009451795,1.8948778188548304e-07,0.33021070636718886,0.03993055555555556
231,0.5,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is the robotically assisted laparoscopic radical prostatectomy procedure less invasive than retropubic radical prostatectomy? Yes, it is generally considered to be less invasive.",1.421158364141118e-07,0.10541153346308363,0.2222222222222221,0.010880558788691277,0.005406749704256697,0.17561983471074386,0.010864809245717241,0.10240722279981362,0.11342155009451795,1.4211583641411233e-07,0.21898507125696476,0.03993055555555556
231,0.5,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy less invasive than the retropubic method? Yes, it is commonly thought to be less invasive.",1.8948778188548245e-07,0.010101353658758416,0.2222222222222221,0.014507411718255037,0.09467670885272472,0.17561983471074386,0.014486412327622988,0.20776773845763907,0.11342155009451795,1.8948778188548304e-07,0.33021070636718886,0.03993055555555556
231,0.5,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Yes, it is usually considered less invasive.",1.421158364141118e-07,0.10541153346308363,0.2222222222222221,0.010880558788691277,0.005406749704256697,0.17561983471074386,0.010864809245717241,0.10240722279981362,0.11342155009451795,1.4211583641411233e-07,0.21898507125696476,0.03993055555555556
231,0.5,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy a minimally invasive alternative to retropubic radical prostatectomy? Yes, it is generally considered less invasive.",1.8948778188548245e-07,0.010101353658758416,0.2222222222222221,0.014507411718255037,0.09467670885272472,0.17561983471074386,0.014486412327622988,0.20776773845763907,0.11342155009451795,1.8948778188548304e-07,0.33021070636718886,0.03993055555555556
231,0.5,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy less invasive in comparison to retropubic radical prostatectomy? Yes, it is generally regarded as less invasive.",1.658018091497971e-07,0.05889151782818969,0.2222222222222221,0.012693985253473157,0.043383414465174575,0.17561983471074386,0.012675610786670115,0.15370051718736377,0.11342155009451795,1.6580180914979768e-07,0.27305229252724006,0.03993055555555556
231,0.5,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is the robotically assisted laparoscopic radical prostatectomy technique less invasive than retropubic radical prostatectomy? Yes, it is typically considered less invasive.",1.8948778188548245e-07,0.010101353658758416,0.2222222222222221,0.014507411718255037,0.09467670885272472,0.17561983471074386,0.014486412327622988,0.20776773845763907,0.11342155009451795,1.8948778188548304e-07,0.33021070636718886,0.03993055555555556
231,0.5,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy a less invasive option than retropubic radical prostatectomy? Yes, it is commonly regarded as less invasive.",1.658018091497971e-07,0.05889151782818969,0.2222222222222221,0.012693985253473157,0.043383414465174575,0.17561983471074386,0.012675610786670115,0.15370051718736377,0.11342155009451795,1.6580180914979768e-07,0.27305229252724006,0.03993055555555556
231,0.5,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is usually considered to be less invasive.",1.8948778188548245e-07,0.010101353658758416,0.2222222222222221,0.014507411718255037,0.09467670885272472,0.17561983471074386,0.014486412327622988,0.20776773845763907,0.11342155009451795,1.8948778188548304e-07,0.33021070636718886,0.03993055555555556
232,0.5,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
232,0.5,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Can Nd:YAG laser-induced thermo therapy locally open the blood-brain barrier in rodents for paclitaxel delivery: a novel approach to adjuvant glioma treatment? Answer: This research investigates Nd:YAG laser-induced thermo therapy as a method to transiently disrupt the blood-brain barrier in rodents to enhance drug delivery.,0.0,0.09241962407465998,0.06223417666242062,0.0,0.09452007007635421,0.06641709938413236,0.0,0.06447880749394885,0.04613236961451247,0.0,0.03300700859809158,0.023795359904818555
232,0.5,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Is it possible to use Nd:YAG laser-induced thermo therapy to open the rodent blood-brain barrier locally for paclitaxel in glioma therapy? Answer: The study examines the use of Nd:YAG laser-induced thermo therapy to achieve localized blood-brain barrier opening in rodents, improving drug penetration.",4.737194547137081e-08,0.08343322737874903,0.02622309633001059,0.0036268529295637453,0.08252766137826795,0.025654443236860808,0.003621603081905733,0.08301276041885997,0.025409572112868817,4.737194547137081e-08,0.0834475231974281,0.02498356344510192
232,0.5,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Locoregional disruption of the rodent blood-brain barrier by Nd:YAG laser-induced thermo therapy for paclitaxel administration: a new adjuvant glioma treatment concept? Answer: The investigation focuses on Nd:YAG laser-induced thermo therapy as a technique to open the blood-brain barrier locally in rodents, facilitating enhanced drug delivery.",0.0,0.0,1.3877787807814457e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
232,0.5,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Could Nd:YAG laser-induced thermo therapy provide locoregional opening of the rodent blood-brain barrier for paclitaxel in glioma therapy? Answer: This study evaluates the feasibility of using Nd:YAG laser-induced thermo therapy to transiently open the blood-brain barrier in rodents for improved chemotherapy delivery.,7.105791820705622e-08,0.07779474044644408,0.006139993836935864,0.005440279394345618,0.07522830233962896,0.003300728575453847,0.0054324046228586,0.07473861686064831,0.0017409330596143968,7.105791820705622e-08,0.07410797215372344,0.0
232,0.5,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Is locoregional opening of the rodent blood-brain barrier achievable with Nd:YAG laser-induced thermo therapy for paclitaxel treatment in glioma? Answer: The research explores Nd:YAG laser-induced thermo therapy as a novel method to locally disrupt the blood-brain barrier in rodents, enhancing drug access.",7.105791820705622e-08,0.07779474044644408,0.0061399938369358364,0.005440279394345618,0.07522830233962896,0.003300728575453847,0.0054324046228586,0.07473861686064831,0.0017409330596143968,7.105791820705622e-08,0.07410797215372344,0.0
232,0.5,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Using Nd:YAG laser-induced thermo therapy for locoregional opening of the rodent blood-brain barrier to deliver paclitaxel: a new adjuvant glioma therapy approach? Answer: The study investigates the potential of Nd:YAG laser-induced thermo therapy to locally compromise the blood-brain barrier in rodents to improve therapeutic delivery.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
232,0.5,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Nd:YAG laser-induced thermo therapy as a means to locally open the rodent blood-brain barrier for paclitaxel: a novel concept in adjuvant glioma therapy? Answer: This research assesses the capability of Nd:YAG laser-induced thermo therapy to transiently open the blood-brain barrier in rodents, facilitating better drug delivery.",2.3685972735685406e-08,0.005479097535291189,0.019036287923854867,0.0018134264647818726,0.023873153186523055,0.0010031775464828113,0.0018108015409528666,0.02372223194622114,0.0005276493146384141,2.3685972735685406e-08,0.023530497410194418,0.0
232,0.5,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Can locoregional opening of the rodent blood-brain barrier be achieved with Nd:YAG laser-induced thermo therapy for paclitaxel in glioma therapy? Answer: The study evaluates Nd:YAG laser-induced thermo therapy for its potential to locally open the blood-brain barrier in rodents to enhance chemotherapy delivery.,4.737194547137081e-08,0.08343322737874903,0.02622309633001059,0.0036268529295637453,0.08252766137826795,0.025654443236860808,0.003621603081905733,0.08301276041885997,0.025409572112868817,4.737194547137081e-08,0.0834475231974281,0.02498356344510192
232,0.5,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Exploring Nd:YAG laser-induced thermo therapy for locoregional blood-brain barrier opening in rodents to improve paclitaxel delivery: a new concept for adjuvant glioma therapy? Answer: The research investigates the use of Nd:YAG laser-induced thermo therapy to achieve localized blood-brain barrier disruption in rodents, allowing for improved drug penetration.",4.737194547137081e-08,0.04872877855390323,0.003672901956103411,0.0036268529295637453,0.04719147474695973,0.00196304417083637,0.003621603081905733,0.04689523646551175,0.0010318865838346326,4.737194547137081e-08,0.04652001563489394,0.0
233,0.5,1,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients considered a unique clinical entity? Answer: Research is ongoing to ascertain whether colorectal cancer in young patients represents a distinct clinical entity. Some studies indicate differences in tumor characteristics and,7.10579182070559e-08,0.05634536816721303,0.016057525951557072,0.005440279394345618,0.09161903752274592,0.006593590561224494,0.005432404622858607,0.12863669998736116,0.03158757716049383,7.105791820705622e-08,0.12902029702356588,0.0302734375
233,0.5,2,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Does colorectal cancer in young patients constitute a separate clinical entity? Answer: Ongoing studies aim to determine if colorectal cancer in young patients is a distinct clinical entity. Certain research points to variations in tumor features and,4.73719454713706e-08,0.02478334784960934,0.01891278306817784,0.0036268529295637453,0.06014745969624036,0.004277281160398036,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.5,3,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young individuals a distinct clinical condition? Answer: There is active investigation into whether colorectal cancer in young individuals forms a separate clinical entity. Some findings suggest differences in tumor attributes and,9.47438909427412e-08,0.08891717961365497,0.013049591508268857,0.0072537058591274975,0.12410143412991248,0.009041602072670907,0.00724320616381148,0.16096077608021542,0.03334762528744492,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
233,0.5,4,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Can colorectal cancer in young patients be classified as a unique clinical entity? Answer: Research continues to explore if colorectal cancer in young patients is a distinct clinical entity. Some studies reveal differences in tumor characteristics and,4.73719454713706e-08,0.02478334784960934,0.01891278306817784,0.0036268529295637453,0.06014745969624036,0.004277281160398036,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.5,5,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in younger patients a distinct clinical entity? Answer: Studies are ongoing to find out if colorectal cancer in younger patients represents a unique clinical entity. Some evidence shows differences in tumor traits and,7.10579182070559e-08,0.05634536816721303,0.016057525951557072,0.005440279394345618,0.09161903752274592,0.006593590561224494,0.005432404622858607,0.12863669998736116,0.03158757716049383,7.105791820705622e-08,0.12902029702356588,0.0302734375
233,0.5,6,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients a separate clinical entity? Answer: Research efforts are underway to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest variations in tumor characteristics and,7.10579182070559e-08,0.05634536816721303,0.016057525951557072,0.005440279394345618,0.09161903752274592,0.006593590561224494,0.005432404622858607,0.12863669998736116,0.03158757716049383,7.105791820705622e-08,0.12902029702356588,0.0302734375
233,0.5,7,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Does colorectal cancer in young patients represent a distinct clinical entity? Answer: There is ongoing research to clarify if colorectal cancer in young patients is a unique clinical entity. Some studies highlight differences in tumor features and,4.73719454713706e-08,0.02478334784960934,0.01891278306817784,0.0036268529295637453,0.06014745969624036,0.004277281160398036,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.5,8,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients considered a distinct clinical entity? Answer: Investigations are ongoing to see if colorectal cancer in young patients constitutes a separate clinical entity. Some research points to differences in tumor characteristics and,4.73719454713706e-08,0.02478334784960934,0.01891278306817784,0.0036268529295637453,0.06014745969624036,0.004277281160398036,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.5,9,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Current research is focused on determining if colorectal cancer in young patients is a distinct clinical entity. Some studies indicate there are differences in tumor features and,2.36859727356853e-08,0.0058288376710153855,0.021626297577854642,0.0018134264647818726,0.029626200911009093,0.0020824800508438407,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.5,10,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients a distinct clinical entity? Answer: There is ongoing research aimed at establishing whether colorectal cancer in young patients is a unique clinical entity. Some studies suggest differences in tumor characteristics and,4.73719454713706e-08,0.02478334784960934,0.01891278306817784,0.0036268529295637453,0.06014745969624036,0.004277281160398036,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
234,0.5,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Can analyzing APC mutations aid in making treatment decisions for familial adenomatous polyposis? Yes, assessing APC mutations can assist in selecting the best therapeutic strategy for patients with familial adenomatous polyposis by revealing mutation details that inform targeted therapy or surgery choices.",3.552895910352811e-07,0.3051379698617125,0.004747583902498076,0.02720139697172809,0.29324837909817303,0.0181755829903978,0.027162023114293,0.3254224004346309,0.0,3.552895910352811e-07,0.33270575382573453,0.0
234,0.5,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Indeed, analyzing APC mutations provides crucial insights that help tailor treatment plans, including targeted treatments or surgical options, for those with familial adenomatous polyposis.",4.97405427449393e-07,0.4353462702177384,0.02485307359808625,0.03808195576041933,0.4557673085959473,0.0181755829903978,0.03802683236001021,0.4924764850977952,0.0,4.974054274493935e-07,0.5045560107523945,0.0
234,0.5,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Does APC mutation testing influence treatment decisions in familial adenomatous polyposis? Yes, mutation analysis of APC can offer important information on the mutation type, aiding in deciding between targeted therapies or surgical interventions.",5.684633456564489e-07,0.48535001858971416,0.05339978640085441,0.04352223515476497,0.5481406287269626,0.0181755829903978,0.04345923698286883,0.5877866649021204,0.0,5.684633456564497e-07,0.6029960835656478,0.0
234,0.5,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Can APC mutation analysis impact therapeutic strategies in familial adenomatous polyposis? Yes, examining APC mutations can inform the appropriate therapeutic approach by identifying specific mutations that guide treatment decisions such as surgery or targeted therapy.",5.210914001850783e-07,0.4247253967732787,0.05339978640085441,0.03989538222520121,0.48562027174562905,0.0181755829903978,0.039837633900963086,0.5232481437645489,0.0,5.210914001850789e-07,0.5363047090669744,0.0
234,0.5,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Is the analysis of APC mutations beneficial for therapeutic decisions in familial adenomatous polyposis? Yes, it provides valuable mutation-specific information that helps determine the most suitable treatment, including targeted therapies or surgical procedures.",5.684633456564489e-07,0.48535001858971416,0.05339978640085441,0.04352223515476497,0.5481406287269626,0.0181755829903978,0.04345923698286883,0.5877866649021204,0.0,5.684633456564497e-07,0.6029960835656478,0.0
234,0.5,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Does APC mutation analysis contribute to treatment planning in familial adenomatous polyposis? Yes, by revealing the exact mutation, APC analysis can guide clinicians in choosing effective therapies or surgical options.",6.395212638635048e-07,0.5837900914029674,0.05339978640085441,0.04896251454911061,0.649923323036905,0.0181755829903978,0.048891641605727454,0.6931471805599458,0.0,6.39521263863506e-07,0.7121953755306385,0.0
234,0.5,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Can APC mutation testing assist in therapy selection for familial adenomatous polyposis? Yes, it offers critical mutation details that support making informed decisions regarding targeted therapies or surgical interventions.",6.632072365991901e-07,0.6188814112142365,0.05339978640085441,0.05077594101389249,0.6862909672077797,0.0181755829903978,0.05070244314668033,0.7308875085427928,0.0,6.632072365991914e-07,0.751416088683921,0.0
234,0.5,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Is APC mutation analysis a useful tool for therapeutic decision-making in familial adenomatous polyposis? Yes, it helps identify the mutation type, enabling personalized treatment choices such as targeted therapy or surgery.",6.158352911278195e-07,0.5498885397272857,0.05339978640085441,0.04714908808432873,0.614832003225636,0.0181755829903978,0.04708084006477458,0.6567795363890712,0.0,6.158352911278206e-07,0.6744550475477915,0.0
234,0.5,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Can analyzing APC mutations help determine treatment in familial adenomatous polyposis? Yes, APC mutation analysis provides important information that guides the selection of appropriate therapeutic methods, including surgical and targeted treatments.",6.158352911278195e-07,0.5498885397272857,0.05339978640085441,0.04714908808432873,0.614832003225636,0.0181755829903978,0.04708084006477458,0.6567795363890712,0.0,6.158352911278206e-07,0.6744550475477915,0.0
234,0.5,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Does APC mutation analysis play a role in therapeutic decisions for familial adenomatous polyposis? Yes, it can offer mutation-specific insights that assist in choosing the best treatment options, such as targeted therapies or surgery.",5.447773729207636e-07,0.4545783599229605,0.05339978640085441,0.04170880868998309,0.5163919304123827,0.0181755829903978,0.04164843544191596,0.5549968420791287,0.0,5.447773729207643e-07,0.5690945318899661,0.0
235,0.5,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults participating in PICT who have more symptoms might trade off quality of life for experimental therapies.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms influence patient selection for phase I clinical trials? Answer: Older adults enrolled in PICT with a higher symptom burden may compromise quality of life in favor of experimental treatment.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.5,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be considered when enrolling patients in phase I clinical trials? Answer: Older adults in PICT experiencing more symptoms might sacrifice quality of life to undergo experimental treatments.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
235,0.5,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom presence significant when choosing patients for phase I clinical trials? Answer: Older adults with more symptoms enrolled in PICT may accept reduced quality of life for experimental therapy.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms affect eligibility for phase I clinical trials? Answer: Older adults participating in PICT who report more symptoms may give up quality of life in exchange for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms a factor in selecting patients for phase I clinical trials? Answer: Older adults enrolled in PICT with increased symptoms might lose quality of life due to experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does the presence of symptoms matter in phase I clinical trial patient selection? Answer: Older adults with more symptoms in PICT may forfeit quality of life to receive experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptom severity be considered when enrolling patients in phase I clinical trials? Answer: Older adults in PICT showing more symptoms may trade quality of life for access to experimental treatment.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.5,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom burden relevant when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT who have more symptoms might sacrifice quality of life for experimental therapies.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in patient consideration for phase I clinical trials? Answer: Older adults with greater symptomatology in PICT may compromise quality of life to undergo experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
236,0.5,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or",Is a surgeon's prior experience a factor in their ability to perform transurethral resection of the prostate? The senior urologist was able to resect tissue at a rate four times higher than that of less experienced surgeons. This suggests that a surgeon's experience might be crucial in minimizing the risk of secondary TURP caused by recurring adenomas.,2.3685972735685406e-08,0.006736750945891323,0.017851239669421492,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
236,0.5,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon's previous experience affect their proficiency in performing transurethral resection of the prostate? The senior urologist resected tissue four times faster than inexperienced surgeons, indicating that experience may play a key role in lowering the chance of secondary TURP from recurring adenomas.",2.8423167282822487e-07,0.2461330695389088,0.0,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
236,0.5,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the capability to perform transurethral resection of the prostate dependent on the surgeon's experience? The senior urologist could resect four times more tissue per unit time compared to less experienced surgeons, implying that experience is important to reduce the risk of secondary TURP due to adenoma recurrence.",1.8948778188548325e-07,0.15718558352241319,0.0,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
236,0.5,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does prior experience influence a surgeon's ability to carry out transurethral resection of the prostate? The senior urologist resected tissue at a rate four times greater than that of inexperienced surgeons, suggesting that experience might be vital to decrease the likelihood of secondary TURP from recurring adenomas.",2.1317375462116866e-07,0.17869178874337655,0.0,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
236,0.5,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the skill to perform transurethral resection of the prostate affected by the surgeon's previous experience? The senior urologist was able to resect tissue four times faster than less experienced surgeons, highlighting that experience could be important in preventing secondary TURP caused by recurrent adenomas.",2.6054570009253947e-07,0.22314355131420927,0.0,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
236,0.5,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon's experience impact their efficiency in performing transurethral resection of the prostate? The senior urologist resected four times as much tissue per time unit as inexperienced surgeons, indicating that experience may be key to reducing secondary TURP risk from recurring adenomas.",3.079176455639103e-07,0.2696635669491032,0.0,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
236,0.5,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the ability to perform transurethral resection of the prostate influenced by how experienced the surgeon is? The senior urologist resected tissue four times more rapidly than less experienced surgeons, suggesting that experience might be essential to lower the risk of secondary TURP due to adenoma recurrence.",2.1317375462116866e-07,0.17869178874337655,0.0,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
236,0.5,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the proficiency in performing transurethral resection of the prostate related to a surgeon's prior experience? The senior urologist was able to resect four times more tissue per unit time than inexperienced surgeons, implying that experience may help reduce the risk of secondary TURP from recurring adenomas.",2.1317375462116866e-07,0.17869178874337655,0.0,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
236,0.5,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does a surgeon's previous experience affect their ability to perform transurethral resection of the prostate? The senior urologist resected tissue at a rate four times higher than less experienced surgeons, suggesting that experience may be important to minimize secondary TURP caused by recurrent adenomas.",2.8423167282822487e-07,0.2461330695389088,0.0,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
236,0.5,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the efficiency of performing transurethral resection of the prostate dependent on the surgeon's experience? The senior urologist was capable of resecting four times more tissue per time unit than less experienced surgeons, indicating that experience might be critical to reduce the risk of secondary TURP due to recurring adenomas.",1.4211583641411244e-07,0.11551288712184427,0.0,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
237,0.5,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does pretreatment with estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? E2 and antagonist pretreatment does not seem to enhance IVF results in the microdose leuprolide protocol versus standard OCP in poor responders. Randomized trials with sufficient power are needed.,1.4211583641411244e-07,0.07606584423379381,0.029406265907723675,0.010880558788691236,0.06783131708282175,0.03767781622452902,0.0108648092457172,0.09594281514771996,0.01922337562475971,1.4211583641411244e-07,0.12516314295400566,0.0
237,0.5,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Is estradiol and antagonist pretreatment before microdose leuprolide beneficial for IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not appear to improve IVF outcomes in the microdose leuprolide protocol compared to standard OCP in poor responders. Adequately powered randomized trials are required.,7.105791820705622e-08,0.09189127909676609,0.023927067425609683,0.005440279394345618,0.033681800587132216,0.01768614608708629,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
237,0.5,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does estradiol plus antagonist pretreatment prior to microdose leuprolide improve IVF success in poor responders compared to oral contraceptive pills? The E2 and antagonist pretreatment does not seem to offer better IVF outcomes than standard OCP in poor responders using the microdose leuprolide protocol. Randomized controlled trials with sufficient sample size are needed.,4.737194547137081e-08,0.01601776676871758,0.015239599241057,0.0036268529295637453,0.013335528443453981,0.01807781622452903,0.003621603081905733,0.012561206208669073,0.01922337562475971,4.737194547137081e-08,0.04000533461369837,0.0
237,0.5,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Does pretreatment with estradiol and antagonist before microdose leuprolide enhance IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 and antagonist pretreatment does not improve IVF outcomes in the microdose leuprolide protocol when compared to standard OCP in poor responders. Randomized trials with adequate power are necessary.,9.474389094274162e-08,0.11495577547793356,0.02614010691137643,0.0072537058591274906,0.054450342337760915,0.017278510668973467,0.007243206163811466,0.05338320072892344,0.01922337562475971,9.474389094274162e-08,0.0816780310142673,0.0
237,0.5,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Is E2 and antagonist pretreatment prior to microdose leuprolide more effective than oral contraceptive pills in improving IVF outcomes for poor responders? Current evidence suggests no improvement in IVF outcomes with E2 plus antagonist pretreatment compared to standard OCP in poor responders undergoing the microdose leuprolide protocol. Well-powered randomized studies are warranted.,7.105791820705622e-08,0.01034455197206574,0.03303473812994588,0.005440279394345618,0.005955913364734222,0.03767781622452902,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
237,0.5,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does using estradiol and antagonist pretreatment before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? The pretreatment with E2 and antagonist does not appear to enhance IVF results over the standard OCP in poor responders. Randomized trials with sufficient power are needed to confirm.,1.4211583641411244e-07,0.04718471171046268,0.05004058642862262,0.010880558788691236,0.06783131708282175,0.03767781622452902,0.0108648092457172,0.09594281514771996,0.01922337562475971,1.4211583641411244e-07,0.12516314295400566,0.0
237,0.5,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Does pretreatment with estradiol and antagonist prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not seem to improve IVF outcomes in the microdose leuprolide protocol relative to standard OCP in poor responders. Randomized controlled trials with adequate power are necessary.,2.3685972735685406e-08,0.02111403091767361,0.0016874840922763285,0.0018134264647818726,0.020054214100678536,0.0007221837754709873,0.0018108015409528666,0.019940821287388832,0.0003766243752402823,2.3685972735685406e-08,0.019802627296179764,0.0
237,0.5,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Is pretreatment with estradiol and antagonist before microdose leuprolide protocol superior to oral contraceptive pills in improving IVF outcomes in poor responders? Evidence suggests that E2 and antagonist pretreatment does not improve IVF outcomes compared to standard OCP in poor responders. Randomized trials with adequate power are needed.,1.6580180914979784e-07,0.09896272997566946,0.02809543027870623,0.012693985253473108,0.08933752230378511,0.03767781622452902,0.012675610786670066,0.11792172186649497,0.01922337562475971,1.6580180914979784e-07,0.14763599880606337,0.0
237,0.5,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does estradiol and antagonist pretreatment prior to microdose leuprolide enhance IVF outcomes in poor responders compared to oral contraceptive pills? The current data indicate no improvement in IVF success with E2 and antagonist pretreatment over standard OCP in poor responders. Adequately powered randomized trials are required.,2.1317375462116866e-07,0.14638059187603147,0.025301957517700993,0.016320838183036854,0.16529597490007042,0.014962835153679913,0.0162972138685758,0.1633840959432522,0.01922337562475971,2.1317375462116866e-07,0.19415601444095731,0.0
237,0.5,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Does pretreatment with estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders as compared to oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not appear to improve IVF outcomes in the microdose leuprolide protocol relative to standard OCP in poor responders. Randomized trials with sufficient power are necessary.,2.3685972735685406e-08,0.07342702567691539,0.03738852510256828,0.0018134264647818726,0.020054214100678536,0.0007221837754709873,0.0018108015409528666,0.019940821287388832,0.0003766243752402823,2.3685972735685406e-08,0.019802627296179764,0.0
238,0.5,1,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Does minimal access major surgery in newborns cause less pain? Minimal access major surgery in newborns results in less pain than traditional open surgery due to smaller incisions and techniques used.,4.73719454713706e-08,0.1223007861842329,0.03755102040816327,0.003626852929563759,0.12374687100750004,0.03873673469387749,0.003621603081905747,0.12510478610370823,0.03927346938775517,4.737194547137081e-08,0.1263441813444901,0.03916122448979589
238,0.5,2,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Is pain reduced with minimal access major surgery in newborns? Newborns undergoing minimal access major surgery experience less pain compared to those having conventional open surgery because of smaller incisions.,7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.06664620128616727,0.024657348146359143,0.005432404622858621,0.06428512718019963,0.029344282091534828,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.5,3,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Does minimal access surgery in newborns lead to less pain? Compared to traditional open surgery, minimal access major surgery in newborns is linked to reduced pain due to smaller incisions.",7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.01713568838902768,0.059997970381568295,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.5,4,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Is there less pain with minimal access major surgery in newborns? Minimal access surgery in newborns causes less pain than open surgery because it involves smaller incisions and advanced methods.,7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.032374824508111466,0.09566326530612247,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.5,5,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Does minimal access major surgery cause less pain in newborns? Newborns have less pain after minimal access major surgery compared to open surgery, owing to smaller incisions.",1.421158364141118e-07,0.24762862519516204,0.026311350986675613,0.010880558788691277,0.19185740968848464,0.01626818023995988,0.010864809245717241,0.1884861922862111,0.024738628910921615,1.4211583641411244e-07,0.18399836022560345,0.03443877551020409
238,0.5,6,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Is pain less intense with minimal access major surgery in newborns? Minimal access surgery results in less pain for newborns than open surgery, thanks to smaller incisions.",1.421158364141118e-07,0.0876715835274835,0.08404897959183671,0.010880558788691277,0.08095386079889266,0.09566326530612247,0.010864809245717241,0.13072392723955062,0.06632653061224487,1.4211583641411244e-07,0.18399836022560345,0.03443877551020409
238,0.5,7,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Do newborns feel less pain after minimal access major surgery? Minimal access major surgery in newborns is associated with less pain than traditional open surgery due to smaller incisions.,9.47438909427412e-08,0.1087761361759525,0.016848979591836705,0.007253705859127518,0.055337055259796486,0.058681016785412425,0.007243206163811494,0.05068121956601335,0.06632653061224487,9.474389094274162e-08,0.10061675128655301,0.03443877551020409
238,0.5,8,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Is minimal access major surgery less painful for newborns? Newborns undergoing minimal access major surgery experience reduced pain compared to open surgery because of smaller incisions.,1.658018091497971e-07,0.23992860612592715,0.004680384550514463,0.012693985253473157,0.23730038541247023,0.01301863720694893,0.012675610786670115,0.23355720953312442,0.022938100860178744,1.6580180914979784e-07,0.2284501227964375,0.03443877551020409
238,0.5,9,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Does minimal access major surgery reduce pain in newborns? Pain is less severe in newborns after minimal access major surgery than after traditional open surgery, due to smaller incisions.",9.47438909427412e-08,0.10877613617595161,0.01684897959183669,0.007253705859127518,0.10668129085682976,0.022063265306122487,0.007243206163811494,0.10400023345524012,0.027926530612244864,9.474389094274162e-08,0.10061675128655301,0.03443877551020409
238,0.5,10,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Is pain minimized in newborns with minimal access major surgery? Minimal access major surgery in newborns leads to less pain than open surgery, largely because of the smaller incisions used.",7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.01713568838902768,0.059997970381568295,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
239,0.5,1,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Is there a link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in patients with hypertension? Answer: Research indicates that specific polymorphisms in the ACE-1 gene could raise the likelihood of chronic kidney disease among hypertensive individuals.,2.36859727356853e-08,0.027846328995862812,0.0013369225080936895,0.0018134264647818726,0.027654231691776943,0.000709606002398791,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
239,0.5,2,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Can polymorphisms in the ACE-1 gene cause chronic kidney disease in hypertensive patients? Answer: Evidence suggests that particular ACE-1 gene polymorphisms may contribute to an increased risk of chronic kidney disease in those with hypertension.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.12863669998736116,0.03158757716049383,0.005432404622858614,0.12902029702356588,0.0302734375,7.105791820705622e-08,0.08961215868968697,0.0
239,0.5,3,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Does the ACE-1 gene polymorphism influence the development of chronic kidney disease in hypertensive patients? Answer: There is data supporting that certain ACE-1 gene polymorphisms are associated with a higher risk of chronic kidney disease in hypertensive patients.,0.0,0.14592572222314715,0.09987461419753085,0.0,0.11240224549620859,0.07951357004387306,0.0,0.11552453009332453,0.08264462809917354,0.0,0.07921682063542201,0.056932966023875105
239,0.5,4,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Is chronic kidney disease among hypertensive patients related to angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? Answer: Studies show that some polymorphisms in the ACE-1 gene might elevate the risk of chronic kidney disease in hypertensive individuals.,7.10579182070559e-08,0.08849205776082192,0.004463830221405965,0.005440279394345625,0.08786333642501098,0.0023785838179777724,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
239,0.5,5,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Does having polymorphisms in the ACE-1 gene increase chronic kidney disease risk in hypertensive patients? Answer: Evidence points to the fact that specific ACE-1 gene polymorphisms may increase susceptibility to chronic kidney disease in patients with hypertension.,2.36859727356853e-08,0.06610763146679632,0.027980691187150207,0.0018134264647818726,0.028439735720487747,0.0007489292013101653,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
239,0.5,6,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Are ACE-1 gene polymorphisms a factor in chronic kidney disease development in hypertensive patients? Answer: Research supports that certain polymorphisms in the ACE-1 gene can heighten the risk of chronic kidney disease among hypertensive patients.,7.10579182070559e-08,0.1281004680785336,0.03249180169753086,0.005440279394345625,0.08786333642501098,0.0023785838179777724,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
239,0.5,7,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Could polymorphisms in the ACE-1 gene lead to chronic kidney disease in those with hypertension? Answer: There is evidence indicating that some ACE-1 gene polymorphisms may predispose hypertensive patients to chronic kidney disease.,1.184298636784265e-07,0.19414249725014132,0.0375308641975309,0.009067132323909384,0.1510362934640943,0.004211308950296141,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
239,0.5,8,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Does the presence of ACE-1 gene polymorphisms contribute to chronic kidney disease in hypertensive patients? Answer: Data suggests that particular ACE-1 gene polymorphisms are linked to an increased risk of chronic kidney disease in hypertensive individuals.,4.73719454713706e-08,0.21215342034535123,0.10753086419753088,0.0036268529295637453,0.17653607726025422,0.08537676160378205,0.00362160308190574,0.13870514096464825,0.05859375,4.737194547137081e-08,0.10084942005686903,0.0302734375
239,0.5,9,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Is the ACE-1 gene polymorphism associated with chronic kidney disease in patients suffering from hypertension? Answer: Studies indicate that certain polymorphisms in the ACE-1 gene might increase the risk of chronic kidney disease in hypertensive patients.,4.73719454713706e-08,0.17364524364757639,0.0828066186200074,0.0036268529295637453,0.13692766694254344,0.05795476466049383,0.00362160308190574,0.09793177740229808,0.029384756657483937,4.737194547137081e-08,0.058840500022933284,0.0
239,0.5,10,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Does polymorphism in the angiotensin-converting enzyme-1 gene cause chronic kidney disease among hypertensive patients? Answer: Evidence suggests that specific ACE-1 gene polymorphisms may raise the risk of developing chronic kidney disease in those with hypertension.,7.10579182070559e-08,0.08849205776082192,0.004463830221405965,0.005440279394345625,0.08786333642501098,0.0023785838179777724,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
240,0.5,1,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does receiving birth center care during a woman's initial pregnancy affect her subsequent reproductive outcomes? The influence of birth center care in a woman's first pregnancy on her later reproductive health remains insufficiently documented. More studies are required to clarify any potential effects.,9.474389094274162e-08,0.08123870143649503,0.11307005069998831,0.0072537058591274906,0.08874330885323722,0.12590200831024928,0.007243206163811466,0.06222327032293373,0.11176857330703485,9.474389094274162e-08,0.03131914542397851,0.09204470742932283
240,0.5,2,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Is there an effect of birth center care during a woman's first pregnancy on her future reproductive health? The impact of birth center care during a woman's initial pregnancy on her future reproduction is not well established. Additional research is necessary to understand any possible influence.,2.3685972735685406e-08,0.028006273506252732,0.0034240321402483898,0.0018134264647818726,0.027373896522682628,0.003119631572877063,0.0018108015409528666,0.026653086832310713,0.0024973546708044053,2.3685972735685406e-08,0.006406091783423218,0.02103879026955953
240,0.5,3,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Can birth center care during a woman's first pregnancy influence her future reproductive outcomes? The effects of birth center care during the first pregnancy on later reproduction have not been thoroughly studied. Further investigation is needed to assess any impact.,1.6580180914979774e-07,0.036032281960885815,0.08285147806383321,0.012693985253473108,0.02639340164796744,0.09780787250778014,0.012675610786670066,0.05320568631217926,0.08476240046752868,1.6580180914979784e-07,0.04872356224955565,0.09204470742932283
240,0.5,4,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does care at a birth center during a woman’s first pregnancy have consequences for her future reproduction? The relationship between birth center care in a first pregnancy and subsequent reproductive outcomes is currently unclear. More research is essential to determine any effects.,1.1842986367842703e-07,0.08853806047513402,0.13542376536139528,0.009067132323909363,0.09786275385115539,0.1502770083102493,0.009054007704764333,0.036905462338642,0.11176857330703485,1.1842986367842703e-07,0.005343659020720537,0.09204470742932283
240,0.5,5,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,What is the effect of birth center care during a woman’s first pregnancy on her later reproductive health? There is limited documentation on how birth center care during a first pregnancy impacts future reproduction. Additional studies are required to explore this potential connection.,9.474389094274162e-08,0.015224684240310093,0.06720233747260773,0.0072537058591274906,0.02111919367665749,0.07756232686980606,0.007243206163811466,0.007091447733060363,0.06190707746215952,9.474389094274162e-08,0.004226863835505412,0.06642143873126188
240,0.5,6,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does receiving birth center care during the first pregnancy affect a woman’s future reproductive health? The impact of birth center care on future reproduction following a first pregnancy is not well documented. Further research is needed to identify any effects.,1.6580180914979774e-07,0.00048627270140189083,0.10768707897086272,0.012693985253473108,0.010088028907819346,0.12398044147314191,0.012675610786670066,0.01573827114677684,0.11176857330703485,1.6580180914979784e-07,0.04872356224955565,0.09204470742932283
240,0.5,7,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Is birth center care during a woman’s first pregnancy linked to changes in her future reproductive outcomes? The influence of such care during the initial pregnancy on later reproduction is not well understood. More research is required to determine any associations.,1.4211583641411244e-07,0.09681220403334567,0.1590924044146497,0.010880558788691236,0.07254494586686366,0.1502770083102493,0.0108648092457172,0.010929975935384029,0.11176857330703485,1.4211583641411244e-07,0.02132458806144033,0.09204470742932283
240,0.5,8,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does care at a birth center during a woman’s first pregnancy have any bearing on her future reproductive health? The effects of birth center care in a first pregnancy on subsequent reproduction are not well documented. Further study is necessary to clarify potential impacts.,7.105791820705622e-08,0.13931141714701978,0.1376750160453554,0.005440279394345618,0.1466529180205871,0.1502770083102493,0.0054324046228586,0.08691588291330543,0.11176857330703485,7.105791820705622e-08,0.05663695340827024,0.09204470742932283
240,0.5,9,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Can birth center care during a woman’s first pregnancy affect her subsequent reproductive outcomes? The impact of birth center care during the initial pregnancy on future reproduction has yet to be clearly established. Additional research is needed to ascertain any effects.,1.4211583641411244e-07,0.027497485977351133,0.10956902848794738,0.010880558788691236,0.001452927347895372,0.09914479501587384,0.0108648092457172,0.025551454620402314,0.08547200646992748,1.4211583641411244e-07,0.02132458806144033,0.09204470742932283
240,0.5,10,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,"Is there any impact of birth center care during a woman’s first pregnancy on her later reproductive health? The influence of birth center care during the first pregnancy on future reproduction is not well documented, and further research is necessary to explore this question.",7.105791820705622e-08,0.010353802159123404,0.048210372534696816,0.005440279394345618,0.014624883628215901,0.056094182825484784,0.0054324046228586,0.019291767736725696,0.06311637080867852,7.105791820705622e-08,0.02197959438027386,0.06706114398422092
241,0.5,1,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is there a link between the CYP2D6*4 allele and breast cancer risk? Currently, no evidence supports a direct connection between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.23790035997346903,0.0756,0.005440279394345639,0.24205601883956573,0.08189999999999996,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.5,2,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Does the CYP2D6*4 allele increase breast cancer risk? At present, there is no proof indicating a direct association between the CYP2D6*4 allele and breast cancer risk.",9.47438909427412e-08,0.12356231312578059,0.016631404958677695,0.007253705859127518,0.06338140618250288,0.06401209829867678,0.007243206163811494,0.05765417888111335,0.07359999999999998,9.474389094274162e-08,0.11373507077394018,0.03840000000000001
241,0.5,3,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is the CYP2D6*4 allele associated with breast cancer risk? Presently, no evidence suggests a direct relationship between the CYP2D6*4 allele and breast cancer risk.",1.421158364141118e-07,0.2214096023547767,0.006899999999999962,0.010880558788691277,0.15564389817637636,0.06024852607709753,0.010864809245717241,0.14862595708684134,0.07359999999999998,1.4211583641411238e-07,0.2090452505782654,0.03840000000000001
241,0.5,4,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is there any correlation between the CYP2D6*4 allele and breast cancer risk? Currently, no data supports a direct link between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.23790035997346903,0.0756,0.005440279394345639,0.24205601883956573,0.08189999999999996,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.5,5,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is the CYP2D6*4 allele connected to breast cancer risk? To date, there is no evidence indicating a direct association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.07794331830578871,0.02097844990548202,0.005440279394345639,0.020248921060382674,0.06566944444444447,0.005432404622858621,0.015094564462317717,0.07359999999999998,7.105791820705622e-08,0.06928330820310613,0.03840000000000001
241,0.5,6,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Does carrying the CYP2D6*4 allele affect breast cancer risk? Currently, no evidence points to a direct association between the CYP2D6*4 allele and breast cancer risk.",1.184298636784265e-07,0.17131577945163246,0.01195102040816326,0.009067132323909398,0.10845242342941619,0.06221157024793391,0.009054007704764368,0.1021059414519474,0.07359999999999998,1.1842986367842703e-07,0.16025508640883412,0.03840000000000001
241,0.5,7,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is breast cancer risk influenced by the CYP2D6*4 allele? At this time, no evidence suggests a direct connection between the CYP2D6*4 allele and breast cancer risk.",9.47438909427412e-08,0.0681105386809846,0.05500491493383737,0.007253705859127518,0.005619141135842387,0.10560000000000004,0.007243206163811494,0.05765417888111335,0.07359999999999998,9.474389094274162e-08,0.11373507077394018,0.03840000000000001
241,0.5,8,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is there an association between the CYP2D6*4 allele and breast cancer risk? As of now, no evidence supports a direct link between the CYP2D6*4 allele and breast cancer risk.",2.36859727356853e-08,0.14094138186722205,0.06394710743801663,0.0018134264647818796,0.1445572834646227,0.07001983471074381,0.0018108015409528735,0.14832791234568576,0.07516033057851236,2.3685972735685406e-08,0.15225702259844365,0.07936859504132227
241,0.5,9,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is the CYP2D6*4 allele a risk factor for breast cancer? Currently, no evidence shows a direct association between the CYP2D6*4 allele and breast cancer risk.",1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.10845242342941619,0.06221157024793391,0.009054007704764368,0.1021059414519474,0.07359999999999998,1.1842986367842703e-07,0.16025508640883412,0.03840000000000001
241,0.5,10,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is there any evidence linking the CYP2D6*4 allele to breast cancer risk? At present, no direct association has been found between the CYP2D6*4 allele and breast cancer risk.",4.73719454713706e-08,0.03427865544636299,0.025024999999999964,0.003626852929563759,0.02110455264846811,0.06720000000000004,0.003621603081905747,0.025727430057937095,0.07359999999999998,4.737194547137081e-08,0.026723693784310498,0.03840000000000001
242,0.5,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is linked to carotid atherosclerosis in healthy Koreans.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
242,0.5,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Does high-sensitivity C-reactive protein relate to carotid atherosclerosis in healthy Koreans? Answer: Yes, it does relate to carotid atherosclerosis in healthy Koreans.",4.73719454713706e-08,0.0022575780824838354,0.03460207612456748,0.003626852929563759,0.05365950761657867,0.020686488102866385,0.003621603081905747,0.11421419381959597,0.012364730803515828,4.7371945471370706e-08,0.1139811463877578,0.009623402888937857
242,0.5,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, an association exists between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans.",1.184298636784265e-07,0.1633485704796791,0.005285467128027632,0.009067132323909398,0.1515050433399714,0.02160493827160484,0.009054007704764368,0.08576913921652807,0.07111764373339369,1.1842986367842703e-07,0.07900706524429868,0.08722307020684539
242,0.5,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Can high-sensitivity C-reactive protein be associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, it can be associated with carotid atherosclerosis in healthy Koreans.",0.0,0.057762265046662264,0.019992310649750128,0.0,0.0,0.0,0.0,0.06301338005090384,0.03987551725317193,0.0,0.06601401719618494,0.04470606340412431
242,0.5,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Does high-sensitivity C-reactive protein show an association with carotid atherosclerosis in healthy Koreans? Answer: Yes, it shows an association with carotid atherosclerosis in healthy Koreans.",2.36859727356853e-08,0.11244720317811563,0.02614805087751254,0.0018134264647818796,0.05511662855937516,0.0067114667761019875,0.0018108015409528735,0.007602768775565316,0.03324099722991694,2.3685972735685406e-08,0.010492090125448161,0.03878116343490301
242,0.5,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein connected with carotid atherosclerosis in healthy Koreans? Answer: Yes, it is connected with carotid atherosclerosis in healthy Koreans.",4.73719454713706e-08,0.0022575780824838354,0.03460207612456748,0.003626852929563759,0.05365950761657867,0.020686488102866385,0.003621603081905747,0.11421419381959597,0.012364730803515828,4.7371945471370706e-08,0.1139811463877578,0.009623402888937857
242,0.5,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is there a correlation between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, there is a correlation between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans.",1.421158364141118e-07,0.16538128626754656,0.007785467128027662,0.010880558788691277,0.10294066894572973,0.04688271604938271,0.010864809245717241,0.0341180937924892,0.10703601108033248,1.4211583641411244e-07,0.023932813494046634,0.13331717451523553
242,0.5,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein related to carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is related to carotid atherosclerosis in healthy Koreans.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
242,0.5,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Does high-sensitivity C-reactive protein have an association with carotid atherosclerosis in healthy Koreans? Answer: Yes, it has an association with carotid atherosclerosis in healthy Koreans.",2.36859727356853e-08,0.11244720317811563,0.02614805087751254,0.0018134264647818796,0.05511662855937516,0.0067114667761019875,0.0018108015409528735,0.007602768775565316,0.03324099722991694,2.3685972735685406e-08,0.010492090125448161,0.03878116343490301
242,0.5,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein a factor in carotid atherosclerosis among healthy Koreans? Answer: Yes, it is a factor in carotid atherosclerosis among healthy Koreans.",0.0,0.057762265046662264,0.019992310649750128,0.0,0.0,0.0,0.0,0.06301338005090384,0.03987551725317193,0.0,0.06601401719618494,0.04470606340412431
243,0.5,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Is fragility of the esophageal mucosa a definitive endoscopic marker of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis features a delicate esophageal lining that easily tears with slight trauma during routine diagnostic endoscopy. This 'crêpe-paper' appearance can help endoscopists identify the disease even when other signs are absent.,4.737194547137081e-08,0.014251352598789513,0.019106653337357282,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
243,0.5,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other","Question: Can fragile esophageal mucosa be considered a pathognomonic endoscopic indicator of primary eosinophilic esophagitis? Answer: In primary eosinophilic esophagitis, the esophageal mucosa is notably fragile and tears easily with minor trauma during standard diagnostic endoscopy. This 'crêpe-paper' sign may serve as a warning to endoscopists about the disease's presence when other symptoms are not evident.",1.1842986367842703e-07,0.10035125020839786,0.003618700802974578,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
243,0.5,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Does the fragility of the esophageal mucosa serve as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is marked by an esophageal mucosa that is fragile and prone to tearing from slight trauma during otherwise normal diagnostic endoscopy. This characteristic 'crêpe-paper' sign can alert endoscopists to the disease even if other signs are missing.,1.8948778188548325e-07,0.156068525731349,0.005491780045351474,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
243,0.5,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Is the fragile nature of the esophageal mucosa a definitive endoscopic sign of primary eosinophilic esophagitis? Answer: The hallmark of primary eosinophilic esophagitis is a fragile esophageal mucosa that tears easily with minimal trauma during routine diagnostic endoscopy. This 'crêpe-paper' sign may help endoscopists detect the disease when other indicators are absent.,4.737194547137081e-08,0.014693966764237842,0.0175454960895923,0.0036268529295637453,0.01282309223879885,0.019599999999999992,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
243,0.5,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Could the fragility of the esophageal mucosa be a pathognomonic endoscopic feature of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by a delicate esophageal lining that readily tears upon minor trauma during otherwise unremarkable diagnostic endoscopy. This 'crêpe-paper' sign might alert endoscopists to the disease's presence when other signs are not apparent.,9.474389094274162e-08,0.10674069778240858,0.021418629603259385,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
243,0.5,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other","Question: Is fragile esophageal mucosa a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: In primary eosinophilic esophagitis, the esophageal mucosa is fragile and tears easily with slight trauma during standard diagnostic endoscopy. This 'crêpe-paper' appearance can alert endoscopists to the disease even if other signs are lacking.",7.105791820705622e-08,0.09491050338732743,0.023602502295684086,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
243,0.5,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Does fragile esophageal mucosa represent a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The disease primary eosinophilic esophagitis is characterized by an esophageal mucosa that is fragile and tears readily upon minor trauma during otherwise normal diagnostic endoscopy. This 'crêpe-paper' sign may indicate the disease to endoscopists when other signs are not present.,9.474389094274162e-08,0.055396462185375306,0.015432766243752394,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
243,0.5,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Is esophageal mucosal fragility an endoscopic hallmark of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis presents with a fragile esophageal mucosa that easily tears with minor trauma during routine diagnostic endoscopy. This 'crêpe-paper' sign can help endoscopists recognize the disease even in the absence of other findings.,7.105791820705622e-08,0.03591925397797047,0.018664014912833465,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
243,0.5,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Can the fragility of the esophageal mucosa be considered a specific endoscopic sign of primary eosinophilic esophagitis? Answer: The condition primary eosinophilic esophagitis is marked by a fragile esophageal mucosa that tears easily with minimal trauma during diagnostic endoscopy. This 'crêpe-paper' sign may alert endoscopists to the disease when other signs are not obvious.,9.474389094274162e-08,0.08106857998389172,0.0029483070348455126,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
243,0.5,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Is the delicate nature of the esophageal mucosa a pathognomonic sign in endoscopy for primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is identified by fragile esophageal mucosa that tears readily during minor trauma in otherwise uneventful diagnostic endoscopy. This 'crêpe-paper' sign may serve as an alert to endoscopists about the disease's presence when other signs are missing.,1.6580180914979784e-07,0.13783812944348428,0.004889233241505968,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
244,0.5,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: The effect of earlier patient discharge from Winnipeg hospitals on care quality is a complicated matter needing more research. Although it might boost patient satisfaction and lower healthcare expenses, there are risks like insufficient follow-up and readmission.",1.4211583641411244e-07,0.04398535134073489,0.04775793000450997,0.010880558788691236,0.06678880318369318,0.03340811626341167,0.0108648092457172,0.06510218308112092,0.03631185475258099,1.4211583641411244e-07,0.0921109178578674,0.01851192595229618
244,0.5,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission",Question: Is the quality of care compromised by discharging patients earlier from Winnipeg hospitals? Answer: Understanding the impact of early discharge from Winnipeg hospitals on care quality is complex and calls for further study. It could improve patient satisfaction and reduce costs but also carries risks such as poor follow-up care and hospital readmissions.,9.474389094274162e-08,0.022688916857239505,0.06804733727810654,0.0072537058591274906,0.0001577971919872745,0.0533997864008544,0.007243206163811466,0.02509684846742255,0.03631185475258099,9.474389094274162e-08,0.051288923337613035,0.01851192595229618
244,0.5,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does earlier discharge from Winnipeg hospitals harm quality of care? Answer: The influence of early discharge on care quality in Winnipeg hospitals is multifaceted and requires additional research. It may enhance patient satisfaction and cut healthcare costs, yet risks like inadequate follow-up and readmission remain.",2.8423167282822487e-07,0.14559055090316075,0.06469754022201578,0.02176111757738247,0.1668962874711788,0.0533997864008544,0.0217296184914344,0.19572236549818545,0.03631185475258099,2.8423167282822487e-07,0.22564231048239058,0.01851192595229618
244,0.5,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: How does discharging patients earlier from Winnipeg hospitals affect quality of care? Answer: The relationship between early discharge from Winnipeg hospitals and care quality is complex and warrants further examination. While it might increase patient satisfaction and reduce costs, potential dangers include insufficient follow-up and readmission.",2.6054570009253947e-07,0.15307877070094378,0.04351985427160254,0.0199476911126006,0.17522997297734078,0.03118904259920151,0.019918816950481533,0.17273284727348592,0.03631185475258099,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
244,0.5,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does early patient discharge from Winnipeg hospitals adversely impact care quality? Answer: The consequences of earlier discharge on care quality at Winnipeg hospitals are intricate and need more investigation. Benefits might include higher patient satisfaction and lower healthcare costs, but risks such as inadequate follow-up and readmission exist.",2.1317375462116866e-07,0.07912662093070022,0.06608438180547038,0.016320838183036854,0.10093831967938272,0.0533997864008544,0.0162972138685758,0.1282810847026532,0.03631185475258099,2.1317375462116866e-07,0.15664943899543893,0.01851192595229618
244,0.5,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: What are the effects of discharging patients earlier from Winnipeg hospitals on care quality? Answer: The effects of early discharge from Winnipeg hospitals on quality of care are complex and require more study. It may lead to better patient satisfaction and cost savings, but also risks like poor follow-up care and readmission.",1.1842986367842703e-07,0.10350031545689875,0.008157356537671329,0.009067132323909363,0.10080701578981488,0.005193963599145597,0.009054007704764333,0.07262536298600031,0.016320184615138254,1.1842986367842703e-07,0.07149163065513164,0.01851192595229618
244,0.5,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission",Question: Is patient care quality affected by earlier discharge from Winnipeg hospitals? Answer: The impact of earlier discharge from Winnipeg hospitals on care quality is a complicated issue needing further research. It could improve patient satisfaction and reduce healthcare expenses but involves risks such as insufficient follow-up and readmissions.,2.1317375462116866e-07,0.16577001850069362,0.0042636559244951105,0.016320838183036854,0.15992956908873968,0.010930650598385272,0.0162972138685758,0.15841791864004184,0.01458345969085259,2.1317375462116866e-07,0.15664943899543893,0.01851192595229618
244,0.5,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does releasing patients sooner from Winnipeg hospitals reduce care quality? Answer: The effect of sooner patient release from Winnipeg hospitals on quality of care is a complex topic that needs more study. While it may increase patient satisfaction and lower costs, there are risks like inadequate follow-up and readmission.",1.8948778188548325e-07,0.0862096445156495,0.04616586664023723,0.014507411718254981,0.10876604300488024,0.03257588418265612,0.014486412327622933,0.10677487948168984,0.03631185475258099,1.8948778188548325e-07,0.13467053227666392,0.01851192595229618
244,0.5,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission",Question: Are there negative effects on care quality when patients are discharged earlier from Winnipeg hospitals? Answer: The impact of earlier discharge from Winnipeg hospitals on care quality is multifaceted and requires further investigation. It might result in higher patient satisfaction and reduced costs but also poses risks such as poor follow-up and readmissions.,9.474389094274162e-08,0.02962407790200139,0.030508284023668654,0.0072537058591274906,0.026501709752626113,0.03417641077609469,0.007243206163811466,0.02509684846742255,0.03631185475258099,9.474389094274162e-08,0.051288923337613035,0.01851192595229618
244,0.5,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: How does earlier discharge from Winnipeg hospitals influence the quality of patient care? Answer: The influence of early discharge from Winnipeg hospitals on patient care quality is complex and needs additional research. It may enhance patient satisfaction and decrease healthcare costs, yet risks like insufficient follow-up care and readmission remain.",1.6580180914979784e-07,0.09260115555430826,0.027152738527969233,0.012693985253473108,0.11584906658982952,0.012657369017422967,0.012675610786670066,0.11460260280718737,0.015487952534382704,1.6580180914979784e-07,0.11316432705570056,0.01851192595229618
245,0.5,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a link between androgens and sexual desire in women? The current study found that FT and androstenedione had a statistically significant correlation with sexual desire across the entire group of women. ADT-G did not show a stronger correlation with sexual desire than circulating androgens, indicating it is not a better measure than mass spectrometry of circulating androgens.",4.737194547137081e-08,0.08833854797210483,0.039975857338820364,0.0036268529295637453,0.03748687923508642,0.0012705324385313965,0.003621603081905733,0.01161238772230444,0.017851239669421492,4.737194547137081e-08,0.037041271680350096,0.0
245,0.5,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does a relationship exist between androgens and sexual desire in women? This study revealed that FT and androstenedione were significantly correlated with sexual desire in the total female cohort. ADT-G was not more strongly correlated than circulating androgens, so it is not superior to measuring circulating androgens via mass spectrometry.",1.6580180914979784e-07,0.0322395803911828,0.1048575826165686,0.012693985253473108,0.11460260280718737,0.015487952534382711,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.5,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is sexual desire in women correlated with androgens? The present research demonstrated that FT and androstenedione had statistically significant correlations with sexual desire in the overall group of women. ADT-G did not correlate more strongly than circulating androgens, thus it is not a better indicator than mass spectrometry measurement of circulating androgens.",1.1842986367842703e-07,0.009984712783731808,0.10644964598084133,0.009067132323909363,0.07262536298600031,0.01632018461513826,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.5,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgens linked to sexual desire in women? According to this study, FT and androstenedione showed statistically significant correlations with sexual desire among all women studied. ADT-G did not have a stronger correlation than circulating androgens, so it is not superior to measuring circulating androgens by mass spectrometry.",2.1317375462116866e-07,0.046824458185414475,0.12433345935727794,0.016320838183036854,0.1282810847026532,0.036311854752580995,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
245,0.5,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there an association between androgens and women's sexual desire? The study found FT and androstenedione to be significantly correlated with sexual desire in the entire female cohort. ADT-G did not correlate more strongly than circulating androgens and thus is not a better measure than mass spectrometry of circulating androgens.,1.6580180914979784e-07,0.003947858735675158,0.12520069444444448,0.012693985253473108,0.08572147028385668,0.036311854752580995,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.5,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Do androgens correlate with sexual desire in women? This study identified a statistically significant correlation between FT and androstenedione and sexual desire in the total cohort of women. ADT-G did not show a stronger correlation than circulating androgens, indicating it is not superior to mass spectrometry measurement of circulating androgens.",1.6580180914979784e-07,0.0322395803911828,0.1048575826165686,0.012693985253473108,0.11460260280718737,0.015487952534382711,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.5,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a connection between androgens and sexual desire in women? The current study demonstrated that FT and androstenedione were statistically significantly correlated with sexual desire in the full cohort of women. ADT-G did not correlate more strongly than circulating androgens, so it is not a better measure than mass spectrometry of circulating androgens.",7.105791820705622e-08,0.05050248360208576,0.10792218377547103,0.005440279394345618,0.03233826955493324,0.017088479127821285,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
245,0.5,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgens associated with sexual desire in women? The study revealed that FT and androstenedione had statistically significant correlations with sexual desire in the entire group of women. ADT-G was not more strongly correlated than circulating androgens, hence it is not superior to measuring circulating androgens by mass spectrometry.",1.8948778188548325e-07,0.08291882185289579,0.08337777777777781,0.014507411718254981,0.1657661288910468,0.006157281049888136,0.014486412327622933,0.19047948401256942,0.021728395061728398,1.8948778188548325e-07,0.16362942378180145,0.0
245,0.5,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is sexual desire in women linked to androgens? Findings from the study indicate that FT and androstenedione were significantly correlated with sexual desire across the total female cohort. ADT-G did not show a stronger correlation than circulating androgens and is therefore not a superior measure compared to mass spectrometry of circulating androgens.,1.1842986367842703e-07,0.037166955158631776,0.12600000000000006,0.009067132323909363,0.044899475763602315,0.036311854752580995,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.5,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does sexual desire in women correlate with androgens? The present study found that FT and androstenedione had statistically significant correlations with sexual desire among all women participants. ADT-G did not correlate more strongly than circulating androgens, so it is not a better measure than mass spectrometry of circulating androgens.",1.8948778188548325e-07,0.02515655680623352,0.12477609778180175,0.014507411718254981,0.10677487948168984,0.036311854752580995,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
246,0.5,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Does engaging in a medically supervised weight loss program before surgery enhance the results of bariatric surgery? Evidence indicates that such preoperative programs can lead to better bariatric surgery outcomes by helping patients lose weight, minimizing surgical risks, and promoting long-term success.",9.474389094274162e-08,0.0917488250833074,0.13017751479289946,0.0072537058591274906,0.06222327032293373,0.11176857330703485,0.007243206163811466,0.03131914542397851,0.09204470742932283,9.474389094274162e-08,0.0010624327627026808,0.0710059171597633
246,0.5,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Is a medically supervised weight loss program prior to bariatric surgery beneficial for improving surgical outcomes? Research suggests that undergoing a medically supervised weight loss regimen before surgery can improve outcomes by facilitating weight loss, reducing risks during surgery, and supporting sustained results.",7.105791820705622e-08,0.016181657730003796,0.03599468930813496,0.005440279394345618,0.014520289851564172,0.039053891866591625,0.0054324046228586,0.012677764647723855,0.042183211584447496,7.105791820705622e-08,0.01063295561892863,0.04538264846170235
246,0.5,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Can participating in a medically supervised weight loss program before bariatric surgery improve the surgery’s effectiveness? There is evidence supporting that preoperative medically guided weight loss helps patients lose weight, lowers surgical complications, and enhances long-term outcomes.",2.1317375462116823e-07,0.07681247986266504,0.10242241275208314,0.016320838183036854,0.071308122301589,0.11176857330703485,0.016297213868575806,0.105881976089504,0.09204470742932283,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
246,0.5,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Does a preoperative medically supervised weight loss program positively impact bariatric surgery results? Studies show that such programs can improve outcomes by aiding weight loss, decreasing surgical risks, and contributing to better long-term success.",2.8423167282822413e-07,0.12531568015452033,0.13017751479289946,0.021761117577382492,0.16092028099127598,0.11176857330703485,0.021729618491434427,0.1982552962205193,0.09204470742932283,2.8423167282822487e-07,0.2374512108269342,0.0710059171597633
246,0.5,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Will a medically supervised weight loss program before bariatric surgery improve the surgery’s outcomes? Evidence suggests that preoperative weight loss under medical supervision can lead to improved surgical results by reducing risks, promoting weight loss, and improving long-term outcomes.",1.6580180914979763e-07,0.02071851245040035,0.10388094795579209,0.012693985253473108,0.01573827114677684,0.11176857330703485,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
246,0.5,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? Data indicates that these programs help patients lose weight, reduce surgical risks, and enhance long-term benefits of the surgery.",2.6054570009253883e-07,0.09546271700483855,0.13017751479289946,0.019947691112600613,0.1301486223245223,0.11176857330703485,0.019918816950481553,0.16650659790593947,0.09204470742932283,2.6054570009253947e-07,0.2046613880039425,0.0710059171597633
246,0.5,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Does a medically supervised weight loss program before bariatric surgery enhance patient outcomes? Research supports that preoperative weight loss programs under medical supervision can improve surgical outcomes by facilitating weight loss, lowering risks, and improving long-term success.",2.1317375462116823e-07,0.07681247986266504,0.10242241275208314,0.016320838183036854,0.071308122301589,0.11176857330703485,0.016297213868575806,0.105881976089504,0.09204470742932283,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
246,0.5,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Can a preoperative medically supervised weight loss program improve the results of bariatric surgery? Evidence suggests that such programs help patients lose weight, reduce the risk of complications, and improve long-term surgical outcomes.",3.0791764556390943e-07,0.156087338821274,0.13017751479289946,0.023574544042164372,0.1926689793058558,0.11176857330703485,0.0235404200323873,0.231045119043511,0.09204470742932283,3.079176455639103e-07,0.271352762502616,0.0710059171597633
246,0.5,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Does undergoing a medically supervised weight loss program prior to bariatric surgery improve outcomes? Studies indicate that preoperative medical supervision for weight loss can enhance bariatric surgery results by aiding weight loss, minimizing surgical risks, and improving long-term success.",1.6580180914979763e-07,0.05719994300618714,0.07770837899043032,0.012693985253473108,0.01573827114677684,0.11176857330703485,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
246,0.5,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Is a preoperative medically supervised weight loss program effective in improving bariatric surgery outcomes? There is evidence that these programs contribute to weight loss, reduce surgical risks, and promote better long-term results.",3.3160361829959473e-07,0.18783603713585384,0.13017751479289946,0.02538797050694625,0.2254588021288475,0.11176857330703485,0.025351221573340174,0.26494667071919276,0.09204470742932283,3.316036182995957e-07,0.306444082313885,0.0710059171597633
247,0.5,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to diagnostic characteristics of child bipolar I disorder? The TEAM sample might not represent all child bipolar I disorder cases, as diagnostic traits can differ among individuals, requiring more research to confirm broader applicability.",4.974054274493935e-07,0.22389243184257746,0.11807039030023539,0.038081955760419325,0.26243473751643176,0.10050216075633846,0.0380268323600102,0.2794047995227289,0.09566326530612247,4.974054274493935e-07,0.33108986178921773,0.06525084641428129
247,0.5,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Is the ""Treatment of Early Age Mania (TEAM)"" sample representative of child bipolar I disorder diagnostic features? The TEAM sample may not be generalizable to all children with bipolar I disorder due to variability in diagnostic characteristics, and additional studies are necessary to assess wider relevance.",4.500334819780227e-07,0.1755643329883112,0.12012304573821192,0.03445510283085558,0.21441440330889883,0.1015825395903079,0.034405229278104466,0.23177675053347446,0.09566326530612247,4.500334819780227e-07,0.282299697619786,0.06525084641428129
247,0.5,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Can the diagnostic characteristics of child bipolar I disorder in the ""Treatment of Early Age Mania (TEAM)"" sample be generalized? The TEAM sample likely does not encompass all cases, given individual differences in diagnosis, and further investigation is crucial to validate its generalizability.",5.210914001850789e-07,0.18294412175882346,0.1644713421146316,0.0398953822252012,0.2535252804974002,0.12429752066115701,0.039837633900963065,0.3040974121131006,0.09566326530612247,5.210914001850789e-07,0.35640766977350946,0.06525084641428129
247,0.5,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" sample reflect the diagnostic features of child bipolar I disorder broadly? Diagnostic traits differ among patients, so the TEAM sample might not apply universally, highlighting the need for more research.",6.395212638635056e-07,0.30969582739796575,0.1644713421146316,0.04896251454911056,0.3835784087455978,0.12429752066115701,0.0488916416057274,0.43762880473762333,0.09566326530612247,6.39521263863506e-07,0.493608791286992,0.06525084641428129
247,0.5,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Is the ""Treatment of Early Age Mania (TEAM)"" sample applicable to the general population of child bipolar I disorder? Since diagnostic characteristics vary, the TEAM sample may not generalize, and further studies are required to determine its broader relevance.",6.158352911278203e-07,0.2830275803158049,0.1644713421146316,0.04714908808432869,0.35617943455748247,0.12429752066115701,0.04708084006477453,0.4094579277709265,0.09566326530612247,6.158352911278206e-07,0.46462125441374047,0.06525084641428129
247,0.5,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" sample extend to all children with bipolar I disorder in terms of diagnostic features? Variations among individuals suggest the TEAM sample might not be generalizable, necessitating additional research.",6.868932093348762e-07,0.3652656785527779,0.1644713421146316,0.05258936747867431,0.44073682258554614,0.12429752066115701,0.052513244687633145,0.4964693047605566,0.09566326530612247,6.868932093348768e-07,0.5542334131034274,0.06525084641428129
247,0.5,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Are the diagnostic characteristics found in the ""Treatment of Early Age Mania (TEAM)"" sample generalizable to all child bipolar I disorder cases? Differences among individuals imply limited generalizability of the TEAM sample, and more research is needed.",6.63207236599191e-07,0.33709480158608107,0.1644713421146316,0.050775941013892434,0.41174928571229463,0.12429752066115701,0.05070244314668027,0.46661634161087484,0.09566326530612247,6.632072365991914e-07,0.5234617544366738,0.06525084641428129
247,0.5,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Can findings from the ""Treatment of Early Age Mania (TEAM)"" sample be generalized to child bipolar I disorder diagnostics? Given individual variability, the TEAM sample might not represent all cases, requiring further study.",7.579511275419321e-07,0.4548778372424649,0.1644713421146316,0.05802964687301995,0.5331101427165614,0.12429752066115701,0.057945649310491766,0.5917794845648818,0.09566326530612247,7.57951127541933e-07,0.6526734859166807,0.06525084641428129
247,0.5,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to the broader diagnostic characteristics of child bipolar I disorder? Due to differences across individuals, the sample may not be fully representative, and further research is necessary.",6.63207236599191e-07,0.33709480158608107,0.1644713421146316,0.050775941013892434,0.41174928571229463,0.12429752066115701,0.05070244314668027,0.46661634161087484,0.09566326530612247,6.632072365991914e-07,0.5234617544366738,0.06525084641428129
247,0.5,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Is the ""Treatment of Early Age Mania (TEAM)"" sample representative of diagnostic traits in child bipolar I disorder? Diagnostic characteristics vary, so the TEAM sample may not generalize to all cases, emphasizing the need for additional research.",6.63207236599191e-07,0.33709480158608107,0.1644713421146316,0.050775941013892434,0.41174928571229463,0.12429752066115701,0.05070244314668027,0.46661634161087484,0.09566326530612247,6.632072365991914e-07,0.5234617544366738,0.06525084641428129
248,0.5,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese males? Yes, these increased indexes can signify early vascular abnormalities in this group, potentially pointing to a higher risk of future cardiovascular diseases.",3.316036182995955e-07,0.032916031424930825,0.2222222222222222,0.025387970506946217,0.02190305395620218,0.19937500000000002,0.025351221573340132,0.07897108197045499,0.1713265913146937,3.316036182995957e-07,0.1384301850326577,0.1388888888888889
248,0.5,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Do higher carotid artery pulsatility and resistance indexes signal early vascular abnormalities in young obese men? Indeed, elevated levels of these indexes are early markers of vascular problems and may suggest an increased likelihood of cardiovascular disease later on.",3.316036182995955e-07,0.032916031424930825,0.2222222222222222,0.025387970506946217,0.02190305395620218,0.19937500000000002,0.025351221573340132,0.07897108197045499,0.1713265913146937,3.316036182995957e-07,0.1384301850326577,0.1388888888888889
248,0.5,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Is an increase in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Yes, such increases are indicative of early vascular changes and could imply a greater risk for cardiovascular conditions in the future.",2.8423167282822487e-07,0.08420932581248053,0.2222222222222222,0.02176111757738247,0.030740679529216663,0.19937500000000002,0.0217296184914344,0.024903860700178804,0.1713265913146937,2.8423167282822487e-07,0.08286033387784553,0.1388888888888889
248,0.5,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Can increased carotid artery pulsatility and resistance indexes serve as early indicators of vascular abnormalities in young obese males? Yes, these elevated indexes are considered early signs of vascular dysfunction and may predict a higher chance of cardiovascular disease development.",3.079176455639102e-07,0.023345508568704876,0.19659895352416126,0.023574544042164344,0.004765193125958689,0.19937500000000002,0.023540420032387266,0.05157210778233967,0.1713265913146937,3.079176455639103e-07,0.11025930806596085,0.1388888888888889
248,0.5,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are raised carotid artery pulsatility and resistance indexes early signs of vascular abnormalities among young obese males? Yes, these raised indexes can be viewed as early markers of vascular issues that may increase the risk of future cardiovascular diseases.",3.316036182995955e-07,0.0035653991308555177,0.19592565538511483,0.025387970506946217,0.02190305395620218,0.19937500000000002,0.025351221573340132,0.07897108197045499,0.1713265913146937,3.316036182995957e-07,0.1384301850326577,0.1388888888888889
248,0.5,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Do increased carotid artery pulsatility and resistance indexes reflect early vascular abnormalities in young obese males? Yes, such increases are early indicators of vascular problems and might suggest an elevated risk of cardiovascular disease down the line.",3.789755637709661e-07,0.021151189845345364,0.2222222222222222,0.029014823436509962,0.07747290511101435,0.19937500000000002,0.028972824655245873,0.13612949581040334,0.1713265913146937,3.789755637709665e-07,0.19727068505559098,0.1388888888888889
248,0.5,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Is the presence of increased carotid artery pulsatility and resistance indexes an early indication of vascular abnormalities in young obese males? Yes, these increases are early signs of vascular dysfunction and could signal a heightened risk of cardiovascular disease in the future.",2.6054570009253947e-07,0.07508988081456236,0.1978472222222222,0.0199476911126006,0.05605848751350839,0.19937500000000002,0.019918816950481533,0.001071625703079171,0.1713265913146937,2.6054570009253947e-07,0.05619208679568466,0.1388888888888889
248,0.5,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are higher carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Yes, elevated indexes indicate early vascular abnormalities and may point to an increased cardiovascular disease risk later.",4.50033481978022e-07,0.15017148686891124,0.1919487847222222,0.0344551028308556,0.16708506380070132,0.19937500000000002,0.03440522927810449,0.22850281594141864,0.1713265913146937,4.500334819780227e-07,0.2925808648599162,0.1388888888888889
248,0.5,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Do increased carotid artery pulsatility and resistance indexes represent early signs of vascular abnormalities in young obese males? Yes, these increases are early markers of vascular issues and suggest a potential rise in future cardiovascular disease risk.",3.789755637709661e-07,0.05965936654312021,0.19446712018140588,0.029014823436509962,0.07747290511101435,0.19937500000000002,0.028972824655245873,0.13612949581040334,0.1713265913146937,3.789755637709665e-07,0.19727068505559098,0.1388888888888889
248,0.5,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Is an elevation in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Yes, such elevations can be considered early indicators of vascular abnormalities and may imply a higher risk for developing cardiovascular diseases in the future.",2.1317375462116866e-07,0.09205117989815825,0.175821270407826,0.016320838183036854,0.07184164308484853,0.17557964009518146,0.0162972138685758,0.0510820462777426,0.1713265913146937,2.1317375462116866e-07,0.004898792408134955,0.1388888888888889
249,0.5,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Is neck dissection necessary for metastatic carcinoma in cervical nodes when the primary head and neck site is unknown? Based on our experience, definitive radiotherapy targeting the neck and possible mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection indication, especially for early nodal involvement, remains to be clarified.",2.3685972735685406e-07,0.18413474306267474,0.023079566137464695,0.018134264647818754,0.20036049186458804,0.033293697978596916,0.018108015409528666,0.1800655752867959,0.01694411414982164,2.3685972735685406e-07,0.15906469462968964,0.0
249,0.5,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","For metastatic carcinoma to cervical nodes from an unknown head and neck primary, is neck dissection required? Our findings suggest that definitive radiotherapy to the neck and potential mucosal areas, whether done after neck dissection or not, successfully provides good local control in unknown primary head and neck cancers. The role of neck dissection, particularly in early nodal cases, is still under consideration.",2.1317375462116866e-07,0.1440484333297647,0.006090713403160419,0.01632083818303688,0.16034751494358712,0.016388888888888897,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
249,0.5,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Should neck dissection be performed in cases of metastatic carcinoma to cervical nodes with an unknown primary head and neck site? Our experience shows that definitive radiotherapy to the neck and possible mucosal sites, regardless of prior neck dissection, is effective for achieving good local control in unknown primary head and neck cancers. The decision for neck dissection, especially in early nodal disease, is important to evaluate.",1.1842986367842703e-07,0.11947161702424403,0.03307730881213793,0.009067132323909391,0.13809078882079273,0.046045785639958384,0.009054007704764333,0.11854512002258577,0.03121748178980229,1.1842986367842703e-07,0.09837765118330122,0.01586888657648284
249,0.5,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Is there a need for neck dissection in metastatic carcinoma involving cervical nodes from an unknown head and neck primary? We have found that definitive radiotherapy to the neck and potential mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly in early nodal disease, requires careful consideration.",1.6580180914979784e-07,0.13186437317614974,0.020050941945405625,0.012693985253473136,0.12736518805655095,0.015868886576482836,0.012675610786670066,0.10697211955217067,0.0,1.6580180914979784e-07,0.10863384100279827,0.0
249,0.5,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","When metastatic carcinoma is present in cervical nodes from an unknown head and neck primary, should neck dissection be done? Our experience indicates that definitive radiotherapy to the neck and mucosal sites, with or without neck dissection beforehand, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, especially for early nodal involvement, needs to be defined.",1.8948778188548325e-07,0.12698334977047931,0.005328719723183412,0.014507411718255009,0.14372044347394297,0.016124697661918846,0.014486412327622933,0.12323264042395188,0.0,1.8948778188548325e-07,0.1251631429540092,0.0
249,0.5,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Is neck dissection necessary for metastatic carcinoma to cervical lymph nodes from an unknown primary site in the head and neck? According to our experience, definitive radiotherapy targeting the neck and possible mucosal sites, whether preceded by neck dissection or not, effectively achieves good local control in unknown primary head and neck cancers. The use of neck dissection, particularly in early nodal cases, remains an important consideration.",1.1842986367842703e-07,0.07746269699030872,0.003180193646085898,0.009067132323909391,0.07410797215372167,0.0,0.009054007704764333,0.07522342123759085,0.0,1.1842986367842703e-07,0.0763729787845735,0.0
249,0.5,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","For metastatic carcinoma in cervical nodes from an unknown primary head and neck site, is neck dissection warranted? Our experience suggests that definitive radiotherapy to the neck and potential mucosal sites, regardless of prior neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The indication for neck dissection, especially in early nodal disease, should be assessed.",2.1317375462116866e-07,0.18876760626911526,0.03785334268409447,0.01632083818303688,0.20579978907866536,0.049048751486325794,0.0162972138685758,0.18597175441249192,0.033293697978596916,2.1317375462116866e-07,0.1654667758656423,0.01694411414982164
249,0.5,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Does metastatic carcinoma to cervical nodes from an unknown head and neck primary require neck dissection? Based on our experience, definitive radiotherapy to the neck and potential mucosal sites, whether or not preceded by neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The decision for neck dissection, particularly for early nodal involvement, needs to be evaluated.",1.8948778188548325e-07,0.12698334977047931,0.005328719723183412,0.014507411718255009,0.14372044347394297,0.016124697661918846,0.014486412327622933,0.12323264042395188,0.0,1.8948778188548325e-07,0.1251631429540092,0.0
249,0.5,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Is neck dissection indicated for metastatic carcinoma to cervical nodes from an unknown primary head and neck cancer? Our findings indicate that definitive radiotherapy to the neck and potential mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, especially in early nodal disease, remains to be determined.",2.1317375462116866e-07,0.18876760626911615,0.03785334268409447,0.01632083818303688,0.20579978907866536,0.049048751486325794,0.0162972138685758,0.18597175441249192,0.033293697978596916,2.1317375462116866e-07,0.1654667758656423,0.01694411414982164
249,0.5,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","In cases of metastatic carcinoma to cervical nodes from an unknown primary site in the head and neck, is neck dissection necessary? Our experience shows that definitive radiotherapy to the neck and mucosal sites, whether preceded by neck dissection or not, is effective for achieving good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for early nodal involvement, should be considered.",9.474389094274162e-08,0.06148432141605209,0.002506454098183404,0.007253705859127518,0.05884050002293417,0.0,0.007243206163811466,0.059719234701625545,0.0,9.474389094274162e-08,0.06062462181643724,0.0
250,0.5,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy affect peri-sinusoidal cell function? Laparoscopic surgery resulted in measurable harm to Kupffer and endothelial cells, indicated by increased post-operative serum HA levels. However, this liver and perisinusoidal cell damage showed no clinical impact.",9.47438909427412e-08,0.07266757538074708,0.025623268698060954,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
250,0.5,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is peri-sinusoidal cell activity altered by laparoscopic cholecystectomy? The laparoscopic approach caused observable injury to Kupffer and endothelial cells, evidenced by raised HA serum levels after surgery. This damage to liver hepatocytes and perisinusoidal cells did not manifest clinically.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.5,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy impact the activity of peri-sinusoidal cells? Laparoscopic methods led to detectable damage in Kupffer and endothelial cells, as shown by elevated serum HA levels post-operation. Nonetheless, the injury to liver hepatocytes and perisinusoidal cells was clinically insignificant.",0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
250,0.5,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"How does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? The procedure induced measurable damage to Kupffer and endothelial cells, reflected by increased HA serum levels following surgery. The liver hepatocyte and perisinusoidal cell damage had no clinical consequences.",7.10579182070559e-08,0.04449669841405024,0.025623268698060954,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
250,0.5,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy cause changes in peri-sinusoidal cell activity? Laparoscopic surgery caused detectable injury to Kupffer and endothelial cells, indicated by higher post-operative HA serum levels. The resulting damage to liver hepatocytes and perisinusoidal cells showed no clinical effect.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.5,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is peri-sinusoidal cell function affected by laparoscopic cholecystectomy? The laparoscopic technique caused identifiable damage to Kupffer and endothelial cells, as evidenced by elevated serum HA levels after surgery. This damage to liver hepatocytes and perisinusoidal cells had no clinical relevance.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
250,0.5,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy alter peri-sinusoidal cell activity? Laparoscopic procedures resulted in measurable harm to Kupffer and endothelial cells, demonstrated by increased HA serum levels post-operatively. The damage to liver hepatocytes and perisinusoidal cells was not clinically significant.",7.10579182070559e-08,0.04449669841405024,0.025623268698060954,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
250,0.5,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"How does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? The operation caused detectable damage to Kupffer and endothelial cells, reflected by elevated post-operative serum HA levels. The liver hepatocyte and perisinusoidal cell damage had no clinical impact.",9.47438909427412e-08,0.07266757538074708,0.025623268698060954,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
250,0.5,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy influence the function of peri-sinusoidal cells? Laparoscopic surgery led to measurable damage to Kupffer and endothelial cells, as shown by increased HA serum levels after surgery. The injury to liver hepatocytes and perisinusoidal cells was clinically insignificant.",0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
250,0.5,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? The laparoscopic procedure caused detectable damage to Kupffer and endothelial cells, indicated by elevated post-operative HA serum levels. This damage to liver hepatocytes and perisinusoidal cells had no clinical effect.",4.73719454713706e-08,0.054565139391337336,0.0013829041414452105,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
251,0.5,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does losing consciousness indicate neuropsychological decline following a concussion? The study's findings question the significance of LOC in forecasting neuropsychological test results in the early recovery period after mild traumatic brain injury. Neuropsychological testing,2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
251,0.5,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a predictor of neuropsychological impairments after concussion? This study's results challenge the role of LOC as an indicator of neuropsychological test outcomes during the acute recovery phase from mild traumatic brain injury. Neuropsychological testing,1.1842986367842671e-07,0.1642191208045447,0.027006172839506164,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
251,0.5,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness predict neuropsychological deficits post-concussion? The findings suggest that LOC may not be a reliable predictor of neuropsychological performance in the acute phase of mild traumatic brain injury recovery. Neuropsychological testing,2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
251,0.5,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does LOC forecast neuropsychological decline after a concussion? The study raises doubts about the predictive value of LOC for neuropsychological test performance during the early recovery from mild traumatic brain injury. Neuropsychological testing,2.3685972735685321e-07,0.2719337154836414,0.0,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
251,0.5,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is the loss of consciousness a reliable predictor of neuropsychological impairments following concussion? The study's results question the importance of LOC in predicting neuropsychological test scores during the acute phase after mild traumatic brain injury. Neuropsychological testing,1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,0.5,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does experiencing loss of consciousness predict neuropsychological test deficits after concussion? This research casts doubt on the predictive role of LOC for neuropsychological performance during the acute recovery from mild traumatic brain injury. Neuropsychological testing,1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
251,0.5,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness serve as a predictor for neuropsychological declines post-concussion? The results indicate that LOC may not be a significant predictor of neuropsychological test outcomes in the acute phase of mild traumatic brain injury recovery. Neuropsychological testing,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
251,0.5,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness an effective predictor of neuropsychological decrements after concussion? The study's findings question the relevance of LOC as a predictor of neuropsychological test performance during early recovery from mild traumatic brain injury. Neuropsychological testing,1.42115836414112e-07,0.2311670332228073,0.055363321799307974,0.010880558788691236,0.19783241553260567,0.02854671280276816,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,0.5,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness predict neuropsychological impairments following concussion? The study suggests that LOC is not a strong predictor of neuropsychological test results during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
251,0.5,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a valid predictor of neuropsychological deficits after concussion? The study's findings cast doubt on the importance of LOC in forecasting neuropsychological test performance during the acute recovery phase from mild traumatic brain injury. Neuropsychological testing,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
252,0.5,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: How effective is PET/CT compared to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? Answer: PET/CT plays a limited role in staging liver metastases of colorectal carcinoma. While PET/CT is more sensitive in detecting extrahepatic disease in certain anatomical areas, its overall impact is...",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
252,0.5,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT provide additional value over multidetector CT in the preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT has a restricted role in the hepatic staging of liver metastases from colorectal cancer. It shows greater sensitivity for identifying extrahepatic disease in some regions, but its findings are...",2.3685972735685406e-08,0.007213231144150178,0.020321361058601158,0.0018134264647818726,0.02150620522096336,0.0,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
252,0.5,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In preoperative staging of liver metastases from colorectal carcinoma, does PET/CT offer advantages over multidetector CT? Answer: PET/CT is limited in its use for hepatic staging of liver metastases from colorectal carcinoma. Although it detects extrahepatic disease with higher sensitivity in certain locations, its results are...",2.3685972735685406e-08,0.14269475020322897,0.08581257892896144,0.0018134264647818726,0.1452050721516538,0.08804283164782865,0.0018108015409528666,0.11699292592841459,0.06781677572873293,2.3685972735685406e-08,0.08746832571864793,0.046400951814396206
252,0.5,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: What is the added benefit of PET/CT compared to multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT has a limited role in staging liver metastases of colorectal carcinoma. It is more sensitive in detecting extrahepatic disease in some anatomical sites, yet its overall contribution is...",4.737194547137081e-08,0.04287659944973932,0.0008672350871665457,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
252,0.5,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT improve preoperative staging of liver metastases in colorectal carcinoma beyond what multidetector CT offers? Answer: PET/CT’s role in hepatic staging of colorectal carcinoma liver metastases is limited. It has higher sensitivity for extrahepatic disease detection in certain areas, but its results remain...",7.105791820705622e-08,0.13098241316347448,0.04655023508601083,0.005440279394345618,0.06744128079553224,0.0,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
252,0.5,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: How does PET/CT compare with multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? Answer: PET/CT has a limited role in hepatic staging of liver metastases from colorectal carcinoma. While it is more sensitive in detecting extrahepatic disease in some anatomical locations, its findings are...",0.0,0.11798249881871392,0.08360874280398993,0.0,0.12054733574955545,0.08616780045351476,0.0,0.09241962407465909,0.06632653061224489,0.0,0.06301338005090473,0.045351473922902494
252,0.5,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Is there a significant advantage of PET/CT over multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT plays a limited role in hepatic staging of liver metastases in colorectal carcinoma. Despite its higher sensitivity for extrahepatic disease in certain regions, its results are...",2.3685972735685406e-08,0.02214741445367352,0.00046185441900629606,0.0018134264647818726,0.021978906718775004,0.0,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
252,0.5,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: What role does PET/CT have in the preoperative staging of liver metastases from colorectal carcinoma compared to multidetector CT? Answer: PET/CT is limited in hepatic staging of liver metastases from colorectal carcinoma. It detects extrahepatic disease more sensitively in some anatomical sites, but its outcomes are...",2.3685972735685406e-08,0.14269475020322897,0.08581257892896144,0.0018134264647818726,0.1452050721516538,0.08804283164782865,0.0018108015409528666,0.11699292592841459,0.06781677572873293,2.3685972735685406e-08,0.08746832571864793,0.046400951814396206
252,0.5,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Can PET/CT add value to multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT has a limited role in hepatic staging of liver metastases from colorectal cancer. It shows higher sensitivity for extrahepatic disease detection in certain locations, though its results are...",4.737194547137081e-08,0.04479602859327958,0.0009442031589307898,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
252,0.5,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT enhance the preoperative staging of liver metastases from colorectal carcinoma compared to multidetector CT? Answer: PET/CT has a restricted role in hepatic staging of liver metastases from colorectal carcinoma. It is more sensitive for detecting extrahepatic disease in some anatomical regions, but its findings are...",0.0,0.11798249881871392,0.08360874280398993,0.0,0.12054733574955545,0.08616780045351476,0.0,0.09241962407465909,0.06632653061224489,0.0,0.06301338005090473,0.045351473922902494
253,0.5,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it justified to screen for coeliac disease in high-risk groups? Long-term adherence to diet in patients detected through screening was satisfactory. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Therefore, active screening in risk groups appears to be beneficial rather than detrimental.",4.737194547137081e-08,0.12488049958022218,0.060964083175803374,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.5,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should coeliac disease screening be conducted in risk groups? Patients identified via screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to those without coeliac disease and to the general population. Hence, proactive screening in at-risk groups seems justified and not harmful.",2.3685972735685406e-08,0.03537474524045736,0.04014018095760509,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.5,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is screening for coeliac disease among risk groups warranted? Screen-detected patients showed strong long-term dietary adherence. Their quality of life and bone mineral density were on par with non-coeliac subjects and the wider population. Active screening in these groups appears reasonable and not harmful.,1.4211583641411244e-07,0.045745017450540715,0.060964083175803374,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
253,0.5,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Does screening for coeliac disease in risk groups make sense? Those diagnosed through screening adhered well to dietary recommendations over the long term. Their quality of life and bone mineral density were comparable to non-coeliac individuals and the general population. Thus, active screening in risk groups seems justified rather than harmful.",2.3685972735685406e-08,0.049626097839246874,0.021033527620247808,0.0018134264647818726,0.007672434452772325,0.020399305555555556,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.5,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it appropriate to screen risk groups for coeliac disease? Patients discovered by screening demonstrated good long-term compliance with dietary guidelines. Their quality of life and bone mineral density were similar to those without coeliac disease and the general population. Therefore, active screening in risk groups seems sensible and not harmful.",2.3685972735685406e-08,0.07735198506164442,0.04097241303836064,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.5,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening justified in risk populations? Screen-detected patients maintained excellent long-term dietary compliance. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Active screening in these risk groups appears to be a reasonable approach rather than a harmful one.,2.3685972735685406e-08,0.06425587776378805,0.060964083175803374,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.5,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should individuals in risk groups be screened for coeliac disease? Those detected through screening adhered well to the diet over time. Their quality of life and bone mineral density were comparable with non-coeliac subjects and the general population. Consequently, active screening in risk groups seems beneficial instead of harmful.",2.3685972735685406e-08,0.006493612717126229,0.019376181474480114,0.0018134264647818726,0.05054903390251164,0.0212665406427221,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.5,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it reasonable to conduct coeliac disease screening in risk groups? Patients identified by screening showed good long-term dietary adherence. Their quality of life and bone mineral density were similar to those in non-coeliac and general populations. Active screening in these groups seems justified rather than harmful.,7.105791820705622e-08,0.008440570592397112,0.039235688114074976,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
253,0.5,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in at-risk groups justified? Patients found through screening maintained good dietary compliance long term. Their quality of life and bone mineral density were equivalent to those without coeliac disease and the general population. Thus, active screening in risk groups appears reasonable and not harmful.",2.3685972735685406e-08,0.03537474524045736,0.04014018095760509,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.5,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to perform coeliac disease screening in risk groups? Screen-detected patients exhibited strong long-term adherence to dietary recommendations. Their quality of life and bone mineral density were comparable to non-coeliac subjects and the general population. Active screening in these risk groups seems appropriate and not harmful.,4.737194547137081e-08,0.013706843861276408,0.039697542533081276,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
254,0.5,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","The insertion allele of the ACE gene I/D polymorphism is considered a candidate gene for insulin resistance. We conclude that the increased cardiovascular risk associated with the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. However, we observe heightened sensitivity in NIDDM patients carrying the ACE DD genotype.",0.0,0.02772588722239755,0.019938885418112832,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.5,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Regarding the insertion allele of the ACE gene I/D polymorphism as a potential candidate gene for insulin resistance, we find that the elevated cardiovascular risk linked to the DD genotype does not result from insulin resistance or fibrinolysis defects. On the other hand, NIDDM individuals with the ACE DD genotype show increased sensitivity.",4.737194547137081e-08,0.04135347370885123,0.0015305555555555558,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,0.5,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","The ACE gene I/D polymorphism's insertion allele is examined as a possible candidate gene for insulin resistance. Our findings indicate that the higher cardiovascular risk of the DD genotype is not caused by insulin resistance or fibrinolysis abnormalities. In contrast, NIDDM subjects with the ACE DD genotype demonstrate increased sensitivity.",2.3685972735685406e-08,0.02133437618373879,0.0008118618278758691,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
254,0.5,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Considering the insertion allele of the ACE gene I/D polymorphism as a candidate gene for insulin resistance, we conclude that the greater cardiovascular risk of the DD genotype is not mediated by insulin resistance or fibrinolysis issues. Conversely, increased sensitivity is observed in NIDDM patients with the ACE DD genotype.",2.3685972735685406e-08,0.02133437618373879,0.0008118618278758691,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
254,0.5,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","The insertion allele of the ACE gene I/D polymorphism has been proposed as a candidate gene for insulin resistance. We determine that the cardiovascular risk elevation in the DD genotype is not due to insulin resistance or fibrinolysis abnormalities, but NIDDM subjects with the ACE DD genotype exhibit increased sensitivity.",2.3685972735685406e-08,0.02133437618373879,0.0008118618278758621,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
254,0.5,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","We investigated the insertion allele of the ACE gene I/D polymorphism as a candidate gene for insulin resistance. Our conclusion is that the DD genotype's increased cardiovascular risk is not mediated through insulin resistance or fibrinolysis defects, though NIDDM subjects with the ACE DD genotype show heightened sensitivity.",7.105791820705622e-08,0.03591925397797047,0.018664014912833465,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.5,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","The ACE gene I/D polymorphism's insertion allele is a candidate gene for insulin resistance. We conclude that the DD genotype's increased cardiovascular risk is not caused by insulin resistance or fibrinolysis abnormalities, but NIDDM patients with the ACE DD genotype have increased sensitivity.",1.8948778188548325e-07,0.1519086212980736,0.01613519565073701,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
254,0.5,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","In examining the insertion allele of the ACE gene I/D polymorphism as a candidate gene for insulin resistance, we find that the DD genotype's elevated cardiovascular risk is not linked to insulin resistance or fibrinolysis abnormalities. However, NIDDM subjects with the ACE DD genotype display increased sensitivity.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.5,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","The insertion allele of the ACE gene I/D polymorphism is a potential candidate gene for insulin resistance. We conclude that the increased cardiovascular risk associated with the DD genotype is not mediated by insulin resistance or fibrinolysis abnormalities, but NIDDM patients with the ACE DD genotype show increased sensitivity.",4.737194547137081e-08,0.07201361764545178,0.02229166666666664,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.5,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","We conclude that the insertion allele of the ACE gene I/D polymorphism, a candidate gene for insulin resistance, does not mediate the increased cardiovascular risk of the DD genotype through insulin resistance or fibrinolysis abnormalities. However, NIDDM subjects with the ACE DD genotype exhibit increased sensitivity.",1.1842986367842703e-07,0.14232836528768944,0.026395975056689322,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
255,0.5,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical","Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? In this study, employing an endoscope during VPS surgeries did not raise the infection risk.",1.894877818854824e-07,0.2274906230323297,0.029384756657483937,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
255,0.5,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is there an impact on ventriculoperitoneal shunt infection rates when a neuroendoscope is used simultaneously? Our study found that endoscope use during VPS procedures did not increase infection risk.,1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,0.5,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does simultaneous neuroendoscope use influence ventriculoperitoneal shunt infection occurrence? Findings indicate that incorporating an endoscope in VPS operations does not elevate infection risk.,2.842316728282236e-07,0.39454470769549665,0.029384756657483937,0.021761117577382555,0.45198512374305855,0.0,0.021729618491434483,0.47000362924573613,0.0,2.8423167282822477e-07,0.48954822531870645,0.0
255,0.5,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the concurrent use of a neuroendoscope affect the incidence of infections in ventriculoperitoneal shunts? The current research shows no increased surgical infection risk with endoscope use during VPS.,1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,0.5,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is the incidence of ventriculoperitoneal shunt infection affected by the simultaneous use of a neuroendoscope? This study reveals that endoscope utilization during VPS does not heighten infection risk.,1.658018091497971e-07,0.1897502950494827,0.029384756657483937,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
255,0.5,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does simultaneous neuroendoscope application impact ventriculoperitoneal shunt infection rates? The study concludes that using an endoscope in VPS procedures does not increase infection risk.,2.605457000925383e-07,0.3500929451246626,0.029384756657483937,0.019947691112600675,0.4054651081081646,0.0,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
255,0.5,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the use of a neuroendoscope at the same time influence ventriculoperitoneal shunt infection rates? Results from this study indicate no increased risk of surgical infection with endoscope use during VPS.,9.47438909427412e-08,0.08438977939165726,0.029384756657483937,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
255,0.5,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical","Does employing a neuroendoscope concurrently affect the likelihood of ventriculoperitoneal shunt infections? According to this study, endoscope use during VPS does not raise infection risk.",2.36859727356853e-07,0.30753333070586697,0.029384756657483937,0.018134264647818796,0.36101334553733055,0.0,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
255,0.5,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is the rate of ventriculoperitoneal shunt infection influenced by simultaneous neuroendoscope use? The present study demonstrates no increased risk of infection when an endoscope is used during VPS procedures.,1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,0.5,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does simultaneous neuroendoscope usage alter the incidence of ventriculoperitoneal shunt infections? The findings here show that endoscope use during VPS does not increase surgical infection risk.,2.131737546211677e-07,0.26671133618561216,0.029384756657483937,0.016320838183036916,0.3184537311185349,0.0,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
256,0.5,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Could analyzing APC mutations assist in making treatment choices for familial adenomatous polyposis? Answer: Since the age at onset and disease progression can differ significantly even among individuals with the same germline mutations, treatment decisions should rely on colonoscopy results for each patient rather than mutation location. However, in patients with mutations",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
256,0.5,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Answer: Given that the age of disease onset and its progression can vary widely even among carriers of identical germline mutations, therapeutic choices should be informed by colonoscopic findings in each patient instead of the mutation site. Nonetheless, in patients with mutations",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
256,0.5,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation testing influence treatment strategies in familial adenomatous polyposis? Answer: Because the age at disease manifestation and its course may vary considerably, even among those with the same germline mutations, treatment should be based on individual colonoscopy findings rather than mutation location. Yet, in patients with mutations",1.6580180914979784e-07,0.10877613617595294,0.017851239669421492,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
256,0.5,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Does analyzing APC mutations help in therapeutic decision-making for familial adenomatous polyposis? Answer: Since age at disease onset and progression can be quite variable, even in carriers of the same germline mutations, therapeutic decisions should depend on colonoscopic examination results per patient rather than mutation site. However, in patients with mutations",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,0.5,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation analysis guide treatment decisions in familial adenomatous polyposis? Answer: As the age when symptoms appear and the disease course may vary significantly, even among individuals with identical germline mutations, treatment decisions should be based on colonoscopy findings for each patient rather than on mutation location. However, in patients with mutations",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
256,0.5,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is it possible for APC mutation analysis to aid therapeutic choices in familial adenomatous polyposis? Answer: Because the age at disease onset and progression can differ widely, even among carriers of the same germline mutations, therapeutic decisions should rely on colonoscopic findings specific to each patient rather than mutation site. However, in patients with mutations",2.3685972735685406e-08,0.006736750945891323,0.017851239669421492,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
256,0.5,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Could APC mutation analysis play a role in therapy decisions for familial adenomatous polyposis? Answer: Since the age at manifestation and disease progression may vary greatly even in individuals with identical germline mutations, treatment should be guided by colonoscopy findings in each patient instead of mutation location. However, in patients with mutations",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
256,0.5,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Does analysis of APC mutations contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Given the variability in age at onset and disease course, even among carriers of the same germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than the mutation site. However, in patients with mutations",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
256,0.5,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can the analysis of APC mutations inform therapeutic decisions in familial adenomatous polyposis? Answer: Because the age at manifestation and disease progression can be quite variable, even among those with identical germline mutations, treatment decisions should be based on individual colonoscopic findings rather than mutation site. However, in patients with mutations",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,0.5,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation analysis beneficial for therapeutic decision-making in familial adenomatous polyposis? Answer: Since the age of onset and disease course vary, even in carriers of identical germline mutations, therapy should be guided by colonoscopic findings in each patient rather than mutation location. However, in patients with mutations",1.8948778188548325e-07,0.1293954233786887,0.017851239669421492,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
257,0.5,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do the features of a general practice affect the adoption of an IT innovation in primary care? The analysis indicates that structural features of a practice do not relate to the adoption of a new IT system, but usage might be impacted by post-graduate training in the specific clinical area. For this diabetes system, the involvement of practice nurses was essential.",4.737194547137081e-08,0.11231598237303997,0.0867860422405877,0.0036268529295637453,0.08032944945809639,0.033856571252693125,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
257,0.5,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Does the nature of general practice influence the uptake of IT innovations in primary care? Findings suggest that practice structural characteristics do not determine the adoption of new IT tools, although post-graduate education in the clinical field may affect usage. Specifically for this diabetes IT system, practice nurse participation was crucial.",2.8423167282822487e-07,0.1703922066775947,0.0322222222222222,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
257,0.5,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Are general practice traits linked to the adoption of IT innovations in primary care? The study shows no association between practice structure and IT uptake, but post-graduate education related to the clinical condition could influence usage. In the case of this diabetes system, the role of practice nurses was key.",3.079176455639103e-07,0.2188866356506214,0.011822916666666645,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
257,0.5,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do characteristics of general practices impact the adoption of an IT innovation in primary care? Analyses reveal that structural aspects of a practice are unrelated to uptake of new IT facilities, yet usage may be influenced by relevant post-graduate clinical education. For this diabetes system, practice nurses’ use was vital.",3.079176455639103e-07,0.1905949139951133,0.0322222222222222,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
257,0.5,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Is the uptake of IT innovations in primary care affected by general practice characteristics? Results demonstrate no link between practice structural characteristics and IT adoption, but post-graduate education in the clinical area might affect usage. For the diabetes system studied, practice nurse involvement was critical.",4.263475092423373e-07,0.2982255781874783,0.0322222222222222,0.03264167636607371,0.3496737484797481,0.0,0.0325944277371516,0.35667494393873156,0.0,4.263475092423373e-07,0.36396537720141087,0.0
257,0.5,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do the attributes of general practices influence the adoption of IT innovations in primary care? Data indicate that structural characteristics do not correlate with uptake of new IT resources, but usage may depend on post-graduate education in the relevant clinical condition. Practice nurse use was essential for this diabetes system.",3.079176455639103e-07,0.1905949139951133,0.0322222222222222,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
257,0.5,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Does the uptake of an IT innovation in primary care depend on general practice characteristics? Analysis shows no connection between structural practice features and IT adoption, although post-graduate education in the clinical specialty might affect use. Practice nurses played a crucial role in this diabetes system.",4.026615365066519e-07,0.2757527223354206,0.0322222222222222,0.030828249901291835,0.32668423025504856,0.0,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
257,0.5,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Are structural characteristics of general practices related to the adoption of IT innovations in primary care? The findings suggest no association, but post-graduate clinical education could influence usage. In this diabetes IT system, practice nurse participation was critical.",5.921493183921348e-07,0.47149729946151453,0.0322222222222222,0.045335661619546816,0.5273549257172001,0.0,0.045270038523821665,0.538996500732686,0.0,5.921493183921352e-07,0.5511769192895568,0.0
257,0.5,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do general practice structural features influence the uptake of IT innovations in primary care? The analysis found no relationship between structural features and IT adoption, but post-graduate education in the clinical condition may impact use. Practice nurse engagement was key for this diabetes system.",4.500334819780227e-07,0.35345450015915203,0.008979591836734677,0.03445510283085558,0.3732042458899425,0.0,0.034405229278104466,0.3807724955177916,0.0,4.500334819780227e-07,0.38865798979178257,0.0
257,0.5,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Is the use of IT innovations in primary care affected by general practice characteristics? The study indicates no link between practice structure and IT uptake, but post-graduate education in the relevant clinical field might influence usage. Practice nurses were crucial for this diabetes system.",4.500334819780227e-07,0.3212150964121778,0.0322222222222222,0.03445510283085558,0.3732042458899425,0.0,0.034405229278104466,0.3807724955177916,0.0,4.500334819780227e-07,0.38865798979178257,0.0
258,0.5,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Does timing influence the relationship between living in an urban environment and non-communicable disease risk in Thailand? Yes, timing is important, as factors like exposure duration, outdoor time, and activity timing affect health outcomes.",7.105791820705614e-07,0.5145991305326816,0.09418282548476452,0.0544027939434562,0.5719601363666613,0.06420927467300831,0.054324046228586026,0.6087082484855464,0.049048751486325794,7.105791820705622e-07,0.6469373685226154,0.033293697978596916
258,0.5,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","In Thailand, does the timing of living in an urban setting affect non-communicable disease risk? Indeed, timing matters due to factors such as how long one is exposed, time spent outside, and when activities occur, influencing health risks.",6.158352911278202e-07,0.40018877935493613,0.09418282548476452,0.04714908808432869,0.4541771007102775,0.06420927467300831,0.04708084006477453,0.4873473914812796,0.049048751486325794,6.158352911278206e-07,0.5217742255686084,0.033293697978596916
258,0.5,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Is timing a factor in the connection between urban living and non-communicable disease risk in Thailand? Timing does play a role, with exposure length, outdoor time, and activity schedules impacting individual health.",7.57951127541932e-07,0.5771194875140151,0.09418282548476452,0.05802964687301996,0.6364986575042328,0.06420927467300831,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7159302400095662,0.033293697978596916
258,0.5,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","When considering urban living and non-communicable disease risk in Thailand, does timing matter? Yes, because exposure duration, outdoor activity time, and timing influence health effects.",9.237529366917291e-07,0.8330528616512165,0.09418282548476452,0.07072363212649312,0.9022018232372382,0.06420927467300831,0.07062126009716188,0.9516529996123775,0.049048751486325794,9.237529366917308e-07,1.0036123124613487,0.033293697978596916
258,0.5,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Does the timing of living in an urban environment affect non-communicable disease risk in Thailand? Timing is crucial, as the length of exposure, outdoor time, and activity timing all contribute to health impact.",7.342651548062467e-07,0.5453707891994353,0.09418282548476452,0.05621622040823808,0.6037088346812411,0.06420927467300831,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.6808389201982972,0.033293697978596916
258,0.5,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","In Thailand, does the timing of urban residence influence the risk of non-communicable diseases? Yes, timing matters due to factors like exposure duration, time spent outdoors, and when activities take place affecting health.",7.342651548062467e-07,0.5453707891994353,0.09418282548476452,0.05621622040823808,0.6037088346812411,0.06420927467300831,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.6808389201982972,0.033293697978596916
258,0.5,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Is the timing of exposure to urban environments significant for non-communicable disease risk in Thailand? Timing matters, considering factors such as exposure length, outdoor time, and timing of activities.",8.290090457489879e-07,0.7284126947210967,0.05851753056021034,0.0634699262673656,0.7418591731620583,0.06420927467300831,0.06337805393335039,0.7845989149492105,0.049048751486325794,8.290090457489892e-07,0.8292589253165703,0.033293697978596916
258,0.5,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Regarding urban living and non-communicable disease risk in Thailand, does timing have an impact? Yes, timing is important because duration of exposure, outdoor time, and activity timing can affect health.",8.053230730133026e-07,0.6438108620126886,0.09418282548476452,0.06165649980258372,0.7054915289911836,0.06420927467300831,0.06156725239239752,0.7468585869663635,0.049048751486325794,8.053230730133038e-07,0.7900382121632878,0.033293697978596916
258,0.5,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Does the timing of living in an urban area affect the risk of non-communicable diseases in Thailand? Timing does matter as exposure duration, outdoor time, and activity timing influence health outcomes.",7.816371002776173e-07,0.6099093103370068,0.09418282548476452,0.05984307333780184,0.6704002091799146,0.06420927467300831,0.05975645085144465,0.7104909427954889,0.049048751486325794,7.816371002776184e-07,0.7522978841804409,0.033293697978596916
258,0.5,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","In Thailand, does the timing related to urban living influence non-communicable disease risk? Timing is significant, with exposure length, outdoor time, and timing of activities playing a role in health impacts.",7.816371002776173e-07,0.6099093103370068,0.09418282548476452,0.05984307333780184,0.6704002091799146,0.06420927467300831,0.05975645085144465,0.7104909427954889,0.049048751486325794,7.816371002776184e-07,0.7522978841804409,0.033293697978596916
259,0.5,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is anxiety caused by withdrawal in alcoholism linked to a deficiency of beta-endorphin? Our findings provide initial proof that reduced beta-endorphin levels during alcohol withdrawal might play a role in the anxiety commonly observed in this condition.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.5,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Does withdrawal-related anxiety in alcoholism stem from a lack of beta-endorphin? The results we obtained offer the first evidence that decreased beta-endorphin during alcohol withdrawal could contribute to the anxiety frequently experienced during this phase.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.5,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Is the anxiety seen in alcohol withdrawal due to beta-endorphin deficiency? Our study presents the first evidence suggesting that lowered beta-endorphin levels during alcohol withdrawal may be involved in causing anxiety, a common symptom in this state.",7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.5,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is withdrawal-induced anxiety in alcoholism caused by beta-endorphin deficiency? Our data provide initial evidence that reduced beta-endorphin during alcohol withdrawal might contribute to the anxiety commonly associated with this condition.,9.47438909427412e-08,0.12921173148000697,0.0,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
259,0.5,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the anxiety during alcohol withdrawal linked to a deficiency in beta-endorphin? Our results offer the first indication that lowered beta-endorphin levels during withdrawal may play a role in the anxiety frequently seen in this state.,4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.5,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is beta-endorphin deficiency the basis for withdrawal-induced anxiety in alcoholism? Our findings give the first evidence that decreased beta-endorphin during alcohol withdrawal could contribute to the anxiety commonly present during this condition.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
259,0.5,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Does beta-endorphin deficiency underlie anxiety caused by alcohol withdrawal? Our results provide initial evidence that lowered beta-endorphin during withdrawal may be a factor in the anxiety often experienced in this state.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
259,0.5,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the anxiety associated with alcohol withdrawal due to a lack of beta-endorphin? Our study provides the first evidence that reduced beta-endorphin during withdrawal might contribute to the anxiety commonly observed in this condition.,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,0.5,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is withdrawal anxiety in alcoholism related to beta-endorphin deficiency? Our findings offer the first evidence that lowered beta-endorphin levels during alcohol withdrawal may be linked to the anxiety that commonly occurs during this phase.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,0.5,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is anxiety during alcohol withdrawal based on a deficiency of beta-endorphin? Our results provide initial evidence that reduced beta-endorphin during withdrawal may contribute to the anxiety frequently seen in this state.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
260,0.5,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts truly exist? Answer: Based on our study findings and international literature, the concept of the globulomaxillary cyst is no longer valid.",9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.5,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts real? Answer: Our research and global literature indicate that the term globulomaxillary cyst is no longer supported.,1.8948778188548245e-07,0.33647223662121384,0.0,0.014507411718255037,0.3513978868378893,0.0,0.014486412327622988,0.3677247801253176,0.0,1.8948778188548304e-07,0.38566248081198395,0.0
260,0.5,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a genuine entity? Answer: Evidence from our study and worldwide literature shows that the globulomaxillary cyst is no longer a justified diagnosis.,4.73719454713706e-08,0.18074599993217522,0.07638888888888888,0.003626852929563759,0.13241281558092455,0.03993055555555556,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
260,0.5,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts actually exist? Answer: According to our study results and international sources, the globulomaxillary cyst is an outdated concept.",1.658018091497971e-07,0.28768207245178257,0.0,0.012693985253473157,0.30010459245033916,0.0,0.012675610786670115,0.3136575588550423,0.0,1.6580180914979768e-07,0.32850406697203516,0.0
260,0.5,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts a real condition? Answer: Findings from our research and international literature suggest that the globulomaxillary cyst is no longer a recognized entity.,7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.5,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is there such a thing as a globulomaxillary cyst? Answer: Our study and global literature data reveal that the globulomaxillary cyst is no longer a valid classification.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,0.5,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts exist in reality? Answer: Based on our study and international reports, the globulomaxillary cyst is no longer a justified entity.",1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.5,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts an actual medical condition? Answer: The results of our research and international literature indicate that the globulomaxillary cyst is no longer justified.,7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.5,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the globulomaxillary cyst a legitimate diagnosis? Answer: According to our study and worldwide literature, the globulomaxillary cyst is no longer warranted.",1.421158364141118e-07,0.36718881691869676,0.09,0.010880558788691277,0.3173284454770928,0.047500000000000014,0.010864809245717241,0.26236426446749217,0.0,1.4211583641411233e-07,0.27443684570175986,0.0
260,0.5,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts exist as a distinct entity? Answer: Our findings and data from international literature confirm that the globulomaxillary cyst is no longer considered a valid entity.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
261,0.5,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea impact aerobic fitness? In a US Air Force cohort, OSA generally does not predict reduced aerobic fitness based on cycle ergometry. Yet, individuals with an apnea-hypopnea index over 20 show a significant decline in aerobic fitness compared to normal subjects, according to this study.",1.6580180914979784e-07,0.09131571616334622,0.034096781156585855,0.012693985253473108,0.08933752230378511,0.03767781622452902,0.012675610786670066,0.11792172186649497,0.01922337562475971,1.6580180914979784e-07,0.14763599880606337,0.0
261,0.5,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Is aerobic fitness affected by obstructive sleep apnea? Research in a US Air Force group indicates that OSA does not generally lead to decreased aerobic fitness as measured by cycle ergometry. However, those with an apnea-hypopnea index above 20 experience a statistically significant reduction in aerobic fitness relative to the normal population.",7.105791820705622e-08,0.04476631271899523,0.024603358750462975,0.005440279394345618,0.005955913364734222,0.03767781622452902,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
261,0.5,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea influence aerobic fitness? Overall findings in a US Air Force population suggest OSA does not predict lower aerobic fitness via cycle ergometry. Still, patients with an apnea-hypopnea index greater than 20 have a notable decrease in aerobic fitness compared to normal individuals, as shown in this study.",9.474389094274162e-08,0.0276705749629782,0.035371651661865226,0.0072537058591274906,0.02615862068225283,0.03767781622452902,0.007243206163811466,0.05338320072892344,0.01922337562475971,9.474389094274162e-08,0.0816780310142673,0.0
261,0.5,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","How does obstructive sleep apnea affect aerobic fitness? In a US Air Force sample, OSA does not typically predict diminished aerobic fitness measured by cycle ergometry. Nonetheless, individuals with an apnea-hypopnea index exceeding 20 demonstrate a statistically significant drop in aerobic fitness compared to the general population.",1.8948778188548325e-07,0.11346313061701974,0.03363492673757956,0.014507411718254981,0.11131642902256011,0.03767781622452902,0.014486412327622933,0.14039457771855268,0.01922337562475971,1.8948778188548325e-07,0.1706255170307629,0.0
261,0.5,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Can obstructive sleep apnea reduce aerobic fitness? The study in a US Air Force population shows OSA generally does not predict decreased aerobic fitness through cycle ergometry. However, patients with an apnea-hypopnea index above 20 show a significant decline in aerobic fitness compared to normal controls.",2.1317375462116866e-07,0.1361117447566258,0.03315257799765507,0.016320838183036854,0.13378928487461783,0.03767781622452902,0.0162972138685758,0.1633840959432522,0.01922337562475971,2.1317375462116866e-07,0.19415601444095731,0.0
261,0.5,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Is there an effect of obstructive sleep apnea on aerobic fitness? Findings from a US Air Force population reveal that OSA does not usually predict lowered aerobic fitness as assessed by cycle ergometry. Yet, those with an apnea-hypopnea index higher than 20 have a statistically significant reduction in aerobic fitness relative to normal individuals.",2.3685972735685406e-08,0.03216772300377446,0.03650237505374583,0.0018134264647818726,0.03326479978854824,0.03767781622452902,0.0018108015409528666,0.007241421087510691,0.01922337562475971,2.3685972735685406e-08,0.019802627296179764,0.0
261,0.5,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea lead to reduced aerobic fitness? Research involving a US Air Force cohort indicates that OSA overall does not predict a decrease in aerobic fitness measured by cycle ergometry. However, patients with an apnea-hypopnea index greater than 20 exhibit a significant decrease in aerobic fitness compared to the normal population.",4.737194547137081e-08,0.04070249542113791,0.0021127298458399058,0.0036268529295637453,0.04051777081835395,0.0014725377946296705,0.003621603081905733,0.04028709343106707,0.0007682945126830237,4.737194547137081e-08,0.04000533461369837,0.0
261,0.5,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","What is the impact of obstructive sleep apnea on aerobic fitness? In a US Air Force population, OSA generally does not predict reduced aerobic fitness as measured by cycle ergometry. Still, those with an apnea-hypopnea index above 20 have a statistically significant decrease in aerobic fitness compared to normal individuals.",1.1842986367842703e-07,0.0484391167136069,0.03496401624375241,0.009067132323909363,0.04677790788498859,0.03767781622452902,0.009054007704764333,0.0744366099267566,0.01922337562475971,1.1842986367842703e-07,0.10318423623523065,0.0
261,0.5,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","How does obstructive sleep apnea affect aerobic capacity? The study shows that in a US Air Force group, OSA does not predict a decline in aerobic fitness measured by cycle ergometry. However, patients with an apnea-hypopnea index greater than 20 experience a significant reduction in aerobic fitness compared to the normal population.",7.105791820705622e-08,0.034506545194199933,0.016212967780149266,0.005440279394345618,0.033681800587132216,0.01768614608708629,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
261,0.5,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea cause a decrease in aerobic fitness? Overall, in a US Air Force population, OSA does not predict lowered aerobic fitness as measured by cycle ergometry. Nevertheless, patients with an apnea-hypopnea index exceeding 20 have a statistically significant decrease in aerobic fitness compared to the normal population.",1.1842986367842703e-07,0.10502256002462262,0.005600761376495421,0.009067132323909363,0.07565904040831928,0.01685391400633074,0.009054007704764333,0.0744366099267566,0.01922337562475971,1.1842986367842703e-07,0.10318423623523065,0.0
262,0.5,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts real? Answer: Yes, globulomaxillary cysts are real. They are uncommon, benign growths found between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.12742698604294844,0.03840000000000001,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,0.5,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Do globulomaxillary cysts truly exist? Answer: Indeed, globulomaxillary cysts exist. These are rare, non-cancerous lesions located between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.12742698604294844,0.03840000000000001,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,0.5,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Is there such a thing as a globulomaxillary cyst? Answer: Yes, globulomaxillary cysts are genuine. They are infrequent, benign cysts appearing between the roots of the maxillary lateral incisor and canine.",7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
262,0.5,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Can globulomaxillary cysts be found in patients? Answer: Yes, globulomaxillary cysts can be found. They are rare, benign lesions situated between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
262,0.5,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts an actual medical condition? Answer: Yes, globulomaxillary cysts are an actual condition. They are rare, benign growths occurring between the roots of the maxillary lateral incisor and canine.",7.10579182070559e-08,0.012344348431239993,0.06420927467300831,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
262,0.5,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Do globulomaxillary cysts exist in reality? Answer: Yes, globulomaxillary cysts exist. These are rare, benign lesions that develop between the roots of the maxillary lateral incisor and canine.",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.5,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Is the existence of globulomaxillary cysts confirmed? Answer: Yes, the existence of globulomaxillary cysts is confirmed. They are rare benign lesions found between the roots of the maxillary lateral incisor and canine.",9.47438909427412e-08,0.039755402515464944,0.12244897959183673,0.007253705859127518,0.003992819662763214,0.09566326530612247,0.007243206163811494,0.05068121956601335,0.06632653061224487,9.474389094274162e-08,0.10061675128655301,0.03443877551020409
262,0.5,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts recognized as real entities? Answer: Yes, globulomaxillary cysts are recognized as real entities. They are rare, benign lesions located between the roots of the maxillary lateral incisor and canine.",9.47438909427412e-08,0.0035662962695313105,0.09274673008323425,0.007253705859127518,0.09343116554146613,0.0322222222222222,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
262,0.5,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Do globulomaxillary cysts actually occur? Answer: Yes, globulomaxillary cysts do occur. They are rare and benign lesions that appear between the roots of the maxillary lateral incisor and canine.",2.36859727356853e-08,0.012711934020451121,0.03443877551020409,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
262,0.5,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Is there evidence that globulomaxillary cysts exist? Answer: Yes, there is evidence that globulomaxillary cysts exist. They are rare, benign lesions found between the roots of the maxillary lateral incisor and canine.",9.47438909427412e-08,0.0035662962695313105,0.09274673008323425,0.007253705859127518,0.04871199260211467,0.06420927467300831,0.007243206163811494,0.09689103160334289,0.033293697978596916,9.474389094274162e-08,0.14842000511827314,0.0
263,0.5,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? For most patients undergoing MMT and receiving medical care at various locations, opioid dependence and MMT are documented in their medical records, though some records lack this information.",7.105791820705622e-08,0.012677764647723855,0.04218321158444751,0.005440279394345618,0.04363996421702332,0.021876731301939047,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
263,0.5,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Is opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? In patients treated with MMT and medical care across different sites, the majority have documentation of opioid dependence and MMT in their medical records, but some do not.",7.105791820705622e-08,0.012677764647723855,0.04218321158444751,0.005440279394345618,0.04363996421702332,0.021876731301939047,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
263,0.5,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Does the medical record include documentation of opioid dependence and methadone maintenance treatment (MMT)? Among patients receiving MMT and medical care at multiple sites, most have opioid dependence and MMT recorded in their medical records, although it is absent in some cases.",4.737194547137081e-08,0.013705450822062204,0.043392504930966504,0.0036268529295637453,0.017433506001244048,0.02251643655489808,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
263,0.5,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Are opioid dependence and methadone maintenance treatment (MMT) documented in patients' medical records? For the majority of patients receiving MMT and medical care at various sites, these details are recorded, but some records are incomplete.",2.1317375462116802e-07,0.105881976089504,0.09204470742932284,0.016320838183036868,0.1751480396207037,0.0475,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
263,0.5,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Most patients receiving MMT and medical care at different locations have these documented, but some records are missing this information.",2.1317375462116802e-07,0.105881976089504,0.09204470742932284,0.016320838183036868,0.1751480396207037,0.0475,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
263,0.5,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Are opioid dependence and methadone maintenance treatment (MMT) reflected in the medical record? Among patients treated with MMT and medical care at diverse sites, the majority have these conditions documented, though some records lack it.",2.1317375462116802e-07,0.105881976089504,0.09204470742932284,0.016320838183036868,0.1751480396207037,0.0475,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
263,0.5,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Is opioid dependence and methadone maintenance treatment (MMT) included in the medical record? For most patients undergoing MMT and medical care at various sites, documentation exists, but it is absent in some.",2.842316728282239e-07,0.1982552962205193,0.09204470742932284,0.021761117577382506,0.2704582194250289,0.0475,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
263,0.5,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? Among patients receiving MMT and medical care at different locations, the majority have these documented, but some records do not include them.",2.1317375462116802e-07,0.105881976089504,0.09204470742932284,0.016320838183036868,0.1751480396207037,0.0475,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
263,0.5,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Does the medical record document opioid dependence and methadone maintenance treatment (MMT)? Most patients receiving MMT and medical care across different sites have this information recorded, though it is missing in some cases.",2.605457000925386e-07,0.16650659790593947,0.09204470742932284,0.019947691112600627,0.2376683966020372,0.0475,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
263,0.5,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Among patients receiving MMT and medical care at various sites, most have documentation of these, but some records are incomplete.",2.605457000925386e-07,0.16650659790593947,0.09204470742932284,0.019947691112600627,0.2376683966020372,0.0475,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
264,0.5,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Does the quantity of needles influence acupuncture treatment for neck pain? For this condition, whether using 5 or 11 needles does not appear to significantly affect the therapeutic outcome if the stimulation duration is equal in both groups.",2.1317375462116834e-07,0.15744981597009122,0.043388429752066124,0.016320838183036854,0.19233700995598957,0.02221074380165289,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
264,0.5,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In acupuncture for neck pain, does the number of needles used matter? It seems that the therapeutic effect is not significantly impacted by using either 5 or 11 needles, provided the stimulation time is consistent between groups.",2.3685972735685364e-07,0.18484879015820654,0.043388429752066124,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
264,0.5,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","When treating neck pain with acupuncture, is the number of needles important? The data suggests that using 5 or 11 needles yields similar therapeutic effects when the stimulation time is held constant across groups.",3.0791764556390954e-07,0.2718601671478367,0.043388429752066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
264,0.5,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Regarding acupuncture treatment for neck pain, does the needle count affect results? The number of needles, whether 5 or 11, does not seem to be a critical factor in therapeutic efficacy if stimulation time is the same for both groups.",1.6580180914979774e-07,0.10480608248467238,0.043388429752066124,0.012693985253473108,0.13826978868571338,0.02221074380165289,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
264,0.5,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Is the number of needles a key factor in acupuncture therapy for neck pain? For this condition, using 5 or 11 needles appears to produce comparable therapeutic effects when stimulation duration is identical in both groups.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
264,0.5,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Does the number of needles used in acupuncture influence neck pain treatment outcomes? It appears that 5 or 11 needles result in similar therapeutic effects as long as the stimulation time is equal between groups.,2.8423167282822424e-07,0.2420072039981549,0.043388429752066124,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
264,0.5,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In treating neck pain with acupuncture, does needle quantity matter? The therapeutic effect seems unaffected by using 5 versus 11 needles when both groups receive the same stimulation time.",4.2634750924233604e-07,0.43616321843911265,0.043388429752066124,0.03264167636607376,0.48001908240777036,0.02221074380165289,0.03259442773715166,0.5260930958967793,0.0,4.263475092423373e-07,0.5423242908253623,0.0
264,0.5,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","For acupuncture treatment of neck pain, does the needle number impact effectiveness? The choice between 5 or 11 needles does not seem to influence the therapeutic effect if stimulation time is consistent across the groups.",2.8423167282822424e-07,0.2420072039981549,0.043388429752066124,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
264,0.5,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","When applying acupuncture for neck pain, is the number of needles significant? The therapeutic results appear similar whether 5 or 11 needles are used, assuming equal stimulation times in both groups.",3.7897556377096544e-07,0.3671703469521619,0.043388429752066124,0.029014823436510004,0.4085601184256267,0.02221074380165289,0.028972824655245914,0.45198512374305766,0.0,3.789755637709665e-07,0.4653632496892328,0.0
264,0.5,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Does the count of needles affect acupuncture therapy for neck pain? It seems that using either 5 or 11 needles does not change the therapeutic outcome when both groups have the same stimulation duration.,3.0791764556390954e-07,0.2718601671478367,0.043388429752066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
265,0.5,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? Yes, studies have shown that endometrial polyp formation is associated with increased expression of VEGF and TGF-beta1, which are involved in angiogenesis and tissue remodeling, potentially contributing to polyp development and growth.",3.079176455639103e-07,0.03294434782135225,0.17993079584775093,0.023574544042164344,0.03407780870738231,0.14097543609825555,0.023540420032387266,0.1033160308601837,0.09719008264462808,3.079176455639103e-07,0.12867243041871834,0.08264462809917351
265,0.5,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Does endometrial polyp formation correlate with higher expression of vascular endothelial growth factor and transforming growth factor-beta1? Indeed, endometrial polyps are associated with increased VEGF and TGF-beta1 expression, factors that aid angiogenesis and tissue remodeling, influencing polyp growth.",6.158352911278202e-07,0.2681607449625676,0.17993079584775093,0.04714908808432869,0.34237916836189886,0.14097543609825555,0.04708084006477453,0.41916898027866134,0.09719008264462808,6.158352911278206e-07,0.4524595075126143,0.08264462809917351
265,0.5,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is there a connection between endometrial polyp formation and increased expression of VEGF and TGF-beta1? Yes, the formation of endometrial polyps is linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1, which promote angiogenesis and tissue remodeling, facilitating polyp development.",4.737194547137081e-07,0.11787854191323088,0.17993079584775093,0.03626852929563745,0.18822848853464125,0.14097543609825555,0.03621603081905733,0.2609449750637669,0.09719008264462808,4.737194547137081e-07,0.2899405780148401,0.08264462809917351
265,0.5,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions elevated in endometrial polyp formation? Yes, increased expression of VEGF and TGF-beta1 is associated with endometrial polyp formation, contributing to angiogenesis and tissue remodeling processes involved in polyp growth.",5.921493183921349e-07,0.27797392843619306,0.15363422901064355,0.045335661619546816,0.31498019417378353,0.14097543609825555,0.045270038523821665,0.3909981033119645,0.09719008264462808,5.921493183921352e-07,0.4234719706393628,0.08264462809917351
265,0.5,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Does the development of endometrial polyps involve increased levels of VEGF and TGF-beta1? Yes, endometrial polyp formation is connected to higher expressions of vascular endothelial growth factor and transforming growth factor-beta1, which play roles in angiogenesis and tissue remodeling related to polyp growth.",4.974054274493935e-07,0.1414090393234253,0.17993079584775093,0.038081955760419325,0.21232604011370126,0.14097543609825555,0.0380268323600102,0.2856375876541386,0.09719008264462808,4.974054274493935e-07,0.3152583859991318,0.08264462809917351
265,0.5,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is increased expression of vascular endothelial growth factor and transforming growth factor-beta1 observed in endometrial polyp formation? Yes, the formation of endometrial polyps is associated with elevated VEGF and TGF-beta1, growth factors that contribute to angiogenesis and tissue remodeling involved in polyp development.",4.974054274493935e-07,0.1414090393234253,0.17993079584775093,0.038081955760419325,0.21232604011370126,0.14097543609825555,0.0380268323600102,0.2856375876541386,0.09719008264462808,4.974054274493935e-07,0.3152583859991318,0.08264462809917351
265,0.5,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is the presence of endometrial polyps linked to upregulated vascular endothelial growth factor and transforming growth factor-beta1? Yes, endometrial polyps show increased expression of VEGF and TGF-beta1, which are crucial for angiogenesis and tissue remodeling, aiding polyp growth.",6.158352911278202e-07,0.30562816012797,0.15292462300824478,0.04714908808432869,0.34237916836189886,0.14097543609825555,0.04708084006477453,0.41916898027866134,0.09719008264462808,6.158352911278206e-07,0.4524595075126143,0.08264462809917351
265,0.5,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Are higher levels of vascular endothelial growth factor and transforming growth factor-beta1 found in endometrial polyp formation? Yes, increased expression of these growth factors, VEGF and TGF-beta1, is associated with the development and growth of endometrial polyps through angiogenesis and tissue remodeling.",5.210914001850789e-07,0.16550659090248532,0.17993079584775093,0.0398953822252012,0.23701865270407296,0.14097543609825555,0.039837633900963065,0.31095539563843033,0.09719008264462808,5.210914001850789e-07,0.3412338724023898,0.08264462809917351
265,0.5,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is the expression of VEGF and TGF-beta1 elevated in cases of endometrial polyp formation? Yes, endometrial polyps are linked to increased levels of vascular endothelial growth factor and transforming growth factor-beta1, which facilitate angiogenesis and tissue remodeling contributing to polyp growth.",5.447773729207643e-07,0.19019920349285702,0.17993079584775093,0.04170880868998307,0.2623364606883647,0.14097543609825555,0.04164843544191593,0.3369308820416883,0.09719008264462808,5.447773729207643e-07,0.36790211948455065,0.08264462809917351
265,0.5,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Does endometrial polyp formation involve increased vascular endothelial growth factor and transforming growth factor-beta1 expression? Yes, the formation of these polyps correlates with elevated VEGF and TGF-beta1, growth factors that support angiogenesis and tissue remodeling in polyp development.",6.158352911278202e-07,0.2681607449625676,0.17993079584775093,0.04714908808432869,0.34237916836189886,0.14097543609825555,0.04708084006477453,0.41916898027866134,0.09719008264462808,6.158352911278206e-07,0.4524595075126143,0.08264462809917351
266,0.5,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Does misclassification of gestational age account for the birthweight differences between Australian aborigines and whites? Gestational age misclassification might partially explain the birthweight gap between Australian aborigines and whites, but it is not the only reason. Other elements like socioeconomic inequalities also play a role.",0.0,0.06301338005090518,0.0416280665760915,0.0,0.06447880749394796,0.045643755614926625,0.0,0.0,0.0,0.0,0.0,0.0
266,0.5,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Is gestational age misclassification responsible for the birthweight disparities observed between Australian aborigines and whites? While gestational age misclassification may partly explain the birthweight differences between Australian aborigines and whites, it is not the sole cause. Additional factors such as socioeconomic status differences contribute as well.",2.3685972735685406e-08,0.05818043788090321,0.02321912509022689,0.0018134264647818726,0.05742706313623902,0.0242279317005899,0.0018108015409528666,0.024298102261311794,0.0005527295193310314,2.3685972735685406e-08,0.024097551579060017,0.0
266,0.5,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Can the difference in birthweights between Australian aborigines and whites be explained by gestational age misclassification? Gestational age misclassification could be a contributing factor to the birthweight differences between Australian aborigines and whites, but it is not the only one. Other influences like socioeconomic disparities are also involved.",7.105791820705622e-08,0.16852229915124672,0.0690267101914011,0.005440279394345618,0.1361252279086509,0.04865627767725671,0.0054324046228586,0.07119333872682354,0.001584616103165664,7.105791820705622e-08,0.07061756721395396,0.0
266,0.5,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Does the misclassification of gestational age explain why Australian aborigines and whites have different birthweights? Misclassification of gestational age may help explain some of the birthweight differences between Australian aborigines and whites, but it is not the only factor. Socioeconomic disparities and other variables also contribute.",2.3685972735685406e-08,0.0889869792391238,0.04402163988312635,0.0018134264647818726,0.05742706313623902,0.0242279317005899,0.0018108015409528666,0.024298102261311794,0.0005527295193310314,2.3685972735685406e-08,0.024097551579060017,0.0
266,0.5,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Is the birthweight difference between Australian aborigines and whites due to gestational age misclassification? Gestational age misclassification might explain part of the birthweight difference between Australian aborigines and whites, but it is not the sole explanation. Other factors, including socioeconomic disparities, also have an impact.",0.0,0.0,0.0,0.0,0.032239403746974205,0.022221220548516427,0.0,0.09902102579427963,0.07038746557994595,0.0,0.1014361727648696,0.07271468144044323
266,0.5,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Does gestational age misclassification account for the birthweight variation between Australian aborigines and whites? Gestational age misclassification may partly account for the birthweight variation between Australian aborigines and whites, but it is not the only reason. Other factors such as socioeconomic differences also influence the outcome.",2.3685972735685406e-08,0.06504572755197557,0.050684992769934906,0.0018134264647818726,0.10010638699102081,0.08079479874351667,0.0018108015409528666,0.13689891647355923,0.11207023542023624,2.3685972735685406e-08,0.14093749141140366,0.11687363038714388
266,0.5,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Could gestational age misclassification be the reason for the birthweight differences between Australian aborigines and whites? Gestational age misclassification might contribute to the birthweight differences between Australian aborigines and whites, yet it is not the only contributing factor. Socioeconomic disparities and other factors also play a role.",4.737194547137081e-08,0.023903921249885496,0.012808346266458104,0.0036268529295637453,0.010419259084665455,0.03813280736357663,0.003621603081905733,0.0464997358688235,0.06620464009518144,4.737194547137081e-08,0.04909016225166862,0.06937499999999999
266,0.5,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Is the difference in birthweights between Australian aborigines and whites explained by gestational age misclassification? Gestational age misclassification may explain some differences in birthweights between Australian aborigines and whites, but it is not the sole factor. Other aspects like socioeconomic disparities also contribute.",4.737194547137081e-08,0.02401523704528552,0.014507750994237456,0.0036268529295637453,0.05391866435451753,0.004376037640070912,0.003621603081905733,0.11975523265533106,0.05071157946698568,4.737194547137081e-08,0.12110243909363172,0.05113221329437545
266,0.5,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Does gestational age misclassification explain the disparity in birthweights between Australian aborigines and whites? Gestational age misclassification could contribute to the disparity in birthweights between Australian aborigines and whites, but it is not the only factor involved. Socioeconomic disparities and other factors also matter.",2.3685972735685406e-08,0.09259732176930324,0.04124003831756573,0.0018134264647818726,0.12562194260894666,0.0679552925706772,0.0018108015409528666,0.16015083092241778,0.09580340552728026,2.3685972735685406e-08,0.1633220487023599,0.09876543209876547
266,0.5,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Is gestational age misclassification the cause of birthweight differences between Australian aborigines and whites? Gestational age misclassification may play a role in the birthweight differences between Australian aborigines and whites, but it is not the only cause. Other elements such as socioeconomic disparities are also influential.",2.3685972735685406e-08,0.027373896522683516,0.003119631572877063,0.0018134264647818726,0.005586316914663048,0.01972386587771202,0.0018108015409528666,0.04018070523263706,0.04557964009518144,2.3685972735685406e-08,0.04191646561712403,0.047500000000000014
267,0.5,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does the distribution of health care benefits in Kenya align with the principles of universal coverage? Answer: Universal coverage principles dictate that health care benefits must be allocated based on need. However, Kenya's health sector is evidently inequitable, and benefits are not distributed according to need. Focused efforts are necessary to restructure the Kenyan health system.",9.474389094274162e-08,0.02012605172789872,0.06310013717421128,0.0072537058591274906,0.024920066907852423,0.0325259476218471,0.007243206163811466,0.04755733706628362,0.017236072637734686,9.474389094274162e-08,0.07275935428242919,0.0
267,0.5,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Answer: Universal coverage requires that everyone receives health care benefits according to their needs. The Kenyan health sector is clearly unfair, with benefits not allocated based on need. Intentional measures should be taken to reform the Kenyan health system.",1.6580180914979784e-07,0.11620569945609294,0.0054494598765432445,0.012693985253473108,0.1091231954277605,0.012301530612244892,0.012675610786670066,0.10471575090623375,0.017236072637734686,1.6580180914979784e-07,0.13102826240640475,0.0
267,0.5,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does Kenya's health care benefits distribution adhere to the principles of universal coverage? Answer: The principles of universal coverage mandate that all individuals benefit from health care according to their needs. The Kenyan health sector is evidently inequitable, and benefits are not distributed by need. Targeted efforts should be made to restructure the Kenyan health system.",9.474389094274162e-08,0.07889497406637869,0.006834567901234573,0.0072537058591274906,0.07533077094857576,0.0036623747131988987,0.007243206163811466,0.07322945486480048,0.0012758533145614953,9.474389094274162e-08,0.07275935428242919,0.0
267,0.5,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Are health care benefits in Kenya distributed according to the principles of universal coverage? Answer: Universal coverage principles require that health care benefits be provided based on need. The Kenyan health sector is clearly inequitable, with benefits not distributed on this basis. Deliberate restructuring of the Kenyan health system is needed.",2.1317375462116866e-07,0.13261846288538637,0.02090214554376317,0.016320838183036854,0.15047666913661173,0.010770975056689343,0.0162972138685758,0.14472108551993212,0.017236072637734686,2.1317375462116866e-07,0.17185025692665912,0.0
267,0.5,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does the Kenyan health care benefits distribution fulfill universal coverage principles? Answer: Universal coverage demands that health care benefits be allocated according to need. The Kenyan health sector is evidently unfair, and benefits are not distributed based on need. Focused restructuring efforts are necessary for the Kenyan health system.",2.6054570009253947e-07,0.2832939466804705,0.13536155202821867,0.0199476911126006,0.2333912897771584,0.055965136054421716,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
267,0.5,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Is the distribution of health care benefits in Kenya in line with universal coverage principles? Answer: Principles of universal coverage require health care benefits to be allocated according to need. The Kenyan health sector is clearly inequitable, and benefits are not distributed on this basis. Intentional efforts should focus on restructuring the health system in Kenya.",9.474389094274162e-08,0.004629204720670632,0.045365645697911045,0.0072537058591274906,0.024920066907852423,0.0325259476218471,0.007243206163811466,0.04755733706628362,0.017236072637734686,9.474389094274162e-08,0.07275935428242919,0.0
267,0.5,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does Kenya's distribution of health care benefits satisfy the principles of universal coverage? Answer: Universal coverage principles state that health care benefits should be distributed according to need. The Kenyan health sector is evidently inequitable, with benefits not allocated based on need. Deliberate restructuring of the Kenyan health system is essential.",2.1317375462116866e-07,0.13261846288538637,0.02090214554376317,0.016320838183036854,0.15047666913661173,0.010770975056689336,0.0162972138685758,0.14472108551993212,0.017236072637734686,2.1317375462116866e-07,0.17185025692665912,0.0
267,0.5,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Are the principles of universal coverage met by the distribution of health care benefits in Kenya? Answer: Universal coverage requires that all receive health care benefits according to need. The Kenyan health sector is clearly inequitable, and benefits are not distributed on this basis. Focused efforts should be directed towards restructuring the Kenyan health system.",1.1842986367842703e-07,0.07440870097944874,0.008765432098765472,0.009067132323909363,0.06940808915271957,0.013719282091534848,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
267,0.5,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does the allocation of health care benefits in Kenya comply with universal coverage principles? Answer: The principles of universal coverage require health care benefits to be provided according to need. The Kenyan health sector is evidently inequitable, with benefits not distributed by need. Intentional restructuring efforts are necessary for the Kenyan health system.",1.6580180914979784e-07,0.11620569945609294,0.0054494598765432445,0.012693985253473108,0.1091231954277605,0.012301530612244892,0.012675610786670066,0.10471575090623375,0.017236072637734686,1.6580180914979784e-07,0.13102826240640475,0.0
267,0.5,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Is the Kenyan health care benefits distribution consistent with the principles of universal coverage? Answer: Universal coverage principles require that health care benefits be allocated based on need. The Kenyan health sector is clearly inequitable, and benefits are not distributed according to need. Deliberate efforts should be made to restructure the Kenyan health system.",1.4211583641411244e-07,0.14014334721710497,0.09394290123456789,0.010880558788691236,0.12509808519282561,0.045698469387755083,0.0108648092457172,0.08529766504913106,0.017236072637734686,1.4211583641411244e-07,0.11122563511022499,0.0
268,0.5,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: What is the long-term importance of postictal psychotic episodes II? Do they forecast interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) do not always predict interictal psychotic episodes (IPEs). Although PPEs can happen right after seizures, their long-term role in anticipating IPEs is",4.737194547137081e-08,0.07149151684630972,0.08019405940403868,0.0036268529295637453,0.0464997358688235,0.06620464009518144,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
268,0.5,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: How significant are postictal psychotic episodes II over the long term? Are they indicators of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not reliable predictors of interictal psychotic episodes (IPEs). PPEs may arise immediately post-seizure, but their long-term predictive value for IPEs is",0.0,0.09241962407465998,0.06414581811541276,0.0,0.06301338005090429,0.0446485260770975,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
268,0.5,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: What is the long-term relevance of postictal psychotic episodes II? Can they predict interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) do not necessarily serve as predictors for interictal psychotic episodes (IPEs). While PPEs occur soon after seizures, their long-term significance in forecasting IPEs is",0.0,0.12322616543287968,0.08669749866270601,0.0,0.09452007007635643,0.06728501892915088,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
268,0.5,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: Long-term importance of postictal psychotic episodes II: Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not inherently predictive of interictal psychotic episodes (IPEs). Although PPEs may follow seizures immediately, their long-term predictive significance for IPEs is",9.474389094274162e-08,0.05064485104980809,0.02433714464602499,0.0072537058591274906,0.07325549678650756,0.015493060628195762,0.007243206163811466,0.10094507507642758,0.00238063831257343,9.474389094274162e-08,0.10008345855698142,0.0
268,0.5,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: What is the long-term impact of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) do not inherently predict interictal psychotic episodes (IPEs). PPEs might occur right after seizures, but their long-term role in predicting IPEs is",4.737194547137081e-08,0.03925211309933507,0.056623311190205056,0.0036268529295637453,0.01349272727073103,0.04249999999999998,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
268,0.5,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: Long-term significance of postictal psychotic episodes II: Are they indicators of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily indicators of interictal psychotic episodes (IPEs). While PPEs can happen immediately after seizures, their long-term importance in predicting IPEs is",7.105791820705622e-08,0.021413144818899443,0.029076373670968325,0.005440279394345618,0.046026979877014984,0.01728531855955677,0.0054324046228586,0.07473861686064831,0.0017409330596143968,7.105791820705622e-08,0.07410797215372344,0.0
268,0.5,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: How predictive are postictal psychotic episodes II for interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) do not always predict interictal psychotic episodes (IPEs). PPEs may manifest immediately post-seizure, but their long-term predictive value for IPEs is",1.8948778188548293e-07,0.10167601211721156,0.05639501462597293,0.014507411718254981,0.11315211205811737,0.06224489795918367,0.014486412327622933,0.17361265045717467,0.023242630385487524,1.8948778188548325e-07,0.21130909366720596,0.0
268,0.5,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: What is the long-term predictive value of postictal psychotic episodes II regarding interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). Although PPEs occur immediately after seizures, their long-term significance in predicting IPEs is",7.105791820705622e-08,0.044600872377285494,0.07670641368327982,0.005440279394345618,0.021597135299565196,0.06562499999999999,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
268,0.5,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: Long-term meaning of postictal psychotic episodes II: Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) do not necessarily predict interictal psychotic episodes (IPEs). While PPEs may arise immediately following seizures, their long-term significance in forecasting IPEs is",9.474389094274162e-08,0.01697926412677253,0.07304601899196503,0.0072537058591274906,0.003940778730513017,0.06501643655489808,0.007243206163811466,0.06539906581694366,0.023242630385487524,9.474389094274162e-08,0.10008345855698142,0.0
268,0.5,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Question: What is the long-term implication of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not always predictive of interictal psychotic episodes (IPEs). Though PPEs can occur right after seizures, their long-term predictive significance for IPEs is",0.0,0.061613082716439393,0.04206125204046199,0.0,0.031506690025452144,0.022183224271267066,0.0,0.0,0.0,0.0,0.0,0.0
269,0.5,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness affect microvascular function in healthy adults who are at risk of Type 2 diabetes? Yes, aerobic fitness positively impacts microvascular function in these individuals. Engaging in regular aerobic exercise enhances blood flow and boosts the density of small blood vessels.",3.079176455639103e-07,0.09142572051940379,0.1164940828402367,0.023574544042164344,0.07817497726160827,0.13562500000000002,0.023540420032387266,0.07216048040122036,0.14617283950617282,3.079176455639103e-07,0.10106552383949063,0.131358024691358
269,0.5,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Is there an effect of aerobic fitness on microvascular function in healthy adults at risk for Type 2 diabetes? Indeed, aerobic fitness improves microvascular function in such adults. Consistent aerobic activity promotes better blood circulation and increases the number of small blood vessels.",3.079176455639103e-07,0.09142572051940379,0.1164940828402367,0.023574544042164344,0.07817497726160827,0.13562500000000002,0.023540420032387266,0.07216048040122036,0.14617283950617282,3.079176455639103e-07,0.10106552383949063,0.131358024691358
269,0.5,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Can aerobic fitness influence microvascular function in healthy adults predisposed to Type 2 diabetes? Yes, it does. Regular aerobic exercise supports improved microvascular function by enhancing blood flow and raising small vessel density.",5.447773729207635e-07,0.30766010899376406,0.1562825182101977,0.0417088086899831,0.32394778189247964,0.16000000000000003,0.04164843544191597,0.3598425528530016,0.14617283950617282,5.447773729207643e-07,0.3973313399826619,0.131358024691358
269,0.5,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness have an impact on microvascular function in healthy adults who might develop Type 2 diabetes? Yes, it positively affects microvascular function. Routine aerobic workouts improve blood circulation and increase the density of microvessels.",4.737194547137076e-07,0.1747262515190795,0.1875,0.03626852929563746,0.23157446176146435,0.16000000000000003,0.036216030819057346,0.2645323730486764,0.14617283950617282,4.737194547137081e-07,0.2988912671694086,0.131358024691358
269,0.5,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Is microvascular function in healthy adults at risk of Type 2 diabetes influenced by aerobic fitness? Yes, aerobic fitness benefits microvascular function. Regular aerobic exercise helps increase blood flow and the density of small blood vessels.",4.737194547137076e-07,0.1747262515190795,0.1875,0.03626852929563746,0.23157446176146435,0.16000000000000003,0.036216030819057346,0.2645323730486764,0.14617283950617282,4.737194547137081e-07,0.2988912671694086,0.131358024691358
269,0.5,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness contribute to microvascular function in healthy adults susceptible to Type 2 diabetes? Yes, aerobic fitness enhances microvascular function by improving blood flow and the density of small vessels through regular aerobic exercise.",4.974054274493929e-07,0.2852605155170309,0.12890625,0.03808195576041934,0.2614274249111461,0.16000000000000003,0.03802683236001022,0.29530403171543007,0.14617283950617282,4.974054274493935e-07,0.33063996548398844,0.131358024691358
269,0.5,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Can microvascular function in healthy adults at risk of Type 2 diabetes be improved by aerobic fitness? Yes, aerobic fitness positively influences microvascular function by increasing blood flow and small vessel density with consistent aerobic exercise.",4.737194547137076e-07,0.21433466183679073,0.15895328719723184,0.03626852929563746,0.23157446176146435,0.16000000000000003,0.036216030819057346,0.2645323730486764,0.14617283950617282,4.737194547137081e-07,0.2988912671694086,0.131358024691358
269,0.5,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Is there a relationship between aerobic fitness and microvascular function in healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness positively affects microvascular function, as regular aerobic exercise improves blood flow and small vessel density.",4.500334819780223e-07,0.1850635512501575,0.15974489795918367,0.03445510283085558,0.20258692488821284,0.16000000000000003,0.03440522927810447,0.2346794098989946,0.14617283950617282,4.500334819780227e-07,0.2681196085026549,0.131358024691358
269,0.5,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness play a role in microvascular function among healthy adults at risk of developing Type 2 diabetes? Yes, it does. Regular aerobic exercise enhances microvascular function by boosting blood flow and increasing the density of small vessels.",4.026615365066517e-07,0.1289695838378928,0.16120343316289262,0.030828249901291835,0.14701707373340067,0.16000000000000003,0.030783626196198732,0.17752099605904625,0.14617283950617282,4.026615365066519e-07,0.20927910847972164,0.131358024691358
269,0.5,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness impact the microvascular function of healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness improves microvascular function by promoting better blood flow and increasing the density of small blood vessels through regular aerobic activity.",4.026615365066517e-07,0.1654510143936796,0.13503086419753085,0.030828249901291835,0.14701707373340067,0.16000000000000003,0.030783626196198732,0.17752099605904625,0.14617283950617282,4.026615365066519e-07,0.20927910847972164,0.131358024691358
270,0.5,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does initiating migraine treatment early reduce the time to reach headache peak and lessen its intensity? Early treatment with triptans might shorten the interval from migraine onset to peak but does not decrease headache severity.,7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
270,0.5,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early intervention in migraine shorten the time to headache peak and mitigate its severity? Early use of triptans may reduce the duration from migraine start to peak but does not relieve the headache.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
270,0.5,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does treating migraines early shorten the time until the headache peaks and lower its severity? Early treatment including triptans could lead to a quicker peak time but does not reduce headache intensity.,1.421158364141118e-07,0.17693070815907896,0.0,0.01088055878869127,0.18232155679395534,0.0,0.010864809245717241,0.18805223150294026,0.0,1.4211583641411244e-07,0.19415601444095776,0.0
270,0.5,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is the time to headache peak shortened and severity reduced by early migraine treatment? Early use of triptans may shorten the time from migraine onset to peak but does not ease the headache.,1.184298636784265e-07,0.18850370862949672,0.031217481789802305,0.009067132323909391,0.14953173397096364,0.0,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
270,0.5,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early migraine treatment speed up reaching headache peak and lessen headache severity? Early treatment with triptans might shorten the time to peak but does not alleviate headache pain.,2.131737546211677e-07,0.27871340246902143,0.0,0.01632083818303691,0.2876820724517808,0.0,0.016297213868575862,0.29725152346793093,0.0,2.1317375462116866e-07,0.3074846997479619,0.0
270,0.5,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early treatment of migraines reduce the duration to headache peak and decrease its severity? Early triptan use may shorten the time from migraine onset to peak but does not lessen headache severity.,1.184298636784265e-07,0.14518200984449914,0.0,0.009067132323909391,0.14953173397096364,0.0,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
270,0.5,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early intervention with triptans shorten time to migraine headache peak and reduce its severity? Early treatment may lead to a shorter time to peak but does not relieve the headache.,1.658018091497971e-07,0.2559303430194002,0.033293697978596916,0.01269398525347315,0.2162231084696371,0.0,0.012675610786670115,0.22314355131420927,0.0,1.6580180914979784e-07,0.23052365861183244,0.0
270,0.5,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is early migraine treatment effective in shortening time to headache peak and reducing severity? Early use of triptans can shorten the duration to peak but does not reduce headache intensity.,1.894877818854824e-07,0.24362208265775243,0.0,0.01450741171825503,0.2513144282809061,0.0,0.014486412327622988,0.25951119548508395,0.0,1.8948778188548325e-07,0.2682639865946794,0.0
270,0.5,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does starting migraine treatment early shorten the duration to headache peak and reduce its severity? Early triptan treatment may lead to a quicker peak but does not alleviate headache symptoms.,1.894877818854824e-07,0.24362208265775243,0.0,0.01450741171825503,0.2513144282809061,0.0,0.014486412327622988,0.25951119548508395,0.0,1.8948778188548325e-07,0.2682639865946794,0.0
270,0.5,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early treatment of migraines shorten time to headache peak and decrease severity? Early use of triptans may shorten the time from onset to peak but does not improve headache severity.,1.658018091497971e-07,0.20972053098207066,0.0,0.01269398525347315,0.2162231084696371,0.0,0.012675610786670115,0.22314355131420927,0.0,1.6580180914979784e-07,0.23052365861183244,0.0
271,0.5,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? The consultation resulted in changes to the treatment plan in over one third of cases. Additional research is required to assess if these changes enhance outcomes for older patients.,2.1317375462116866e-07,0.09363356020013835,0.07439043209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.5,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients altered by a geriatric oncology consultation? More than one third of cases saw modifications to the treatment plan following the consultation. Further studies must evaluate whether these adjustments improve outcomes for older adults.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.5,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting a geriatric oncologist affect the cancer treatment strategy for elderly patients? The consultation modified the treatment plan in over one third of cases. Additional studies are necessary to determine if these modifications lead to better outcomes for older patients.,2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.5,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation influence the cancer treatment plan for elderly patients? Treatment plans were changed in more than one third of cases after the consultation. Further research is needed to understand if these changes improve patient outcomes.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.5,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a consultation in geriatric oncology alter cancer treatment plans for elderly patients? The treatment plan was modified in over one third of cases following the consultation. More studies are required to see if these changes improve outcomes for older individuals.,2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.5,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Does a geriatric oncology consultation impact the cancer treatment plan for elderly patients? In more than one third of cases, the consultation led to treatment plan modifications. Further investigation is needed to confirm if these changes enhance outcomes for elderly patients.",2.3685972735685406e-07,0.15382883325821428,0.04890393625389012,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.5,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation? The consultation caused changes in over one third of cases. Additional studies are necessary to verify if these modifications improve the outcomes for older patients.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.5,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation result in changes to the cancer treatment plan for elderly patients? More than one third of cases had their treatment plans altered after the consultation. Further research is essential to determine if these changes benefit older patients.,2.1317375462116866e-07,0.05982150261184849,0.09876543209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.5,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting a geriatric oncologist change the cancer treatment plan for elderly patients? The consultation led to modifications in the treatment plan in over one third of cases. Further studies are needed to evaluate whether these changes improve outcomes for elderly patients.,2.1317375462116866e-07,0.12744561778842822,0.050113229600409114,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.5,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation modify cancer treatment plans for elderly patients? More than one third of cases experienced changes to their treatment plans following the consultation. Additional research is required to assess if these modifications improve outcomes for older patients.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
272,0.5,1,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is it possible for computerized tomography to substitute bone scintigraphy in identifying bone metastases originating from breast cancer? Answer: Both computerized tomography (CT) and bone scintigraphy serve as imaging methods to detect bone metastases from breast cancer. Although CT can,1.184298636784265e-07,0.1929440081010898,0.04012345679012341,0.00906713232390937,0.21874784863818242,0.05859375,0.009054007704764347,0.18308751829384207,0.0302734375,1.1842986367842703e-07,0.14518200984449914,0.0
272,0.5,2,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can computerized tomography take the place of bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: Computerized tomography (CT) and bone scintigraphy are imaging techniques utilized to identify bone metastases from breast cancer. While CT is capable of,1.184298636784265e-07,0.22760136712908707,0.06438194951708463,0.00906713232390937,0.21874784863818242,0.05859375,0.009054007704764347,0.18308751829384207,0.0302734375,1.1842986367842703e-07,0.14518200984449914,0.0
272,0.5,3,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Could computerized tomography replace bone scintigraphy when detecting bone metastases from breast cancer? Answer: Imaging methods like computerized tomography (CT) and bone scintigraphy are used to find bone metastases from breast cancer. CT can,2.36859727356853e-08,0.03481230309644445,0.0037983881622407067,0.0018134264647818796,0.03232407609285426,0.0017600481269510818,0.0018108015409528735,0.032084437417815526,0.0009440442898023052,2.3685972735685406e-08,0.031748698314579826,0.0
272,0.5,4,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is computerized tomography a viable replacement for bone scintigraphy in the detection of bone metastases caused by breast cancer? Answer: Both computerized tomography (CT) and bone scintigraphy are imaging techniques used to detect bone metastases from breast cancer. CT can,1.184298636784265e-07,0.22760136712908707,0.06438194951708463,0.00906713232390937,0.21874784863818242,0.05859375,0.009054007704764347,0.18308751829384207,0.0302734375,1.1842986367842703e-07,0.14518200984449914,0.0
272,0.5,5,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can CT scans supplant bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Computerized tomography (CT) and bone scintigraphy are both imaging modalities used for detecting bone metastases from breast cancer. While CT can,4.73719454713706e-08,0.10374224208175642,0.032369146005509636,0.003626852929563752,0.06168878756909857,0.003230428200692026,0.003621603081905747,0.0612410097391578,0.0017267246972318406,4.737194547137081e-08,0.060624621816435464,0.0
272,0.5,6,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: May computerized tomography replace bone scintigraphy for identifying bone metastases due to breast cancer? Answer: Both computerized tomography (CT) and bone scintigraphy are imaging techniques employed to detect bone metastases from breast cancer. CT can,0.0,0.07921682063542201,0.05392795138888887,0.0,0.0815467271246999,0.05859375,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0
272,0.5,7,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is it feasible for computerized tomography to replace bone scintigraphy in the detection of breast cancer bone metastases? Answer: Computerized tomography (CT) and bone scintigraphy are imaging techniques used to detect bone metastases from breast cancer. While CT can,9.47438909427412e-08,0.23516361770981797,0.08775667559451342,0.0072537058591274975,0.19277236223492444,0.05859375,0.00724320616381148,0.1564192712116812,0.0302734375,9.474389094274162e-08,0.11778303565638382,0.0
272,0.5,8,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can computerized tomography serve as an alternative to bone scintigraphy in detecting bone metastases from breast cancer? Answer: Both computerized tomography (CT) and bone scintigraphy are imaging methods used to detect bone metastases from breast cancer. CT can,7.10579182070559e-08,0.0978729970465948,0.010330578512396688,0.005440279394345625,0.09116928482195785,0.004716198979591822,0.005432404622858614,0.09051212032579103,0.0025183354591836703,7.105791820705622e-08,0.08961215868968697,0.0
272,0.5,9,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Does computerized tomography have the potential to replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Computerized tomography (CT) and bone scintigraphy are imaging techniques used to identify bone metastases from breast cancer. While CT can,1.184298636784265e-07,0.15828664907309253,0.016439909297052135,0.00906713232390937,0.14765583011921413,0.00746153670562455,0.009054007704764347,0.14660608773805572,0.003976870662892627,1.1842986367842703e-07,0.14518200984449914,0.0
272,0.5,10,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Could CT be used instead of bone scintigraphy to detect bone metastases in breast cancer patients? Answer: Computerized tomography (CT) and bone scintigraphy are both imaging techniques utilized to detect bone metastases from breast cancer. While CT can,7.10579182070559e-08,0.13435442760238114,0.03508266051518645,0.005440279394345625,0.09116928482195785,0.004716198979591822,0.005432404622858614,0.09051212032579103,0.0025183354591836703,7.105791820705622e-08,0.08961215868968697,0.0
273,0.5,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should patients infected with HIV undergo screening for silent myocardial ischemia using gated myocardial perfusion SPECT? At present, there is no agreement on routine screening for silent myocardial ischemia in HIV-infected individuals with gated myocardial perfusion SPECT. More studies are required to assess the advantages, potential harms, and cost-effectiveness of this approach in this group. Healthcare providers should weigh individual patient circumstances and existing guidelines when deciding on screening.",4.737194547137081e-08,0.05456409258140926,0.017158703961837135,0.0036268529295637453,0.032851929263171264,0.0018130297497083794,0.003621603081905733,0.03208443741781242,0.0009440442898022948,4.737194547137081e-08,0.009924937948410317,0.015380859375
273,0.5,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is it recommended to screen HIV-positive patients for silent myocardial ischemia via gated myocardial perfusion SPECT? Currently, no consensus exists on routine screening of HIV-infected patients for silent myocardial ischemia using gated myocardial perfusion SPECT. Additional research is necessary to determine the benefits, risks, and economic feasibility of such screening. Clinicians should base their screening decisions on patient-specific factors and clinical guidelines.",1.1842986367842703e-07,0.06810648013957366,0.00737757032865545,0.009067132323909363,0.08715190952543228,0.005052679496953247,0.009054007704764333,0.0850169698594625,0.0026390894628908305,1.1842986367842703e-07,0.1065933427609762,0.017236072637734686
273,0.5,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should silent myocardial ischemia screening with gated myocardial perfusion SPECT be performed on patients with HIV? There is no established consensus on routinely screening HIV-infected patients for silent myocardial ischemia using gated myocardial perfusion SPECT at this time. Further investigation is needed to evaluate the screening's benefits, risks, and cost-effectiveness in this population. Screening decisions should be individualized, considering patient factors and professional guidelines.",7.105791820705622e-08,0.009512157509756314,0.025792385434639048,0.005440279394345618,0.029021222036811345,0.013011857435314612,0.0054324046228586,0.027413657468905228,0.014828592900913398,7.105791820705622e-08,0.04879016416943571,0.0
273,0.5,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is screening for silent myocardial ischemia using gated myocardial perfusion SPECT advisable for HIV-infected patients? Currently, consensus is lacking on whether HIV patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. More research is essential to understand the screening's benefits, risks, and cost-effectiveness. Clinicians should take into account individual patient profiles and guidelines when deciding on screening.",1.1842986367842703e-07,0.09083261720711278,0.008258135778431208,0.009067132323909363,0.13336172156276405,0.037491580983473854,0.009054007704764333,0.15550651364521784,0.05280172259977238,1.1842986367842703e-07,0.17829822350855729,0.06858710562414265
273,0.5,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should HIV-infected individuals be routinely screened for silent myocardial ischemia with gated myocardial perfusion SPECT? There is no current consensus on routine screening for silent myocardial ischemia in HIV patients using gated myocardial perfusion SPECT. Further studies are needed to clarify the benefits, potential risks, and cost-effectiveness of this screening strategy. Screening choices should be guided by patient-specific factors and clinical recommendations.",1.1842986367842703e-07,0.045380343072033646,0.02325387746307947,0.009067132323909363,0.0640470035067695,0.011412355270416293,0.009054007704764333,0.06152045526421013,0.014273367639980654,1.1842986367842703e-07,0.08269171584511614,0.0
273,0.5,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is it appropriate to use gated myocardial perfusion SPECT to screen HIV-positive patients for silent myocardial ischemia? At present, no consensus supports routine screening of HIV-infected patients for silent myocardial ischemia using gated myocardial perfusion SPECT. Additional research must assess the benefits, risks, and cost-effectiveness of this practice. Decisions about screening should consider individual patient details and relevant guidelines.",1.8948778188548325e-07,0.10168864594053106,0.019127994731916495,0.014507411718254981,0.11898844094989869,0.008804715312822516,0.014486412327622933,0.11496495028809672,0.013366242120380803,1.8948778188548325e-07,0.13580154115906407,0.0
273,0.5,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should gated myocardial perfusion SPECT be used to screen for silent myocardial ischemia in patients with HIV? Currently, there is no agreement on routine screening of HIV-infected patients for silent myocardial ischemia with gated myocardial perfusion SPECT. More research is required to evaluate the benefits, risks, and cost-effectiveness of this screening method. Clinicians should consider patient-specific factors and guidelines when making screening decisions.",9.474389094274162e-08,0.027287069210935044,0.0245430300123725,0.0072537058591274906,0.04638139470218228,0.012225099628965827,0.007243206163811466,0.0443217283712416,0.014555603019334038,9.474389094274162e-08,0.06559728248581642,0.0
273,0.5,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is it necessary to screen HIV-infected patients for silent myocardial ischemia using gated myocardial perfusion SPECT? There is no current consensus on routine screening for silent myocardial ischemia in HIV patients with gated myocardial perfusion SPECT. Further research is warranted to assess the benefits, risks, and economic viability of such screening. Screening decisions should be individualized based on patient factors and clinical guidelines.",9.474389094274162e-08,0.027287069210935933,0.02454303001237247,0.0072537058591274906,0.04638139470218228,0.012225099628965834,0.007243206163811466,0.0443217283712416,0.014555603019334038,9.474389094274162e-08,0.06559728248581642,0.0
273,0.5,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should clinicians screen HIV-positive patients for silent myocardial ischemia using gated myocardial perfusion SPECT? At this time, there is no consensus on routine screening for silent myocardial ischemia in HIV-infected individuals with gated myocardial perfusion SPECT. Additional studies are needed to evaluate the potential benefits, risks, and cost-effectiveness of this approach. Screening should be tailored to individual patient circumstances and guidelines.",1.4211583641411244e-07,0.06380348977887218,0.02192302487411002,0.010880558788691236,0.08202894755291368,0.010572320503046725,0.0108648092457172,0.07902000094411754,0.013981409152067609,1.4211583641411244e-07,0.10008345855698497,0.0
273,0.5,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is routine screening for silent myocardial ischemia with gated myocardial perfusion SPECT recommended in HIV-infected patients? Currently, no consensus exists on this practice. Further research is necessary to determine the benefits, risks, and cost-effectiveness of screening in this population. Clinicians should consider patient-specific factors and existing guidelines when making screening decisions.",3.789755637709665e-07,0.130600516479503,0.10456765297328353,0.029014823436509962,0.19725654956224847,0.06127385111529163,0.028972824655245866,0.24436037366678542,0.031217481789802295,3.789755637709665e-07,0.29298712468147725,0.0
274,0.5,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Does crime relate to over-the-counter pharmacy syringe sales? Answer: No direct link exists between crime and over-the-counter pharmacy syringe sales, though improper syringe disposal or misuse may impact public health.",7.10579182070559e-08,0.10371196381111192,0.005972732485293793,0.005440279394345639,0.10292162785997583,0.003221293720401787,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
274,0.5,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Are over-the-counter pharmacy syringe sales connected to crime? Answer: Over-the-counter pharmacy syringe sales are not directly connected to crime; however, improper disposal or misuse of syringes can affect public health.",7.10579182070559e-08,0.19613158788577145,0.06982371666594836,0.005440279394345639,0.15072488169169596,0.03736962383434036,0.005432404622858621,0.15129320720708161,0.035665294924554176,7.105791820705622e-08,0.10536051565782545,0.0
274,0.5,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Is there a relationship between crime and over-the-counter pharmacy syringe sales? Answer: There is no direct relationship between crime and over-the-counter pharmacy syringe sales, but improper syringe disposal or misuse may pose public health risks.",4.73719454713706e-08,0.09479212181546126,0.10373657048184795,0.003626852929563759,0.09992049721031515,0.11146979526132728,0.003621603081905747,0.10551532315441081,0.1189060642092747,4.737194547137081e-08,0.06542657521741901,0.09274673008323425
274,0.5,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Does selling syringes over the counter at pharmacies correlate with crime? Answer: No direct correlation exists between crime and over-the-counter pharmacy syringe sales, although improper disposal or misuse of syringes can harm public health.",2.36859727356853e-08,0.11387080321755416,0.06035379812695108,0.0018134264647818796,0.07409335745175127,0.031217481789802305,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
274,0.5,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Is crime linked to the sale of syringes at pharmacies without a prescription? Answer: Crime is not directly linked to over-the-counter pharmacy syringe sales, yet improper disposal or misuse can contribute to public health issues.",4.73719454713706e-08,0.10324992977309444,0.03180708532418292,0.003626852929563759,0.10394632060143305,0.031217481789802305,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
274,0.5,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Are over-the-counter pharmacy syringe sales associated with criminal activity? Answer: There is no direct association between criminal activity and over-the-counter pharmacy syringe sales; however, improper disposal or misuse of syringes can affect public health.",2.36859727356853e-08,0.03232407609285426,0.0017600481269510818,0.0018134264647818796,0.032084437417815526,0.0009440442898023052,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
274,0.5,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Does crime have any association with the sale of syringes over the counter at pharmacies? Answer: Crime does not have a direct association with over-the-counter pharmacy syringe sales, but improper disposal or misuse of syringes may impact public health.",1.421158364141118e-07,0.17997990621206839,0.009221584832575631,0.010880558788691257,0.2151719557116576,0.031217481789802305,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
274,0.5,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Is there any crime connection to over-the-counter syringe sales at pharmacies? Answer: There is no direct crime connection to over-the-counter pharmacy syringe sales, though improper disposal or misuse of syringes can lead to public health concerns.",7.10579182070559e-08,0.055504686964177985,0.02229082997222246,0.005440279394345639,0.053717036839262544,0.0257154842340728,0.005432404622858621,0.05159995656866556,0.029384756657483937,7.105791820705622e-08,0.09531017980432521,0.0
274,0.5,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Are criminal activities related to the sale of syringes without prescription at pharmacies? Answer: Criminal activities are not directly related to over-the-counter pharmacy syringe sales; however, improper disposal or misuse of syringes can contribute to public health problems.",1.184298636784265e-07,0.11565214666041834,0.018013548811824424,0.009067132323909384,0.18850370862949672,0.031217481789802305,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
274,0.5,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Does the sale of syringes over the counter in pharmacies associate with crime? Answer: The sale of syringes over the counter at pharmacies is not directly associated with crime, but improper disposal or misuse of syringes can negatively affect public health.",1.894877818854825e-07,0.05163579233975435,0.16196454097339494,0.014507411718255002,0.09317845495922183,0.09123149780203443,0.01448641232762296,0.08739040460656167,0.1012244897959184,1.8948778188548325e-07,0.12694448639687117,0.0783673469387755
275,0.5,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Could D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Recent research indicates that D-dimer, a blood test detecting blood presence,",9.47438909427412e-08,0.1603426500751799,0.0,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
275,0.5,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: Studies have recently demonstrated that D-dimer, a blood test to identify blood presence,",7.10579182070559e-08,0.11778303565638426,0.0,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
275,0.5,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Can D-dimer be considered a new diagnostic parameter for acute appendicitis? Answer: Recent studies reveal that D-dimer, a blood test used to detect blood presence,",4.73719454713706e-08,0.07696104113612945,0.0,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,0.5,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Might D-dimer become a novel diagnostic indicator for acute appendicitis? Answer: Recent findings show that D-dimer, a blood test for detecting blood presence,",9.47438909427412e-08,0.1603426500751799,0.0,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
275,0.5,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Is it possible for D-dimer to be a new diagnostic marker for acute appendicitis? Answer: Recent studies have found that D-dimer, a blood test used to detect the presence of blood,",9.47438909427412e-08,0.13815033848081715,0.0,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
275,0.5,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Could D-dimer be introduced as a new diagnostic parameter for acute appendicitis? Answer: Recent research has shown that D-dimer, a blood test that detects blood presence,",2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.5,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Can D-dimer act as a new diagnostic tool for acute appendicitis? Answer: Recent studies indicate that D-dimer, a blood test for blood detection,",9.47438909427412e-08,0.1603426500751799,0.0,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
275,0.5,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: May D-dimer serve as a novel diagnostic parameter for acute appendicitis? Answer: Recent research shows that D-dimer, a blood test used to identify blood presence,",4.73719454713706e-08,0.07696104113612945,0.0,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,0.5,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Is D-dimer likely to become a new diagnostic marker for acute appendicitis? Answer: Recent studies demonstrate that D-dimer, a blood test detecting blood presence,",7.10579182070559e-08,0.11778303565638426,0.0,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
275,0.5,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Could D-dimer be used as a new diagnostic indicator for acute appendicitis? Answer: Recent findings have revealed that D-dimer, a blood test for detecting blood presence,",2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
276,0.5,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Can the lipid-lowering agent bezafibrate, which activates peroxisome proliferator-activated receptors, prevent colon cancer in individuals with coronary artery disease? Answer: Limited evidence indicates that bezafibrate might help prevent colon cancer in these patients.",2.3685972735685332e-07,0.2617616993409939,0.0020447074293228062,0.018134264647818747,0.29256309585745166,0.014722222222222213,0.018108015409528694,0.2904919775702224,0.0078472222222222,2.3685972735685406e-07,0.28768207245178123,0.0
276,0.5,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Does bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, reduce the risk of colon cancer in coronary artery disease patients? Answer: There is some limited evidence that bezafibrate may have a protective effect against colon cancer in this group.",4.737194547137081e-08,0.013705450822062204,0.04339250493096651,0.0036268529295637453,0.017433506001244048,0.022516436554898097,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
276,0.5,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Is the lipid-lowering drug bezafibrate, which targets peroxisome proliferator-activated receptors, effective in preventing colon cancer in patients with coronary artery disease? Answer: Evidence is limited but suggests a possible preventive role for bezafibrate.",2.3685972735685332e-07,0.13573493923918578,0.09204470742932284,0.018134264647818747,0.20591969828745738,0.047500000000000014,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
276,0.5,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Does the peroxisome proliferator-activated receptor ligand bezafibrate, known for lowering lipids, prevent colon cancer in those with coronary artery disease? Answer: Some limited data suggest bezafibrate may prevent colon cancer in these patients.",2.3685972735685332e-07,0.2617616993409939,0.0020447074293228062,0.018134264647818747,0.29256309585745166,0.014722222222222213,0.018108015409528694,0.2904919775702224,0.0078472222222222,2.3685972735685406e-07,0.28768207245178123,0.0
276,0.5,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Can bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor activator, help prevent colon cancer in patients suffering from coronary artery disease? Answer: There is limited evidence supporting a potential preventive effect.",3.316036182995945e-07,0.26494667071919276,0.09204470742932284,0.025387970506946266,0.33945109091197967,0.047500000000000014,0.025351221573340188,0.3839231431116885,0.024375,3.316036182995957e-07,0.43078291609245367,0.0
276,0.5,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Is there evidence that bezafibrate, a lipid-lowering drug activating peroxisome proliferator-activated receptors, prevents colon cancer in coronary artery disease patients? Answer: Limited evidence suggests it might.",4.026615365066504e-07,0.37414596268418343,0.09204470742932284,0.030828249901291904,0.4527797762189838,0.047500000000000014,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
276,0.5,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Does the use of bezafibrate, a peroxisome proliferator-activated receptor ligand that lowers lipids, prevent colon cancer in patients with coronary artery disease? Answer: Some limited evidence points to a preventive effect.",2.842316728282239e-07,0.1982552962205193,0.09204470742932284,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
276,0.5,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Could bezafibrate, a lipid-lowering drug activating peroxisome proliferator-activated receptors, reduce colon cancer risk in coronary artery disease patients? Answer: There is limited evidence indicating this possibility.",4.026615365066504e-07,0.37414596268418343,0.09204470742932284,0.030828249901291904,0.4527797762189838,0.047500000000000014,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
276,0.5,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Is bezafibrate, a lipid-lowering agent that activates peroxisome proliferator-activated receptors, effective in colon cancer prevention among coronary artery disease patients? Answer: Limited evidence suggests a potential benefit.",3.789755637709651e-07,0.33640563470133644,0.09204470742932284,0.029014823436510025,0.41355906306570134,0.047500000000000014,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
276,0.5,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Does bezafibrate, which lowers lipids by activating peroxisome proliferator-activated receptors, prevent colon cancer in patients with coronary artery disease? Answer: Evidence is limited but suggests it may have a preventive effect.",2.842316728282239e-07,0.1982552962205193,0.09204470742932284,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
277,0.5,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The R14C KCNQ1 mutation by itself does not cause atrial fibrillation (AF); instead, a 'second hit' such as hypertension, which increases atrial stretch, may be necessary.",6.868932093348752e-07,0.7444361038975584,0.01851192595229618,0.05258936747867438,0.7922380832041758,0.0,0.052513244687633215,0.8157495026522783,0.0,6.868932093348768e-07,0.8407831793660097,0.0
277,0.5,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","These findings indicate that the R14C KCNQ1 mutation alone cannot trigger AF, but a combination with environmental factors like hypertension that induce atrial stretch might be required.",6.632072365991899e-07,0.705215390744276,0.01851192595229618,0.0507759410138925,0.751416088683921,0.0,0.05070244314668034,0.7731898882334827,0.0,6.632072365991914e-07,0.7963314167951756,0.0
277,0.5,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Our data imply that the R14C KCNQ1 mutation is not solely responsible for AF; rather, AF may develop when accompanied by a secondary factor such as hypertension causing atrial stretch.",5.92149318392134e-07,0.5960160987792853,0.01851192595229618,0.045335661619546865,0.6380874033769168,0.0,0.04527003852382172,0.6554068525770984,0.0,5.921493183921352e-07,0.6737290947028427,0.0
277,0.5,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The R14C KCNQ1 mutation is insufficient on its own to produce AF; a secondary insult, for example hypertension leading to atrial stretch, is likely needed.",7.105791820705605e-07,0.7852580984178132,0.01851192595229618,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
277,0.5,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","These results suggest that the R14C KCNQ1 mutation alone does not cause AF, and that additional factors like hypertension-induced atrial stretch contribute to its pathogenesis.",7.105791820705605e-07,0.7852580984178132,0.01851192595229618,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
277,0.5,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby",The R14C KCNQ1 mutation by itself is inadequate to cause AF; a 'second hit' such as an environmental stressor like hypertension promoting atrial stretch is implicated.,6.868932093348752e-07,0.7444361038975584,0.01851192595229618,0.05258936747867438,0.7922380832041758,0.0,0.052513244687633215,0.8157495026522783,0.0,6.868932093348768e-07,0.8407831793660097,0.0
277,0.5,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","According to the data, the R14C KCNQ1 mutation alone cannot cause AF; instead, a 'second hit' including environmental factors like hypertension that increase atrial stretch may be necessary.",6.395212638635046e-07,0.667475062761429,0.01851192595229618,0.048962514549110624,0.7121953755306385,0.0,0.04889164160572747,0.7323678937132279,0.0,6.39521263863506e-07,0.75377180237638,0.0
277,0.5,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The evidence points to the R14C KCNQ1 mutation being insufficient alone to cause AF, with a secondary factor such as hypertension-induced atrial stretch playing a role.",6.868932093348752e-07,0.7444361038975584,0.01851192595229618,0.05258936747867438,0.7922380832041758,0.0,0.052513244687633215,0.8157495026522783,0.0,6.868932093348768e-07,0.8407831793660097,0.0
277,0.5,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby",These data propose that AF does not result solely from the R14C KCNQ1 mutation but requires a secondary trigger like hypertension that causes atrial stretch.,7.105791820705605e-07,0.7852580984178132,0.01851192595229618,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
277,0.5,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The R14C KCNQ1 mutation alone does not lead to AF; a secondary environmental factor such as hypertension, which promotes atrial stretch, is likely involved.",7.342651548062458e-07,0.8278177128366089,0.01851192595229618,0.05621622040823814,0.8792494601938055,0.0,0.05613484776953896,0.9067212808580063,0.0,7.342651548062476e-07,0.9360933591703349,0.0
278,0.5,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient to assess cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for evaluating the cervical spine in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.5,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,"Question: In geriatric blunt trauma patients with low-energy mechanisms, are clinical predictors reliable for cervical spine fractures? Answer: Clinical predictors do not seem reliable for cervical spine evaluation in geriatric trauma patients with low-energy mechanisms.",0.0,0.0815467271246999,0.044650404540514305,0.0,0.08401784006787194,0.05855226608232362,0.0,0.0433216987849967,0.031004740432419922,0.0,0.0,0.0
278,0.5,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors adequately detect cervical spine fractures in elderly patients with low-energy blunt trauma? Answer: Clinical predictors appear inadequate for cervical spine assessment in elderly trauma patients experiencing low-energy mechanisms.,7.10579182070559e-08,0.018109342425028707,0.07270408163265309,0.005440279394345639,0.011292339736452828,0.06035379812695108,0.005432404622858621,0.0551183740282557,0.031217481789802305,7.105791820705622e-08,0.10178269430994247,0.0
278,0.5,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective for identifying cervical spine fractures in geriatric blunt trauma cases involving low-energy mechanisms? Answer: Clinical predictors seem inadequate for cervical spine evaluation in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.08876045812260802,0.07836734693877552,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
278,0.5,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,"Question: In elderly blunt trauma patients with low-energy mechanisms, are clinical predictors adequate for cervical spine fracture evaluation? Answer: Clinical predictors appear insufficient for assessing the cervical spine in elderly trauma patients with low-energy mechanisms.",0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.5,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors provide adequate evaluation of cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for cervical spine assessment in geriatric trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.5,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient to evaluate cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear inadequate for evaluating cervical spine injuries in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.5,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors adequately assess cervical spine fractures in geriatric patients with low-energy blunt trauma? Answer: Clinical predictors appear insufficient for cervical spine evaluation in geriatric trauma patients with low-energy mechanisms.,7.10579182070559e-08,0.07132900345367421,0.013041903151793321,0.005440279394345639,0.05750215177378237,0.027060100148354166,0.005432404622858621,0.0551183740282557,0.031217481789802305,7.105791820705622e-08,0.10178269430994247,0.0
278,0.5,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors reliable for cervical spine fracture evaluation in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for assessing cervical spine injuries in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.5,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,"Question: In geriatric blunt trauma patients with low-energy mechanisms, are clinical predictors adequate for cervical spine fracture assessment? Answer: Clinical predictors appear inadequate for evaluating cervical spine fractures in elderly trauma patients with low-energy mechanisms.",0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
279,0.5,1,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Does the target motion vary between the upper and lower parts of the clinical target volume in the prostate bed? The study concluded that no significant difference exists in target motion between these regions.,5.68463345656449e-07,0.34534308936342883,0.13722316729855144,0.043522235154764964,0.38632899279543675,0.12244897959183676,0.043459236982868826,0.4473192206455159,0.08999999999999998,5.684633456564497e-07,0.48509819370805385,0.0736
279,0.5,2,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Is there a difference in interfractional motion of the prostate bed target between its superior and inferior sections? Findings indicate no notable motion difference between these areas of the clinical target volume.,6.158352911278196e-07,0.4105736992501776,0.13527438257632923,0.04714908808432872,0.4508675139330083,0.12244897959183676,0.04708084006477457,0.5140105951441893,0.08999999999999998,6.158352911278206e-07,0.5540910651950046,0.0736
279,0.5,3,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"According to the study, does prostate bed target motion differ between the superior and inferior portions of the clinical target volume? The results show no significant variation in motion between these parts.",6.158352911278196e-07,0.3658545263108266,0.16749660479855144,0.04714908808432872,0.4508675139330083,0.12244897959183676,0.04708084006477457,0.5140105951441893,0.08999999999999998,6.158352911278206e-07,0.5540910651950046,0.0736
279,0.5,4,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Does interfractional motion of the prostate bed target vary between the top and bottom areas of the clinical target volume? The research found no meaningful difference in motion between superior and inferior portions.,5.921493183921343e-07,0.37742752678124436,0.13627912300874914,0.045335661619546844,0.4180776911100166,0.12244897959183676,0.0452700385238217,0.4801090434685076,0.08999999999999998,5.921493183921352e-07,0.5189997453837356,0.0736
279,0.5,5,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Is there a disparity in target motion between the superior and inferior regions of the prostate bed clinical target volume? The study observed no significant difference in motion across these sections.,6.395212638635049e-07,0.3986443491338183,0.16749660479855144,0.0489625145491106,0.48476906560869004,0.12244897959183676,0.04889164160572745,0.5491019149554583,0.08999999999999998,6.39521263863506e-07,0.5904587093658793,0.0736
279,0.5,6,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Does the prostate bed target exhibit different interfractional motion in its superior versus inferior clinical target volume areas? The study reports no significant motion difference between these regions.,7.105791820705608e-07,0.5040048647916437,0.16749660479855144,0.05440279394345624,0.5939683575736807,0.12244897959183676,0.05432404622858607,0.6624306002624625,0.08999999999999998,7.105791820705622e-07,0.7082417450222636,0.0736
279,0.5,7,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Is there a significant difference in prostate bed target motion between the superior and inferior parts of the clinical target volume? The study found none.,7.816371002776167e-07,0.621787900448028,0.16749660479855144,0.05984307333780188,0.7165706796660136,0.12244897959183676,0.05975645085144469,0.790263971772347,0.08999999999999998,7.816371002776184e-07,0.8417731376467872,0.0736
279,0.5,8,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Does the clinical target volume of the prostate bed show varying interfractional motion between its superior and inferior portions? The study concluded that motion is consistent between these parts.,6.868932093348755e-07,0.46763722062076907,0.16749660479855144,0.05258936747867436,0.5562280295908337,0.12244897959183676,0.052513244687633194,0.62320988710918,0.08999999999999998,6.868932093348768e-07,0.6674197505020087,0.0736
279,0.5,9,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Are there differences in target motion between the superior and inferior portions of the prostate bed clinical target volume? The study determined no significant difference exists.,7.579511275419314e-07,0.5809659059277732,0.16749660479855144,0.05802964687302,0.674011065247218,0.12244897959183676,0.057945649310491815,0.7458122092015129,0.08999999999999998,7.57951127541933e-07,0.7952531220118932,0.0736
279,0.5,10,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Does the motion of the prostate bed target differ between upper and lower sections of the clinical target volume? The study found no significant variation in motion between these portions.,6.632072365991902e-07,0.4803491546412202,0.13305782928834736,0.05077594101389248,0.519860385419959,0.12244897959183676,0.05070244314668032,0.585469559126333,0.08999999999999998,6.632072365991914e-07,0.6281990373487263,0.0736
280,0.5,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Can mental imagery functional magnetic resonance imaging forecast recovery in patients with consciousness disorders?,1.136926691312897e-06,1.2333290479890247,0.2808159722222222,0.08704447030953003,1.401493758266116,0.14532871972318342,0.08691847396573776,1.5151665689405815,0.11649408284023667,1.1369266913128989e-06,1.638349782973072,0.08543965824136704
280,0.5,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Is it possible for mental imagery fMRI to predict recovery in patients suffering from disorders of consciousness?,1.065868773105841e-06,1.0256896832107807,0.2808159722222222,0.0816041909151844,1.1783502069519063,0.14532871972318342,0.08148606934287914,1.2740045121236938,0.11649408284023667,1.0658687731058429e-06,1.3759855185055803,0.08543965824136704
280,0.5,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Mental imagery functional magnetic resonance imaging can be used to anticipate recovery in patients with consciousness disorders, correct?",1.0421828003701558e-06,0.9650650613943457,0.2808159722222222,0.07979076445040252,1.1138116858143357,0.14532871972318342,0.07967526780192627,1.2050116406367417,0.11649408284023667,1.0421828003701574e-06,1.301877546351859,0.08543965824136704
280,0.5,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Does mental imagery fMRI have the ability to predict recovery outcomes in patients with disorders of consciousness?,1.065868773105841e-06,1.0256896832107807,0.2808159722222222,0.0816041909151844,1.1783502069519063,0.14532871972318342,0.08148606934287914,1.2740045121236938,0.11649408284023667,1.0658687731058429e-06,1.3759855185055803,0.08543965824136704
280,0.5,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Can recovery in patients with consciousness disorders be predicted using mental imagery functional magnetic resonance imaging?,1.0895547458415264e-06,1.0902282043483513,0.2808159722222222,0.08341761737996628,1.2473430784388584,0.14532871972318342,0.08329687088383202,1.348112484277415,0.11649408284023667,1.0895547458415283e-06,1.4560282261791166,0.08543965824136704
280,0.5,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Studies indicate that mental imagery fMRI can potentially forecast recovery in patients with disorders of consciousness, right?",1.065868773105841e-06,1.0256896832107807,0.2808159722222222,0.0816041909151844,1.1783502069519063,0.14532871972318342,0.08148606934287914,1.2740045121236938,0.11649408284023667,1.0658687731058429e-06,1.3759855185055803,0.08543965824136704
280,0.5,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","By evaluating neural activity during mental imagery tasks, can fMRI predict recovery in patients with consciousness disorders?",1.065868773105841e-06,1.0256896832107807,0.2808159722222222,0.0816041909151844,1.1783502069519063,0.14532871972318342,0.08148606934287914,1.2740045121236938,0.11649408284023667,1.0658687731058429e-06,1.3759855185055803,0.08543965824136704
280,0.5,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Is mental imagery functional magnetic resonance imaging effective in predicting recovery in patients with disorders of consciousness?,1.065868773105841e-06,1.0256896832107807,0.2808159722222222,0.0816041909151844,1.1783502069519063,0.14532871972318342,0.08148606934287914,1.2740045121236938,0.11649408284023667,1.0658687731058429e-06,1.3759855185055803,0.08543965824136704
280,0.5,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Can mental imagery fMRI provide predictions about recovery in patients who have disorders of consciousness?,1.1132407185772118e-06,1.1592210758353034,0.2808159722222222,0.08523104384474815,1.3214510505925796,0.14532871972318342,0.08510767242478488,1.4281551919509514,0.11649408284023667,1.1132407185772135e-06,1.5430396031687468,0.08543965824136704
280,0.5,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Does mental imagery functional magnetic resonance imaging offer insights into recovery potential in patients with consciousness disorders?,1.065868773105841e-06,1.0256896832107807,0.2808159722222222,0.0816041909151844,1.1783502069519063,0.14532871972318342,0.08148606934287914,1.2740045121236938,0.11649408284023667,1.0658687731058429e-06,1.3759855185055803,0.08543965824136704
281,0.5,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This research shows that hospital management can promote the creation of care programs by incorporating case-mix reimbursement into hospital budgeting. Further studies are suggested to verify this result and to explore whether the implementation of care programs will eventually result in more...,1.8948778188548325e-07,0.08089532743657513,0.044244628099173504,0.014507411718254981,0.10240450977053595,0.031101530612244906,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
281,0.5,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does reimbursement based on case-mix foster the growth of process-oriented care delivery? The study indicates that hospital management can drive the development of care programs by adopting case-mix reimbursement in hospital budgets. Additional research is needed to confirm these findings and to assess if establishing care programs will ultimately lead to more...,2.1317375462116866e-07,0.07417664177935057,0.06304462809917352,0.016320838183036854,0.09502489469181619,0.0507015306122449,0.0162972138685758,0.14472108551993212,0.017236072637734686,2.1317375462116866e-07,0.17185025692665912,0.0
281,0.5,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is process-oriented care delivery stimulated by case-mix based reimbursement? Findings from this study reveal that hospital management can encourage care program development through the use of case-mix reimbursement in budgeting. Future investigations are recommended to validate this outcome and to determine whether care programs will over time contribute to more...,2.6054570009253947e-07,0.08699973401814942,0.08264462809917351,0.0199476911126006,0.13584688921207055,0.0507015306122449,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
281,0.5,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does the use of case-mix based reimbursement promote process-oriented care delivery? This study illustrates that hospital management can foster care program development by integrating case-mix reimbursement into hospital budgeting. Further research is advised to confirm this finding and to examine if the creation of care programs will eventually lead to more...,2.3685972735685406e-07,0.06679702670063081,0.08264462809917351,0.018134264647818726,0.1152276020093348,0.0507015306122449,0.018108015409528666,0.16534037272266788,0.017236072637734686,2.3685972735685406e-07,0.19290366612449228,0.0
281,0.5,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Can case-mix based reimbursement drive the advancement of process-oriented care delivery? The study demonstrates that hospital management can stimulate the formation of care programs by adopting case-mix reimbursement in budgeting processes. It is recommended that future research confirm these findings and investigate whether care programs will ultimately result in more...,2.6054570009253947e-07,0.1152914556736575,0.06224532254361796,0.0199476911126006,0.13584688921207055,0.0507015306122449,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
281,0.5,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does adopting case-mix based reimbursement encourage the development of process-oriented care delivery? This research shows hospital management can promote care program creation by using case-mix reimbursement within budgeting. Further studies are needed to confirm this finding and to explore whether care programs will in time lead to more...,3.079176455639103e-07,0.12867243041871834,0.08264462809917351,0.023574544042164344,0.17840650363086707,0.0507015306122449,0.023540420032387266,0.2298788938602394,0.017236072637734686,3.079176455639103e-07,0.25886163391628836,0.0
281,0.5,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is the development of process-oriented care delivery encouraged by case-mix based reimbursement? The study suggests hospital management can stimulate care program development through case-mix reimbursement in budgeting. Additional research is necessary to confirm this and to determine if care programs will eventually lead to more...,3.789755637709665e-07,0.19463039821051442,0.08264462809917351,0.029014823436509962,0.24584778442639932,0.0507015306122449,0.028972824655245866,0.29887176534719107,0.017236072637734686,3.789755637709665e-07,0.3294792011302423,0.0
281,0.5,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement facilitate the growth of process-oriented care delivery? Findings indicate that hospital management can encourage care programs by integrating case-mix reimbursement into budget planning. Future research is recommended to validate this and to assess if care programs will in time lead to more...,3.552895910352811e-07,0.2029640837166764,0.060433884297520626,0.02720139697172809,0.2228582662016998,0.0507015306122449,0.027162023114293,0.27534126793699665,0.017236072637734686,3.552895910352811e-07,0.3053816495511823,0.0
281,0.5,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Can the introduction of case-mix based reimbursement stimulate process-oriented care delivery? This study finds that hospital management can promote care program development by adopting case-mix reimbursement in budgeting. Further research is suggested to confirm this and to explore whether care programs will eventually lead to more...,3.552895910352811e-07,0.1721575423584567,0.08264462809917351,0.02720139697172809,0.2228582662016998,0.0507015306122449,0.027162023114293,0.27534126793699665,0.017236072637734686,3.552895910352811e-07,0.3053816495511823,0.0
281,0.5,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does the implementation of case-mix based reimbursement spur the development of process-oriented care delivery? The study demonstrates hospital management's ability to foster care programs by incorporating case-mix reimbursement in budgeting. Future research should verify this and determine if care programs will ultimately result in more...,3.789755637709665e-07,0.226137088235967,0.0599296470283244,0.029014823436509962,0.24584778442639932,0.0507015306122449,0.028972824655245866,0.29887176534719107,0.017236072637734686,3.789755637709665e-07,0.3294792011302423,0.0
282,0.5,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration during pregnancy cause kidney damage in women with multiple parities? Research indicates it does not necessarily result in kidney harm, but more studies are required to clarify long-term effects and risks.",4.2634750924233657e-07,0.28914709185855036,0.14035916824196598,0.03264167636607373,0.39083532818362343,0.039930555555555566,0.03259442773715163,0.4295413719699721,0.020399305555555556,4.263475092423373e-07,0.47000362924573613,0.0
282,0.5,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Is kidney damage caused by glomerular hyperfiltration in pregnant women who have had several parities? Current research suggests no direct kidney damage, though further investigation is needed to understand long-term consequences.",4.974054274493925e-07,0.3844572716628756,0.14035916824196598,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5313240662799146,0.020399305555555556,4.974054274493935e-07,0.5753641449035616,0.0
282,0.5,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration in pregnancy harm the kidneys of women with higher parity numbers? Studies show it may not cause damage, but additional research is necessary to assess long-term impacts.",5.210914001850778e-07,0.41835882333855734,0.14035916824196598,0.03989538222520125,0.5243667208081457,0.039930555555555566,0.03983763390096312,0.5676917104507893,0.020399305555555556,5.210914001850789e-07,0.6131044728864086,0.0
282,0.5,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Can glomerular hyperfiltration during pregnancy lead to kidney injury in women with many parities? Evidence points to no definite damage, but more research is essential to evaluate long-term risks.",5.447773729207631e-07,0.45345014314982635,0.14035916824196598,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6054320384336362,0.020399305555555556,5.447773729207643e-07,0.652325186039691,0.0
282,0.5,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does pregnancy-related glomerular hyperfiltration damage kidneys in women with multiple births? Research suggests it does not inherently cause damage, though further studies are needed for long-term effect understanding.",5.684633456564484e-07,0.489817787320701,0.14035916824196598,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6446527515869187,0.020399305555555556,5.684633456564497e-07,0.6931471805599458,0.0
282,0.5,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Is kidney damage a result of glomerular hyperfiltration in women with increased parities during pregnancy? Findings indicate no guaranteed damage, but further research is needed to explore potential long-term risks.",5.210914001850778e-07,0.41835882333855734,0.14035916824196598,0.03989538222520125,0.5243667208081457,0.039930555555555566,0.03983763390096312,0.5676917104507893,0.020399305555555556,5.210914001850789e-07,0.6131044728864086,0.0
282,0.5,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration during pregnancy cause kidney harm in women with more pregnancies? Research implies it does not necessarily damage kidneys, yet additional studies are required to fully understand long-term effects.",4.974054274493925e-07,0.3844572716628756,0.14035916824196598,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5313240662799146,0.020399305555555556,4.974054274493935e-07,0.5753641449035616,0.0
282,0.5,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does kidney damage occur from glomerular hyperfiltration in pregnant women with multiple parities? Research suggests no direct harm, but additional investigation is needed to confirm long-term outcomes.",5.921493183921337e-07,0.527558115303548,0.14035916824196598,0.045335661619546885,0.6376954061151499,0.039930555555555566,0.04527003852382174,0.6854747461071735,0.020399305555555556,5.921493183921352e-07,0.7357067949787415,0.0
282,0.5,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Is there kidney damage from glomerular hyperfiltration in pregnancy among women with higher parity? Studies suggest it is unlikely, but further research is necessary to determine long-term consequences.",5.684633456564484e-07,0.489817787320701,0.14035916824196598,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6446527515869187,0.020399305555555556,5.684633456564497e-07,0.6931471805599458,0.0
282,0.5,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration in pregnancy adversely affect kidneys in women with several parities? Research indicates no definite damage, but more studies are required to assess potential long-term risks.",5.684633456564484e-07,0.489817787320701,0.14035916824196598,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6446527515869187,0.020399305555555556,5.684633456564497e-07,0.6931471805599458,0.0
283,0.5,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Answer: Septoplasty is a surgical operation designed to fix a deviated septum, whereas compensatory hypertrophy involves the enlargement of the middle turbinate.",0.0,0.0407733635623484,0.028815199011446413,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0,0.0,0.0,0.0
283,0.5,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Can septoplasty affect the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgery intended to correct a deviated septum, and compensatory hypertrophy means the middle turbinate becomes enlarged.",4.73719454713706e-08,0.02494792869938145,0.025186726789224186,0.003626852929563759,0.020511436947397765,0.0302734375,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
283,0.5,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Does septoplasty modify the size of compensatory hypertrophy in the middle turbinate? Answer: Septoplasty is a procedure performed to correct a deviated septum, while compensatory hypertrophy is the increase in size of the middle turbinate.",2.36859727356853e-08,0.032482396607166564,0.002448011511446413,0.0018134264647818796,0.07186188318361753,0.0302734375,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
283,0.5,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Is the size of compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: Septoplasty is a surgical technique used to correct a deviated septum, with compensatory hypertrophy referring to the enlargement of the middle turbinate.",4.73719454713706e-08,0.06395397443367212,0.004764320912272871,0.003626852929563759,0.0612410097391578,0.0017267246972318406,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
283,0.5,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Does undergoing septoplasty influence the dimensions of compensatory hypertrophy in the middle turbinate? Answer: Septoplasty is surgery aimed at straightening a deviated septum, and compensatory hypertrophy is the swelling or growth of the middle turbinate.",2.36859727356853e-08,0.07209080692487779,0.030475982987571308,0.0018134264647818796,0.07186188318361753,0.0302734375,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
283,0.5,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Can the dimensions of compensatory hypertrophy of the middle turbinate be altered by septoplasty? Answer: Septoplasty is a surgical intervention to correct a deviated septum, whereas compensatory hypertrophy denotes enlargement of the middle turbinate.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
283,0.5,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Does the procedure of septoplasty impact the size of compensatory hypertrophy in the middle turbinate? Answer: Septoplasty is an operation to correct a deviated septum, and compensatory hypertrophy refers to the middle turbinate's enlargement.",0.0,0.0407733635623484,0.028815199011446413,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0,0.0,0.0,0.0
283,0.5,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Will septoplasty change the size of compensatory hypertrophy in the middle turbinate? Answer: Septoplasty is a surgical procedure to fix a deviated septum, while compensatory hypertrophy means the middle turbinate has enlarged.",4.73719454713706e-08,0.02494792869938145,0.025186726789224186,0.003626852929563759,0.020511436947397765,0.0302734375,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
283,0.5,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Does septoplasty have an effect on the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgery intended to correct a deviated septum, with compensatory hypertrophy being the enlargement of the middle turbinate.",4.73719454713706e-08,0.06395397443367212,0.004764320912272871,0.003626852929563759,0.0612410097391578,0.0017267246972318406,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
283,0.5,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Question: Is compensatory hypertrophy of the middle turbinate affected in size by septoplasty? Answer: Septoplasty is a surgical method to correct a deviated septum, and compensatory hypertrophy is the enlargement of the middle turbinate.",2.36859727356853e-08,0.03355963256444161,0.0025910509885536254,0.0018134264647818796,0.032084437417815526,0.0009440442898023052,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
284,0.5,1,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians experience premature aging? Answer: Scientific studies do not support the idea that Indigenous Australians age prematurely. Nevertheless, elements like socioeconomic challenges, healthcare accessibility, and lifestyle habits may influence health problems impacting aging.",1.6580180914979731e-07,0.15591594991548163,0.018953287197231855,0.012693985253473115,0.15339948449985608,0.024375,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
284,0.5,2,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Is there premature aging among Indigenous Australians? Answer: There is no scientific proof indicating that Indigenous Australians age earlier than others. However, factors such as socioeconomic status, healthcare availability, and lifestyle decisions might affect health conditions related to aging.",7.105791820705611e-08,0.008093954957539395,0.047500000000000014,0.005440279394345618,0.042173849389631535,0.024375,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
284,0.5,3,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Are Indigenous Australians prone to premature aging? Answer: Research does not show any evidence that Indigenous Australians age prematurely. Still, issues like socioeconomic disadvantages, healthcare access, and lifestyle choices can contribute to health concerns influencing the aging process.",9.474389094274141e-08,0.07055087191658371,0.02120343316289264,0.0072537058591274906,0.0688420964717924,0.024375,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
284,0.5,4,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians tend to age faster? Answer: No scientific evidence suggests that Indigenous Australians age faster than others. However, socioeconomic difficulties, limited healthcare access, and lifestyle factors may play a role in health issues that impact aging.",9.474389094274141e-08,0.07055087191658371,0.02120343316289264,0.0072537058591274906,0.0688420964717924,0.024375,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
284,0.5,5,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Is premature aging observed in Indigenous Australians? Answer: There is no scientific data confirming premature aging in Indigenous Australians. Nonetheless, factors including socioeconomic disadvantage, healthcare access, and lifestyle choices may affect health conditions that influence aging.",1.42115836414112e-07,0.16515301602662324,0.00786332179930796,0.010880558788691236,0.12441194762660457,0.024375,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
284,0.5,6,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians show signs of early aging? Answer: Scientific evidence does not indicate that Indigenous Australians age prematurely. Yet, socioeconomic challenges, healthcare availability, and lifestyle habits might contribute to health issues affecting the aging process.",1.42115836414112e-07,0.1266448393288484,0.019744897959183685,0.010880558788691236,0.12441194762660457,0.024375,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
284,0.5,7,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Are Indigenous Australians subject to premature aging? Answer: No scientific evidence supports the claim that Indigenous Australians age prematurely. However, socioeconomic factors, healthcare access, and lifestyle choices can impact health outcomes related to aging.",1.8948778188548261e-07,0.18606844003337164,0.018115243342516078,0.014507411718254995,0.18325244764953785,0.024375,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
284,0.5,8,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Does premature aging affect Indigenous Australians? Answer: There is no scientific basis to suggest that Indigenous Australians experience premature aging. Still, factors such as socioeconomic status, access to healthcare, and lifestyle decisions may influence health problems affecting aging.",9.474389094274141e-08,0.03406944136079737,0.047500000000000014,0.0072537058591274906,0.0688420964717924,0.024375,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
284,0.5,9,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age at an accelerated rate? Answer: Scientific research does not indicate that Indigenous Australians age at an accelerated rate. However, socioeconomic disadvantages, healthcare access, and lifestyle choices may contribute to health issues impacting the aging process.",7.105791820705611e-08,0.1858240012549599,0.07793252595155703,0.005440279394345618,0.18809957161277868,0.07943122837370242,0.0054324046228586,0.19036378696591916,0.08044982698961935,7.105791820705622e-08,0.15705906106908385,0.055363321799307974
284,0.5,10,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Is early aging a characteristic of Indigenous Australians? Answer: There is no scientific evidence to confirm that Indigenous Australians age early. Nonetheless, factors like socioeconomic difficulties, healthcare accessibility, and lifestyle habits may affect health conditions related to aging.",9.474389094274141e-08,0.03406944136079737,0.047500000000000014,0.0072537058591274906,0.0688420964717924,0.024375,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
285,0.5,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Is there a discrepancy between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? There might be differences due to varying training, experience, or subjective views. Effective communication and teamwork are crucial for accurate diagnosis and patient care.",5.210914001850789e-07,0.23701865270407385,0.14097543609825555,0.0398953822252012,0.2882292585708912,0.11282578875171473,0.039837633900963065,0.3412338724023898,0.08264462809917351,5.210914001850789e-07,0.396129987475736,0.0507015306122449
285,0.5,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Could clinical pathologists and clinicians disagree when reporting and interpreting red blood cell morphology? Such discordance may arise from differences in expertise, training, or personal interpretation. Collaboration is key to ensure precise diagnosis and proper management.",6.395212638635054e-07,0.3705500453285966,0.14097543609825555,0.04896251454911057,0.4254303800843737,0.11282578875171473,0.04889164160572741,0.4823124706622961,0.08264462809917351,6.39521263863506e-07,0.5413119973202352,0.0507015306122449
285,0.5,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? Potential discordance can result from diverse training backgrounds, experience levels, or subjective assessments. Ensuring clear communication and cooperation is vital for accurate patient diagnosis and treatment.",4.974054274493935e-07,0.21232604011370215,0.14097543609825555,0.038081955760419325,0.2629114505865995,0.11282578875171473,0.0380268323600102,0.3152583859991318,0.08264462809917351,4.974054274493935e-07,0.36946174039357516,0.0507015306122449
285,0.5,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Is there a mismatch between clinical pathologists and clinicians in the interpretation and reporting of red blood cell morphology? Differences in training, experience, or subjective interpretation might cause this. Strong collaboration and communication help secure accurate diagnosis and effective patient management.",5.210914001850789e-07,0.23701865270407385,0.14097543609825555,0.0398953822252012,0.2882292585708912,0.11282578875171473,0.039837633900963065,0.3412338724023898,0.08264462809917351,5.210914001850789e-07,0.396129987475736,0.0507015306122449
285,0.5,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Do clinical pathologists and clinicians differ in how they report and interpret red blood cell morphology? Such differences may stem from variations in training, experience, or subjective judgment. To achieve accurate diagnoses and appropriate care, communication and teamwork are essential.",5.447773729207642e-07,0.2623364606883656,0.14097543609825555,0.04170880868998307,0.3142047449741492,0.11282578875171473,0.04164843544191593,0.36790211948455065,0.08264462809917351,5.447773729207643e-07,0.42352896166385134,0.0507015306122449
285,0.5,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Is discordance present between clinical pathologists and clinicians when interpreting and reporting red blood cell morphology? This could be due to differences in training, experience, or subjective viewpoints. Collaboration and communication between both groups are necessary for precise diagnosis and patient management.",4.974054274493935e-07,0.21232604011370215,0.14097543609825555,0.038081955760419325,0.2629114505865995,0.11282578875171473,0.0380268323600102,0.3152583859991318,0.08264462809917351,4.974054274493935e-07,0.36946174039357516,0.0507015306122449
285,0.5,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Are there inconsistencies between clinical pathologists and clinicians regarding red blood cell morphology reporting and interpretation? These may arise from differing training, experience, or subjective interpretation. Effective collaboration is important to ensure correct diagnosis and management.",6.395212638635054e-07,0.3705500453285966,0.14097543609825555,0.04896251454911057,0.4254303800843737,0.11282578875171473,0.04889164160572741,0.4823124706622961,0.08264462809917351,6.39521263863506e-07,0.5413119973202352,0.0507015306122449
285,0.5,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Might clinical pathologists and clinicians disagree in their reporting and interpretation of red blood cell morphology? Such discordance could be caused by differences in training, experience, or subjective perspectives. Communication and cooperation are vital for accurate diagnosis and patient care.",5.447773729207642e-07,0.2623364606883656,0.14097543609825555,0.04170880868998307,0.3142047449741492,0.11282578875171473,0.04164843544191593,0.36790211948455065,0.08264462809917351,5.447773729207643e-07,0.42352896166385134,0.0507015306122449
285,0.5,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Is there potential discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Differences in training, experience, or subjective interpretation may explain this. Clear communication and collaboration are essential for accurate diagnosis and treatment.",5.921493183921348e-07,0.3149801941737844,0.14097543609825555,0.045335661619546816,0.3682719662444254,0.11282578875171473,0.045270038523821665,0.4234719706393628,0.08264462809917351,5.921493183921352e-07,0.4806873755037997,0.0507015306122449
285,0.5,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Do clinical pathologists and clinicians experience discordance in reporting and interpreting red blood cell morphology? This may be due to differences in training, experience, or subjective interpretation. Ensuring collaboration and communication is crucial for accurate diagnosis and appropriate patient management.",5.447773729207642e-07,0.2623364606883656,0.14097543609825555,0.04170880868998307,0.3142047449741492,0.11282578875171473,0.04164843544191593,0.36790211948455065,0.08264462809917351,5.447773729207643e-07,0.42352896166385134,0.0507015306122449
286,0.5,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better clinical outcomes? Individuals diagnosed with type 2 diabetes who have lower initial blood sugar levels, indicating an earlier stage of the disease, tend to experience fewer negative health events despite similar progression in blood sugar control. Because these individuals are often asymptomatic when diagnosed, proactive screening programs are necessary to detect them.",9.474389094274162e-08,0.04278627525790579,0.012806186849250962,0.0072537058591274906,0.06287160478442821,0.000946939836354287,0.007243206163811466,0.06252035698133263,0.0,9.474389094274162e-08,0.06351340572232633,0.0
286,0.5,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there a connection between lower fasting plasma glucose at type 2 diabetes diagnosis and improved health outcomes? Patients with type 2 diabetes presenting with lower initial glucose levels, suggesting earlier disease onset, show fewer adverse clinical events even though their glycemic control worsens similarly. Since most are symptom-free at diagnosis, active case finding initiatives are essential to identify these patients.",9.474389094274162e-08,0.06742663438990615,0.002076216188794621,0.0072537058591274906,0.06708912468234107,0.0010752275733388016,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
286,0.5,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Do lower fasting plasma glucose values at the diagnosis of type 2 diabetes correlate with better outcomes? People diagnosed earlier in their type 2 diabetes course, indicated by lower initial glycemia, have fewer harmful clinical outcomes despite comparable glycemic progression. Because these individuals usually have no symptoms at diagnosis, active detection programs are needed to find them.",1.8948778188548325e-07,0.13972020673666652,0.004447813134751875,0.014507411718254981,0.13900222078069824,0.0023066964139149618,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
286,0.5,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis associated with better clinical outcomes? Those presenting with type 2 diabetes with lower initial blood sugar, likely earlier in disease progression, experience fewer adverse outcomes despite similar glycemic trends. Since most are asymptomatic when diagnosed, active screening strategies are required to identify them.",1.8948778188548325e-07,0.13972020673666652,0.004447813134751875,0.014507411718254981,0.13900222078069824,0.0023066964139149618,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
286,0.5,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there an association between lower fasting plasma glucose at type 2 diabetes diagnosis and improved clinical outcomes? Individuals with type 2 diabetes who have lower initial glycemia, possibly reflecting earlier disease stages, suffer fewer negative outcomes despite similar blood sugar progression. Because they are often asymptomatic at diagnosis, active case detection programs are necessary to find them.",1.6580180914979784e-07,0.12115202414784232,0.0038238405242473107,0.012693985253473108,0.12053361970622767,0.0019823530929386525,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
286,0.5,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Does having lower fasting plasma glucose at the diagnosis of type 2 diabetes relate to better outcomes? Patients with type 2 diabetes presenting with lower initial glucose levels, indicating earlier disease phase, show fewer adverse clinical events despite similar glycemic progression. As most are asymptomatic at diagnosis, proactive detection efforts are needed to identify them.",2.3685972735685406e-07,0.17792157360743488,0.005764766730907759,0.018134264647818726,0.17699463782030733,0.0029920601690792935,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
286,0.5,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose levels at type 2 diabetes diagnosis linked to improved outcomes? Individuals diagnosed with lower initial glycemia, suggesting earlier disease onset, have fewer negative clinical outcomes despite comparable glycemic progression. Since most are asymptomatic at diagnosis, active screening programs must be implemented to detect them.",3.789755637709665e-07,0.24436037366678542,0.031217481789802295,0.029014823436509962,0.27098245228274953,0.01586888657648284,0.028972824655245866,0.29849298855599704,0.0,3.789755637709665e-07,0.30421137440299084,0.0
286,0.5,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is lower fasting plasma glucose at the time of type 2 diabetes diagnosis associated with better outcomes? People presenting with type 2 diabetes with lower initial blood sugar, likely earlier in their disease, experience fewer adverse clinical outcomes despite similar glycemic progression. Because most are asymptomatic at diagnosis, active case-finding programs are needed to identify them.",2.1317375462116866e-07,0.15863890338292874,0.005094372962778693,0.016320838183036854,0.15781812522704897,0.002643039375813342,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
286,0.5,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are reduced fasting plasma glucose levels at diagnosis of type 2 diabetes connected to improved outcomes? Those diagnosed with type 2 diabetes at lower initial glycemia, potentially earlier in disease course, have fewer adverse clinical outcomes despite similar glycemic progression. Since most are asymptomatic when diagnosed, active detection initiatives are necessary to identify them.",2.6054570009253947e-07,0.19758246578179683,0.0064603344347267215,0.0199476911126006,0.19654584235599293,0.0033544890482768708,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
286,0.5,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there a link between lower fasting plasma glucose at type 2 diabetes diagnosis and better clinical outcomes? Patients presenting with lower initial glycemia, possibly earlier in their disease course, have fewer negative outcomes despite similar progression of glycemia. As most are asymptomatic at diagnosis, active case detection programs are required to find them.",2.6054570009253947e-07,0.1452694710225555,0.031217481789802295,0.0199476911126006,0.16988633541137954,0.01586888657648284,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
287,0.5,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.5,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do parents, their children, and the children's doctors differ in perceiving body image? Answer: Numerous children underestimated how overweight they were. This misperception was also common among their parents and the doctors who cared for them. The study highlights the importance of improving physician education to better identify obesity and overweight, enabling them to advise children and their families effectively.",1.4211583641411244e-07,0.10601989389366206,0.0017866941015089038,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
287,0.5,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, children, and pediatricians have different views on body image? Answer: Many children did not accurately perceive their overweight status, a misunderstanding shared by their parents and even their doctors. The findings emphasize the necessity of enhancing physician training to detect obesity and overweight, so they can provide proper guidance to children and families.",0.0,0.025205352020361893,0.0181755829903978,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.5,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Is there a difference in body image perception among parents, their children, and children's doctors? Answer: A significant number of children underestimated their overweight condition, with parents and attending physicians also holding this inaccurate view. This study underscores the need for better physician education to identify obesity and overweight, allowing them to counsel children and families appropriately.",4.737194547137081e-08,0.060923434622440986,0.0181755829903978,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
287,0.5,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do children, their parents, and their doctors perceive body image? Answer: Many children underestimated their level of overweight, and this misperception was also found among their parents and physicians. The research points to the need for further physician education to recognize obesity and overweight, so they can effectively counsel children and their families.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.5,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are there differences in body image perception between children, their parents, and doctors? Answer: Many children underestimated their overweight status, a misconception shared by their parents and attending physicians. The study calls for enhanced education for physicians to better identify obesity and overweight, enabling them to support children and families.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
287,0.5,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, children, and doctors perceive body image in the same way? Answer: Many children underestimated their overweight condition, and this misperception was common among parents and even their doctors. The study highlights the importance of educating physicians to better recognize obesity and overweight, so they can provide appropriate counseling to children and families.",2.3685972735685406e-08,0.0068562133521661295,0.0181755829903978,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.5,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: What differences exist in body image perception among children, parents, and physicians? Answer: A large number of children underestimated how overweight they were, and this misperception was shared by their parents and doctors. The study emphasizes the need for improved physician training to identify obesity and overweight and counsel children and their families accordingly.",2.3685972735685406e-08,0.0068562133521661295,0.0181755829903978,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.5,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do perceptions of body image vary among children, parents, and their doctors? Answer: Many children underestimated their overweight status, and this misunderstanding was also present among their parents and physicians. The research highlights the necessity of better educating physicians to recognize obesity and overweight to counsel children and families.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
287,0.5,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are body image perceptions different among children, their parents, and physicians? Answer: Many children underestimated their overweight condition, with parents and doctors sharing this misperception. This study stresses the importance of educating physicians to properly identify obesity and overweight so they can advise children and their families effectively.",1.6580180914979784e-07,0.11092682230421813,0.0181755829903978,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
288,0.5,1,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is screening for coeliac disease in high-risk groups warranted? Yes, it is justified. High-risk groups encompass people with a family history of coeliac disease, autoimmune disorders, and symptoms such as chronic diarrhea or weight loss. Early diagnosis is beneficial.",2.6054570009253926e-07,0.08199498380525538,0.1602113696708291,0.0199476911126006,0.14475856817034138,0.08264462809917357,0.019918816950481533,0.1781417891399122,0.06353305785123965,2.6054570009253947e-07,0.2130196671249034,0.043388429752066124
288,0.5,2,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Should coeliac disease screening be performed in risk groups? Yes, screening is justified in these groups, which include individuals with a family history, autoimmune conditions, and symptoms like chronic diarrhea or weight loss. Early detection aids in management.",2.8423167282822456e-07,0.07218180033162991,0.18650793650793648,0.02176111757738247,0.1721575423584567,0.08264462809917357,0.0217296184914344,0.20631266610660903,0.06353305785123965,2.8423167282822487e-07,0.2420072039981549,0.043388429752066124
288,0.5,3,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is it appropriate to screen for coeliac disease in risk groups? Yes, screening is justified. Risk groups consist of those with a family history, autoimmune disorders, and symptoms such as chronic diarrhea or weight loss. Early diagnosis improves outcomes.",2.6054570009253926e-07,0.04551355324946904,0.18650793650793648,0.0199476911126006,0.14475856817034138,0.08264462809917357,0.019918816950481533,0.1781417891399122,0.06353305785123965,2.6054570009253947e-07,0.2130196671249034,0.043388429752066124
288,0.5,4,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Does coeliac disease screening make sense in risk groups? Yes, it is justified. Risk groups include people with a family history, autoimmune diseases, and symptoms like chronic diarrhea or weight loss. Early detection leads to better management.",3.0791764556390986e-07,0.09958077451974523,0.18650793650793648,0.023574544042164344,0.20032841932515355,0.08264462809917357,0.023540420032387273,0.23530020297986054,0.06353305785123965,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
288,0.5,5,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is coeliac disease screening justified for individuals in risk groups? Yes, it is. Risk groups include those with a family history, autoimmune disorders, and symptoms such as chronic diarrhea or weight loss. Early diagnosis is key.",3.3160361829959516e-07,0.12775165148644207,0.18650793650793648,0.025387970506946224,0.22931595619840506,0.08264462809917357,0.025351221573340146,0.2651531661295423,0.06353305785123965,3.316036182995957e-07,0.30263182581459036,0.043388429752066124
288,0.5,6,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is screening for coeliac disease recommended in risk groups? Yes, it is justified. Risk groups are individuals with a family history, autoimmune diseases, and symptoms like chronic diarrhea or weight loss. Early detection can improve health outcomes.",3.0791764556390986e-07,0.09958077451974523,0.18650793650793648,0.023574544042164344,0.20032841932515355,0.08264462809917357,0.023540420032387273,0.23530020297986054,0.06353305785123965,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
288,0.5,7,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Should people in risk groups be screened for coeliac disease? Yes, screening is justified. Risk groups include those with a family history, autoimmune disorders, and symptoms such as chronic diarrhea or weight loss. Early diagnosis is beneficial.",3.0791764556390986e-07,0.13808895121752007,0.15875283446712016,0.023574544042164344,0.20032841932515355,0.08264462809917357,0.023540420032387273,0.23530020297986054,0.06353305785123965,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
288,0.5,8,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is it justified to screen for coeliac disease in risk groups? Yes, it is. Risk groups include individuals with a family history, autoimmune diseases, and symptoms like chronic diarrhea or weight loss. Early detection helps.",3.5528959103528046e-07,0.15673918835969358,0.18650793650793648,0.027201396971728103,0.25916891934808683,0.08264462809917357,0.02716202311429302,0.295924824796296,0.06353305785123965,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
288,0.5,9,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is coeliac disease screening warranted in risk groups? Yes, it is justified. Risk groups include those with a family history, autoimmune disorders, and symptoms such as chronic diarrhea or weight loss. Early diagnosis is advantageous.",3.5528959103528046e-07,0.15673918835969358,0.18650793650793648,0.027201396971728103,0.25916891934808683,0.08264462809917357,0.02716202311429302,0.295924824796296,0.06353305785123965,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
288,0.5,10,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is coeliac disease screening in risk groups appropriate? Yes, it is justified. Risk groups consist of people with a family history, autoimmune diseases, and symptoms like chronic diarrhea or weight loss. Early detection facilitates better care.",3.3160361829959516e-07,0.1673600618041533,0.15796122370516832,0.025387970506946224,0.22931595619840506,0.08264462809917357,0.025351221573340146,0.2651531661295423,0.06353305785123965,3.316036182995957e-07,0.30263182581459036,0.043388429752066124
289,0.5,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Do family practice experiences at residency teaching locations mirror those in community settings? Answer: The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care opportunities comparable to those reported in a national survey of family and general practitioners.,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
289,0.5,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Is family practice at residency teaching sites representative of community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine deliver patient care opportunities akin to those documented in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
289,0.5,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice during residency at teaching sites align with community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care experiences similar to those found in a national survey of family and general practitioners.,2.3685972735685406e-08,0.0246926125903717,0.0,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
289,0.5,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Are residency teaching site family practices reflective of community practice? Answer: The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care opportunities that resemble those in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.5,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice at residency teaching facilities correspond to community practice? Answer: Patient care opportunities at the residency training sites of Northeastern Ohio Universities College of Medicine are similar to those identified in a national survey of family and general practitioners.,2.3685972735685406e-08,0.0246926125903717,0.0,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
289,0.5,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Is the family practice at residency teaching sites consistent with that in community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those reported in a national survey of family and general practitioners.,7.105791820705622e-08,0.07232066157962613,0.0,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
289,0.5,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice at residency teaching sites reflect the nature of community practice? Answer: The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care opportunities comparable to those in a national survey of family and general practitioners.,2.3685972735685406e-08,0.0246926125903717,0.0,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
289,0.5,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Are family practice experiences at residency teaching sites comparable to those in community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care experiences similar to those found in a national survey of family and general practitioners.,7.105791820705622e-08,0.04008125783265193,0.023242630385487524,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
289,0.5,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice at residency teaching sites match community practice? Answer: The residency training sites at Northeastern Ohio Universities College of Medicine provide patient care opportunities that are similar to those reported in a national survey of family and general practitioners.,2.3685972735685406e-08,0.0246926125903717,0.0,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
289,0.5,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Is family practice at residency teaching sites indicative of community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine offer patient care opportunities akin to those found in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
290,0.5,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. Monitoring end-tidal CO2 is useful for tracking trends.,2.3685972735685406e-08,0.03285545717155136,0.03723853486973019,0.0018134264647818726,0.007379615078719759,0.019599999999999996,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
290,0.5,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there a correlation between end-tidal CO2 and arterial CO2 in extremely low birth weight infants in the first week of life? Yes, end-tidal CO2 and arterial CO2 show good correlation and agreement in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring aids in trend observation.",7.105791820705622e-08,0.10492253451610267,0.06978879706152431,0.005440279394345618,0.12008577701152756,0.04262222222222223,0.0054324046228586,0.12086665312744449,0.04246913580246913,7.105791820705622e-08,0.09331573555892092,0.021728395061728398
290,0.5,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"In extremely low birth weight infants during their initial week, does end-tidal CO2 measurement align with arterial CO2 levels? There is a strong correlation and agreement between end-tidal and arterial CO2 in ELBW infants for EtCO2 values between 30 and 50 mmHg. End-tidal CO2 monitoring can assist in trend analysis.",7.105791820705622e-08,0.009368836003363246,0.035646471505457446,0.005440279394345618,0.03344237944153461,0.019599999999999996,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
290,0.5,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Does measuring end-tidal CO2 correspond with arterial CO2 in ELBW infants within the first week? Yes, there is good agreement and correlation between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 is between 30 and 50 mmHg. End-tidal CO2 monitoring is helpful for tracking changes.",1.4211583641411244e-07,0.20816025758526813,0.10111111111111111,0.010880558788691236,0.19040052465376522,0.046726530612244896,0.0108648092457172,0.19084675156078834,0.045351473922902494,1.4211583641411244e-07,0.16285958616403873,0.023242630385487524
290,0.5,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is there a relationship between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants during the first week? A strong correlation and agreement exist between end-tidal CO2 and arterial CO2 in ELBW infants in the 30-50 mmHg EtCO2 range. End-tidal CO2 monitoring helps in trend tracking.,7.105791820705622e-08,0.06595227931437941,0.004598765432098778,0.005440279394345618,0.03344237944153461,0.019599999999999996,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
290,0.5,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal CO2 measurement reflect arterial CO2 levels in extremely low birth weight infants in their first week? There is good correlation and agreement between end-tidal and arterial CO2 in ELBW infants with EtCO2 values from 30 to 50 mmHg. End-tidal CO2 monitoring is useful for monitoring trends.,1.1842986367842703e-07,0.0534493385022734,0.03391975308641975,0.009067132323909363,0.07600199386033113,0.019599999999999996,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
290,0.5,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"In the first week of life, does end-tidal CO2 correlate with arterial CO2 in extremely low birth weight infants? Yes, end-tidal CO2 and arterial CO2 correlate well and agree in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. Monitoring end-tidal CO2 can aid in trend evaluation.",1.1842986367842703e-07,0.1235735271406635,0.05449266870981313,0.009067132323909363,0.07600199386033113,0.019599999999999996,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
290,0.5,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is there a correlation between end-tidal CO2 and arterial CO2 in ELBW infants during their first week? There is good agreement and correlation between end-tidal and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring is beneficial for trending.,1.8948778188548325e-07,0.31246957708832923,0.09645061728395062,0.014507411718254981,0.30464029339073395,0.09466592797783926,0.014486412327622933,0.2733744129390563,0.0710059171597633,1.8948778188548325e-07,0.2458723465828987,0.04865220249835634
290,0.5,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Does end-tidal carbon dioxide measurement correspond with arterial carbon dioxide in extremely low birth weight infants in the first week? Yes, there is strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants for EtCO2 levels between 30 and 50 mmHg. End-tidal CO2 monitoring assists in trend observation.",4.737194547137081e-08,0.011965540180375545,0.036458333333333315,0.0036268529295637453,0.01282309223879885,0.019599999999999996,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
290,0.5,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"In extremely low birth weight infants during the first week, does end-tidal CO2 measurement correlate with arterial CO2? There is good correlation and agreement between end-tidal and arterial CO2 in ELBW infants when EtCO2 is in the 30-50 mmHg range. End-tidal CO2 monitoring can be helpful for tracking trends.",9.474389094274162e-08,0.0022858124184139683,0.0555649866706906,0.0072537058591274906,0.05449578863936777,0.019599999999999996,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
291,0.5,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH levels? Antral follicle assessment offers crucial information for predicting IVF success. While age and FSH are significant, antral follicle count gives extra insight into ovarian reserve and treatment response, potentially making it a better predictor.",3.079176455639103e-07,0.24485422375041432,0.014800134930005038,0.023574544042164344,0.274708981244542,0.025199012812434363,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
291,0.5,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Can antral follicle assessment better predict IVF results than age and FSH? Antral follicle evaluation can provide important data for forecasting IVF outcomes. Although age and FSH are key factors, the antral follicle count adds further understanding of ovarian reserve and treatment response, possibly making it a more accurate predictor.",3.079176455639103e-07,0.18827078043939816,0.02693520697503958,0.023574544042164344,0.2169467161978802,0.016388888888888897,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
291,0.5,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Does antral follicle assessment outperform age and FSH in predicting IVF outcomes? Assessing antral follicles supplies valuable information regarding IVF prognosis. Age and FSH levels remain important, but antral follicle count offers additional insight into ovarian reserve and response to treatment, potentially serving as a better predictor.",3.789755637709665e-07,0.24630648536035826,0.06647760510369644,0.029014823436509962,0.3122917786936714,0.005821854912763994,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
291,0.5,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle count a more reliable predictor of IVF success than age and FSH? Antral follicle assessment provides useful predictive information for IVF. Despite the importance of age and FSH, the antral follicle count gives deeper insight into ovarian reserve and treatment response, which may make it a superior predictor.",2.8423167282822487e-07,0.19388288637402296,0.008504205084680388,0.02176111757738247,0.22461915065065252,0.004010416666666659,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
291,0.5,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","How does antral follicle assessment compare to age and FSH in predicting IVF outcomes? It provides valuable predictive data for IVF success. While age and FSH are important, the antral follicle count offers additional insight into ovarian reserve and potential treatment response, making it possibly a better predictor.",3.552895910352811e-07,0.22287665244126353,0.06784449316916853,0.02720139697172809,0.28964316455406536,0.0053395061728395005,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
291,0.5,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Can antral follicle assessment serve as a better predictor of IVF outcomes than age and FSH? This assessment delivers important information about IVF prognosis. Although age and FSH are critical, the antral follicle count adds further insight into ovarian reserve and treatment responsiveness, potentially making it a better indicator.",3.316036182995957e-07,0.19997976669938788,0.06915532879818596,0.025387970506946217,0.23800012539571336,0.016388888888888897,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
291,0.5,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle assessment more effective than age and FSH in predicting IVF outcomes? It provides valuable insight for IVF prediction. Age and FSH are important, but antral follicle count offers extra information about ovarian reserve and treatment response, possibly making it a better predictor.",4.263475092423373e-07,0.29486781619538105,0.06356077529167525,0.03264167636607371,0.35918701515918317,0.006853741496598627,0.0325944277371516,0.35667494393873156,0.0,4.263475092423373e-07,0.36396537720141087,0.0
291,0.5,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Does antral follicle count provide better prediction of IVF outcomes than age and FSH? It offers essential predictive information for IVF. While age and FSH remain key factors, antral follicle assessment adds further understanding of ovarian reserve and response to treatment, potentially making it a superior predictor.",3.789755637709665e-07,0.21616965142296918,0.08798912126834206,0.029014823436509962,0.2814852373354517,0.016388888888888897,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
291,0.5,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle assessment a stronger predictor of IVF success compared to age and FSH? This method gives valuable data for forecasting IVF outcomes. Though age and FSH are important, antral follicle count provides additional insight into ovarian reserve and treatment response, which may make it a better predictor.",3.316036182995957e-07,0.17109863417605675,0.08978964931908492,0.025387970506946217,0.23800012539571336,0.016388888888888897,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
291,0.5,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","How effective is antral follicle assessment versus age and FSH in predicting IVF results? It supplies valuable predictive information for IVF. Age and FSH are significant, but the antral follicle count offers more insight into ovarian reserve and treatment response, potentially making it a better predictor.",4.026615365066519e-07,0.27029451434162555,0.0650510204081633,0.030828249901291835,0.335464783212962,0.006326092181960213,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
292,0.5,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a viable alternative to thrombolysis? Reorganizing care to provide primary angioplasty was well accepted by patients and their caregivers. Satisfaction was generally high across all care types, except in discharge and aftercare.",2.1317375462116802e-07,0.2111341471458017,0.01701619515691227,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.5,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty be considered an acceptable substitute for thrombolysis? Patients and their carers accepted the restructured care offering primary angioplasty. Satisfaction levels remained high regardless of care type, except for discharge and aftercare.",2.3685972735685332e-07,0.20021374673313375,0.046400951814396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.5,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable option compared to thrombolysis? The reorganization of services to include primary angioplasty was welcomed by patients and carers. Satisfaction was high across care types, with the exception of discharge and aftercare.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
292,0.5,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Does primary angioplasty serve as an acceptable alternative to thrombolysis? Care reorganization to provide primary angioplasty was accepted by patients and their carers. Satisfaction levels were high irrespective of care type, except for discharge and aftercare.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
292,0.5,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a suitable alternative to thrombolysis? Patients and carers accepted the reorganization of care to offer primary angioplasty. Satisfaction was high across all forms of care, except in discharge and aftercare.",2.605457000925386e-07,0.23098540539988743,0.046400951814396206,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.5,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty replace thrombolysis acceptably? Offering primary angioplasty through reorganized care was accepted by patients and carers. Satisfaction remained high regardless of care type, except for discharge and aftercare.",3.316036182995945e-07,0.37722873204486085,0.011962176304192114,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
292,0.5,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable alternative treatment to thrombolysis? The introduction of primary angioplasty services was accepted by patients and carers. Satisfaction levels were high across care types, except during discharge and aftercare.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.5,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a good alternative to thrombolysis? Patients and carers accepted the care reorganization to provide primary angioplasty. Satisfaction was high irrespective of care type, except in discharge and aftercare.",3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
292,0.5,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable substitute for thrombolysis? Reorganizing care to include primary angioplasty was accepted by patients and carers. Satisfaction levels were generally high, except for discharge and aftercare.",3.316036182995945e-07,0.37722873204486085,0.011962176304192114,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
292,0.5,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable alternative approach to thrombolysis? Patients and carers accepted the reorganization of care to offer primary angioplasty. Satisfaction was high regardless of care type, with the exception of discharge and aftercare.",2.1317375462116802e-07,0.2111341471458017,0.01701619515691227,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
293,0.5,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better outcomes? Lower fasting plasma glucose levels at diagnosis of type 2 diabetes correlate with improved outcomes, reflecting superior glycemic control and a decreased risk of complications. Effective management to maintain lower glucose levels can result in enhanced long-term health for type 2 diabetes patients.",9.474389094274162e-08,0.002146592524828961,0.0015999999999999348,0.0072537058591274906,0.0046017413237757765,0.014951940192239277,0.007243206163811466,0.040480436511152185,0.0746300264145382,9.474389094274162e-08,0.06693940943015697,0.09528752344559228
293,0.5,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is there an association between lower fasting plasma glucose levels at type 2 diabetes diagnosis and improved health outcomes? Yes, lower fasting plasma glucose levels at diagnosis are tied to better outcomes due to improved glycemic management and a lower chance of complications. Proper control of glucose levels can promote better long-term health in type 2 diabetes patients.",1.6580180914979784e-07,2.4158835765675235e-05,0.10417392753019572,0.012693985253473108,0.02151259391194804,0.06465185980855465,0.012675610786670066,0.01654056411629945,0.07183636902297869,1.6580180914979784e-07,0.01415109373329404,0.07584354023100469
293,0.5,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Do patients diagnosed with type 2 diabetes who have lower fasting plasma glucose levels experience better outcomes? Lower fasting plasma glucose at diagnosis is linked to favorable outcomes, indicating better blood sugar control and reduced complication risks. Maintaining these lower levels through management strategies supports improved long-term health in type 2 diabetes.",3.079176455639103e-07,0.016183024147328418,0.20373671344499766,0.023574544042164344,0.06651677142090007,0.11314883212689374,0.023540420032387266,0.08472911683256656,0.10580096879286693,3.079176455639103e-07,0.08058989379264458,0.11282578875171474
293,0.5,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are improved outcomes observed in type 2 diabetes patients diagnosed with lower fasting plasma glucose levels? Indeed, lower fasting plasma glucose levels at diagnosis are associated with better outcomes, signifying enhanced glycemic control and fewer complications. Sustaining these levels via appropriate treatment can lead to better long-term health.",4.026615365066519e-07,0.07761895977603128,0.21806694214876032,0.030828249901291835,0.15472027378993314,0.10969095793038318,0.030783626196198732,0.17240174487558546,0.1039895305467696,4.026615365066519e-07,0.16760127078227383,0.11282578875171474
293,0.5,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is there a connection between low fasting plasma glucose at type 2 diabetes diagnosis and better patient outcomes? Lower fasting plasma glucose levels at diagnosis correspond with improved outcomes, as they reflect better control of blood sugar and decreased complication risk. Managing glucose levels properly can yield better long-term health for those with type 2 diabetes.",2.1317375462116866e-07,0.06723208977897022,0.20932010765090348,0.016320838183036854,0.04022392636150851,0.13456746173015313,0.0162972138685758,0.02203422026443569,0.1262002743484225,2.1317375462116866e-07,0.0005471861191077565,0.11282578875171474
293,0.5,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Does a lower fasting plasma glucose level at the time of type 2 diabetes diagnosis indicate improved outcomes? Yes, it is associated with improved outcomes, demonstrating superior glycemic control and a reduced likelihood of complications. Effective management to keep glucose levels low can enhance long-term health in type 2 diabetes patients.",3.316036182995957e-07,0.017291543611296145,0.24166944444444438,0.025387970506946217,0.05955942594913122,0.13268008212689375,0.025351221573340132,0.07705668237979424,0.1262002743484225,3.316036182995957e-07,0.10164330299047775,0.11282578875171474
293,0.5,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2",Are better outcomes linked to lower fasting plasma glucose levels when type 2 diabetes is first diagnosed? Lower fasting plasma glucose levels at diagnosis are connected to improved outcomes due to better glycemic regulation and less risk of complications. Maintaining these levels through management can improve long-term patient health.,3.789755637709665e-07,0.08360320655748676,0.1989553719008264,0.029014823436509962,0.1614272748082275,0.08954632983120965,0.028972824655245866,0.17988996467336849,0.08281184459635636,3.789755637709665e-07,0.1759349562884358,0.09061504495006185
293,0.5,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is there evidence that lower fasting plasma glucose at diagnosis of type 2 diabetes leads to improved outcomes? Lower fasting plasma glucose at diagnosis is associated with better outcomes, indicating improved blood sugar control and fewer complications. Appropriate management to sustain low glucose levels promotes better long-term health.",4.026615365066519e-07,0.13661020918538824,0.17672471655328792,0.030828249901291835,0.21499394166471086,0.06691158722893455,0.030783626196198732,0.23401482759202485,0.0598737437361776,4.026615365066519e-07,0.23061465083317856,0.06747431482881225
293,0.5,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Do lower fasting plasma glucose levels at the diagnosis of type 2 diabetes relate to improved health outcomes? Yes, they are linked to improved outcomes as they signify better glycemic control and a reduced risk of complications. Maintaining lower glucose through effective management strategies can result in improved long-term health.",3.552895910352811e-07,0.024248889083064995,0.2612006944444444,0.02720139697172809,0.05188699149635889,0.1530793876824493,0.027162023114293,0.0981100915776274,0.1262002743484225,3.552895910352811e-07,0.1231495082114411,0.11282578875171474
293,0.5,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is improved prognosis observed in type 2 diabetes patients diagnosed with lower fasting plasma glucose levels? Lower fasting plasma glucose at diagnosis correlates with better outcomes, reflecting enhanced glycemic control and a decreased risk of complications. Proper management to maintain these levels can lead to improved long-term health.",4.026615365066519e-07,0.07761895977603128,0.21806694214876032,0.030828249901291835,0.15472027378993314,0.10969095793038318,0.030783626196198732,0.17240174487558546,0.1039895305467696,4.026615365066519e-07,0.16760127078227383,0.11282578875171474
294,0.5,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does the position of the head affect the depth of the anterior chamber in pseudoexfoliation syndrome? In patients showing clinically evident unilateral pseudoexfoliation, the lens appears to be more mobile in the affected eye, causing a shallower anterior chamber when the head is prone.",4.737194547137081e-08,0.0805675026012409,0.02502670362358031,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
294,0.5,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? Patients with clinically visible unilateral pseudoexfoliation have a more mobile lens in the affected eye, leading to a shallower anterior chamber when lying prone.",2.6054570009253883e-07,0.25946224600006795,0.014963539718935746,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
294,0.5,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does head posture impact anterior chamber depth in pseudoexfoliation syndrome? In cases of clinically apparent unilateral pseudoexfoliation, the affected eye's lens is more mobile, resulting in a reduced anterior chamber depth when the head is prone.",2.3685972735685353e-07,0.26891816619988873,0.012584669647455422,0.018134264647818733,0.29860247286444963,0.029384756657483937,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
294,0.5,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Can head positioning alter anterior chamber depth in pseudoexfoliation syndrome? The lens in the affected eye of patients with unilateral pseudoexfoliation is more mobile, causing the anterior chamber to become shallower when the head is placed prone.",2.1317375462116823e-07,0.20003864529554471,0.016593194335603353,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
294,0.5,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Is the depth of the anterior chamber affected by head position in pseudoexfoliation syndrome? In unilateral pseudoexfoliation patients, the lens shows increased mobility in the affected eye, which leads to a shallower anterior chamber in the prone position.",1.8948778188548293e-07,0.20906632474046027,0.009529254643988488,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
294,0.5,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does changing head position influence anterior chamber depth in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the lens in the affected eye tends to be more mobile, resulting in a shallower anterior chamber when the head is prone.",1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
294,0.5,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does head orientation affect anterior chamber depth in pseudoexfoliation syndrome? The lens in the affected eye of patients with unilateral pseudoexfoliation shows greater mobility, causing the anterior chamber to be shallower when the head is prone.",2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
294,0.5,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Is anterior chamber depth dependent on head positioning in pseudoexfoliation syndrome? Patients with clinically apparent unilateral pseudoexfoliation have more lens mobility in the affected eye, leading to a shallower anterior chamber when prone.",3.0791764556390943e-07,0.3226352030391513,0.013130814586617377,0.023574544042164372,0.3502024294331152,0.0,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
294,0.5,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does the positioning of the head impact anterior chamber depth in pseudoexfoliation syndrome? In unilateral pseudoexfoliation, the lens is more mobile in the affected eye, resulting in a shallower anterior chamber when the head is in a prone position.",1.6580180914979763e-07,0.21690753899485404,0.034019050562355824,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
294,0.5,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does head placement influence the anterior chamber depth in pseudoexfoliation syndrome? In cases of clinically evident unilateral pseudoexfoliation, the lens in the affected eye is more mobile, causing a shallower anterior chamber when the head is prone.",2.1317375462116823e-07,0.20003864529554471,0.016593194335603353,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
295,0.5,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Does automatic transmission enhance driving behavior in elderly drivers? Research on the exact effects of automatic transmission on older drivers' behavior is scarce. Nonetheless, it is commonly thought that automatic transmission",1.184298636784265e-07,0.0510199101408122,0.06780045351473918,0.009067132323909398,0.07751796750498885,0.05859375,0.009054007704764368,0.12229413125734023,0.0302734375,1.1842986367842703e-07,0.16989903679539697,0.0
295,0.5,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Is driving behavior in older adults improved by automatic transmission? Limited studies exist on the precise influence of automatic transmission on the driving habits of older individuals. Still, it is widely assumed that automatic transmission",2.36859727356853e-08,0.10245773455530571,0.14696180555555555,0.0018134264647818796,0.051693763975018125,0.05859375,0.0018108015409528735,0.011237261367182061,0.0302734375,2.3685972735685406e-08,0.031748698314579826,0.0
295,0.5,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Can automatic transmission positively affect driving behavior among older drivers? There is a lack of extensive research regarding the specific impact of automatic transmission on older drivers' behavior. However, it is generally accepted that automatic transmission",0.0,0.11882523095313413,0.0880165289256198,0.0,0.0815467271246999,0.05859375,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0
295,0.5,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Does the use of automatic transmission benefit the driving behavior of senior drivers? Research specifically addressing how automatic transmission affects older drivers is limited. Yet, it is generally believed that automatic transmission",9.47438909427412e-08,0.014686176709213683,0.07238076364116786,0.007253705859127518,0.04361641582930709,0.05859375,0.007243206163811494,0.08720281144607123,0.0302734375,9.474389094274162e-08,0.1335313926245223,0.0
295,0.5,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Is there an improvement in driving behavior for older drivers when using automatic transmission? Few studies have investigated the particular effects of automatic transmission on older drivers' behavior. Nevertheless, it is commonly believed that automatic transmission",0.0,0.1733835882355459,0.1770088427527874,0.0,0.0815467271246999,0.05859375,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0
295,0.5,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Does automatic transmission contribute to better driving behavior in older adults? Research on the direct impact of automatic transmission on the driving behavior of older adults is limited. However, it is generally thought that automatic transmission",0.0,0.03960841031771123,0.028656492080009283,0.0,0.0815467271246999,0.05859375,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0
295,0.5,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Does automatic transmission lead to improved driving behavior among elderly drivers? There is limited research focused on the specific effect of automatic transmission on driving behavior in older drivers. Still, it is generally considered that automatic transmission",2.36859727356853e-08,0.11110367476650351,0.06230486685032138,0.0018134264647818796,0.11053426399795141,0.05859375,0.0018108015409528735,0.07186188318361753,0.0302734375,2.3685972735685406e-08,0.030771658666753687,0.0
295,0.5,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Can the driving behavior of older drivers be improved by automatic transmission? There is a scarcity of studies on the specific impact of automatic transmission on older drivers' behavior. However, it is generally believed that automatic transmission",2.36859727356853e-08,0.20265469882217912,0.17780045351473922,0.0018134264647818796,0.11053426399795141,0.05859375,0.0018108015409528735,0.07186188318361753,0.0302734375,2.3685972735685406e-08,0.030771658666753687,0.0
295,0.5,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Is automatic transmission associated with enhanced driving behavior in older drivers? Research specifically exploring the impact of automatic transmission on older drivers is limited. Nonetheless, it is generally accepted that automatic transmission",9.47438909427412e-08,0.014686176709213683,0.07238076364116786,0.007253705859127518,0.04361641582930709,0.05859375,0.007243206163811494,0.08720281144607123,0.0302734375,9.474389094274162e-08,0.1335313926245223,0.0
295,0.5,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Does the presence of automatic transmission improve driving behavior in senior drivers? Limited research exists on the specific influence of automatic transmission on older drivers' behavior. However, it is commonly believed that automatic transmission",4.73719454713706e-08,0.01226873407201401,0.0488888888888889,0.003626852929563759,0.02239959347673315,0.027376268210197695,0.003621603081905747,0.020511436947397765,0.0302734375,4.737194547137081e-08,0.06453852113757153,0.0
296,0.5,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does the use of provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program? The Medicaid Demonstration in Florida seems to lower PMPM expenditures. Provider Service Networks (PSNs) showed slightly larger expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for delivering care to Medicaid recipients.,2.3685972735685406e-08,0.005671230627996238,0.016528925619834704,0.0018134264647818726,0.018133879844112855,0.00031297436329903727,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
296,0.5,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with lower spending compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration appears to reduce PMPM costs. Demonstration PSNs achieved marginally greater expenditure reductions than Demonstration HMOs. PSNs present a promising approach for Medicaid care delivery.,2.8423167282822487e-07,0.19023356724713203,0.029841852872155912,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
296,0.5,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks reduce expenditures more than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida results in lower PMPM expenditures. Demonstration PSNs produced slightly higher reductions in costs relative to Demonstration HMOs. PSNs seem to be a promising model for Medicaid care.,2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.5,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is there a cost advantage to provider service networks over HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration shows reduced PMPM expenditures. PSNs in the Demonstration achieved slightly greater cost savings than Demonstration HMOs. PSNs appear to be an effective care delivery model for Medicaid enrollees.,1.8948778188548325e-07,0.1044410115930905,0.031578577796441576,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.5,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks lead to lower Medicaid expenditures compared to HMOs or primary care case management in Florida? The Medicaid Demonstration in Florida shows decreased PMPM spending. Demonstration PSNs reduced expenditures slightly more than Demonstration HMOs. PSNs are a promising method for providing care to Medicaid enrollees.,2.6054570009253947e-07,0.13859052808878003,0.05157024793388431,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
296,0.5,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration results in reduced PMPM costs. Demonstration PSNs generated somewhat greater reductions than Demonstration HMOs. PSNs seem to be a viable model for Medicaid care delivery.,2.8423167282822487e-07,0.19023356724713203,0.029841852872155912,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
296,0.5,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does Florida's Medicaid program see lower expenses with provider service networks compared to HMOs or primary care case management? The Medicaid Demonstration in Florida appears to lower PMPM expenditures. Demonstration PSNs achieved marginally greater expenditure reductions than Demonstration HMOs. PSNs are a promising approach for delivering Medicaid care.,2.6054570009253947e-07,0.13859052808878003,0.05157024793388431,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
296,0.5,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks outperform HMOs or primary care case management in reducing expenditures in Florida's Medicaid program? The Medicaid Demonstration in Florida results in lower PMPM costs. Demonstration PSNs have slightly greater expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for Medicaid care delivery.,2.3685972735685406e-07,0.11753711889094687,0.05157024793388431,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
296,0.5,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are costs lower under provider service networks than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida shows reduced PMPM expenditures. Demonstration PSNs produced slightly larger cost reductions than Demonstration HMOs. PSNs appear to be a promising Medicaid care model.,3.079176455639103e-07,0.1820756400285184,0.05157024793388431,0.023574544042164344,0.2345406802124308,0.017538265306122455,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
296,0.5,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks result in decreased expenditures compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration appears to lower PMPM costs. Demonstration PSNs achieved somewhat greater reductions in expenditures than Demonstration HMOs. PSNs seem to be a promising model for Medicaid care delivery.,2.1317375462116866e-07,0.1252095533437192,0.031170942378328754,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
297,0.5,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers release GABA? Answer: We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. The physiological function of this mossy fiber GABAergic signal remains unclear, though it might play a role in development. Additional data also imply that this",9.474389094274162e-08,0.12684896146452207,0.02577160493827161,0.0072537058591274906,0.12690248065430154,0.024375,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
297,0.5,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Are mossy fibers capable of releasing GABA? Answer: Our findings strongly support the existence of a GABAergic signal from mossy fibers. While the exact physiological purpose of this mossy fiber GABAergic signal is not fully understood, it could be important during development. Further evidence suggests that this",1.1842986367842703e-07,0.1489963759181956,0.026233459357277902,0.009067132323909363,0.14888138737307655,0.024375,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
297,0.5,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Is GABA released by mossy fibers? Answer: We have demonstrated convincing evidence of a mossy fiber GABAergic signal. The physiological significance of this signal is still uncertain, but it may have developmental relevance. Other research also indicates that this",7.105791820705611e-08,0.008093954957539395,0.04750000000000001,0.005440279394345618,0.042173849389631535,0.024375,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
297,0.5,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers emit GABA? Answer: Compelling evidence has been provided showing a GABAergic signal originating from mossy fibers. The role of this mossy fiber GABAergic signal in physiology is not yet clear, although it might be crucial during development. Additional findings suggest that this",7.105791820705622e-08,0.10420034732491601,0.025289256198347116,0.005440279394345618,0.10442962480224383,0.024375,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.5,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers a source of GABA release? Answer: We have supplied strong evidence for a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is uncertain but could be important for development. Other studies also point to this,4.737194547137081e-08,0.0810273428056254,0.024785018929150898,0.0036268529295637453,0.0814401065775443,0.024375,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
297,0.5,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Do mossy fibers discharge GABA? Answer: Evidence strongly supports the existence of a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal remains unknown but may be significant in developmental processes. Other data further suggest that this,0.0,0.03300700859809247,0.023704640095181452,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0
297,0.5,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Is there GABA release from mossy fibers? Answer: We have provided convincing evidence confirming a mossy fiber GABAergic signal. Though the physiological function of this signal is unclear, it might be relevant for development. Additional evidence indicates that this",7.105791820705611e-08,0.008093954957539395,0.04750000000000001,0.005440279394345618,0.042173849389631535,0.024375,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
297,0.5,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers secrete GABA? Answer: Strong evidence has been presented that mossy fibers have a GABAergic signal. The physiological importance of this mossy fiber GABAergic signal is uncertain, though it could be significant during development. Other evidence also suggests that this",0.0,0.03300700859809247,0.023704640095181452,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0
297,0.5,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Can mossy fibers release GABA? Answer: We have shown compelling evidence for a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is not well defined but may be important developmentally. Further evidence suggests that this,2.3685972735685406e-08,0.008104408028834165,0.023125000000000007,0.0018134264647818726,0.009119444997918169,0.024375,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
297,0.5,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers involved in GABA release? Answer: There is strong evidence indicating a mossy fiber GABAergic signal. The physiological role of this signal is uncertain but might hold developmental importance. Other evidence supports this,1.6580180914979731e-07,0.1163075395977704,0.04750000000000001,0.012693985253473115,0.15339948449985608,0.024375,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
298,0.5,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","What is the prognosis for low-tone sudden deafness—does it always lead to Meniere's disease? There is no certainty that low-tone sudden deafness will develop into Meniere's disease. Although it can happen in some instances, it is not a definite result. The outlook varies for each case.",2.3685972735685406e-08,0.06776188767256075,0.06395705665186187,0.0018134264647818726,0.03914022686438168,0.04434829637641968,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
298,0.5,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness inevitably progress to Meniere's disease? There is no assurance that low-tone sudden deafness will evolve into Meniere's disease. While it may occur in certain cases, it is not a guaranteed progression. Each patient's prognosis differs.",1.8948778188548304e-07,0.14347076212472576,0.033698664651045616,0.014507411718254981,0.17159890957505697,0.017342123536913518,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
298,0.5,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Is progression from low-tone sudden deafness to Meniere's disease inevitable? Low-tone sudden deafness does not necessarily lead to Meniere's disease. Some cases may progress, but it is not an absolute outcome. The prognosis is individual-specific.",2.8423167282822424e-07,0.30405362681042547,0.0012411485579316567,0.021761117577382486,0.29055076562133575,0.014074858876419682,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
298,0.5,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness always result in Meniere's disease? There is no definite link that low-tone sudden deafness will advance to Meniere's disease. Although possible in some patients, it is not a universal progression. Prognosis depends on the individual.",1.8948778188548304e-07,0.14347076212472576,0.033698664651045616,0.014507411718254981,0.17159890957505697,0.017342123536913518,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
298,0.5,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Will low-tone sudden deafness inevitably develop into Meniere's disease? There is no guarantee that low-tone sudden deafness will turn into Meniere's disease. It may happen occasionally, but it is not a certain consequence. Prognosis varies per patient.",2.3685972735685364e-07,0.24009965237675335,0.003523172354341214,0.018134264647818726,0.22930975588217795,0.015801583573651523,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
298,0.5,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Is it certain that low-tone sudden deafness progresses to Meniere's disease? Low-tone sudden deafness does not inevitably become Meniere's disease. While some cases do progress, this is not always the case. Each prognosis is unique.",2.8423167282822424e-07,0.2632802632480771,0.027574050453514756,0.021761117577382486,0.29055076562133575,0.014074858876419682,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
298,0.5,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness always progress to Meniere's disease? There is no certainty that low-tone sudden deafness will lead to Meniere's disease. It may occur in some instances, but not universally. Prognosis is case-dependent.",3.0791764556390954e-07,0.3376132593748671,0.003832199546485282,0.023574544042164365,0.3226352030391513,0.013130814586617377,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
298,0.5,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Can low-tone sudden deafness inevitably result in Meniere's disease? There is no assurance that low-tone sudden deafness will develop into Meniere's disease. Some patients may experience this progression, but it is not guaranteed. Prognosis varies individually.",2.6054570009253894e-07,0.23196281988554768,0.02923483442963965,0.019947691112600606,0.25946224600006795,0.014963539718935746,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
298,0.5,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Is progression from low-tone sudden deafness to Meniere's disease guaranteed? Low-tone sudden deafness does not always progress to Meniere's disease. Although it can happen, it is not inevitable. Prognosis is specific to each case.",3.0791764556390954e-07,0.3376132593748671,0.003832199546485282,0.023574544042164365,0.3226352030391513,0.013130814586617377,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
298,0.5,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness necessarily lead to Meniere's disease? There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While it may in some cases, it is not a universal outcome. Prognosis depends on the individual.",1.8948778188548304e-07,0.179952192680513,0.00780045351473925,0.014507411718254981,0.17159890957505697,0.017342123536913518,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
299,0.5,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Is it possible to use mental imagery functional magnetic resonance imaging to predict recovery in patients with disorders of consciousness? Answer: The fMRI mental imagery paradigm shows strong agreement with the subsequent clinical progression of patients in a vegetative state (VS). All five VS patients who exhibited significant activation in regions of interest (ROIs) experienced a favorable clinical course through the observation period. Therefore, we",9.474389094274162e-08,0.11036421136925245,0.0336678921113258,0.0072537058591274906,0.08764342715623652,0.016661878770468257,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
299,0.5,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can functional magnetic resonance imaging of mental imagery forecast recovery in patients suffering from disorders of consciousness? Answer: The mental imagery fMRI paradigm demonstrates high consistency with the later clinical outcomes of patients in a vegetative state. Each of the five VS patients who showed notable activation in regions of interest had a positive clinical progression by the end of the study period. Hence, we",9.474389094274162e-08,0.08903660581356299,0.018310530271914125,0.0072537058591274906,0.08764342715623652,0.016661878770468257,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
299,0.5,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Does mental imagery fMRI have predictive value for recovery in patients with consciousness disorders? Answer: The mental imagery paradigm using fMRI correlates strongly with the subsequent clinical trajectory of patients in a vegetative state. All five VS patients who showed significant activation in targeted brain regions experienced favorable outcomes by the end of the observation. Thus, we",9.474389094274162e-08,0.0239651388400004,0.03151048618020334,0.0072537058591274906,0.04588796546828533,0.016661878770468257,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
299,0.5,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery functional MRI predict recovery in patients diagnosed with disorders of consciousness? Answer: The fMRI mental imagery paradigm aligns well with the future clinical course of patients in a vegetative state. All five VS patients who demonstrated significant activation in regions of interest subsequently had a favorable clinical course until the observation period ended. Consequently, we",7.105791820705622e-08,0.030055696255994135,0.014609975976121709,0.005440279394345618,0.02818838836888471,0.016661878770468257,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
299,0.5,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Is mental imagery fMRI effective in predicting recovery among patients with disorders of consciousness? Answer: The fMRI mental imagery paradigm exhibits strong concordance with the later clinical progression of patients in a vegetative state. All five VS patients who showed significant ROI activation had a positive clinical course throughout the observation period. Therefore, we",1.6580180914979784e-07,0.07938352420493455,0.03053682553402962,0.012693985253473108,0.1009477426513139,0.016661878770468257,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
299,0.5,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery functional magnetic resonance imaging serve as a predictor for recovery in patients with consciousness disorders? Answer: The fMRI mental imagery paradigm shows a high degree of agreement with the future clinical course of patients in a vegetative state. Each of the five VS patients with significant activation of brain regions of interest had a favorable clinical outcome by the end of the observation period. Accordingly, we",1.8948778188548325e-07,0.13113738375178752,0.005660321734259677,0.014507411718254981,0.14826804897267376,0.016661878770468257,0.014486412327622933,0.12715517548524602,0.0,1.8948778188548325e-07,0.1292117314800052,0.0
299,0.5,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Does mental imagery fMRI predict recovery outcomes in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm has a strong correlation with the subsequent clinical course of patients in a vegetative state. All five VS patients exhibiting significant activation in regions of interest enjoyed favorable outcomes until the observation period concluded. Thus, we",1.4211583641411244e-07,0.08577297177894527,0.012736896733744812,0.010880558788691236,0.10792772743767642,0.0018500471818279247,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
299,0.5,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can the mental imagery fMRI paradigm predict recovery in patients with disorders of consciousness? Answer: The fMRI mental imagery paradigm shows high concordance with the later clinical progression of patients in a vegetative state. All five VS patients with significant ROI activation experienced favorable clinical outcomes through the observation period. Therefore, we",2.1317375462116866e-07,0.1447707482784919,0.01064875148632579,0.016320838183036854,0.1394140234791097,0.016661878770468257,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
299,0.5,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Is functional magnetic resonance imaging of mental imagery predictive of recovery in patients with consciousness disorders? Answer: The mental imagery fMRI paradigm demonstrates strong agreement with the subsequent clinical course of patients in a vegetative state. All five VS patients who exhibited significant activation in regions of interest had favorable clinical progression until the end of the observation period. Hence, we",0.0,0.04545227413507824,0.0326598625974369,0.0,0.02310490601866455,0.016661878770468257,0.0,0.0,0.0,0.0,0.0,0.0
299,0.5,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery-based fMRI predict recovery in patients with disorders of consciousness? Answer: The fMRI mental imagery paradigm exhibits a high level of concordance with the future clinical course of patients in a vegetative state. All five VS patients showing significant activation in regions of interest had a positive clinical course by the conclusion of the observation period. Therefore, we",2.3685972735685406e-08,0.02854420323274187,0.032386872715857544,0.0018134264647818726,0.006297787702283841,0.016661878770468257,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
